
<html lang="en"     class="pb-page"  data-request-id="68c6548d-fdd4-46e7-9be4-321e5f61c29f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.9b00875;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery" /></meta><meta name="dc.Creator" content="Nenad  Manevski" /></meta><meta name="dc.Creator" content="Lloyd  King" /></meta><meta name="dc.Creator" content="William R.  Pitt" /></meta><meta name="dc.Creator" content="Fabien  Lecomte" /></meta><meta name="dc.Creator" content="Francesca  Toselli" /></meta><meta name="dc.Description" content="Aldehyde oxidase (AO) catalyzes oxidations of azaheterocycles and aldehydes, amide hydrolysis, and diverse reductions. AO substrates are rare among marketed drugs, and many candidates failed due to..." /></meta><meta name="Description" content="Aldehyde oxidase (AO) catalyzes oxidations of azaheterocycles and aldehydes, amide hydrolysis, and diverse reductions. AO substrates are rare among marketed drugs, and many candidates failed due to..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 6, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00875" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00875" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00875" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00875" /></link>
        
    
    

<title>Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00875" /></meta><meta property="og:title" content="Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0030.jpeg" /></meta><meta property="og:description" content="Aldehyde oxidase (AO) catalyzes oxidations of azaheterocycles and aldehydes, amide hydrolysis, and diverse reductions. AO substrates are rare among marketed drugs, and many candidates failed due to poor pharmacokinetics, interspecies differences, and adverse effects. As most issues arise from complex and poorly understood AO biology, an effective solution is to stop or decrease AO metabolism. This perspective focuses on rational drug design approaches to modulate AO-mediated metabolism in drug discovery. AO biological aspects are also covered, as they are complementary to chemical design and important when selecting the experimental system for risk assessment. The authors’ recommendation is an early consideration of AO-mediated metabolism supported by computational and in vitro experimental methods but not an automatic avoidance of AO structural flags, many of which are versatile and valuable building blocks. Preferably, consideration of AO-mediated metabolism should be part of the multiparametric drug optimization process, with the goal to improve overall drug-like properties." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00875"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00875">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00875&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00875&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00875&amp;href=/doi/10.1021/acs.jmedchem.9b00875" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10955-10994</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00446" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b00885" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Nenad Manevski</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nenad Manevski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCB Celltech, 208 Bath Road, Slough SL13WE, United Kingdom</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +447901253248. E-mail: <a href="/cdn-cgi/l/email-protection#ea848f848b8ec4878b848f9c998183aa9f8988c4898587"><span class="__cf_email__" data-cfemail="d4bab1bab5b0fab9b5bab1a2a7bfbd94a1b7b6fab7bbb9">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nenad++Manevski">Nenad Manevski</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8387-3023" title="Orcid link">http://orcid.org/0000-0001-8387-3023</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lloyd King</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lloyd King</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCB Celltech, 208 Bath Road, Slough SL13WE, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lloyd++King">Lloyd King</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">William R. Pitt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">William R. Pitt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCB Celltech, 208 Bath Road, Slough SL13WE, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=William+R.++Pitt">William R. Pitt</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8164-4550" title="Orcid link">http://orcid.org/0000-0001-8164-4550</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fabien Lecomte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabien Lecomte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCB Celltech, 208 Bath Road, Slough SL13WE, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabien++Lecomte">Fabien Lecomte</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Francesca Toselli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francesca Toselli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCB BioPharma, Chemin du Foriest 1, 1420 Braine-l’Alleud, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francesca++Toselli">Francesca Toselli</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00875&amp;href=/doi/10.1021%2Facs.jmedchem.9b00875" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10955–10994</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 6, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 May 2019</li><li><span class="item_label"><b>Published</b> online</span>6 August 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00875</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10955%26pageCount%3D40%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNenad%2BManevski%252C%2BLloyd%2BKing%252C%2BWilliam%2BR.%2BPitt%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D24%26contentID%3Dacs.jmedchem.9b00875%26title%3DMetabolism%2Bby%2BAldehyde%2BOxidase%253A%2BDrug%2BDesign%2Band%2BComplementary%2BApproaches%2Bto%2BChallenges%2Bin%2BDrug%2BDiscovery%26numPages%3D40%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10994%26publicationDate%3DDecember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00875"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6438</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00875" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nenad&quot;,&quot;last_name&quot;:&quot;Manevski&quot;},{&quot;first_name&quot;:&quot;Lloyd&quot;,&quot;last_name&quot;:&quot;King&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;R. Pitt&quot;},{&quot;first_name&quot;:&quot;Fabien&quot;,&quot;last_name&quot;:&quot;Lecomte&quot;},{&quot;first_name&quot;:&quot;Francesca&quot;,&quot;last_name&quot;:&quot;Toselli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;10955-10994&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00875&quot;},&quot;abstract&quot;:&quot;Aldehyde oxidase (AO) catalyzes oxidations of azaheterocycles and aldehydes, amide hydrolysis, and diverse reductions. AO substrates are rare among marketed drugs, and many candidates failed due to poor pharmacokinetics, interspecies differences, and adverse effects. As most issues arise from complex and poorly understood AO biology, an effective solution is to stop or decrease AO metabolism. This perspective focuses on rational drug design approaches to modulate AO-mediated metabolism in drug discovery. AO biological aspects are also covered, as they are complementary to chemical design and important when selecting the experimental system for risk assessment. The authors’ recommendation is an early consideration of AO-mediated metabolism supported by computational and in vitro experimental methods but not an automatic avoidance of AO structural flags, many of which are versatile and valuable building blocks. Preferably, consideration of AO-mediated metabolism should be part of the multiparametric drug optimi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00875&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00875" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00875&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00875" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00875&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00875" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00875&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00875&amp;href=/doi/10.1021/acs.jmedchem.9b00875" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00875" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00875" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00875%26sid%3Dliteratum%253Aachs%26pmid%3D31385704%26genre%3Darticle%26aulast%3DManevski%26date%3D2019%26atitle%3DMetabolism%2Bby%2BAldehyde%2BOxidase%253A%2BDrug%2BDesign%2Band%2BComplementary%2BApproaches%2Bto%2BChallenges%2Bin%2BDrug%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D24%26spage%3D10955%26epage%3D10994%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=291208" title="Hydrolysis">Hydrolysis</a>,</li><li><a href="/action/doSearch?ConceptID=291091" title="Oxidation">Oxidation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/jmcmar.2019.62.issue-24/20191226/jmcmar.2019.62.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0030.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Aldehyde oxidase (AO) catalyzes oxidations of azaheterocycles and aldehydes, amide hydrolysis, and diverse reductions. AO substrates are rare among marketed drugs, and many candidates failed due to poor pharmacokinetics, interspecies differences, and adverse effects. As most issues arise from complex and poorly understood AO biology, an effective solution is to stop or decrease AO metabolism. This perspective focuses on rational drug design approaches to modulate AO-mediated metabolism in drug discovery. AO biological aspects are also covered, as they are complementary to chemical design and important when selecting the experimental system for risk assessment. The authors’ recommendation is an early consideration of AO-mediated metabolism supported by computational and in vitro experimental methods but not an automatic avoidance of AO structural flags, many of which are versatile and valuable building blocks. Preferably, consideration of AO-mediated metabolism should be part of the multiparametric drug optimization process, with the goal to improve overall drug-like properties.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Aldehyde oxidase (AO, EC1.2.3.1) is a cytosolic molybdenum-containing enzyme involved in the biotransformation of numerous drugs and xenobiotics.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> Although structurally similar to xanthine oxidoreductase (XO),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> AO has a significantly broader substrate selectivity and can catalyze four distinct reactions types: oxidations of azaheterocycles,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> oxidations of aldehydes,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> hydrolysis of amides,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and various reductions.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Each reaction type presents a unique set of challenges and opportunities in drug discovery and development (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Oxidations of azaheterocycles have been reported to contribute to high metabolic clearance and interspecies differences, resulting in the termination of several drug discovery programs in the past, including carbazeran,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> BIBX1382,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and Lu AF09535.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> AO-mediated oxidations of aldehydes in vitro have been described previously, both for endogenous and xenobiotic substrates, but their impact on drug disposition was recognized only recently (e.g., imrecoxib).<a onclick="showRef(event, 'ref8 ref15'); return false;" href="javascript:void(0);" class="ref ref8 ref15">(8,15)</a> Hydrolysis of amides by AO, first described in 2015,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> has also been found to contribute to high metabolic clearance and, depending on the drug of interest, a release of aryl-amine fragments that may be prone to bioactivation. Finally, AO-catalyzed reductions are diverse, affecting mainly nitro, <i>N</i>-oxide, and isoxazole moieties and are mainly of interest from the perspective of bioactivation.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Selected Examples of AO-Related Challenges Experienced in Drug Discovery and Development</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">reaction type</th><th class="colsep0 rowsep0" align="center">observed challenges</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carbazeran</td><td class="colsep0 rowsep0" rowspan="5" align="center" valign="middle">oxidation of azaheterocycle</td><td class="colsep0 rowsep0" rowspan="5" align="center" valign="middle">high metabolic clearance in humans due to oxidations by AO</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIBX1382</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FK3453</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lu AF09535</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RO-1</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNJ-38877605</td><td class="colsep0 rowsep0" align="center">oxidation of azaheterocycle</td><td class="colsep0 rowsep0" align="center">renal toxicity in humans due to accumulation of insoluble AO metabolite; renal toxicity had not been observed in nonclinical studies in rats and dogs</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SGX523</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">high clearance in humans due to AO metabolism; renal toxicity in humans due to accumulation of insoluble AO metabolite</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">momelotinib</td><td class="colsep0 rowsep0" align="center">oxidation of azaheterocycle</td><td class="colsep0 rowsep0" align="center">disproportionate human metabolite due to oxidations by AO [metabolites in safety testing (MIST) issue]</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BILR 355</td><td class="colsep0 rowsep0" align="center">oxidation of azaheterocycle</td><td class="colsep0 rowsep0" align="center">disproportionate human metabolite due to oxidations by AO (MIST issue)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">imidazoquinoline-containing cancer Osaka thyroid kinase inhibitors</td><td class="colsep0 rowsep0" align="center">oxidation of azaheterocycle</td><td class="colsep0 rowsep0" align="center">rapid metabolism by AO in rats prevents pharmacological studies</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pyridine-containing toll-like receptor subtype 7 agonist</td><td class="colsep0 rowsep0" align="center">oxidation of azaheterocycle</td><td class="colsep0 rowsep0" align="center">rapid metabolism by AO in rats prevents toxicological studies</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VX-509 (decernotinib)</td><td class="colsep0 rowsep0" align="center">oxidation of azaheterocycle</td><td class="colsep0 rowsep0" align="center">AO metabolite is a time-dependent inhibitor of CYP3A4, leading to clinically relevant drug−drug interactions</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dantrolene</td><td class="colsep0 rowsep0" align="center">reduction of nitro group</td><td class="colsep0 rowsep0" align="center">bioactivation via AO-mediated nitro reduction and subsequent liver injury</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">imrecoxib</td><td class="colsep0 rowsep0" align="center">aldehyde oxidation</td><td class="colsep0 rowsep0" align="center">in vitro−in vivo disconnect in metabolite abundance due to AO-mediated aldehyde oxidation</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GDC-0834</td><td class="colsep0 rowsep0" align="center">hydrolysis of amide</td><td class="colsep0 rowsep0" align="center">high metabolic clearance in humans due to AO-mediated amide hydrolysis</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td></tr></tbody></table></div></div><div class="NLM_p">The challenge represented by AO-mediated metabolism is driven by several overlapping factors, including the complex biology of the enzyme (<a class="ref internalNav" href="#sec7" aria-label="section 7">section 7</a>), the widespread use of structural motifs that are AO substrates (e.g., azaheterocycle and amides), and common approaches to reduce cytochrome P450 (CYP)-mediated metabolism [e.g., reduction of log <i>D</i> and introduction of electron-withdrawing groups (EWG)]. The limited understanding of AO biology compared to other drug-metabolizing enzymes, such as CYPs or UDP-glucuronosyltransferases (UGTs), makes it a challenge to accurately predict human pharmacokinetics (PK) of drug candidates primarily metabolized by AO, which is reflected by the small number of marketed drugs that are AO substrates. Until a better understanding of AO activity in various tissues, and of how this is affected by genetic polymorphisms and extrinsic factors, is established for humans and nonclinical species, compounds with lower AO-mediated clearance and diversified biotransformation pathways are more likely predicted to have an acceptable human PK and safety. Therefore, it is essential to identify, assess, and modify structural features of drug candidates that lead to AO-mediated metabolism so that elimination pathways can be diversified to include other xenobiotic-metabolizing enzymes.</div><div class="NLM_p">This perspective focuses on rational drug design approaches to control AO metabolism, either by mitigation (e.g., stop, decrease, diversify) or utilization (e.g., design of a prodrug or a modified scaffold) of the enzymatic reaction. AO-mediated xenobiotic metabolism has been extensively reported previously by various groups, but only a few reviews and perspectives focused on drug design have been published,<a onclick="showRef(event, 'ref7 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref7 ref27 ref28">(7,27,28)</a> often discussing exclusively AO-mediated oxidations. The authors’ motivation arose from our experience at UCB and published examples showing that AO-mediated metabolism is best approached at the drug design stage<a onclick="showRef(event, 'ref7 ref24 ref29'); return false;" href="javascript:void(0);" class="ref ref7 ref24 ref29">(7,24,29)</a> as an integral part of the multiparametric optimization process to increase the overall drug-like properties of the compound. Later, during the drug development stage, approaches to assess and predict AO-mediated metabolism in humans are also possible and have been applied, but success has been limited due to an insufficient understanding of AO biology, which has often resulted in poor predictions of human PK by in vitro−in vivo extrapolation (IVIVE) or allometric scaling.</div><div class="NLM_p">The rational drug design aspect of this review focuses on arguably the most common reaction catalyzed by AO in the drug-like chemical space,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> namely the AO-mediated oxidations of electron-deficient azaheterocycles via a nucleophilic mechanism (see graphical abstract). Oxidations of azaheterocycles were historically perceived mainly as a risk for high metabolic clearance in humans. Recent examples have significantly broadened this view to include evidence for renal toxicity due to the formation of insoluble crystalline metabolites,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> metabolites in safety testing (MIST)-related issues,<a onclick="showRef(event, 'ref22 ref30'); return false;" href="javascript:void(0);" class="ref ref22 ref30">(22,30)</a> interspecies differences,<a onclick="showRef(event, 'ref7 ref24'); return false;" href="javascript:void(0);" class="ref ref7 ref24">(7,24)</a> as well as AO-derived metabolites leading to time-dependent inactivation of CYP3A4 (vide infra).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Despite these discouraging examples, AO should not be perceived as an enemy of drug design teams. Oxidative metabolites formed by AO are often metabolically stable (authors’ unpublished observations) and, if pharmacologically active, may provide valuable inspiration for novel scaffolds and improved drug design.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> On the other hand, high turnover of AO substrates enables the potential for a prodrug approach, as exemplified by 5-fluoro-2-pyrimidinone,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> famciclovir,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and fasudil.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In addition, the current perspective will also cover reactions of aldehyde oxidation, amide hydrolysis, and reductions, albeit in less detail, proportional to the number of examples available in the literature. For these reactions, focus will often be placed on safety and drug developability (e.g., interspecies difference and MIST) not high metabolic clearance per se.</div><div class="NLM_p">Although designing away from, or at least reducing, the propensity of drug candidates to be metabolized by AO is desirable in drug discovery, the task faced by design teams is difficult. First, AO structural flags are very common (e.g., azaheterocycles and amides), usually covering a large proportion of the chemical space (see <a class="ref internalNav" href="#sec3_1" aria-label="section 3.1">section 3.1</a>). Second, due to opposing catalytic mechanisms (e.g., electrophilic vs nucleophilic oxidation), common strategies to reduce oxidative metabolism (especially if CYP-mediated) will usually favor AO-mediated metabolism.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Third, directly blocking sites susceptible to attack by AO with bulky groups may alter key pharmacophores and erode ligand efficiency by increasing the molecular weight and log <i>D</i>, ultimately degrading the overall drug-like properties.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Therefore, designing away from AO-mediated metabolism requires a thoughtful approach based on understanding and application of several overlapping factors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), including the catalytic mechanism, substrate specificity, structure−activity relationship (SAR) with the therapeutic target, AO biology, and various supporting tools (e.g., computational and experimental methods to assess metabolism by AO). Although the focus is on human AO, examples of AO-mediated metabolism in nonclinical species are also provided, especially when available human data are limited and interspecies differences played a major role in the decision making. Emphasis is also placed on preservation of the key drug-like properties, including lipophilicity, solubility, permeability, ligand efficiency, and recognition and (if possible) removal of known structural alerts.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Factors influencing AO-mediated metabolism and drug design. Representation of AO-catalyzed sites of oxidation on quinazoline is prepared based on transition state energies calculated in Montefiori et al. 2017.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Drawings of human body and mouse are authored by Mikael Häggström and David Liao, respectively, and are freely provided for reuse under the Creative Commons license. Drug disappearance and metabolite appearance curves are simulated with GraphPad Prism 8.1 (GraphPad Software). Representation of AO active site is prepared based on published cocrystal structure of human AO (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UHX">4UHX</a>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> using the PyMOL 2.3 software (Schrödinger, Inc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A summary of factors influencing AO drug design is presented in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. <a class="ref internalNav" href="#sec2" aria-label="Section 2">Section 2</a> covers the structure and catalytic mechanisms of AO, providing a rational basis for further discussion. Reactions catalyzed by AO and their substrate specificity are covered in <a class="ref internalNav" href="#sec3" aria-label="section 3">section 3</a>, including examples of oxidation, hydrolysis, and reduction. <a class="ref internalNav" href="#sec4" aria-label="Section 4">Section 4</a> explores computational approaches to evaluate metabolism by AO, even before the compound is synthesized. <a class="ref internalNav" href="#sec5" aria-label="Section 5">Section 5</a> summarizes key chemical design approaches to control AO-mediated metabolism, including methods to stop, decrease, or utilize AO-catalyzed reactions. <a class="ref internalNav" href="#sec6" aria-label="Section 6">Section 6</a> is dedicated to examples of drug discovery programs that tackled AO metabolism, providing a valuable insight into challenges, pitfalls, and opportunities encountered by design teams. Finally, <a class="ref internalNav" href="#sec7" aria-label="section 7">section 7</a> and <a class="ref internalNav" href="#sec8" aria-label="8">8</a> provide in-depth information about AO biology, including reported suggestions of AO as a therapeutic target and experimental assessment, complementing the drug design approaches.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Enzyme Structure and Catalytic Mechanism of AO</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Understanding of AO structure and catalytic mechanism is important to support rational drug design. Additionally, it is beneficial to appreciate differences and similarities between AO and other key drug-metabolizing enzymes (e.g., CYPs and various hydrolases) so that medicinal chemistry design can be driven on a balance of overall biotransformation liabilities.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.1.  Structure of Human AO</h3><div class="NLM_p">Human AO is a butterfly shaped homodimer with approximate dimensions of 150 Å × 90 Å × 65 Å (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref2 ref3 ref37'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref37">(2,3,37)</a> Each monomer can be further divided into three distinct domains: (I) a small N-terminal domain (20 kDa), which harbors the two [2Fe-2S] clusters, (II) the central domain with flavin adenine dinucleotide (FAD) cofactor stacked between two leucine residues (40 kDa), and (III) the large C-terminal domain (90 kDa) containing the molybdenum pyranopterin cofactor (MoCo) and the substrate binding site (for reactions of oxidation and hydrolysis; reductions likely occur at the FAD-binding site<a onclick="showRef(event, 'ref3 ref10'); return false;" href="javascript:void(0);" class="ref ref3 ref10">(3,10)</a>). The three domains are connected by two linker regions bridging domains I/II and domains II/III.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of human AO (A) and its MoCo active site (B). Representations are prepared based on published cocrystal structure of human AO (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UHX">4UHX</a>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> using the PyMOL 2.3 software (Schrödinger, Inc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Substrate access to and product release from the MoCo active site are governed by a funnel that leads into the active site cavity.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Features of this funnel are defined by two flexible loops on the surface of the protein, gates 1 and 2, and the amino acid composition of these loops may explain unique substrate specifies of various mammalian AO enzymes.<a onclick="showRef(event, 'ref3 ref37'); return false;" href="javascript:void(0);" class="ref ref3 ref37">(3,37)</a> Gate 1 is predominantly composed of hydrophobic residues, whereas gate 2 is a short, dynamic loop characterized by the presence of residue Phe885, the second residue after the gate, which interacts with the substrate molecule, oriening it toward the catalytic site.<a onclick="showRef(event, 'ref3 ref37'); return false;" href="javascript:void(0);" class="ref ref3 ref37">(3,37)</a> At the MoCo active site (reactions of oxidations and hydrolysis), important and conserved residues are Glu1270, Phe923, Lys893, and Gln776.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Glu1270 and Lys893 are believed to be directly involved in the catalytic mechanism by providing hydrogen bonding to stabilize the transition state (see <a class="ref internalNav" href="#sec2_2" aria-label="section 2.2">section 2.2</a>). On the other hand, two conserved aromatic residues, Phe885 and Phe923, are likely important for the substrate orientation toward the MoCo.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In addition to the MoCo active site, human AO is thought to have an allosteric inhibitor binding site (occupied by thioridazine in the available crystal structure)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and FAD active site responsible for reduction reactions.<a onclick="showRef(event, 'ref3 ref10'); return false;" href="javascript:void(0);" class="ref ref3 ref10">(3,10)</a> The structure, sequence conservation, single nucleotide polymorphisms, and evolution of mammalian AO and related proteins have been extensively reviewed elsewhere.<a onclick="showRef(event, 'ref3 ref4 ref38'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref38">(3,4,38)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2.  Catalytic Mechanism of AO</h3><div class="NLM_p">Although catalyzed by the same enzyme, reactions of oxidation, hydrolysis, and reduction by AO have a few differences that deserve to be clarified. Moreover, it is worth highlighting differences between AO and other common drug-metabolizing enzymes, especially CYPs, flavin-containing monooxygenases (FMOs), and hydrolytic enzymes.</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7">2.2.1.  Reactions of Oxidation</h4><div class="NLM_p">In the first step, the site of oxidation, i.e., the electrophilic carbon of the azaheterocycle or aldehyde, is attacked by the nucleophilic −OH ligand of the MoCo ligand (Mo<sup>VI</sup>), likely further activated by Glu1270 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, step i). According to the concerted mechanism hypothesis, hydride transfer to MoCo’s sulfido ligand occurs simultaneously (via a tetrahedral intermediate) to form a transition state stabilized by hydrogen bonding from Glu1270 and Lys893.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> The concerted mechanism is supported by the enzyme kinetic studies (N-substituted heterocycles and deuterium isotope effects) and density functional theory calculations<a onclick="showRef(event, 'ref36 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref36 ref40 ref41">(36,40,41)</a> (see <a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a> for more details). Hydride abstraction and transfer to S of MoCo is likely the rate-limiting step in the formation of the transition stage,<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> opening a possibility for the kinetic deuterium isotope effects (KDIE) to decrease the rate of AO-catalyzed oxidations (<a class="ref internalNav" href="#sec5_3" aria-label="section 5.3">section 5.3</a>). In the second step (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, step ii), a molecule of water hydrolyzes the transition state intermediate, releasing the oxidized product and the reduced MoCo (Mo<sup>IV</sup>). Within each catalytic cycle, oxygen from MoCo is incorporated into the substrate and additional oxygen from H<sub>2</sub>O replenishes the vacant coordination position on the MoCo. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the oxygen that is incorporated into the product is derived from one of two sources: the initial −OH ligand of the MoCo from AO in the first-turnover reaction and from H<sub>2</sub>O via MoCo in the subsequent reactions. The origin of oxygen from H<sub>2</sub>O enables experimental approaches that use <sup>18</sup>O from H<sub>2</sub><sup>18</sup>O (see <a class="ref internalNav" href="#sec8_1" aria-label="sections 8.1">sections 8.1</a> and <a class="ref internalNav" href="#sec8_3" aria-label="8.3">8.3</a>). The catalytic cycle is closed by the reoxidation of the MoCo (Mo<sup>IV</sup> → Mo<sup>VI</sup>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, step iii). Two reducing equivalents (2e<sup>−</sup>) are transferred via two [2Fe−2S] clusters and the FAD cofactor to molecular oxygen as their final acceptor to generate superoxide and/or hydrogen peroxide.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In addition to molecular oxygen, the electron acceptor can be another molecule, including a xenobiotic, leading to AO-catalyzed reductions (see <a class="ref internalNav" href="#sec3_4" aria-label="section 3.4">section 3.4</a> below).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed concerted catalytic mechanisms of AO-catalyzed oxidations<a onclick="showRef(event, 'ref40 ref41 ref45'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref45">(40,41,45)</a> (A) and amide hydrolysis<a onclick="showRef(event, 'ref9 ref28'); return false;" href="javascript:void(0);" class="ref ref9 ref28">(9,28)</a> (B). Amino acid residues are numbered according to the human AO sequence.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although both AO and CYPs catalyze C atom hydroxylations, it is important to emphasize that catalytic mechanisms are different (or even contrasting), leading to unique substrate specificity and site of metabolism (SOM) on the drug-like compounds. Whereas AO-catalyzed oxidations occur by nucleophilic attack of the −OH group of the MoCo ligand (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, step i), CYP-catalyzed oxidations are driven by the electrophilic attack of the activated oxygen species (perferryl oxygen complex FeO<sup>3+</sup> or oxene, an electrophilic atom with only six electrons in the outer layer).<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> Similarly, FMOs catalyze oxidations of soft nucleophiles (e.g., basic amines and sulfides) by electrophilic attack of the 4a-hydroperoxyflavin moiety (FADH−OOH complex).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> These differences play a profound role in drug design: whereas electron-deficient moieties will be largely protected from CYP- and FMO-catalyzed oxidations, this may leave them vulnerable to AO-catalyzed oxidations (see <a class="ref internalNav" href="#sec5" aria-label="section 5">section 5</a>). Examples of both CYPs and AO catalyzing the same reaction do exist, however, O<sub>6</sub>-benzylguanine is oxidized at the position 8 of the guanine by both CYP1A2 and AO.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Another interesting and useful difference between CYP- and AO-catalyzed oxidations is the origin of oxygen atom; whereas CYPs utilize oxygen from atmospheric O<sub>2</sub>,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> AO uses oxygen from H<sub>2</sub>O.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> This unique feature of the AO catalytic mechanisms can be used for analytic purposes, for example, in experiments with H<sub>2</sub><sup>18</sup>O to identify metabolites formed by AO.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">2.2.2.  Reactions of Hydrolysis</h4><div class="NLM_p last">On the basis of the example of the amide hydrolysis of GDC-0834,<a onclick="showRef(event, 'ref9 ref28'); return false;" href="javascript:void(0);" class="ref ref9 ref28">(9,28)</a> the following catalytic mechanism was proposed (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The carbonyl group of the amide is attacked by the nucleophilic hydroxymolybdenum moiety to form a tetrahedral intermediate.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As this step requires a relatively strong nucleophile, the authors proposed the Mo<sup>IV</sup> oxidative state,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> instead of the Mo<sup>VI</sup> involved in the AO-catalyzed oxidations (see above). This proposed mechanism, like AO-catalyzed reductions, would require accumulation of the enzyme in the Mo<sup>IV</sup> oxidative state, probably by the previous oxidation of another compound, either endogenous or exogenous.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The formed tetrahedral intermediate yields the free amine (M1) and possibly ester bound to molybdenum, which is further hydrolyzed to release the free acid metabolite (M2) and the free Mo<sup>IV</sup> hydroxymolybdenum (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).<a onclick="showRef(event, 'ref9 ref28'); return false;" href="javascript:void(0);" class="ref ref9 ref28">(9,28)</a> Amide hydrolysis is also catalyzed by various hydrolytic enzymes, including amidases, esterases, and peptidases.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Although hydrolases are a diverse group of enzymes, the general catalytic mechanism of hydrolysis is fairly preserved; a nucleophilic group of the enzyme (e.g., −OH of serine, −SH of cysteine, or activated H<sub>2</sub>O) attacks the carbonyl C atom of the amide, while an electrophilic group at the active site polarizes the carbonyl C atom and the proton donor (H−B) facilitates leaving of the cleaved amine.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">2.2.3.  Reactions of Reduction</h4><div class="NLM_p last">In contrast to reactions of oxidation and hydrolysis, the catalytic mechanism of AO-catalyzed reductions is poorly understood. Historically, reactions of AO-mediated reduction were performed under specific incubation conditions: under anaerobic atmosphere and in the presence of electron donors such as 2-hydroxypyrimidine, N<sup>1</sup>-methylnicotine, benzaldehyde, or NADPH.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> More recent results show that reductions by AO can also occur under aerobic conditions.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Regardless of the oxygen levels, AO-catalyzed reductions likely need to be coupled with an oxidation of another substrate (“electron donor”), either endogenous or exogenous.<a onclick="showRef(event, 'ref10 ref26'); return false;" href="javascript:void(0);" class="ref ref10 ref26">(10,26)</a> Moreover, on the basis of recent enzyme kinetic evidence, AO-mediated reductions likely occur at a site distinct from the oxidative MoCo site,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> either the FAD-binding site or near the [2Fe-2S] clusters.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">3.  Substrate Specificity and Reactions Catalyzed</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As described above, AO catalyzes four known reaction types: oxidations of azaheterocycles, oxidations of aldehydes, hydrolysis of amides, and various reductions. In this section, we will review structural features leading to these reactions based on published reports.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.1.  Oxidation of Azaheterocycles</h3><div class="NLM_p">Oxidations of azaheterocycle-containing drugs and drug candidates are the most common reactions catalyzed by AO (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Oxidations usually occur at the electron-deficient sp<sup>2</sup> carbons adjacent to nitrogen, which are part of aromatic azaheterocycles (−CH═N− moiety) or nonaromatic charged azaheterocycles (−CH═N<sup>+</sup>< moiety, iminium ions). AO has a significantly broader substrate specificity than the closely related enzyme xanthine oxidoreductase (XO), which is mainly restricted to the metabolism of hypoxanthine and xanthine in catabolism of purines.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">3.1.1.  Oxidations of Aromatic Azaheterocycles</h4><div class="NLM_p">A large variety of aromatic azaheterocycles and fused heteroaromatic systems were reported to be oxidized by AO, generally resulting in pyridone-like metabolites (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Although prevalence of AO structural alerts was not fully investigated, 56% of Pfizer’s kinase-targeted compounds,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and 36% of all ChEMBL-reported drugs (authors’ unpublished observations; <a href="https://www.ebi.ac.uk/chembl/g/#browse/drugs" class="extLink">https://www.ebi.ac.uk/chembl/g/#browse/drugs</a>, last accessed in June 2018<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a>) were predicted to be potential substrates for AO. The sites of oxidations are predominantly carbons adjacent to nitrogen, although important exceptions are quinoline,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> pyridazine (authors’ observations), cinnoline,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> acridine,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> and cryptoleptine motifs,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> where oxidations are also observed at distant carbons (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The susceptibility to oxidations by AO generally increases with nitrogen count, especially if the affected carbon is between two nitrogens; for instance, pyrimidine oxidations are more commonly reported than pyridine oxidations. Conversely, oxidations of phenyl analogues or heterocycles without nitrogen are not reported at all, even if electron-deficient carbons near electron-withdrawing group (EWG) are present. On the basis of literature reports, some common heterocycles like pyrimidine, quinoline, and purine have a high likelihood of being AO substrates, indicating that such chemotypes should always be tested for AO activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The impact of overall molecular size and geometry is difficult to estimate without complementary docking approaches, but reported AO substrates have widely different sizes ranging from 130 Da (quinoline) to 823 Da (quinoline-containing azetidinyl ketolide).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Analysis of published AO oxidative substrates also indicates that successful clinical progression is still possible (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, marked in bold typeface), although comparatively rare (e.g., imatinib,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> AMG900,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> lenvantinib,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> etc.).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Examples of aromatic azaheterocycles oxidized by AO. Star denotes the site of oxidation by AO, if reported in the literature. See <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> for the list of published AO substrates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selected Examples of Common Azaheterocycles Oxidized by AO<a class="ref internalNav" href="#tbl2-fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0028.gif" alt="" id="gr28" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Drugs currently on the market.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">For fasudil<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and famciclovir<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (both prodrugs), high metabolic clearance by AO is not a liability as the AO-formed oxidative metabolite is active.</p></div><div class="footnote" id="tbl2-fn1"><sup><sup>c</sup></sup><p class="last">Exact sites of oxidation by AO, if specified in the literature, are marked with an asterisk. Compounds that failed in human clinical trials due to poor PK or related issues are underlined. Compounds that have acceptable human PK despite being AO substrates are marked in bold.</p></div></div><div></div></div><div class="NLM_p">The size of an azaheterocyclic ring also plays an important role, especially in nonfused systems, with 6-membered rings being more prone to AO-mediated oxidations than 5-membered rings. Exceptions to this observation are the reported oxidations of oxazoles<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> and benzothiazole.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Various nitrogen-containing fused heteroaromatics, both in 6,6 and 6,5 arrangements, are also commonly reported as AO substrates (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The sites of oxidation by AO in such systems are less predictable and generally occur on carbons adjacent to nitrogens in both 6- and 5-membered rings. Oxidations of fused heteroaromatic 5,5 systems are not reported, however, indicating a possibility for AO-mitigating design of molecules.</div><div class="NLM_p last">The susceptibility to oxidations by AO may be modulated by ring substitutions. On the basis of the nucleophilic catalytic mechanism and published SAR examples, the consensus is that EWG and electron-donating (EDG) groups usually enhance and reduce oxidations by AO, respectively.<a onclick="showRef(event, 'ref28 ref79 ref82 ref111'); return false;" href="javascript:void(0);" class="ref ref28 ref79 ref82 ref111">(28,79,82,111)</a> Examples of azaheterocycles where both EWG and EDG are present are more difficult to predict and complementary computational approaches are recommended (see <a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a>) to help design and decision-making. However, some EDG ring substituents may enhance AO-mediated oxidations by facilitating binding to the enzyme, even if electronics of the affected carbon would suggest otherwise.<a onclick="showRef(event, 'ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref77">(75−77)</a> Broad interspecies differences in azaheterocyclic substrate specificity between human and rodent AO have been reported, most likely due to differences in AO isoforms expressed, their tissue distribution, and their binding site properties; this will be discussed in more detail in <a class="ref internalNav" href="#sec7" aria-label="sections 7">sections 7</a> and <a class="ref internalNav" href="#sec8" aria-label="8">8</a>.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">3.1.2.  Oxidation of Nonaromatic Azaheterocycles (Iminium Ions)</h4><div class="NLM_p">In addition to the typical oxidations of aromatic heterocycles, several authors reported AO involvement in oxidations of nonaromatic heterocycles, often after initial oxidation by another drug-metabolizing enzyme like monoamine oxidase B (MAO-B) and CYPs. The piperazine ring of KW-2449, a multikinase inhibitor developed for treatment of leukemia, was oxidized to iminium ion by MAO-B and then by AO to the pharmacodynamically active piperazinone metabolite (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The iminium ion intermediate of KW-2449 was also an irreversible inhibitor of AO, possibly through covalent binding to the enzyme.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> A similar metabolic pathway was observed for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic pro-neurotoxin which induces parkinsonism in humans and other primates (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B).<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114,115)</a> The morpholine ring of momelotinib, an inhibitor of Janus kinase 1/2 and activin A receptor type 1, was first oxidized by CYPs to iminium ion and then by AO to the corresponding morpholin-3-one metabolite (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In contrast to the low levels observed in rat and dog plasma (<10% of drug-related material), morpholin-3-one was the most abundant circulating metabolite in human plasma (64.2% of drug-related material), leading to a MIST issue that was resolved only by subsequent administration of the isolated metabolite to rats.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> AO-mediated oxidations of the corresponding iminium ions to lactams were also reported for several older pyrrolidines-containing drugs, including nicotine, tremorine, and prolintane.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Examples of nonaromatic azaheterocycles oxidized by AO, often in combination with other oxidative drug-metabolizing enzymes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">3.2.  Oxidation of Aldehydes</h3><div class="NLM_p">The oxidation of aldehydes to carboxylic acids can be catalyzed by several enzymes with an overlapping substrate selectivity, most notably aldehyde dehydrogenase (ALDH), AO, and XO. Although aldehydes are rarely present in therapeutic drugs, this functional group can be formed as an intermediate after oxidation of primary alcohols [by alcohol dehydrogenase (ADH)] or terminal methyl group (by CYPs). Retinal and pyridoxal are examples of endogenous aldehydes oxidized by AO (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116,117)</a> Study of vanillin, isovanillin, and protocatechuic aldehyde oxidations found that vanillin was rapidly oxidized by AO (in guinea pig liver), whereas isovanillin was mainly oxidized by ALDH and protocatechuic aldehyde was oxidized by all three tested enzymes (AO, ALDH, and XO) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B).<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118,119)</a> Further studies with a set of 11 benzaldehydes confirmed that AO plays an important role in the metabolism of aromatic aldehydes.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Examples of aldehyde oxidations catalyzed by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Imrecoxib, a cyclooxygenase-2 inhibitor, has a benzylic methyl group that is oxidized to carboxylic acid, a major metabolite in human plasma (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In vitro studies revealed that oxidations to alcohol and aldehyde are catalyzed by CYP3A4 and CYP2D6, but subsequent oxidation to carboxylic acid is predominantly catalyzed by AO.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Lu AA21004, a multimodal antidepressant in clinical development was first oxidized by CYP2D6 to benzyl-alcohol and then by ADH, ALDH, and AO to benzoic acid (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Further examples of AO-mediated oxidations of intermediate aldehydes include serotonin, citalopram, tamoxifen, and cyclophosphamide.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">3.3.  Amide Hydrolysis</h3><div class="NLM_p">GDC-0834, an amide-containing Bruton’s tyrosine kinase inhibitor, was hydrolyzed more extensively in humans compared to nonclinical species (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A), triggering a number of mechanistic assays to identify the responsible enzyme.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Enzymatic assays and proteomic analysis revealed that AO and carboxylesterase were both involved, whereas in silico modeling suggested that the amide bond of GDC-0834 binds near the MoCo, potentially enabling nucleophilic attack on the carbonyl of the amide bond by the hydroxyl of MoCo.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This novel reaction of amide hydrolysis by AO raised concerns not only because of high metabolic clearance and ubiquity of amide bonds in drug-like compounds, but also due to the potential formation of aryl-amines (anilines) as hydrolysis products of aromatic amides, metabolites that carry a significant genotoxic risk.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Examples of amide hydrolysis catalyzed by AO. (A) GDC-0834 was the first reported example of amide hydrolysis by AO.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (B) Modifications of amine moiety affected rates of amide hydrolysis, with EDGs in the ortho position giving the highest propensity toward hydrolysis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (C) Modifications of acyl moiety had less impact, with most tested compounds being AO substrates.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">SAR of AO-catalyzed hydrolysis was explored with a set of 75 synthetic amides, including various aromatic and aliphatic analogues (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B,C).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In general, aromatic amides were more susceptible to AO hydrolysis, and structure of the amine part of the amide bond (aniline moiety) had a greater impact on the hydrolysis rates. Substitutions of aniline moieties in <i>meta</i> positions with EDG and EWG groups increased and decreased propensity toward AO hydrolysis, respectively. Substitutions of <i>ortho</i> and <i>para</i> positions generally reduced hydrolysis regardless if EDG or EWG was introduced. Tertiary amides, sterically hindered and less flexible anilines or aliphatic amines, were also generally stable (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In contrast to aniline moiety, the structure of acyl moiety generally had less impact on the hydrolysis rates: furane, indole, 2-methylenindole, (3-fluorophenyl)propane, cyclohexane, pyrazine, and pyridine were all substrates (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Tested bis-aliphatic amides were generally not substrates.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">3.4.  Reductions</h3><div class="NLM_p">AO is known to catalyze reductions of nitro groups, <i>N</i>-oxides, sulfoxides, isoxazoles, isothiazoles, nitrite, and hydroxamic acids (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In contrast to oxidative metabolism, reductions catalyzed by AO require an electron donor, commonly 2-hydroxypyrimidine, <i>N</i><sup>1</sup>-methylnicotine, benzaldehyde, or NADPH, likely occur at the FAD-binding site<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and were historically thought to occur exclusively in anaerobic conditions.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> However, recent studies challenged these views and showed that not only these reductions can occur under standard aerobic conditions in vitro but also that reduced metabolites are formed in vivo, contributing to metabolic clearance, interspecies differences, and safety profiles of drug-like compounds. Selected examples of AO-catalyzed reductions are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Examples of Reductions Catalyzed by AO</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">reaction catalyzed</th><th class="colsep0 rowsep0" align="center">enzyme source</th><th class="colsep0 rowsep0" align="center">incubation conditions</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2-nitrofluorene, 4-nitrobiphenyl, 1-nitronaphthalene, 1-nitropyrene</td><td class="colsep0 rowsep0" align="center">nitro → amino or hydroxylamine</td><td class="colsep0 rowsep0" align="center">rabbit liver cytosol and purified rabbit AO</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nitrazepam</td><td class="colsep0 rowsep0" align="center">nitro → amino</td><td class="colsep0 rowsep0" align="center">HLC<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> and purified human AO</td><td class="colsep0 rowsep0" align="center">aerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clonazepam, flunitrazepam, flutamide, nilutamide, nimesulide</td><td class="colsep0 rowsep0" align="center">nitro → amino</td><td class="colsep0 rowsep0" align="center">HLC<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> and purified AO</td><td class="colsep0 rowsep0" align="center">aerobic; <i>N</i>1-methylnicotinamide as electron donor</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nimesulide</td><td class="colsep0 rowsep0" align="center">nitro → amino</td><td class="colsep0 rowsep0" align="center">human and rat liver cytosol</td><td class="colsep0 rowsep0" align="center">aerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dantrolene</td><td class="colsep0 rowsep0" align="center">nitro → amino</td><td class="colsep0 rowsep0" align="center">HLC<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">aerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">imidacloprid</td><td class="colsep0 rowsep0" align="center">nitro → amino or hydroxylamine</td><td class="colsep0 rowsep0" align="center">liver cytosol and S9 fraction from various species</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nitrite ion to nitric oxide</td><td class="colsep0 rowsep0" align="center">NO<sub>2</sub><sup>−</sup> → NO</td><td class="colsep0 rowsep0" align="center">purified rat liver AO</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref125 ref126">(125,126)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">imipramine <i>N</i>-oxide and nicotinamide <i>N</i>-oxide</td><td class="colsep0 rowsep0" align="center"><i>N</i>-oxide → deoxy analogues</td><td class="colsep0 rowsep0" align="center">liver cytosol of rabbits, rats, mice, hamsters, and hogs</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref55 ref127'); return false;" href="javascript:void(0);" class="ref ref55 ref127">(55,127)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">quinoxaline <i>N</i>-oxides</td><td class="colsep0 rowsep0" align="center">quinoxaline-1,4-di-<i>N</i>-oxides → 1-deoxy analogues</td><td class="colsep0 rowsep0" align="center">purified porcine AO</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">zonisamide</td><td class="colsep0 rowsep0" align="center">isoxazole reductive ring opening</td><td class="colsep0 rowsep0" align="center">liver cytosol from rabbits, hamsters, mice, rats, and guinea pigs</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ziprasidone</td><td class="colsep0 rowsep0" align="center">isothioazole reductive ring opening</td><td class="colsep0 rowsep0" align="center">HLC<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">aerobic, 2-hydroxpyrimidine as electron donor</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oximes of acetophenone, salicylic acid, and camphor</td><td class="colsep0 rowsep0" align="center">oxime → ketimines → ketones (nonenzymatic)</td><td class="colsep0 rowsep0" align="center">rabbit liver cytosol</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hydroxamic acids</td><td class="colsep0 rowsep0" align="center">hydroxamic acids → amides</td><td class="colsep0 rowsep0" align="center">rabbit liver cytosol</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sulindac</td><td class="colsep0 rowsep0" align="center">sulfoxide → sulfide</td><td class="colsep0 rowsep0" align="center">guinea pig liver AO</td><td class="colsep0 rowsep0" align="center">anaerobic</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">HLC, human liver cytosol.</p></div></div></div><div id="sec3_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">3.4.1.  Reduction of Nitro Compounds</h4><div class="NLM_p">Comparable to amide hydrolysis, reduction of nitro group leads to formation of hydroxylamines and primary amines. These metabolites may undergo metabolic bioactivation, potentially contributing to a range of adverse drug reactions.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> A study with rabbit liver cytosol and purified rabbit AO, performed under anaerobic conditions and in the presence of electron donors, showed that carcinogenic 2-nitrofluorene, 4-nitrobiphenyl, 1-nitronaphthalene, and 1-nitropyrene were reduced to the corresponding hydroxylamines and/or amines (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Similarly, nitrazepam, a nitro-containing benzodiazepine hypnotic, was primarily reduced by AO to 7-amino-nitrazepam (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B) under aerobic conditions, a metabolite that is subsequently acetylated and thought to be involved in liver injury and teratogenicity of nitrazepam.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Nitro reduction was more prominent in human liver cytosol (HLC) compared to microsomes and increased by 50% with inclusion of NADPH; subsequent purification of the enzymatically active fraction confirmed involvement of AO.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Nimesulide, a nonsteroidal anti-inflammatory drug, was reduced by rat and human AO to amino-nimesulide, a metabolite that further undergoes CYP oxidations and GSH trapping and contributes to hepatotoxicity of nimesulide (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> To assess AO involvement, incubations were performed in human and rat liver cytosol under aerobic conditions and activity was inhibited by estradiol,<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> a steroid previously reported to be a potent AO inhibitor.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> The nitro group of dantrolene, a skeletal muscle relaxant, was also reduced by AO under aerobic conditions and in the presence of electron donors (NADPH or <i>N</i><sup>1</sup>-methylnicotineamide) to form an aminodantrolene, a metabolite that is further acetylated and <i>N</i>-hydroxylated, resulting in metabolic bioactivation and liver injury (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Safety risks of AO-mediated nitro reductions were highlighted in studies of imidacloprid metabolism, a widely used neonicotinoid insecticide whose nitro-imine group is reduced to nitroso-imine and hydrazine metabolites (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>E).<a onclick="showRef(event, 'ref16 ref124 ref135'); return false;" href="javascript:void(0);" class="ref ref16 ref124 ref135">(16,124,135)</a> In vitro studies of imidacloprid metabolism found that nitro reduction is catalyzed by AO across species that express the enzyme, especially in the presence of electron donors such as benzaldehyde or <i>N</i><sup>1</sup>-methylnicotineamide.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Mechanistic studies in mice confirmed AO involvement in vivo, mainly through use of chemical inhibition (hydralazine and tungsten) and AO-deficient animals,<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> whereas a study in New Zealand rabbits found that imidacloprid induces a clastogenic effect (micronucleus assay) that is diminished by coadministration of tungsten as an AO inhibitor.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Examples of nitro reductions catalyzed by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SAR of nitroaromatic reductions to aryl-amines was recently investigated in a set of 11 drugs; incubations were performed under aerobic conditions in human liver cytosol.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The study found that six compounds (clonazepam, flunitrazepam, flutamide, nilutamide, nimesulide, and nimetazepam) were significantly reduced by human AO, whereas the remaining five compounds either exhibited minor reduction (azelnidipine, nifedipine, and nimodipine) or were not affected (metronidazole and tolcapone).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Authors suggested that propensity toward nitro reduction is governed by electronic effects; relatively electron-rich nitro groups were more readily reduced compared to electron-deficient nitro groups.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In addition to organic nitro compounds, AO was found to catalyze the reduction of nitrite ion itself to nitric oxide (NO<sub>2</sub><sup>−</sup> → NO), a mechanism that may contribute to NO formation under hypoxic conditions in human cells (see also <a class="ref internalNav" href="#sec7_3" aria-label="section 7.3">section 7.3</a>).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div><div class="NLM_p">To elucidate interplay between oxidative and reductive metabolism of AO under standard aerobic conditions, 5-nitroquinoline was incubated with human liver cytosol and recombinant human AO (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Incubations resulted in three metabolites, oxidized 5-nitroquinoline-2-on, reduced 5-aminoquinoline, and oxidized/reduced 5-aminoquinoline-2-one, whereas enzyme kinetic assays suggested presence of two distinct AO active sites, one for oxidations and second for reductions. These results suggested that nitro group in 5-nitroquinoline can compete favorably with oxygen for the AO reducing equivalents (see <a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Example of mechanistically important and simultaneous oxidation/reduction of 5-nitroquinoline catalyzed by AO. Prepared based on results from Paragas et al.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">3.4.2.  Reductions of <i>N</i>-Oxides</h4><div class="NLM_p">Imipramine <i>N</i>-oxide and nicotinamide <i>N</i>-oxide were reduced to imipramine and nicotinamide, respectively, under anaerobic conditions by liver cytosol of rabbits, rats, mice, hamsters, and hogs (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A).<a onclick="showRef(event, 'ref55 ref127'); return false;" href="javascript:void(0);" class="ref ref55 ref127">(55,127)</a> Several quinoxaline-1,4-di-<i>N</i>-oxides (quinocetone, mequindox, and cyadox) were reduced to corresponding 1-deoxy analogues by porcine aldehyde oxidase under anaerobic conditions (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Surprisingly, tirapazamine, an experimental anticancer compound that is activated to a toxic radical under anoxic conditions, was not reduced by human AO under anaerobic conditions and presence of benzaldehyde as an electron donor (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Examples of <i>N</i>-oxide reductions catalyzed by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">3.4.3.  Reductive Opening of Isoxazole and Isothiazole Rings</h4><div class="NLM_p">Zonisamide, an isoxazole-containing anticonvulsant used to treat epilepsy and Parkinson’s disease, undergoes reductive cleavage of the isoxazole ring catalyzed by liver AO from rabbits, hamsters, mice, rats, and guinea pigs (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Reactions were performed under anaerobic conditions, included an electron donor (2-hydroxypyrimidine or NADPH) and were inhibited by menadione.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Interestingly, AO was recently found to oxidize 2<i>H</i>-oxazoles to 2-oxazolones under aerobic conditions.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Ziprasidone, a 5-hydroxytryptamine-2A and dopamine-2 receptors antagonist, showed reductive opening of the isothiazole ring in aerobic incubations with human liver cytosol (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Isothiazole reduction was enhanced by inclusion of electron donor (2-hydroxypyrimidine) and inhibited by menadione, indicating aldehyde oxidase involvement, and the reaction also proceeded nonenzymatically in the presence of reduced glutathione.<a onclick="showRef(event, 'ref130 ref137'); return false;" href="javascript:void(0);" class="ref ref130 ref137">(130,137)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Examples of various reductions catalyzed by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">3.4.4.  Other Examples of AO-Catalyzed Reductions</h4><div class="NLM_p last">Oximes of acetophenone, salicylic acid, and camphor were reduced to corresponding ketimines by rabbit liver cytosol under anaerobic conditions and presence of 2-hydroxypyrimidine as an electron donor (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C).<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Authors proposed that formed ketimines undergo nonenzymatic hydrolysis to ketones or aldehydes with release of equimolar amount of ammonia.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> A number of hydroxamic acids (salicylhydroxamic acid, benzohydroxamic acid, anthranilhydroxamic acid, and nicotinohydroxamic acid) were also reduced under anaerobic conditions to corresponding amides (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>D).<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Sulindac, a nonsteroidal anti-inflammatory drug with a methyl-sulfoxide group, was reduced to corresponding sulfide by guinea pig liver aldehyde oxidase (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>E).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">4.  Computational Approaches To Predict AO Metabolism</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Undeniably, it would be very useful for drug design if the likelihood, site, or rate of AO metabolism could be calculated from a chemical structure even before it is synthesized. Ever since there have been data on experimentally determined substrates, researchers have investigated how to tackle these tasks. How to identify the SOM on known substrates has also been subject of several studies. Research was predominantly performed on AO-mediated oxidations, leaving reactions of hydrolysis and reduction less explored.</div><div class="NLM_p">The earliest attempt at finding quantitative structure−metabolism relationships (QSMR) within AO substrates was carried out by Ghafourian and Rashidi.<a onclick="showRef(event, 'ref83 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85">(83−85)</a> They used a data set of <i>K</i><sub>m</sub>s and <i>V</i><sub>max</sub>s of 14 and 15 substituted phthalazines and quinazolines, respectively. They did not find a consistent or global model for these two series, but they did conclude that reduced electron density at the SOM of the quinazolines was favored by the enzyme, consistent with the mechanism of action (MOA) and with later studies. Torres et al.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> made the first attempt to predict the regioselectivity of AO substrates. A little surprisingly, given the results of later studies, they did not find the most positive carbon to be predictive of the SOM of eight drug substrates. Looking for a better method, the authors calculated the relative energies of tetrahedral intermediates (see proposed transition states in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) at each available position around the nitrogen-containing ring system.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In all but one of their test molecules, the SOM had the lowest energy. Jones and Korzekwa<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> produced a mechanistic model designed to predict the rate of intrinsic clearance by AO: predicted CL<sub>int,AO</sub> = A HrRel + B steric + C. They fitted parameters A, B, and C using seven known substrates. The HrRel is the relative energy of the tetrahedral intermediate compared to that of quinolone. At the time of this study, the structure of human AO had not been determined. Not deterred, the authors modeled the shape of the active site as a “reaction wedge” pseudomolecule. The steric accessibility of each substrate SOM was calculated with a molecular mechanics energy calculation after constrained minimization at fixed separations from this entity. Their results were mainly validated using an additional two compounds. This was a creative study, but as the authors point out, hamstrung by the very small training and validation sets and the unreliability of the experimental data. However, their “reaction wedge” was taken up by Xu et al.,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> who modeled the likelihood that any given potential site of oxidation of an azaheterocycle using two parameters: <b>Δ</b><i>E</i><sub><b>inter</b></sub> and <b>Steric</b>, the former being the relative energy of the tetrahedral reaction intermediate and the latter a measure of steric hindrance. They constructed a decision tree using data on 35 compounds and validated it by testing 15 azaheterocycle containing c-Met inhibitors for AO metabolism. Their method proved correct for all but one compound, which was a false positive. Three others were correctly predicted as previously unidentified AO substrates and their SOM’s correctly identified. The <b>Steric</b> factor was decisive in nearly every instance.</div><div class="NLM_p">Different catalytic mechanisms were proposed and studied with density functional theory (DFT) calculations on simplified models by Montefiori et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Each reaction mechanism was found to be equally useful because the calculated transition state energies at different sites of a set of seven 6-substituted 4-quinazolinones were highly correlated. On balance of evidence, they decided the concerted mechanism, without prior deprotonation of MoCo, was the most likely.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> They concluded that, although the SOM of a known substrate could be determined by the comparison of DFT calculated activation energies at all possible sites, this could also be determined much more quickly and easily with ESP (electrostatic potential) derived partial charges. The carbon with the most positive ESP charge in nitrogen containing heteroaromatic ring systems was most likely to be the SOM.</div><div class="NLM_p">Lepri at al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> provided a step change to studies on this subject by measuring the metabolism of 198 azo-aromatic ring system containing compounds and 75 amides in HLC and publishing the results. They then proceeded to examine the structure−metabolism relationships (SMR) that can be observed in this data, including insights from the results of DFT calculations and docking into the crystal structure of human AO in their analysis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> For the oxidation of azo-aromatic moieties, they found that the DFT calculated partial charges method is the best and most pragmatic approach for such large number of compounds. As suggested by Montefiori et al.,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> the most positive unsubstituted carbon ortho to the nitrogen was usually found to be the SOM. Using FLAP (Molecular Discovery) for docking, they also found that substrates tended to occupy a productive binding pose more often than nonsubstrates. They also observed that pyridine, indole, and pyrazole tend to be shielded against AO metabolism. For the pyridine, all 18 examples tested were found not to be substrates, evidence for the benefit of the latter two ring systems is harder to discern. The authors conclude by suggesting the following strategies to protect against AO azo-aromatic oxidation:<table class="listgroup" border="0" width="95%" id="list1" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Substitution at the most positive carbon (adjacent to a nitrogen).</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Lower the partial charge of the most positive carbon by substituting elsewhere in the ring system. EDGs seem to help, except on pyrimidines.</p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Add substituents that could hinder productive binding to the catalytic site.</p></td></tr></table></div><div class="NLM_p">For AO mediated amide hydrolysis, they find that EWGs on the anilide moieties tend to be more stable following the order of stability ortho < meta < para. No statistics were produced to back-up these conclusions.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Cruciani et al.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> extended this data set of experimentally measured AO metabolism to over 600 compounds, which they used to parametrize a computational tool (MetaSite, Molecular Discovery) for the prediction of the likelihood of metabolism by AO. To our knowledge, at the time of writing, this is the only available packaged computational tool to calculate whether a chemical structure will lead to AO metabolism and at which SOM. They stress that modeling the exposure of potential SOMs to the enzyme active site is important for the prediction of AO substrates and designing an AO liability. Their results show that they correctly predicted that a compound is a substrate and at which site it is metabolized for 88% of the 535 compounds tested.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><div class="NLM_p">Montefiori et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> investigated further the observation that the SOM can be identified by calculating point charges using DFT methods using a set of 78 substrates extracted from the literature. They confirm that this works most of the time but similarly reliable results can be achieved by calculating NMR measurables, namely the carbon electropositivity based on the chemical shift. As described in <a class="ref internalNav" href="#sec2_2" aria-label="section 2.2">section 2.2</a>, the mechanism of AO-mediated oxidations relies on the electrophilicity of the carbon at the site of reaction.<a onclick="showRef(event, 'ref36 ref79'); return false;" href="javascript:void(0);" class="ref ref36 ref79">(36,79)</a> One simple approach to assess electrophilicity of carbons is through the measurement of the <sup>13</sup>C shift by NMR spectroscopy, as this is directly related to the electron environment around the carbon nucleus.<a onclick="showRef(event, 'ref7 ref36'); return false;" href="javascript:void(0);" class="ref ref7 ref36">(7,36)</a> Generation of the <sup>13</sup>C chemical shifts of potential AO substrates by NMR spectroscopy will provide the best measurement of ppm values, but software such as Mestrenova (Mestrelab research, Spain) or ChemBioDraw (PerkinElmer) can provide very good, and consistent, estimate of ppm values. This is an approach we have found useful for AO SOM predictions in the past [presentation at the DMDG Open Meeting, Cambridge September 21, 2019, and/or Poster, 21st North American ISSX meeting, Providence RI]. Montefiori et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> used the ChemBioDraw (PerkinElmer) to determine the chemical shift for the carbon atoms and DFT calculated chemical shielding. They found both descriptors are as good at identifying the AO SOM for azaheterocycle oxidation as DFT calculated point charges. In isolation, the calculated or measured <sup>13</sup>C ppm values of the most electrophilic sp<sup>2</sup> carbons cannot identify the propensity of the molecule to be an AO substrate. However, the calculated ppm values in Montefiori paper and from additional calculations carried out at UCB show a trend of greater AO susceptibility where shifts of sp<sup>2</sup> carbons are greater than 140 ppm, although other structural facets need to be in place such as the presence of nitrogen(s) in the ring system(s).</div><div class="NLM_p last">In summary, the SOM of known oxidative azaheterocyclic substrates can be predicted with a high degree of reliability using DFT-calculated relative energies of tetrahedral intermediates, point charges, or calculated chemical shifts. Both Cruciani et al.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> and Montefiori et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> favor the DFT-calculated point charge method due to its simplicity and ease of automation. For a drug-like compound to be an AO substrate, it should have at least one potential SOM but also at least one which is accessible to the MoCo in the catalytic site. This latter property is perhaps harder to predict, but as the number of known substrates and nonsubstrates has grown, the methods designed to do this have become more sophisticated. For example, Hayes et al.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> used docking to the AO cocrystal structure<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> to guide chemical design in the series of pyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one analogues (see <a class="ref internalNav" href="#sec6_2" aria-label="section 6.2">section 6.2</a>).</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">5.  Drug Design Approaches To Modulate Metabolism by AO</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Considering the broad substrate selectivity, four distinct reaction types, interspecies differences, and often significant clinical consequences (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), our recommendation is to consider AO liability early in the drug discovery process, particularly in the context of drug design, as this affords the best opportunity to remove or limit the potential for AO-mediated metabolism. Many computational (<a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a>) and experimental (<a class="ref internalNav" href="#sec8" aria-label="section 8">section 8</a>) tools are available to predict and assess AO metabolism early, enabling design teams to make timely, informed decisions. Late-stage risk assessments of AO substrates are possible, and sometimes indeed necessary, but may suffer from our insufficient understanding of AO biology and its clinical translation (<a class="ref internalNav" href="#sec7" aria-label="section 7">section 7</a>). While oxidations of azaheterocycles (<a class="ref internalNav" href="#sec3_1" aria-label="section 3.1">section 3.1</a>) and amide hydrolysis (<a class="ref internalNav" href="#sec3_3" aria-label="section 3.3">section 3.3</a>) are of specific relevance to control of the metabolic clearance (or even prodrug design), all AO reaction types may profoundly affect developability of the compounds, for example, through bioactivation (formation of aryl-amines), interspecies differences (e.g., MIST issues), and poor in vitro−in vivo correlation (IVIVC). Although we recommend an early consideration of AO liability, our opinion is that this should not result in automatic avoidance of AO structural flags. Azaheterocycles or aromatic amides are common and versatile building blocks that may bring additional value to discovery programs, even if increasing the risk for metabolism by AO. Ideally, AO-mediated metabolism should be evaluated as a part of the multiparametric optimization process with a goal to increase overall compound quality.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">5.1.  General Considerations about AO-Catalyzed Oxidations</h3><div class="NLM_p">Most chemotypes with azaheterocyclic motifs should be evaluated for AO activity, especially if they are key pharmacophores within the chemotype (e.g., kinase inhibitors). Early accessible criteria should be used to reduce the number of specific experiments, for example, structural flags (predicted in cerebro or in silico), previously available metabolite identification results (from hepatocytes or in vivo samples), or “suspicious” discovery findings (e.g., disconnect between microsomal and hepatocyte clearance, poor IVIVC, and interspecies differences, especially absence of specific metabolites in dog). Exceptions are fully substituted azaheterocycles where AO reactions cannot occur.</div><div class="NLM_p">If AO-catalyzed oxidations of the chemotype are confirmed, design teams generally have four options (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>): (1) to stop AO reactions, (2) to decrease the rate of AO reactions, (3) to use AO metabolite as a novel scaffold or prodrug inspiration, or (4) to proceed at risk. In all cases, identification of the exact oxidation site (<a class="ref internalNav" href="#sec8_3" aria-label="section 8.3">section 8.3</a>), application of computational tools (<a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a>), and continuous pharmacological evaluation will facilitate design. Preferably, if possible within the constraints of the chemotype and the target, design teams should aim to completely stop AO-mediated oxidations (<a class="ref internalNav" href="#sec5_2" aria-label="section 5.2">section 5.2</a>). Examples of confirmed AO substrates with acceptable clinical pharmacokinetics are rare, likely limited to very low turnover substrates (e.g., imatinib,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> idelalisib,<a onclick="showRef(event, 'ref103 ref104 ref105 ref106 ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref103 ref104 ref105 ref106 ref107 ref108">(103−108)</a> lenvantinib<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a>) or compounds where AO oxidations are not a rate-limiting step (momelotinib<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>). The current relative absence of AO substrates on the market may have been driven by several factors, such as historical use of inappropriate in vitro methods (e.g., liver microsomes instead of cytosol), wrong choice of nonclinical species (e.g., dog, which lacks expression of hepatic AO; see <a class="ref internalNav" href="#sec7" aria-label="section 7">section 7</a>), and high extrahepatic AO expression (<a class="ref internalNav" href="#sec7" aria-label="section 7">section 7</a>). Therefore, design approaches to decrease or ignore AO metabolism must be complemented by means to accurately predict human metabolic clearance (<a class="ref internalNav" href="#sec8_2" aria-label="section 8.2">section 8.2</a>). Lastly, if AO metabolites retain pharmacological activity, they may be used as a novel scaffold or inspiration for prodrug approach (<a class="ref internalNav" href="#sec5_4" aria-label="section 5.4">section 5.4</a>).</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Options to manage AO-catalyzed oxidations in the context of drug discovery.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An overview of design approaches to control AO-catalyzed oxidations is presented in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Before going into detail, readers should note that common approaches to reduce oxidative metabolism like lowering log <i>D</i> and introduction of EWG (e.g., fluorination) are less likely to be productive in this area. Analysis of published substrates indicate that AO-mediated oxidations are log <i>D</i>-independent.<a onclick="showRef(event, 'ref7 ref95'); return false;" href="javascript:void(0);" class="ref ref7 ref95">(7,95)</a> The reaction mechanism of these oxidations is nucleophilic in nature (as opposed to CYP-catalyzed reactions), leading to increased reaction rates in electron-deficient heterocycles (<a class="ref internalNav" href="#sec2_2" aria-label="section 2.2">section 2.2</a>). The border between medicinal chemistry approaches to stop and decrease metabolism by AO is blurry, however, and mainly assigned based on success/failure rates observed in the past. All reviewed approaches are best complemented with computational tools to enable rational design and prioritization of efforts (<a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a>). Additionally, efforts to block or decrease AO oxidations may lead to compensatory metabolism by other drug-metabolizing enzymes, a phenomenon known as “metabolic switching”,<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> resulting in limited changes of the compound’s overall metabolic clearance, especially in vivo.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Although underlying mechanisms of compensatory metabolism are multifactorial, a broad substrate specificity of many enzymes may play a significant role, allowing for multiple binding poses within the active site.<a onclick="showRef(event, 'ref139 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref141">(139,141)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. An Overview of Drug Design Approaches to Mitigate AO-Catalyzed Oxidations of Azaheterocycles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0029.gif" alt="" id="gr29" /></img><div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">5.2.  Approaches to Stop AO-Mediated Oxidations</h3><div class="NLM_p">To stop AO oxidations, several design approaches have proven successful: direct blocking of the oxidation site, replacement of the affected carbon with a heteroatom, removal of nitrogens, and saturation of aromatic and unsaturated azaheterocycles (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Additionally, in nonfused aromatic systems, reducing ring size from 6 to 5 atoms has been reasonably successful,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> with only oxazole reported as the low turnover substrate.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> In addition to these, modulation of ring system electronics, either by rearranging heteroatoms and substituents, or introducing EDG or/and EWG, has generally resulted in mixed success rates.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">5.2.1.  Blocking of the Oxidation Site</h4><div class="NLM_p last">Direct substitution of the affected carbon reliably blocks AO metabolism<a onclick="showRef(event, 'ref7 ref29 ref51 ref74 ref88 ref93 ref95'); return false;" href="javascript:void(0);" class="ref ref7 ref29 ref51 ref74 ref88 ref93 ref95">(7,29,51,74,88,93,95)</a> but often disturbs key interactions with the target and diminishes potency.<a onclick="showRef(event, 'ref29 ref93'); return false;" href="javascript:void(0);" class="ref ref29 ref93">(29,93)</a> Therefore, selection of blocking groups should carefully consider potency SAR as well as physicochemical properties and safety profile of the chemotype. Even if not actively contributing to potency, substitutions with common alkyl groups (e.g., methyl, ethyl, cyclopropyl, etc.) will reduce ligand efficiency and may be contraindicated in lipophilic chemotypes, leading to diminished solubility and increased non-AO metabolism.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Difluoromethyl group (−CHF<sub>2</sub>) can be introduced with a “litmus test” (<a class="ref internalNav" href="#sec8_4" aria-label="section 8.4">section 8.4</a>),<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> providing a convenient means of both testing and blocking AO metabolism. Substituents like methoxy,<a onclick="showRef(event, 'ref29 ref95'); return false;" href="javascript:void(0);" class="ref ref29 ref95">(29,95)</a> amino,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and fluoro<a onclick="showRef(event, 'ref29 ref51'); return false;" href="javascript:void(0);" class="ref ref29 ref51">(29,51)</a> previously gave balanced results in terms of preservation of physicochemical properties and blocking AO metabolism. Substitution with an amino group leads to aryl-amine structures that may undergo bioactivation and increase risks for genotoxicity.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Similarly, substitutions with chlorine or cyano groups result in electron-deficient azaheterocycles that may be prone to chemical or metabolism based nucleophilic attack that can be detected in the reactive metabolite glutathione (GSH) trapping assays.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">5.2.2.  Replacement of Carbon with a Heteroatom</h4><div class="NLM_p last">Replacing the affected carbon with nitrogen was successful in a series of pyridine analogues (pyridine → pyridazine), effectively blocking the site of AO metabolism (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref7 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref7 ref65 ref66">(7,65,66)</a> A similar approach was helpful in UCB’s internal project (isoquinoline → cinnoline; data not shown). This approach may preserve key interactions with the target and even help improve physicochemical properties like log <i>D</i> and solubility. As a disadvantage, introduction of an additional heteroatom may shift or introduce new sites of AO metabolism. For example, in a series of 7-azaindole analogues (oxidized in the position 2), replacement of affected carbon with nitrogen (7-azaindazole analogues) did not stop AO oxidations but only served to shift the affected site within the core (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Comparable AO “metabolic switching” is expected if quinoline or isoquinoline cores (oxidized in positions 2 or 1, respectively) are replaced with cinnoline, opening new potential sites of AO oxidation in positions 3 and 4. Additionally, introduction of new heteroatoms into unsaturated ring systems will increase polar surface area and hydrogen bond acceptor count, generally affecting both passive permeability<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> and efflux transporter liabilities of the chemotype.<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146,147)</a></div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">5.2.3.  Removal of Nitrogens</h4><div class="NLM_p last">Phenyl rings (or other carbon homocycles) and heterocycles without nitrogen were not reported as AO substrates, even if strongly electron-deficient carbons are present (see <a class="ref internalNav" href="#sec3_1" aria-label="section 3.1">section 3.1</a>). This approach was applied in the imidazo[1,2-<i>a</i>]pyrimidine series by removing nitrogen in position 7 to form a imidazo[1,2-<i>a</i>]pyridine system (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a> C).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Although nitrogen removal stopped AO metabolism, the resulting analogue was more lipophilic (cLogP 5.51 vs 4.51), translating into higher CYP-mediated metabolism and lower solubility.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">5.2.4.  Saturation of Aromatic Azaheterocycle</h4><div class="NLM_p last">As most AO oxidations are affecting aromatic azaheterocycles, the removal of aromaticity, or at least partial saturation, usually stops AO metabolism. The exceptions are AO-catalyzed oxidations of iminium ions formed by initial CYP- or FMO-catalyzed oxidations of nonaromatic heterocycles (see <a class="ref internalNav" href="#sec3_1" aria-label="section 3.1">section 3.1</a>). This approach was successful in a series of imidazo[1,2-<i>a</i>]pyrimidine analogues where saturation of the 6-membered aromatic ring stopped AO oxidation (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>F).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Removal of aromaticity may affect geometry of the compounds or remove π−π stacking interactions, however, diminishing the potency.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">5.2.5.  Reduction of Ring Size</h4><div class="NLM_p last">On the basis of analysis of reported substrates, most AO oxidations occur on the 6-membered azaheterocycles (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Although ring size generally impacts susceptibility to AO oxidations, the distinction should be made between monocyclic and polycyclic (i.e., fused) systems. In monocyclic systems, reduction of ring size from 6 to 5 usually stops AO oxidations. For example, whereas oxidations of diazines and triazines are commonly reported (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), corresponding diazoles and triazoles appear unaffected. The only reported exception is oxidation of oxazole.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Interestingly, isoxazole<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> and isothiazole<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> undergo AO-catalyzed reductive ring openings but not oxidations. Ring constriction approach was applied in a series of pyridine analogues: replacement with oxazole, thiazole, and isoxazole blocked oxidations (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref7 ref65'); return false;" href="javascript:void(0);" class="ref ref7 ref65">(7,65)</a> Oxidations of smaller (<5) or larger (>6) monocyclic azaheterocycles are largely unexplored, opening a possibility for future research and design ideas. In contrast to monocyclics, polycyclic azaheterocycles display complex behavior. Oxidations may occur in both fused 6,6 and 6,5 systems, even on the 5-membered rings which are predominantly inert when monocyclic. As an example, benzimidazole,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> 7-azaindole,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and 1<i>H</i>-imidazo[4,5-<i>b</i>]pyrazine<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> were oxidized on the 5-membered rings. The 6,6 → 6,5 approach is still worth attempting, however. In a series of zoniporide analogues, quinoline replacement with indole and indazole stopped AO oxidations, but benzimidazole was still a low-turnover substrate (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Similarly, replacement of quinoline with imidazo[1,2-<i>a</i>]pyridine stopped AO oxidations in a series of c-Met inhibitors,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> a problem that previously plagued several quinoline-containing kinase inhibitors, including PF-04217903,<a onclick="showRef(event, 'ref86 ref148'); return false;" href="javascript:void(0);" class="ref ref86 ref148">(86,148)</a> JNJ-38877605,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> capmatinib,<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a> and SGX523.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Interestingly, AO-catalyzed oxidations of fused 5,5 systems are not reported, providing a design opportunity.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33">5.3.  Approaches to Decrease Rates of AO-Mediated Oxidations</h3><div class="NLM_p">As exemplified by several discovery projects,<a onclick="showRef(event, 'ref7 ref24 ref29 ref86 ref93 ref95'); return false;" href="javascript:void(0);" class="ref ref7 ref24 ref29 ref86 ref93 ref95">(7,24,29,86,93,95)</a> azaheterocycles metabolized by AO are often key pharmacophores that cannot be easily modified without a significant loss of pharmacodynamic activity. Common approaches to stop AO-mediated metabolism, mentioned in the previous <a class="ref internalNav" href="#sec5_2" aria-label="section 5.2">section 5.2</a>, may not be applicable. If this is the case, several alternative design changes are worth exploring, including modulation of azaheterocycle electronics, introduction of steric hindrance adjacent to the oxidation site, modification of distal substituents, and introduction of kinetic deuterium isotope effect (KDIE). Some of these approaches are overlapping, with some substituents affecting ring electronics, introducing steric hindrance and preventing binding to the enzyme in various degrees. In contrast to methods highlighted in <a class="ref internalNav" href="#sec5_2" aria-label="section 5.2">section 5.2</a>, these approaches generally have mixed success rate and often just slow down AO-mediated metabolism but do not fully stop it. As some residual AO activity will likely remain, these approaches are best accompanied by IVIVC methods to predict human metabolic clearance. Moreover, if steric hindrance or distal modifications are introduced, in silico docking to both target protein and AO may be needed to enable rational design.</div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">5.3.1.  Modulate Electronics of the Affected Azaheterocycle</h4><div class="NLM_p last">This idea is to reduce susceptibility of the affected carbon to AO oxidations, usually by rearranging heteroatoms and existing substituents or by introducing new EDG or/and EWG but without directly blocking affected carbon or significantly reducing compound’s binding affinity to AO. As mentioned in the <a class="ref internalNav" href="#sec3_1" aria-label="section 3.1">section 3.1</a>, removal of nitrogens and introduction of EDGs is generally beneficial, whereas instalment of EWGs has mixed to negative effects. Outcomes may be difficult to predict in complex systems, especially if multiple heteroatoms and substituents are present. These design approaches were applied in a series of methyl-pyridine analogues (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>): replacement of -methyl with electron-donating −amino or −OCH<sub>3</sub> groups stopped AO oxidations; replacement with electron-withdrawing −CF<sub>3</sub> slowed but did not prevent AO metabolism.<a onclick="showRef(event, 'ref7 ref65'); return false;" href="javascript:void(0);" class="ref ref7 ref65">(7,65)</a> Modifications of imidazo[1,2-<i>a</i>]pyrimidine core by rearranging existing substituents and/or introducing new substituents (−methyl, −F, −Br) resulted in mixed success rate (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Interesting and successful example of nitrogen rearrangement approach to alter AO metabolism was provided by shifting from 1,8-naphthyridines to 1,5-naphthyridines (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In a series of quinoline analogues heavily oxidized by AO (zoniporide series), introduction of distal −methyl, −OH, and −OCH<sub>3</sub> groups significantly reduced reaction rates (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>), a shift of quinoline attachment point was unsuccessful, however (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">5.3.2.  Introduce Steric Hindrance near the Affected Carbon</h4><div class="NLM_p last">If tolerated in terms of potency, steric hindrance in the vicinity of the affected carbon may be an option. In a program to find novel c-Met kinase inhibitors, a Novartis team investigated a series of 3-substituted quinolines (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Quinoline was reported to be an important binding motif for c-Met inhibitors, with some of the previous analogues already oxidized at C2 by AO, for example, SGX523<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and JNJ-38877605.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Calculations of energy required to form the tetrahedral intermediate (Δ<i>G</i>) and docking studies were performed in parallel. Results showed that 3-substitution can significantly impact susceptibility of quinoline to AO metabolism. Whereas smaller and electron-donating substituents (e.g., compounds <b>51</b>, <b>53</b>, and <b>71</b>) showed high AO turnover, larger groups generally mitigated oxidations probably due to steric effects (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>). Interspecies differences were also pronounced.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">5.3.3.  Modify Distant Substituents to Prevent Binding to AO and/or Access to MoCo</h4><div class="NLM_p last">This approach aims to disrupt binding of compound to the AO, usually through modifications of distal substituents that are amenable to change (e.g., groups exposed to solvent or noncritical pharmacophores). If pursued rationally, this approach requires good understanding of SAR for both target and AO binding, conditions that were rarely met in practice. For example, in a series of 1,6-naphthyridine and isoquinoline analogues empirical introduction of pendant polar groups failed to reduce AO metabolism.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Similarly, to slow down AO-catalyzed oxidations of the imidazo-1,5-naphthyridine scaffold, distant modifications were attempted (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Whereas R2 substitutions (piperidine motif; compounds <b>13</b>−<b>19</b>) had modest impact on half-lives in human liver S9 (<i>t</i><sub>1/2</sub> = 6.5−38.7 min), R1 substitution of pyridine with indazole significantly diminished AO reaction rates and increased half-lives to 156−158 min (compounds <b>21</b> and <b>23</b>). As improved compounds were still AO substrates, and AO metabolic clearance was historically often underpredicted from in vitro data,<a onclick="showRef(event, 'ref87 ref149'); return false;" href="javascript:void(0);" class="ref ref87 ref149">(87,149)</a> the team applied an empirical scaling approach based on in vitro and in vivo data from four known AO substrates: carbazeran, zoniporide, zaleplon, and PF-04217903. This analysis showed that compounds <b>18</b>, <b>21</b>, and <b>23</b> could have acceptable human clearance. In a series of pyridine analogues, modifications of distal substituent R1 gave mixed success: whereas ethyl-oxazole and tetrahydropyran analogues were not AO substrates, isoxazole and pyrazole analogues were metabolized (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In a imidazo[1,2-<i>a</i>]pyrimidine scaffold, distal modifications to pyridine ring were well tolerated from perspective of potency (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a> A) but did not stop AO metabolism.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> In a series of quinoline analogues (zoniporide series), structural variations of distal acylguanidine moiety and cyclopropyl group modulated AO reaction rates but did not stop the oxidations (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">5.3.4.  Introduce Kinetic Deuterium Isotope Effect (KDIE)</h4><div class="NLM_p">Kinetic isotope effect is the change of the enzymatic reaction rate when atoms in the substrate are replaced by one of its isotopes, usually hydrogen with deuterium in drug-like examples.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> On the basis of increased strength of a C−D bond compared to a C−H bond, and current understanding of AO catalytic mechanism where hydride subtraction from a substrate is likely to be rate-limiting step (see <a class="ref internalNav" href="#sec2_2" aria-label="section 2.2">section 2.2</a>),<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> kinetic deuterium isotope effect (KDIE) is expected to play a significant role in AO-catalyzed reactions. In principle, KDIE can be intramolecular (i.e., intrinsic) or intermolecular, referring to change in the reaction rates between two isotopes in the same molecule or two isotopes in two different molecules, respectively.</div><div class="NLM_p">Carbazeran (phosphodiesterase-2 inhibitor) and zoniporide (Na<sup>+</sup>/H<sup>+</sup> exchanger-1 inhibitor) were Pfizer’s development candidates discontinued due to high clearance in humans, mostly due to AO-mediated metabolism.<a onclick="showRef(event, 'ref12 ref73'); return false;" href="javascript:void(0);" class="ref ref12 ref73">(12,73)</a> As exact sites of AO metabolism were identified for both compounds, corresponding deuterated analogues were prepared and their KDIE evaluated (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> In parallel, monodeuterated phthalazine, quinoxaline, and quinoline were synthesized to mechanistically investigate intramolecular KDIE (phthalazine and quinoxaline have two identical C−H bonds attacked by AO; if one is substituted with C−D, intramolecular KDIE can be determined accurately) (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a> B).</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Examples of kinetic deuterium isotope effect (KDIE) in AO-catalyzed oxidations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Determined in liver cytosol of human, rat, and guinea pig, intramolecular (phthalazine and quinoxaline) and intermolecular (carbazeran, zoniporide, and quinoline) the KDIE were 4.7−5.1 and 3.6−6.1, respectively.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Further, on the basis of steady-state experiments with quinoline, deuteration mainly reduced <i>V</i><sub>max</sub> of the reaction without significantly affecting the <i>K</i><sub>m</sub>. Taken together, these results suggested that AO reaction mechanism is conserved across species, with C−H bond cleavage being the rate-limiting reaction step. In contrast to liver cytosol, KDIE values observed in more complex in vitro systems, such as hepatocytes or cofactor supplemented liver S9 fraction, were generally lower, especially in human hepatocytes (KDIE 1.5−1.9). Observed reduction in apparent KDIE values may be related to alternative metabolic routes present in hepatocytes (e.g., Fm<sub>AO</sub> < 1), such as glucuronidation of carbazeran, or “metabolic switching” phenomena commonly occurring when substrate is competing for multiple biotransformation pathways. In vivo results with carbazeran and zoniporide revealed further complexities, with observed KDIEs varying depending on the test compound (carbazeran vs zoniporide), administration route (oral vs intravenous), and animal species (Hartley guinea pigs vs Sprague−Dawley rats).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> For example, deuteration of carbazeran resulted in approximately 2- and 21-fold AUC increase in rats and guinea pigs, respectively, whereas deuteration of zoniporide showed no significant effect in vivo. Such differences could be rationalized in terms of overall clearance level in relation to hepatic blood flow (CL<sub>plasma</sub> vs <i>Q</i><sub>h</sub>) and fractional clearance by AO (Fm<sub>AO</sub>). Considering the differences in AO expression between rat and guinea pig, however, both in terms of isoforms expressed and their tissue localization (see <a class="ref internalNav" href="#sec7_1" aria-label="section 7.1">section 7.1</a>), we speculate that these species-specific effects on PK might be also partially explained by different substrate-specificities of the various rat and guinea pig AO enzymes. The authors concluded that clear understanding of the overall clearance rates and mechanisms is important; deuteration of AO substrates could help pharmacokinetics only for low-to-moderate clearance compounds and if non-AO clearance mechanisms are not predominant.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></div><div class="NLM_p">JNJ-38877605, the inhibitor of c-Met kinase, was discontinued due to renal toxicity caused by accumulation of the AO-formed quinolin-2-one metabolite despite the acceptable human plasma clearance of 12 mL/min/kg (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>C).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Replacement of a hydrogen atom with deuterium at C2 of the quinoline ring led to apparent reduction of AO metabolism in monkey liver S9 fraction (without NADPH); the reaction rates were not determined, unfortunately.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> A subsequent pharmacokinetic study in cynomolgus monkeys found decreased levels of the AO metabolite and 1.88-fold increase in parent AUC compared to JNJ-38877605, indicating that deuterium replacement significantly reduced AO metabolism in vivo.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p last">VX-984, an inhibitor of DNA-dependent protein kinase discovered by Vertex and currently developed by Merck, is another example of KDIE applied to reduce AO metabolism (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>D). Although details are not published at the time of writing, the 4,6-dideuteriopyrimidine motif is thought to reduce AO liabilities (<a href="https://clinicaltrials.gov/ct2/show/NCT02644278" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02644278</a>). Similarly, MET763 was developed as a deuterated analogue of MET401 (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a> E), a c-Met inhibitor constructed around the novel triazolopyrimidine scaffold affected by AO oxidations.<a onclick="showRef(event, 'ref98 ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref98 ref99 ref100">(98−100)</a></div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38">5.4.  Application of AO Oxidations for Prodrug Design or Novel Scaffolds</h3><div class="NLM_p">AO oxidations are often rapid in vivo, with rates of metabolic clearance reaching or even exceeding liver blood flow. If oxidative metabolites retain pharmacological activity, they may be used as an inspiration for prodrug approach or a novel scaffold. For example, lactam (pyridone-like) metabolites are often stable to further metabolism (authors’ unpublished observations) but may suffer from lower solubility and permeability. Decreased solubility of lactam metabolites is often related to changes in p<i>K</i><sub>a</sub>: from slightly basic in many common azaheterocycles to generally neutral in corresponding lactams.</div><div class="NLM_p">Famciclovir, a substituted purine analogue, undergoes hydrolysis and oxidation in humans to form the active antiviral drug, penciclovir (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>A).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Because of the combination of efficient famciclovir absorption and fast presystemic metabolic conversion, overall human bioavailability of penciclovir is high, 77%.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> The oxidative step was initially attributed to XO, mainly based on famciclovir’s structural similarity to 6-deoxyacyclovir, an attempted prodrug of acyclovir with confirmed XO involvement.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Subsequent studies showed that oxidations of famciclovir and 6-deoxipenciclovir (hydrolyzed intermediate) are catalyzed by AO (from human, guinea pig, rabbit, and rat liver), with minimal contribution from XO.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Application of AO metabolites as novel scaffolds or prodrugs in drug discovery.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">5-Fluoro-2-pyrimidinone was proposed as a prodrug of 5-fluorouracil,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> an antitumor agent with inconsistent bioavailability in humans (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>B).<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Prodrug was oxidized to 5-fluorouracil by liver AO of humans, rats, and mice; oxidations did not occur in the intestinal tissues, however.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> PK studies in mice showed good bioavailability of 5-fluoro-2-pyrimidinone (78−100%), followed by a relatively slow conversion to 5-fluorouracil over the course of several hours.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Fasudil, an isoquinoline-containing inhibitor of Rho-associated kinase, is rapidly oxidized to an active metabolite hydroxyfasudil, effectively providing a prodrug approach (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>C).<a onclick="showRef(event, 'ref34 ref81'); return false;" href="javascript:void(0);" class="ref ref34 ref81">(34,81)</a> In vitro, fasudil was oxidized by AO to hydroxyfasudil by the human and rat liver S9 but not by dog liver S9.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> In healthy volunteers, fasudil was practically quantitatively converted to hydroxyfasudil, with in vivo concentrations of the prodrug (fasudil) remaining low.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><div class="NLM_p last">Inhibitors of c-Met kinase often incorporate quinoline as the key pharmacophore, leading to numerous examples of AO metabolism (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Inspired by AO metabolism, methyl-isoquinolinone was suggested as a suitable replacement scaffold.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In an effort to find positive allosteric modulators of muscarinic acetylcholine subtype 4 receptor, a series of thieno[2,3-<i>c</i>]pyridines were discovered and found to be affected by AO oxidations.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> As resulting pyridone metabolite retained potency, the team used AO metabolism as an inspiration for further exploration, eventually leading to thieno[3,2-<i>e</i>][1,2,4]triazolo[4,3-<i>a</i>]pyridine tricyclic analogues with improved properties.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39">5.5.  Considerations of AO-Catalyzed Aldehyde Oxidations</h3><div class="NLM_p last">Although aldehydes are rare in drug-like molecules, they are often formed as intermediates after oxidations of primary alcohols or terminal alkyl groups.<a onclick="showRef(event, 'ref8 ref15 ref155 ref156'); return false;" href="javascript:void(0);" class="ref ref8 ref15 ref155 ref156">(8,15,155,156)</a> At this stage, AO may play a role in further oxidation to carboxylic acid (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D), often in synergy with enzymes that share a similar function, like ALDH and XO. Even if AO involvement is limited to a single step in a multistep pathway, it may affect the overall reaction equilibrium, leading to interspecies differences in metabolite exposure (MIST issues) or problems in IVIVC. In the case of imrecoxib, a stepwise oxidation of the terminal methyl group resulted in the major carboxylic acid metabolite, accounting for 68% of the systemic exposure in humans (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The acid metabolite was also major in rat plasma.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> In vitro incubations revealed differences in metabolic pathways between rats and humans, however. In humans, initial oxidations to alcohol and aldehyde were catalyzed by CYP3A4/CYP2D6, but subsequent aldehyde oxidation to acid (rate-limiting step) was mainly catalyzed by AO.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In rats, oxidation to acid was already occurring in liver microsomes and was NADPH-dependent, suggesting limited involvement of AO.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> The situation was further complicated by poor metabolite IVIVC in humans: acid metabolite was minor in vitro but major in vivo. Possible explanations are disbalanced role of reductive enzymes in vitro or extrahepatic AO metabolism in vivo.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These examples highlight that AO-catalyzed aldehyde oxidations may play an indirect (or “silent”) role in drug design, mainly through potentiation of interspecies differences and poor IVIVC. Design teams may address these concerns either through structural modifications (e.g., replacement of terminal −CH<sub>3</sub> with −CF<sub>3</sub> or −CHF<sub>2</sub>) or timely identification of AO-driven pathways and challenges they may bring.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40">5.6.  Approaches to AO-Catalyzed Amide Hydrolyses</h3><div class="NLM_p">As amide functionality is both very common and often critical for function in drug-like molecules, avoidance is unlikely to be a sensible approach despite the potential for AO-mediated hydrolysis. Therefore, our recommendation is to guide chemical design based on available discovery data (in vitro and in vivo), including metabolic clearance in AO-competent systems (see <a class="ref internalNav" href="#sec8_1" aria-label="section 8.1">section 8.1</a>), metabolite identification, interspecies differences, and IVIVC. If AO involvement in amide hydrolysis is confirmed, the consequences are usually 2-fold: (a) high human metabolic clearance and interspecies differences (as exemplified by GDC-0834<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>) and (b) potential release of aryl-amine (aniline-like) metabolites that may undergo bioactivation and contribute to adverse effects.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> As already mentioned in <a class="ref internalNav" href="#sec3_2" aria-label="section 3.2">section 3.2</a>, relatively little data is available on SAR of AO-mediated amide hydrolysis (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), making rational design decisions challenging. One approach is to keep the amide group intact but alter the structures of amine or acyl moieties to stop or decrease AO-catalyzed hydrolysis. An alternative approach is to replace the affected amide with a suitable isostere (or bioisostere; if amide contributes to biological function). It should also be emphasized that AO is not the only enzyme contributing to amide hydrolysis. These reactions can be catalyzed by various hydrolytic enzymes<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> or even occur nonenzymatically, for example, under acidic conditions of the stomach. Therefore, new designs should be based on an overall balance of available evidence and properties, considering both hydrolysis pathways and potency SAR of the chemotype.</div><div class="NLM_p">A study of 75 amides highlighted that aromatic amides are more susceptible to AO hydrolysis compared to aliphatic ones and that structure of the amine (or aniline/aryl-amine) part plays a greater role in the hydrolysis rate.<a onclick="showRef(event, 'ref28 ref159'); return false;" href="javascript:void(0);" class="ref ref28 ref159">(28,159)</a> Substitutions of aryl-amines in <i>meta</i> positions with EDG and EWG groups increased and decreased propensity toward AO hydrolysis, respectively. Substitutions of <i>ortho</i> and <i>para</i> positions generally reduced hydrolysis regardless if EDG or EWG was introduced.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Tertiary amides, sterically hindered and less flexible anilines or aliphatic amines, were also generally stable (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In contrast to aniline moiety, the structure of acyl moiety generally had less impact on the hydrolysis rates: furane, indole, 2-methylenindole, (3-fluorophenyl)propane, cyclohexane, pyrazine, and pyridine were all substrates (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). Tested bis-aliphatic amides were generally not substrates.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Comparable findings were reported during lead optimization of GDC-0834,<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> even before the team knew that AO metabolism was responsible for the observed non-CYP mediated amide hydrolysis.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The successful approach involved a combination of steric hindrance and electronic effects by substituting the 2- and 6- positions of the aniline (methyl and fluorine gave best results).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><div class="NLM_p last">An alternative approach is to replace amide functionality with an amide (bio)isostere. For example, available experimental results suggest that hydrazides, ureas, and carbamates are resistant to AO hydrolysis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Amide isosteres of GDC-0834, sulphonamide, and − NHCHCF<sub>3</sub>−, as well as inverted and ternary amides, reduced metabolism but also abolished potency.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Other commonly applied amide isosteres are trifluoroethylamine, sulphonamide, guanidine and amidine, oxetan-3-amines, cyclopropanamine fluoroethylene, and various 5-membered heterocycles, including oxadiazoles and triazoles.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> These isosteres offer a range of physicochemical properties, geometries, and HBA/HBD motifs that should be tailored according to a project’s needs. Although synthetic investment and risk of potency decrease are higher, amide isosteres may address multiple liabilities at once, including amide hydrolysis catalyzed by several enzymes (e.g., AO and hydrolytic enzymes) and safety concerns of released aryl-amine metabolites.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41">5.7.  Approaches to AO-Catalyzed Reductions</h3><div class="NLM_p">Whereas AO-catalyzed oxidations and hydrolysis are mainly discussed from the perspective of metabolic clearance, AO reductions play a somewhat different role in drug design. Metabolic clearance is now less of an issue, but challenges of safety, interspecies differences, and IVIVC remain. For example, nitro reductions lead to formation of aryl-hydroxylamines and aryl-amines, metabolites that may undergo bioactivation and contribute to a range of adverse effects, including liver toxicity<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and genotoxicity.<a onclick="showRef(event, 'ref16 ref121'); return false;" href="javascript:void(0);" class="ref ref16 ref121">(16,121)</a> Reductions of <i>N</i>-oxides may be counteracted with CYP/FMO-catalyzed reoxidations, resulting in complex biotransformation equilibriums that are challenging to predict from in vitro assays.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Lastly, reductive ring openings of isoxazole and isothiazole are infrequent biotransformation pathways that may go unnoticed and contribute to interspecies differences.<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a> Therefore, even if functional outcomes of reductions are different, our recommendations are similar to oxidations and hydrolysis; AO reductions should be detected early and considered in design decisions as a part of the multiparametric optimization effort.</div><div class="NLM_p last">When an aromatic nitro group is affected by AO reduction, the first step may be to assess the biological consequences of this process, for example, by in vitro safety testing of the corresponding aryl-amines, especially for hepatotoxicity and genotoxicity. If the structural motif is still deemed risky, design teams should aim to eliminate, or at least decrease, AO-catalyzed nitro reduction. It should be emphasized that genotoxicity (if likely to occur) is not evaluated from the classical therapeutic window perspective, meaning that even small amounts of genotoxic metabolites will render the drug unsafe and stop further progression. On the basis of a recent study of 11 nitroaromatic compounds, one design possibility is to increase relative electron-richness of the functionality, for example, by introducing electron-donating substituents in the aromatic ring.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The alternative is to replace nitro group with a suitable isostere, for example pyridine,<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> carboxylate,<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> or difulorophenyl moiety.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> The nitroaromatic group of nimesulide, a nonsteroidal anti-inflammatory drug exhibiting hepatotoxicity facilitated by AO-mediated reduction, was successfully replaced with pyridine.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Fruitful pyridine replacement of aromatic nitro group was also achieved in a series of β-adrenergic antagonists.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a><i>N</i>-Oxides are relatively rare in drug-like chemical space,<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> with some examples being minoxidil, seletalisib, chlordiazepoxide, and otamixaban. If reduced by AO, formed metabolites can often be reoxidized by other oxidative drug-metabolizing enzymes (e.g., CYPs and FMOs), leading to complex equilibria as exemplified by seletalisib.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">6.  Examples of Discovery Programs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The following sections are summaries of where a variety of medicinal chemistry approaches have been employed to mitigate AO activity. The use of examples such as these should always form part of any drug design strategy, as learning from other groups’ successes and failures is one of the most successful ways to reduce the drug design cycle.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43">6.1.  Example of Disubstituted 1,6-Naphthyridines and Isoquinolines</h3><div class="NLM_p">In a research program to discover cyclin-dependent kinase 8 and 19 inhibitors, 2,8-disubstituted-1,6-naphthyridines and 4,6-disubstituted-isoquinolines were rapidly oxidized by AO (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Analysis of metabolites identified C1 (isoquinolines) or C5 (1,6-naphthyridines) carbon, adjacent to nitrogen, as the main sites of AO oxidations. Formed pyridone metabolites were pharmacologically inactive, consistent with results from the ligand−target cocrystal structure showing naphthyridine nitrogen N6 interacting with the backbone −NH− of the hinge residue alanine 100. The team used incubations with HLC and chemical “litmus test”<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> (<a class="ref internalNav" href="#sec8_4" aria-label="section 8.4">section 8.4</a>) to design away from AO metabolism. Enzymatic oxidations and radical-based −CHF<sub>2</sub> additions were well correlated. Initial attempts to indirectly reduce the AO metabolism, focused on introduction of distal polar substituents and reduction of log <i>D</i>, were unsuccessful. This result was in line with previous observations that AO metabolism is largely independent of log <i>D</i> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Direct blocking of affected carbon with methoxy, methyl, difluoromethyl, or amino group was successful, but only amino substituted analogues retained desired pharmacological activity.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Example of disubstituted 1,6-naphthyridines and isoquinolines. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on Mallinger et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44">6.2.  Example of Pyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one Analogues</h3><div class="NLM_p">In a search for JmjC histone lysine demethylase inhibitors, pyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one analogues were oxidized by AO at the C2-position (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Oxidations were observed both in human and mouse liver cytosol, inhibited by raloxifene but not allopurinol, and the exact site of metabolism was identified by high resolution LC-MS and <sup>1</sup>H NMR. Consistent with in vitro results showing AO involvement, compounds exhibited high blood clearance in mice (>liver blood flow) and poor oral bioavailability (2%). The available crystal structure of human aldehyde oxidase and Glide docking were used to guide design.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Direct blocking of affected C2 position with methyl or ethyl groups stopped AO metabolism and preserved potency.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Example of pyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one analogues. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on Hayes et al.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45">6.3.  Examples of Azaindole Analogues</h3><div class="NLM_p">The quest for inhibitors of influenza viral polymerase at Vertex Pharmaceuticals led to discovery of 7-azaindole analogues that were oxidized by AO at the C2 position (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>A).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Oxidations by AO were monitored in human liver cytosol, and the site of oxidation was determined by <sup>1</sup>H NMR after metabolite isolation. Co-crystal ligand−target structures showed that azaindole ring is the key pharmacophore involved in hydrogen bonding with lysine 376 and glutamic acid 361. As this finding indicated that AO metabolites would be pharmacologically inactive, the team embarked on designing-out AO activity. The strategy to mitigate AO metabolism followed two directions: (a) direct substitutions of the C2-position and (b) inclusion of additional nitrogen to form the 7-azaindazole motif. Small alkyl groups (methyl and cyclopropyl) and carboxylic acid at the C2-position significantly diminished potency, but a hydroxymethyl group and oxime were well tolerated (design was helped by cocrystal structures indicating possibility for additional interactions with Glu361 and Arg332). When assayed for AO activity in human liver cytosol, all C2-substituted compounds were metabolically stable.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Examples of azaindole analogues. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on results from refs <a onclick="showRef(event, 'ref25 ref51 ref93'); return false;" href="javascript:void(0);" class="ref ref25 ref51 ref93">(25,51,and93)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast to C2-substituted analogues, 7-azaindazole compounds were equipotent to corresponding 7-azaindole analogues. The 7-azaindazole analogues were rapidly metabolized and reactions were inhibited by raloxifene, however, suggesting that AO metabolism was not stopped.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Although this surprising result was not investigated further, incorporation of additional nitrogen may have modulated the electronics of the 7-azaindazole system, leading to novel sites of AO oxidation in the positions C4 or C6. Metabolic switching to unsubstituted carbon of pyrimidine was also possible, although less likely based on previous results from C2-substituted 7-azaindazoles.</div><div class="NLM_p">Similar AO-mediated C2 oxidation of 7-azaindole was previously observed for VX-509 (decernotinib), a Janus kinase 3 inhibitor in clinical development for treatment of rheumatoid arthritis (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>B).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The VX-509 oxidative metabolite was found to be involved in clinically relevant time-dependent inhibition of CYP3A4, possibly due to covalent binding to the enzyme.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As human liver microsomes (a subcellular fraction that lacks AO activity) were used for CYP inhibition studies in preclinical development, drug interaction potential remained undiscover until VX-509 increased the AUC of midazolam, atorvastatin, and methyl-prednisolone by 12.0-, 2.7-, and 4.3-fold, respectively.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">In a research program to find inhibitors of ataxia telangiectasia and Rad-3 related protein, 6-azaindole analogues were identified as very potent (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>C).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Biotransformation experiments with human liver cytosols and <sup>18</sup>O-labeled water revealed that compound was an AO substrate, but the exact structure of the metabolite was not reported. The 5-fluoro-6-azaindole analogue stopped AO metabolism and improved Caco-2 permeability.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46">6.4.  Example of Imidazoquinoline Analogues</h3><div class="NLM_p">In a Novartis discovery program to find inhibitors of Cancer Osaka thyroid kinase, a high-throughput screening identified a 2.6 μM hit based around 1<i>H</i>-imidazo[4,5-<i>c</i>]quinoline scaffold (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Hit-to-lead efforts to increase potency, improve kinase selectivity, reduce log <i>D</i>, and enhance solubility, resulted in the optimized compound with 1<i>H</i>-imidazo[4,5-<i>c</i>][1,7]naphthyridine core and low nanomolar potency. X-ray cocrystal structure with the target confirmed tight interactions of the imidazoquinoline core with several key amino acid residues. Subsequent pharmacokinetic experiments in rats showed very high plasma clearance (221 mL/min/kg), however, far exceeding the liver blood flow and preventing the execution of pharmacological studies. Mechanistic studies in bile-cannulated rats and human and rat liver S9 (without NADPH) identified and isolated a major oxidative metabolite on the C2 position of 1<i>H</i>-imidazo[4,5-<i>c</i>][1,7]naphthyridine core (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). Oxidations in human and rat liver S9 fractions were inhibited by raloxifene, a potent AO inhibitor,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> confirming the involvement of AO.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Because of poor pharmacokinetics in rats, subsequent pharmacological experiments were performed in dogs, a species that lacks functional AO.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This example shows the need for early identification and mitigation of AO activity in the chemical series, especially if AO structural alert overlaps with the key pharmacophore.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Example of imidazoquinoline analogues. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on results from Glatthar et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47">6.5.  Example of 1,5-Naphthyridine Analogues</h3><div class="NLM_p">A Pfizer research program to find structurally differentiated and dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors, identified promising hits with imidazo-1,5-naphthyridine scaffold (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Optimization goals were to increase cellular potency and improve overall drug-like properties (metabolic stability, permeability, solubility, and log <i>D</i>). Incubations with human liver S9 without NADPH, inhibition by raloxifene, and metabolite isolation confirmed metabolism by AO, with the site of oxidation being C2 of the 1,5-naphthyridine scaffold.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> As docking studies and cocrystal structure indicated that the naphthyridine ring nitrogen forms a key hydrogen bond with the hinge residue of PI3K, the team’s approach to mitigate AO metabolism was to modify distal substituents R1 and R2 without changing the 1,5-naphthyridine core itself (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Whereas R2 substitutions (piperidine motif; compounds <b>13</b>−<b>19</b>) had modest impact on half-lives in human liver S9 (<i>t</i><sub>1/2</sub> = 6.5−38.7 min), R1 substitution of pyridine with indazole significantly diminished AO reaction rates and increased half-lives to 156−158 min (compounds <b>21</b> and <b>23</b>). As improved compounds were still AO substrates, and AO metabolic clearance was historically often underpredicted from in vitro data,<a onclick="showRef(event, 'ref87 ref149'); return false;" href="javascript:void(0);" class="ref ref87 ref149">(87,149)</a> the team applied an empirical scaling approach based on in vitro and in vivo data from four known AO substrates: carbazeran, zoniporide, zaleplon, and PF-04217903. This analysis showed that compounds <b>18</b>, <b>21</b>, and <b>23</b> could have acceptable human clearance. Finally, compound <b>18</b> was selected based on overall balance of properties despite the moderate half-life of 38.7 min in human liver S9.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Example of 1,5-naphthyridine analogues. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on results from Cheng et al.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48">6.6.  Example of Pyridine Analogues</h3><div class="NLM_p">In Pfizer’s program to find agonists of toll-like receptor subtype 7, several imidazopyridine analogues with pyridine substituents were prepared (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref7 ref65'); return false;" href="javascript:void(0);" class="ref ref7 ref65">(7,65)</a> Despite a good balance of in vitro properties, lead compounds exhibited very high clearance in rat plasma (up to 144 mL/min/kg), preventing the execution of planned toxicological studies. Incubations with rat liver cytosol and inhibition by menadione confirmed oxidation of methyl-pyridine moiety by rat AO; this reaction was not occurring in human liver cytosol, however. To enable toxicological studies in rat and reduce interspecies differences, the team focused on designing-out AO metabolism in rat. Several complementary approaches were used, including (a) directly blocking or replacing site of metabolism at the pyridine, (b) modulating electronics of the pyridine, (c) introducing steric hindrance at pyridine, and (d) modifying distal substituent R1 (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>). In addition to experimental studies, molecular orbital calculations were performed to estimate reaction energies for the addition of the hydroxyl anion to a range of substituted pyridines; these calculations reflected only electronic properties of the pyridine ring and did not consider steric factors.<a onclick="showRef(event, 'ref7 ref40'); return false;" href="javascript:void(0);" class="ref ref7 ref40">(7,40)</a> Results showed that almost all pyridine modifications mitigated rat AO metabolism without introducing human AO metabolism. An interesting exception was a trifluoromethyl-pyridyl compound that was oxidized at the lower rate compared to methyl-pyridine (1.5 vs 11 μL/min/mg), despite the highest reactivity predicted from the calculated reaction energies. Modifications of distal group R1 resulted in mixed outcomes: whereas ethyl-oxazole and tetrahydropyran analogues were not AO substrates, isoxazole, and pyrazole analogues were metabolized.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Examples of pyridine analogues. Prepared based on results from Pryde et al.<a onclick="showRef(event, 'ref7 ref65'); return false;" href="javascript:void(0);" class="ref ref7 ref65">(7,65)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49">6.7.  Example of Imidazo[1,2-<i>a</i>]pyrimidine Analogues</h3><div class="NLM_p">In a Pfizer program to discover selective antagonist of androgen receptor, a lead compound was identified with imidazo[1,2-<i>a</i>]pyrimidine scaffold (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref95 ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref95 ref96 ref97">(95−97)</a> Despite low clearance in human microsomes and hepatocytes, as well as satisfactory rat pharmacokinetics, incubations with human liver S9 (without NADPH) and inhibition by raloxifene indicated oxidation by AO. Ion fragmentation analysis identified imidazo[1,2-<i>a</i>]pyrimidine scaffold as the site of AO metabolism, although the exact position of oxidation was not determined. Because only one oxidative metabolite was observed, the team hypothesized that likely sites of AO oxidation are electron deficient carbons adjacent to nitrogens (C22, C27, and C29) if they are spatially accessible by MoCo. Several complementary approaches to mitigate AO metabolism were attempted, including modifications to distal substituents to prevent AO binding, direct blocking of carbons C22 and C29, and rearrangement and removal of nitrogens from the ring system. Distal modifications to pyridine ring were well tolerated from a perspective of potency (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>A) but did not stop AO metabolism. An attempt to block AO oxidation at C22 with a methyl group was also unsuccessful, indicating that likely SoM are C27 or C29; blocking C29 with methoxy group stopped the oxidation (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>B). Replacement of nitrogen in position 30 with carbon was also successful, confirming that C29 was the likely site of AO oxidation (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>C). Removal of N30 led to higher microsomal clearance and lower solubility, however, exemplifying the potential shortcomings of this approach. AO oxidation persisted when nitrogen was moved from position 29 to 30, possibly due to a novel exposed site at C29 (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>D). Various attempts at modulating electronics of the ring system, changing attachment point, or introducing substituents at C28 resulted in mixed outcomes (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>E). Interestingly, imidazo[1,2-<i>a</i>]pyrimidine core was oxidized in contrast to [1,2,4]triazolo[1,5-<i>a</i>]pyrazine core, suggesting that electronics of the ring system can play a major role. Finally, removing aromaticity from the 6-membered ring also blocked oxidations (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>F).</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Example of imidazo[1,2-<i>a</i>]pyrimidine analogues. Prepared based on results from Linton et al.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50">6.8.  Example of Naphthyridine Analogues in Azetidinyl Ketolides</h3><div class="NLM_p">A research program to overcome bacterial resistance and improve safety of ketolide macrolides resulted in a novel series of azetidinyl ketolides (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Synthesized compounds were derivatives of telithromycin with its imidazolyl-pyridine motif replaced with various naphthyridine analogues. DMPK optimization focused on microsomal clearance and time-dependent inhibition of CYP3A4, resulting in the nomination of 1,8-naphthyridine <b>6q</b> for clinical development (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>). Clinical pharmacokinetics was poor, however, with achieved exposures 5-fold lower compared to those anticipated. Subsequent incubations with human liver cytosol and inhibition by raloxifene revealed AO metabolism on the [1,8]-naphthyridine moiety; the exact site of oxidation was not determined. The primary approach to mitigate AO oxidations was to modulate electronics of the affected azaheterocycle by rearranging nitrogens and introducing hydroxyl substituents. Two 1,8-naphthyridine analogues were prepared (<b>6m</b> and <b>6r</b>), but AO oxidations persisted. The 1,5-naphthyridine analogues (<b>6l</b> and <b>6s</b>) were not oxidized, however, and 3-hydroxy-[1,5]naphthyridine analogue was selected for further progression.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Example of naphthyridine analogues in azetidinyl ketolides. Prepared based on results from Magee et al.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Exact sites of AO oxidation were not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51">6.9.  Examples of Quinoline Analogues</h3><div class="NLM_p">Zoniporide is an inhibitor of the sodium/hydrogen exchanger that failed in clinical trials due to high metabolic clearance, a process that was later attributed to AO-mediated oxidation of its quinoline core at the C2.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> To understand the SAR of zoniporide oxidation, several analogues were prepared and assayed in human liver S9 without NADPH (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Half-lives of the parent compounds (<i>t</i><sub>1/2</sub>) were reported as a measure of metabolic stability, and sites of oxidation were investigated by LC-MS. Structural variations included analogues of the acylguanidine moiety, cyclopropyl group, and the quinoline core. Results showed that distal modifications to acylguanidine and cyclopropyl moieties can slow down, but not completely stop, AO oxidations. To enable rational design and compound progression, this approach relies on complementary in silico tools (docking or electronic properties calculations) and IVIVC approaches to predict impact of residual AO activity on human clearance. Modifications to the quinoline core were also partially successful, even without directly blocking the SoM. Interestingly, 6-substituted quinolines were more metabolically stable (<i>t</i><sub>1/2</sub> = 120 min) and reduction of ring size (6 → 5) generally mitigated AO metabolism (<i>t</i><sub>1/2</sub> = 120 min), even if benzimidazole was a low-turnover substrate.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Example of quinoline analogues (zoniporide series). Prepared based on results from Dalvie et al.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a program to find novel c-Met kinase inhibitors, a Novartis team investigated a series of 3-substituted quinolines (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Quinoline was reported to be an important binding motif for c-Met inhibitors, with some of the previous analogues already oxidized at C2 by AO, for example, SGX523<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and JNJ-38877605.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> To assess AO metabolism, compounds were incubated with human, mouse, rat, and monkey liver cytosol without NADPH and half-lives were reported as a measure of metabolic stability. Calculations of energy required to form the tetrahedral intermediate (Δ<i>G</i>), and docking studies were performed in parallel. Results showed that 3-substitution can significantly impact susceptibility of quinoline to AO metabolism: whereas smaller and electron-donating substituents (e.g., compounds <b>51</b>, <b>53</b>, and <b>71</b>) showed high AO turnover, larger groups generally mitigated oxidations, probably due to steric effects (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>). Interspecies differences were also pronounced. Compound <b>51</b> showed relatively low turnover in human liver cytosol (<i>t</i><sub>1/2</sub> = 283 min) but much higher in monkey (<i>t</i><sub>1/2</sub> = 3 min). Conversely, compound <b>53</b> was relatively stable in rat cytosol (<i>t</i><sub>1/2</sub> = 229 min) but much less so in monkey and human cytosol (<i>t</i><sub>1/2</sub> = 9.1 and 88 min, respectively). As these differences may affect suitability of pharmacological and toxicological nonclinical species, early cross-species screening was a good practice.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The energy needed to form the tetrahedral intermediate (Δ<i>G</i>) did not correlate with experimental results.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Example of quinoline analogues (c-Met inhibitors). Prepared based on results from Zhang et al.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a quest to identify novel inhibitors of phosphoinositide 3-kinase β, a team from Gilead Sciences observed a unique example of atropisomerism (stereoisomers due to hindered rotation around a single bond) affecting the rate of AO-mediated quinoline oxidations.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> In this case, restricting the free rotation around the C−N bond connecting the two bicyclic systems led to two atropisomeric compounds (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>): (M)-28 with significant AO metabolism (predicted Fm<sub>AO</sub> was 69%) and (P)-28 with significantly reduced AO metabolism (Fm<sub>AO</sub> was unmeasurable). By a combination of thoughtful design and serendipity, (P)-28 was also the eutomer, providing the team with an orally bioavailable compound for further studies.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Stereoselective AO metabolism was previously observed for RS-8359 (pyrimidine analogue) and cinchona alkaloids (quinoline analogues).<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Example of atropisomerism affecting the rate of AO metabolism of the quinoline analogues. Asterisk denotes the site of AO oxidation. Prepared based on results from Chandrasekhar et al. 2018.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52">6.10.  Lessons Learned from Discovery Programs</h3><div class="NLM_p">As highlighted by the presented discovery programs, early identification of AO metabolism and complementary information, e.g., SoM, pharmacological activity, and cross-species variability, play a positive role toward the success of discovery programs. The variety of examples presented in this section suggests that the most straightforward and reliable approaches to design away from AO metabolism rely on direct blockade of the SoM by substitution or modification of the heterocycle system with introduction of a heteroatom. This strategy highlights the usefulness of early identification of the SoM, initially by soft-spot identification and later isolation and full characterization of metabolites (<a class="ref internalNav" href="#sec8_3" aria-label="section 8.3">section 8.3</a>). Alternatives and complementary approaches, such as in silico prediction or litmus test (allowing immediate blockade of the putative site) are still underutilized and their reliability remains to be assessed.</div><div class="NLM_p last">If direct blocking or replacement of SoM cannot be applied, due to loss of potency or any other critical parameters, changing heterocycles or substituting them at remote positions to either modulate the electronic effects or introduce steric hindrance have also proved to be successful, but the SAR seems to less predictable. Additionally, these approaches often reduce, but do not completely stop AO activity, necessitating the means to predict human PK during compound optimization (<a class="ref internalNav" href="#sec8_2" aria-label="section 8.2">section 8.2</a>). Few remaining design approaches, such as heterocyclic ring constriction, saturation, or KDIE, have been rarely applied, perhaps indicating that design teams are less familiar with these tactics. As a warning, while looking at AO metabolism, one should remain vigilant of cross-species variability (<a class="ref internalNav" href="#sec7_1" aria-label="sections 7.1">sections 7.1</a> and <a class="ref internalNav" href="#sec7_2" aria-label="7.2">7.2</a>), thus early screening is advisible.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">7.  Biology of AO: Species Differences and Physiological Roles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Why is AO metabolism often underpredicted from in vitro liver models or significantly different between species? Understanding of AO biology will help us rationalize these observations and is complementary to drug design approaches. Diversity and tissue expression of AO enzymes (<a class="ref internalNav" href="#sec7_1" aria-label="section 7.1">section 7.1</a>) translates into profound interspecies differences (<a class="ref internalNav" href="#sec7_2" aria-label="section 7.2">section 7.2</a>). Lastly, physiological role of AO is briefly reviewed (<a class="ref internalNav" href="#sec7_3" aria-label="section 7.3">section 7.3</a>). While excellent and comprehensive reviews have been recently written on these aspects,<a onclick="showRef(event, 'ref1 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref4 ref5">(1,4,5)</a> to which the reader is referred for more details, a concise overview will be given here, with the aim of providing some basic knowledge on species and assays to select, in order to complement and drive drug design strategies.</div><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54">7.1.  Diversity and Tissue Expression of Mammalian AO Enzymes</h3><div class="NLM_p">Mammalian AOs share high sequence and protein structure similarity.<a onclick="showRef(event, 'ref4 ref168'); return false;" href="javascript:void(0);" class="ref ref4 ref168">(4,168)</a> Along with the other vertebrate enzymes in this family, they have evolved from a common xanthine dehydrogenase ancestor through a series of species-specific gene deletions and pseudogenizations that led to the variety of AOX genes found in the different species today.<a onclick="showRef(event, 'ref4 ref168 ref169 ref170'); return false;" href="javascript:void(0);" class="ref ref4 ref168 ref169 ref170">(4,168−170)</a> In total, four mammalian AO enzymes exist: the highest number (four) is expressed in mouse, rat, and potentially rabbit (provisional entries in the NCBI Gene database, <a href="https://www.ncbi.nlm.nih.gov/gene/" class="extLink">https://www.ncbi.nlm.nih.gov/gene/</a>, last accessed July 2019) and the lowest in humans (one).<a onclick="showRef(event, 'ref4 ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref4 ref170 ref171">(4,170,171)</a> The AO isoforms expressed in humans and the most common nonclinical species used in drug development, along with their tissue expression, are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. AO Genes and Their Expression in Humans and Nonclinical Species Relevant to Drug Development</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">gene symbol</th><th class="colsep0 rowsep0" align="center">isoenzyme<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></th><th class="colsep0 rowsep0" colspan="2" align="center">accession no.</th><th class="colsep0 rowsep0" align="center">tissue expression<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="center">AOX1</td><td class="colsep0 rowsep0" align="center">AO1</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001159.3</td><td class="colsep0 rowsep0" align="center">adrenal gland, liver, kidney, seminal vesicles, ovaries, adipose tissue, prostate, testis, pancreas, urinary bladder, thyroid, bone, trachea, esophagus, colon, endometrium, placenta, lung, heart, glial cells of spinal cord</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref4 ref172 ref173 ref174'); return false;" href="javascript:void(0);" class="ref ref4 ref172 ref173 ref174">(4,172−174)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">protein</td><td class="colsep0 rowsep0" align="center">NP_001150.3</td><td class="colsep0 rowsep0" align="center">adrenal gland, liver, gallbladder, pancreas, kidney; brain, stomach, duodenum, small intestine, colon, rectum, testis, seminal vesicle, placenta, skin; skeletal muscle, lung, bronchus, urinary bladder, prostate, fallopian tube, breast, endometrium, soft tissue</td><td class="colsep0 rowsep0" align="center">Human Protein Atlas, version 18.1 (data available from <a href="https://www.proteinatlas.org/ENSG00000138356-AOX1/tissue" class="extLink">https://www.proteinatlas.org/ENSG00000138356-AOX1/tissue</a>, accessed on April 13, 2019)<a onclick="showRef(event, 'ref175 ref176'); return false;" href="javascript:void(0);" class="ref ref175 ref176">(175,176)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">       </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="center">Aox1</td><td class="colsep0 rowsep0" align="center">AO1</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_009676.2</td><td class="colsep0 rowsep0" align="center">bladder, adipose tissue, inner ear, seminal vesicles, liver, esophagus, mammary gland, lung, adrenal, heart, ovary, brain, testis, colon, kidney, thymus, choroid plexus, spinal cord, spleen, eye</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref4 ref170 ref171 ref177 ref178 ref179'); return false;" href="javascript:void(0);" class="ref ref4 ref170 ref171 ref177 ref178 ref179">(4,170,171,177−179)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">protein</td><td class="colsep0 rowsep0" align="center">NP_033806</td><td class="colsep0 rowsep0" align="center">lung, liver, brain, spinal cord, heart, esophagus</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref178 ref180 ref181 ref182'); return false;" href="javascript:void(0);" class="ref ref178 ref180 ref181 ref182">(178,180−182)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Aox2</td><td class="colsep0 rowsep0" align="center">AOX3L1, AOH3</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001008419.2</td><td class="colsep0 rowsep0" align="center">olfactory mucosa, thymus, testis, ovaries, placenta, frontal lobe, bladder, large intestine, colon</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref170 ref177 ref181 ref182'); return false;" href="javascript:void(0);" class="ref ref170 ref177 ref181 ref182">(170,177,181,182)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">protein</td><td class="colsep0 rowsep0" align="center">NP_001008419.1</td><td class="colsep0 rowsep0" align="center">olfactory mucosa</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref181 ref182'); return false;" href="javascript:void(0);" class="ref ref181 ref182">(181,182)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Aox3</td><td class="colsep0 rowsep0" align="center">AO3, AOH1</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_023617.2</td><td class="colsep0 rowsep0" align="center">liver, lung, testis, lung, bladder, adipose tissue, ovaries, mammary gland, brain, kidney, heart, adrenal gland, stomach, placenta, skin</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref4 ref177 ref180 ref183'); return false;" href="javascript:void(0);" class="ref ref4 ref177 ref180 ref183">(4,177,180,183)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">protein</td><td class="colsep0 rowsep0" align="center">NP_076106.2</td><td class="colsep0 rowsep0" align="center">liver, lung, esophagus, skin</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref180 ref181 ref182'); return false;" href="javascript:void(0);" class="ref ref180 ref181 ref182">(180−182)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Aox4</td><td class="colsep0 rowsep0" align="center">AO4, AOH2</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_023631.2</td><td class="colsep0 rowsep0" align="center">Harderian gland, stomach, testis, brain, placenta, lung, ovaries, thymus, stomach, skin, inner ear, tongue</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref4 ref170 ref177 ref180'); return false;" href="javascript:void(0);" class="ref ref4 ref170 ref177 ref180">(4,170,177,180)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">protein</td><td class="colsep0 rowsep0" align="center">NP_076120.2</td><td class="colsep0 rowsep0" align="center">Harderian gland, esophagus, stomach, skin, oral cavity</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref180 ref182'); return false;" href="javascript:void(0);" class="ref ref180 ref182">(180,182)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">      </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="center">Aox1</td><td class="colsep0 rowsep0" align="center">AO1</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_019363.2</td><td class="colsep0 rowsep0" align="center">liver, testis, lung, uterus, adrenal gland, kidney, heart, brain, thymus</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Aox2</td><td class="colsep0 rowsep0" align="center">AOX3L1, AOH3</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001008522.1</td><td class="colsep0 rowsep0" align="center">kidney, thymus, adrenal gland, liver, testis</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Aox3</td><td class="colsep0 rowsep0" align="center">AO3, AOH1</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001008527.1</td><td class="colsep0 rowsep0" align="center">liver, testis, lung, heart, adrenal gland, kidney, uterus, thymus</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Aox4</td><td class="colsep0 rowsep0" align="center">AO4, AOH2</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001008523.1</td><td class="colsep0 rowsep0" align="center">lung, kidney, uterus, thymus</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">unclear</td><td class="colsep0 rowsep0" align="center">unclear</td><td class="colsep0 rowsep0" align="center">protein</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">liver, lung, tongue, kidney, esophagus, stomach, large and small intestine, bile duct, trachea, heart, skin, bladder, brain</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref185 ref186 ref187'); return false;" href="javascript:void(0);" class="ref ref185 ref186 ref187">(185−187)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">       </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">guinea pig</td><td class="colsep0 rowsep0" align="center">Aox1</td><td class="colsep0 rowsep0" align="center">AO1</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001308442.1</td><td class="colsep0 rowsep0" align="center">liver, lung, heart, testis, kidney, brain, Harderian gland, olfactory mucosa</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Aox2</td><td class="colsep0 rowsep0" align="center">AOX3L1, AOH3</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001278764.1</td><td class="colsep0 rowsep0" align="center">kidney, Harderian gland, olfactory mucosa</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Aox4</td><td class="colsep0 rowsep0" align="center">AO4, AOH2</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001278780.1</td><td class="colsep0 rowsep0" align="center">liver, testis, kidney, brain, Harderian gland, olfactory mucosa</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="center">AOX2</td><td class="colsep0 rowsep0" align="center">AOX3L1, AOH3</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001048132.1</td><td class="colsep0 rowsep0" align="center">nasal mucosa</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref170 ref188'); return false;" href="javascript:void(0);" class="ref ref170 ref188">(170,188)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">AOX4</td><td class="colsep0 rowsep0" align="center">AO4, AOH2</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001044749.1</td><td class="colsep0 rowsep0" align="center">nictitating gland</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref170 ref188'); return false;" href="javascript:void(0);" class="ref ref170 ref188">(170,188)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cynomolgus monkey</td><td class="colsep0 rowsep0" align="center">AOX1</td><td class="colsep0 rowsep0" align="center">AO1</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001284744.1</td><td class="colsep0 rowsep0" align="center">liver, lung, kidney, lacrimal gland, olfactory mucosa</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">AOX2</td><td class="colsep0 rowsep0" align="center">AOX3L1, AOH3</td><td class="colsep0 rowsep0" align="center">mRNA</td><td class="colsep0 rowsep0" align="center">NM_001308400.1</td><td class="colsep0 rowsep0" align="center">skin, olfactory mucosa</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></td></tr></tbody></table></div></div><div class="NLM_p">Briefly, the major source of AO mRNA and protein in humans are the adrenal gland and liver. Here, developmental AO expression varies, being already high in fetal adrenal<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> but very low in new-born liver, only to reach adult hepatic expression levels at two years of age.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Once adult expression levels are reached, the amount of total AO protein and catalytic activity in human liver shows large interindividual variability,<a onclick="showRef(event, 'ref190 ref191 ref192'); return false;" href="javascript:void(0);" class="ref ref190 ref191 ref192">(190−192)</a> which does not seem to be predicted by age, race, or gender.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Some single nucleotide polymorphisms (SNPs) in the human AO gene have been found to alter the catalytic activity of the recombinantly expressed enzyme,<a onclick="showRef(event, 'ref193 ref194'); return false;" href="javascript:void(0);" class="ref ref193 ref194">(193,194)</a> but these effects do not seem to translate to human hepatocytes<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> and their impact in vivo and in vivo has yet to be established.</div><div class="NLM_p last">With regard to nonclinical species, dog liver enzymes deserve a special mention. While dog liver does not express any AO form (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), it does express XO,<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> which can in some cases metabolize compounds that are substrates of AO in humans to the same metabolite. This has been observed for the PI3Kδ inhibitor idelalisib for example<a onclick="showRef(event, 'ref103 ref195'); return false;" href="javascript:void(0);" class="ref ref103 ref195">(103,195)</a> and could potentially result in the erroneous selection of dog as nonclinical species for PK and toxicology studies.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56">7.2.  Interspecies Differences in Drug Metabolism by AO</h3><div class="NLM_p">Wide interspecies and interstrain differences in AO activity have been observed toward many AO substrates and seem to be largely substrate specific. Such species specificities likely reflect qualitative and quantitative differences in number of AO isoforms expressed, their tissue expression patterns (as described in <a class="ref internalNav" href="#sec7_1" aria-label="section 7.1">section 7.1</a>) and their binding sites structure.<a onclick="showRef(event, 'ref37 ref89 ref196 ref197'); return false;" href="javascript:void(0);" class="ref ref37 ref89 ref196 ref197">(37,89,196,197)</a> Few studies have investigated interspecies variability in AO activity directly with recombinant enzymes due to limited availability of such systems (see <a class="ref internalNav" href="#sec8_1" aria-label="section 8.1">section 8.1</a>). Studies on mouse and human recombinant AO highlighted how some human AO aza-heterocyclic substrates are metabolized with similar efficiency by mAO1 (e.g., O<sub>6</sub>-benzylguanine<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a>), whereas others by mAO3 or mAO3L1 (e.g., phthalazine<a onclick="showRef(event, 'ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref197 ref198">(197,198)</a>) and that interspecies differences are also found with respect to potency of AO inhibitors.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div><div class="NLM_p">Variability in AO activity between species is exemplified by the oxidation of two typical AO substrates, carbazeran, and methotrexate. While rabbit liver AO completely lacks carbazeran oxidation capacity in vitro,<a onclick="showRef(event, 'ref118 ref199 ref200'); return false;" href="javascript:void(0);" class="ref ref118 ref199 ref200">(118,199,200)</a> it metabolizes methotrexate with an efficiency that is orders of magnitude higher than that of other species.<a onclick="showRef(event, 'ref89 ref200 ref201'); return false;" href="javascript:void(0);" class="ref ref89 ref200 ref201">(89,200,201)</a> Some more recent examples include the sodium/hydrogen exchanger 1 (NHE-1) inhibitor zoniporide, which displays a 22-fold variation in in vitro intrinsic clearance (CL<sub>int</sub>) among species, with the highest being in rabbit, the lowest in nonhuman primates, and the value in rodents being the closest to human CL<sub>int</sub>.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> Conversely, the rate of oxidation of the monoamine oxidase A inhibitor RS-8359 by AO is highest in monkeys and humans and two orders of magnitude lower in mouse, rabbit, and rat.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Another recent example is the mGlu5-negative allosteric modulator auglurant (VU0424238), with the highest in vitro CL<sub>int</sub> value reported in cynomolgus monkey and rat and the lowest in humans and guinea pigs.<a onclick="showRef(event, 'ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref68 ref69 ref70">(68−70)</a> Finally, in vitro CL<sub>int</sub> of the epidermal growth factor receptor inhibitor BIBX1382 is highest in nonhuman primates, humans, minipigs, and guinea pigs and lowest in rats and mice, further emphasizing the wide variation in species ranking.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> Many other examples are found in the literature, and the reader is invited to review more specific and comprehensive reports on the subject.<a onclick="showRef(event, 'ref1 ref57'); return false;" href="javascript:void(0);" class="ref ref1 ref57">(1,57)</a></div><div class="NLM_p last">The major consequence of these broad, substrate-dependent, interspecies differences in AO activity is a substantial difficulty in predicting human PK of AO substrates based on studies in nonclinical species. Indeed, an area for future development of better predictive models for human PK of AO substrates may in fact rely on improved in vitro systems, such as hepatocytes retaining high levels of AO activity, or integrated approaches that take into account extrahepatic AO.</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57">7.3.  Physiological Role of AO</h3><div class="NLM_p">In addition to xenobiotic substrates, mammalian AOs have been found to catalyze the oxidation of some endogenous compounds, namely retinoic acid and pyridoxal,<a onclick="showRef(event, 'ref56 ref182'); return false;" href="javascript:void(0);" class="ref ref56 ref182">(56,182)</a> although the significance of these physiological biotransformation pathways is still unknown.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The very high cross-species conservation of AOX1, however, suggests the involvement of this enzyme in important endogenous roles, such as vision and synaptic transmission.<a onclick="showRef(event, 'ref168 ref171 ref182 ref204 ref205'); return false;" href="javascript:void(0);" class="ref ref168 ref171 ref182 ref204 ref205">(168,171,182,204,205)</a> In mouse, high expression of AOX1 at the blood−brain barrier may indicate a role for AO in protecting the brain from the entrance of xenobiotics.<a onclick="showRef(event, 'ref171 ref179'); return false;" href="javascript:void(0);" class="ref ref171 ref179">(171,179)</a> In humans, the expression of AOX1 in the adrenal glands may indicate a role in the biosynthesis of steroid hormones.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Several studies in various cell lines have also indicated potential physiological functions for AO: a role in modulating the phospholipid and cholesterol efflux in hepatocytes through interactions with ABCA1,<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> in adipogenesis<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> and myogenesis,<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> probably through the generation of reactive oxygen species, and in epithelial barrier integrity in the lung.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a></div><div class="NLM_p last">Studies suggesting roles for AO in disease biology are scarce. Some have implicated AO in the pathogenesis of amyotrophic lateral sclerosis, following the detection of mouse and human AO expression in the motor neurons of the spinal cord.<a onclick="showRef(event, 'ref174 ref179'); return false;" href="javascript:void(0);" class="ref ref174 ref179">(174,179)</a> AO may also mediate the neurological impairments caused by molybdenum cofactor deficiency (MoCD; one of the root causes of, e.g., pediatric epilepsy),<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> possibly due to decreased levels of AO and other molybdenum-containing enzymes and consequent accumulation of their endogenous substrates. Finally, hepatic metabolism of <i>N</i><sup>1</sup>-methylnicotinamide by AO has been recently proposed to be part of the pathobiology of nonalcoholic fatty liver disease, suggesting the inhibition of AO as a treatment to reduce its symptoms.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">8.  Experimental Assessment of AO-Mediated Metabolism</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As only known challenges can be addressed, sound experimental assessment of AO-mediated metabolism is a prerequisite for a successful drug design. Whereas timely identification of AO substrates is a first step in the right direction (<a class="ref internalNav" href="#sec8_1" aria-label="section 8.1">section 8.1</a>), many projects will benefit from additional insights, especially predictions of human metabolic clearance (<a class="ref internalNav" href="#sec8_2" aria-label="section 8.2">section 8.2</a>) and synthesis and structural elucidation of metabolites (<a class="ref internalNav" href="#sec8_3" aria-label="section 8.3">section 8.3</a>). Finally, “litmus test” is a chemical reaction mimicking the catalytic mechanism of AO, enabling identification, characterization, and blocking of AO-catalyzed oxidations (<a class="ref internalNav" href="#sec8_4" aria-label="section 8.4">section 8.4</a>).</div><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59">8.1.  Identification of AO Substrates in Vitro</h3><div class="NLM_p">Several in vitro assays allow a qualitative assessment of AO-mediated metabolism. As AO is a soluble cytosolic enzyme, incubations with liver cytosol, liver S9 fraction, or hepatocytes are preferable.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Assays with liver S9 in the presence or absence of NADPH can thoroughly differentiate oxidations catalyzed by AO or XO from those catalyzed by CYPs or FMOs, which use NADPH as the cofactor. Assays run in liver S9 in the presence of H<sub>2</sub><sup>18</sup>O can be used to provide additional evidence for contributions of AO (and XO) versus CYPs, as AO and XO utilize oxygen from water rather than atmospheric oxygen to catalyze oxidations, and they can also provide information on the site of metabolism.<a onclick="showRef(event, 'ref51 ref210'); return false;" href="javascript:void(0);" class="ref ref51 ref210">(51,210)</a> The role of XO, a closely related molybdo-flavoenzyme, is mostly endogenous and relates to purine catabolism.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> However, drug metabolism by XO has been reported, with some overlapping specificity with AO: recent examples include the mGlu5-negative allosteric modulators VU0409106 in human and rat liver S9<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> and VU0424238 in rat and mouse liver S9,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> as well as the ghrelin receptor inverse agonist PF-5190457 in human liver cytosol.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Additionally, some compounds may be exclusive AO substrates in species that express the enzyme, but XO substrates in dog, which does not (as might be the case for the PI3Kδ inhibitor idelalisib, see <a class="ref internalNav" href="#sec7_1" aria-label="section 7.1">section 7.1</a>). To discriminate between the two enzymes, allopurinol has been extensively used as a selective XO inhibitor,<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> although more recently febuxostat has been shown to provide better potency and high selectivity toward XO.<a onclick="showRef(event, 'ref67 ref212'); return false;" href="javascript:void(0);" class="ref ref67 ref212">(67,212)</a></div><div class="NLM_p">Assays with recombinant AO have also been suggested, as they provide direct evidence for AO-mediated metabolism.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> While initial attempts at recombinant expression of human AO in <i>Escherichia coli</i> struggled to yield adequate levels of active protein expression, probably due to low MoCo incorporation,<a onclick="showRef(event, 'ref41 ref190 ref193'); return false;" href="javascript:void(0);" class="ref ref41 ref190 ref193">(41,190,193)</a> a ∼100-fold increase in holoprotein expression levels was recently attained through a method combining codon optimization of the construct with in vitro chemical sulfuration of the recombinant protein.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> Future commercial availability of such systems is warranted and will be useful in providing definitive evidence for AO-specific metabolism.</div><div class="NLM_p last">Care must be taken when using incubations with human liver microsomes (HLM). These subcellular fractions, often used as initial screening during drug discovery phases, can reliably identify only CYP- and FMO-catalyzed biotransformation pathways, but not AO/XO-mediated reactions. However, high cytosolic contamination of HLM preparations can occur and has been found to result in detectable AO-mediated metabolism.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> Therefore, HLM incubations with and without NADPH may be helpful in initial discriminations between AO/XO- and CYP/FMO-mediated reactions. However, due to potentially large differences in HLM preparations and residual AO activities (e.g., different batches and manufacturers), the authors would advise against this approach. In addition to minimal and variable AO activity, HLM are a poor choice for evaluation of general amide hydrolysis; many hydrolases (including carboxylesterases) are soluble enzymes located in the lumen of the endoplasmic reticulum and may be lost during tissue homogenization and subcellular fractionation.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a></div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60">8.2.  Human Clearance Predictions for AO Substrates</h3><div class="NLM_p">Once the AO-mediated metabolism of the compound of interest is confirmed, various approaches have been reported in the literature to measure the fraction-metabolized by AO (Fm<sub>AO</sub>) to refine predictions of human in vivo clearance. While very few drugs currently on the market are AO substrates or inhibitors, therefore not posing a significant risk for AO-mediated drug−drug interactions (DDI), as more AO drug substrates make their way into clinical trials, the risks of DDI due to AO activity might increase and may eventually become clinically significant, making the correct measurement of Fm<sub>AO</sub> even more necessary.<a onclick="showRef(event, 'ref5 ref25 ref63 ref67 ref217 ref218'); return false;" href="javascript:void(0);" class="ref ref5 ref25 ref63 ref67 ref217 ref218">(5,25,63,67,217,218)</a></div><div class="NLM_p">The current established approach for the determination of Fm<sub>AO</sub> is the time-dependent inhibition of AO activity by hydralazine, either in hepatocytes or liver S9 fractions.<a onclick="showRef(event, 'ref210 ref219 ref220 ref221 ref222'); return false;" href="javascript:void(0);" class="ref ref210 ref219 ref220 ref221 ref222">(210,219−222)</a> This method is not without caveats, however, as hydralazine is known to inhibit some of the major hepatic CYPs at the concentrations needed for AO inhibition.<a onclick="showRef(event, 'ref223 ref224'); return false;" href="javascript:void(0);" class="ref ref223 ref224">(223,224)</a> Indeed, many compounds have been used historically to inhibit AO, with estradiol, raloxifene, menadione, chlorpromazine, and quetiapine showing the highest potency in liver cytosol<a onclick="showRef(event, 'ref134 ref217 ref225 ref226'); return false;" href="javascript:void(0);" class="ref ref134 ref217 ref225 ref226">(134,217,225,226)</a> or recombinant enzyme assays.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> However, all these compounds, except for estradiol, also inhibit major liver CYPs, more strongly than hydralazine,<a onclick="showRef(event, 'ref222 ref226'); return false;" href="javascript:void(0);" class="ref ref222 ref226">(222,226)</a> while estradiol is cleared too rapidly in human hepatocytes to be used in inhibition assays.<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a> Additionally, AO inhibitors like menadione and raloxifene were reported to inhibit efflux transporters,<a onclick="showRef(event, 'ref227'); return false;" href="javascript:void(0);" class="ref ref227">(227)</a> potentially further confounding clearance and Fm<sub>AO</sub> predictions when using hepatocytes and chemotypes affected by transporter-mediated disposition. Therefore, a truly selective and potent AO inhibitor suitable to assays in hepatocytes has yet to be reported, and this area is a subject of active research.<a onclick="showRef(event, 'ref228'); return false;" href="javascript:void(0);" class="ref ref228">(228)</a> An extensive summary of AO inhibitors has been published recently by Dalvie and Di.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Regarding the IVIVE of the metabolic clearance of AO substrates, several strategies are currently applied. As in vitro enzyme assays typically tend to underestimate in vivo metabolic clearance by AO, one recommended approach is to select batches of human hepatocytes, liver cytosol, or S9 fractions with high enzyme activity toward several reference substrates with known human PK properties.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> The results can then be used to extrapolate in vivo human clearance of the test compounds based on the generated regression lines.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> This method can be used for quantitative clearance predictions by in vitro−in vivo extrapolation<a onclick="showRef(event, 'ref192 ref221'); return false;" href="javascript:void(0);" class="ref ref192 ref221">(192,221)</a> or semiquantitative PK predictions by the “yardstick” method.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> With this method, the compound of interest can be predicted to belong to a low-, medium-, or high-clearance group based on how it benchmarks against the reference substrates (with known human PK) used in the same batch of hepatocytes or subcellular fractions.<a onclick="showRef(event, 'ref14 ref87'); return false;" href="javascript:void(0);" class="ref ref14 ref87">(14,87)</a></div><div class="NLM_p">Other authors recommend the use of hepatocyte or subcellular fraction pools from as many donors as possible to be more representative of the entire human population and avoid yet unknown effects of SNPs on single-donor enzyme activity.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a> However, several AO substrates have a reported human plasma clearance higher than liver blood flow rate, which cannot be predicted by any in vitro assays using hepatocytes or liver subcellular fractions (for a very informative recent example, see Jensen et al.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>).</div><div class="NLM_p">With regard to predicting human clearance of AO substrates from nonclinical species, different approaches have been recommended. IVIVC of CL<sub>int</sub> values for cynomolgus monkey, using hepatocytes in vitro CL<sub>int</sub> and in vivo clearance values from PK studies, was found to be the best approach to estimate human in vivo CL<sub>int</sub> of zaleplon, ziprasidone, and zoniporide despite still resulting in underprediction.<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a> Others have suggested single-species scaling of in vivo clearance from rhesus or cynomolgus monkey to human, after finding similarly high in vivo clearance values across these three species for the AO substrate BIBX3182.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> However, as species similarities in AO-mediated metabolism seem to be largely substrate-dependent (Choughule et al.<a onclick="showRef(event, 'ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91">(89−91)</a> and <a class="ref internalNav" href="#sec7_1" aria-label="section 7.1">section 7.1</a>), underprediction of human clearance from PK studies in nonhuman primates can still occur, either due to species-specific extrahepatic AO activity<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> or to human-specific metabolism by AO, as it was found for the compound RO1.<a onclick="showRef(event, 'ref14 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref18">(14,18)</a></div><div class="NLM_p">A novel approach for the selection of the appropriate nonclinical species for PK predictions of AO drug substrates has been recently proposed by Crouch et al.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> In their workflow, substrate CL<sub>int</sub> is initially measured in liver S9 fractions or hepatocytes from humans and several other species, including nonhuman primates, rodents, and minipigs.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> In vitro CL<sub>int</sub> values from the nonclinical species are then used to predict human in vitro CL<sub>int</sub> by single-species scaling or multiple-species allometry. This value is then compared to the observed human in vitro CL<sub>int</sub> measured experimentally in the same system, and the species (or combination of species) that gives the best prediction is then used in in vivo PK studies. The data from in vivo PK are then used to predict in vivo human clearance by traditional allometry. Interestingly, the species combination that leads to the best estimates of human in vitro CL<sub>int</sub> (by multiple-species allometry) of the AO substrates used in this study is nonhuman primates, guinea pigs, and minipig.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> While this approach was successfully applied to clearance predictions for the two AO substrates zoniporide and BIBX1382,<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> which have plasma clearance values higher than liver blood flow rate, it assumes that hepatic metabolism is always the major clearance route. Presumably, the clearance of compounds with a significant component of extrahepatic metabolism could still be underpredicted, considering the interspecies differences in AO tissue expression and activity described earlier (<a class="ref internalNav" href="#sec7" aria-label="section 7">section 7</a>).</div><div class="NLM_p">Finally, a novel chimeric animal model with humanized liver, the PXB mouse, has been used by some authors to predict human metabolism by AO<a onclick="showRef(event, 'ref14 ref230 ref231 ref232'); return false;" href="javascript:void(0);" class="ref ref14 ref230 ref231 ref232">(14,230−232)</a> but still resulted in clearance underpredictions. Additionally, as humanization is limited to liver and even in this tissue it does not reach 100%, contributions of mouse AO to metabolic clearance are still possible and may also confound predictions.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">Use of cellular or subcellular systems to provide a translatable profile of AO-mediated metabolite generation can be difficult due to the chemo- and regio-specificity of the enzyme, coupled with the variability in the expression of the enzyme in the different systems. Use of a MoCo producing <i>E. coli</i>-based bacterial system, ecoAO,<a onclick="showRef(event, 'ref213 ref233'); return false;" href="javascript:void(0);" class="ref ref213 ref233">(213,233)</a> can provide a means by which AO metabolites can be generated in sufficient quantities for structural identification by NMR and for use as an authentic standard in any kinetic profile assay where substrate depletion alone will not provide all the relevant data.</div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61">8.3.  Synthesis and Structural Elucidation of AO Metabolites</h3><div class="NLM_p">Early and accurate identification of AO reaction rate, type, and site of metabolism will help guide chemical design, particularly if multiple sites of metabolism are possible. For example, discovery programs that unambiguously identified sites of AO metabolism<a onclick="showRef(event, 'ref29 ref88 ref93'); return false;" href="javascript:void(0);" class="ref ref29 ref88 ref93">(29,88,93)</a> generally had a better starting point for the rational design compared to programs that had tentative metabolite assignment.<a onclick="showRef(event, 'ref51 ref95'); return false;" href="javascript:void(0);" class="ref ref51 ref95">(51,95)</a> Additional advantages may be gained from analytical approaches that enable differentiation between similar and overlapping pathways, especially AO, XO, and CYP, and FMO-catalyzed oxidations.</div><div class="NLM_p">High resolution mass spectrometry (HRMS) is employed in the majority of metabolite profiling studies, but increasingly it is being used to both quantitatively and qualitatively profile samples concurrently from in vitro and in vivo assays, termed QuanQual profiling.<a onclick="showRef(event, 'ref234 ref235 ref236'); return false;" href="javascript:void(0);" class="ref ref234 ref235 ref236">(234−236)</a> This approach has been adopted at UCB and in other research organizations for in vitro profiling of AO metabolism<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and has been shown to provide useful qualitative data from routine screening assays, such as the providing the ability to profile appearance of metabolites as well as loss of parent, with no method development, in a single analytical run. Therefore, QuanQual approach is our recommendation for routine AO evaluations, offering the option to simultaneously assess both metabolic clearance and AO reaction type/site of metabolism. For qualitative monitoring of AO metabolism, the resulting metabolites often exhibit predictable elemental gains (e.g., +O) or losses (e.g., amide hydrolysis, −O, or −2H) with corresponding mass changes, whereas MS/MS data enables early assessment of type and site of metabolism. Generic conditions for metabolite profiling by HPLC typically comprise reverse phase acidic mobile phases and C<sub>18</sub> stationary phases. Under these conditions the AO mediated hydroxylated metabolites for heterocycles often elute later than that of the substrate due to their increased lipophilicity,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> giving a quick indication as to the likely involvement of AO in the biotransformation of the substrate.</div><div class="NLM_p">Once AO involvement is confirmed and tentative metabolism site is assigned by LC-(HR)MS, it may be beneficial to determine unambiguously the site of metabolism and/or differentiate between AO and CYP/FMO-catalyzed reactions. Additional analytical approaches can be useful at this stage, including NMR, hydrogen−deuterium exchange (HDX), or “litmus test” (<a class="ref internalNav" href="#sec8_4" aria-label="section 8.4">section 8.4</a>). Analytical techniques can be tailored to focus on potential AO mediated metabolism based on what is known about its mechanism or the potential products of the metabolic pathways. As it is known that the source of oxygen for the AO mediated metabolism of a substrate is derived from water,<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> numerous examples exist where <sup>18</sup>O isotope labeled H<sub>2</sub>O has been used as the aqueous component of the in vitro incubation.<a onclick="showRef(event, 'ref23 ref64 ref211'); return false;" href="javascript:void(0);" class="ref ref23 ref64 ref211">(23,64,211)</a> If AO is responsible for the subsequent oxidation, the mass gain will be 17.9992 Da, giving a clear indication as to the involvement of AO, even if there is also CYP mediated hydroxylation as this would be represented by a 15.9949 Da mass gain.</div><div class="NLM_p">In some cases, the AO metabolism introduces exchangeable protons in metabolites, for example, pyridone-like metabolites after oxidations of 6-membered azaheterocycles, in contrast to corresponding CYP/FMO metabolism, which yields pyridine <i>N</i>-oxides, metabolites without exchangeable protons. In these cases, using deuterated H<sub>2</sub>O as the HPLC mobile phase,<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a> or even ND<sub>3</sub> as the nebulizing gas,<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a> results in a D for H exchange and with the corresponding mass increase of 1.0066 Da per exchangeable proton.</div><div class="NLM_p last">Because of the significant overlap in the mechanism of AO- and XO-mediated metabolism, these analytical approaches to structural identification, such as incorporation of <sup>18</sup>O from H<sub>2</sub><sup>18</sup>O, could also be employed in XO profiling,<a onclick="showRef(event, 'ref33 ref211 ref239'); return false;" href="javascript:void(0);" class="ref ref33 ref211 ref239">(33,211,239)</a> once an XO-mediated pathway has been differentiated from AO or CYP/FMO (see <a class="ref internalNav" href="#sec8_1" aria-label="section 8.1">section 8.1</a>).</div></div><div id="sec8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62">8.4.  Litmus Test</h3><div class="NLM_p">Although enzymatic in vitro approaches<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> (e.g., cellular or subcellular systems described in <a class="ref internalNav" href="#sec8_1" aria-label="section 8.1">section 8.1</a>) are the most physiologically relevant assays to assess AO-mediated metabolism, these systems may neither have the capacity to generate sufficient levels of metabolites for isolation and structural elucidation nor the throughput to test large number of compounds in discovery settings. The so-called “litmus test” approach has been developed to address these challenges.<a onclick="showRef(event, 'ref142 ref240'); return false;" href="javascript:void(0);" class="ref ref142 ref240">(142,240)</a> Inspired by catalytic mechanism of AO oxidations, the nucleophilic attack on electropositive (electron-deficient) sp<sup>2</sup> carbons, a chemical “litmus test” was proposed to rapidly evaluate susceptibility to AO metabolism<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Radical-based C−H functionalization with bis(((difluoromethyl)sulfinyl)oxy)zinc (DFMS) reagent was applied in the presence of TBHP, resulting in −CHF<sub>2</sub> adducts on electron-deficient sp2 carbons (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>).<a onclick="showRef(event, 'ref240 ref142'); return false;" href="javascript:void(0);" class="ref ref240 ref142">(240,142)</a> On the basis of evaluation of eight known AO substrates, the tested chemical reaction predicted sites of AO oxidations well, apart from compounds where binding to enzyme plays a major role in oxidation rates (e.g., large quinoline-based azetidinyl ketolide, <a class="ref internalNav" href="#sec6_8" aria-label="section 6.8">section 6.8</a>).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Applications of the chemical “Litmus test”. Prepared based on results from O’Hara et al.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The resulting CHF<sub>2</sub> coupled product can be generated in amounts suitable for unambiguous identification by NMR. Identification of the site of CHF<sub>2</sub> addition can then be correlated with the site of the oxidative metabolism by AO. In the case of the litmus test assay, the introduction of a CHF<sub>2</sub> moiety onto the molecule(s) can provide a specific and sensitive handle from which one can perform the reaction in situ in an NMR tube and employ heteronuclear NMR techniques, such as <sup>1</sup>H−<sup>13</sup>C or <sup>19</sup>F−<sup>13</sup>C heteronuclear single quantum coherence spectroscopy (HSQC), to identify the site of metabolism without any purification steps. This has been employed at UCB to assist structural identification of products from the litmus test approach (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).</div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Example of HSQC <sup>1</sup>H−<sup>13</sup>C of litmus test reaction in an NMR tube. The HSQC spectra of the reaction mixtures show the <sup>1</sup>H−<sup>13</sup>C correlation before (A) and after (B) addition of the litmus test reagent, TBHP. The unreacted pyridyl C−H correlations (signals 1 and 2) can be seen to split into two peaks (1a/b and 2a/b) due to the shift effect of the addition of the CHF<sub>2</sub> on a neighboring carbon. C−H (3) is still a single signal as this represents unreacted starting material with the product no longer having a C−H in this position.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In addition to providing structural information, it can also be employed as a simple, late-stage functionalization approach to generate compounds with the site of AO metabolism blocked, and therefore potential drug-like molecules in their own right. Despite its utility, it is important to keep in mind that the litmus test has the propensity to generate false positives as it is purely a chemical approach and does not factor in the binding to the AO enzyme.</div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">9.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Considering broad substrate selectivity, complex biology, and potentially serious clinical consequences, our recommendations are<ul class="NLM_list-list_type-bullet"><li><p class="inline">An early consideration of AO-mediated metabolism (e.g., in hit-to-lead and lead optimization), but not an automatic avoidance of AO structural flags, many of which are valuable and common building blocks (e.g., various azaheterocycles and amides).</p></li><li><p class="inline">A timely and rational application of drug design to control AO-mediated metabolism (stop, decrease, or utilize for prodrug design) supported by complementary approaches: computational and experimental assessment and understanding of AO biology.</p></li><li><p class="inline">Although designing-out AO-mediated metabolism is the safest way to enable clinical progression, successful development of AO substrates is still possible and precedented in the literature. This task relies on accurate predictions of human metabolic clearance and overcoming of other development challenges, especially interspecies differences and metabolite safety.</p></li></ul></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00875" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nenad Manevski</span> - <span class="hlFld-Affiliation affiliation">UCB
Celltech, 208 Bath Road, Slough SL13WE, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8387-3023" title="Orcid link">http://orcid.org/0000-0001-8387-3023</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bed0dbd0dfda90d3dfd0dbc8cdd5d7fecbdddc90ddd1d3"><span class="__cf_email__" data-cfemail="e68883888782c88b87888390958d8fa6938584c885898b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lloyd King</span> - <span class="hlFld-Affiliation affiliation">UCB
Celltech, 208 Bath Road, Slough SL13WE, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William R. Pitt</span> - <span class="hlFld-Affiliation affiliation">UCB
Celltech, 208 Bath Road, Slough SL13WE, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8164-4550" title="Orcid link">http://orcid.org/0000-0001-8164-4550</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabien Lecomte</span> - <span class="hlFld-Affiliation affiliation">UCB
Celltech, 208 Bath Road, Slough SL13WE, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesca Toselli</span> - <span class="hlFld-Affiliation affiliation">UCB
BioPharma, Chemin du Foriest 1, 1420 Braine-l’Alleud, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Nenad Manevski</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=bio1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nenad Manevski</b> Nenad is a DMPK design lead at UCB, working in multidisciplinary teams towards improvement of drug-like properties and PKPD in drug discovery. A pharmacist by training, Nenad did his Ph.D. at the University of Helsinki, Finland (enzymology and medicinal chemistry), and postdoc at Novartis in Basel, Switzerland (biotransformation). Current interests and research topics include drug design, extrahepatic metabolism, early prediction of efficacious dose, and in vitro−in vivo correlations. Nenad authored 14 peer-reviewed articles and presented his work at numerous research conferences.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Lloyd King</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=bio2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lloyd King</b> After graduating in Oceanography from Swansea University, Lloyd joined the physical chemistry team at Wyeth Laboratories (UK). Having gained experience in numerous analytical techniques, predominantly NMR, LC-MS, IR, Lloyd then moved roles and companies to provide bioanalytical and metabolite profiling support at what was formally Celltech, now UCB, in Slough, UK. He is now part of the biotransformation team providing metabolite profiling and drug design input into NCE projects in both CNS and immunology therapeutic areas.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="30" class="article__inlineFigure"><h2 class="fig-label">William R. Pitt</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=bio3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>William R. Pitt</b> Will is a Senior Principal Scientist in the Computer-Aided Drug Discovery Group of UCB Pharma, based at their research site in Slough, UK. He did his Ph.D. at Birkbeck College, supervised by Julia Goodfellow. His current role is to accelerate early discovery programs, primarily through the application of computational techniques. He has over 20 years’ experience of doing this, first at Wyeth Laboratories (UK) and then at Chiroscience, which eventually became part of UCB. He was recently made a Fellow of the Royal Society of Chemistry.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Fabien Lecomte</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=bio4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Fabien Lecomte</b> After graduating from the ENSCM (School of Chemistry and Chemical Engineering, Montpellier, France), Fabien Lecomte received his Ph.D. from the University of Cergy-Pontoise (France) in 2005 under the supervision of Professor Gérard Cahiez on the cross-coupling reactions between organomanganese compounds and organic halides in the presence of manganese salts. He then joined the group of Professor Stephen Hanessian at the University of Montreal (Canada) as a postdoctoral fellow where he worked on the total synthesis of natural products. In 2007, he moved to UCB pharma (Slough, UK) and is currently working there as a Principal Scientist in medicinal chemistry.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Francesca Toselli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=bio5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Francesca Toselli</b> After receiving her Master’s degree in Biotechnology at the University of Bologna (Italy) in 2006, Francesca moved to the University of Queensland (Australia), where she pursued a Ph.D. in Biochemistry studying cytochrome P450 enzymes in the human brain. Upon graduation, she moved to the University of Toronto (Canada) for her first postdoctoral project on in vivo brain drug metabolism. This was followed by a second postdoctoral term at AstraZeneca (Sweden), where she worked on the novel metabolism of oxetanes by human microsomal epoxide hydrolase, now also known as microsomal oxirane/oxetane hydrolase. Francesca then joined the iADME group at UCB (Belgium) in July 2017, where she currently works supporting pipeline projects and other research activities as DDI and drug metabolism expert.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28843" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28843" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Lisa Joedicke for her contributions to the enzyme structure and function of AO (section 2) and Harry Mackenzie for his contributions to the HSQC NMR work. Emre M. Işin is acknowledged for his valuable advice on drug design and organization of the text.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADH</td><td class="NLM_def"><p class="first last">alcohol dehydrogenase</p></td></tr><tr><td class="NLM_term">ALDH</td><td class="NLM_def"><p class="first last">aldehyde dehydrogenase</p></td></tr><tr><td class="NLM_term">AO</td><td class="NLM_def"><p class="first last">aldehyde oxidase</p></td></tr><tr><td class="NLM_term">AOH</td><td class="NLM_def"><p class="first last">aldehyde oxidase homologue</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">Intrinsic clearance</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">EDG</td><td class="NLM_def"><p class="first last">electron-donating group</p></td></tr><tr><td class="NLM_term">EWG</td><td class="NLM_def"><p class="first last">electron-withdrawing group</p></td></tr><tr><td class="NLM_term">Fm<sub>AO</sub></td><td class="NLM_def"><p class="first last">fraction metabolized by AO</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">FMO</td><td class="NLM_def"><p class="first last">flavin-containing monooxygenases</p></td></tr><tr><td class="NLM_term">HLC</td><td class="NLM_def"><p class="first last">human liver cytosol</p></td></tr><tr><td class="NLM_term">IVIVE</td><td class="NLM_def"><p class="first last">in vitro−in vivo extrapolation</p></td></tr><tr><td class="NLM_term">IVIVC</td><td class="NLM_def"><p class="first last">in vitro−in vivo correlation</p></td></tr><tr><td class="NLM_term">KDIE</td><td class="NLM_def"><p class="first last">kinetic deuterium isotope effect</p></td></tr><tr><td class="NLM_term">MOA</td><td class="NLM_def"><p class="first last">mechanism of action</p></td></tr><tr><td class="NLM_term">MIST</td><td class="NLM_def"><p class="first last">Metabolites in Safety Testing</p></td></tr><tr><td class="NLM_term">MoCD</td><td class="NLM_def"><p class="first last">molybdenum cofactor deficiency</p></td></tr><tr><td class="NLM_term">MoCo</td><td class="NLM_def"><p class="first last">molybdenum pyranopterin cofactor</p></td></tr><tr><td class="NLM_term">MAO-B</td><td class="NLM_def"><p class="first last">monoamine oxidase B</p></td></tr><tr><td class="NLM_term">MPTP</td><td class="NLM_def"><p class="first last">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">SNP</td><td class="NLM_def"><p class="first last">single-nucleotide polymorphism</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure−activity relationship</p></td></tr><tr><td class="NLM_term">SOM</td><td class="NLM_def"><p class="first last">site of metabolism</p></td></tr><tr><td class="NLM_term">UGT</td><td class="NLM_def"><p class="first last">UDP-glucuronosyltransferases</p></td></tr><tr><td class="NLM_term">XO</td><td class="NLM_def"><p class="first last">xanthine oxidase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 240 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltani, S.</span></span> <span> </span><span class="NLM_article-title">An Overview of Aldehyde Oxidase: An Enzyme of Emerging Importance in Novel Drug Discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1080/17460441.2017.1284198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F17460441.2017.1284198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28095715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Cis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=305-316&issue=3&author=M.+R.+Rashidiauthor=S.+Soltani&title=An+Overview+of+Aldehyde+Oxidase%3A+An+Enzyme+of+Emerging+Importance+in+Novel+Drug+Discovery&doi=10.1080%2F17460441.2017.1284198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery</span></div><div class="casAuthors">Rashidi, Mohammad-Reza; Soltani, Somaieh</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-316</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Given the rising trend in medicinal chem. strategy to reduce cytochrome P 450-dependent metab., aldehyde oxidase (AOX) has recently gained increased attention in drug discovery programs and the no. of drug candidates that are metabolized by AOX is steadily growing.  Despite the emerging importance of AOX in drug discovery, there are certain major recognized problems assocd. with AOX-mediated metab. of drugs.  Intra- and inter-species variations in AOX activity, the lack of reliable and predictive animal models using the common exptl. animals, and failure in the predictions of in vivo metabolic activity of AOX using traditional in vitro methods are among these issues that are covered in this article.  A comprehensive review of computational human AOX (hAOX) related studies are also provided.  Following the recent progress in the stem cell field, the authors recommend the application of organoids technol. as an effective tool to solve the fundamental problems assocd. with the evaluation of AOX in drug discovery.  The recent success in resolving the hAOX crystal structure can too be another valuable data source for the study of AOX-catalyzed metab. of new drug candidates, using computer-aided drug discovery methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqNIV9RHOPk7Vg90H21EOLACvtfcHk0ljukW0n2DyNXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Cis7c%253D&md5=fa5242a96053f718c70369a15621db95</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1284198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1284198%26sid%3Dliteratum%253Aachs%26aulast%3DRashidi%26aufirst%3DM.%2BR.%26aulast%3DSoltani%26aufirst%3DS.%26atitle%3DAn%2520Overview%2520of%2520Aldehyde%2520Oxidase%253A%2520An%2520Enzyme%2520of%2520Emerging%2520Importance%2520in%2520Novel%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26issue%3D3%26spage%3D305%26epage%3D316%26doi%3D10.1080%2F17460441.2017.1284198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for the Role of Mammalian Aldehyde Oxidases in the Metabolism of Drugs and Xenobiotics</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2017.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.cbpa.2017.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28126656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=39-47&author=M.+J.+Romaoauthor=C.+Coelhoauthor=T.+Santos-Silvaauthor=A.+Fotiauthor=M.+Teraoauthor=E.+Garattiniauthor=S.+Leimkuhler&title=Structural+Basis+for+the+Role+of+Mammalian+Aldehyde+Oxidases+in+the+Metabolism+of+Drugs+and+Xenobiotics&doi=10.1016%2Fj.cbpa.2017.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the role of mammalian aldehyde oxidases in the metabolism of drugs and xenobiotics</span></div><div class="casAuthors">Romao, Maria Joao; Coelho, Catarina; Santos-Silva, Teresa; Foti, Alessandro; Terao, Mineko; Garattini, Enrico; Leimkehler, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-47</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs) are molybdo-flavoenzymes characterized by broad substrate specificity, oxidizing arom./aliph. aldehydes into the corresponding carboxylic acids and hydroxylating various heteroarom. rings.  Mammals are characterized by a complement of species-specific AOX isoenzymes, that varies from one in humans (AOX1) to four in rodents (AOX1, AOX2, AOX3 and AOX4).  The physiol. function of mammalian AOX isoenzymes is unknown, although human AOX1 is an emerging enzyme in phase-I drug metab.  Indeed, the no. of therapeutic mols. under development which act as AOX substrates is increasing.  The recent crystn. and structure detn. of human AOX1 as well as mouse AOX3 has brought new insights into the mechanisms underlying substrate/inhibitor binding as well as the catalytic activity of this class of enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm_agFEt6t-7Vg90H21EOLACvtfcHk0ljukW0n2DyNXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKjsLg%253D&md5=87985d602479342e0c5cb9b63512b951</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2017.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Role%2520of%2520Mammalian%2520Aldehyde%2520Oxidases%2520in%2520the%2520Metabolism%2520of%2520Drugs%2520and%2520Xenobiotics%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D37%26spage%3D39%26epage%3D47%26doi%3D10.1016%2Fj.cbpa.2017.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkühler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romão, M. J.</span></span> <span> </span><span class="NLM_article-title">Critical Overview on the Structure and Metabolism of Human Aldehyde Oxidase and Its Role in Pharmacokinetics</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2018.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.ccr.2018.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFGrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2018&pages=35-59&author=C.+Motaauthor=C.+Coelhoauthor=S.+Leimk%C3%BChlerauthor=E.+Garattiniauthor=M.+Teraoauthor=T.+Santos-Silvaauthor=M.+J.+Rom%C3%A3o&title=Critical+Overview+on+the+Structure+and+Metabolism+of+Human+Aldehyde+Oxidase+and+Its+Role+in+Pharmacokinetics&doi=10.1016%2Fj.ccr.2018.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Critical overview on the structure and metabolism of human aldehyde oxidase and its role in pharmacokinetics</span></div><div class="casAuthors">Mota, Cristiano; Coelho, Catarina; Leimkuhler, Silke; Garattini, Enrico; Terao, Mineko; Santos-Silva, Teresa; Romao, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-59</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidases are molybdenum and flavin dependent enzymes characterized by a very wide substrate specificity and performing diverse reactions that include oxidns. (e.g., aldehydes and aza-heterocycles), hydrolysis of amide bonds, and redns. (e.g., nitro, S-oxides and N-oxides).  Oxidn. reactions and amide hydrolysis occur at the molybdenum site while the redns. are proposed to occur at the flavin site.  AOX activity affects the metab. of different drugs and xenobiotics, some of which designed to resist other liver metabolizing enzymes (e.g., cytochrome P 450 monooxygenase isoenzymes), raising its importance in drug development.  This work consists of a comprehensive overview on aldehyde oxidases, concerning the genetic evolution of AOX, its diversity among the human population, the crystal structures available, the known catalytic reactions and the consequences in pre-clin. pharmacokinetic and pharmacodynamic studies.  Anal. of the different animal models generally used for pre-clin. trials and comparison between the human (hAOX1), mouse homologs as well as the related xanthine oxidase (XOR) are extensively considered.  The data reviewed also include a systematic anal. of representative classes of mols. that are hAOX1 substrates as well as of typical and well characterized hAOX1 inhibitors.  The considerations made on the basis of a structural and functional anal. are correlated with reported kinetic and metabolic data for typical classes of drugs, searching for potential structural determinants that may dictate substrate and/or inhibitor specificities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYNjsJXx2C1bVg90H21EOLACvtfcHk0lj5q4ehdB9SXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFGrt70%253D&md5=269eec7a7e99e17af05ad73fc126d4cd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2018.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2018.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DMota%26aufirst%3DC.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DLeimk%25C3%25BChler%26aufirst%3DS.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DRom%25C3%25A3o%26aufirst%3DM.%2BJ.%26atitle%3DCritical%2520Overview%2520on%2520the%2520Structure%2520and%2520Metabolism%2520of%2520Human%2520Aldehyde%2520Oxidase%2520and%2520Its%2520Role%2520in%2520Pharmacokinetics%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2018%26volume%3D368%26spage%3D35%26epage%3D59%26doi%3D10.1016%2Fj.ccr.2018.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Mammalian Aldehyde Oxidases</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1007/s00204-016-1683-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00204-016-1683-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26920149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1Ort7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=753-780&issue=4&author=M.+Teraoauthor=M.+J.+Romaoauthor=S.+Leimkuhlerauthor=M.+Bolisauthor=M.+Fratelliauthor=C.+Coelhoauthor=T.+Santos-Silvaauthor=E.+Garattini&title=Structure+and+Function+of+Mammalian+Aldehyde+Oxidases&doi=10.1007%2Fs00204-016-1683-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of mammalian aldehyde oxidases</span></div><div class="casAuthors">Terao, Mineko; Romao, Maria Joao; Leimkuhler, Silke; Bolis, Marco; Fratelli, Maddalena; Coelho, Catarina; Santos-Silva, Teresa; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-780</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Mammalian aldehyde oxidases (AOXs; EC1.2.3.1) are a group of conserved proteins belonging to the family of molybdo-flavoenzymes along with the structurally related xanthine dehydrogenase enzyme.  AOXs are characterized by broad substrate specificity, oxidizing not only arom. and aliph. aldehydes into the corresponding carboxylic acids, but also hydroxylating a series of heteroarom. rings.  The no. of AOX isoenzymes expressed in different vertebrate species is variable.  The two extremes are represented by humans, which express a single enzyme (AOX1) in many organs and mice or rats which are characterized by tissue-specific expression of four isoforms (AOX1, AOX2, AOX3, and AOX4).  In vertebrates each AOX isoenzyme is the product of a distinct gene consisting of 35 highly conserved exons.  The extant species-specific complement of AOX isoenzymes is the result of a complex evolutionary process consisting of a first phase characterized by a series of asynchronous gene duplications and a second phase where the pseudogenization and gene deletion events prevail.  In the last few years remarkable advances in the elucidation of the structural characteristics and the catalytic mechanisms of mammalian AOXs have been made thanks to the successful crystn. of human AOX1 and mouse AOX3.  Much less is known about the physiol. function and physiol. substrates of human AOX1 and other mammalian AOX isoenzymes, although the importance of these proteins in xenobiotic metab. is fairly well established and their relevance in drug development is increasing.  This review article provides an overview and a discussion of the current knowledge on mammalian AOX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS5HLUCQFuwrVg90H21EOLACvtfcHk0lj5q4ehdB9SXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1Ort7s%253D&md5=9b1267ba46528c89ccbaf26dbd0e36cf</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00204-016-1683-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-016-1683-1%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DBolis%26aufirst%3DM.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DStructure%2520and%2520Function%2520of%2520Mammalian%2520Aldehyde%2520Oxidases%26jtitle%3DArch.%2520Toxicol.%26date%3D2016%26volume%3D90%26issue%3D4%26spage%3D753%26epage%3D780%26doi%3D10.1007%2Fs00204-016-1683-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase and Its Role as a Drug Metabolizing Enzyme</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.pharmthera.2019.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=31128989" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=D.+Dalvieauthor=L.+Di&title=Aldehyde+Oxidase+and+Its+Role+as+a+Drug+Metabolizing+Enzyme&doi=10.1016%2Fj.pharmthera.2019.05.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DAldehyde%2520Oxidase%2520and%2520Its%2520Role%2520as%2520a%2520Drug%2520Metabolizing%2520Enzyme%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26doi%3D10.1016%2Fj.pharmthera.2019.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battelli, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, A.</span></span> <span> </span><span class="NLM_article-title">Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">4027</span>– <span class="NLM_lpage">4036</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160725091915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.2174%2F0929867323666160725091915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27458036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVOhu7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=4027-4036&issue=35&author=M.+G.+Battelliauthor=L.+Politoauthor=M.+Bortolottiauthor=A.+Bolognesi&title=Xanthine+Oxidoreductase+in+Drug+Metabolism%3A+Beyond+a+Role+as+a+Detoxifying+Enzyme&doi=10.2174%2F0929867323666160725091915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme</span></div><div class="casAuthors">Battelli, Maria Giulia; Polito, Letizia; Bortolotti, Massimo; Bolognesi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">4027-4036</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The enzyme xanthine oxidoreductase (XOR) catalyzes the last two steps of purine catabolism in the highest uricotelic primates.  XOR is an enzyme with dehydrogenase activity that, in mammals, may be converted into oxidase activity under a variety of pathophysiol. conditions.  XOR activity is highly regulated at the transcriptional and post-translational levels and may generate reactive oxygen and nitrogen species, which trigger different consequences, ranging from cytotoxicity to inflammation.  The low specificity for substrates allows XOR to metabolize a no. of endogenous metabolites and a variety of exogenous compds., including drugs.  The present review focuses on the role of XOR as a drug-metabolizing enzyme, specifically for drugs with anticancer, antimicrobial, antiviral, immunosuppressive or vasodilator activities, as well as drugs acting on metab. or inducing XOR expression.  XOR has an activating role that is essential to the pharmacol. action of quinone drugs, cyadox, antiviral nucleoside analogs, allopurinol, nitrate and nitrite.  XOR activity has a degrdn. function toward thiopurine nucleotides, pyrazinoic acid, methylxanthines and tolbutamide, whose half-life may be prolonged by the use of XOR inhibitors.  In conclusion, to avoid potential drug interaction risks, such as a toxic excess of drug bioavailability or a loss of drug efficacy, caution is suggested in the use of XOR inhibitors, as in the case of hyperuricemic patients affected by gout or tumor lysis syndrome, when it is necessary to simultaneously administer therapeutic substances that are activated or degraded by the drug-metabolizing activity of XOR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlrIvvW2UuYbVg90H21EOLACvtfcHk0lj5q4ehdB9SXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVOhu7bE&md5=f90b40a1cea0b863f6226aefcc6e1bd9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160725091915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160725091915%26sid%3Dliteratum%253Aachs%26aulast%3DBattelli%26aufirst%3DM.%2BG.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DBortolotti%26aufirst%3DM.%26aulast%3DBolognesi%26aufirst%3DA.%26atitle%3DXanthine%2520Oxidoreductase%2520in%2520Drug%2520Metabolism%253A%2520Beyond%2520a%2520Role%2520as%2520a%2520Detoxifying%2520Enzyme%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26issue%3D35%26spage%3D4027%26epage%3D4036%26doi%3D10.2174%2F0929867323666160725091915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckworth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry Approaches to Avoid Aldehyde Oxidase Metabolism</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2856</span>– <span class="NLM_lpage">2860</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2012.02.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22429467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2856-2860&issue=8&author=D.+C.+Prydeauthor=T.+D.+Tranauthor=P.+Jonesauthor=J.+Duckworthauthor=M.+Howardauthor=I.+Gardnerauthor=R.+Hylandauthor=R.+Websterauthor=T.+Wenhamauthor=S.+Bagalauthor=K.+Omotoauthor=R.+P.+Schneiderauthor=J.+Lin&title=Medicinal+Chemistry+Approaches+to+Avoid+Aldehyde+Oxidase+Metabolism&doi=10.1016%2Fj.bmcl.2012.02.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry approaches to avoid aldehyde oxidase metabolism</span></div><div class="casAuthors">Pryde, David C.; Tran, Thien-Duc; Jones, Peter; Duckworth, Jonathan; Howard, Martin; Gardner, Iain; Hyland, Ruth; Webster, Rob; Wenham, Tracey; Bagal, Sharan; Omoto, Kiyoyuki; Schneider, Richard P.; Lin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2856-2860</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a molybdenum-contg. enzyme distributed throughout the animal kingdom and capable of metabolising a wide range of aldehydes and N-heterocyclic compds.  Although metab. by this enzyme in man is recognized to have significant clin. impact where human AO activity was not predicted by screening in preclin. species, there is very little reported literature offering real examples where drug discoverers have successfully designed away from AO oxidn.  This article reports on some strategies adopted in the Pfizer TLR7 agonist program to successfully switch off AO metab. that was seen principally in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZKVEe9ZUzMbVg90H21EOLACvtfcHk0li0O1UNkEoG9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSitbs%253D&md5=4c4c68b64f1c7013ad978408add0b09a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.069%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DTran%26aufirst%3DT.%2BD.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DDuckworth%26aufirst%3DJ.%26aulast%3DHoward%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DHyland%26aufirst%3DR.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWenham%26aufirst%3DT.%26aulast%3DBagal%26aufirst%3DS.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DR.%2BP.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DMedicinal%2520Chemistry%2520Approaches%2520to%2520Avoid%2520Aldehyde%2520Oxidase%2520Metabolism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2856%26epage%3D2860%26doi%3D10.1016%2Fj.bmcl.2012.02.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Differences in the in Vivo and in Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1320</span>– <span class="NLM_lpage">1328</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.081182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.118.081182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29980580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFGgt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=1320-1328&issue=9&author=X.+Houauthor=J.+Zhouauthor=S.+Yuauthor=L.+Zhouauthor=Y.+Zhangauthor=D.+Zhongauthor=X.+Chen&title=Differences+in+the+in+Vivo+and+in+Vitro+Metabolism+of+Imrecoxib+in+Humans%3A+Formation+of+the+Rate-Limiting+Aldehyde+Intermediate&doi=10.1124%2Fdmd.118.081182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in the in vivo and in vitro metabolism of imrecoxib in humans: formation of the rate-limiting aldehyde intermediate</span></div><div class="casAuthors">Hou, Xiangyu; Zhou, Jialan; Yu, Songda; Zhou, Lei; Zhang, Yifan; Zhong, Dafang; Chen, Xiaoyan</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1320-1328,S1-S6</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Imrecoxib is a typical cyclooxygenase-2 inhibitor and the benzylic carbon motif is its major site of oxidative metab., producing a hydroxymethyl metabolite (M1) and a carboxylic acid metabolite (M2).  The plasma exposure of M2 is four times higher than those of both M0 and M1 in humans.  However, this metabolite is rarely formed in in vitro expts.  Therefore, this study aims to investigate the formation mechanism of M2 and to further elucidate the reason for the discrepancy between in vitro and in vivo metabolic data.  By employing human hepatocytes, human liver microsomes (HLMs), human liver cytosols (HLCs), recombinant enzymes, and selective enzyme inhibitors, the metabolic map of imrecoxib was elaborated as follows: the parent drug was initially hydroxylated to form M1 in HLMs, mainly mediated by CYP3A4 and CYP2D6, and to subsequently form aldehyde imrecoxib (M-CHO) in HLMs and HLCs.  The latter process is the rate-limiting step in generating the end-product M2.  In further M-CHO metab., two opposite reactions (namely, rapid oxidn. catalyzed by CYP3A4, CYP2D6, and cytosolic aldehyde oxidase to form M2 vs. redn. to regenerate M1 mediated by NADPH-dependent reductases in HLMs and HLCs, such as cytochrome P 450 reductase) led to marked underestimation of the M2 amt. in static in vitro incubations.  The findings provided a possible explanation for the difference between in vitro and in vivo metab. of imrecoxib, suggesting that the effect of competitive redn. on the static oxidn. metab. in in vitro metabolic expts. should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpKb_-F2d-KLVg90H21EOLACvtfcHk0li0O1UNkEoG9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFGgt77N&md5=2c96fffd86f1159e31e54a0cdb280103</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.081182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.081182%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DDifferences%2520in%2520the%2520in%2520Vivo%2520and%2520in%2520Vitro%2520Metabolism%2520of%2520Imrecoxib%2520in%2520Humans%253A%2520Formation%2520of%2520the%2520Rate-Limiting%2520Aldehyde%2520Intermediate%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26issue%3D9%26spage%3D1320%26epage%3D1328%26doi%3D10.1124%2Fdmd.118.081182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J. S.</span></span> <span> </span><span class="NLM_article-title">A Novel Reaction Mediated by Human Aldehyde Oxidase: Amide Hydrolysis of Gdc-0834</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.061804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.061804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25845827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlCrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=908-915&issue=6&author=J.+K.+Sodhiauthor=S.+Wongauthor=D.+S.+Kirkpatrickauthor=L.+Liuauthor=S.+C.+Khojastehauthor=C.+E.+Hopauthor=J.+T.+Barrauthor=J.+P.+Jonesauthor=J.+S.+Halladay&title=A+Novel+Reaction+Mediated+by+Human+Aldehyde+Oxidase%3A+Amide+Hydrolysis+of+Gdc-0834&doi=10.1124%2Fdmd.114.061804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834</span></div><div class="casAuthors">Sodhi, Jasleen K.; Wong, Susan; Kirkpatrick, Donald S.; Liu, Lichuan; Khojasteh, S. Cyrus; Hop, Cornelis E. C. A.; Barr, John T.; Jones, Jeffrey P.; Halladay, Jason S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">908-915</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">GDC-0834, a Bruton's tyrosine kinase inhibitor investigated as a potential treatment of rheumatoid arthritis, was previously reported to be extensively metabolized by amide hydrolysis such that no measurable levels of this compd. were detected in human circulation after oral administration.  In vitro studies in human liver cytosol detd. that GDC-0834 (R)-N-(3-(6-(4-(1,4-dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide was rapidly hydrolyzed with a CLint of 0.511 mL/min per mg of protein.  Aldehyde oxidase (AO) and carboxylesterase (CES) were putatively identified as the enzymes responsible after cytosolic fractionation and mass spectrometry-proteomics anal. of the enzymically active fractions.  Results were confirmed by a series of kinetic expts. with inhibitors of AO, CES, and xanthine oxidase (XO), which implicated AO and CES, but not XO, as mediating GDC-0834 amide hydrolysis.  Further supporting the interaction between GDC-0834 and AO, GDC-0834 was shown to be a potent reversible inhibitor of six known AO substrates with IC50 values ranging from 0.86 to 1.87 μM.  Addnl., in silico modeling studies suggest that GDC-0834 is capable of binding in the active site of AO with the amide bond of GDC-0834 near the molybdenum cofactor (MoCo), orientated in such a way to enable potential nucleophilic attack on the carbonyl of the amide bond by the hydroxyl of MoCo.  Together, the in vitro and in silico results suggest the involvement of AO in the amide hydrolysis of GDC-0834.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAO_iWKyUVLVg90H21EOLACvtfcHk0li0O1UNkEoG9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlCrtrw%253D&md5=4cf67605bc094945de8229be5c9cacae</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.061804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.061804%26sid%3Dliteratum%253Aachs%26aulast%3DSodhi%26aufirst%3DJ.%2BK.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26aulast%3DHop%26aufirst%3DC.%2BE.%26aulast%3DBarr%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26atitle%3DA%2520Novel%2520Reaction%2520Mediated%2520by%2520Human%2520Aldehyde%2520Oxidase%253A%2520Amide%2520Hydrolysis%2520of%2520Gdc-0834%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26issue%3D6%26spage%3D908%26epage%3D915%26doi%3D10.1124%2Fdmd.114.061804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paragas, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">The Two Faces of Aldehyde Oxidase: Oxidative and Reductive Transformations of 5-Nitroquinoline</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2017.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28888950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKltbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2017&pages=210-217&author=E.+M.+Paragasauthor=S.+C.+Humphreysauthor=J.+Minauthor=C.+A.+Joswig-Jonesauthor=J.+P.+Jones&title=The+Two+Faces+of+Aldehyde+Oxidase%3A+Oxidative+and+Reductive+Transformations+of+5-Nitroquinoline&doi=10.1016%2Fj.bcp.2017.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline</span></div><div class="casAuthors">Paragas, Erickson M.; Humphreys, Sara C.; Min, Joshua; Joswig-Jones, Carolyn A.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">210-217</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is a cytosolic enzyme responsible for the metab. of some drugs and drug candidates.  AOX catalyzes the oxidative hydroxylation of substrates including several aliph. and arom. aldehydes, and nitrogen-contg. heterocyclic compds.  AOX is also reported to catalyze the reductive metab. of nitro-compds., N-oxides, sulfoxides, isoxazoles, isothiazoles, nitrite and hydroxamic acids.  These reductive transformations are not well understood and are generally believed to only occur at low oxygen concns.  In this study, we used 5-nitroquinoline (5NQ) as a substrate to further understand both the oxidative and the reductive transformations catalyzed by AOX.  In vitro reaction of 5NQ with AOX under aerobic conditions generated the oxidized (2-oxo-5-nitroquinoline, 2-oxo-5NQ), the reduced (5-aminoquinoline, 5AQ) and the oxidized/reduced (2-oxo-5-aminoquinoline, 2-oxo-5AQ) metabolites.  Interestingly, in human liver cytosol, co-incubation of 5NQ and known AOX oxidative substrates DACA and phthalazine significantly increased the yield of the reduced metabolite, while oxidized metabolites prodn. decreased.  These data indicate that 5NQ can be reduced at atm. oxygen concns. and that the reductive transformation occurs at a second site that is kinetically distinct from the oxidative site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEP7SDjFQWZ7Vg90H21EOLACvtfcHk0ljbpFK1wlnDbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKltbfE&md5=4a2acff32f835e365bdb5a079c291eab</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DParagas%26aufirst%3DE.%2BM.%26aulast%3DHumphreys%26aufirst%3DS.%2BC.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520Two%2520Faces%2520of%2520Aldehyde%2520Oxidase%253A%2520Oxidative%2520and%2520Reductive%2520Transformations%2520of%25205-Nitroquinoline%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D145%26spage%3D210%26epage%3D217%26doi%3D10.1016%2Fj.bcp.2017.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogiso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span> <span> </span><span class="NLM_article-title">Substrate Selectivity of Human Aldehyde Oxidase 1 in Reduction of Nitroaromatic Drugs</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>659</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2018.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.abb.2018.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30367827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCktL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=659&publication_year=2018&pages=85-92&author=T.+Ogisoauthor=T.+Fukamiauthor=K.+Mishiroauthor=K.+Konishiauthor=J.+P.+Jonesauthor=M.+Nakajima&title=Substrate+Selectivity+of+Human+Aldehyde+Oxidase+1+in+Reduction+of+Nitroaromatic+Drugs&doi=10.1016%2Fj.abb.2018.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate selectivity of human aldehyde oxidase 1 in reduction of nitroaromatic drugs</span></div><div class="casAuthors">Ogiso, Takuo; Fukami, Tatsuki; Mishiro, Kenji; Konishi, Keigo; Jones, Jeffrey P.; Nakajima, Miki</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">659</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-92</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human aldehyde oxidase 1 (AOX1) catalyzes the oxidn. of various drugs and endogenous compds.  Recently, we found that AOX1 catalyzed the redn. of drugs such as nitrazepam and dantrolene.  In this study, we aimed to clarify the substrate selectivity of human AOX1 for the redn. of nitroarom. drugs to obtain helpful information for drug development.  We investigated whether 11 nitroarom. drugs were reduced by AOX1 using recombinant AOX1 and human liver cytosol (HLC) in the presence of N1-methylnicotinamide, an electron donor to AOX1.  We found that clonazepam, flunitrazepam, flutamide, nilutamide, nimesulide, and nimetazepam were substantially reduced by recombinant AOX1 and HLC, whereas azelnidipine, nifedipine, and nimodipine were slightly reduced and metronidazole and tolcapone were not reduced.  Via structural anal., we obsd. that nitroarom. drugs reduced by AOX1 possessed a relatively electron-deficient nitro group.  Since the addn. of NADPH to human liver microsomes (HLM) did not increase the reductase activities of the drugs that were reduced by recombinant AOX1, it was detd. that NADPH-dependent enzymes in microsomes, such as cytochrome P 450, were not involved in this process.  Inhibition studies using known AOX1 inhibitors supported the role of AOX1 in the redn. of drugs in HLC.  In conclusion, this provides new information related to the substrate selectivity of human AOX1 for the redn. of nitroarom. drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcrsu5gv3v-rVg90H21EOLACvtfcHk0ljbpFK1wlnDbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCktL%252FM&md5=3a2759d9a707a3b25f4c372970cdbed9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2018.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2018.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DOgiso%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DMishiro%26aufirst%3DK.%26aulast%3DKonishi%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DNakajima%26aufirst%3DM.%26atitle%3DSubstrate%2520Selectivity%2520of%2520Human%2520Aldehyde%2520Oxidase%25201%2520in%2520Reduction%2520of%2520Nitroaromatic%2520Drugs%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2018%26volume%3D659%26spage%3D85%26epage%3D92%26doi%3D10.1016%2Fj.abb.2018.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offerman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillis, W. S.</span></span> <span> </span><span class="NLM_article-title">A Species Difference in the Presystemic Metabolism of Carbazeran in Dog and Man</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.3109/00498258409151492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498258409151492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=6531941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2MXhsVaksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1984&pages=935-945&issue=12&author=B.+Kayeauthor=J.+L.+Offermanauthor=J.+L.+Reidauthor=H.+L.+Elliottauthor=W.+S.+Hillis&title=A+Species+Difference+in+the+Presystemic+Metabolism+of+Carbazeran+in+Dog+and+Man&doi=10.3109%2F00498258409151492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A species difference in the presystemic metabolism of carbazeran in dog and man</span></div><div class="casAuthors">Kaye, B.; Offerman, J. L.; Reid, J. L.; Elliott, H. L.; Hillis, W. S.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">935-45</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    </div><div class="casAbstract">The bioavailability of carbazeran (I)  [70724-25-3] and the metab. of 14C-labeled I were studied in the dog and man following oral administration.  The drug was moderately well absorbed in both species, but there was a marked difference in bioavailability and in routes of metab.  In the dog, systemic bioavailability was approx. 68% and biotransformation involved mainly O-demethylation.  In man, bioavailability was not measurable and carbazeran was almost completely cleared via 4-hydroxylation of the phthalazine moiety.  Thus, the lack of detectable pharmacol. effect in man following oral administration of the drug appears to be due to presystemic metab. by a particularly active pathway not found in the dog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDeBO_IO2xVLVg90H21EOLACvtfcHk0ljbpFK1wlnDbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhsVaksbo%253D&md5=7725513a84c38d58065c31ce84624a23</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3109%2F00498258409151492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498258409151492%26sid%3Dliteratum%253Aachs%26aulast%3DKaye%26aufirst%3DB.%26aulast%3DOfferman%26aufirst%3DJ.%2BL.%26aulast%3DReid%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DH.%2BL.%26aulast%3DHillis%26aufirst%3DW.%2BS.%26atitle%3DA%2520Species%2520Difference%2520in%2520the%2520Presystemic%2520Metabolism%2520of%2520Carbazeran%2520in%2520Dog%2520and%2520Man%26jtitle%3DXenobiotica%26date%3D1984%26volume%3D14%26issue%3D12%26spage%3D935%26epage%3D945%26doi%3D10.3109%2F00498258409151492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerny, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilpin, K.</span></span> <span> </span><span class="NLM_article-title">Cynomolgus Monkey as a Surrogate for Human Aldehyde Oxidase Metabolism of the Egfr Inhibitor Bibx1382</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1760</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.059030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.059030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25035284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12jsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1751-1760&issue=10&author=J.+M.+Hutzlerauthor=M.+A.+Cernyauthor=Y.+S.+Yangauthor=C.+Asherauthor=D.+Wongauthor=K.+Frederickauthor=K.+Gilpin&title=Cynomolgus+Monkey+as+a+Surrogate+for+Human+Aldehyde+Oxidase+Metabolism+of+the+Egfr+Inhibitor+Bibx1382&doi=10.1124%2Fdmd.114.059030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382</span></div><div class="casAuthors">Hutzler, J. Matthew; Cerny, Matthew A.; Yang, Young-Sun; Asher, Constance; Wong, Diane; Frederick, Kosea; Gilpin, Kyle</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1751-1760, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">BIBX1382 was an epidermal growth factor receptor inhibitor under clin. investigation for treatment of cancer.  This candidate possessed an attractive preclin. absorption, distribution, metab., and excretion profile, yet failed in clin. studies due in part to poor oral exposure, resulting from extensive metab. by aldehyde oxidase (AO).  In vitro metab. studies were performed in liver cytosol and cryopreserved hepatocytes from multiple species.  In addn., a pharmacokinetic study was performed in cynomolgus monkey for comparison with the reported human pharmacokinetics of BIBX1382.  Estd. hepatic clearance of BIBX1382 in rhesus (42 mL/min per kg) and cynomolgus monkey (43 mL/min per kg) liver cytosol was comparable to human (≥93% of liver blood flow).  Metabolite identification after incubation of BIBX1382 in liver cytosol fortified with the AO inhibitor raloxifene confirmed that AO is involved in the formation of the predominant metabolite (BIBU1476, M1) in cynomolgus monkey.  After i.v. and oral administration of BIBX1382 to cynomolgus monkeys, high plasma clearance (118 mL/min per kg) and low oral exposure (Cmax = 12.7 nM and 6% oral bioavailability) was obsd., with the exposure of M1 exceeding BIBX1382 after oral dosing.  This pharmacokinetic profile compared favorably with the human clin. data of BIBX1382 (plasma clearance 25-55 mL/min per kg and 5% oral bioavailability).  Thus, it appears that cynomolgus monkey represents a suitable surrogate for the obsd. human AO metab. of BIBX1382.  To circumvent clin. failures due to uncharacterized metab. by AO, in vitro studies in the appropriate subcellular fraction, followed by pharmacokinetic and toxicokinetic studies in the appropriately characterized surrogate species should be conducted for substrates of AO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmMUPaJpQsG7Vg90H21EOLACvtfcHk0lh4ZaKbzX5ULA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12jsbrI&md5=ccb9a5ee98921b41bae55a73e7198b22</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.059030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.059030%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DCerny%26aufirst%3DM.%2BA.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DAsher%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DFrederick%26aufirst%3DK.%26aulast%3DGilpin%26aufirst%3DK.%26atitle%3DCynomolgus%2520Monkey%2520as%2520a%2520Surrogate%2520for%2520Human%2520Aldehyde%2520Oxidase%2520Metabolism%2520of%2520the%2520Egfr%2520Inhibitor%2520Bibx1382%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D10%26spage%3D1751%26epage%3D1760%26doi%3D10.1124%2Fdmd.114.059030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilausen, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thale, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasena, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, M.</span></span> <span> </span><span class="NLM_article-title">Lack of Exposure in a First-in-Man Study Due to Aldehyde Oxidase Metabolism: Investigated by Use of 14c-Microdose, Humanized Mice, Monkey Pharmacokinetics, and in Vitro Methods</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.072793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.116.072793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27737930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlSkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=68-75&issue=1&author=K.+G.+Jensenauthor=A.+M.+Jacobsenauthor=C.+Bundgaardauthor=D.+O.+Nilausenauthor=Z.+Thaleauthor=G.+Chandrasenaauthor=M.+Jorgensen&title=Lack+of+Exposure+in+a+First-in-Man+Study+Due+to+Aldehyde+Oxidase+Metabolism%3A+Investigated+by+Use+of+14c-Microdose%2C+Humanized+Mice%2C+Monkey+Pharmacokinetics%2C+and+in+Vitro+Methods&doi=10.1124%2Fdmd.116.072793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of exposure in a first-in-man study due to aldehyde oxidase metabolism: investigated by use of 14C-microdose, humanized mice, monkey pharmacokinetics, and in vitro methods</span></div><div class="casAuthors">Jensen, Klaus Gjervig; Jacobsen, Anne-Marie; Bundgaard, Christoffer; Nilausen, Dorrit Oestergaard; Thale, Zia; Chandrasena, Gamini; Joergensen, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-75</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inclusion of a microdose of 14C-labeled drug in the first-in-man study of new investigational drugs and subsequent anal. by accelerator mass spectrometry has become an integrated part of drug development at Lundbeck.  It has been found to be highly informative with regard to investigations of the routes and rates of excretion of the drug and the human metabolite profiles according to metabolites in safety testing guidance and also when addnl. metab.-related issues needed to be addressed.  In the first-in-man study with the NCE Lu AF09535, contrary to anticipated, surprisingly low exposure was obsd. when measuring the parent compd. using conventional bioanal.  Parallel accelerator mass spectrometry anal. revealed that the low exposure was almost exclusively attributable to extensive metab.  The metab. obsd. in humans was mediated via a human specific metabolic pathway, whereas an equiv. extent of metab. was not obsd. in preclin. species.  In vitro, incubation studies in human liver cytosol revealed involvement of aldehyde oxidase (AO) in the biotransformation of Lu AF09535.  In vivo, substantially lower plasma exposure of Lu AF09535 was obsd. in chimeric mice with humanized livers compared with control animals.  In addn., Lu AF09535 exhibited very low oral bioavailability in monkeys despite relatively low clearance after i.v. administration in contrast to the pharmacokinetics in rats and dogs, both showing low clearance and high bioavailability.  The in vitro and in vivo methods applied were proved useful for identifying and evaluating AO-dependent metab.  Different strategies to integrate these methods for prediction of in vivo human clearance of AO substrates were evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMEbOS64YnLVg90H21EOLACvtfcHk0lh4ZaKbzX5ULA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlSkt7s%253D&md5=670770579f69820969ad76dfa153156e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.072793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.072793%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DK.%2BG.%26aulast%3DJacobsen%26aufirst%3DA.%2BM.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DNilausen%26aufirst%3DD.%2BO.%26aulast%3DThale%26aufirst%3DZ.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DM.%26atitle%3DLack%2520of%2520Exposure%2520in%2520a%2520First-in-Man%2520Study%2520Due%2520to%2520Aldehyde%2520Oxidase%2520Metabolism%253A%2520Investigated%2520by%2520Use%2520of%252014c-Microdose%252C%2520Humanized%2520Mice%252C%2520Monkey%2520Pharmacokinetics%252C%2520and%2520in%2520Vitro%2520Methods%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2017%26volume%3D45%26issue%3D1%26spage%3D68%26epage%3D75%26doi%3D10.1124%2Fdmd.116.072793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hvenegaard, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang-Andersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalgaard, L.</span></span> <span> </span><span class="NLM_article-title">Identification of the Cytochrome P450 and Other Enzymes Involved in the in Vitro Oxidative Metabolism of a Novel Antidepressant, Lu Aa21004</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.044610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.044610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22496396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrs73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1357-1365&issue=7&author=M.+G.+Hvenegaardauthor=B.+Bang-Andersenauthor=H.+Pedersenauthor=M.+Jorgensenauthor=A.+Puschlauthor=L.+Dalgaard&title=Identification+of+the+Cytochrome+P450+and+Other+Enzymes+Involved+in+the+in+Vitro+Oxidative+Metabolism+of+a+Novel+Antidepressant%2C+Lu+Aa21004&doi=10.1124%2Fdmd.112.044610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004</span></div><div class="casAuthors">Hvenegaard, Mette G.; Bang-Andersen, Benny; Pedersen, Henrik; Joergensen, Morten; Puschl, Ask; Dalgaard, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1357-1365</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]-piperazine (Lu AA21004) is a novel antidepressant that is currently in late-stage clin. development for major depressive disorder.  In the present study, the metab. of Lu AA21004 was investigated using human liver microsomes (HLM), human liver S9 fraction, and recombinant enzymes.  Lu AA21004 was found in vitro to be oxidized to a 4-hydroxy-Ph metabolite, a sulfoxide, an N-hydroxylated piperazine, and a benzylic alc., which was further oxidized to the corresponding benzoic acid [3-methyl-4-(2-piperazin-1-yl-phenysulfanyl)-benzoic acid (Lu AA34443)].  The formation of the 4-hydroxy-Ph metabolite was catalyzed by CYP2D6 with some contribution from CYP2C9, whereas the formation of the sulfoxide was mediated by CYP3A4/5 and CYP2A6.  CYP2C9 and CYP2C19 were the primary enzymes responsible for formation of the N-hydroxylated metabolite.  The benzylic alc. was formed by CYP2D6 only.  The oxidn. of the benzylic alc. to the corresponding benzoic acid of Lu AA21004 was catalyzed by alc. dehydrogenase and aldehyde dehydrogenase, with some contribution from aldehyde oxidase.  CYP2D6 was also capable of catalyzing the formation of the benzoic acid of Lu AA21004; however, its overall contribution to this pathway was negligible.  Enzyme kinetic parameters revealed that the rate-limiting step in the formation of the benzoic acid from Lu AA21004 is the formation of the corresponding alc.  Thus, the intrinsic clearance (Vmax/Km) in HLM for metab. of Lu AA21004 to the benzylic alc. was 1.13 × 10-6 l · min-1 · mg-1, whereas the subsequent metab. of the benzylic alc. to the benzoic acid of Lu AA21004 is characterized by an intrinsic clearance (Vmax/Km) in S9 fraction of 922 × 10-6 l · min-1 · mg-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztxSrnmvMrLVg90H21EOLACvtfcHk0lh4ZaKbzX5ULA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrs73O&md5=d8c7d282b8a8433f4fee14dbd3da34c3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.044610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.044610%26sid%3Dliteratum%253Aachs%26aulast%3DHvenegaard%26aufirst%3DM.%2BG.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DPedersen%26aufirst%3DH.%26aulast%3DJorgensen%26aufirst%3DM.%26aulast%3DPuschl%26aufirst%3DA.%26aulast%3DDalgaard%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520the%2520Cytochrome%2520P450%2520and%2520Other%2520Enzymes%2520Involved%2520in%2520the%2520in%2520Vitro%2520Oxidative%2520Metabolism%2520of%2520a%2520Novel%2520Antidepressant%252C%2520Lu%2520Aa21004%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D7%26spage%3D1357%26epage%3D1365%26doi%3D10.1124%2Fdmd.112.044610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vardavas, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozcagli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragkiadaki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stivaktakis, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzatzarakis, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegakis, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilaki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaloudis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsiaoussis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouretas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsitsimpikou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsatsakis, A. M.</span></span> <span> </span><span class="NLM_article-title">The Metabolism of Imidacloprid by Aldehyde Oxidase Contributes to Its Clastogenic Effect in New Zealand Rabbits</span>. <i>Mutat. Res., Genet. Toxicol. Environ. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>829−830</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.mrgentox.2018.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.mrgentox.2018.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29704990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslKltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=829%E2%88%92830&publication_year=2018&pages=26-32&author=A.+I.+Vardavasauthor=E.+Ozcagliauthor=P.+Fragkiadakiauthor=P.+D.+Stivaktakisauthor=M.+N.+Tzatzarakisauthor=A.+K.+Alegakisauthor=F.+Vasilakiauthor=K.+Kaloudisauthor=J.+Tsiaoussisauthor=D.+Kouretasauthor=C.+Tsitsimpikouauthor=F.+Carvalhoauthor=A.+M.+Tsatsakis&title=The+Metabolism+of+Imidacloprid+by+Aldehyde+Oxidase+Contributes+to+Its+Clastogenic+Effect+in+New+Zealand+Rabbits&doi=10.1016%2Fj.mrgentox.2018.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of imidacloprid by aldehyde oxidase contributes to its clastogenic effect in New Zealand rabbits</span></div><div class="casAuthors">Vardavas, Alexander I.; Ozcagli, Eren; Fragkiadaki, Persefoni; Stivaktakis, Polychronis D.; Tzatzarakis, Manolis N.; Alegakis, Athanasios K.; Vasilaki, Fotini; Kaloudis, Kostas; Tsiaoussis, John; Kouretas, Dimitrios; Tsitsimpikou, Christina; Carvalho, Felix; Tsatsakis, Aristidis M.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology and Environmental Mutagenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">829-830</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-32</span>CODEN:
                <span class="NLM_cas:coden">MRGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1383-5718</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Imidacloprid (IMI) is a systemic, chloro-nicotinyl insecticide classified in Regulation N° 1272/2008 of the European Commision as "harmful if swallowed and very toxic to aquatic life, with long-lasting effects".  IMI is metabolized in vitro both by aldehyde oxidase (AOX) (redn.) and by cytochrome P450s enzymes (CYPs).  In the present study, the AOX inhibitor sodium tungstate dihydrate (ST) was used to elucidate the relative contribution of CYP 450 and AOX metabolic pathways on IMI metab., in male rabbits exposed to IMI for two months.  To evaluate the inhibition effectiveness, various metabolite concns. in the IMI and IMI+ST exposed groups were monitored.  DNA damage was also evaluated in micronucleus (MN) and single cell electrophoresis (SCGC) assays in both groups, along with oxidative stress (OS) with the inflammatory status of the exposed animals, in order to clarify which metabolic pathway is more detrimental in this exptl. setting.  A significant increase in the frequency of binucleated cells with MN (BNMN, 105%) and micronuclei (MN, 142%) was obsd. after exposure to IMI (p<0.001).  The increase in the ST co-exposed animals was less pronounced (BNMN 75%, MN 95%).  The Cytokinesis Block Proliferation Index (CBPI) showed no significant difference between controls and exposed animals at any time of exposure (p>0.05), which indicates no cytotoxic effect.  Similarly, comet results show that the IMI group exhibited the highest achieved tail intensity, which reached 70.7% over the control groups, whereas in the IMI+ST groups the increase remained at 48.5%.  No differences were obsd. between all groups for oxidative-stress biomarkers.  The results indicate that the AOX metabolic pathway plays a more important role in the systemic toxicity of IMI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMa0IXCzmcdbVg90H21EOLACvtfcHk0lind9yZJzLS_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslKltL8%253D&md5=b71dad717a62caf31143566177c3bbeb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.mrgentox.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrgentox.2018.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DVardavas%26aufirst%3DA.%2BI.%26aulast%3DOzcagli%26aufirst%3DE.%26aulast%3DFragkiadaki%26aufirst%3DP.%26aulast%3DStivaktakis%26aufirst%3DP.%2BD.%26aulast%3DTzatzarakis%26aufirst%3DM.%2BN.%26aulast%3DAlegakis%26aufirst%3DA.%2BK.%26aulast%3DVasilaki%26aufirst%3DF.%26aulast%3DKaloudis%26aufirst%3DK.%26aulast%3DTsiaoussis%26aufirst%3DJ.%26aulast%3DKouretas%26aufirst%3DD.%26aulast%3DTsitsimpikou%26aufirst%3DC.%26aulast%3DCarvalho%26aufirst%3DF.%26aulast%3DTsatsakis%26aufirst%3DA.%2BM.%26atitle%3DThe%2520Metabolism%2520of%2520Imidacloprid%2520by%2520Aldehyde%2520Oxidase%2520Contributes%2520to%2520Its%2520Clastogenic%2520Effect%2520in%2520New%2520Zealand%2520Rabbits%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D2018%26volume%3D829%25E2%2588%2592830%26spage%3D26%26epage%3D32%26doi%3D10.1016%2Fj.mrgentox.2018.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akabane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teramura, T.</span></span> <span> </span><span class="NLM_article-title">Case Report of Extensive Metabolism by Aldehyde Oxidase in Humans: Pharmacokinetics and Metabolite Profile of Fk3453 in Rats, Dogs, and Humans</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.3109/00498254.2010.549970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2010.549970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21385103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=372-384&issue=5&author=T.+Akabaneauthor=K.+Tanakaauthor=M.+Irieauthor=S.+Terashitaauthor=T.+Teramura&title=Case+Report+of+Extensive+Metabolism+by+Aldehyde+Oxidase+in+Humans%3A+Pharmacokinetics+and+Metabolite+Profile+of+Fk3453+in+Rats%2C+Dogs%2C+and+Humans&doi=10.3109%2F00498254.2010.549970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Case report of extensive metabolism by aldehyde oxidase in humans: Pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans</span></div><div class="casAuthors">Akabane, Takafumi; Tanaka, Kohichiro; Irie, Megumi; Terashita, Shigeyuki; Teramura, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-384</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The in vitro and in vivo pharmacokinetic profiles of FK3453 [6-(2-amino-4-phenylpyrimidin-5-yl)-2-isopropylpyridazin-3(2H)-one] in rats, dogs, and humans were described, and the mechanism responsible for poor oral exposure of FK3453 in humans was investigated.  FK3453 showed favorable profiles in preclin. pharmacokinetic studies, including satisfactory abs. bioavailability and total body clearance in animals (30.5-41.4%, 54.7-68.2%, and 71.3-93.4% and 10.8-17.6, 1.9-17.1, and 5.0 mL/min/kg in male rats, female rats, and dogs, resp.), and good metabolic stability in liver microsomes (42.3, 14.5, and 1.1 mL/min/kg in male rats, dogs, and humans, resp.).  However, despite these promising preclin. findings, plasma concns. of FK3453 in humans were extremely low, with the oxidative metabolite of the aminopyrimidine moiety (M4) identified as a major metabolite.  Given that aldehyde oxidase (AO) and xanthine oxidase (XO) were presumed to be the enzymes responsible for M4 formation, the mechanism of M4 formation was studied using human liver subcellular fractions.  M4 was detected in the incubation mixt. with S9 and cytosol but not with microsomes, and M4 formation was inhibited by AO inhibitors (menadione, isovanillin) but not by cytochrome P 450 inhibitor (1-aminobenzotriazole) or XO inhibitor (allopurinol).  These results suggest that M4 formation is catalyzed by AO, and therefore, its poor exposure in humans was attributed to extensive AO metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRrHt4c8_yd7Vg90H21EOLACvtfcHk0lind9yZJzLS_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wnsr8%253D&md5=7ba62d51a4213f8c37472bb182f2687f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3109%2F00498254.2010.549970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2010.549970%26sid%3Dliteratum%253Aachs%26aulast%3DAkabane%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DIrie%26aufirst%3DM.%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DTeramura%26aufirst%3DT.%26atitle%3DCase%2520Report%2520of%2520Extensive%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%2520in%2520Humans%253A%2520Pharmacokinetics%2520and%2520Metabolite%2520Profile%2520of%2520Fk3453%2520in%2520Rats%252C%2520Dogs%252C%2520and%2520Humans%26jtitle%3DXenobiotica%26date%3D2011%26volume%3D41%26issue%3D5%26spage%3D372%26epage%3D384%26doi%3D10.3109%2F00498254.2010.549970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monshouwer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peltz, G.</span></span> <span> </span><span class="NLM_article-title">In Silico and in Vitro Pharmacogenetics: Aldehyde Oxidase Rapidly Metabolizes a P38 Kinase Inhibitor</span>. <i>Pharmacogenomics J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1038/tpj.2010.8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Ftpj.2010.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=20177421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlaisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=15-24&issue=1&author=X.+Zhangauthor=H.+H.+Liuauthor=P.+Wellerauthor=M.+Zhengauthor=W.+Taoauthor=J.+Wangauthor=G.+Liaoauthor=M.+Monshouwerauthor=G.+Peltz&title=In+Silico+and+in+Vitro+Pharmacogenetics%3A+Aldehyde+Oxidase+Rapidly+Metabolizes+a+P38+Kinase+Inhibitor&doi=10.1038%2Ftpj.2010.8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor</span></div><div class="casAuthors">Zhang, X.; Liu, H.-H.; Weller, P.; Zheng, M.; Tao, W.; Wang, J.; Liao, G.; Monshouwer, M.; Peltz, G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenomics Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">PJHOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1470-269X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. development of a candidate p38 kinase inhibitor was terminated because of its unexpectedly rapid clearance in human subjects.  Its short half-life and metabolic profile in human beings were vastly different from that in rats, dogs, and monkeys characterized during routine pre-clin. studies.  Mice generated the predominant drug (4-hydroxylated) metabolite produced in human beings, which was not found in other species.  The data from a murine in vitro drug biotransformation assay that used liver exts. from 14 inbred mouse strains were analyzed by haplotype-based computational genetic anal.  This led to the identification of aldehyde oxidase-1 (AOX1) as the enzyme responsible for the rapid metab. of this drug.  Specific enzyme inhibitors and expressed recombinant enzymes were used to confirm that AOX catalyzed the formation of the 4-hydroxylated drug metabolite in mouse and man.  Genetic variation within Aox1 regulated the level of hepatic Aox1 mRNA, AOX1 protein, and enzyme activity among the inbred strains.  Thus, computational murine pharmacogenetic anal. can facilitate the identification and characterization of drug metab. pathways that are differentially utilized by humans and other species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqwWgdlWC4zrVg90H21EOLACvtfcHk0ljuxkya3n0aZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlaisLo%253D&md5=f440e4ef770c2d78eeb90ff6458896a1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Ftpj.2010.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftpj.2010.8%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%2BH.%26aulast%3DWeller%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DMonshouwer%26aufirst%3DM.%26aulast%3DPeltz%26aufirst%3DG.%26atitle%3DIn%2520Silico%2520and%2520in%2520Vitro%2520Pharmacogenetics%253A%2520Aldehyde%2520Oxidase%2520Rapidly%2520Metabolizes%2520a%2520P38%2520Kinase%2520Inhibitor%26jtitle%3DPharmacogenomics%2520J.%26date%3D2011%26volume%3D11%26issue%3D1%26spage%3D15%26epage%3D24%26doi%3D10.1038%2Ftpj.2010.8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolkema, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohets, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkenau, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lampo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jonge, M. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doorn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellemans, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskens, F.</span></span> <span> </span><span class="NLM_article-title">The C-Met Tyrosine Kinase Inhibitor Jnj-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2297</span>– <span class="NLM_lpage">2304</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1158%2F1078-0432.CCR-14-3258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25745036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXoslOktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2297-2304&issue=10&author=M.+P.+Lolkemaauthor=H.+H.+Bohetsauthor=H.+T.+Arkenauauthor=A.+Lampoauthor=E.+Baraleauthor=M.+J.+A.+de+Jongeauthor=L.+van+Doornauthor=P.+Hellemansauthor=J.+S.+de+Bonoauthor=F.+Eskens&title=The+C-Met+Tyrosine+Kinase+Inhibitor+Jnj-38877605+Causes+Renal+Toxicity+through+Species-Specific+Insoluble+Metabolite+Formation&doi=10.1158%2F1078-0432.CCR-14-3258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation</span></div><div class="casAuthors">Lolkema, Martijn P.; Bohets, Hilde H.; Arkenau, Hendrik-Tobias; Lampo, Ann; Barale, Erio; de Jonge, Maja J. A.; van Doorn, Leni; Hellemans, Peter; de Bono, Johann S.; Eskens, Ferry A. L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2297-2304</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The receptor tyrosine kinase c-Met plays an important role in tumorigenesis and is a novel target for anticancer treatment.  This phase I, first-in-human trial, explored safety, pharmacokinetics, pharmacodynamics, and initial antitumor activity of JNJ-38877605, a potent and selective c-Met inhibitor.  Exptl. Design: We performed a phase I dose-escalation study according to the std. 3+3 design.  Results: Even at subtherapeutic doses, mild though recurrent renal toxicity was obsd. in virtually all patients.  Renal toxicity had not been obsd. in preclin. studies in rats and dogs.  Addnl. preclin. studies pointed toward the rabbit as a suitable toxicol. model, as the formation of the M10 metabolite of JNJ-38877605 specifically occurred in rabbits and humans.  Addnl. toxicol. studies in rabbits clearly demonstrated that JNJ-38877605 induced species-specific renal toxicity.  Histopathol. evaluation in rabbits revealed renal crystal formation with degenerative and inflammatory changes.  Identification of the components of these renal crystals revealed M1/3 and M5/6 metabolites.  Accordingly, it was found that humans and rabbits showed significantly increased systemic exposure to these metabolites relative to other species.  These main culprit insol. metabolites were generated by aldehyde oxidase activity.  Alternative dosing schedules of JNJ-3877605 and concomitant probenecid administration in rabbits failed to prevent renal toxicity at dose levels that could be pharmacol. active.  Conclusions: Combined clin. and correlative preclin. studies suggest that renal toxicity of JNJ-38877605 is caused by the formation of species-specific insol. metabolites.  These observations preclude further clin. development of JNJ-38877605.  Clin Cancer Res; 21(10); 2297-304. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro1cpkCcM_IbVg90H21EOLACvtfcHk0ljuxkya3n0aZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXoslOktbc%253D&md5=9900b077fbb0766d9c26b3908e7ee1c4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3258%26sid%3Dliteratum%253Aachs%26aulast%3DLolkema%26aufirst%3DM.%2BP.%26aulast%3DBohets%26aufirst%3DH.%2BH.%26aulast%3DArkenau%26aufirst%3DH.%2BT.%26aulast%3DLampo%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DE.%26aulast%3Dde%2BJonge%26aufirst%3DM.%2BJ.%2BA.%26aulast%3Dvan%2BDoorn%26aufirst%3DL.%26aulast%3DHellemans%26aufirst%3DP.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DEskens%26aufirst%3DF.%26atitle%3DThe%2520C-Met%2520Tyrosine%2520Kinase%2520Inhibitor%2520Jnj-38877605%2520Causes%2520Renal%2520Toxicity%2520through%2520Species-Specific%2520Insoluble%2520Metabolite%2520Formation%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26issue%3D10%26spage%3D2297%26epage%3D2304%26doi%3D10.1158%2F1078-0432.CCR-14-3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span> <span> </span><span class="NLM_article-title">Unexpected Renal Toxicity Associated with Sgx523, a Small Molecule Inhibitor of Met</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1007/s10637-012-9823-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs10637-012-9823-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22547164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsleis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=363-369&issue=2&author=J.+R.+Infanteauthor=T.+Ruggauthor=M.+Gordonauthor=I.+Rooneyauthor=L.+Rosenauthor=K.+Zehauthor=R.+Liuauthor=H.+A.+Burrisauthor=R.+K.+Ramanathan&title=Unexpected+Renal+Toxicity+Associated+with+Sgx523%2C+a+Small+Molecule+Inhibitor+of+Met&doi=10.1007%2Fs10637-012-9823-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of MET</span></div><div class="casAuthors">Infante, Jeffrey R.; Rugg, Terence; Gordon, Michael; Rooney, Isabelle; Rosen, Lee; Zeh, Karin; Liu, Raymond; Burris, Howard A.; Ramanathan, Ramesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">363-369</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose SGX523 is an orally bio-available, ATP competitive, small mol. inhibitor of MET, binding the kinase domain active site in a novel mode.  Two phase 1, open-label, dose-escalation studies of SGX523 were conducted to evaluate both interrupted and continuous dosing schedules.  Methods Thirty-six patients per study were planned to be enrolled.  The first study explored a 21-day cycle with SGX523 administered on an intermittent schedule at a starting dose of 60 mg PO BID for 14 days followed by 7 days of rest.  The second protocol explored a continuous 28-day dosing schedule with SGX523 administered at a starting dose of 20 mg PO BID for 28 days without rest.  Results A total of 10 patients were enrolled, 2 on the intermittent dosing protocol and 8 on the continuous dosing protocol.  All 6 patients that received daily doses of ≥ 80 mg developed unexpected renal failure manifested by an early rise of serum blood urea nitrogen and creatinine.  Human PK anal. revealed the formation of two insol. metabolites at levels not seen in the rat or dog preclin. toxicol. studies.  Subsequent primate toxicol. and toxicokinetic evaluation replicated human findings, and histol. examn. of the monkey kidneys revealed the formation of crystals both within the renal tubules and within giant cell macrophages.  Conclusion Two-species toxicol. studies of SGX523 did not predict the occurrence of renal toxicity in the human.  Subsequent primate toxicol. studies suggest the cause of the renal failure seen in humans was a crystal nephropathy secondary to insol. metabolites.  SGX523 is no longer in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ewYHwc5RhrVg90H21EOLACvtfcHk0ljuxkya3n0aZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsleis7g%253D&md5=fe939cff3ba4a95ca7c21ff5744d043f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs10637-012-9823-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-012-9823-9%26sid%3Dliteratum%253Aachs%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DRugg%26aufirst%3DT.%26aulast%3DGordon%26aufirst%3DM.%26aulast%3DRooney%26aufirst%3DI.%26aulast%3DRosen%26aufirst%3DL.%26aulast%3DZeh%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26atitle%3DUnexpected%2520Renal%2520Toxicity%2520Associated%2520with%2520Sgx523%252C%2520a%2520Small%2520Molecule%2520Inhibitor%2520of%2520Met%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26issue%3D2%26spage%3D363%26epage%3D369%26doi%3D10.1007%2Fs10637-012-9823-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maduskuie, T. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falahatpisheh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeleswaram, S.</span></span> <span> </span><span class="NLM_article-title">Species-Specific Metabolism of Sgx523 by Aldehyde Oxidase and the Toxicological Implications</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.032375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.110.032375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=20421447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1277-1285&issue=8&author=S.+Diamondauthor=J.+Boerauthor=T.+P.+Maduskuieauthor=N.+Falahatpishehauthor=Y.+Liauthor=S.+Yeleswaram&title=Species-Specific+Metabolism+of+Sgx523+by+Aldehyde+Oxidase+and+the+Toxicological+Implications&doi=10.1124%2Fdmd.110.032375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications</span></div><div class="casAuthors">Diamond, Sharon; Boer, Jason; Maduskuie, Thomas P., Jr.; Falahatpisheh, Nikoo; Li, Yu; Yeleswaram, Swamy</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1277-1285</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">An investigation was conducted to follow up on the apparent species-dependent toxicity reported for 6-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio]quinoline (SGX523), a mesenchymal-epithelial transition factor (c-MET) inhibitor that entered clin. development for the treatment of solid tumors.  Patients treated with SGX523 exhibited compromised renal function presumably resulting from crystal deposits in renal tubules.  Our independent metabolite profiling of SGX523 indicates that a major NADPH-independent, late-eluting metabolite [6-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio)quinolin-2(1H)-one (M11)] was generated by monkey and human liver S-9, and to a lesser extent by rat S-9, whereas M11 was absent in dog S-9 incubations.  We confirmed the identity of M11 as 2-quinolinone-SGX523.  Expts. with various molybdenum hydroxylase inhibitors showed that aldehyde oxidase (AO), and not xanthine oxidase, metabolized SGX523 to M11 in monkey and human liver cytosol.  In addn., the oxygen incorporated into M11 was derived from water rather than atm. oxygen, corroborating M11 formation via AO.  After oral dosing in monkeys, metabolite profiling of plasma and urine showed that SGX523 was indeed metabolized to M11 and its N-demethyl analog (M8).  In urine, M11 levels were ∼70-fold greater than that of SGX523, and the soly. of M11 in urine was only 3% of that of SGX523.  In summary, SGX523 is metabolized by AO in a species-specific manner to a markedly less-sol. metabolite, M11.  We propose that M11 is likely involved in the obsd. obstructive nephropathy reported in clin. studies.  Moreover, this study illustrates the need to conduct thorough metabolic evaluations early in drug development to select the most relevant nonclin. species for toxicol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryx8buDjc41LVg90H21EOLACvtfcHk0ljqHoWjzg-apw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjM&md5=27450436ad7a69d72d4cc8ae9860ccd9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.032375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.032375%26sid%3Dliteratum%253Aachs%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DMaduskuie%26aufirst%3DT.%2BP.%26aulast%3DFalahatpisheh%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYeleswaram%26aufirst%3DS.%26atitle%3DSpecies-Specific%2520Metabolism%2520of%2520Sgx523%2520by%2520Aldehyde%2520Oxidase%2520and%2520the%2520Toxicological%2520Implications%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D8%26spage%3D1277%26epage%3D1285%26doi%3D10.1124%2Fdmd.110.032375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warr, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorehead, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemenway, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, J. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical Development</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1124/dmd.117.078899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.117.078899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29311136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsV2ktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=237-247&issue=3&author=J.+Zhengauthor=Y.+Xinauthor=J.+Zhangauthor=R.+Subramanianauthor=B.+P.+Murrayauthor=J.+A.+Whitneyauthor=M.+R.+Warrauthor=J.+Lingauthor=L.+Mooreheadauthor=E.+Kwanauthor=J.+Hemenwayauthor=B.+J.+Smithauthor=J.+A.+Silverman&title=Pharmacokinetics+and+Disposition+of+Momelotinib+Revealed+a+Disproportionate+Human+Metabolite-Resolution+for+Clinical+Development&doi=10.1124%2Fdmd.117.078899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and disposition of momelotinib revealed a disproportionate human metabolite-resolution for clinical development</span></div><div class="casAuthors">Zheng, Jim; Xin, Yan; Zhang, Jingyu; Subramanian, Raju; Murray, Bernard P.; Whitney, J. Andrew; Warr, Matthew R.; Ling, John; Moorehead, Lisa; Kwan, Ellen; Hemenway, Jeffrey; Smith, Bill J.; Silverman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-247,S1-S28</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Momelotinib (MMB), a small-mol. inhibitor of Janus kinase (JAK)1/2 and of activin A receptor type 1 (ACVR1), is in clin. development for the treatment of myeloproliferative neoplasms.  The pharmacokinetics and disposition of [14C]MMB were characterized in a single-dose, human mass-balance study.  Metab. and the pharmacol. activity of key metabolites were elucidated in multiple in vitro and in vivo expts.  MMB was rapidly absorbed following oral dosing with approx. 97% of the radioactivity recovered, primarily in feces with urine as a secondary route.  Mean blood-to-plasma [14C] area under the plasma concn.-time curve ratio was 0.72, suggesting low assocn. of MMB and metabolites with blood cells. [14C]MMB-derived radioactivity was detectable in blood for ≤48 h, suggesting no irreversible binding of MMB or its metabolites.  The major circulating human metabolite, M21 (a morpholino lactam), is a potent inhibitor of JAK1/2 and ACVR1 in vitro.  Estn. of pharmacol. activity index suggests M21 contributes significantly to the pharmacol. activity of MMB for the inhibition of both JAK1/2 and ACVR1.  M21 was obsd. in disproportionately higher amts. in human plasma than in rat or dog, the rodent and nonrodent species used for the general nonclin. safety assessment of this mol.  This discrepancy was resolved with addnl. nonclin. studies wherein the circulating metabolites and drug-drug interactions were further characterized.  The human metab. of MMB was mediated primarily by multiple cytochrome P 450 enzymes, whereas M21 formation involved initial P 450 oxidn. of the morpholine ring followed by metab. via aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGdMwZyk81C7Vg90H21EOLACvtfcHk0ljqHoWjzg-apw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsV2ktb8%253D&md5=cf73dce851338a404b11a90fe2287ca4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fdmd.117.078899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.117.078899%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DB.%2BP.%26aulast%3DWhitney%26aufirst%3DJ.%2BA.%26aulast%3DWarr%26aufirst%3DM.%2BR.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DMoorehead%26aufirst%3DL.%26aulast%3DKwan%26aufirst%3DE.%26aulast%3DHemenway%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DSilverman%26aufirst%3DJ.%2BA.%26atitle%3DPharmacokinetics%2520and%2520Disposition%2520of%2520Momelotinib%2520Revealed%2520a%2520Disproportionate%2520Human%2520Metabolite-Resolution%2520for%2520Clinical%2520Development%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26issue%3D3%26spage%3D237%26epage%3D247%26doi%3D10.1124%2Fdmd.117.078899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitcher-Johnstone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D. J.</span></span> <span> </span><span class="NLM_article-title">Metabolic Switching of Bilr 355 in the Presence of Ritonavir. Ii. Uncovering Novel Contributions by Gut Bacteria and Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1130</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.044362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.044362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22393121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlWnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1130-1137&issue=6&author=Y.+Liauthor=J.+Xuauthor=W.+G.+Laiauthor=A.+Whitcher-Johnstoneauthor=D.+J.+Tweedie&title=Metabolic+Switching+of+Bilr+355+in+the+Presence+of+Ritonavir.+Ii.+Uncovering+Novel+Contributions+by+Gut+Bacteria+and+Aldehyde+Oxidase&doi=10.1124%2Fdmd.111.044362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic switching of BILR 355 in the presence of ritonavir. II. Uncovering novel contributions by gut bacteria and aldehyde oxidase</span></div><div class="casAuthors">Li, Yongmei; Xu, Jun; Lai, W. George; Whitcher-Johnstone, Andrea; Tweedie, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1130-1137</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ritonavir (RTV) was used as a boosting agent to increase the clin. exposure of 11-ethyl-5,11-dihydro-5-methyl-8-[2-[(1-oxido-4-quinolinyl)oxy]ethyl]-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one (BILR 355), an inhibitor of the human immunodeficiency virus, by inhibiting the CYP3A-mediated metab. of BILR 355.  However, although the levels of BILR 355 increased upon concomitant administration of RTV, a metabolite of BILR 355, BILR 516, which was not detected previously in humans dosed with BILR 355 alone, became a disproportionate human metabolite with levels exceeding the parent levels at steady state.  This was an unusual finding based on the in vitro and in vivo metabolic profiles of BILR 355 available at that time.  Our studies reveal that BILR 355 is reduced to an intermediate, BILR 402, by gut bacteria and the reduced metabolite (BILR 402) is then oxidized by aldehyde oxidase to form BILR 516, the disproportionate human metabolite.  The role of aldehyde oxidase helped to explain the some-what unique formation of BILR 516 in humans compared with preclin. animal species.  This article underlines the increasing importance of two individually atypical enzymes in drug development, gut bacterial biotransformation and aldehyde oxidase, which in combination provided a unique metabolic pathway.  In addn., this article clearly elucidates an example of novel metabolic switching and, it is hoped, raises awareness of the potential for metabolic switching in combination drug therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot96hVZ6iS27Vg90H21EOLACvtfcHk0ljcekTQ0Lah-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlWnsrY%253D&md5=4373d80f720051a930c5348391148923</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.044362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.044362%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DW.%2BG.%26aulast%3DWhitcher-Johnstone%26aufirst%3DA.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26atitle%3DMetabolic%2520Switching%2520of%2520Bilr%2520355%2520in%2520the%2520Presence%2520of%2520Ritonavir.%2520Ii.%2520Uncovering%2520Novel%2520Contributions%2520by%2520Gut%2520Bacteria%2520and%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D6%26spage%3D1130%26epage%3D1137%26doi%3D10.1124%2Fdmd.111.044362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glatthar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troxler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beerli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gassmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druckes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fendrich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny-Baron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornfeld, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peel, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparrer, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (Cot) Kinase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7544</span>– <span class="NLM_lpage">7560</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSms7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7544-7560&issue=16&author=R.+Glattharauthor=A.+Stojanovicauthor=T.+Troxlerauthor=H.+Mattesauthor=H.+Mobitzauthor=R.+Beerliauthor=J.+Blanzauthor=E.+Gassmannauthor=P.+Druckesauthor=G.+Fendrichauthor=S.+Gutmannauthor=G.+Martiny-Baronauthor=F.+Spenceauthor=J.+Hornfeldauthor=J.+E.+Peelauthor=H.+Sparrer&title=Discovery+of+Imidazoquinolines+as+a+Novel+Class+of+Potent%2C+Selective%2C+and+in+Vivo+Efficacious+Cancer+Osaka+Thyroid+%28Cot%29+Kinase+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors</span></div><div class="casAuthors">Glatthar, Ralf; Stojanovic, Aleksandar; Troxler, Thomas; Mattes, Henri; Mobitz, Henrik; Beerli, Rene; Blanz, Joachim; Gassmann, Ernst; Druckes, Peter; Fendrich, Gabriele; Gutmann, Sascha; Martiny-Baron, Georg; Spence, Fiona; Hornfeld, Jeff; Peel, John Edmonson; Sparrer, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7544-7560</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages.  Thus, pharmacol. inhibition of COT should be a valid approach to therapeutically intervene in the pathogenesis of macrophage-driven inflammatory diseases such as rheumatoid arthritis.  We report the discovery and chem. optimization of a novel series of COT kinase inhibitors, with unprecedented nanomolar potency for the inhibition of TNFα.  Pharmacol. profiling in vivo revealed a high metab. of these compds. in rats which was demonstrated to be predominantly attributed to aldehyde oxidase.  Due to the very low activity of hepatic AO in the dog, the selected candidate 32 displayed significant blood exposure in dogs which resulted in a clear prevention of inflammation-driven lameness.  Taken together, the described compds. both potently and selectively inhibit COT kinase in primary human cells and ameliorate inflammatory pathologies in vivo, supporting the notion that COT is an appropriate therapeutic target for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHVRjwV5VvurVg90H21EOLACvtfcHk0ljcekTQ0Lah-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSms7nN&md5=26f882f203e21bf78d9c9e5090f8fc5b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00598%26sid%3Dliteratum%253Aachs%26aulast%3DGlatthar%26aufirst%3DR.%26aulast%3DStojanovic%26aufirst%3DA.%26aulast%3DTroxler%26aufirst%3DT.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DMobitz%26aufirst%3DH.%26aulast%3DBeerli%26aufirst%3DR.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DGassmann%26aufirst%3DE.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DGutmann%26aufirst%3DS.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DSpence%26aufirst%3DF.%26aulast%3DHornfeld%26aufirst%3DJ.%26aulast%3DPeel%26aufirst%3DJ.%2BE.%26aulast%3DSparrer%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520Imidazoquinolines%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%252C%2520Selective%252C%2520and%2520in%2520Vivo%2520Efficacious%2520Cancer%2520Osaka%2520Thyroid%2520%2528Cot%2529%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D16%26spage%3D7544%26epage%3D7560%26doi%3D10.1021%2Facs.jmedchem.6b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zetterberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakilam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hariparsad, N.</span></span> <span> </span><span class="NLM_article-title">Vx-509 (Decernotinib)-Mediated Cyp3a Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1286</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.071100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.116.071100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27298338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1286-1295&issue=8&author=C.+Zetterbergauthor=F.+Maltaisauthor=L.+Laitinenauthor=S.+Liaoauthor=H.+Tsaoauthor=A.+Chakilamauthor=N.+Hariparsad&title=Vx-509+%28Decernotinib%29-Mediated+Cyp3a+Time-Dependent+Inhibition%3A+An+Aldehyde+Oxidase+Metabolite+as+a+Perpetrator+of+Drug-Drug+Interactions&doi=10.1124%2Fdmd.116.071100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">VX-509 (Decernotinib)-mediated CYP3A time-dependent inhibition: an aldehyde oxidase metabolite as a perpetrator of drug-drug interactions</span></div><div class="casAuthors">Zetterberg, Craig; Maltais, Francois; Laitinen, Leena; Liao, Shengkai; Tsao, Hong; Chakilam, Ananthsrinivas; Hariparsad, Niresh</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1286-1295</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(R)-2-((2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2- methyl-N-(2,2,2-trifluoroethyl)butanamide (VX-509, decernotinib) is an oral Janus kinase 3 inhibitor that has been studied in patients with rheumatoid arthritis.  Patients with rheumatoid arthritis often receive multiple medications, such as statins and steroids, to manage the signs and symptoms of comorbidities, which increases the chances of drug-drug interactions (DDIs).  Mechanism-based inhibition is a subset of time-dependent inhibition (TDI) and occurswhen amol. forms a reactive metabolite which irreversibly binds and inactivates drug-metabolizing enzymes, potentially increasing the systemic load to toxic concns.  Traditionally, perpetrating compds. are screened using human liver microsomes (HLMs); however, this system may be inadequate when the precipitant is activated by a non-cytochrome P 450 (P 450)-mediated pathway.  Even though studies assessing competitive inhibition and TDI using HLM suggested a low risk for CYP3A4-mediated DDI in the clinic, VX-509 increased the area under the curve of midazolam, atorvastatin, and methyl-prednisolone by approx. 12.0-, 2.7-, and 4.3-fold, resp.  Metabolite identification studies using human liver cytosol indicated that VX-509 is converted to an oxidative metabolite,which is the perpetrator of the DDIs obsd. in the clinic.  As opposed to HLM, hepatocytes contain the full complement of drug-metabolizing enzymes and transporters and can be used to assess TDI arising from non-P 450-mediated metabolic pathways.  In the current study, we highlight the role of aldehyde oxidase in the formation of the hydroxylmetabolite of VX-509, which is involved in clin. significant TDIbased DDIs and represents an addnl. example in which a system-dependent prediction of TDI would be evident.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR_yvvbiu6ybVg90H21EOLACvtfcHk0ljwbPcFYUNzaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurjE&md5=82ee148002f4dba2d8ddb495988e64f4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.071100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.071100%26sid%3Dliteratum%253Aachs%26aulast%3DZetterberg%26aufirst%3DC.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DLaitinen%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DH.%26aulast%3DChakilam%26aufirst%3DA.%26aulast%3DHariparsad%26aufirst%3DN.%26atitle%3DVx-509%2520%2528Decernotinib%2529-Mediated%2520Cyp3a%2520Time-Dependent%2520Inhibition%253A%2520An%2520Aldehyde%2520Oxidase%2520Metabolite%2520as%2520a%2520Perpetrator%2520of%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1286%26epage%3D1295%26doi%3D10.1124%2Fdmd.116.071100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogiso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Enzymes Responsible for Dantrolene Metabolism in the Human Liver: A Clue to Uncover the Cause of Liver Injury</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2018.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29522712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkt1Gltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=69-78&author=T.+Amanoauthor=T.+Fukamiauthor=T.+Ogisoauthor=D.+Hiroseauthor=J.+P.+Jonesauthor=T.+Taniguchiauthor=M.+Nakajima&title=Identification+of+Enzymes+Responsible+for+Dantrolene+Metabolism+in+the+Human+Liver%3A+A+Clue+to+Uncover+the+Cause+of+Liver+Injury&doi=10.1016%2Fj.bcp.2018.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injury</span></div><div class="casAuthors">Amano, Takayuki; Fukami, Tatsuki; Ogiso, Takuo; Hirose, Daisuke; Jones, Jeffrey P.; Taniguchi, Tsuyoshi; Nakajima, Miki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-78</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dantrolene is used for malignant hyperthermia during anesthesia, and it sometimes causes severe liver injury as a side effect.  Dantrolene is metabolized to acetylaminodantrolene, which is formed via the redn. of dantrolene to aminodantrolene and subsequent acetylation.  Formation of hydroxylamine during the metabolic process may be assocd. with liver injury.  We identified the enzymes responsible for dantrolene metab. in humans to elucidate the mechanism of liver injury.  Dantrolene reductase activity was not detected in human liver microsomes, but it was detected in cytosol.  Formation was increased in the presence of N1-methylnicotineamide, which is an electron donor to aldehyde oxidase 1 (AOX1).  Potent inhibitors of AOX1 and a correlation study with a marker of AOX1 activity, namely phthalazine oxidase activity, in a panel of 28 human liver cytosol samples supported the role of AOX1 in dantrolene redn.  Acetylaminodantrolene formation from aminodantrolene was highly detected in recombinant N-acetyltransferase (NAT) 2 rather than NAT1.  A glutathione trapping assay revealed the formation of hydroxylamine via an AOX1-dependent redn. of dantrolene but not via hydroxylation of aminodantrolene.  In conclusion, we found that AOX1 and NAT2 were responsible for dantrolene metab. in humans and that AOX1-dependent metab. dets. dantrolene-induced liver injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozmdPV3PSsEbVg90H21EOLACvtfcHk0ljwbPcFYUNzaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkt1Gltro%253D&md5=f3ae6b3c787604e998bee8f10b9c7d89</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DAmano%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DOgiso%26aufirst%3DT.%26aulast%3DHirose%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DNakajima%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Enzymes%2520Responsible%2520for%2520Dantrolene%2520Metabolism%2520in%2520the%2520Human%2520Liver%253A%2520A%2520Clue%2520to%2520Uncover%2520the%2520Cause%2520of%2520Liver%2520Injury%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D151%26spage%3D69%26epage%3D78%26doi%3D10.1016%2Fj.bcp.2018.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. C.</span></span>, <span> </span><span class="NLM_article-title">Aldehyde Oxidase Metabolism in Drug Discovery</span>. In  <i>Medicinal Chemistry Reviews</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J. J.</span></span>, Ed.; <span class="NLM_publisher-name">American Chemical Society</span>, <span class="NLM_publisher-loc">Washington, D.C.</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">52</span>, Chapter 21.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+C.+Burnsauthor=J.+J.+Bronson&title=Medicinal+Chemistry+Reviews"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DA.%2BC.%26atitle%3DAldehyde%2520Oxidase%2520Metabolism%2520in%2520Drug%2520Discovery%26btitle%3DMedicinal%2520Chemistry%2520Reviews%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2017%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goracci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span> <span> </span><span class="NLM_article-title">Structure-Metabolism Relationships in Human-Aox: Chemical Insights from a Large Database of Aza-Aromatic and Amide Compounds</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">E3178</span>– <span class="NLM_lpage">E3187</span>, <span class="refDoi"> DOI: 10.1073/pnas.1618881114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1073%2Fpnas.1618881114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28373537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsV2nsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E3178-E3187&issue=16&author=S.+Lepriauthor=M.+Ceccarelliauthor=N.+Milaniauthor=S.+Tortorellaauthor=A.+Cuccoauthor=A.+Valeriauthor=L.+Goracciauthor=A.+Brinkauthor=G.+Cruciani&title=Structure-Metabolism+Relationships+in+Human-Aox%3A+Chemical+Insights+from+a+Large+Database+of+Aza-Aromatic+and+Amide+Compounds&doi=10.1073%2Fpnas.1618881114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds.</span></div><div class="casAuthors">Lepri, Susan; Ceccarelli, Martina; Milani, Nicolo; Tortorella, Sara; Cucco, Andrea; Valeri, Aurora; Goracci, Laura; Brink, Andreas; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">E3178-E3187</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is a metabolic enzyme catalyzing the oxidn. of aldehyde and aza-arom. compds. and the hydrolysis of amides, moieties frequently shared by the majority of drugs.  Despite its key role in human metab., to date only fragmentary information about the chem. features responsible for AOX susceptibility are reported and only "very local" structure-metab. relationships based on a small no. of similar compds. have been developed.  This study reports a more comprehensive coverage of the chem. space of structures with a high risk of AOX phase I metab. in humans.  More than 270 compds. were studied to identify the site of metab. and the metabolite(s).  Both electronic [supported by d. functional theory (DFT) calcns.] and exposure effects were considered when rationalizing the structure-metab. relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotA9C1TVn-9bVg90H21EOLACvtfcHk0ljNetrCrpMMhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsV2nsb8%253D&md5=81cd013f7b63399e10d950e30377dbc0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1618881114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1618881114%26sid%3Dliteratum%253Aachs%26aulast%3DLepri%26aufirst%3DS.%26aulast%3DCeccarelli%26aufirst%3DM.%26aulast%3DMilani%26aufirst%3DN.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DCucco%26aufirst%3DA.%26aulast%3DValeri%26aufirst%3DA.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DBrink%26aufirst%3DA.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DStructure-Metabolism%2520Relationships%2520in%2520Human-Aox%253A%2520Chemical%2520Insights%2520from%2520a%2520Large%2520Database%2520of%2520Aza-Aromatic%2520and%2520Amide%2520Compounds%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26issue%3D16%26spage%3DE3178%26epage%3DE3187%26doi%3D10.1073%2Fpnas.1618881114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sejberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for Cdk8/19</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=573-578&issue=6&author=A.+Mallingerauthor=K.+Schiemannauthor=C.+Rinkauthor=J.+Sejbergauthor=M.+A.+Honeyauthor=P.+Czodrowskiauthor=M.+Stubbsauthor=O.+Poeschkeauthor=M.+Buschauthor=R.+Schneiderauthor=D.+Schwarzauthor=D.+Musilauthor=R.+Burkeauthor=K.+Urbahnsauthor=P.+Workmanauthor=D.+Wienkeauthor=P.+A.+Clarkeauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=C.+Esdarauthor=F.+Rohdichauthor=J.+Blagg&title=2%2C8-Disubstituted-1%2C6-Naphthyridines+and+4%2C6-Disubstituted-Isoquinolines+with+Potent%2C+Selective+Affinity+for+Cdk8%2F19&doi=10.1021%2Facsmedchemlett.6b00022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19</span></div><div class="casAuthors">Mallinger, Aurelie; Schiemann, Kai; Rink, Christian; Sejberg, Jimmy; Honey, Mark A.; Czodrowski, Paul; Stubbs, Mark; Poeschke, Oliver; Busch, Michael; Schneider, Richard; Schwarz, Daniel; Musil, Djordje; Burke, Rosemary; Urbahns, Klaus; Workman, Paul; Wienke, Dirk; Clarke, Paul A.; Raynaud, Florence I.; Eccles, Suzanne A.; Esdar, Christina; Rohdich, Felix; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">573-578</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We demonstrate a designed scaffold-hop approach to the discovery of 2,8-disubstituted-1,6-naphthyridine- and 4,6-disubstituted-isoquinoline-based dual CDK8/19 ligands.  Optimized compds. in both series exhibited rapid aldehyde oxidase-mediated metab., which could be abrogated by introduction of an amino substituent at C5 of the 1,6-naphthyridine scaffold or at C1 of the isoquinoline scaffold.  Compds. 51 and 59 were progressed to in vivo pharmacokinetic studies, and 51 also demonstrated sustained inhibition of STAT1SER727 phosphorylation, a biomarker of CDK8 inhibition, in an SW620 colorectal carcinoma human tumor xenograft model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcHD7cu5uM2rVg90H21EOLACvtfcHk0ljNetrCrpMMhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCrs70%253D&md5=20854b532b81db1be40afcd811ac5731</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00022%26sid%3Dliteratum%253Aachs%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DRink%26aufirst%3DC.%26aulast%3DSejberg%26aufirst%3DJ.%26aulast%3DHoney%26aufirst%3DM.%2BA.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3D2%252C8-Disubstituted-1%252C6-Naphthyridines%2520and%25204%252C6-Disubstituted-Isoquinolines%2520with%2520Potent%252C%2520Selective%2520Affinity%2520for%2520Cdk8%252F19%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D6%26spage%3D573%26epage%3D578%26doi%3D10.1021%2Facsmedchemlett.6b00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellriegel, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, P.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Identification and Human Exposure Prediction of Two Aldehyde Oxidase-Mediated Metabolites of a Methylquinoline-Containing Drug Candidate</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1080/00498254.2018.1444815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498254.2018.1444815" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29473769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1OjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2019&pages=302-312&issue=3&author=A.+C.+Liauthor=D.+Cuiauthor=E.+Yuauthor=K.+Dobsonauthor=E.+T.+Hellriegelauthor=P.+Robertson&title=Identification+and+Human+Exposure+Prediction+of+Two+Aldehyde+Oxidase-Mediated+Metabolites+of+a+Methylquinoline-Containing+Drug+Candidate&doi=10.1080%2F00498254.2018.1444815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and human exposure prediction of two aldehyde oxidase-mediated metabolites of a methylquinoline-containing drug candidate</span></div><div class="casAuthors">Li, Austin C.; Cui, Donghui; Yu, Erya; Dobson, Kyle; Hellriegel, Edward T.; Robertson Jr, Philmore</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">302-312</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. Aldehyde oxidase (AO enzymes)-mediated oxidn. predominantly occurs at a carbon atom adjacent to the nitrogen on arom. azaheterocycles.  In the current report, we identified that AO enzymes oxidn. took place at both the C-2 and C-4 positions of the methylquinoline moiety of Compd. A based on data from mass spectrometric anal., AO enzymes "litmus" test, and comparison with authentic stds.2.  To assess the potential for inadequate coverage for these two AO enzyme-mediated metabolites in nonclin. safety studies, given concerns due to differences in AO enzymes expression between preclin. species and humans, the human circulating levels of the two AO enzyme-mediated metabolites were predicted prospectively using in vitro and in vivo models.  Both formation clearance and elimination clearance of the two metabolites were predicted based on in vitro to in vivo correlation and comparison with in vivo data from rats.3.  The result showed that the 4-OH metabolite of Compd. A would account for less than 3% of the total drug-related exposure in human plasma, while the exposure to the 2-oxo metabolite would be relatively high (∼70%).4.  The predicted human exposure levels for the two metabolites are in similar ranges as those obsd. in monkeys.  These data taken together support the advancement to clin. development of Compd. A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUVUnEkPWCa7Vg90H21EOLACvtfcHk0ljNetrCrpMMhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1OjtL4%253D&md5=2a22b0830ecba7adcf1bd05b4e99145d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F00498254.2018.1444815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2018.1444815%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.%2BC.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DE.%26aulast%3DDobson%26aufirst%3DK.%26aulast%3DHellriegel%26aufirst%3DE.%2BT.%26aulast%3DRobertson%26aufirst%3DP.%26atitle%3DIdentification%2520and%2520Human%2520Exposure%2520Prediction%2520of%2520Two%2520Aldehyde%2520Oxidase-Mediated%2520Metabolites%2520of%2520a%2520Methylquinoline-Containing%2520Drug%2520Candidate%26jtitle%3DXenobiotica%26date%3D2019%26volume%3D49%26issue%3D3%26spage%3D302%26epage%3D312%26doi%3D10.1080%2F00498254.2018.1444815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Triazolopyridazines Substituted with Methylisoquinolinone as Selective C-Met Kinase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">7185</span>– <span class="NLM_lpage">7188</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2011.09.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22001029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7185-7188&issue=23&author=J.+W.+Ryuauthor=S.+Y.+Hanauthor=J.+I.+Yunauthor=S.+U.+Choiauthor=H.+Jungauthor=J.+D.+Haauthor=S.+Y.+Choauthor=C.+O.+Leeauthor=N.+S.+Kangauthor=J.+S.+Kohauthor=H.+R.+Kimauthor=J.+Lee&title=Design+and+Synthesis+of+Triazolopyridazines+Substituted+with+Methylisoquinolinone+as+Selective+C-Met+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2011.09.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors</span></div><div class="casAuthors">Ryu, Jae Wook; Han, Sun-Young; Yun, Jeong In; Choi, Sang-Un; Jung, Heejung; Ha, Jae Du; Cho, Sung Yun; Lee, Chong Ock; Kang, Nam Sook; Koh, Jong Sung; Kim, Hyoung Rae; Lee, Jongkook</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7185-7188</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of triazolopyridazines substituted with methylisoquinolinone, e.g. I (R = Ph, pyrrolidin-1-yl, thiazol-3-yl, 3-FC6H4), were designed and synthesized.  Some of the triazolopyridazines strongly inhibited c-Met kinase and showed good anti-proliferative activity against a panel of c-Met-amplified gastric cancer cell lines (MKN-45, SNU-5 and Hs746T).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooR--kJy29qbVg90H21EOLACvtfcHk0ljG8pm_LdQGrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7F&md5=d0416a66a0bfc8c1e3564f306704a1d4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.066%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DJ.%2BW.%26aulast%3DHan%26aufirst%3DS.%2BY.%26aulast%3DYun%26aufirst%3DJ.%2BI.%26aulast%3DChoi%26aufirst%3DS.%2BU.%26aulast%3DJung%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DJ.%2BD.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DC.%2BO.%26aulast%3DKang%26aufirst%3DN.%2BS.%26aulast%3DKoh%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Triazolopyridazines%2520Substituted%2520with%2520Methylisoquinolinone%2520as%2520Selective%2520C-Met%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D23%26spage%3D7185%26epage%3D7188%26doi%3D10.1016%2Fj.bmcl.2011.09.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner-Tung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzorno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. C.</span></span> <span> </span><span class="NLM_article-title">5-Fluoro-2-Pyrimidinone, a Liver Aldehyde Oxidase-Activated Prodrug of 5-Fluorouracil</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1111</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(95)98508-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0006-2952%2895%2998508-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7748192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2MXltl2rsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=1111-1116&issue=8&author=X.+Guoauthor=M.+Lerner-Tungauthor=H.+X.+Chenauthor=C.+N.+Changauthor=J.+L.+Zhuauthor=C.+P.+Changauthor=G.+Pizzornoauthor=T.+S.+Linauthor=Y.+C.+Cheng&title=5-Fluoro-2-Pyrimidinone%2C+a+Liver+Aldehyde+Oxidase-Activated+Prodrug+of+5-Fluorouracil&doi=10.1016%2F0006-2952%2895%2998508-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">5-Fluoro-2-pyramidinone, a liver aldehyde oxidase-activated prodrug of 5-fluorouracil</span></div><div class="casAuthors">Guo, Xin; Lerner-Tung, Mary; Chen, Hong-Xing; Chang, Chien-Neng; Zhu, Ju-Liang; Chang, Chia-Ping; Pizzorno, Giuseppe; Lin, Tai-Shun; Cheng, Yung-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1111-16</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">5-Fluorouracil (5-FU) is an effective antitumor agent used in treating various cancers.  Because of its metab. by intestinal and other cells, 5-FU has an inconsistent bioavailability that limits its oral use.  5-Fluoro-2-pyramidinone (5-FP) a 5-FU prodrug, was synthesized and converted to 5-FU by aldehyde oxidase, an enzyme present in high concns. in the livers of mice and humans but not in the gastrointestinal tract.  Using BDF1 mice, the pharmacokinetics of 5-FP were studied and compared with those of 5-FU.  The bioavailability of 5-FP given orally was 100% at a dosage of 25 μg/kg and 78% at a dosage of 50 mg/kg.  The half-lives of both doses of 5-FP were at least 2-fold longer than the half-lives of the same doses of 5-FU, and the clearance rates of 5-FP were 3-fold slower.  5-FP was converted rapidly to 5-FU in vivo.  The resulting 5-FU was measured at a steady-state level of 40-70 μM in plasma, at a dosage of 25 mg/kg, that was sustained for at least 4 h.  Also, when given orally, 5-FP was shown to have potent activity against Colon 38 tumor cells and P388 leukemia cells in mice.  The therapeutic index of 5-FP was similar to that of 5-FU in these mouse tumor models.  The potential clin. use of 5-FP as a prodrug of 5-FU should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqibLmX9x1QmLVg90H21EOLACvtfcHk0ljG8pm_LdQGrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltl2rsbs%253D&md5=8a8b747501650cce544fa2dd59bb99f1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2998508-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252998508-7%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DLerner-Tung%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%2BX.%26aulast%3DChang%26aufirst%3DC.%2BN.%26aulast%3DZhu%26aufirst%3DJ.%2BL.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DPizzorno%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DT.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BC.%26atitle%3D5-Fluoro-2-Pyrimidinone%252C%2520a%2520Liver%2520Aldehyde%2520Oxidase-Activated%2520Prodrug%2520of%25205-Fluorouracil%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26issue%3D8%26spage%3D1111%26epage%3D1116%26doi%3D10.1016%2F0006-2952%2895%2998508-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">In Vitro Oxidation of Famciclovir and 6-Deoxypenciclovir by Aldehyde Oxidase from Human, Guinea Pig, Rabbit, and Rat Liver</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9224775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFCgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=805-813&issue=7&author=M.+R.+Rashidiauthor=J.+A.+Smithauthor=S.+E.+Clarkeauthor=C.+Beedham&title=In+Vitro+Oxidation+of+Famciclovir+and+6-Deoxypenciclovir+by+Aldehyde+Oxidase+from+Human%2C+Guinea+Pig%2C+Rabbit%2C+and+Rat+Liver"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver</span></div><div class="casAuthors">Rashidi, Mohammad R.; Smith, John A.; Clarke, Stephen E.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">805-813</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Famciclovir, a 9-substituted guanine deriv., is a new antiviral agent which undergoes rapid hydrolysis and oxidn. in man to yield the active antiherpes agent, penciclovir.  Studies with human liver cytosol have indicated that the oxidn. of the penultimate metabolite, 6-deoxypenciclovir, to penciclovir is catalyzed by the molybdenum hydroxylase, aldehyde oxidase.  In the present study the oxidn. of famciclovir and 6-deoxypenciclovir with partially purified molybdenum hydroxylases from human, guinea pig, rabbit, and rat livers and bovine milk xanthine oxidase has been investigated.  Famciclovir and 6-deoxypenciclovir were oxidized predominantly to 6-oxo-famciclovir and penciclovir, resp., by human, guinea pig, and rat liver aldehyde oxidase.  Small amts. of 8-oxo and 6,8-dioxo-metabolites were also formed from each substrate.  Famciclovir and 6-deoxypenciclovir were good substrates for rabbit liver aldehyde oxidase but, in each case, two major metabolites were formed.  6-Deoxypenciclovir was converted to penciclovir and 8-oxo-6-deoxypenciclovir in approx. equal quantities; famciclovir was oxidized to 6-oxo-famciclovir and a second metabolite which, on the basis of chromatog. and UV spectral data, was thought to be 8-oxo-famciclovir.  Two groups of Sprague Dawley rats were identified; those contg. hepatic aldehyde oxidase and xanthine oxidase and those with only xanthine oxidase.  These have been designated AO-active and AO-inactive rats, resp.  Famciclovir was not oxidized by enzyme from AO-inactive rats or bovine milk xanthine oxidase although 6-deoxypenciclovir was slowly converted to penciclovir by rat liver or milk xanthine oxidase.  Inhibitor studies showed in human, guinea pig, and rabbit liver that xanthine oxidase did not contribute to the oxidn. of famciclovir and 6-deoxypenciclovir; thus it is proposed that drug activation in vivo would be catalyzed solely by aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq-gDS733rprVg90H21EOLACvtfcHk0ljG8pm_LdQGrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFCgur4%253D&md5=c719a9ec021d9001e396ecea39957364</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRashidi%26aufirst%3DM.%2BR.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DIn%2520Vitro%2520Oxidation%2520of%2520Famciclovir%2520and%25206-Deoxypenciclovir%2520by%2520Aldehyde%2520Oxidase%2520from%2520Human%252C%2520Guinea%2520Pig%252C%2520Rabbit%252C%2520and%2520Rat%2520Liver%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D25%26issue%3D7%26spage%3D805%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takayasu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikegaki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, T.</span></span> <span> </span><span class="NLM_article-title">Antivasospastic Effects of Hydroxyfasudil, a Rho-Kinase Inhibitor, after Subarachnoid Hemorrhage</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1254/jphs.11075FP</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1254%2Fjphs.11075FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22186620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ygsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2012&pages=92-98&issue=1&author=S.+Satohauthor=M.+Takayasuauthor=K.+Kawasakiauthor=I.+Ikegakiauthor=A.+Hitomiauthor=K.+Yanoauthor=M.+Shibuyaauthor=T.+Asano&title=Antivasospastic+Effects+of+Hydroxyfasudil%2C+a+Rho-Kinase+Inhibitor%2C+after+Subarachnoid+Hemorrhage&doi=10.1254%2Fjphs.11075FP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage</span></div><div class="casAuthors">Satoh, Shin-ichi; Takayasu, Masakazu; Kawasaki, Koh; Ikegaki, Ichiro; Hitomi, Asako; Yano, Kazuo; Shibuya, Masato; Asano, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-98</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">We investigated the anti-vasospastic potential of fasudil's active metabolite, hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage (SAH) and also its effect on hemorheol. abnormalities following cerebral ischemia.  Chronic cerebral vasospasm was produced using a two-hemorrhage canine model.  On day 7, angiog. vasospasm was obsd. in all animals, and i.v. administration of hydroxyfasudil (3 mg·kg-1·30 min-1) significantly reversed the vasospasm (predose diam. of the basilar artery, 57.9% ± 2.0% of the baseline before the injection of blood; postdose diam., 64.5% ± 1.9%).  The viscosity of whole blood was significantly increased 24 h after 1 h middle cerebral artery occlusion in rats.  Hydroxyfasudil (3 and 10 mg/kg, i.p.) significantly decreased blood viscosity.  The specificity of hydroxyfasudil was examd. against a panel of 17 protein kinases using ELISA anal.  Hydroxyfasudil inhibited Rho-kinase α and β at a concn. of 10 μM by 97.6% and 97.7%, resp.  No other protein kinase was inhibited with 10 μM hydroxyfasudil by over 40%.  The present results indicate hydroxyfasudil is a selective inhibitor of Rho-kinase.  The results also suggest that hydroxyfasudil contributes to the potency of fasudil to prevent cerebral vasospasm and hyperviscosity and suggest the potential utility of hydroxyfasudil as a therapeutic agent for patients with SAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomBZxR6Kp1xrVg90H21EOLACvtfcHk0ljQb9YIsUmSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ygsbw%253D&md5=1ba639cc41eb9ba63437a4dad5cbb15e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1254%2Fjphs.11075FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.11075FP%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DS.%26aulast%3DTakayasu%26aufirst%3DM.%26aulast%3DKawasaki%26aufirst%3DK.%26aulast%3DIkegaki%26aufirst%3DI.%26aulast%3DHitomi%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DK.%26aulast%3DShibuya%26aufirst%3DM.%26aulast%3DAsano%26aufirst%3DT.%26atitle%3DAntivasospastic%2520Effects%2520of%2520Hydroxyfasudil%252C%2520a%2520Rho-Kinase%2520Inhibitor%252C%2520after%2520Subarachnoid%2520Hemorrhage%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D118%26issue%3D1%26spage%3D92%26epage%3D98%26doi%3D10.1254%2Fjphs.11075FP" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6421</span>– <span class="NLM_lpage">6467</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6421-6467&issue=15&author=R.+J.+Youngauthor=P.+D.+Leeson&title=Mapping+the+Efficiency+and+Physicochemical+Trajectories+of+Successful+Optimizations&doi=10.1021%2Facs.jmedchem.8b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span></div><div class="casAuthors">Young, Robert J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6421-6467</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The practices and tactics employed in successful optimizations are examd., judged from the trajectories of ligand efficiency and property evolution.  A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technol.) and types of mols., including those beyond the rule of five.  The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable.  What is clear is that while targets are different, successful mols. are almost invariably among the most efficient for their target, even at the extremes.  Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQtcLKSk7q7Vg90H21EOLACvtfcHk0ljQb9YIsUmSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D&md5=f040ef02d161e070bb5021fde1585e66</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DMapping%2520the%2520Efficiency%2520and%2520Physicochemical%2520Trajectories%2520of%2520Successful%2520Optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467%26doi%3D10.1021%2Facs.jmedchem.8b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jørgensen, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4237</span>– <span class="NLM_lpage">4244</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b00658</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b00658" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ohtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=4237-4244&issue=8&author=M.+Montefioriauthor=F.+S.+J%C3%B8rgensenauthor=L.+Olsen&title=Aldehyde+Oxidase%3A+Reaction+Mechanism+and+Prediction+of+Site+of+Metabolism&doi=10.1021%2Facsomega.7b00658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism</span></div><div class="casAuthors">Montefiori, Marco; Joergensen, Flemming Steen; Olsen, Lars</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4237-4244</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a Mo-contg. enzyme involved in the clearance of drug compds. contg. aldehydes and N-contg. heterocyclic fragments.  AO has gained considerable interest in recent years because of examples of too fast clearance of drug compds. in development.  Thus, it is important to be able to predict AO-mediated drug metab.  Therefore, we characterized the structural and energetic aspects of different mechanisms with DFT using the Mo cofactor (MoCo) as model for the reactive part of the enzyme.  For a series of 6-substituted 4-quinazolinones, the trend in activation energies was the same for 3 tested reaction mechanisms.  Using the concerted mechanism as model for the enzymic reaction, the transition states for formation of all possible metabolites for a series of known AO substrates were detd.  The lowest activation energies corresponded in all cases to the exptl. obsd. sites of metab. (SOMs).  Various mol. properties were calcd. and investigated as more easily determinable markers for reactivity.  Both the stabilities of the intermediates and products correlated to some extent with the transition state energies, and may be used to predict the SOM.  The electrostatic potential (ESP)-derived charges were also good markers for prediction of the exptl. SOMs for this set of compds. and may pave the way for the development of fast methods for prediction of SOMs for AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWMl-me1-SlbVg90H21EOLACvtfcHk0ljQb9YIsUmSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ohtr3J&md5=5aa9f790b1ff0f28cb270322618de06c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b00658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b00658%26sid%3Dliteratum%253Aachs%26aulast%3DMontefiori%26aufirst%3DM.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DF.%2BS.%26aulast%3DOlsen%26aufirst%3DL.%26atitle%3DAldehyde%2520Oxidase%253A%2520Reaction%2520Mechanism%2520and%2520Prediction%2520of%2520Site%2520of%2520Metabolism%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26issue%3D8%26spage%3D4237%26epage%3D4244%26doi%3D10.1021%2Facsomega.7b00658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into Xenobiotic and Inhibitor Binding to Human Aldehyde Oxidase</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">783</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Fnchembio.1895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26322824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlylsrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=779-783&issue=10&author=C.+Coelhoauthor=A.+Fotiauthor=T.+Hartmannauthor=T.+Santos-Silvaauthor=S.+Leimkuhlerauthor=M.+J.+Romao&title=Structural+Insights+into+Xenobiotic+and+Inhibitor+Binding+to+Human+Aldehyde+Oxidase&doi=10.1038%2Fnchembio.1895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase</span></div><div class="casAuthors">Coelho, Catarina; Foti, Alessandro; Hartmann, Tobias; Santos-Silva, Teresa; Leimkuhler, Silke; Romao, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">779-783</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is a xanthine oxidase (XO)-related enzyme with emerging importance due to its role in the metab. of drugs and xenobiotics.  We report the first crystal structures of human AOX1, substrate free (2.6-Å resoln.) and in complex with the substrate phthalazine and the inhibitor thioridazine (2.7-Å resoln.).  Anal. of the protein active site combined with steady-state kinetic studies highlight the unique features, including binding and substrate orientation at the active site, that characterize human AOX1 as an important drug-metabolizing enzyme.  Structural anal. of the complex with the noncompetitive inhibitor thioridazine revealed a new, unexpected and fully occupied inhibitor-binding site that is structurally conserved among mammalian AOXs and XO.  The new structural insights into the catalytic and inhibition mechanisms of human AOX that we now report will be of great value for the rational anal. of clin. drug interactions involving inhibition of AOX1 and for the prediction and design of AOX-stable putative drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbH6qUJJ5AMbVg90H21EOLACvtfcHk0ljQb9YIsUmSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlylsrnJ&md5=2053b7ec132f3e4ed7a82d011a46072a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1895%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26atitle%3DStructural%2520Insights%2520into%2520Xenobiotic%2520and%2520Inhibitor%2520Binding%2520to%2520Human%2520Aldehyde%2520Oxidase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D10%26spage%3D779%26epage%3D783%26doi%3D10.1038%2Fnchembio.1895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esmaeeli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span> <span> </span><span class="NLM_article-title">Human Aldehyde Oxidase (Haox1): Structure Determination of the Moco-Free Form of the Natural Variant G1269r and Biophysical Studies of Single Nucleotide Polymorphisms</span>. <i>FEBS Open Bio</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1002/2211-5463.12617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2F2211-5463.12617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30985987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlKqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=925-934&issue=5&author=C.+Motaauthor=M.+Esmaeeliauthor=C.+Coelhoauthor=T.+Santos-Silvaauthor=M.+Wolffauthor=A.+Fotiauthor=S.+Leimkuhlerauthor=M.+J.+Romao&title=Human+Aldehyde+Oxidase+%28Haox1%29%3A+Structure+Determination+of+the+Moco-Free+Form+of+the+Natural+Variant+G1269r+and+Biophysical+Studies+of+Single+Nucleotide+Polymorphisms&doi=10.1002%2F2211-5463.12617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Human aldehyde oxidase (hAOX1): structure determination of the Moco-free form of the natural variant G1269R and biophysical studies of single nucleotide polymorphisms</span></div><div class="casAuthors">Mota, Cristiano; Esmaeeli, Mariam; Coelho, Catarina; Santos-Silva, Teresa; Wolff, Martin; Foti, Alessandro; Leimkuehler, Silke; Romao, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Open Bio</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">925-934</span>CODEN:
                <span class="NLM_cas:coden">FOBEB3</span>;
        ISSN:<span class="NLM_cas:issn">2211-5463</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human aldehyde oxidase (hAOX1) is a molybdenum enzyme with high toxicol. importance, but its physiol. role is still unknown. hAOX1 metabolizes different classes of xenobiotics and is one of the main drug-metabolizing enzymes in the liver, along with cytochrome P 450. hAOX1 oxidizes and inactivates a large no. of drug mols. and has been responsible for the failure of several phase I clin. trials.  The interindividual variability of drug-metabolizing enzymes caused by single nucleotide polymorphisms (SNPs) is highly relevant in pharmaceutical treatments.  In this study, we present the crystal structure of the inactive variant G1269R, revealing the first structure of a molybdenum cofactor (Moco)-free form of hAOX1.  These data allowed to model, for the first time, the flexible Gate 1 that controls access to the active site.  Furthermore, we inspected the thermostability of wild-type hAOX1 and hAOX1 with various SNPs (L438V, R1231H, G1269R or S1271L) by CD spectroscopy and ThermoFAD, revealing that amino acid exchanges close to the Moco site can impact protein stability up to 10 °C.  These results correlated with biochem. and structural data and enhance our understanding of hAOX1 and the effect of SNPs in the gene encoding this enzyme in the human population.  Enzymes : Aldehyde oxidase (); xanthine dehydrogenase (); xanthine oxidase ().  Databases : Structural data are available in the Protein Data Bank under the accession no. 6Q6Q.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK4IebI-h967Vg90H21EOLACvtfcHk0li13PyRik_hpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlKqsLo%253D&md5=96642bd514af80a301962a4a83b7a1f1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F2211-5463.12617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F2211-5463.12617%26sid%3Dliteratum%253Aachs%26aulast%3DMota%26aufirst%3DC.%26aulast%3DEsmaeeli%26aufirst%3DM.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26atitle%3DHuman%2520Aldehyde%2520Oxidase%2520%2528Haox1%2529%253A%2520Structure%2520Determination%2520of%2520the%2520Moco-Free%2520Form%2520of%2520the%2520Natural%2520Variant%2520G1269r%2520and%2520Biophysical%2520Studies%2520of%2520Single%2520Nucleotide%2520Polymorphisms%26jtitle%3DFEBS%2520Open%2520Bio%26date%3D2019%26volume%3D9%26issue%3D5%26spage%3D925%26epage%3D934%26doi%3D10.1002%2F2211-5463.12617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyngholm-Kjærby, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jørgensen, F. S.</span></span> <span> </span><span class="NLM_article-title">Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism</span>. <i>Comput. Struct. Biotechnol. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.csbj.2019.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.csbj.2019.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30949305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlt12jsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=345-351&author=M.+Montefioriauthor=C.+Lyngholm-Kj%C3%A6rbyauthor=A.+Longauthor=L.+Olsenauthor=F.+S.+J%C3%B8rgensen&title=Fast+Methods+for+Prediction+of+Aldehyde+Oxidase-Mediated+Site-of-Metabolism&doi=10.1016%2Fj.csbj.2019.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism</span></div><div class="casAuthors">Montefiori, Marco; Lyngholm-Kjaerby, Casper; Long, Anthony; Olsen, Lars; Joergensen, Flemming Steen</div><div class="citationInfo"><span class="NLM_cas:title">Computational and Structural Biotechnology Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">345-351</span>CODEN:
                <span class="NLM_cas:coden">CSBJAC</span>;
        ISSN:<span class="NLM_cas:issn">2001-0370</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde Oxidase (AO) is an enzyme involved in the metab. of aldehydes and N-contg. heterocyclic compds.  Many drug compds. contain heterocyclic moieties, and AO metab. has lead to failure of several late-stage drug candidates.  Therefore, it is important to take AO-mediated metab. into account early in the drug discovery process, and thus, to have fast and reliable models to predict the site of metab. (SOM).  We have collected a dataset of 78 substrates of human AO with a total of 89 SOMs and 347 non-SOMs and detd. at. descriptors for each compd.  The descriptors comprise NMR shielding and ESP charges from d. functional theory (DFT), NMR chem. shift from ChemBioDraw, and Gasteiger charges from RDKit.  Addnl., at. accessibility was considered using 2D-SASA and relative span descriptors from SMARTCyp.  Finally, stability of the product, the metabolite, was detd. with DFT and also used as a descriptor.  All descriptors have AUC larger than 0.75.  In particular, descriptors related to the chem. shielding and chem. shift (AUC = 0.96) and ESP charges (AUC = 0.96) proved to be good descriptors.  We recommend two simple methods to identify the SOM for a given mol.: (1) use ChemBioDraw to calc. the chem. shift or (2) calc. ESP charges or chem. shift using DFT.  The first approach is fast but somewhat difficult to automate, while the second is more time-consuming, but can easily be automated.  The two methods predict correctly 93% and 91%, resp., of the 89 exptl. obsd. SOMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8QYgsDr8OrLVg90H21EOLACvtfcHk0li13PyRik_hpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlt12jsLw%253D&md5=8a01ea8667b1bfcccc7ab59570df6739</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.csbj.2019.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.csbj.2019.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DMontefiori%26aufirst%3DM.%26aulast%3DLyngholm-Kj%25C3%25A6rby%26aufirst%3DC.%26aulast%3DLong%26aufirst%3DA.%26aulast%3DOlsen%26aufirst%3DL.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DF.%2BS.%26atitle%3DFast%2520Methods%2520for%2520Prediction%2520of%2520Aldehyde%2520Oxidase-Mediated%2520Site-of-Metabolism%26jtitle%3DComput.%2520Struct.%2520Biotechnol.%2520J.%26date%3D2019%26volume%3D17%26spage%3D345%26epage%3D351%26doi%3D10.1016%2Fj.csbj.2019.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korzekwa, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMasters, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Use of Density Functional Calculations to Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4642</span>– <span class="NLM_lpage">4647</span>, <span class="refDoi"> DOI: 10.1021/jm0703690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0703690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4642-4647&issue=19&author=R.+A.+Torresauthor=K.+R.+Korzekwaauthor=D.+R.+McMastersauthor=C.+M.+Fandozziauthor=J.+P.+Jones&title=Use+of+Density+Functional+Calculations+to+Predict+the+Regioselectivity+of+Drugs+and+Molecules+Metabolized+by+Aldehyde+Oxidase&doi=10.1021%2Fjm0703690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Density Functional Calculations To Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase</span></div><div class="casAuthors">Torres, Rhonda A.; Korzekwa, Kenneth R.; McMasters, Daniel R.; Fandozzi, Christine M.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4642-4647</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase is a molybdenum hydroxylase that catalyzes the oxidn. of aldehydes and nitrogen-contg. heterocycles.  The enzyme plays a dual role in the metab. of physiol. important endogenous compds. and the biotransformation of xenobiotics.  Using d. functional theory methods, geometry optimization of tetrahedral intermediates of drugs and druglike compds. was examd. to predict the likely metabolites of aldehyde oxidase.  The calcns. suggest that the lowest energy tetrahedral intermediate resulting from the initial substrate corresponds to the obsd. metabolite ≥90% of the time.  Addnl. calcns. were performed on a series of heterocyclic compds. where the products resulting from metab. by xanthine oxidase and aldehyde oxidase differ in many instances.  Again, the lowest energy tetrahedral intermediate corresponded to the obsd. product of aldehyde oxidase metab. ≥90% for the compds. examd., while the obsd. products of xanthine oxidase were not well predicted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmnIR2Ha4_oLVg90H21EOLACvtfcHk0li13PyRik_hpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D&md5=514ee5703f306287a3b7315fc5cea434</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0703690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703690%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DR.%2BA.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DUse%2520of%2520Density%2520Functional%2520Calculations%2520to%2520Predict%2520the%2520Regioselectivity%2520of%2520Drugs%2520and%2520Molecules%2520Metabolized%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D19%26spage%3D4642%26epage%3D4647%26doi%3D10.1021%2Fjm0703690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alfaro, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Studies on the Mechanism of Aldehyde Oxidase and Xanthine Oxidase</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9469</span>– <span class="NLM_lpage">9472</span>, <span class="refDoi"> DOI: 10.1021/jo801053u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo801053u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGku7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=9469-9472&issue=23&author=J.+F.+Alfaroauthor=J.+P.+Jones&title=Studies+on+the+Mechanism+of+Aldehyde+Oxidase+and+Xanthine+Oxidase&doi=10.1021%2Fjo801053u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the Mechanism of Aldehyde Oxidase and Xanthine Oxidase</span></div><div class="casAuthors">Alfaro, Joshua F.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9469-9472</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DFT calcns. support a concerted mechanism for xanthine oxidase and aldehyde oxidase hydride displacement from the sp2 carbon of 6-substituted 4-quinazolinones.  The variations in transition state structure show that C-O bond formation is nearly complete in the transition state and the transition state changes are anti-Hammond with the C-H and C-O bond lengths being more product-like for the faster reactions.  The C-O bond length in the transition state is around 90% formed.  However, the C-H bond is only about 80% broken.  This leads to a very tetrahedral transition state with an O-C-N angle of 109°.  Thus, while the mechanism is concerted, the antibonding orbital of the C-H bond that is broken is not directly attacked by the nucleophile and instead hydride displacement occurs after almost complete tetrahedral transition state formation.  In support of this the C=N bond is lengthened in the transition state indicating that attack on the electrophilic carbon occurs by addn. to the C=N bond with neg. charge increasing on the nitrogen.  Differences in exptl. reaction rates are accurately reproduced by these calcns. and tend to support this mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrK9tmdy1IwLVg90H21EOLACvtfcHk0li5bKOL7yU0HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGku7vI&md5=188f70b1454b3e6bfd19301aafae2908</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo801053u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801053u%26sid%3Dliteratum%253Aachs%26aulast%3DAlfaro%26aufirst%3DJ.%2BF.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DStudies%2520on%2520the%2520Mechanism%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26issue%3D23%26spage%3D9469%26epage%3D9472%26doi%3D10.1021%2Fjo801053u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryde, U.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Active-Site Design of Molybdenum Oxo-Transfer Enzymes by Quantum Mechanical Calculations</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">11913</span>– <span class="NLM_lpage">11924</span>, <span class="refDoi"> DOI: 10.1021/ic5010837</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic5010837" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=11913-11924&issue=22&author=J.+Liauthor=U.+Ryde&title=Comparison+of+the+Active-Site+Design+of+Molybdenum+Oxo-Transfer+Enzymes+by+Quantum+Mechanical+Calculations&doi=10.1021%2Fic5010837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the Active-Site Design of Molybdenum Oxo-Transfer Enzymes by Quantum Mechanical Calculations</span></div><div class="casAuthors">Li, Jilai; Ryde, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11913-11924</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are three families of mononuclear molybdenum enzymes that catalyze oxygen atom transfer (OAT) reactions, named after a typical example from each family, viz., DMSO reductase (DMSOR), sulfite oxidase (SO), and xanthine oxidase (XO).  These families differ in the construction of their active sites, with two molybdopterin (MPT) groups in the DMSOR family, two oxy groups in the SO family, and a sulfido group in the XO family.  We have employed d. functional theory calcns. on cluster models of the active sites to understand the selection of molybdenum ligands in the three enzyme families.  Our calcns. show that the DMSOR active site has a much stronger oxidative power than the other two sites, owing to the extra molybdopterin ligand.  However, the active sites do not seem to have been constructed to make the OAT reaction as exergonic as possible, but instead to keep the reaction free energy close to zero (to avoid excessive loss of energy), thereby making the reoxidn. (SO and XO) or reredn. of the active sites (DMSOR) after the OAT reaction facile.  We also show that active-site models of the three enzyme families can all catalyze the redn. of DMSO and that the DMSOR model does not give the lowest activation barrier.  Likewise, all three models can catalyze the oxidn. of sulfite, provided that the Coulombic repulsion between the substrate and the enzyme model can be overcome, but for this harder reaction, the SO model gives the lowest activation barrier, although the differences are not large.  However, only the XO model can catalyze the oxidn. of xanthine, owing to its sulfido ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWu06wRwr8LrVg90H21EOLACvtfcHk0li5bKOL7yU0HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrsLbM&md5=384e5cf521267956acf0b9cee807e2c7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fic5010837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic5010837%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DRyde%26aufirst%3DU.%26atitle%3DComparison%2520of%2520the%2520Active-Site%2520Design%2520of%2520Molybdenum%2520Oxo-Transfer%2520Enzymes%2520by%2520Quantum%2520Mechanical%2520Calculations%26jtitle%3DInorg.%2520Chem.%26date%3D2014%26volume%3D53%26issue%3D22%26spage%3D11913%26epage%3D11924%26doi%3D10.1021%2Fic5010837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, W.</span></span> <span> </span><span class="NLM_article-title">A Combined Qm/Mm Study on the Reductive Half-Reaction of Xanthine Oxidase: Substrate Orientation and Mechanism</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">14885</span>– <span class="NLM_lpage">14902</span>, <span class="refDoi"> DOI: 10.1021/ja9045394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9045394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=14885-14902&issue=41&author=S.+Metzauthor=W.+Thiel&title=A+Combined+Qm%2FMm+Study+on+the+Reductive+Half-Reaction+of+Xanthine+Oxidase%3A+Substrate+Orientation+and+Mechanism&doi=10.1021%2Fja9045394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A Combined QM/MM Study on the Reductive Half-Reaction of Xanthine Oxidase: Substrate Orientation and Mechanism</span></div><div class="casAuthors">Metz, Sebastian; Thiel, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">14885-14902</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quantum mech./mol. mech. (QM/MM) methods were used to investigate the conversion of xanthine to uric acid in xanthine oxidase.  Seven mechanistic variants were considered with different tautomeric forms of xanthine, different protonation states of the active-site residues, and different substrate orientations.  The most favorable pathway (setup G) has a B3LYP/MM barrier of about 14 kcal mol-1, consistent with the available exptl. data.  This multistep mechanism starts with Glu1261 deprotonating the xanthine at the N3 position followed by a proton transfer from the cofactor to the N9 atom of xanthine; the thus activated cofactor and substrate then react to form a tetrahedral intermediate, and a subsequent rate-limiting hydride transfer generates the product.  The substrate orientation that has commonly been assumed in the literature leads to the most stable reactant complex, but the opposite orientation ("upside down") is computed to be the most favorable one during the reaction (setup G).  In the "upside down" conformation, the Arg880 residue can best stabilize the reactive xanthine species with the neg. charged N3 atom, esp. the tetrahedral intermediate and the following transition state for hydride transfer which is generally the highest point on the computed energy profiles.  QM-only calcns. for a minimal gas-phase model and for larger cluster models are performed for comparison, in particular for establishing intrinsic reactivities and a common energy scale.  An anal. of the computational results provides detailed insight into the essential mechanistic role of the active-site residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-z1Egy9O7xLVg90H21EOLACvtfcHk0liGlj73GITOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltLjM&md5=55c9e18fc825b1b019b7a65ab8040a6a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja9045394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9045394%26sid%3Dliteratum%253Aachs%26aulast%3DMetz%26aufirst%3DS.%26aulast%3DThiel%26aufirst%3DW.%26atitle%3DA%2520Combined%2520Qm%252FMm%2520Study%2520on%2520the%2520Reductive%2520Half-Reaction%2520of%2520Xanthine%2520Oxidase%253A%2520Substrate%2520Orientation%2520and%2520Mechanism%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26issue%3D41%26spage%3D14885%26epage%3D14902%26doi%3D10.1021%2Fja9045394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hille, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velayutham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweier, J. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of Superoxide Production from Aldehyde Oxidase: An Important Source of Oxidants in Biological Tissues</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>460</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2006.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.abb.2006.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=17353002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjslSlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2007&pages=113-121&issue=1&author=T.+K.+Kunduauthor=R.+Hilleauthor=M.+Velayuthamauthor=J.+L.+Zweier&title=Characterization+of+Superoxide+Production+from+Aldehyde+Oxidase%3A+An+Important+Source+of+Oxidants+in+Biological+Tissues&doi=10.1016%2Fj.abb.2006.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of superoxide production from aldehyde oxidase: An important source of oxidants in biological tissues</span></div><div class="casAuthors">Kundu, Tapan Kumar; Hille, Russ; Velayutham, Murugesan; Zweier, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO), a molybdoflavoenzyme that plays an important role in aldehyde biotransformation, requires oxygen as substrate and produces reduced oxygen species.  However, little information is available regarding its importance in cellular redox stress.  Therefore, studies were undertaken to characterize its superoxide and hydrogen peroxide prodn.  Aldehyde oxidase was purified to >98% purity and exhibited a single band at ∼290 kDa on native polyacrylamide gradient gel electrophoresis.  Superoxide generation was measured and quantitated by cytochrome c redn. and EPR spin trapping with p-dimethyl aminocinnamaldehyde as reducing substrate.  Prominent superoxide generation was obsd. with an initial rate of 295 nmol min-1 mg-1.  Electrochem. measurements of oxygen consumption and hydrogen peroxide formation yielded values of 650 and 355 nmol min-1 mg-1.  In view of the ubiquitous distribution of aldehydes in tissues, aldehyde oxidase can be an important basal source of superoxide that would be enhanced in disease settings where cellular aldehyde levels are increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRlJ1RBG6al7Vg90H21EOLACvtfcHk0liGlj73GITOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjslSlsrs%253D&md5=087d50b1d52b072e7775613d9848a0d6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2006.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2006.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DKundu%26aufirst%3DT.%2BK.%26aulast%3DHille%26aufirst%3DR.%26aulast%3DVelayutham%26aufirst%3DM.%26aulast%3DZweier%26aufirst%3DJ.%2BL.%26atitle%3DCharacterization%2520of%2520Superoxide%2520Production%2520from%2520Aldehyde%2520Oxidase%253A%2520An%2520Important%2520Source%2520of%2520Oxidants%2520in%2520Biological%2520Tissues%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2007%26volume%3D460%26issue%3D1%26spage%3D113%26epage%3D121%26doi%3D10.1016%2Fj.abb.2006.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trincao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span> <span> </span><span class="NLM_article-title">The First Mammalian Aldehyde Oxidase Crystal Structure: Insights into Substrate Specificity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">40690</span>– <span class="NLM_lpage">40702</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.390419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M112.390419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23019336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslantr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=40690-40702&issue=48&author=C.+Coelhoauthor=M.+Mahroauthor=J.+Trincaoauthor=A.+T.+Carvalhoauthor=M.+J.+Ramosauthor=M.+Teraoauthor=E.+Garattiniauthor=S.+Leimkuhlerauthor=M.+J.+Romao&title=The+First+Mammalian+Aldehyde+Oxidase+Crystal+Structure%3A+Insights+into+Substrate+Specificity&doi=10.1074%2Fjbc.M112.390419"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The First Mammalian Aldehyde Oxidase Crystal Structure</span></div><div class="casAuthors">Coelho, Catarina; Mahro, Martin; Trincao, Jose; Carvalho, Alexandra T. P.; Ramos, Maria Joao; Terao, Mineko; Garattini, Enrico; Leimkuehler, Silke; Romao, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">40690-40702</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs) are homodimeric proteins belonging to the xanthine oxidase family of molybdenum-contg. enzymes.  Each 150-kDa monomer contains a FAD redox cofactor, two spectroscopically distinct [2Fe-2S] clusters, and a molybdenum cofactor located within the protein active site.  AOXs are characterized by broad range substrate specificity, oxidizing different aldehydes and arom. N-heterocycles.  Despite increasing recognition of its role in the metab. of drugs and xenobiotics, the physiol. function of the protein is still largely unknown.  We have crystd. and solved the crystal structure of mouse liver aldehyde oxidase 3 to 2.9 Å.  This is the first mammalian AOX whose structure has been solved.  The structure provides important insights into the protein active center and further evidence on the catalytic differences characterizing AOX and xanthine oxidoreductase.  The mouse liver aldehyde oxidase 3 three-dimensional structure combined with kinetic, mutagenesis data, mol. docking, and mol. dynamics studies make a decisive contribution to understand the mol. basis of its rather broad substrate specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJhbcCiD1gB7Vg90H21EOLACvtfcHk0liGlj73GITOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslantr7L&md5=df014384e84736af9a937fd383f24523</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.390419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.390419%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DMahro%26aufirst%3DM.%26aulast%3DTrincao%26aufirst%3DJ.%26aulast%3DCarvalho%26aufirst%3DA.%2BT.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520First%2520Mammalian%2520Aldehyde%2520Oxidase%2520Crystal%2520Structure%253A%2520Insights%2520into%2520Substrate%2520Specificity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D48%26spage%3D40690%26epage%3D40702%26doi%3D10.1074%2Fjbc.M112.390419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Cytochrome P450 Substrate Oxidation: Minireview</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1002/jbt.20174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fjbt.20174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=17936929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGjtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=163-168&issue=4&author=F.+P.+Guengerich&title=Mechanisms+of+Cytochrome+P450+Substrate+Oxidation%3A+Minireview&doi=10.1002%2Fjbt.20174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of cytochrome P 450 substrate oxidation</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Molecular Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">163-168</span>CODEN:
                <span class="NLM_cas:coden">JBMTFQ</span>;
        ISSN:<span class="NLM_cas:issn">1095-6670</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (P 450) isoforms catalyze a variety of oxidn. reactions and some redn. reactions, collectively involving thousands of substrates.  A general chem. mechanism can be used to rationalize most of the oxidns. and involves a perferryl intermediate (FeO3+) and odd-electron chem., i.e., abstraction of a H atom or electron followed by O rebound and sometimes rearrangement.  This general mechanism can explain C atom hydroxylation, heteroatom oxygenation and dealkylation, epoxidn., desatn., heme destruction, and other reactions.  Another approach to understanding catalysis involves anal. of the more general catalytic cycle, including substrate specificity, because complex patterns of cooperativity are obsd. with several P 450s.  Some of the complexity is due to slow conformational changes in the proteins that occur on the same timescale as other steps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCChTcULy-L7Vg90H21EOLACvtfcHk0lhkzFhGJASufA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGjtLrN&md5=9d9c6d02db1a91dcdc167d0b4a05e6e9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fjbt.20174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbt.20174%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DMechanisms%2520of%2520Cytochrome%2520P450%2520Substrate%2520Oxidation%253A%2520Minireview%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D2007%26volume%3D21%26issue%3D4%26spage%3D163%26epage%3D168%26doi%3D10.1002%2Fjbt.20174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Visser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, S.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3947</span>– <span class="NLM_lpage">3980</span>, <span class="refDoi"> DOI: 10.1021/cr020443g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr020443g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=3947-3980&issue=9&author=B.+Meunierauthor=S.+P.+de+Visserauthor=S.+Shaik&title=Mechanism+of+Oxidation+Reactions+Catalyzed+by+Cytochrome+P450+Enzymes&doi=10.1021%2Fcr020443g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes</span></div><div class="casAuthors">Meunier, Bernard; de Visser, Samueel P.; Shaik, Sason</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3947-3980</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The exact nature of the active species in cytochrome P 450 enzymes (the putative high-valent iron-oxo intermediate) is still a matter of intensive debates.  Site-directed mutagenesis studies in conjunction with structural studies allowed different hypotheses to be checked.  Theor. calcns. became available and enabled various hypotheses to be tested and new solns. to be offered.  All these studies have enriched the knowledge on mol. enzymol. and the coordination chem. of metal-peroxo and high-valent metal-oxo species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR8qIfDs6uAbVg90H21EOLACvtfcHk0lhkzFhGJASufA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVejtr8%253D&md5=d10f62537d0af7d3895217ee91a5119b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcr020443g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020443g%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DB.%26aulast%3Dde%2BVisser%26aufirst%3DS.%2BP.%26aulast%3DShaik%26aufirst%3DS.%26atitle%3DMechanism%2520of%2520Oxidation%2520Reactions%2520Catalyzed%2520by%2520Cytochrome%2520P450%2520Enzymes%26jtitle%3DChem.%2520Rev.%26date%3D2004%26volume%3D104%26issue%3D9%26spage%3D3947%26epage%3D3980%26doi%3D10.1021%2Fcr020443g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shephard, E. A.</span></span> <span> </span><span class="NLM_article-title">Drug Metabolism by Flavin-Containing Monooxygenases of Human and Mouse</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1239718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F17425255.2017.1239718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27678284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1eiur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=167-181&issue=2&author=I.+R.+Phillipsauthor=E.+A.+Shephard&title=Drug+Metabolism+by+Flavin-Containing+Monooxygenases+of+Human+and+Mouse&doi=10.1080%2F17425255.2017.1239718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Drug metabolism by flavin-containing monooxygenases of human and mouse</span></div><div class="casAuthors">Phillips, Ian R.; Shephard, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-181</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Flavin-contg. monooxygenases (FMOs) play an important role in drug metab.: We focus on the role of FMOs in the metab. of drugs in human and mouse.  We describe FMO genes and proteins of human and mouse; the catalytic mechanism of FMOs and their significance for drug metab.; differences between FMOs and CYPs; factors contributing to potential underestimation of the contribution of FMOs to drug metab.; the developmental and tissue-specific expression of FMO genes and differences between human and mouse; and factors that induce or inhibit FMOs.  We discuss the contribution of FMOs of human and mouse to the metab. of drugs and how genetic variation of FMOs affects drug metab.  Finally, we discuss the utility of animal models for FMO-mediated drug metab. in humans.: The contribution of FMOs to drug metab. may be underestimated.  As FMOs are not readily induced or inhibited and their reactions are generally detoxifications, the design of drugs that are metabolized predominantly by FMOs offers clin. advantages.  Fmo1(-/-),Fmo2(-/-),Fmo4(-/-) mice provide a good animal model for FMO-mediated drug metab. in humans.  Identification of roles for FMO1 and FMO5 in endogenous metab. has implications for drug therapy and initiates an exciting area of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJQXt-nCk13LVg90H21EOLACvtfcHk0ljNRLcqKcYBbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1eiur7K&md5=82ffec82f5438321d8211ff0482e7dbd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1239718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1239718%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26aulast%3DShephard%26aufirst%3DE.%2BA.%26atitle%3DDrug%2520Metabolism%2520by%2520Flavin-Containing%2520Monooxygenases%2520of%2520Human%2520and%2520Mouse%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26issue%3D2%26spage%3D167%26epage%3D181%26doi%3D10.1080%2F17425255.2017.1239718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korzekwa, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschel, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, M. E.</span></span> <span> </span><span class="NLM_article-title">Human Liver Oxidative Metabolism of O6-Benzylguanine</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1385</span>– <span class="NLM_lpage">1389</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(95)02019-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0006-2952%2895%2902019-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7503788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2MXpslOisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=1385-1389&issue=9&author=S.+K.+Royauthor=K.+R.+Korzekwaauthor=F.+J.+Gonzalezauthor=R.+C.+Moschelauthor=M.+E.+Dolan&title=Human+Liver+Oxidative+Metabolism+of+O6-Benzylguanine&doi=10.1016%2F0006-2952%2895%2902019-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Human liver oxidative metabolism of O6-benzylguanine</span></div><div class="casAuthors">Roy, Sandip K.; Korzekwa, Kenneth R.; Gonzalez, Frank J.; Moschel, Robert C.; Dolan, M. Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1385-9</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The oxidn. of O6-benzylguanine, an inactivator of O6-alkylguaine-DNA alkyltransferase, was examd. using human liver cytosol, microsomes, and several P 450 isoforms.  Incubation of O6-benzylguanine with human liver cytosol resulted in the formation of O6-benzyl-8-oxoguanine, which was inhibited by menadione, a potent inhibitor of aldehyde oxidase.  Inhibition by allopurinol, a xanthine oxidase inhibitor, was less dramatic.  Oxidn. of O6-benzylguanine also occurred with pooled human liver microsomes and was inhibited by both furafylline and troleandomycin, selective inhibitors of CYPIA2 and CYP3A4, resp.  Human P450s, CYPIA2, CYP2B6, CYP2C8, CYP2C9, CYP2E1, and CYP3A4 expressed in Hep G2 hepatoma cells using vaccinia virus vectors were incubated with 10 or 200 μM O6-benzylguanine.  At 10 μM, O6-benzylguanine was oxidized primarily by CYP1A2 and to a lesser extent by CYP3A4.  However, an appreciable increase in CYP3A4 contribution was noted at 200 μM.  CYP1A2 exhibited a more than 200-fold higher relative catalytic activity (Vmax/Km) compared with CYP3A4.  Therefore, at therapeutically relevant concns. of O6-benzylguanine, CYP1A2 could be primarily involved in its oxidn. since it shows a much lower Km value (1.3 μM) than CYP3A4 (52.2 μM) and cytosol (81.5 μM).  However, one would expect interindividual variation in the extent of oxidn. of O6-benzylguanine depending on the levels of aldehyde oxidase, CYP1A2, and CYP3A4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdpuhyULK3OrVg90H21EOLACvtfcHk0ljNRLcqKcYBbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslOisr0%253D&md5=1c356de65d29834d1f1f916e4eb1cc71</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2902019-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252902019-5%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%2BK.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26atitle%3DHuman%2520Liver%2520Oxidative%2520Metabolism%2520of%2520O6-Benzylguanine%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26issue%3D9%26spage%3D1385%26epage%3D1389%26doi%3D10.1016%2F0006-2952%2895%2902019-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hille, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, P.</span></span> <span> </span><span class="NLM_article-title">The Mononuclear Molybdenum Enzymes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3963</span>– <span class="NLM_lpage">4038</span>, <span class="refDoi"> DOI: 10.1021/cr400443z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400443z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=3963-4038&issue=7&author=R.+Hilleauthor=J.+Hallauthor=P.+Basu&title=The+Mononuclear+Molybdenum+Enzymes&doi=10.1021%2Fcr400443z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Mononuclear Molybdenum Enzymes</span></div><div class="casAuthors">Hille, Russ; Hall, James; Basu, Partha</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3963-4038</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Molybdenum is the only second-row transition metal required by most living organisms and is nearly universally distributed in biol.  Enzymes contg. molybdenum in their active sites have long been recognized, and many have been characterized structurally and biochem.  Furthermore, it is now well-established that with the exception of nitrogenase (in which molybdenum is incorporated into a [MoFe7S9] active site cluster) all mononuclear molybdenum-contg. enzymes fall into one of three large and mutually exclusive families.  The enzymes xanthine oxidase, sulfite oxidase, and DMSO reductase, each of which represents a good example of one of the three molybdenum-contg. enzyme families, are the focus of the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaH5_H7dhwRLVg90H21EOLACvtfcHk0lj35jlUsfaNQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCnu74%253D&md5=698a13bf02d700be36c3ce2f1e951b22</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcr400443z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400443z%26sid%3Dliteratum%253Aachs%26aulast%3DHille%26aufirst%3DR.%26aulast%3DHall%26aufirst%3DJ.%26aulast%3DBasu%26aufirst%3DP.%26atitle%3DThe%2520Mononuclear%2520Molybdenum%2520Enzymes%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26issue%3D7%26spage%3D3963%26epage%3D4038%26doi%3D10.1021%2Fcr400443z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barsanti, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aversa, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramurthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taricani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Q.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (Abi) as Atr Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/ml500352s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500352s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVelurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=42-46&issue=1&author=P.+A.+Barsantiauthor=Y.+Panauthor=Y.+Luauthor=R.+Jainauthor=M.+Coxauthor=R.+J.+Aversaauthor=M.+P.+Dillonauthor=R.+Ellingauthor=C.+Huauthor=X.+Jinauthor=M.+Knappauthor=J.+Lanauthor=S.+Ramurthyauthor=P.+Rudewiczauthor=L.+Settiauthor=S.+Subramanianauthor=M.+Mathurauthor=L.+Taricaniauthor=G.+Thomasauthor=L.+Xiaoauthor=Q.+Yue&title=Structure-Based+Drug+Design+of+Novel%2C+Potent%2C+and+Selective+Azabenzimidazoles+%28Abi%29+as+Atr+Inhibitors&doi=10.1021%2Fml500352s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR Inhibitors</span></div><div class="casAuthors">Barsanti, Paul A.; Pan, Yue; Lu, Yipin; Jain, Rama; Cox, Matthew; Aversa, Robert J.; Dillon, Michael P.; Elling, Robert; Hu, Cheng; Jin, Xianming; Knapp, Mark; Lan, Jiong; Ramurthy, Savithri; Rudewicz, Patrick; Setti, Lina; Subramanian, Sharadha; Mathur, Michelle; Taricani, Lorena; Thomas, George; Xiao, Linda; Yue, Qin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-46</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compd. I was discovered through morphing of the ATR biochem. HTS hit I.  The ABI series was potent and selective for ATR.  Incorporation of a 6-azaindole afforded a marked increase in cellular potency but was assocd. with poor PK and hERG ion channel inhibition.  DMPK expts. established that CYP P 450 and AO metab. in conjunction with Pgp and BCRP efflux were major causative mechanisms for the obsd. PK.  The series also harbored the CYP3A4 TDI liability driven by the presence of both a morpholine and an indole moiety.  Incorporation of an adjacent fluorine or nitrogen into the 6-azaindole addressed many of the various medicinal chem. issues encountered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDC1_FhPys3rVg90H21EOLACvtfcHk0lj35jlUsfaNQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVelurvN&md5=0af868d4812510335fe92b74d34a8910</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml500352s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500352s%26sid%3Dliteratum%253Aachs%26aulast%3DBarsanti%26aufirst%3DP.%2BA.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DCox%26aufirst%3DM.%26aulast%3DAversa%26aufirst%3DR.%2BJ.%26aulast%3DDillon%26aufirst%3DM.%2BP.%26aulast%3DElling%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DKnapp%26aufirst%3DM.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DRamurthy%26aufirst%3DS.%26aulast%3DRudewicz%26aufirst%3DP.%26aulast%3DSetti%26aufirst%3DL.%26aulast%3DSubramanian%26aufirst%3DS.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DTaricani%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DYue%26aufirst%3DQ.%26atitle%3DStructure-Based%2520Drug%2520Design%2520of%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Azabenzimidazoles%2520%2528Abi%2529%2520as%2520Atr%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D1%26spage%3D42%26epage%3D46%26doi%3D10.1021%2Fml500352s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilworth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athersuch, T. J.</span></span> <span> </span><span class="NLM_article-title">Metabolic Hydrolysis of Aromatic Amides in Selected Rat, Minipig, and Human in Vitro Systems</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2405</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-20464-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Fs41598-018-20464-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29402925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BC1MvnsFyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=2405&author=P.+R.+Bradshawauthor=I.+D.+Wilsonauthor=R.+U.+Gillauthor=P.+J.+Butlerauthor=C.+Dilworthauthor=T.+J.+Athersuch&title=Metabolic+Hydrolysis+of+Aromatic+Amides+in+Selected+Rat%2C+Minipig%2C+and+Human+in+Vitro+Systems&doi=10.1038%2Fs41598-018-20464-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Hydrolysis of Aromatic Amides in Selected Rat, Minipig, and Human In Vitro Systems</span></div><div class="casAuthors">Bradshaw Peter R; Wilson Ian D; Athersuch Toby J; Gill Rachel Upcott; Butler Philip J; Dilworth Clive; Athersuch Toby J</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2405</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The release of aromatic amines from drugs and other xenobiotics resulting from the hydrolysis of metabolically labile amide bonds presents a safety risk through several mechanisms, including geno-, hepato- and nephrotoxicity.  Whilst multiple in vitro systems used for studying metabolic stability display serine hydrolase activity, responsible for the hydrolysis of amide bonds, they vary in their efficiency and selectivity.  Using a range of amide-containing probe compounds (0.5-10 μM), we have investigated the hydrolytic activity of several rat, minipig and human-derived in vitro systems - including Supersomes, microsomes, S9 fractions and hepatocytes - with respect to their previously observed human in vivo metabolism.  In our hands, human carboxylesterase Supersomes and rat S9 fractions systems showed relatively poor prediction of human in vivo metabolism.  Rat S9 fractions, which are commonly utilised in the Ames test to assess mutagenicity, may be limited in the detection of genotoxic metabolites from aromatic amides due to their poor concordance with human in vivo amide hydrolysis.  In this study, human liver microsomes and minipig subcellular fractions provided more representative models of human in vivo hydrolytic metabolism of the aromatic amide compounds tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMzpsIkzpxmRcr74wzj5o5fW6udTcc2eYX4j08H_a5ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvnsFyrsA%253D%253D&md5=9f1f65ed68d8a58788dda69bb41cd7d3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-20464-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-20464-4%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DP.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26aulast%3DGill%26aufirst%3DR.%2BU.%26aulast%3DButler%26aufirst%3DP.%2BJ.%26aulast%3DDilworth%26aufirst%3DC.%26aulast%3DAthersuch%26aufirst%3DT.%2BJ.%26atitle%3DMetabolic%2520Hydrolysis%2520of%2520Aromatic%2520Amides%2520in%2520Selected%2520Rat%252C%2520Minipig%252C%2520and%2520Human%2520in%2520Vitro%2520Systems%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D2405%26doi%3D10.1038%2Fs41598-018-20464-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B. M. J. M.</span></span> <i>Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology</i>; <span class="NLM_publisher-name">Verlag Helvetica Chimica Acta</span>, <span class="NLM_publisher-loc">Zürich</span>, <span class="NLM_year">2006</span>; <span class="refDoi"> DOI: 10.1002/9783906390444</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2F9783906390444" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=B.+M.+J.+M.+Testa&title=Hydrolysis+in+Drug+and+Prodrug+Metabolism%3A+Chemistry%2C+Biochemistry%2C+and+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2F9783906390444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783906390444%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%2BM.%2BJ.%2BM.%26btitle%3DHydrolysis%2520in%2520Drug%2520and%2520Prodrug%2520Metabolism%253A%2520Chemistry%252C%2520Biochemistry%252C%2520and%2520Enzymology%26pub%3DVerlag%2520Helvetica%2520Chimica%2520Acta%26date%3D2006%26doi%3D10.1002%2F9783906390444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narai, N.</span></span> <span> </span><span class="NLM_article-title">Reductive Metabolism of Aromatic Nitro Compounds Including Carcinogens by Rabbit Liver Preparations</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1089</span>– <span class="NLM_lpage">1093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3943085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL28XhvVWnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=1089-1093&author=K.+Tatsumiauthor=S.+Kitamuraauthor=N.+Narai&title=Reductive+Metabolism+of+Aromatic+Nitro+Compounds+Including+Carcinogens+by+Rabbit+Liver+Preparations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations</span></div><div class="casAuthors">Tatsumi, Kiyoshi; Kitamura, Shigeyuki; Narai, Noriko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1089-93</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Reductive metab. of arom. nitro compds. was examd. with rabbit liver prepns.  Under anaerobic conditions, carcinogenic 2-nitrofluorene (I)  [607-57-8], 4-nitrobiphenyl  [92-93-3] and 1-nitronaphthalene  [86-57-7] were reduced to the corresponding hydroxylamines and amines, whereas the carcinogenic 1-nitropyrene  [5522-43-0] was reduced only to the corresponding amine by liver cytosol in the presence of 2-hydroxypyrimidine  [557-01-7], an electron donor of aldehyde oxidase  [9029-07-6].  Both liver microsomes and cytosol catalyzed the redn. of these arom. nitro compds. in varying degrees.  The microsomes required reduced pyridine nucleotides for occurrence of the nitroreductase activities.  In this case, NADPH  [53-57-6] was more effective than NADH  [58-68-4] as an electron donor.  The cytosol by itself exhibited some nitroreductase  [9037-41-6] activities, which were markedly enhanced by addn. of an electron donor of aldehyde oxidase, i.e., N1-methylnicotinamide  [3106-60-3] or 2-hydroxypyrimidine.  The full activities of the cytosol with the electron donor were much higher than those of the microsomes with the reduced pyridine nucleotide.  Purified liver aldehyde oxidase, like the cytosol, exhibited significant nitroreductase activities in the presence of its electron donor.  Evidently cytosolic aldehyde oxidase functions as a major enzyme responsible for the redn. of arom. nitro compds. including carcinogens in rabbit liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3zkVEW2OV27Vg90H21EOLACvtfcHk0lgb6LL4xvgv3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvVWnu7s%253D&md5=f25b77244a97c6192fb51ad20b0d3b6a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNarai%26aufirst%3DN.%26atitle%3DReductive%2520Metabolism%2520of%2520Aromatic%2520Nitro%2520Compounds%2520Including%2520Carcinogens%2520by%2520Rabbit%2520Liver%2520Preparations%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D1089%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span> <span> </span><span class="NLM_article-title">Reduction of Tertiary Amine N-Oxides by Liver Preparations: Function of Aldehyde Oxidase as a Major N-Oxide Reductase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(84)90742-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0006-291X%2884%2990742-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=6743317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2cXltVKgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1984&pages=749-754&issue=3&author=S.+Kitamuraauthor=K.+Tatsumi&title=Reduction+of+Tertiary+Amine+N-Oxides+by+Liver+Preparations%3A+Function+of+Aldehyde+Oxidase+as+a+Major+N-Oxide+Reductase&doi=10.1016%2F0006-291X%2884%2990742-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of tertiary amine N-oxides by liver preparations:  function of aldehyde oxidase as a major N-oxide reductase</span></div><div class="casAuthors">Kitamura, Shigeyuki; Tatsumi, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">749-54</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The redn. of tertiary amine N-oxides to the corresponding amines by liver prepns. was investigated with imipramine N-oxide and cyclobenzaprine N-oxide under anaerobic conditions.  Rabbit liver cytosol in the presence of an electron donor of aldehyde oxidase exhibited a significant N-oxide reductase activity which was comparable to the activity of the liver microsomes supplemented with NADPH.  Rabbit liver aldehyde oxidase also exhibited the N-oxide reductase activity in the presence of its electron donor, indicating that the activity obsd. in the liver cytosol was due to this cytosolic enzyme.  Furthermore, the tertiary amine N-oxide reductase activity of liver cytosols from rats, mice, hamsters, and hogs was demonstrated by comparison with that of liver microsomes from these mammalian species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWJVbhTVDm0bVg90H21EOLACvtfcHk0lgb6LL4xvgv3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVKgtr8%253D&md5=734ebab5cd63c6ada04df82a2155239e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2884%2990742-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252884%252990742-3%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DReduction%2520of%2520Tertiary%2520Amine%2520N-Oxides%2520by%2520Liver%2520Preparations%253A%2520Function%2520of%2520Aldehyde%2520Oxidase%2520as%2520a%2520Major%2520N-Oxide%2520Reductase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1984%26volume%3D121%26issue%3D3%26spage%3D749%26epage%3D754%26doi%3D10.1016%2F0006-291X%2884%2990742-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase and Its Importance in Novel Drug Discovery: Present and Future Challenges</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1517/17460441.2013.788497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1517%2F17460441.2013.788497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23565746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFynsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=641-654&issue=6&author=E.+Garattiniauthor=M.+Terao&title=Aldehyde+Oxidase+and+Its+Importance+in+Novel+Drug+Discovery%3A+Present+and+Future+Challenges&doi=10.1517%2F17460441.2013.788497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase and its importance in novel drug discovery: present and future challenges</span></div><div class="casAuthors">Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">641-654</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Aldehyde oxidases (AOXs) are molybdo-flavoenzymes that oxidize arom. aldehydes into the corresponding carboxylic acids and heterocycles into hydroxylated derivs.  AOXs have broad substrate specificity and are present in the liver of humans and many exptl. animals.  These enzymes play an important role in Phase I metab. of drugs and xenobiotics of toxicol. interest.  Areas covered: Preclin. studies on the AOX-dependent metab. of new drug candidates are problematic.  Furthermore, there is a general lack of reliable in silico methodologies to predict whether a new org. mol. is an AOX substrate.  In vitro systems, for the design of high- or medium-throughput screening tests, to identify AOX substrates have many limitations.  In vivo studies on AOX-dependent metab. in animal models, on the other hand, are difficult because the complement of liver AOXs in humans and popular exptl. animals is different.  The authors discuss the possible ways to overcome all these problems.  Expert opinion: The significance of AOXs as drug-metabolizing enzymes is increasing, as the current strategies of org. synthesis designed to avoid cytochrome P 450 (CYP450)-dependent metab. tend to enrich for new chem. structures efficiently oxidized by these enzymes.  There is need for reliable methods to screen for, predict, and validate AOX-dependent metab. of new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTholvCIK88LVg90H21EOLACvtfcHk0lh6Ai-qKKZF2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFynsbg%253D&md5=c1829fd49bb8c76f518231105105708c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.788497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.788497%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DAldehyde%2520Oxidase%2520and%2520Its%2520Importance%2520in%2520Novel%2520Drug%2520Discovery%253A%2520Present%2520and%2520Future%2520Challenges%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D641%26epage%3D654%26doi%3D10.1517%2F17460441.2013.788497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. D.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8441</span>– <span class="NLM_lpage">8460</span>, <span class="refDoi"> DOI: 10.1021/jm100888d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&issue=24&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.+D.+Tran&title=Aldehyde+Oxidase%3A+An+Enzyme+of+Emerging+Importance+in+Drug+Discovery&doi=10.1021%2Fjm100888d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0lh6Ai-qKKZF2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.%2BD.%26atitle%3DAldehyde%2520Oxidase%253A%2520An%2520Enzyme%2520of%2520Emerging%2520Importance%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D24%26spage%3D8441%26epage%3D8460%26doi%3D10.1021%2Fjm100888d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutowo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cibrian-Uhalte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magarinos, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadatos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span> <span> </span><span class="NLM_article-title">The Chembl Database in 2017</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D945</span>– <span class="NLM_lpage">D954</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1093%2Fnar%2Fgkw1074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27899562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D945-D954&issue=D1&author=A.+Gaultonauthor=A.+Herseyauthor=M.+Nowotkaauthor=A.+P.+Bentoauthor=J.+Chambersauthor=D.+Mendezauthor=P.+Mutowoauthor=F.+Atkinsonauthor=L.+J.+Bellisauthor=E.+Cibrian-Uhalteauthor=M.+Daviesauthor=N.+Dedmanauthor=A.+Karlssonauthor=M.+P.+Magarinosauthor=J.+P.+Overingtonauthor=G.+Papadatosauthor=I.+Smitauthor=A.+R.+Leach&title=The+Chembl+Database+in+2017&doi=10.1093%2Fnar%2Fgkw1074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The ChEMBL database in 2017</span></div><div class="casAuthors">Gaulton, Anna; Hersey, Anne; Nowotka, Micha-l; Bento, A. Patricia; Chambers, Jon; Mendez, David; Mutowo, Prudence; Atkinson, Francis; Bellis, Louisa J.; Cibrian-Uhalte, Elena; Davies, Mark; Dedman, Nathan; Karlsson, Anneli; Magarinos, Maria Paula; Overington, John P.; Papadatos, George; Smit, Ines; Leach, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D945-D954</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 and 2014 Nucleic Acids Research Database Issues.  Since then, alongside the continued extn. of data from the medicinal chem. literature, new sources of bioactivity data have also been added to the database.  These include: deposited data sets from neglected disease screening; crop protection data; drug metab. and disposition data and bioactivity data from patents.  A no. of improvements and new features have also been incorporated.  These include the annotation of assays and targets using ontologies, the inclusion of targets and indications for clin. candidates, addn. of metabolic pathways for drugs and calcn. of structural alerts.  The ChEMBL data can be accessed via a web-interface, RDF distribution, data downloads and RESTful web-services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB0IuNShSHIrVg90H21EOLACvtfcHk0lh6Ai-qKKZF2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D&md5=1dcbb641f8c2d11410663f97505a4911</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1074%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNowotka%26aufirst%3DM.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DMendez%26aufirst%3DD.%26aulast%3DMutowo%26aufirst%3DP.%26aulast%3DAtkinson%26aufirst%3DF.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DCibrian-Uhalte%26aufirst%3DE.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DDedman%26aufirst%3DN.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DMagarinos%26aufirst%3DM.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DPapadatos%26aufirst%3DG.%26aulast%3DSmit%26aufirst%3DI.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26atitle%3DThe%2520Chembl%2520Database%2520in%25202017%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26issue%3DD1%26spage%3DD945%26epage%3DD954%26doi%3D10.1093%2Fnar%2Fgkw1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stubley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stell, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieson, D. W.</span></span> <span> </span><span class="NLM_article-title">The Oxidation of Azaheterocycles with Mammalian Liver Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.3109/00498257909087261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498257909087261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=516790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL3cXhtVKgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1979&pages=475-484&issue=8&author=C.+Stubleyauthor=J.+G.+Stellauthor=D.+W.+Mathieson&title=The+Oxidation+of+Azaheterocycles+with+Mammalian+Liver+Aldehyde+Oxidase&doi=10.3109%2F00498257909087261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The oxidation of azaheterocycles with mammalian liver aldehyde oxidase</span></div><div class="casAuthors">Stubley, C.; Stell, J. G. P.; Mathieson, D. W.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">475-84</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    </div><div class="casAbstract">Rabbit liver aldehyde oxidase (EC 1.2.3.1.) (I) oxidized isoquinoline, cinnoline, quinoxaline, quinazoline, and phthalazine to 1-hydroxyisoquinoline, 4-hydroxycinnoline, 2-hydroxy- and 2,3-dihydroxyquinoxaline, 4-hydroxy- and 2,4-dihydroxyquinazoline, and 1-hydroxyphthalazine, resp.  Michaelis-Menten consts. were detd. for the action of I on each of these compds. and showed that these compds. were among the most efficient substrates yet described for rabbit liver I.  Incubation of these compds. with bovine milk xanthine oxidase yielded significant amts. of metabolites only with quinazoline and phthalazine, for which the Km values were detd.  Incubation of the compds. with 100,000-g supernatant from rat liver gave qual. the same results as with rabbit liver, but smaller amts. of the oxidn. products were detected.  The substrate specificities of the enzymes are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLJEfWfGpohrVg90H21EOLACvtfcHk0ljtLG0gksAmpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhtVKgt70%253D&md5=6a8f77c49aa3838d7372a7094a4b5464</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3109%2F00498257909087261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498257909087261%26sid%3Dliteratum%253Aachs%26aulast%3DStubley%26aufirst%3DC.%26aulast%3DStell%26aufirst%3DJ.%2BG.%26aulast%3DMathieson%26aufirst%3DD.%2BW.%26atitle%3DThe%2520Oxidation%2520of%2520Azaheterocycles%2520with%2520Mammalian%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D1979%26volume%3D9%26issue%3D8%26spage%3D475%26epage%3D484%26doi%3D10.3109%2F00498257909087261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Evidence for Substrate-Dependent Inhibition Profiles for Human Liver Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.048546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.048546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22996261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=24-29&issue=1&author=J.+T.+Barrauthor=J.+P.+Jones&title=Evidence+for+Substrate-Dependent+Inhibition+Profiles+for+Human+Liver+Aldehyde+Oxidase&doi=10.1124%2Fdmd.112.048546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase</span></div><div class="casAuthors">Barr, John T.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-29</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The goal of this study was to provide a reasonable assessment of how probe substrate selection may impact the results of in vitro aldehyde oxidase (I) inhibition expts.  Here, the authors used a previously studied set of 7 known I inhibitors to probe the inhibition profile of a pharmacol. relevant substrate, N-[(2-dimethylamino)ethyl]acridine-4-carboxamide (DACA).  DACA oxidn. by I in human liver cytosol was characterized with a measured Vmax of 2.3 nmol product/min/mg and a Km of 6.3 μM.  The Kii and Kis values describing the inhibition of DACA oxidn. by the panel of 7 inhibitors were tabulated and compared with previous findings with phthalazine as substrate.  In every case, the inhibition profile shifted to a much less uncompetitive mode of inhibition for DACA relative to phthalazine.  With the exception of one inhibitor, raloxifene, this change in inhibition profile appeared to be a result of a decrease in the uncompetitive mode of inhibition (an affected Kii value), whereas the competitive mode (Kis) appeared to be relatively consistent between substrates.  Raloxifene was found to inhibit competitively when using DACA as a probe, and a previous report showed that raloxifene inhibited uncompetitively with other substrates.  The relevance of these data to the mechanistic understanding of I inhibition and potential implications on drug-drug interactions was discussed.  Overall, it appears that the choice in substrate may be crit. when conducting mechanistic inhibition or in vitro drug-drug interactions prediction studies with I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWZ7cJVqkp_bVg90H21EOLACvtfcHk0ljtLG0gksAmpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1OjsQ%253D%253D&md5=8980b8d7b3951f27ec63023706cb3188</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.048546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.048546%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DEvidence%2520for%2520Substrate-Dependent%2520Inhibition%2520Profiles%2520for%2520Human%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26issue%3D1%26spage%3D24%26epage%3D29%26doi%3D10.1124%2Fdmd.112.048546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stell, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelhouse, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, C. W.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Cryptolepine and 2-Fluorocryptolepine by Aldehyde Oxidase</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.2011.01408.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1111%2Fj.2042-7158.2011.01408.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22221099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVSisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=237-243&issue=2&author=J.+G.+Stellauthor=R.+T.+Wheelhouseauthor=C.+W.+Wright&title=Metabolism+of+Cryptolepine+and+2-Fluorocryptolepine+by+Aldehyde+Oxidase&doi=10.1111%2Fj.2042-7158.2011.01408.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of cryptolepine and 2-fluorocryptolepine by aldehyde oxidase</span></div><div class="casAuthors">Stell, J. Godfrey P.; Wheelhouse, Richard T.; Wright, Colin W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">237-243</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives To investigate the metab. of cryptolepine and some cryptolepine analogs by aldehyde oxidase, and to assess the implications of the results on the potential of cryptolepine analogs as antimalarial agents.  Methods The products resulting from the oxidn. of cryptolepine and 2-fluorocryptolepine by a rabbit liver prepn. of aldehyde oxidase were isolated and identified using chromatog. and spectroscopic techniques.  The antiplasmodial activity of cryptolepine-11-one was assessed against Plasmodium falciparum using the parasite lactate dehydrogenase assay.  Key findings Cryptolepine was oxidized by aldehyde oxidase give cryptolepine-11-one.  Although 2-fluorocryptolepine was found to have less affinity for the enzyme than cryptolepine, it was a better substrate for aldehyde oxidase than the parent compd.  In contrast, quindoline, the 11-chloro-, 2,7-dibromo- and 2-methoxy analogs of cryptolepine were not readily oxidized.  Cryptolepine-11-one was found to be inactive against P. falciparum in vitro raising the possibility that the effectiveness of cryptolepine as an antimalarial, may be compromised by metab. to an inactive metabolite by liver aldehyde oxidase.  Conclusions Cryptolepine and 2-fluorocryptolepine are substrates for aldehyde oxidase.  This may have implications for the design and development of cryptolepine analogs as antimalarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS7nWldURg1LVg90H21EOLACvtfcHk0ljtLG0gksAmpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVSisLY%253D&md5=42fc6fc32d2f38ce0247b6c28ea04b7b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2011.01408.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2011.01408.x%26sid%3Dliteratum%253Aachs%26aulast%3DStell%26aufirst%3DJ.%2BG.%26aulast%3DWheelhouse%26aufirst%3DR.%2BT.%26aulast%3DWright%26aufirst%3DC.%2BW.%26atitle%3DMetabolism%2520of%2520Cryptolepine%2520and%25202-Fluorocryptolepine%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2012%26volume%3D64%26issue%3D2%26spage%3D237%26epage%3D243%26doi%3D10.1111%2Fj.2042-7158.2011.01408.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magee, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripp, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chupak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finegan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granskog, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardink, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huband, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamicker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knickerbocker, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzien, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, U. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait-Kamradt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whipple, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widlicka, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishka, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkowski, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">7446</span>– <span class="NLM_lpage">7457</span>, <span class="refDoi"> DOI: 10.1021/jm900729s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900729s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKktLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7446-7457&issue=23&author=T.+V.+Mageeauthor=S.+L.+Rippauthor=B.+Liauthor=R.+A.+Buzonauthor=L.+Chupakauthor=T.+J.+Doughertyauthor=S.+M.+Fineganauthor=D.+Girardauthor=A.+E.+Hagenauthor=M.+J.+Falconeauthor=K.+A.+Farleyauthor=K.+Granskogauthor=J.+R.+Hardinkauthor=M.+D.+Hubandauthor=B.+J.+Kamickerauthor=T.+Kanekoauthor=M.+J.+Knickerbockerauthor=J.+L.+Lirasauthor=A.+Marraauthor=I.+Medinaauthor=T.+T.+Nguyenauthor=M.+C.+Noeauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnellauthor=J.+B.+Penzienauthor=U.+D.+Reillyauthor=J.+R.+Schaferauthor=Y.+Shenauthor=G.+G.+Stoneauthor=T.+J.+Strelevitzauthor=J.+Sunauthor=A.+Tait-Kamradtauthor=A.+D.+Vazauthor=D.+A.+Whippleauthor=D.+W.+Widlickaauthor=D.+G.+Wishkaauthor=J.+P.+Wolkowskiauthor=M.+E.+Flanagan&title=Discovery+of+Azetidinyl+Ketolides+for+the+Treatment+of+Susceptible+and+Multidrug+Resistant+Community-Acquired+Respiratory+Tract+Infections&doi=10.1021%2Fjm900729s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections</span></div><div class="casAuthors">Magee, Thomas V.; Ripp, Sharon L.; Li, Bryan; Buzon, Richard A.; Chupak, Lou; Dougherty, Thomas J.; Finegan, Steven M.; Girard, Dennis; Hagen, Anne E.; Falcone, Michael J.; Farley, Kathleen A.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Kamicker, Barbara J.; Kaneko, Takushi; Knickerbocker, Michael J.; Liras, Jennifer L.; Marra, Andrea; Medina, Ivy; Nguyen, Thuy-Trinh; Noe, Mark C.; Obach, R. Scott; O'Donnell, John P.; Penzien, Joseph B.; Reilly, Usa Datta; Schafer, John R.; Shen, Yue; Stone, Gregory G.; Strelevitz, Timothy J.; Sun, Jianmin; Tait-Kamradt, Amelia; Vaz, Alfin D. N.; Whipple, David A.; Widlicka, Daniel W.; Wishka, Donn G.; Wolkowski, Joanna P.; Flanagan, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7446-7457</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Respiratory tract bacterial strains are becoming increasingly resistant to currently marketed macrolide antibiotics.  The current alternative telithromycin (1) from the newer ketolide class of macrolides addresses resistance but is hampered by serious safety concerns, hepatotoxicity in particular.  We have discovered a novel series of azetidinyl ketolides that focus on mitigation of hepatotoxicity by minimizing hepatic turnover and time-dependent inactivation of CYP3A isoforms in the liver without compromising the potency and efficacy of 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7QWmxQD6817Vg90H21EOLACvtfcHk0li3mZOV6qjzsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKktLbJ&md5=af3db30db1415fb477bffd6b5a2bab7c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm900729s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900729s%26sid%3Dliteratum%253Aachs%26aulast%3DMagee%26aufirst%3DT.%2BV.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DBuzon%26aufirst%3DR.%2BA.%26aulast%3DChupak%26aufirst%3DL.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DFinegan%26aufirst%3DS.%2BM.%26aulast%3DGirard%26aufirst%3DD.%26aulast%3DHagen%26aufirst%3DA.%2BE.%26aulast%3DFalcone%26aufirst%3DM.%2BJ.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DGranskog%26aufirst%3DK.%26aulast%3DHardink%26aufirst%3DJ.%2BR.%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DKamicker%26aufirst%3DB.%2BJ.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DKnickerbocker%26aufirst%3DM.%2BJ.%26aulast%3DLiras%26aufirst%3DJ.%2BL.%26aulast%3DMarra%26aufirst%3DA.%26aulast%3DMedina%26aufirst%3DI.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DPenzien%26aufirst%3DJ.%2BB.%26aulast%3DReilly%26aufirst%3DU.%2BD.%26aulast%3DSchafer%26aufirst%3DJ.%2BR.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DStone%26aufirst%3DG.%2BG.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTait-Kamradt%26aufirst%3DA.%26aulast%3DVaz%26aufirst%3DA.%2BD.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DWidlicka%26aufirst%3DD.%2BW.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DWolkowski%26aufirst%3DJ.%2BP.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520Azetidinyl%2520Ketolides%2520for%2520the%2520Treatment%2520of%2520Susceptible%2520and%2520Multidrug%2520Resistant%2520Community-Acquired%2520Respiratory%2520Tract%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D23%26spage%3D7446%26epage%3D7457%26doi%3D10.1021%2Fjm900729s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R. A.</span></span> <span> </span><span class="NLM_article-title">Refinement of in Vitro Methods for Identification of Aldehyde Oxidase Substrates Reveals Novel Metabolites of Kinase Inhibitors</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.080960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.118.080960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29615437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWlsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=846-859&issue=6&author=R.+A.+Dick&title=Refinement+of+in+Vitro+Methods+for+Identification+of+Aldehyde+Oxidase+Substrates+Reveals+Novel+Metabolites+of+Kinase+Inhibitors&doi=10.1124%2Fdmd.118.080960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of in vitro methods for identification of aldehyde oxidase substrates reveals metabolites of kinase inhibitors</span></div><div class="casAuthors">Dick, Ryan A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">846-859</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">To identify aldehyde oxidase (AO) substrates, an assay procedure was developed that leverages the capabilities of high-resoln. mass spectrometry to simultaneously monitor parent loss and formation of hydroxylated metabolite over time in incubations with liver cytosol.  By incorporating metabolite monitoring, false positives resulting from metab. by other cytosolic enzymes or processes were decreased.  A diverse set of 34 kinase inhibitors contg. AO-substrate motifs was screened, and 35% of the compds. were identified as human AO substrates.  Confirmation was obtained through detn. of the site of metab.  Human AO substrates identified contained unsubstituted diazanaphthalene moieties (A77-01, INCB 28060, ML-347, LDN-193189, and SB-525334), 4-aminoquinazoline cores (lapatinib, lapatinib M1, and CL-387785), and terminal pyridine and pyrimidine groups (imatinib, bafetinib, and AMG 900).  Rat and cynomolgus monkey AO displayed substrate specificities that overlapped moderately with human; rates of metab. were often higher and lower for cynomolgus monkey and rat, resp., compared with human.  A subset of novel AO substrates identified in this study was also subjected to two other methods for AO substrate detn.: comparison of human liver microsome and hepatocyte stability, and the effect of hydralazine, an AO-specific inhibitor, on hepatocyte stability.  These methods appeared to correlate and be capable of identifying AO substrates when more than one-third of metab. in hepatocytes was AO-mediated; however, significant limitations exist.  Considering the sensitivity, efficiency, and definitiveness of the cytosol assay with metabolite monitoring, its use is recommended as a primary screen for AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlGGJzSPQLDbVg90H21EOLACvtfcHk0li3mZOV6qjzsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWlsb7M&md5=0b08ae43f93b6a9874f10b40422d93b2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.080960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.080960%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DR.%2BA.%26atitle%3DRefinement%2520of%2520in%2520Vitro%2520Methods%2520for%2520Identification%2520of%2520Aldehyde%2520Oxidase%2520Substrates%2520Reveals%2520Novel%2520Metabolites%2520of%2520Kinase%2520Inhibitors%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26issue%3D6%26spage%3D846%26epage%3D859%26doi%3D10.1124%2Fdmd.118.080960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, T.</span></span> <span> </span><span class="NLM_article-title">Oxidative Metabolic Pathway of Lenvatinib Mediated by Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1326</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.058073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.058073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24914245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKntbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1326-1333&issue=8&author=K.+Inoueauthor=H.+Mizuoauthor=S.+Kawaguchiauthor=K.+Fukudaauthor=K.+Kusanoauthor=T.+Yoshimura&title=Oxidative+Metabolic+Pathway+of+Lenvatinib+Mediated+by+Aldehyde+Oxidase&doi=10.1124%2Fdmd.114.058073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase</span></div><div class="casAuthors">Inoue, Kazuko; Mizuo, Hitoshi; Kawaguchi, Shinki; Fukuda, Katsuyuki; Kusano, Kazutomi; Yoshimura, Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1326-1333, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lenvatinib is a multityrosine kinase inhibitor that inhibits vascular endothelial growth factor receptors, and is being developed as an anticancer drug.  P450s are involved in one of the elimination pathways of lenvatinib, and mono-oxidized metabolites, such as N-oxide (M3) and desmethylated metabolite (M2), form in rats, dogs, monkeys, and humans.  Meanwhile, two other oxidative metabolites are produced only in monkey and human liver S9 fractions, and their structures have been identified using high-resoln. mass spectrometry as a quinolinone form of lenvatinib (M3') and a quinolinone form of desmethylated lenvatinib (M2').  The formation of M3' from lenvatinib occurred independently of NADPH and was effectively inhibited by typical inhibitors of aldehyde oxidase, indicating the involvement of aldehyde oxidase, but not P450s, in this pathway.  M2' was a dioxidized metabolite arising from a combination of mono-oxidn. and desmethylation and could only be produced from M2 in a NADPH-independent manner; M2' could not be generated from M3 or M3'.  These results suggested that M2' is formed from lenvatinib by a unique two-step pathway through M2.  Although both lenvatinib and M2 were substrates for aldehyde oxidase, an enzyme kinetic study indicated that M2 was a much more favorable substrate than lenvatinib.  No inhibitory activities of lenvatinib, M2', or M3' and no significant inhibitory activities of M2 or M3 on aldehyde oxidase were obsd., suggesting a low possibility of drug-drug interactions in combination therapy with substrates of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor7zodBgKGsLVg90H21EOLACvtfcHk0li3mZOV6qjzsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKntbzE&md5=c8b203525c5d1fdf2157d95784d88b53</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.058073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.058073%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DMizuo%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DS.%26aulast%3DFukuda%26aufirst%3DK.%26aulast%3DKusano%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DT.%26atitle%3DOxidative%2520Metabolic%2520Pathway%2520of%2520Lenvatinib%2520Mediated%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D8%26spage%3D1326%26epage%3D1333%26doi%3D10.1124%2Fdmd.114.058073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bish, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaramella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckworth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horscroft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laxton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span> <span> </span><span class="NLM_article-title">Design and Optimisation of Orally Active Tlr7 Agonists for the Treatment of Hepatitis C Virus Infection</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2389</span>– <span class="NLM_lpage">2393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2011.02.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21419626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12ku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2389-2393&issue=8&author=T.+D.+Tranauthor=D.+C.+Prydeauthor=P.+Jonesauthor=F.+M.+Adamauthor=N.+Bensonauthor=G.+Bishauthor=F.+Caloauthor=G.+Ciaramellaauthor=R.+Dixonauthor=J.+Duckworthauthor=D.+N.+Foxauthor=D.+A.+Hayauthor=J.+Hitchinauthor=N.+Horscroftauthor=M.+Howardauthor=I.+Gardnerauthor=H.+M.+Jonesauthor=C.+Laxtonauthor=T.+Parkinsonauthor=G.+Parsonsauthor=K.+Proctorauthor=M.+C.+Smithauthor=N.+Smithauthor=A.+Thomas&title=Design+and+Optimisation+of+Orally+Active+Tlr7+Agonists+for+the+Treatment+of+Hepatitis+C+Virus+Infection&doi=10.1016%2Fj.bmcl.2011.02.092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization of orally active TLR7 agonists for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Tran, Thien-Duc; Pryde, David C.; Jones, Peter; Adam, Fiona M.; Benson, Neil; Bish, Gerwyn; Calo, Frederick; Ciaramella, Guiseppe; Dixon, Rachel; Duckworth, Jonathan; Fox, David N. A.; Hay, Duncan A.; Hitchin, James; Horscroft, Nigel; Howard, Martin; Gardner, Iain; Jones, Hannah M.; Laxton, Carl; Parkinson, Tanya; Parsons, Gemma; Proctor, Katie; Smith, Mya C.; Smith, Nicholas; Thomas, Amy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2389-2393</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationships of a series of novel interferon inducers are described.  Pharmacokinetic studies and efficacy assessment of a series of 8-oxo-3-deazapurine analogs led to the identification of compd. I, a potent and selective agonist of the TLR7 receptor with an excellent in vivo efficacy profile in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq2lV4cNSHv7Vg90H21EOLACvtfcHk0liQzcznaWYgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12ku74%253D&md5=49e8d72575cf93b1e9cc8ecc69ddd035</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.092%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BD.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DAdam%26aufirst%3DF.%2BM.%26aulast%3DBenson%26aufirst%3DN.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DCalo%26aufirst%3DF.%26aulast%3DCiaramella%26aufirst%3DG.%26aulast%3DDixon%26aufirst%3DR.%26aulast%3DDuckworth%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DD.%2BN.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DHitchin%26aufirst%3DJ.%26aulast%3DHorscroft%26aufirst%3DN.%26aulast%3DHoward%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DLaxton%26aufirst%3DC.%26aulast%3DParkinson%26aufirst%3DT.%26aulast%3DParsons%26aufirst%3DG.%26aulast%3DProctor%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%2BC.%26aulast%3DSmith%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DA.%26atitle%3DDesign%2520and%2520Optimisation%2520of%2520Orally%2520Active%2520Tlr7%2520Agonists%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D8%26spage%3D2389%26epage%3D2393%26doi%3D10.1016%2Fj.bmcl.2011.02.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wickremsinhe, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmieri, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmel, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, K. C.</span></span> <span> </span><span class="NLM_article-title">Disposition and Metabolism of Ly2603618, a Chk-1 Inhibitor Following Intravenous Administration in Patients with Advanced and/or Metastatic Solid Tumors</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.3109/00498254.2014.900589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2014.900589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24666335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GntL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=827-841&issue=9&author=E.+R.+Wickremsinheauthor=S.+M.+Hynesauthor=M.+D.+Palmieriauthor=M.+I.+Mitchellauthor=T.+L.+Abrahamauthor=J.+F.+Rehmelauthor=E.+Chanaauthor=L.+M.+Jostauthor=K.+C.+Cassidy&title=Disposition+and+Metabolism+of+Ly2603618%2C+a+Chk-1+Inhibitor+Following+Intravenous+Administration+in+Patients+with+Advanced+and%2For+Metastatic+Solid+Tumors&doi=10.3109%2F00498254.2014.900589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Disposition and metabolism of LY2603618, a Chk-1 inhibitor following intravenous administration in patients with advanced and/or metastatic solid tumors</span></div><div class="casAuthors">Wickremsinhe, Enaksha R.; Hynes, Scott M.; Palmieri, Margo D.; Mitchell, Malcolm I.; Abraham, Trent L.; Rehmel, Jessica Fayer; Chana, Emilie; Jost, Lorenz M.; Cassidy, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">827-841</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">1. The disposition and metab. of a Chk-1 inhibitor (LY2603618) was characterized following a 1-h i.v. administration of a single 250-mg dose of [14C]LY2603618 (50 μCi) to patients with advanced or metastatic solid tumors.  2. LY2603618 was well tolerated with no clin. significant adverse events.  Study was limited to three patients due to challenges of conducting ADME studies in patients with advanced cancer.  Plasma, urine and feces were analyzed for radioactivity, LY2603618 and metabolites.  LY2603618 had a half-life of 10.5 h and was the most abundant entity in plasma, accounting for approx. 69% of total plasma radioactivity.  The second most abundant metabolites, H2 and H5, accounted for <10% of total circulating radioactivity.  The major route of clearance was via CYP450 metab.  The mean total recovery of radioactivity was 83%, with approx. 72% of the radioactivity recovered in the feces and approx. 11% in the urine.  LY2603618 represented approx. 6% and 3% of the administered dose in feces and urine, resp.  3. A total of 12 metabolites were identified.  In vitro phenotyping indicated that CYP3A4 was predominantly responsible for the metabolic clearance of LY2603618.  Addnl., aldehyde oxidase was involved in the formation of a unique human and non-human primate metabolite, H5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Q8Zu_a3bF7Vg90H21EOLACvtfcHk0liQzcznaWYgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GntL7J&md5=6306e281d6757c7a804f2a3d68da6783</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3109%2F00498254.2014.900589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2014.900589%26sid%3Dliteratum%253Aachs%26aulast%3DWickremsinhe%26aufirst%3DE.%2BR.%26aulast%3DHynes%26aufirst%3DS.%2BM.%26aulast%3DPalmieri%26aufirst%3DM.%2BD.%26aulast%3DMitchell%26aufirst%3DM.%2BI.%26aulast%3DAbraham%26aufirst%3DT.%2BL.%26aulast%3DRehmel%26aufirst%3DJ.%2BF.%26aulast%3DChana%26aufirst%3DE.%26aulast%3DJost%26aufirst%3DL.%2BM.%26aulast%3DCassidy%26aufirst%3DK.%2BC.%26atitle%3DDisposition%2520and%2520Metabolism%2520of%2520Ly2603618%252C%2520a%2520Chk-1%2520Inhibitor%2520Following%2520Intravenous%2520Administration%2520in%2520Patients%2520with%2520Advanced%2520and%252For%2520Metastatic%2520Solid%2520Tumors%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26issue%3D9%26spage%3D827%26epage%3D841%26doi%3D10.3109%2F00498254.2014.900589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adusumalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamwal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leggio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhlaghi, F.</span></span> <span> </span><span class="NLM_article-title">Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist Pf-5190457: A Reverse Translational Bed-to-Bench Approach</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1124/dmd.119.087015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.119.087015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=31182423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSgtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=874-882&issue=8&author=S.+Adusumalliauthor=R.+Jamwalauthor=R.+S.+Obachauthor=T.+F.+Ryderauthor=L.+Leggioauthor=F.+Akhlaghi&title=Role+of+Molybdenum-Containing+Enzymes+in+the+Biotransformation+of+the+Novel+Ghrelin+Receptor+Inverse+Agonist+Pf-5190457%3A+A+Reverse+Translational+Bed-to-Bench+Approach&doi=10.1124%2Fdmd.119.087015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Role of molybdenum-containing enzymes in the biotransformation of the novel ghrelin receptor inverse agonist PF-5190457: a reverse translational bed-to-bench approach</span></div><div class="casAuthors">Adusumalli, Sravani; Jamwal, Rohitash; Obach, R. Scott; Ryder, Tim F.; Leggio, Lorenzo; Akhlaghi, Fatemeh</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">874-882</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(R)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)-1-(2-(5-(6-methylpyrimidin- 4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonan-7-yl)ethan- 1-one (PF-5190457) was identified as a potent and selective inverse agonist of the ghrelin receptor [growth hormone secretagogue receptor 1a (GHS-R1a)].  The present translational bed-to-bench work characterizes the biotransformation of this compd. in vivo and then further explores in vitro metab. in fractions of human liver and primary hepatocytes.  Following oral administration of PF-5190457 in a phase 1b clin. study, hydroxyl metabolites of the compd. were obsd., including one that had not been obsd. in previously performed human liver microsomal incubations.  PF-6870961 or (R)-1-(2-(5-(2-hydroxy-6-methylpyrimidin- 4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonan-7-yl)-2- (2-methylimidazo[2,1-b]thiazol-6-yl)ethan-1-one was biosynthesized using liver cytosol, and the site of hydroxylation was shown to be on the pyrimidine using NMR spectroscopy.  The aldehyde oxidase (AO) inhibitor raloxifene and the xanthine oxidase inhibitor febuxostat inhibited the formation of PF-6870961 in human liver cytosol, suggesting both enzymes were involved in the metab. of the drug.  However, greater inhibition was obsd. with raloxifene, indicating AO is a dominant enzyme in the biotransformation.  The intrinsic clearance of the drug in human liver cytosol was estd. to be 0.002 mL/min per mg protein.  This study provides important novel information at three levels: 1) it provides addnl. new information on the recently developed novel compd. PF-5190457, the first GHS-R1a blocker that has moved to development in humans; 2) it provides an example of a reverse translational approach where a discovery in humans was brought back, validated, and further investigated at the bench level; and 3) it demonstrates the importance of considering the molybdenumcontaining oxidases during the development of new drug entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS5C1istD71LVg90H21EOLACvtfcHk0liQzcznaWYgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSgtr7I&md5=c23536428f968c1479374385a5f7b185</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1124%2Fdmd.119.087015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.119.087015%26sid%3Dliteratum%253Aachs%26aulast%3DAdusumalli%26aufirst%3DS.%26aulast%3DJamwal%26aufirst%3DR.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DLeggio%26aufirst%3DL.%26aulast%3DAkhlaghi%26aufirst%3DF.%26atitle%3DRole%2520of%2520Molybdenum-Containing%2520Enzymes%2520in%2520the%2520Biotransformation%2520of%2520the%2520Novel%2520Ghrelin%2520Receptor%2520Inverse%2520Agonist%2520Pf-5190457%253A%2520A%2520Reverse%2520Translational%2520Bed-to-Bench%2520Approach%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2019%26volume%3D47%26issue%3D8%26spage%3D874%26epage%3D882%26doi%3D10.1124%2Fdmd.119.087015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">1303</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.068338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.115.068338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26936972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1296-1303&issue=8&author=R.+D.+Crouchauthor=R.+D.+Morrisonauthor=F.+W.+Byersauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=J.+S.+Daniels&title=Evaluating+the+Disposition+of+a+Mixed+Aldehyde+Oxidase%2FCytochrome+P450+Substrate+in+Rats+with+Attenuated+P450+Activity&doi=10.1124%2Fdmd.115.068338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating the disposition of a mixed aldehyde oxidase/cytochrome P450 substrate in rats with attenuated P450 activity</span></div><div class="casAuthors">Crouch, Rachel D.; Morrison, Ryan D.; Byers, Frank W.; Lindsley, Craig W.; Emmitte, Kyle A.; Daniels, J. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1296-1303</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Marketed drugs cleared by aldehyde oxidase (AO) are few, with no known clin. relevant pharmacokinetic drug interactions assocd. with AO inhibition, whereas cytochrome P 450 (P 450) inhibition or induction mediates a no. of clin. drug interactions.  Little attention has been given to the consequences of coadministering a P 450 inhibitor with a compd. metabolized by both AO and P 450.  Upon discovering that VU0409106 (1) was metabolized by AO (to M1) and P 450 enzymes (to M4-M6), we sought to evaluate the in vivo disposition of 1 and its metabolites in rats with attenuated P 450 activity.  Male rats were orally pretreated with the pan-P 450 inactivator, 1-aminobenzotriazole (ABT), before an i.p. dose of 1.  Interestingly, the plasma area under the curve (AUC) of M1 was increased 15-fold in ABT-treated rats, indicating a metabolic shunt toward AO resulted from the drug interaction condition.  The AUC of 1 also increased 7.8- fold.  Accordingly, plasma clearance of 1 decreased from 53.5 to 15.3 mL/min per kilogramin ABT-pretreated rats receiving an i.v. dose of 1.  Consistentwith these data,M1 formation in hepatic S9 increased with NADPH-exclusion to eliminate P 450 activity (50% over reactions contg. NADPH).  These studies reflect possible consequences of a drug interaction between P 450 inhibitors and compds. cleared by both AO and P 450 enzymes.  Notably, increased exposure to an AO metabolite may hold clin. relevance for active metabolites or those mediating toxicity at elevated concns.  The recent rise in clin. drug candidates metabolized by AO underscores the importance of these findings and the need for clin. studies to fully understand these risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof5dGfI2A47bVg90H21EOLACvtfcHk0liIRvezBxtSSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurrK&md5=a8435edfa1bba3e71112e468d731d76f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.068338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.068338%26sid%3Dliteratum%253Aachs%26aulast%3DCrouch%26aufirst%3DR.%2BD.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DEvaluating%2520the%2520Disposition%2520of%2520a%2520Mixed%2520Aldehyde%2520Oxidase%252FCytochrome%2520P450%2520Substrate%2520in%2520Rats%2520with%2520Attenuated%2520P450%2520Activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1296%26epage%3D1303%26doi%3D10.1124%2Fdmd.115.068338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing Mglu5-Negative Allosteric Modulator Vu0424238 (Auglurant)</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1259</span>, <span class="refDoi"> DOI: 10.1124/dmd.117.077552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.117.077552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28939686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVansL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=1245-1259&issue=12&author=R.+D.+Crouchauthor=A.+L.+Blobaumauthor=A.+S.+Feltsauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Species-Specific+Involvement+of+Aldehyde+Oxidase+and+Xanthine+Oxidase+in+the+Metabolism+of+the+Pyrimidine-Containing+Mglu5-Negative+Allosteric+Modulator+Vu0424238+%28Auglurant%29&doi=10.1124%2Fdmd.117.077552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Species-specific involvement of aldehyde oxidase and xanthine oxidase in the metabolism of the pyrimidine-containing mGlu5-negative allosteric modulator VU0424238 (auglurant)</span></div><div class="casAuthors">Crouch, Rachel D.; Blobaum, Anna L.; Felts, Andrew S.; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1245-1259</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) and xanthine oxidase (XO) are molybdo-flavoenzymes that catalyze oxidn. of arom. azaheterocycles.  Differences in AO activity have been reported among various species, including rats, humans, and monkeys.  Herein we report a species difference in the enzymes responsible for the metab. of the neg. allosteric modulator of metabotropic glutamate receptor subtype 5 (mGlu5 NAM) VU0424238 (VU238, auglurant).  Hepatic S9 incubations with AO and XO specific inhibitors hydralazine and allopurinol indicated that rats and cynomolgus monkeys both oxidized VU238 to the 6-oxopyrimidine metabolite M1 via an AO-mediated pathway, whereas secondary oxidn. to the 2,6-dioxopyrimidine metabolite M2 was mediated predominantly by AO in monkeys and XO in rats.  Despite differences in enzymic pathways, intrinsic clearance (CLint) of M1 was similar between species (cynomolgus and rat CLint = 2.00 ± 0.040 and 2.19 ± 0.201 μl/min per mg of protein, resp.).  Inhibitor studies in the S9 of multiple species indicated that oxidn. of VU238 to M1 was mediated predominantly by AO in humans, cynomolgus and rhesus monkeys, rats, mice, guinea pigs, and minipigs.  Oxidn. of M1 to M2 was mediated predominantly by XO in rats and mice and by AO in monkeys and guinea pigs, whereas low turnover prevented enzyme phenotyping in humans and minipigs.  Addnl., inhibitor expts. indicated that oxidn. at the 2-position of the pyrimidine ring of the known AO substrate, BIBX1382, was mediated by AO in all species, although prodn. of this metabolite was comparatively low in rats and mice.  These data may suggest low reactivity of rat AO toward 2-oxidn. of pyrimidine-contg. compds. and highlight the importance of thoroughly characterizing AO-metabolized drug candidates in multiple preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVGvcWaoRLN7Vg90H21EOLACvtfcHk0liIRvezBxtSSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVansL8%253D&md5=5d60074965ff047ad77a1e4619db143d</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1124%2Fdmd.117.077552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.117.077552%26sid%3Dliteratum%253Aachs%26aulast%3DCrouch%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSpecies-Specific%2520Involvement%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidase%2520in%2520the%2520Metabolism%2520of%2520the%2520Pyrimidine-Containing%2520Mglu5-Negative%2520Allosteric%2520Modulator%2520Vu0424238%2520%2528Auglurant%2529%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2017%26volume%3D45%26issue%3D12%26spage%3D1245%26epage%3D1259%26doi%3D10.1124%2Fdmd.117.077552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klecker, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cysyk, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. M.</span></span> <span> </span><span class="NLM_article-title">Zebularine Metabolism by Aldehyde Oxidase in Hepatic Cytosol from Humans, Monkeys, Dogs, Rats, and Mice: Influence of Sex and Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmc.2005.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16143537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1egsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=62-66&issue=1&author=R.+W.+Kleckerauthor=R.+L.+Cysykauthor=J.+M.+Collins&title=Zebularine+Metabolism+by+Aldehyde+Oxidase+in+Hepatic+Cytosol+from+Humans%2C+Monkeys%2C+Dogs%2C+Rats%2C+and+Mice%3A+Influence+of+Sex+and+Inhibitors&doi=10.1016%2Fj.bmc.2005.07.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: Influence of sex and inhibitors</span></div><div class="casAuthors">Klecker, Raymond W.; Cysyk, Richard L.; Collins, Jerry M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-66</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To aid in the clin. evaluation of zebularine, a potential oral antitumor agent, we initiated studies on the metab. of zebularine in liver cytosol from humans and other mammals.  Metab. by aldehyde oxidase (AO, EC 1.2.3.1) was the major catabolic route, yielding uridine as the primary metabolite, which was metabolized further to uracil by uridine phosphorylase.  The inhibition of zebularine metab. was studied using raloxifene, a known potent inhibitor of AO, and 5-benzylacyclouridine (BAU), a previously undescribed inhibitor of AO.  The Michaelis-Menten kinetics of aldehyde oxidase and its inhibition by raloxifene and BAU were highly variable between species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3KI53bTnEBbVg90H21EOLACvtfcHk0liIRvezBxtSSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1egsLjP&md5=73ead144a54a542635ec99008699688f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DKlecker%26aufirst%3DR.%2BW.%26aulast%3DCysyk%26aufirst%3DR.%2BL.%26aulast%3DCollins%26aufirst%3DJ.%2BM.%26atitle%3DZebularine%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%2520in%2520Hepatic%2520Cytosol%2520from%2520Humans%252C%2520Monkeys%252C%2520Dogs%252C%2520Rats%252C%2520and%2520Mice%253A%2520Influence%2520of%2520Sex%2520and%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26issue%3D1%26spage%3D62%26epage%3D66%26doi%3D10.1016%2Fj.bmc.2005.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasaki, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masubuchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span> <span> </span><span class="NLM_article-title">Species Differences in Enantioselective 2-Oxidations of Rs-8359, a Selective and Reversible Mao-a Inhibitor, and Cinchona Alkaloids by Aldehyde Oxidase</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1002/bdd.494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fbdd.494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16400710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28XktlGhu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=133-139&issue=3&author=K.+Itohauthor=M.+Yamamuraauthor=W.+Takasakiauthor=T.+Sasakiauthor=A.+Masubuchiauthor=Y.+Tanaka&title=Species+Differences+in+Enantioselective+2-Oxidations+of+Rs-8359%2C+a+Selective+and+Reversible+Mao-a+Inhibitor%2C+and+Cinchona+Alkaloids+by+Aldehyde+Oxidase&doi=10.1002%2Fbdd.494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase</span></div><div class="casAuthors">Itoh, Kunio; Yamamura, Mayumi; Takasaki, Wataru; Sasaki, Takamitsu; Masubuchi, Akiko; Tanaka, Yorihisa</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-139</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The 2-oxidn. activity on the pyrimidine ring of RS-8359, a MAO-A inhibitor, is the major metabolic pathway catalyzed by aldehyde oxidase.  This study investigated the species differences in the 2-oxidn. activity by liver cytosolic fractions from rats, mice, guinea-pigs, rabbits, dogs, monkeys, and humans.  The Vmax/Km value for the (S)-enantiomer of RS-8359 was extremely high in monkeys and humans, moderate in guinea-pigs, and low in rats and mice.  Dogs were deficient in 2-oxidn. activity.  The (R)-enantiomer was only oxidized at a very low rate in guinea-pigs, monkeys, and humans, and not oxidized in rats, mice, and rabbits.  Thus, marked species differences and enantioselectivity were obvious for the 2-oxidn. of the (S)-enantiomer of RS-8359.  The in vitro results were in good accordance with previously reported in vivo excretion data of the 2-keto metabolite and the non-detectable blood plasma concns. of the (S)-enantiomer in monkeys and humans after administration of racemic RS-8359.  Enantioselectivity was also obsd. for the oxidn. of cinchona alkaloids catalyzed by aldehyde oxidase.  Among the 4 cinchona alkaloids studied, the oxidn. activity of cinchonidine, which has no substituents at the 6-hydroxy group but bears (8S,9R)-configurations, was highest.  As opposed to the (S)-enantiomer, an extremely high catalytic activity of cinchonidine was confirmed in rabbits, but not in monkeys or humans.  Rabbit liver aldehyde oxidase was suggested to have characteristic properties around the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIB8y7bWsMdLVg90H21EOLACvtfcHk0liudtnikqiuTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktlGhu7c%253D&md5=064c2f816decbfe6ea01debdf3f7afb7</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fbdd.494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.494%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DM.%26aulast%3DTakasaki%26aufirst%3DW.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DMasubuchi%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DSpecies%2520Differences%2520in%2520Enantioselective%25202-Oxidations%2520of%2520Rs-8359%252C%2520a%2520Selective%2520and%2520Reversible%2520Mao-a%2520Inhibitor%252C%2520and%2520Cinchona%2520Alkaloids%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2006%26volume%3D27%26issue%3D3%26spage%3D133%26epage%3D139%26doi%3D10.1002%2Fbdd.494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masubuchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span> <span> </span><span class="NLM_article-title">Stereospecific Oxidation of the (S)-Enantiomer of Rs-8359, a Selective and Reversible Monoamine Oxidase a (Mao-a) Inhibitor, by Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1080/00498250500202106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498250500202106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16192108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWitLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=561-573&issue=6&author=K.+Itohauthor=M.+Yamamuraauthor=S.+Muramatsuauthor=K.+Hoshinoauthor=A.+Masubuchiauthor=T.+Sasakiauthor=Y.+Tanaka&title=Stereospecific+Oxidation+of+the+%28S%29-Enantiomer+of+Rs-8359%2C+a+Selective+and+Reversible+Monoamine+Oxidase+a+%28Mao-a%29+Inhibitor%2C+by+Aldehyde+Oxidase&doi=10.1080%2F00498250500202106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase</span></div><div class="casAuthors">Itoh, K.; Yamamura, M.; Muramatsu, S.; Hoshino, K.; Masubuchi, A.; Sasaki, T.; Tanaka, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">561-573</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">In a previous paper by the authors on RS-8359, a new selective and reversible monoamine oxidase A (MAO-A) inhibitor, it was reported that the (S)-enantiomer of RS-8359 is rapidly eliminated from rats, monkeys and humans as a result of the formation of a 2-oxidative metabolite.  The present study investigates the properties of the enzyme responsible for the 2-oxidn. of RS-8359.  Subcellular localization, cofactor requirement and the inhibitory effects of typical compds. were studied using rat liver prepns.  In addn., the enzyme was purified from rat liver cytosol for further characterization.  The enzyme activity was localized in the cytosolic fraction without the need for any cofactor and was extensively inhibited by menadione, chlorpromazine and quinacrine.  The purified enzyme was also a homodimer with a monomeric mol. wt. of 140 kDa and it had an A280/A450 ratio of 5.1 in the absorption spectrum.  The results suggest that the enzyme responsible for the biotransformation of RS-8359 to give the 2-keto deriv. is aldehyde oxidase (EC 1.2.3.1).  The reaction of aldehyde oxidase is highly stereoselective for the (S)-configuration of RS-8359 and the (9R)-configuration of cinchona alkaloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvGEK_uJKiTrVg90H21EOLACvtfcHk0liudtnikqiuTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWitLbF&md5=22611faf87ab18a56761afceaa02f666</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1080%2F00498250500202106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250500202106%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DM.%26aulast%3DMuramatsu%26aufirst%3DS.%26aulast%3DHoshino%26aufirst%3DK.%26aulast%3DMasubuchi%26aufirst%3DA.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DStereospecific%2520Oxidation%2520of%2520the%2520%2528S%2529-Enantiomer%2520of%2520Rs-8359%252C%2520a%2520Selective%2520and%2520Reversible%2520Monoamine%2520Oxidase%2520a%2520%2528Mao-a%2529%2520Inhibitor%252C%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2005%26volume%3D35%26issue%3D6%26spage%3D561%26epage%3D573%26doi%3D10.1080%2F00498250500202106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolarek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loi, C. M.</span></span> <span> </span><span class="NLM_article-title">Cross-Species Comparison of the Metabolism and Excretion of Zoniporide: Contribution of Aldehyde Oxidase to Interspecies Differences</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.030783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.109.030783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=20040581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOgsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=641-654&issue=4&author=D.+Dalvieauthor=C.+Zhangauthor=W.+Chenauthor=T.+Smolarekauthor=R.+S.+Obachauthor=C.+M.+Loi&title=Cross-Species+Comparison+of+the+Metabolism+and+Excretion+of+Zoniporide%3A+Contribution+of+Aldehyde+Oxidase+to+Interspecies+Differences&doi=10.1124%2Fdmd.109.030783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences</span></div><div class="casAuthors">Dalvie, Deepak; Zhang, Chenghong; Chen, Weichao; Smolarek, Teresa; Obach, R. Scott; Loi, Cho-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-654</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Excretion and metab. of zoniporide were investigated in humans after i.v. infusion of [14C]zoniporide at an 80-mg dose.  Bile was the primary route of excretion because 57% of dose was recovered in the feces after i.v. infusion.  Zoniporide was primarily cleared via metab. in humans.  2-Oxozoniporide (M1) was the major excretory and circulating metabolite in humans and was catalyzed by aldehyde oxidase (Km of 3.4 μM and Vmax of 74 pmol/min/mg protein).  Metabolites M2 (17% of the dose) and M3 (6.4% of circulating radioactivity), in which the guanidine moiety was hydrolyzed to a carboxylic acid, were also detected in human feces and plasma, resp., suggesting that hydrolysis was another route of metab. of zoniporide in humans.  The metab. and excretion of [14C]zoniporide in rats and dogs were also evaluated.  As in humans, bile was the primary route of excretion of the radiolabeled material in both species, and metab. was the primary route of clearance.  A comparison of plasma metabolites showed that for M3, rats had a higher concn. than human or dog.  M1 was absent in dog and present in human and rat plasma at comparable levels, whereas comparison of excreta showed that the total body burden of M1 was greater in rat than that in human.  No further evaluation of M2 was considered because it was detected only in the human fecal exts.  Hence, no further toxicol. evaluation of the three human metabolites was undertaken.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogaZ5SY2KDrbVg90H21EOLACvtfcHk0liudtnikqiuTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOgsrnK&md5=0a9ab410a5296bc500b3a37133def090</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.030783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.030783%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSmolarek%26aufirst%3DT.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DLoi%26aufirst%3DC.%2BM.%26atitle%3DCross-Species%2520Comparison%2520of%2520the%2520Metabolism%2520and%2520Excretion%2520of%2520Zoniporide%253A%2520Contribution%2520of%2520Aldehyde%2520Oxidase%2520to%2520Interspecies%2520Differences%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D4%26spage%3D641%26epage%3D654%26doi%3D10.1124%2Fdmd.109.030783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padilha, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKew, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peccinini, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Application of in Vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (Fop)</span>. <i>Front Pharmacol</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">234</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3389%2Ffphar.2019.00234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=31068801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3M7jslymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=234&author=E.+C.+Padilhaauthor=J.+Wangauthor=E.+Kernsauthor=A.+Leeauthor=W.+Huangauthor=J.+K.+Jiangauthor=J.+McKewauthor=A.+Mutlibauthor=R.+G.+Peccininiauthor=P.+B.+Yuauthor=P.+Sandersonauthor=X.+Xu&title=Application+of+in+Vitro+Drug+Metabolism+Studies+in+Chemical+Structure+Optimization+for+the+Treatment+of+Fibrodysplasia+Ossificans+Progressiva+%28Fop%29&doi=10.3389%2Ffphar.2019.00234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)</span></div><div class="casAuthors">Padilha Elias C; Kerns Ed; Lee Arthur; Huang Wenwei; Jiang Jian-Kang; McKew John; Sanderson Philip; Xu Xin; Padilha Elias C; Peccinini Rosangela G; Wang Jianyao; Wang Jianyao; Mutlib Abdul; Yu Paul B</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Currently no approved treatment exists for fibrodysplasia ossificans progressiva (FOP) patients, and disease progression results in severe restriction of joint function and premature mortality.  LDN-193189 has been demonstrated to be efficacious in a mouse FOP disease model after oral administration.  To support species selection for drug safety evaluation and to guide structure optimization for back-up compounds, in vitro metabolism of LDN-193189 was investigated in liver microsome and cytosol fractions of mouse, rat, dog, rabbit, monkey and human.  Metabolism studies included analysis of reactive intermediate formation using glutathione and potassium cyanide (KCN) and analysis of non-P450 mediated metabolites in cytosol fractions of various species.  Metabolite profiles and metabolic soft spots of LDN-193189 were elucidated using LC/UV and mass spectral techniques.  The in vitro metabolism of LDN-193189 was significantly dependent on aldehyde oxidase, with formation of the major NIH-Q55 metabolite.  The piperazinyl moiety of LDN-193189 was liable to NADPH-dependent metabolism which generated reactive iminium intermediates, as confirmed through KCN trapping experiments, and aniline metabolites (M337 and M380), which brought up potential drug safety concerns.  Subsequently, strategies were employed to avoid metabolic liabilities leading to the synthesis of Compounds 1, 2, and 3.  This study demonstrated the importance of metabolite identification for the discovery of novel and safe drug candidates for the treatment of FOP and helped medicinal chemists steer away from potential metabolic liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ95Ts_1DsHYpdYoSR9eyvsfW6udTcc2ebOGFbKLgKrk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7jslymtQ%253D%253D&md5=d207950bcb621c76cc2239b79da23008</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00234%26sid%3Dliteratum%253Aachs%26aulast%3DPadilha%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKerns%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DJ.%2BK.%26aulast%3DMcKew%26aufirst%3DJ.%26aulast%3DMutlib%26aufirst%3DA.%26aulast%3DPeccinini%26aufirst%3DR.%2BG.%26aulast%3DYu%26aufirst%3DP.%2BB.%26aulast%3DSanderson%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DApplication%2520of%2520in%2520Vitro%2520Drug%2520Metabolism%2520Studies%2520in%2520Chemical%2520Structure%2520Optimization%2520for%2520the%2520Treatment%2520of%2520Fibrodysplasia%2520Ossificans%2520Progressiva%2520%2528Fop%2529%26jtitle%3DFront%2520Pharmacol%26date%3D2019%26volume%3D10%26spage%3D234%26doi%3D10.3389%2Ffphar.2019.00234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Xenobiotics by Aldehyde Oxidase</span>. <i>Curr. Protoc Toxicol</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4.41.1</span>– <span class="NLM_lpage">4.41.13</span>, <span class="refDoi"> DOI: 10.1002/0471140856.tx0441s63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2F0471140856.tx0441s63" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=4.41.1-4.41.13&author=D.+Dalvieauthor=M.+Zientek&title=Metabolism+of+Xenobiotics+by+Aldehyde+Oxidase&doi=10.1002%2F0471140856.tx0441s63"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2F0471140856.tx0441s63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471140856.tx0441s63%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DZientek%26aufirst%3DM.%26atitle%3DMetabolism%2520of%2520Xenobiotics%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DCurr.%2520Protoc%2520Toxicol%26date%3D2015%26volume%3D63%26spage%3D4.41.1%26epage%3D4.41.13%26doi%3D10.1002%2F0471140856.tx0441s63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shardlow, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thewlis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayrton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of the Novel, High-Affinity and Selective Dopamine D3 Receptor Antagonist Sb-277011 in Rat, Dog and Monkey: In Vitro/in Vivo Correlation and the Role of Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">8−9</span>),  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1080/00498250110056531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498250110056531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=11569533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvF2ltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=677-686&issue=8%E2%88%929&author=N.+E.+Austinauthor=S.+J.+Baldwinauthor=L.+Cutlerauthor=N.+Deeksauthor=P.+J.+Kellyauthor=M.+Nashauthor=C.+E.+Shardlowauthor=G.+Stempauthor=K.+Thewlisauthor=A.+Ayrtonauthor=P.+Jeffrey&title=Pharmacokinetics+of+the+Novel%2C+High-Affinity+and+Selective+Dopamine+D3+Receptor+Antagonist+Sb-277011+in+Rat%2C+Dog+and+Monkey%3A+In+Vitro%2Fin+Vivo+Correlation+and+the+Role+of+Aldehyde+Oxidase&doi=10.1080%2F00498250110056531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog, and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase</span></div><div class="casAuthors">Austin, N. E.; Baldwin, S. J.; Cutler, L.; Deeks, N.; Kelly, P. J.; Nash, M.; Shardlow, C. E.; Stemp, G.; Thewlis, K.; Ayrton, A.; Jeffrey, P.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8/9</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. In vitro studies with the selective dopamine D3 receptor antagonist SB-277011 were conducted in liver microsomes and homogenates from rat, dog, cynomolgus monkey, and human to correlate the rate of metab. with the in vivo pharmacokinetics of the compd. in rat, dog, and cynomolgus monkey.  2. In the presence of NADPH, SB-277011 was relatively stable in the presence of liver microsomes from rat, dog, cynomolgus monkey, and human with an intrinsic clearance (CLi) of < 2 mL min-1 g-1 liver for all species.  In total liver homogenates, SB-277011 was metabolized at a similar rate in rat and dog (CLi < 2 mL min-1 g-1 liver) to that in liver microsomes but in cynomolgus monkey and human (CLi = 9.9 and 45 mL min-1 g-1 liver, resp.) the intrinsic clearance was ∼6- and 35-fold higher, resp., than that in liver microsomes.  3. In the absence of NADPH, SB-277011 was rapidly cleared in liver homogenates from cynomolgus monkey and human (CLi = 7.4 and 27 mL min-1 g-1 liver, resp.) demonstrating that a significant pathway of metab. of this compd. was via an NADPH-independent non-microsomal oxidative route.  This pathway was sensitive to inhibition with isovanillin suggesting that the enzyme responsible was aldehyde oxidase.  4. The in vivo pharmacokinetics showed that the plasma clearance of SB-277011 was low in rat (20 mL min-1 kg-1), moderate in dog (14 mL min-1 kg-1) and high in cynomolgus monkey (58 mL min-1 kg-1), which is consistent with the in vitro findings and demonstrated a greater capacity for the monkey to metabolize this compd.  The oral bioavailability of SB-277011 in rat, dog, and cynomolgus monkey was 35, 43 and 2%, resp.  Given the high clearance of this compd. in cynomolgus monkey, the low oral bioavailability is probably as a result of high 1st-pass elimination, specifically by aldehyde oxidase, rather than poor absorption.  5. The high in vitro clearance of SB-277011 in human liver homogenates and the involvement of aldehyde oxidase in the metab. of SB-277011 indicates that the bioavailability of the compd. is likely to be low in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRX0OtLzrYkbVg90H21EOLACvtfcHk0liKL5U3e4ylfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvF2ltL4%253D&md5=c7795b7b9bdd0a71b64de549a4622199</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1080%2F00498250110056531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250110056531%26sid%3Dliteratum%253Aachs%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBaldwin%26aufirst%3DS.%2BJ.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DP.%2BJ.%26aulast%3DNash%26aufirst%3DM.%26aulast%3DShardlow%26aufirst%3DC.%2BE.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%26aulast%3DAyrton%26aufirst%3DA.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520of%2520the%2520Novel%252C%2520High-Affinity%2520and%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonist%2520Sb-277011%2520in%2520Rat%252C%2520Dog%2520and%2520Monkey%253A%2520In%2520Vitro%252Fin%2520Vivo%2520Correlation%2520and%2520the%2520Role%2520of%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2001%26volume%3D31%26issue%3D8%25E2%2588%25929%26spage%3D677%26epage%3D686%26doi%3D10.1080%2F00498250110056531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. Y. J.</span></span> <span> </span><span class="NLM_article-title">Metabolism of C-Met Kinase Inhibitors Containing Quinoline by Aldehyde Oxidase, Electron Donating and Steric Hindrance Effect</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1855</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.081919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.118.081919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30209037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1Onsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=1847-1855&issue=12&author=J.+W.+Zhangauthor=W.+Xiaoauthor=Z.+T.+Gaoauthor=Z.+T.+Yuauthor=J.+Y.+J.+Zhang&title=Metabolism+of+C-Met+Kinase+Inhibitors+Containing+Quinoline+by+Aldehyde+Oxidase%2C+Electron+Donating+and+Steric+Hindrance+Effect&doi=10.1124%2Fdmd.118.081919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of c-Met kinase inhibitors containing quinoline by aldehyde oxidase, electron donating, and steric hindrance effect</span></div><div class="casAuthors">Zhang, Jiang Wei; Xiao, Wen; Gao, Zhen Ting; Yu, Zheng Tian; Zhang, Ji Yue Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1847-1855</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Some quinoline-contg. c-Met kinase inhibitors are aldehyde oxidase (AO) substrates. 3-Substituted quinoline triazolopyridine analogs were synthesized to understand the electron-donating and steric hindrance effects on AO-mediated metab.  Metabolic stability studies for these quinoline analogs were carried out in liver cytosol from mice, rats, cynomolgus monkeys, and humans.  Several 3-N-substituted analogs were found to be unstable in monkey liver cytosolic incubations (half-life, <10 min), and five of them (63, 53, 51, 11, and 71) were chosen for addnl. mechanistic studies.  Mono-oxygenation on the quinoline ring was identified by liq. chromatog. tandem mass spectrometry.  Metabolite formation was inhibited by the AO inhibitors menadione and raloxifene, but not by the xanthine oxidase inhibitor allopurinol.  It was found that small electron-donating groups at the 3-quinoline moiety made the analogs more susceptible to AO metab., whereas large 3-substituents could reverse the trend.  Although species differences were obsd., this trend was applicable to all species tested.  Small electron-donating substituents at the 3-quinoline moiety increased both affinity (decreased Michaelis const.) and Vmax max. velocity toward AO in kinetic studies, whereas large substituents decreased both parameters probably as a result of steric hindrance.  Based on our anal., a common structural feature with high AO liability was proposed.  Our finding could provide useful information for chemists to minimize potential AO liability when designing quinoline analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkGiQQGWoG1bVg90H21EOLACvtfcHk0liKL5U3e4ylfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1Onsbk%253D&md5=87b1321378c2b70c2e2490e23263b3fa</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.081919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.081919%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BW.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DZ.%2BT.%26aulast%3DYu%26aufirst%3DZ.%2BT.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%2BJ.%26atitle%3DMetabolism%2520of%2520C-Met%2520Kinase%2520Inhibitors%2520Containing%2520Quinoline%2520by%2520Aldehyde%2520Oxidase%252C%2520Electron%2520Donating%2520and%2520Steric%2520Hindrance%2520Effect%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26issue%3D12%26spage%3D1847%26epage%3D1855%26doi%3D10.1124%2Fdmd.118.081919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Deuterium-Labeled Jnj38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1218</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.8b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.8b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVChtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=1213-1218&issue=11&author=Z.+Zhanauthor=X.+Pengauthor=Y.+Sunauthor=J.+Aiauthor=W.+Duan&title=Evaluation+of+Deuterium-Labeled+Jnj38877605%3A+Pharmacokinetic%2C+Metabolic%2C+and+in+Vivo+Antitumor+Profiles&doi=10.1021%2Facs.chemrestox.8b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Deuterium-Labeled JNJ38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles</span></div><div class="casAuthors">Zhan, Zhengsheng; Peng, Xia; Sun, Yiming; Ai, Jing; Duan, Wenhu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1213-1218</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C-Met inhibitor JNJ38877605 has proven curative as an antitumor agent, while its clin. study was terminated due to renal toxicity.  It was reported that the renal toxicity was caused by the poor soly. of its aldehyde oxidase (AO) metabolites.  Therefore, blocking AO oxidn. of JNJ38877605 might diminish the toxic metabolites and overcome the renal toxicity.  Compd. 3, the AO metabolic site deuterated JNJ38877605, was then synthesized as the target mol.  In vitro monkey liver S9 fraction incubation of 3 manifested that the renal toxic metabolite M2-2 was significantly reduced, which connoted that this deuteration has partly blocked AO oxidn.  After po. nasal gavage to cynomolgus monkeys, compd. 3 revealed decreased AO metabolites M2-2 and M3-2 in the plasma as well as 1.88-fold AUC and 1.56-fold Cmax compared with JNJ38877605, indicating that deuterium replacement significantly blocked AO metab. in vivo.  Besides, metabolic profiles of 3 were investigated by anal. of the plasma and the urine of the po. administrated cynomolgus monkeys.  Moreover, after oral administration to the EBC-1 tumor-bearing nude mice, compd. 3 exhibited a better antitumor efficacy than JNJ38877605.  In conclusion, deuteration on the AO metabolic site of JNJ38877605 improved its AO metab., oral exposure, as well as in vivo antitumor efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbsjIia0zdsbVg90H21EOLACvtfcHk0liKL5U3e4ylfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVChtrbM&md5=a9e66686424cd885998b17b603827313</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.8b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.8b00191%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DW.%26atitle%3DEvaluation%2520of%2520Deuterium-Labeled%2520Jnj38877605%253A%2520Pharmacokinetic%252C%2520Metabolic%252C%2520and%2520in%2520Vivo%2520Antitumor%2520Profiles%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26issue%3D11%26spage%3D1213%26epage%3D1218%26doi%3D10.1021%2Facs.chemrestox.8b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase Mediated Metabolism in Drug-Like Molecules: A Combined Computational and Experimental Study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2973</span>– <span class="NLM_lpage">2982</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjslyitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2973-2982&issue=7&author=Y.+Xuauthor=L.+Liauthor=Y.+Wangauthor=J.+Xingauthor=L.+Zhouauthor=D.+Zhongauthor=X.+Luoauthor=H.+Jiangauthor=K.+Chenauthor=M.+Zhengauthor=P.+Dengauthor=X.+Chen&title=Aldehyde+Oxidase+Mediated+Metabolism+in+Drug-Like+Molecules%3A+A+Combined+Computational+and+Experimental+Study&doi=10.1021%2Facs.jmedchem.7b00019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: A Combined Computational and Experimental Study</span></div><div class="casAuthors">Xu, Yuan; Li, Liang; Wang, Yulan; Xing, Jing; Zhou, Lei; Zhong, Dafang; Luo, Xiaomin; Jiang, Hualiang; Chen, Kaixian; Zheng, Mingyue; Deng, Pan; Chen, Xiaoyan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2973-2982</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is an important drug-metabolizing enzyme.  However, the current in vitro models for evaluating AOX metab. are sometimes misleading, and preclin. animal models generally fail to predict human AOX-mediated metab.  In this study, the authors report a combined computational and exptl. investigation of drug-like mols. that are potential aldehyde oxidase substrates, of which multiple sites of metab. (SOMs) mediated by AOX and their preferences for the reaction can be unambiguously identified.  In addn., the proposed strategy was used to evaluate the metab. of newly designed c-Met inhibitors, and a success switch-off of AOX metab. was obsd.  Overall, this study provide useful information to guide lead optimization and drug discovery based on AOX-mediated metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPvn1B_ge-grVg90H21EOLACvtfcHk0lileM5zo1pscA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjslyitLc%253D&md5=2cb27d8a575dacef529f20cfe32cf8dc</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00019%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DAldehyde%2520Oxidase%2520Mediated%2520Metabolism%2520in%2520Drug-Like%2520Molecules%253A%2520A%2520Combined%2520Computational%2520and%2520Experimental%2520Study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D7%26spage%3D2973%26epage%3D2982%26doi%3D10.1021%2Facs.jmedchem.7b00019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, H.</span></span> <span> </span><span class="NLM_article-title">Species Differences in Metabolism of Ripasudil (K-115) Are Attributed to Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.3109/00498254.2015.1096981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2015.1096981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26678038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGgtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2016&pages=579-590&author=T.+Isobeauthor=M.+Ohtaauthor=Y.+Kanekoauthor=H.+Kawai&title=Species+Differences+in+Metabolism+of+Ripasudil+%28K-115%29+Are+Attributed+to+Aldehyde+Oxidase&doi=10.3109%2F00498254.2015.1096981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase</span></div><div class="casAuthors">Isobe, Tomoyuki; Ohta, Masayuki; Kaneko, Yoshio; Kawai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. We examd. the metab. of ripasudil (K-115), a selective and potent Rho-assocd. coiled coil-contg. protein kinase (ROCK) inhibitor, by in vitro and in vivo studies.2.  First, we identified metabolites and metabolic enzymes involved in ripasudil metab.  Species differences were obsd. in metabolic clearance and profiles of metabolites in liver S9 fraction and hepatocytes.  In addn., ripasudil was metabolised in humans and monkey S9 without NADP (NADPH).  Studies using specific inhibitors and human recombinant enzyme systems showed that M1 (main metabolite in humans) formation is mediated by aldehyde oxidase (AO).3.  Therefore, we developed ripasudil as an ophthalmic agent.  First, we compared the pharmacokinetic profiles of ripasudil in humans and rats.  The results indicated rapid disappearance of ripasudil from the circulation after instillation in humans and its level remained relatively high only in M1.  In contrast, we found six metabolites from M1 to M6 in plasma after oral administration to rats.4.  Anal. of enzyme kinetics using S9 showed that the formation of M1 is the major metabolic pathway of ripasudil in humans even though CYP3A4/3A5 and CYP2C8/3A4/3A5 were assocd. with the formation of M2 and M4, resp.  In conclusion, AO causes differences in ripasudil metab. between species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ83vnSAoNYrVg90H21EOLACvtfcHk0lileM5zo1pscA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGgtrzF&md5=178a4bb59973d4be6ce3245100f532e7</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.3109%2F00498254.2015.1096981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2015.1096981%26sid%3Dliteratum%253Aachs%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DY.%26aulast%3DKawai%26aufirst%3DH.%26atitle%3DSpecies%2520Differences%2520in%2520Metabolism%2520of%2520Ripasudil%2520%2528K-115%2529%2520Are%2520Attributed%2520to%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2016%26volume%3D46%26spage%3D579%26epage%3D590%26doi%3D10.3109%2F00498254.2015.1096981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, X.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase-Dependent Species Difference in Hepatic Metabolism of Fasudil to Hydroxyfasudil</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1080/00498254.2017.1292016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498254.2017.1292016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28166443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Gksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=170-177&issue=2&author=Z.+Maoauthor=Y.+Wuauthor=Q.+Liauthor=X.+Wangauthor=Y.+Liuauthor=X.+Di&title=Aldehyde+Oxidase-Dependent+Species+Difference+in+Hepatic+Metabolism+of+Fasudil+to+Hydroxyfasudil&doi=10.1080%2F00498254.2017.1292016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase-dependent species difference in hepatic metabolism of fasudil to hydroxyfasudil</span></div><div class="casAuthors">Mao, Zhengsheng; Wu, Yali; Li, Qiuying; Wang, Xin; Liu, Youping; Di, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-177</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">An investigation on the metabolic mechanism of fasudil to hydroxyfasudil was conducted in vitro using liver subcellular fractions of different species.  Hydroxyfasudil was generated in large amts. by rat liver S9 and to a similar extent by human liver S9 but was not detected in dog liver S9 incubations.  Studies with various molybdenum hydroxylase inhibitors demonstrated that aldehyde oxidase (AO), but not xanthine oxidase (XO), selectively catalyzed fasudil to hydroxyfasudil in both rat and human liver cytosol.  In addn., the oxygen atom incorporated into hydroxyfasudil was derived from water rather than atm. oxygen, which further corroborated AO involvement.  Enzyme kinetics expts. revealed that fasudil had a higher affinity to human hepatic AO than to rat hepatic AO.  Besides, significantly different in vivo pharmacokinetic parameters obsd. between male and female rats indicated that the AO activity in rats was gender-dependent.  The present study provided first evidences that AO causes differences in fasudil metab. between species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLweM3FIR00rVg90H21EOLACvtfcHk0lileM5zo1pscA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Gksbk%253D&md5=03b6d2441e74bc60045e1fdcb192a0ec</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1080%2F00498254.2017.1292016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2017.1292016%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDi%26aufirst%3DX.%26atitle%3DAldehyde%2520Oxidase-Dependent%2520Species%2520Difference%2520in%2520Hepatic%2520Metabolism%2520of%2520Fasudil%2520to%2520Hydroxyfasudil%26jtitle%3DXenobiotica%26date%3D2018%26volume%3D48%26issue%3D2%26spage%3D170%26epage%3D177%26doi%3D10.1080%2F00498254.2017.1292016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span> <span> </span><span class="NLM_article-title">Substrate Specificity of Human Liver Aldehyde Oxidase toward Substituted Quinazolines and Phthalazines: A Comparison with Hepatic Enzyme from Guinea Pig, Rabbit, and Baboon</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>319</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1006/abbi.1995.1320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1006%2Fabbi.1995.1320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7786031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Sht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1995&pages=481-490&issue=2&author=C.+Beedhamauthor=D.+J.+Critchleyauthor=D.+J.+Rance&title=Substrate+Specificity+of+Human+Liver+Aldehyde+Oxidase+toward+Substituted+Quinazolines+and+Phthalazines%3A+A+Comparison+with+Hepatic+Enzyme+from+Guinea+Pig%2C+Rabbit%2C+and+Baboon&doi=10.1006%2Fabbi.1995.1320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon</span></div><div class="casAuthors">Beedham, Christine; Critchley, David J. P.; Rance, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">481-90</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Partially purified aldehyde oxidase (EC 1.2.3.1) has been prepd. from human, rabbit, guinea pig, and baboon liver by heat treatment and pptn. with ammonium sulfate.  The interaction of 35 substituted quinazolines and phthalazines with human liver enzyme has been studied using a spectrophotometric assay.  Fifteen quinazoline and 14 phthalazine derivs. were substrates for human liver aldehyde oxidase with Km values ranging from 5 to 500 μM.  The substrate specificity of the quinazolines toward rabbit, guinea pig, and baboon liver aldehyde oxidase has also been investigated; the reaction of substituted phthalazines with mammalian liver enzyme has been reported previously.  Oxidn. products of 2-substituted (4-substituted) quinazolines with rabbit liver aldehyde oxidase were identified by MS as 4-oxo (2-oxo)-quinazolines, resp.  In all cases, unsubstituted compds. gave the highest oxidn. rates and the presence of lipophilic substituents presumably facilitated hydrophobic binding to the enzymes.  However, there were marked differences in substrate specificity between human liver aldehyde oxidase and hepatic enzyme from rabbit, guinea pig, and baboon with the size of substrate being the differentiating factor.  The mol. sizes of the substrates, estd. using calcd. molar refractivities, ranked the size of the binding site of aldehyde oxidase in the order rabbit < guinea pig < baboon < man.  Isoelec. points of the different aldehyde oxidase isoenzymes ranged from pH 5.10 for rabbit to 6.40 for the human liver isoenzyme.  These results indicate that rabbit liver aldehyde oxidase shows marked differences from the human liver enzyme in its handling of quinazoline and phthalazine substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcAxLqZIp9GLVg90H21EOLACvtfcHk0ljfWXHRUnNpAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Sht7w%253D&md5=23598ccf3235f610bb941e5840f90ac2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1995.1320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1995.1320%26sid%3Dliteratum%253Aachs%26aulast%3DBeedham%26aufirst%3DC.%26aulast%3DCritchley%26aufirst%3DD.%2BJ.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26atitle%3DSubstrate%2520Specificity%2520of%2520Human%2520Liver%2520Aldehyde%2520Oxidase%2520toward%2520Substituted%2520Quinazolines%2520and%2520Phthalazines%253A%2520A%2520Comparison%2520with%2520Hepatic%2520Enzyme%2520from%2520Guinea%2520Pig%252C%2520Rabbit%252C%2520and%2520Baboon%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1995%26volume%3D319%26issue%3D2%26spage%3D481%26epage%3D490%26doi%3D10.1006%2Fabbi.1995.1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghafourian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M. R.</span></span> <span> </span><span class="NLM_article-title">Quantitative Study of the Structural Requirements of Phthalazine/Quinazoline Derivatives for Interaction with Human Liver Aldehyde Oxidase</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1071</span>, <span class="refDoi"> DOI: 10.1248/cpb.49.1066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1248%2Fcpb.49.1066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=11558587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=1066-1071&issue=9&author=T.+Ghafourianauthor=M.+R.+Rashidi&title=Quantitative+Study+of+the+Structural+Requirements+of+Phthalazine%2FQuinazoline+Derivatives+for+Interaction+with+Human+Liver+Aldehyde+Oxidase&doi=10.1248%2Fcpb.49.1066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative study of the structural requirements of phthalazine/quinazoline derivatives for interaction with human liver aldehyde oxidase</span></div><div class="casAuthors">Ghafourian, Taravat; Rashidi, Mohammad Reza</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Aldehyde oxidase is a molybdenum-contg. enzyme distributed throughout the animal kingdom.  Although this enzyme is capable of metabolizing a wide range of aldehydes and N-heterocyclic compds., there is no reported detailed study of physicochem. requirements of the enzyme-substrate interactions.  The aim of this study, therefore, was to investigate quant. the relationships between the kinetic consts. of aldehyde oxidase-catalyzed oxidn. of some phthalazine and quinazoline derivs. (as substrates) and their structural parameters.  Multiple regression and stepwise regression analyses showed that polarity of phthalazines (expressed as dipole moment μ, cohesive energy d. δT and an indicator variable for hydrogen-bond acceptor ability of R1 substituent, HBA) had a neg. effect on the enzyme activity (leading to the redn. of Vmax and increase of Km).  Electron withdrawing substituents in the quinazoline series are favorable for interaction with the enzyme.  This finding and also the relationships of 1/Km of phthalazines with the energy of the LUMO and log Vmax/logKm of phthalazines with degree of bonding of the two nitrogen atoms in the mols. are consistent with the mechanism of action.  The reaction involves a nucleophilic attack on an electron-deficient sp2-hybridized carbon atom and formation of an epoxide intermediate following the disruption of the arom. structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo84zHPCsYJ9rVg90H21EOLACvtfcHk0ljfWXHRUnNpAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFyksb4%253D&md5=29f52036a2c36909fc841e5c2cd0741f</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1248%2Fcpb.49.1066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.49.1066%26sid%3Dliteratum%253Aachs%26aulast%3DGhafourian%26aufirst%3DT.%26aulast%3DRashidi%26aufirst%3DM.%2BR.%26atitle%3DQuantitative%2520Study%2520of%2520the%2520Structural%2520Requirements%2520of%2520Phthalazine%252FQuinazoline%2520Derivatives%2520for%2520Interaction%2520with%2520Human%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2001%26volume%3D49%26issue%3D9%26spage%3D1066%26epage%3D1071%26doi%3D10.1248%2Fcpb.49.1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klecker, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katki, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parchment, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boinpally, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoRusso, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivy, S. P.</span></span> <span> </span><span class="NLM_article-title">Metabolic Profile of Xk469 (2(R)-[4-(7-Chloro-2-Quinoxalinyl)Oxyphenoxy]-Propionic Acid; Nsc698215) in Patients and in Vitro: Low Potential for Active or Toxic Metabolites or for Drug-Drug Interactions</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1007/s00280-004-0962-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00280-004-0962-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15895233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFKksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=351-357&issue=4&author=L.+W.+Andersonauthor=J.+M.+Collinsauthor=R.+W.+Kleckerauthor=A.+G.+Katkiauthor=R.+E.+Parchmentauthor=R.+R.+Boinpallyauthor=P.+M.+LoRussoauthor=S.+P.+Ivy&title=Metabolic+Profile+of+Xk469+%282%28R%29-%5B4-%287-Chloro-2-Quinoxalinyl%29Oxyphenoxy%5D-Propionic+Acid%3B+Nsc698215%29+in+Patients+and+in+Vitro%3A+Low+Potential+for+Active+or+Toxic+Metabolites+or+for+Drug-Drug+Interactions&doi=10.1007%2Fs00280-004-0962-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug-drug interactions</span></div><div class="casAuthors">Anderson, Lawrence W.; Collins, Jerry M.; Klecker, Raymond W.; Katki, Aspandiar G.; Parchment, Ralph E.; Boinpally, Ramesh R.; LoRusso, Patricia M.; Ivy, S. Percy</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-357</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">As part of an ongoing phase 1 study, we studied the excretion of XK469 and its metab. in patients and in vitro.  Five primary metabolites were identified by HPLC/MS/MS.  An oxidized product formed by cytosolic aldehyde oxidase was the predominant species both in urine and human hepatocytes in vitro.  Conjugates of XK469 with glycine, taurine, and glucuronic acid, as well as the microsomal product, 4-oxo-XK469, were also found in urine and in vitro, but none were major contributors to the mass balance for XK469 elimination.  Based upon the relative concns. circulating in plasma, systemic exposure to parent drug was 100-fold higher than for the metabolites.  Thus, both toxicity and efficacy of XK469 are most likely to be produced by the parent mol., rather than the metabolites.  Urinary recovery of parent drug was low (2% of dose in 24 h), partly because of the long half-life of XK469 (approx. 3 days).  In addn., the metabolite profile in urine indicates that only 25% of the XK469-derived material was unchanged drug.  Thus, urinary excretion was not a major factor in XK469 elimination.  Variations in systemic exposure to XK469 will be strongly influenced by factors that alter the activity of aldehyde oxidase, including pharmacogenetics, enzyme inhibition, and enzyme induction, but no specific modifiers have been reported.  The multiday half-life of XK469 hampered our ability to obtain a complete mass balance, and the possibility exists that other routes, such as biliary excretion, may also play a substantial role in XK469 disposition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYlfZnoAoC4LVg90H21EOLACvtfcHk0ljfWXHRUnNpAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFKksrs%253D&md5=803b71cb18ef3664a3e752f5993b3ef3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0962-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0962-3%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DL.%2BW.%26aulast%3DCollins%26aufirst%3DJ.%2BM.%26aulast%3DKlecker%26aufirst%3DR.%2BW.%26aulast%3DKatki%26aufirst%3DA.%2BG.%26aulast%3DParchment%26aufirst%3DR.%2BE.%26aulast%3DBoinpally%26aufirst%3DR.%2BR.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26aulast%3DIvy%26aufirst%3DS.%2BP.%26atitle%3DMetabolic%2520Profile%2520of%2520Xk469%2520%25282%2528R%2529-%255B4-%25287-Chloro-2-Quinoxalinyl%2529Oxyphenoxy%255D-Propionic%2520Acid%253B%2520Nsc698215%2529%2520in%2520Patients%2520and%2520in%2520Vitro%253A%2520Low%2520Potential%2520for%2520Active%2520or%2520Toxic%2520Metabolites%2520or%2520for%2520Drug-Drug%2520Interactions%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D56%26issue%3D4%26spage%3D351%26epage%3D357%26doi%3D10.1007%2Fs00280-004-0962-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acheampong, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usansky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harcourt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang-Liu, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of Brimonidine Metabolism with Rat, Rabbit, Dog, Monkey and Human Liver Fractions and Rabbit Liver Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1055</span>, <span class="refDoi"> DOI: 10.3109/00498259609167421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498259609167421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8905918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28Xmt12hsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=1035-1055&issue=10&author=A.+A.+Acheampongauthor=D.+S.+Chienauthor=S.+Lamauthor=S.+Vekichauthor=A.+Breauauthor=J.+Usanskyauthor=D.+Harcourtauthor=S.+A.+Munkauthor=H.+Nguyenauthor=M.+Garstauthor=D.+Tang-Liu&title=Characterization+of+Brimonidine+Metabolism+with+Rat%2C+Rabbit%2C+Dog%2C+Monkey+and+Human+Liver+Fractions+and+Rabbit+Liver+Aldehyde+Oxidase&doi=10.3109%2F00498259609167421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase</span></div><div class="casAuthors">Acheampong, A. A.; Chien, D. -S.; Lam, S.; Vekich, S.; Breau, A.; Usansky, J.; Harcourt, D.; Munk, S. A.; Nguyen, H.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1035-1055</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis</span>)
        </div><div class="casAbstract">The in vitro metab. of [14C]brimonidine by rat, rabbit, dog, monkey and human liver fractions was studied to assess any species differences.  In vitro metab. by rabbit liver aldehyde oxidase and human liver slices, and in vivo metab. in rats were also investigated.  The hepatic and urinary metabolites were characterized by liq. chromatog. and mass spectrometry.  Up to 7, 6, 11 and 14 metabolites were detected in rat liver S9 fraction, human liver S9 fraction, human liver slices and rat urine, resp.  Rabbit liver aldehyde oxidase catalyzed the metab. of brimonidine to 2-oxobrimonidine and 3-oxobrimonidine, and further oxidn. to 2,3-dioxobrimonidine.  Menadione inhibited the liver aldehyde oxidase-mediated oxidn.  Hepatic oxidn. of brimonidine to 2-oxobrimonidine, 3-oxobrimonidine, and 2,3-dioxobrimonidine was a major pathway in all the species studied, except the dog, whose prominent metabolites were 4',5'-dehydrobrimonidine and 5-bromo-6-guanidinoquinoxaline.  These results indicate extensive hepatic metab. of brimonidine and provide evidence for aldehyde oxidase involvement in brimonidine metab.  The species differences in hepatic brimonidine metab. are likely related to the low activity of dog liver aldehyde oxidase.  The principal metabolic pathways of brimonidine are α(N)-oxidn. to 2,3-dioxobrimonidine, and oxidative cleavage of the imidazoline ring to give 5-bromo-6-guanidinoquinoxaline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZf8_3eajv8bVg90H21EOLACvtfcHk0liDgtBnHMMNkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmt12hsro%253D&md5=2185d4cdae5aabc1bd9f221124350f72</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3109%2F00498259609167421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498259609167421%26sid%3Dliteratum%253Aachs%26aulast%3DAcheampong%26aufirst%3DA.%2BA.%26aulast%3DChien%26aufirst%3DD.%2BS.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DVekich%26aufirst%3DS.%26aulast%3DBreau%26aufirst%3DA.%26aulast%3DUsansky%26aufirst%3DJ.%26aulast%3DHarcourt%26aufirst%3DD.%26aulast%3DMunk%26aufirst%3DS.%2BA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DGarst%26aufirst%3DM.%26aulast%3DTang-Liu%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520Brimonidine%2520Metabolism%2520with%2520Rat%252C%2520Rabbit%252C%2520Dog%252C%2520Monkey%2520and%2520Human%2520Liver%2520Fractions%2520and%2520Rabbit%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D1996%26volume%3D26%26issue%3D10%26spage%3D1035%26epage%3D1055%26doi%3D10.3109%2F00498259609167421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knighton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walls, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Highly Potent Pi3k/Mtor Dual Inhibitor Pf-04979064 through Structure-Based Drug Design</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1021/ml300309h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300309h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Cksr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=91-97&issue=1&author=H.+Chengauthor=C.+Liauthor=S.+Baileyauthor=S.+M.+Baxiauthor=L.+Gouletauthor=L.+Guoauthor=J.+Hoffmanauthor=Y.+Jiangauthor=T.+O.+Johnsonauthor=T.+W.+Johnsonauthor=D.+R.+Knightonauthor=J.+Liauthor=K.+K.+Liuauthor=Z.+Liuauthor=M.+A.+Marxauthor=M.+Wallsauthor=P.+A.+Wellsauthor=M.+J.+Yinauthor=J.+Zhuauthor=M.+Zientek&title=Discovery+of+the+Highly+Potent+Pi3k%2FMtor+Dual+Inhibitor+Pf-04979064+through+Structure-Based+Drug+Design&doi=10.1021%2Fml300309h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design</span></div><div class="casAuthors">Cheng, Hengmiao; Li, Chunze; Bailey, Simon; Baxi, Sangita M.; Goulet, Lance; Guo, Lisa; Hoffman, Jacqui; Jiang, Ying; Johnson, Theodore Otto; Johnson, Ted W.; Knighton, Daniel R.; Li, John; Liu, Kevin K.-C.; Liu, Zhengyu; Marx, Matthew A.; Walls, Marlena; Wells, Peter A.; Yin, Min-Jean; Zhu, Jinjiang; Zientek, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-97</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PI3K, AKT, and mTOR are key kinases from PI3K signaling pathway being extensively pursued to treat a variety of cancers in oncol.  To search for a structurally differentiated back-up candidate to PF-04691502, which is currently in phase I/II clin. trials for treating solid tumors, a lead optimization effort was carried out with a tricyclic imidazo[1,5]naphthyridine series.  Integration of structure-based drug design and phys. properties-based optimization yielded a potent and selective PI3K/mTOR dual kinase inhibitor PF-04979064 (I).  This manuscript discusses the lead optimization for the tricyclic series, which both improved the in vitro potency and addressed a no. of ADMET issues including high metabolic clearance mediated by both P 450 and aldehyde oxidase (AO), poor permeability, and poor soly.  An empirical scaling tool was developed to predict human clearance from in vitro human liver S9 assay data for tricyclic derivs. that were AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQSJqL-ssP7Vg90H21EOLACvtfcHk0liDgtBnHMMNkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Cksr7I&md5=0059c9c220419aad748b4fcde92c28bb</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fml300309h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300309h%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBaxi%26aufirst%3DS.%2BM.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DKnighton%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%2BK.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DWalls%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYin%26aufirst%3DM.%2BJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZientek%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520the%2520Highly%2520Potent%2520Pi3k%252FMtor%2520Dual%2520Inhibitor%2520Pf-04979064%2520through%2520Structure-Based%2520Drug%2520Design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D1%26spage%3D91%26epage%3D97%26doi%3D10.1021%2Fml300309h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">In Vitro-in Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.033555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.110.033555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=20444863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1322-1327&issue=8&author=M.+Zientekauthor=Y.+Jiangauthor=K.+Youdimauthor=R.+S.+Obach&title=In+Vitro-in+Vivo+Correlation+for+Intrinsic+Clearance+for+Drugs+Metabolized+by+Human+Aldehyde+Oxidase&doi=10.1124%2Fdmd.110.033555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase</span></div><div class="casAuthors">Zientek, Michael; Jiang, Ying; Youdim, Kuresh; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1322-1327</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability to predict in vivo clearance from in vitro intrinsic clearance for compds. metabolized by aldehyde oxidase has not been demonstrated.  To date, there is no established scaling method for predicting aldehyde oxidase-mediated clearance using in vitro or animal data.  This challenge is exacerbated by the fact that rats and dogs, two of the lab. animal species commonly used to develop in vitro-in vivo correlations of clearance, differ from humans with regard to expression of aldehyde oxidase.  The objective of this investigation was to develop an in vitro-in vivo correlation of intrinsic clearance for aldehyde oxidase, using 11 drugs known to be metabolized by this enzyme.  The set consisted of methotrexate, XK-469, (±-4-(4-cyanoanilino)-5,6-dihydro-7-hydroxy-7H-cyclopenta[d]pyrimidine (RS-8359), zaleplon, 6-deoxypenciclovir, zoniporide, O6-benzylguanine, N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA), carbazeran, PF-4217903, and PF-945863.  These compds. were assayed using two in vitro systems (pooled human liver cytosol and liver S-9 fractions) to calc. scaled unbound intrinsic clearance, and they were then compared with calcd. in vivo unbound intrinsic clearance.  The investigation provided a relative scale that can be used for in vitro-in vivo correlation of aldehyde oxidase clearance and suggests limits as to when a potential new drug candidate that is metabolized by this enzyme will possess acceptable human clearance, or when structural modification is required to reduce aldehyde oxidase catalyzed metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFkx3d5zxrd7Vg90H21EOLACvtfcHk0liDgtBnHMMNkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjJ&md5=296ee366707d82b416e70eb8161f923b</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033555%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DIn%2520Vitro-in%2520Vivo%2520Correlation%2520for%2520Intrinsic%2520Clearance%2520for%2520Drugs%2520Metabolized%2520by%2520Human%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D8%26spage%3D1322%26epage%3D1327%26doi%3D10.1124%2Fdmd.110.033555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanigan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sejberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bihan, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span> <span> </span><span class="NLM_article-title">Pyrido[3,4-D]Pyrimidin-4(3h)-One Metabolism Mediated by Aldehyde Oxidase Is Blocked by C2-Substitution</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1080/00498254.2016.1230245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498254.2016.1230245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27618572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCntb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=771-777&issue=9&author=A.+Hayesauthor=N.+Y.+Mokauthor=M.+Liuauthor=C.+Thaiauthor=A.+T.+Henleyauthor=B.+Atrashauthor=R.+M.+Laniganauthor=J.+Sejbergauthor=Y.+V.+Le+Bihanauthor=V.+Bavetsiasauthor=J.+Blaggauthor=F.+I.+Raynaud&title=Pyrido%5B3%2C4-D%5DPyrimidin-4%283h%29-One+Metabolism+Mediated+by+Aldehyde+Oxidase+Is+Blocked+by+C2-Substitution&doi=10.1080%2F00498254.2016.1230245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by aldehyde oxidase is blocked by C2-substitution</span></div><div class="casAuthors">Hayes, Angela; Mok, N. Yi; Liu, Manjuan; Thai, Ching; Henley, Alan T.; Atrash, Butrus; Lanigan, Rachel M.; Sejberg, Jemmy; Le Bihan, Yann-Vai; Bavetsias, Vassilios; Blagg, Julian; Raynaud, Florence I.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">771-777</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">We have previously described C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-one derivs. as cell permeable inhibitors of the KDM4 and KDM5 subfamilies of JmjC histone lysine demethylases.  Although exemplar compd. exhibited moderate clearance in mouse liver microsomes, it was highly cleared in vivo due to metab. by aldehyde oxidase (AO).  Similar human and mouse AO-mediated metab. was obsd. with the pyrido[3,4-d]pyrimidin-4(3H)-one scaffold and other C8-substituted derivs.  We identified the C2-position as the oxidn. site by LC-MS and 1H-NMR and showed that C2-substituted derivs. are no longer AO substrates.  In addn. to the exptl. data, these observations are supported by mol. modeling studies in the human AO protein crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpSd3R2GorubVg90H21EOLACvtfcHk0lhLhzJm9tLt6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCntb3J&md5=0a06863e46be75e1d0353641054d2687</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1080%2F00498254.2016.1230245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2016.1230245%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DMok%26aufirst%3DN.%2BY.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DThai%26aufirst%3DC.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DLanigan%26aufirst%3DR.%2BM.%26aulast%3DSejberg%26aufirst%3DJ.%26aulast%3DLe%2BBihan%26aufirst%3DY.%2BV.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26atitle%3DPyrido%255B3%252C4-D%255DPyrimidin-4%25283h%2529-One%2520Metabolism%2520Mediated%2520by%2520Aldehyde%2520Oxidase%2520Is%2520Blocked%2520by%2520C2-Substitution%26jtitle%3DXenobiotica%26date%3D2017%26volume%3D47%26issue%3D9%26spage%3D771%26epage%3D777%26doi%3D10.1080%2F00498254.2016.1230245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choughule, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Interspecies Differences in the Metabolism of Methotrexate: An Insight into the Active Site Differences between Human and Rabbit Aldehyde Oxidase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2015.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2015.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26032640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=288-295&issue=3&author=K.+V.+Choughuleauthor=C.+A.+Joswig-Jonesauthor=J.+P.+Jones&title=Interspecies+Differences+in+the+Metabolism+of+Methotrexate%3A+An+Insight+into+the+Active+Site+Differences+between+Human+and+Rabbit+Aldehyde+Oxidase&doi=10.1016%2Fj.bcp.2015.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase</span></div><div class="casAuthors">Choughule, Kanika V.; Joswig-Jones, Carolyn A.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">288-295</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several drug compds. have failed in clin. trials due to extensive biotransformation by aldehyde oxidase (AOX) (EC 1.2.3.1).  One of the main reasons is the difficulty in scaling clearance for drugs metabolized by AOX, from preclin. species to human.  Using methotrexate as a probe substrate, we evaluated AOX metab. in liver cytosol from human and commonly used lab. species such as guinea pig, monkey, rat and rabbit.  We found that the metab. of methotrexate in rabbit liver cytosol was several orders of magnitude higher than any of the other species tested.  The results of protein quantitation revealed that the amt. of AOX1 in human liver was similar to rabbit liver.  To understand if the obsd. differences in activity were due to structural differences, we modelled rabbit AOX1 using the previously generated human AOX1 homol. model.  Mol. docking of methotrexate into the active site of the enzyme led to the identification of important residues that could potentially be involved in substrate binding and account for the obsd. differences.  In order to study the impact of these residue changes on enzyme activity, we used site directed mutagenesis to construct mutant AOX1 cDNAs by substituting nucleotides of human AOX1 with relevant ones of rabbit AOX1.  AOX1 mutant proteins were expressed in Escherichia coli.  Differences in the kinetic properties of these mutants have been presented in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnFnLMbgAZrVg90H21EOLACvtfcHk0lhLhzJm9tLt6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOktr0%253D&md5=2d6c39da8eb19c0a09dcc2076410b63c</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DChoughule%26aufirst%3DK.%2BV.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DInterspecies%2520Differences%2520in%2520the%2520Metabolism%2520of%2520Methotrexate%253A%2520An%2520Insight%2520into%2520the%2520Active%2520Site%2520Differences%2520between%2520Human%2520and%2520Rabbit%2520Aldehyde%2520Oxidase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D96%26issue%3D3%26spage%3D288%26epage%3D295%26doi%3D10.1016%2Fj.bcp.2015.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laljee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase-Catalysed Oxidation of Methotrexate in the Liver of Guinea-Pig, Rabbit and Man</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1211/0022357991772619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1211%2F0022357991772619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10385213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXjsVOlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=411-418&issue=4&author=C.+G.+Jordanauthor=M.+R.+Rashidiauthor=H.+Laljeeauthor=S.+E.+Clarkeauthor=J.+E.+Brownauthor=C.+Beedham&title=Aldehyde+Oxidase-Catalysed+Oxidation+of+Methotrexate+in+the+Liver+of+Guinea-Pig%2C+Rabbit+and+Man&doi=10.1211%2F0022357991772619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase-catalyzed oxidation of methotrexate in the liver of guinea pig, rabbit and man</span></div><div class="casAuthors">Jordan, C. Geraldine M.; Rashidi, Mohammed R.; Laljee, Hussain; Clarke, Stephen E.; Brown, John E.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-418</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">Although 7-hydroxymethotrexate is a major metabolite of methotrexate during high-dose therapy, negligible methotrexate-oxidizing activity has been found in-vitro in the liver in man.  The goals of this study were to det. the role of aldehyde oxidase in the metab. of methotrexate to 7-hydroxymethotrexate in the liver and to study the effects of inhibitors and other substrates on the metab. of methotrexate.  Methotrexate, (±)-methotrexate and (-)-methotrexate were incubated with partially purified aldehyde oxidase from the liver of rabbit, guinea-pig and man and the products analyzed by HPLC.  Rabbit liver aldehyde oxidase was used for purposes of comparison.  In-vitro aldehyde oxidase from the liver of man catalyzes the oxidn. of methotrexate to 7-hydroxymethotrexate, but the turnover is low.  However, formation of 7-hydroxymethotrexate from all forms of methotrexate by the liver in guinea-pig and man was significantly inhibited in the presence of 100 μM menadione and chlorpromazine, potent inhibitors of aldehyde oxidase.  Allopurinol (100 μM) had a negligible inhibitory effect on liver aldehyde oxidase from guinea-pig and man.  Allopurinol is a xanthine oxidase inhibitor.  The prodn. of 7-hydroxymethotrexate was enhanced in the presence of allopurinol.  Although aldehyde oxidase is also responsible for some of this conversion, it is also possible that the closely related xanthine oxidase is responsible for the formation of 7-hydroxymethotrexate.  By employing potent selective inhibitors of aldehyde oxidase, menadione and chlorpromazine, we have demonstrated for the first time that liver aldehyde oxidase from man is minimally involved in methotrexate oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC0SziaiQX67Vg90H21EOLACvtfcHk0lhLhzJm9tLt6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsVOlt78%253D&md5=7541b8594155ae83b4407177055f255a</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1211%2F0022357991772619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357991772619%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DC.%2BG.%26aulast%3DRashidi%26aufirst%3DM.%2BR.%26aulast%3DLaljee%26aufirst%3DH.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26aulast%3DBrown%26aufirst%3DJ.%2BE.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DAldehyde%2520Oxidase-Catalysed%2520Oxidation%2520of%2520Methotrexate%2520in%2520the%2520Liver%2520of%2520Guinea-Pig%252C%2520Rabbit%2520and%2520Man%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1999%26volume%3D51%26issue%3D4%26spage%3D411%26epage%3D418%26doi%3D10.1211%2F0022357991772619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, E. J.</span></span> <span> </span><span class="NLM_article-title">Role of Aldehyde Oxidase in the Hepatic in Vitro Metabolism of 3-Methylindole in Pigs</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1021/jf990805u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf990805u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVWjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=833-837&issue=3&author=G.+J.+Diazauthor=E.+J.+Squires&title=Role+of+Aldehyde+Oxidase+in+the+Hepatic+in+Vitro+Metabolism+of+3-Methylindole+in+Pigs&doi=10.1021%2Fjf990805u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Aldehyde Oxidase in the Hepatic in Vitro Metabolism of 3-Methylindole in Pigs</span></div><div class="casAuthors">Diaz, Gonzalo J.; Squires, E. James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">833-837</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metab. of 3-hydroxy-3-methylindolenine (HMI), a recently discovered metabolite of 3-methylindole (3MI, skatole) produced by porcine liver microsomes, was investigated in vitro using porcine liver cytosol.  HMI was rapidly metabolized to a single product, 3-hydroxy-3-methyloxindole (HMOI), by porcine cytosol.  By the use of the selective inhibitors menadione and quinacrine, it was shown that the enzyme responsible for the oxidn. of HMI into HMOI was aldehyde oxidase (AO; aldehyde:oxygen oxidoreductase, EC 1.2.3.1).  The activity of AO in the conversion of HMI to HMOI was measured in a population of pigs (n = 30) with a wide range of 3MI levels in back fat (0.07-0.30 mg/kg).  AO activity was found to be neg. correlated (r = -0.70; P < 0.001) with the level of 3MI in fat.  The results of the present study suggest that AO plays an important role in the metab. of 3MI in the pig and that its catalytic activity is related to an adequate 3MI clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJEVr91Lr387Vg90H21EOLACvtfcHk0lge0vbY-kaXgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVWjtrY%253D&md5=d6978ef1e3ed62e65419a760fa51d167</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjf990805u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf990805u%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DSquires%26aufirst%3DE.%2BJ.%26atitle%3DRole%2520of%2520Aldehyde%2520Oxidase%2520in%2520the%2520Hepatic%2520in%2520Vitro%2520Metabolism%2520of%25203-Methylindole%2520in%2520Pigs%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2000%26volume%3D48%26issue%3D3%26spage%3D833%26epage%3D837%26doi%3D10.1021%2Fjf990805u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, P.</span></span> <span> </span><span class="NLM_article-title">Effect of Structural Variation on Aldehyde Oxidase-Catalyzed Oxidation of Zoniporide</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1575</span>– <span class="NLM_lpage">1587</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.045823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.045823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22587988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2iurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1575-1587&issue=8&author=D.+Dalvieauthor=H.+Sunauthor=C.+Xiangauthor=Q.+Huauthor=Y.+Jiangauthor=P.+Kang&title=Effect+of+Structural+Variation+on+Aldehyde+Oxidase-Catalyzed+Oxidation+of+Zoniporide&doi=10.1124%2Fdmd.112.045823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide</span></div><div class="casAuthors">Dalvie, Deepak; Sun, Hao; Xiang, Cathie; Hu, Qiyue; Jiang, Ying; Kang, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1575-1587</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Current studies explored the effect of structural changes on the aldehyde oxidase (AO)-mediated metab. of zoniporide (1).  Zoniporide analogs with modifications of the acylguanidine moiety, the cyclopropyl group on the pyrazole ring, and the quinoline ring were studied for their AO-catalyzed metab. using the human S9 fraction.  Anal. of the half-lives suggested that subtle changes in the structure of 1 influenced its metab. and that the guanidine and the quinoline moieties were prerequisites for AO-catalyzed oxidn. to 2-oxozoniporide (M1).  In contrast, replacement of the cyclopropyl group with other alkyl groups was tolerated.  The effect of structural variation on AO properties was rationalized by docking 1 and its analogs into the human AO homol. model.  These studies indicated the importance of electrostatic, π-π stacking and hydrophobic interactions of the three motifs with residues in the active site.  Differences in substrate properties were also rationalized by comparing their half-lives with cLogD, electrophilicity parameters [electrostatic potential (ESP) charges and energy of lowest unoccupied MOs (ELUMO)], and the energies of formation of tetrahedral intermediates.  Whereas the success of energetics in predicting the AO substrate properties of analogs was 87%, the predictive ability of other descriptors was none (cLogD) to 60% (ESP charges and ELUMO).  Overall, the structure-metab. relationship could be rationalized using a combination of both the energy calcns. and docking studies.  This combination method can be incorporated into a strategy for mitigating AO liabilities obsd. in the lead candidate or studying structure-metab. relationships of other AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCkVhA55F__bVg90H21EOLACvtfcHk0lge0vbY-kaXgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2iurbK&md5=b3ec4f1916d516092e72156dd63304a5</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.045823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.045823%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DP.%26atitle%3DEffect%2520of%2520Structural%2520Variation%2520on%2520Aldehyde%2520Oxidase-Catalyzed%2520Oxidation%2520of%2520Zoniporide%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D8%26spage%3D1575%26epage%3D1587%26doi%3D10.1124%2Fdmd.112.045823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bandarage, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledeboer, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrn, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nti Addae, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memmott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span> <span> </span><span class="NLM_article-title">Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00487</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00487" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1KmtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=261-265&issue=2&author=U.+K.+Bandarageauthor=M.+P.+Clarkauthor=E.+Perolaauthor=H.+Gaoauthor=M.+D.+Jacobsauthor=A.+Tsaiauthor=J.+Gillespieauthor=J.+M.+Kennedyauthor=F.+Maltaisauthor=M.+W.+Ledeboerauthor=I.+Daviesauthor=W.+Guauthor=R.+A.+Byrnauthor=K.+Nti+Addaeauthor=H.+Bennettauthor=J.+R.+Leemanauthor=S.+M.+Jonesauthor=C.+O%E2%80%99Brienauthor=C.+Memmottauthor=Y.+Bennaniauthor=P.+S.+Charifson&title=Novel+2-Substituted+7-Azaindole+and+7-Azaindazole+Analogues+as+Potential+Antiviral+Agents+for+the+Treatment+of+Influenza&doi=10.1021%2Facsmedchemlett.6b00487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza</span></div><div class="casAuthors">Bandarage, Upul K.; Clark, Michael P.; Perola, Emanuele; Gao, Huai; Jacobs, Marc D.; Tsai, Alice; Gillespie, Jeffery; Kennedy, Joseph M.; Maltais, Francois; Ledeboer, Mark W.; Davies, Ioana; Gu, Wenxin; Byrn, Randal A.; Nti Addae, Kwame; Bennett, Hamilton; Leeman, Joshua R.; Jones, Steven M.; O'Brien, Colleen; Memmott, Christine; Bennani, Youssef; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-265</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">JNJ-63623872 (2) is a first-in-class, orally bioavailable compd. that offers significant potential for the treatment of pandemic and seasonal influenza.  Early lead optimization efforts in our 7-azaindole series focused on 1,3-diaminocyclohexyl amide and urea substitutions on the pyrimidine-7-azaindole motif.  In this work, we explored two strategies to eliminate obsd. aldehyde oxidase (AO)-mediated metab. at the 2-position of these 7-azaindole analogs.  Substitution at the 2-position of the azaindole ring generated somewhat less potent analogs, but reduced AO-mediated metab.  Incorporation of a ring nitrogen generated 7-azaindazole analogs that were equipotent to the parent 2-H-7-azaindole, but surprisingly, did not appear to improve AO-mediated metab.  Overall, we identified multiple 2-substituted 7-azaindole analogs with enhanced AO stability and we present data for one such compd. (12) that demonstrate a favorable oral pharmacokinetic profile in rodents.  These analogs have the potential to be further developed as anti-influenza agents for the treatment of influenza.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp21HItUy6aabVg90H21EOLACvtfcHk0lge0vbY-kaXgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1KmtL4%253D&md5=8ada3c238e2932e95b938ecced26d8f1</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00487%26sid%3Dliteratum%253Aachs%26aulast%3DBandarage%26aufirst%3DU.%2BK.%26aulast%3DClark%26aufirst%3DM.%2BP.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DTsai%26aufirst%3DA.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DJ.%2BM.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DLedeboer%26aufirst%3DM.%2BW.%26aulast%3DDavies%26aufirst%3DI.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DNti%2BAddae%26aufirst%3DK.%26aulast%3DBennett%26aufirst%3DH.%26aulast%3DLeeman%26aufirst%3DJ.%2BR.%26aulast%3DJones%26aufirst%3DS.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%26aulast%3DMemmott%26aufirst%3DC.%26aulast%3DBennani%26aufirst%3DY.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DNovel%25202-Substituted%25207-Azaindole%2520and%25207-Azaindazole%2520Analogues%2520as%2520Potential%2520Antiviral%2520Agents%2520for%2520the%2520Treatment%2520of%2520Influenza%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D261%26epage%3D265%26doi%3D10.1021%2Facsmedchemlett.6b00487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chopko, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregro, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engers, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poslusney, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamsal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnetz-Boutaud, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stec, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandon, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B. J.</span></span> <span> </span><span class="NLM_article-title">Sar Inspired by Aldehyde Oxidase (Ao) Metabolism: Discovery of Novel, Cns Penetrant Tricyclic M4 Pams</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2019.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=31248774" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=T.+C.+Chopkoauthor=C.+Hanauthor=A.+R.+Gregroauthor=D.+W.+Engersauthor=A.+S.+Feltsauthor=M.+S.+Poslusneyauthor=K.+A.+Bollingerauthor=R.+D.+Morrisonauthor=M.+Bubserauthor=A.+Lamsalauthor=V.+B.+Luscombeauthor=H.+P.+Choauthor=N.+C.+Schnetz-Boutaudauthor=A.+L.+Rodriguezauthor=S.+Changauthor=J.+S.+Danielsauthor=D.+F.+Stecauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=M.+R.+Woodauthor=M.+W.+Woodauthor=M.+E.+Dugganauthor=N.+J.+Brandonauthor=P.+J.+Connauthor=T.+M.+Bridgesauthor=C.+W.+Lindsleyauthor=B.+J.+Melancon&title=Sar+Inspired+by+Aldehyde+Oxidase+%28Ao%29+Metabolism%3A+Discovery+of+Novel%2C+Cns+Penetrant+Tricyclic+M4+Pams&doi=10.1016%2Fj.bmcl.2019.06.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DChopko%26aufirst%3DT.%2BC.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DGregro%26aufirst%3DA.%2BR.%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DPoslusney%26aufirst%3DM.%2BS.%26aulast%3DBollinger%26aufirst%3DK.%2BA.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DLamsal%26aufirst%3DA.%26aulast%3DLuscombe%26aufirst%3DV.%2BB.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DSchnetz-Boutaud%26aufirst%3DN.%2BC.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DStec%26aufirst%3DD.%2BF.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BW.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26atitle%3DSar%2520Inspired%2520by%2520Aldehyde%2520Oxidase%2520%2528Ao%2529%2520Metabolism%253A%2520Discovery%2520of%2520Novel%252C%2520Cns%2520Penetrant%2520Tricyclic%2520M4%2520Pams%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26doi%3D10.1016%2Fj.bmcl.2019.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span> <span> </span><span class="NLM_article-title">Systematic Structure Modifications of Imidazo[1,2-a]Pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (Ao)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7705</span>– <span class="NLM_lpage">7712</span>, <span class="refDoi"> DOI: 10.1021/jm2010942</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010942" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ynu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7705-7712&issue=21&author=A.+Lintonauthor=P.+Kangauthor=M.+Ornelasauthor=S.+Kephartauthor=Q.+Huauthor=M.+Pairishauthor=Y.+Jiangauthor=C.+Guo&title=Systematic+Structure+Modifications+of+Imidazo%5B1%2C2-a%5DPyrimidine+to+Reduce+Metabolism+Mediated+by+Aldehyde+Oxidase+%28Ao%29&doi=10.1021%2Fjm2010942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Structure Modifications of Imidazo[1,2-a]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO)</span></div><div class="casAuthors">Linton, Angelica; Kang, Ping; Ornelas, Martha; Kephart, Susan; Hu, Qiyue; Pairish, Mason; Jiang, Ying; Guo, Chuangxing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7705-7712</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-{trans-3-[(5-Cyano-6-methylpyridin-2-yl)oxy]-2,2,4,4-tetramethylcyclobutyl}imidazo[1,2-a]pyrimidine-3-carboxamide (I) was recently identified as a full antagonist of the androgen receptor, demonstrating excellent in vivo tumor growth inhibition in castration-resistant prostate cancer (CRPC).  However, the imidazo[1,2-a]pyrimidine moiety is rapidly metabolized by aldehyde oxidase (AO).  The present paper describes a no. of medicinal chem. strategies taken to avoid the AO-mediated oxidn. of this particular system.  Guided by an AO protein structure-based model, the investigation revealed the most probable site of AO oxidn. and the observation that altering the heterocycle or blocking the reactive site are two of the more effective strategies for reducing AO metab.  These strategies may be useful for other drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQMDVJxz6g_bVg90H21EOLACvtfcHk0li7qrhpPP9mlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ynu7bL&md5=b6da895d38c71f90eb4f83716f1060f0</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm2010942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010942%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DSystematic%2520Structure%2520Modifications%2520of%2520Imidazo%255B1%252C2-a%255DPyrimidine%2520to%2520Reduce%2520Metabolism%2520Mediated%2520by%2520Aldehyde%2520Oxidase%2520%2528Ao%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D21%26spage%3D7705%26epage%3D7712%26doi%3D10.1021%2Fjm2010942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekeres, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott-Stevens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macleod, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, B.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase and Its Contribution to the Metabolism of a Structurally Novel, Functionally Selective Gabaa Alpha5-Subtype Inverse Agonist</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1080/00498250600567903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498250600567903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16684711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVGnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=315-330&issue=4&author=D.+O%E2%80%99Connorauthor=P.+Jonesauthor=M.+S.+Chambersauthor=R.+Maxeyauthor=H.+J.+Szekeresauthor=N.+Szetoauthor=P.+Scott-Stevensauthor=A.+M.+Macleodauthor=M.+Braunauthor=B.+Cato&title=Aldehyde+Oxidase+and+Its+Contribution+to+the+Metabolism+of+a+Structurally+Novel%2C+Functionally+Selective+Gabaa+Alpha5-Subtype+Inverse+Agonist&doi=10.1080%2F00498250600567903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase and its contribution to the metabolism of a structurally novel, functionally selective GABAA α5-subtype inverse agonist</span></div><div class="casAuthors">O'Connor, D.; Jones, P.; Chambers, M. S.; Maxey, R.; Szekeres, H. J.; Szeto, N.; Scott-Stevens, P.; Macleod, A. M.; Braun, M.; Cato, B.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">315-330</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Compd. (I) was recently identified as a functionally selective, inverse agonist at the benzodiazepine site of GABAA α5-contg. receptors, which enhances performance in animal models of cognition.  The routes of metab. of I in rat, dog, rhesus monkey and human in vitro systems, and in vivo in rat, dog and rhesus monkey have been characterized.  The current study demonstrates that both a cytosolic oxidative reaction and cytochrome P 450 play important roles in the metab. of I.  Chem. inhibition studies showed the oxidn. in human cytosol to be catalyzed predominantly by aldehyde oxidase rather than the related enzyme, xanthine oxidase.  The aldehyde oxidase-mediated metabolites were present in vitro and in vivo in both rat and rhesus monkey, and also in vitro in man.  They were absent both in vitro and in vivo in dog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgcCJQg0f0hrVg90H21EOLACvtfcHk0li7qrhpPP9mlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVGnu7c%253D&md5=273b3ad51a76a8ff473d1b9fffa69b65</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1080%2F00498250600567903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250600567903%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DChambers%26aufirst%3DM.%2BS.%26aulast%3DMaxey%26aufirst%3DR.%26aulast%3DSzekeres%26aufirst%3DH.%2BJ.%26aulast%3DSzeto%26aufirst%3DN.%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DMacleod%26aufirst%3DA.%2BM.%26aulast%3DBraun%26aufirst%3DM.%26aulast%3DCato%26aufirst%3DB.%26atitle%3DAldehyde%2520Oxidase%2520and%2520Its%2520Contribution%2520to%2520the%2520Metabolism%2520of%2520a%2520Structurally%2520Novel%252C%2520Functionally%2520Selective%2520Gabaa%2520Alpha5-Subtype%2520Inverse%2520Agonist%26jtitle%3DXenobiotica%26date%3D2006%26volume%3D36%26issue%3D4%26spage%3D315%26epage%3D330%26doi%3D10.1080%2F00498250600567903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekeres, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wafford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLeod, A. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and Metabolism Studies on (3-Tert-Butyl-7-(5-Methylisoxazol-3-Yl)-2-(1-Methyl-1h-1,2,4-Triazol-5-Ylmethoxy) Pyrazolo[1,5-D][1,2,4]Triazine, a Functionally Selective Gaba(a) Alpha5 Inverse Agonist for Cognitive Dysfunction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">872</span>– <span class="NLM_lpage">875</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2005.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16303300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1Gkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=872-875&issue=4&author=P.+Jonesauthor=J.+R.+Atackauthor=M.+P.+Braunauthor=B.+P.+Catoauthor=M.+S.+Chambersauthor=D.+O%E2%80%99Connorauthor=S.+M.+Cookauthor=S.+C.+Hobbsauthor=R.+Maxeyauthor=H.+J.+Szekeresauthor=N.+Szetoauthor=K.+A.+Waffordauthor=A.+M.+MacLeod&title=Pharmacokinetics+and+Metabolism+Studies+on+%283-Tert-Butyl-7-%285-Methylisoxazol-3-Yl%29-2-%281-Methyl-1h-1%2C2%2C4-Triazol-5-Ylmethoxy%29+Pyrazolo%5B1%2C5-D%5D%5B1%2C2%2C4%5DTriazine%2C+a+Functionally+Selective+Gaba%28a%29+Alpha5+Inverse+Agonist+for+Cognitive+Dysfunction&doi=10.1016%2Fj.bmcl.2005.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)pyrazolo[1,5-d][1,2,4]triazine), a functionally selective GABAA α5 inverse agonist for cognitive dysfunction</span></div><div class="casAuthors">Jones, Philip; Atack, John R.; Braun, Matthew P.; Cato, Brian P.; Chambers, Mark S.; O'Connor, Desmond; Cook, Susan M.; Hobbs, Sarah C.; Maxey, Robert; Szekeres, Helen J.; Szeto, Nicola; Wafford, Keith A.; MacLeod, Angus M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">872-875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">3-Tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)pyrazolo[1,5-d][1,2,4]triazine (1) was recently identified as a functionally selective, inverse agonist at the benzodiazepine site of GABAA α5 receptors and enhances performance in animal models of cognition.  The routes of metab. of this compd. in vivo in rat have been well characterized, the identities of the major metabolites are confirmed by synthesis and their biol. profiles were evaluated.  An unusual oxidn. of the pyrazolo[1,5-d][1,2,4]triazine core to the corresponding pyrazolo[1,5-d][1,2,4]triazin-4(5H)-one scaffold by aldehyde oxidase has been obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3Kn6ffipmLVg90H21EOLACvtfcHk0lheYtmfhks1zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1Gkuw%253D%253D&md5=7b78b6895ef7b3c494fbea1fda5fdee0</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DBraun%26aufirst%3DM.%2BP.%26aulast%3DCato%26aufirst%3DB.%2BP.%26aulast%3DChambers%26aufirst%3DM.%2BS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%26aulast%3DCook%26aufirst%3DS.%2BM.%26aulast%3DHobbs%26aufirst%3DS.%2BC.%26aulast%3DMaxey%26aufirst%3DR.%26aulast%3DSzekeres%26aufirst%3DH.%2BJ.%26aulast%3DSzeto%26aufirst%3DN.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DMacLeod%26aufirst%3DA.%2BM.%26atitle%3DPharmacokinetics%2520and%2520Metabolism%2520Studies%2520on%2520%25283-Tert-Butyl-7-%25285-Methylisoxazol-3-Yl%2529-2-%25281-Methyl-1h-1%252C2%252C4-Triazol-5-Ylmethoxy%2529%2520Pyrazolo%255B1%252C5-D%255D%255B1%252C2%252C4%255DTriazine%252C%2520a%2520Functionally%2520Selective%2520Gaba%2528a%2529%2520Alpha5%2520Inverse%2520Agonist%2520for%2520Cognitive%2520Dysfunction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D4%26spage%3D872%26epage%3D875%26doi%3D10.1016%2Fj.bmcl.2005.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. Y. J.</span></span> <span> </span><span class="NLM_article-title">In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for C-Met Inhibitor Met401</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1007/s13318-019-00557-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs13318-019-00557-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=J.+W.+Zhangauthor=H.+B.+Dengauthor=C.+Y.+Zhangauthor=J.+Q.+Daiauthor=Q.+Liauthor=Q.+G.+Zhengauthor=H.+X.+Wanauthor=H.+P.+Yuauthor=F.+Heauthor=Y.+C.+Xuauthor=S.+Zhaoauthor=J.+Y.+J.+Zhang&title=In+Vitro+Metabolism+by+Aldehyde+Oxidase+Leads+to+Poor+Pharmacokinetic+Profile+in+Rats+for+C-Met+Inhibitor+Met401&doi=10.1007%2Fs13318-019-00557-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1007%2Fs13318-019-00557-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-019-00557-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BW.%26aulast%3DDeng%26aufirst%3DH.%2BB.%26aulast%3DZhang%26aufirst%3DC.%2BY.%26aulast%3DDai%26aufirst%3DJ.%2BQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DQ.%2BG.%26aulast%3DWan%26aufirst%3DH.%2BX.%26aulast%3DYu%26aufirst%3DH.%2BP.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%2BC.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%2BJ.%26atitle%3DIn%2520Vitro%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%2520Leads%2520to%2520Poor%2520Pharmacokinetic%2520Profile%2520in%2520Rats%2520for%2520C-Met%2520Inhibitor%2520Met401%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2019%26doi%3D10.1007%2Fs13318-019-00557-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanoue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uramaru, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span> <span> </span><span class="NLM_article-title">Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.2174/1872312810666161227145358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.2174%2F1872312810666161227145358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28029084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FpvFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=278-285&issue=4&author=C.+Tanoueauthor=K.+Sugiharaauthor=Y.+Tayamaauthor=N.+Uramaruauthor=Y.+Watanabeauthor=S.+Ohtaauthor=S.+Kitamura&title=Variability+of+Zaleplon+5-Oxidase+Activity+in+Mice+and+Humans%2C+and+Inhibition+by+Raloxifene&doi=10.2174%2F1872312810666161227145358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene</span></div><div class="casAuthors">Tanoue Chiaki; Ohta Shigeru; Sugihara Kazumi; Tayama Yoshitaka; Uramaru Naoto; Watanabe Yoko; Kitamura Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Drug metabolism letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">278-285</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Zaleplon (ZAL) is a sedative-hypnotic agent, which is mainly metabolized to inactive 5-oxidized zaleplon (5-oxo-ZAL) and N-des-ethylated ZAL (des-ethyl-ZAL) in mice and humans.  The former reaction is considered to be catalyzed by aldehyde oxidase present in liver cytosol.  METHODS:  Here, we examined sex and strain differences of ZAL metabolism to 5-oxo-ZAL among four strains of mice, as well as the inter-individual variation in humans, in order to evaluate the variability of 5-oxo-ZAL-forming activity and its relationship with aldehyde oxidase activity.  In mice, the activity in C57BL/6J strain was the highest, followed by C3H/He and BALB/c.  The activity in DBA/2J was the lowest, being 2.3-fold lower than that of C57BL/6J mice.  The activity of male mice was higher than that of female mice.  Large inter-individual variations were observed among humans, with a range of 10- fold.  Raloxifene, an inhibitor of aldehyde oxidase, markedly decreased the formation of 5-oxo-ZAL by liver cytosol of mice and humans.  Further, the plasma level of 5-oxo-ZAL in mice was decreased when raloxifene was co-administered with ZAL.  RESULTS:  Our results indicate that the formation of 5-oxo-ZAL from ZAL is mainly catalyzed by aldehyde oxidase in mice and humans, and the variability of 5-oxo-ZAL formation is due primarily to differences of aldehyde oxidase activity.  CONCLUSION:  High inter-individual variability of ZAL 5-oxidase activity and potential for interaction of ZAL with other medicines that are inhibitors of aldehyde oxidase should be taken into consideration in clinical usage of ZAL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCBScGEmrCpIvKgEt20y1XfW6udTcc2eYTv3hIFXccpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FpvFWhuw%253D%253D&md5=3b7cdc7b7e66a9cd11e761e94fdf81da</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.2174%2F1872312810666161227145358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1872312810666161227145358%26sid%3Dliteratum%253Aachs%26aulast%3DTanoue%26aufirst%3DC.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DTayama%26aufirst%3DY.%26aulast%3DUramaru%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DKitamura%26aufirst%3DS.%26atitle%3DVariability%2520of%2520Zaleplon%25205-Oxidase%2520Activity%2520in%2520Mice%2520and%2520Humans%252C%2520and%2520Inhibition%2520by%2520Raloxifene%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2017%26volume%3D10%26issue%3D4%26spage%3D278%26epage%3D285%26doi%3D10.2174%2F1872312810666161227145358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lake, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renwick, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatina, J. A.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Zaleplon by Human Liver: Evidence for Involvement of Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1080/00498250210158915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498250210158915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=12419014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFCktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=835-847&issue=10&author=B.+G.+Lakeauthor=S.+E.+Ballauthor=J.+Kaoauthor=A.+B.+Renwickauthor=R.+J.+Priceauthor=J.+A.+Scatina&title=Metabolism+of+Zaleplon+by+Human+Liver%3A+Evidence+for+Involvement+of+Aldehyde+Oxidase&doi=10.1080%2F00498250210158915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase</span></div><div class="casAuthors">Lake, B. G.; Ball, S. E.; Kao, J.; Renwick, A. B.; Price, R. J.; Scatina, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">835-847</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. The metab. of Zaleplon (CL-284,846; ZAL) was studied in precision-cut human liver slices and liver cytosol prepns.  2. Human liver slices metabolized ZAL to a no. of products including 5-oxo-ZAL (M2), N-desethyl-5-oxo-ZAL (M1), and N-desethyl-ZAL (DZAL), the latter metabolite being known to be formed by CYP3A forms.  3. Human liver cytosol prepns. catalyzed the metab. of ZAL to M2.  Kinetic anal. of 3 cytosol prepns. revealed mean Km and Vmax of 93 mm and 317 pmol/min/mg protein, resp.  4. Using 16 individual human liver cytosol prepns. a 33-fold variability in the metab. of 80 μM ZAL to M2 was obsd.  Correlations were obsd. between M2 formation and the metab. of the aldehyde oxidase substrates phenanthridine (r2 = 0.774) and phthalazine (r2 = 0.460).  5. The metab. of 80 μM ZAL to M2 in liver cytosol prepns. was markedly inhibited by the aldehyde oxidase inhibitors chlorpromazine, promethazine, hydralazine, and menadione.  Addnl. kinetic anal. suggested that chlorpromazine and promethazine were non-competitive inhibitors of M2 formation with Ki of 2.3 and 1.9 μM, resp.  ZAL metab. to M2 was also inhibited by cimetidine.  6. Incubations conducted with human liver cytosol and H218O demonstrated that the oxygen atom incorporated into ZAL and DZAL to form M2 and M1, resp., was derived from water and not from mol. oxygen.  7. In summary, by correlation anal., chem. inhibition and H218O incorporation studies, ZAL metab. to M2 in human liver appears to be catalyzed by aldehyde oxidase.  With human liver slices, ZAL was metabolized to products dependent on both aldehyde oxidase and CYP3A forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokS2P9qpmL0rVg90H21EOLACvtfcHk0lg4HgZiJqIKyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFCktbw%253D&md5=1c2287b2cd01a2290085e707af3a93ad</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1080%2F00498250210158915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250210158915%26sid%3Dliteratum%253Aachs%26aulast%3DLake%26aufirst%3DB.%2BG.%26aulast%3DBall%26aufirst%3DS.%2BE.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DRenwick%26aufirst%3DA.%2BB.%26aulast%3DPrice%26aufirst%3DR.%2BJ.%26aulast%3DScatina%26aufirst%3DJ.%2BA.%26atitle%3DMetabolism%2520of%2520Zaleplon%2520by%2520Human%2520Liver%253A%2520Evidence%2520for%2520Involvement%2520of%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2002%26volume%3D32%26issue%3D10%26spage%3D835%26epage%3D847%26doi%3D10.1080%2F00498250210158915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of (S)-1-(1-(Imidazo[1,2-a]Pyridin-6-Yl)Ethyl)-6-(1-Methyl-1h-Pyrazol-4-Yl)-1h-[1,2, 3]Triazolo[4,5-B]Pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (C-Met) Inhibitor in Clinical Development for Treatment of Cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7577</span>– <span class="NLM_lpage">7589</span>, <span class="refDoi"> DOI: 10.1021/jm500510f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500510f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7577-7589&issue=18&author=H.+Jiaauthor=G.+Daiauthor=J.+Wengauthor=Z.+Zhangauthor=Q.+Wangauthor=F.+Zhouauthor=L.+Jiaoauthor=Y.+Cuiauthor=Y.+Renauthor=S.+Fanauthor=J.+Zhouauthor=W.+Qingauthor=Y.+Guauthor=J.+Wangauthor=Y.+Saiauthor=W.+Su&title=Discovery+of+%28S%29-1-%281-%28Imidazo%5B1%2C2-a%5DPyridin-6-Yl%29Ethyl%29-6-%281-Methyl-1h-Pyrazol-4-Yl%29-1h-%5B1%2C2%2C+3%5DTriazolo%5B4%2C5-B%5DPyrazine+%28Volitinib%29+as+a+Highly+Potent+and+Selective+Mesenchymal-Epithelial+Transition+Factor+%28C-Met%29+Inhibitor+in+Clinical+Development+for+Treatment+of+Cancer&doi=10.1021%2Fjm500510f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer</span></div><div class="casAuthors">Jia, Hong; Dai, Guangxiu; Weng, Jianyang; Zhang, Zhulin; Wang, Qing; Zhou, Feng; Jiao, Longxian; Cui, Yumin; Ren, Yongxin; Fan, Shiming; Zhou, Jinghong; Qing, Weiguo; Gu, Yi; Wang, Jian; Sai, Yang; Su, Weiguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7577-7589</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HGF/c-Met signaling has been implicated in human cancers.  Herein we describe the invention of a series of novel triazolopyrazine c-Met inhibitors.  The structure-activity relation of these compds. was investigated, leading to the identification of Volitinib (I), which demonstrated favorable pharmacokinetic properties in mice and good antitumor activities in the human glioma xenograft model in athymic nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJmuzIGrPGZbVg90H21EOLACvtfcHk0lg4HgZiJqIKyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7jN&md5=aced38bbd7431f5ac01b6698e8657261</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm500510f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500510f%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DQing%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%2528S%2529-1-%25281-%2528Imidazo%255B1%252C2-a%255DPyridin-6-Yl%2529Ethyl%2529-6-%25281-Methyl-1h-Pyrazol-4-Yl%2529-1h-%255B1%252C2%252C%25203%255DTriazolo%255B4%252C5-B%255DPyrazine%2520%2528Volitinib%2529%2520as%2520a%2520Highly%2520Potent%2520and%2520Selective%2520Mesenchymal-Epithelial%2520Transition%2520Factor%2520%2528C-Met%2529%2520Inhibitor%2520in%2520Clinical%2520Development%2520for%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D18%26spage%3D7577%26epage%3D7589%26doi%3D10.1021%2Fjm500510f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, G. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span> <span> </span><span class="NLM_article-title">Identification of 3-Substituted-6-(1-(1h-[1,2,3]Triazolo[4,5-B]Pyrazin-1-Yl)Ethyl)Quinoline Derivatives as Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (C-Met) Inhibitors Via Metabolite Profiling-Based Structural Optimization</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.ejmech.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28411455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFGht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=147-158&author=F.+Zhaoauthor=L.+D.+Zhangauthor=Y.+Haoauthor=N.+Chenauthor=R.+Baiauthor=Y.+J.+Wangauthor=C.+C.+Zhangauthor=G.+S.+Liauthor=L.+J.+Haoauthor=C.+Shiauthor=J.+Zhangauthor=Y.+Maoauthor=Y.+Fanauthor=G.+X.+Xiaauthor=J.+X.+Yuauthor=Y.+J.+Liu&title=Identification+of+3-Substituted-6-%281-%281h-%5B1%2C2%2C3%5DTriazolo%5B4%2C5-B%5DPyrazin-1-Yl%29Ethyl%29Quinoline+Derivatives+as+Highly+Potent+and+Selective+Mesenchymal-Epithelial+Transition+Factor+%28C-Met%29+Inhibitors+Via+Metabolite+Profiling-Based+Structural+Optimization&doi=10.1016%2Fj.ejmech.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization</span></div><div class="casAuthors">Zhao, Fei; Zhang, Le-Duo; Hao, Yu; Chen, Na; Bai, Rui; Wang, Yu-Ji; Zhang, Chun-Chun; Li, Gong-Sheng; Hao, Li-Jun; Shi, Chen; Zhang, Jing; Mao, Yu; Fan, Yi; Xia, Guang-Xin; Yu, Jian-Xin; Liu, Yan-Jun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">C-Met/HGF signaling pathway plays an important role in cancer progression, and it was considered to be related to poor prognosis and drug resistance.  Based on metabolite profiling of (S)-7-fluoro-6-(1-(6-(1-methyl-1H-pyrazol-4-yl)-1H-imidazo[4,5-b]pyrazin-1-yl)ethyl)quinoline, a series of 2-substituted or 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivs. was rationally designed and evaluated.  Most of the 3-substituted derivs. not only exhibited potent activities in both enzymic and cellular assays, but also were stable in liver microsomes among different species (human, rat and monkey).  SAR investigation revealed that introducing of N-methyl-1H-pyrazol-4-yl group at the 3-position of quinoline moiety is beneficial to improve the inhibitory potency, esp. in the cellular assays.  The influence of fluorine atom at 7-position or 5, 7-position of quinoline moiety and substituents at the 6-position of triazolo[4,5-b]pyrazine core on overall activity is not very significant.  Racemate I, an extremely potent and exquisitely selective c-Met inhibitor, demonstrated favorable pharmacokinetic properties in rats, no significant AO metab., and effective tumor growth inhibition in c-Met overexpressed NSCLC (H1993 cell line) and gastric cancer (SNU-5 cell line) xenograft models.  Docking anal. indicated that besides the typical interactions of most selective c-Met inhibitors, the intramol. halogen bond and addnl. hydrogen bond interactions with kinase are beneficial to the binding.  These results may provide deep insight into potential structural modifications for developing potent c-Met inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgyqGUbEUV5LVg90H21EOLACvtfcHk0lg5fA_ukctIxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFGht78%253D&md5=baf9368a3f9c4c7638c53c532686206f</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DL.%2BD.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DG.%2BS.%26aulast%3DHao%26aufirst%3DL.%2BJ.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DG.%2BX.%26aulast%3DYu%26aufirst%3DJ.%2BX.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26atitle%3DIdentification%2520of%25203-Substituted-6-%25281-%25281h-%255B1%252C2%252C3%255DTriazolo%255B4%252C5-B%255DPyrazin-1-Yl%2529Ethyl%2529Quinoline%2520Derivatives%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Mesenchymal-Epithelial%2520Transition%2520Factor%2520%2528C-Met%2529%2520Inhibitors%2520Via%2520Metabolite%2520Profiling-Based%2520Structural%2520Optimization%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D147%26epage%3D158%26doi%3D10.1016%2Fj.ejmech.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robeson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics, Metabolism and Excretion of Idelalisib</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">5570</span>– <span class="NLM_lpage">5570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1182%2Fblood.V122.21.5570.5570" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=5570-5570&issue=21&author=M.+Robesonauthor=H.+Zhouauthor=E.+Kwanauthor=S.+Ramanathan&title=Pharmacokinetics%2C+Metabolism+and+Excretion+of+Idelalisib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1182%2Fblood.V122.21.5570.5570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V122.21.5570.5570%26sid%3Dliteratum%253Aachs%26aulast%3DRobeson%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKwan%26aufirst%3DE.%26aulast%3DRamanathan%26aufirst%3DS.%26atitle%3DPharmacokinetics%252C%2520Metabolism%2520and%2520Excretion%2520of%2520Idelalisib%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26issue%3D21%26spage%3D5570%26epage%3D5570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kearney, B. P.</span></span> <span> </span><span class="NLM_article-title">Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0304-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs40262-015-0304-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26242379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=33-45&issue=1&author=S.+Ramanathanauthor=F.+Jinauthor=S.+Sharmaauthor=B.+P.+Kearney&title=Clinical+Pharmacokinetic+and+Pharmacodynamic+Profile+of+Idelalisib&doi=10.1007%2Fs40262-015-0304-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib</span></div><div class="casAuthors">Ramanathan, Srinivasan; Jin, Feng; Sharma, Shringi; Kearney, Brian P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-45</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Idelalisib is a potent and selective phosphatidylinositol 3-kinase-δ inhibitor, which is a first-in-class agent to be approved for the treatment of relapsed chronic lymphocytic leukemia, follicular B cell non-Hodgkin's lymphoma and small lymphocytic lymphoma.  In dose-ranging studies, idelalisib exposure increased in a less than dose-proportional manner, likely because of soly.-limited absorption.  The approved starting dose of 150 mg twice daily was supported by extensive exposure-response evaluations, with dose redn. to 100 mg twice daily being allowed for specific toxicities.  Idelalisib may be administered without regard to food on the basis of the absence of clin. relevant food effects, and was accordingly dosed in primary efficacy/safety studies.  Idelalisib is metabolized primarily via aldehyde oxidase (AO) and, to a lesser extent, via cytochrome P 450 (CYP) 3A.  Coadministration with the strong CYP3A inhibitor ketoconazole 400 mg once daily resulted in a ∼79 % increase in the idelalisib area under the plasma concn.-time curve (AUC).  Administration with the potent inducer rifampin resulted in a 75 % decrease in idelalisib exposure (AUC) and, as such, coadministration with strong inducers should be avoided.  GS-563117 is an inactive primary circulating metabolite of idelalisib formed mainly via AO.  Unlike idelalisib, GS-563117 is a mechanism-based inhibitor of CYP3A.  Accordingly, idelalisib 150 mg twice-daily dosing increases the midazolam AUC 5.4-fold.  Clin., idelalisib is not an inhibitor of the transporters P-glycoprotein, breast cancer resistance protein, org. anion-transporting polypeptide (OATP) 1B1 or OAPT1B3.  In a population pharmacokinetic model, no meaningful impact on idelalisib pharmacokinetics was noted for any of the covariates tested.  Idelalisib exposure was ∼60 % higher with moderate/severe hepatic impairment; no relevant changes were obsd. with severe renal impairment.  This article reviews a comprehensive pharmacol. program, including drug-drug interaction studies and mechanistic and special population studies, which has allowed a thorough understanding of idelalisib clin. pharmacokinetics and their impact on clin. safety and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprSL8hV_Gha7Vg90H21EOLACvtfcHk0lg5fA_ukctIxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSit7o%253D&md5=df1082fcbb0e1a9aa941769ade9fe962</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0304-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0304-0%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DF.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKearney%26aufirst%3DB.%2BP.%26atitle%3DClinical%2520Pharmacokinetic%2520and%2520Pharmacodynamic%2520Profile%2520of%2520Idelalisib%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26issue%3D1%26spage%3D33%26epage%3D45%26doi%3D10.1007%2Fs40262-015-0304-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choughule, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaba, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">In Vitro Oxidative Metabolism of 6-Mercaptopurine in Human Liver: Insights into the Role of the Molybdoflavoenzymes Aldehyde Oxidase, Xanthine Oxidase, and Xanthine Dehydrogenase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1334</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.058107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.058107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24824603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFentrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1334-1340&issue=8&author=K.+V.+Choughuleauthor=C.+Barnabaauthor=C.+A.+Joswig-Jonesauthor=J.+P.+Jones&title=In+Vitro+Oxidative+Metabolism+of+6-Mercaptopurine+in+Human+Liver%3A+Insights+into+the+Role+of+the+Molybdoflavoenzymes+Aldehyde+Oxidase%2C+Xanthine+Oxidase%2C+and+Xanthine+Dehydrogenase&doi=10.1124%2Fdmd.114.058107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase and xanthine dehydrogenase</span></div><div class="casAuthors">Choughule, Kanika V.; Barnaba, Carlo; Joswig-Jones, Carolyn A.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1334-1340, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Anticancer agent 6-mercaptopurine (6MP) has been in use since 1953 for the treatment of childhood acute lymphoblastic leukemia (ALL) and inflammatory bowel disease.  Despite being available for 60 years, several aspects of 6MP drug metab. and pharmacokinetics in humans are unknown.  Molybdoflavoenzymes such as aldehyde oxidase (AO) and xanthine oxidase (XO) have previously been implicated in the metab. of this drug.  In this study, the authors investigated the in vitro metab. of 6MP to 6-thiouric acid (6TUA) in pooled human liver cytosol.  The authors discovered that 6MP is metabolized to 6TUA through sequential metab. via the 6-thioxanthine (6TX) intermediate.  The role of human AO and XO in the metab. of 6MP was established using the specific inhibitors raloxifene and febuxostat.  Both AO and XO were involved in the metab. of the 6TX intermediate, whereas only XO was responsible for the conversion of 6TX to 6TUA.  These findings were further confirmed using purified human AO and Escherichia coli lysate contg. expressed recombinant human XO.  Xanthine dehydrogenase (XDH), which belongs to the family of xanthine oxidoreductases and preferentially reduces NAD (NAD+), was shown to contribute to the overall prodn. of the 6TX intermediate as well as the final product 6TUA in the presence of NAD+ in human liver cytosol.  In conclusion, the authors present evidence that three enzymes, AO, XO and XDH, contribute to the prodn. of 6TX intermediate, whereas only XO and XDH are involved in the conversion of 6TX to 6TUA in pooled HLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLcFznxA1HqLVg90H21EOLACvtfcHk0lg5fA_ukctIxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFentrfP&md5=97c192f3b6cb6a91a9a1fd06e3948607</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.058107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.058107%26sid%3Dliteratum%253Aachs%26aulast%3DChoughule%26aufirst%3DK.%2BV.%26aulast%3DBarnaba%26aufirst%3DC.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DIn%2520Vitro%2520Oxidative%2520Metabolism%2520of%25206-Mercaptopurine%2520in%2520Human%2520Liver%253A%2520Insights%2520into%2520the%2520Role%2520of%2520the%2520Molybdoflavoenzymes%2520Aldehyde%2520Oxidase%252C%2520Xanthine%2520Oxidase%252C%2520and%2520Xanthine%2520Dehydrogenase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D8%26spage%3D1334%26epage%3D1340%26doi%3D10.1124%2Fdmd.114.058107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, C.</span></span> <span> </span><span class="NLM_article-title">Metabolism and Excretion of 6-Chloro-9-(4-Methoxy-3,5-Dimethylpyridin-2-Ylmethyl)-9h-Purin-2-Ylamine, an Hsp90 Inhibitor, in Rats and Dogs and Assessment of Its Metabolic Profile in Plasma of Humans</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2133</span>– <span class="NLM_lpage">2147</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.054023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.113.054023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24046333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=2133-2147&issue=12&author=L.+Xuauthor=C.+Woodwardauthor=J.+Daiauthor=C.+Prakash&title=Metabolism+and+Excretion+of+6-Chloro-9-%284-Methoxy-3%2C5-Dimethylpyridin-2-Ylmethyl%29-9h-Purin-2-Ylamine%2C+an+Hsp90+Inhibitor%2C+in+Rats+and+Dogs+and+Assessment+of+Its+Metabolic+Profile+in+Plasma+of+Humans&doi=10.1124%2Fdmd.113.054023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and excretion of 6-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine, an HSP90 inhibitor, in rats and dogs and assessment of its metabolic profile in plasma of humans</span></div><div class="casAuthors">Xu, Lin; Woodward, Caroline; Dai, Jing; Prakash, Chandra</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2133-2147</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">6-Chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine (BIIB021), a synthetic HSP90 inhibitor, exhibited promising antitumor activity in preclin. models and was in development for the treatment of breast cancer.  The metab. and excretion of BIIB021 was investigated in rats and dogs after oral administration of [14C]BIIB021.  The administered radioactive dose was quant. recovered in both species, and feces/bile was the major route of excretion.  Metabolic profiling revealed that BIIB021 is extensively metabolized primarily via hydroxylation of the Me group (M7), O-demethylation (M2), and to a lesser extent by glutathione conjugation (M8 and M9).  M7 was further metabolized to form the carboxylic acid (M3) and glucuronide conjugate (M4).  Human plasma obtained from the phase I study in cancer patients were also analyzed to assess the metab. of BIIB021 in humans and to ensure that selected animal species were exposed to all human major metabolites.  Results suggested that BIIB021 is metabolized via hydroxylation followed by carboxylation and glucuronidation in humans consistent with rat and dog; however, an addnl. dominant circulating metabolite, hydroxylation at the purine ring (M10), was identified in humans.  Preliminary in vitro studies using liver cytosolic fractions indicated that M10 formation is primarily catalyzed by aldehyde oxidase (AO).  AO catalytic activity for M10 formation was the highest in the monkey, followed by mouse, human, and rat.  The apparent Km and Vmax values of M10 formation were 174 ± 8 μM and 14.0 ± 0.3 pmol•min-1•mg protein-1 in human and 132 ± 9 μM and 131 ± 4 pmol•min-1•mg protein-1 in monkey, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfFSIHj4horbVg90H21EOLACvtfcHk0liQsvZBdz_U_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbjK&md5=656da9292fac38b27edbb95c7a9c83a5</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.054023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.054023%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DPrakash%26aufirst%3DC.%26atitle%3DMetabolism%2520and%2520Excretion%2520of%25206-Chloro-9-%25284-Methoxy-3%252C5-Dimethylpyridin-2-Ylmethyl%2529-9h-Purin-2-Ylamine%252C%2520an%2520Hsp90%2520Inhibitor%252C%2520in%2520Rats%2520and%2520Dogs%2520and%2520Assessment%2520of%2520Its%2520Metabolic%2520Profile%2520in%2520Plasma%2520of%2520Humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26issue%3D12%26spage%3D2133%26epage%3D2147%26doi%3D10.1124%2Fdmd.113.054023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, M. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of O6-Benzylguanine in Rats and Its Metabolism by Rat Liver Microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1394</span>– <span class="NLM_lpage">1399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8689950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28XhvF2nug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=1394-1399&issue=12&author=S.+K.+Royauthor=E.+Guptaauthor=M.+E.+Dolan&title=Pharmacokinetics+of+O6-Benzylguanine+in+Rats+and+Its+Metabolism+by+Rat+Liver+Microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of O6-benzylguanine in rats and its metabolism by Rat liver microsomes</span></div><div class="casAuthors">Roy, Sandip K.; Gupta, Elora; Dolan, M. Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1394-9</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">O6-benzylguanine is an effective inhibitor of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase, and enhances the effectiveness of 1,3-bis(2-chloroethyl)-1-nitrosourea in cells in culture and animal tumor models.  To prep. O6-benzylguanine for clin. trials and to det. the availability and disposition of O6-benzyl-7,8-dihydro-8-oxoguanine (O6-benzyl-8-oxoguanine), its major metabolite, pharmacokinetic parameters of these compds. were investigated in male Sprague-Dawley rats.  Noncompartmental pharmacokinetic parameters were detd. following i.v. administration of O6-benzylguanine or O6-benzyl-8-oxoguanine in rats.  Half-life, clearance, and vol. of distribution were resp., 1.6 h, 160 mL/h/kg, and 405 g/kg for O6-benzylguanine, and 1.2 h, 312 mL/h/kg, and 405 mL/kg for O6-benzylguanine, and 1.2 h, 312 mL/h/kg, and 507 mL/kg for O6-benzyl-8-oxoguanine.  At least 37% of O6-benzylguanine was converted to O6-benzyl-8-oxoguanine after administration of O6-benzylguanine.  Renal excretion accounted for 8 and 62% of the administered O6-benzyl-8-oxoguanine after administration of O6-benzylguanine,resp.  Administration of phenobarbital to rats before O6-benzylguanine resulted in a 17- to 19-fold increase in the amt. of oxidized product in the urine.  Kinetic consts., KM and Vmax were estd. as 19.6 μM and 0.02 nmol/min/mg protein and 13.4 μM and 0.96 nmol/min/mg protein, for un-induced and induced rat liver microsomes, resp.  The use of inhibitors of cytosolic enzymes, xanthine oxidase, and aldehyde oxidase indicated that aldehyde oxidase is primarily involved in the cytosolic oxidn. of O6-benzylguanine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNzndL4iv85rVg90H21EOLACvtfcHk0liQsvZBdz_U_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvF2nug%253D%253D&md5=d4aa6ace9f95bea963bf1371a211751a</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%2BK.%26aulast%3DGupta%26aufirst%3DE.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26atitle%3DPharmacokinetics%2520of%2520O6-Benzylguanine%2520in%2520Rats%2520and%2520Its%2520Metabolism%2520by%2520Rat%2520Liver%2520Microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1995%26volume%3D23%26issue%3D12%26spage%3D1394%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitchen, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balis, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widemann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, P. C.</span></span> <span> </span><span class="NLM_article-title">Thioguanine Administered as a Continuous Intravenous Infusion to Pediatric Patients Is Metabolized to the Novel Metabolite 8-Hydroxy-Thioguanine</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">870</span>– <span class="NLM_lpage">874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10525111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXntFChu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1999&pages=870-874&issue=2&author=B.+J.+Kitchenauthor=A.+Moserauthor=E.+Loweauthor=F.+M.+Balisauthor=B.+Widemannauthor=L.+Andersonauthor=J.+Strongauthor=S.+M.+Blaneyauthor=S.+L.+Bergauthor=M.+O%E2%80%99Brienauthor=P.+C.+Adamson&title=Thioguanine+Administered+as+a+Continuous+Intravenous+Infusion+to+Pediatric+Patients+Is+Metabolized+to+the+Novel+Metabolite+8-Hydroxy-Thioguanine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxythioguanine</span></div><div class="casAuthors">Kitchen, Brenda J.; Moser, Asher; Lowe, Elizabeth; Balis, Frank M.; Widemann, Brigitte; Anderson, Lawrence; Strong, John; Blaney, Susan M.; Berg, Stacey L.; O'Brien, Michelle; Adamson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">870-874</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thiopurine antimetabolites have been in clin. use for more than 40 yr, yet the metab. of thiopurines remains only partially understood.  Data from our previous pediatric phase 1 trial of continuous i.v. infusion of thioguanine (CIVI-TG) suggested that TG was eliminated by saturable mechanism, with conversion of the drug to an unknown metabolite.  In this study we have identified this metabolite as 8-hydroxythioguanine (8-OH-TG).  The metabolite coeluted with the 8-OH-TG std. on HPLC and had an identical UV spectrum, with a λmax of 350 nm.  On mass spectroscopy, the pos. ion, single quad scan of 8-OH-TG yielded a protonated mol. ion at 184 Da and contained diagnostic ions at m/z 167, 156, 142, and 125 Da.  Incubation of TG in vitro with partially purified aldehyde oxidase resulted in 8-OH-TG formation.  8-OH-TG is the predominant circulating metabolite found in patients receiving CIVI-TG and is likely generated by the action of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcB3qraig1kbVg90H21EOLACvtfcHk0liQsvZBdz_U_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFChu7g%253D&md5=6af192138b458d31826c203f251c89de</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitchen%26aufirst%3DB.%2BJ.%26aulast%3DMoser%26aufirst%3DA.%26aulast%3DLowe%26aufirst%3DE.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26aulast%3DWidemann%26aufirst%3DB.%26aulast%3DAnderson%26aufirst%3DL.%26aulast%3DStrong%26aufirst%3DJ.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DBerg%26aufirst%3DS.%2BL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DAdamson%26aufirst%3DP.%2BC.%26atitle%3DThioguanine%2520Administered%2520as%2520a%2520Continuous%2520Intravenous%2520Infusion%2520to%2520Pediatric%2520Patients%2520Is%2520Metabolized%2520to%2520the%2520Novel%2520Metabolite%25208-Hydroxy-Thioguanine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D291%26issue%3D2%26spage%3D870%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philip, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y. Z.</span></span> <span> </span><span class="NLM_article-title">A Novel Ring Oxidation of 4- or 5-Substituted 2h-Oxazole to Corresponding 2-Oxazolone Catalyzed by Cytosolic Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1676</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.044545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.044545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22621803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1668-1676&issue=9&author=V.+K.+Aroraauthor=T.+Philipauthor=S.+Huangauthor=Y.+Z.+Shu&title=A+Novel+Ring+Oxidation+of+4-+or+5-Substituted+2h-Oxazole+to+Corresponding+2-Oxazolone+Catalyzed+by+Cytosolic+Aldehyde+Oxidase&doi=10.1124%2Fdmd.112.044545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">A novel ring oxidation of 4- or 5-substituted 2H-oxazole to corresponding 2-oxazolone catalyzed by cytosolic aldehyde oxidase</span></div><div class="casAuthors">Arora, Vinod K.; Philip, Thomas; Huang, Stella; Shu, Yue-Zhong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1668-1676</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ring oxidn. of 2H-oxazole, or C2-unsubstituted oxazole, to 2-oxazolone, a cyclic carbamate, was obsd. on various 4- or 5-substituted oxazoles.  Using 5-(3-bromophenyl)oxazole as a model compd., its 2-oxazolone metabolite M1 was fully characterized by liq. chromatog./tandem mass spectrometry and NMR.  The reaction mainly occurred in the liver cytosolic fraction without the requirement of cytochrome P 450 enzymes and cofactor NADPH.  Investigations into the mechanism of formation of 2-oxazolone using various chem. inhibitors indicated that the reaction was primarily catalyzed by aldehyde oxidase and not by xanthine oxidase.  In addn., cytosol incubation of 5-(3-bromophenyl)oxazole in the medium contg. H218O led to the 18O incorporation into M1, substantiating the reaction mechanism of a typical molybdenum hydroxylase.  The rank order of liver cytosols for the 2-oxazolone formation was mouse > monkey >> rat and human liver cytosol, whereas M1 was not formed in dog liver cytosol.  Because the reaction was obsd. with a no. of 4- or 5-substituted 2H-oxazoles in mouse liver cytosols, 2H-oxazoles represent a new substrate chemotype for ring oxidn. catalyzed by aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcTnuHHmEkLVg90H21EOLACvtfcHk0lj8_GHBvyb1qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShtbjM&md5=b2849d6f5d1ac5a35ac330ab225cf1e7</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.044545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.044545%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DPhilip%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DShu%26aufirst%3DY.%2BZ.%26atitle%3DA%2520Novel%2520Ring%2520Oxidation%2520of%25204-%2520or%25205-Substituted%25202h-Oxazole%2520to%2520Corresponding%25202-Oxazolone%2520Catalyzed%2520by%2520Cytosolic%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D9%26spage%3D1668%26epage%3D1676%26doi%3D10.1124%2Fdmd.112.044545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chissick, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K.</span></span> <span> </span><span class="NLM_article-title">The Role of Aldehyde Oxidase in the in Vivo Metabolism of Benzothiazole</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">604S</span>, <span class="refDoi"> DOI: 10.1042/bst023604s</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1042%2Fbst023604s" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8654789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28XhtVWktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=604S&issue=4&author=A.+M.+Fowlerauthor=H.+H.+Chissickauthor=M.+J.+Frearsonauthor=K.+Wilson&title=The+Role+of+Aldehyde+Oxidase+in+the+in+Vivo+Metabolism+of+Benzothiazole&doi=10.1042%2Fbst023604s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The role of aldehyde oxidase in the in vivo metabolism of benzothiazole</span></div><div class="casAuthors">Fowler, A. Michelle; Chissick, Harvey H.; Frearson, Martin J.; Wilson, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">604S</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press</span>)
        </div><div class="casAbstract">Benzothiazole and 2-hydroxybenzothiazole were metabolized to 2-methylmercaptoaniline, 2-methylsulfinylaniline, and 2-methylsulfonylaniline in guinea pigs indicating that aldehyde oxidase may have a key role in the in vivo metab. of benzothiazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Grn-EPTTTLVg90H21EOLACvtfcHk0lj8_GHBvyb1qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtVWktLo%253D&md5=b013e109d3e20c3c04e5ef3aab869b60</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1042%2Fbst023604s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst023604s%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DA.%2BM.%26aulast%3DChissick%26aufirst%3DH.%2BH.%26aulast%3DFrearson%26aufirst%3DM.%2BJ.%26aulast%3DWilson%26aufirst%3DK.%26atitle%3DThe%2520Role%2520of%2520Aldehyde%2520Oxidase%2520in%2520the%2520in%2520Vivo%2520Metabolism%2520of%2520Benzothiazole%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D1995%26volume%3D23%26issue%3D4%26spage%3D604S%26doi%3D10.1042%2Fbst023604s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cesarini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyrakis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosconi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goracci, L.</span></span> <span> </span><span class="NLM_article-title">From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01552</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01552" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOru7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=360-371&issue=1&author=G.+Crucianiauthor=N.+Milaniauthor=P.+Benedettiauthor=S.+Lepriauthor=L.+Cesariniauthor=M.+Baroniauthor=F.+Spyrakisauthor=S.+Tortorellaauthor=E.+Mosconiauthor=L.+Goracci&title=From+Experiments+to+a+Fast+Easy-to-Use+Computational+Methodology+to+Predict+Human+Aldehyde+Oxidase+Selectivity+and+Metabolic+Reactions&doi=10.1021%2Facs.jmedchem.7b01552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions</span></div><div class="casAuthors">Cruciani, Gabriele; Milani, Nicolo; Benedetti, Paolo; Lepri, Susan; Cesarini, Lucia; Baroni, Massimo; Spyrakis, Francesca; Tortorella, Sara; Mosconi, Edoardo; Goracci, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">360-371</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is a molibdo-flavoenzyme that raised great interest in recent years, since its contribution in xenobiotics metab. has not always been identified before clin. trials, with consequent neg. effects on the fate of new potential drugs.  The fundamental role of AOX in metabolizing xenobiotics is also due to the attempt of medicinal chemists to stabilize candidates toward cytochrome P 450 activity, which increases the risk for new compds. to be susceptible to AOX nucleophile attack.  Therefore, novel strategies to predict the potential liability of new entities towards AOX enzyme are urgently needed to increase effectiveness, reduce costs, and prioritize exptl. studies.  In the present work, we present the most up-to-date computational method to predict liability towards human AOX, for applications in drug design and pharmacokinetic optimization.  The method was developed using a large dataset of homogeneous exptl. data, which is also disclosed as supplementary material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_Tnrnus317Vg90H21EOLACvtfcHk0lj8_GHBvyb1qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOru7fK&md5=23c7fd8a5abcba87e7fc065d5e6dafc6</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01552%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DMilani%26aufirst%3DN.%26aulast%3DBenedetti%26aufirst%3DP.%26aulast%3DLepri%26aufirst%3DS.%26aulast%3DCesarini%26aufirst%3DL.%26aulast%3DBaroni%26aufirst%3DM.%26aulast%3DSpyrakis%26aufirst%3DF.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DMosconi%26aufirst%3DE.%26aulast%3DGoracci%26aufirst%3DL.%26atitle%3DFrom%2520Experiments%2520to%2520a%2520Fast%2520Easy-to-Use%2520Computational%2520Methodology%2520to%2520Predict%2520Human%2520Aldehyde%2520Oxidase%2520Selectivity%2520and%2520Metabolic%2520Reactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D1%26spage%3D360%26epage%3D371%26doi%3D10.1021%2Facs.jmedchem.7b01552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosogi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, T.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase B Oxidizes a Novel Multikinase Inhibitor Kw-2449 to Its Iminium Ion and Aldehyde Oxidase Further Converts It to the Oxo-Piperazine Form in Human</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/j.dmpk.2017.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.dmpk.2017.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28751116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=255-264&issue=5&author=J.+Hosogiauthor=R.+Ohashiauthor=H.+Maedaauthor=S.+Tashiroauthor=E.+Fuseauthor=Y.+Yamamotoauthor=T.+Kuwabara&title=Monoamine+Oxidase+B+Oxidizes+a+Novel+Multikinase+Inhibitor+Kw-2449+to+Its+Iminium+Ion+and+Aldehyde+Oxidase+Further+Converts+It+to+the+Oxo-Piperazine+Form+in+Human&doi=10.1016%2Fj.dmpk.2017.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase B oxidizes a novel multikinase inhibitor KW-2449 to its iminium ion and aldehyde oxidase further converts it to the oxo-piperazine form in human</span></div><div class="casAuthors">Hosogi, Jun; Ohashi, Rui; Maeda, Hiroshi; Tashiro, Satoshi; Fuse, Eiichi; Yamamoto, Yorihiro; Kuwabara, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">255-264</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">(E)-1-{4-[2-(1H-Indazol-3-yl)vinyl]benzoyl}piperazine (KW-2449) is a novel multikinase inhibitor.  During our clin. study, we found that KW-2449 is mainly metabolized to its oxo-piperazine form (M1).  An inhibition study suggested that monoamine oxidase-B (MAO-B) oxidizes KW-2449 to an iminium (intermediate) and aldehyde oxidase (AO) then metabolizes the intermediate to M1.  The conversion of KW-2449 to the iminium (intermediate) by MAO-B was confirmed by the formation of its cyanide adduct.  This cooperative metabolic pathway by MAO-B and AO was newly identified in the metab. of piperazine.  The clearance of KW-2449 by MAO-B and AO in human was estd. based on the kinetic anal. with in vitro-in vivo extrapolation.  The systemic clearance in human was similar to the calcd. value, indicating that the extrapolation approach was applicable to KW-2449 metab.  Finally, we found that (E)-3-amino-1-{4-[2-(1H-Indazol-3-yl)vinyl]benzoyl}-pyrrolidine (Compd. A) as a stable compd. against MAO-B and AO.  The total body clearance of Compd. A was reduced to one tenth of KW-2449, demonstrating that preventing the metab. of MAO and AO led to more preferable pharmacokinetic profiles.  As piperazine is often introduced to drug candidates to improve lipophilicity of the compd. to get more hydrophilic nature, the results of this study provide useful information for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2fKwc369Ix7Vg90H21EOLACvtfcHk0lhA2lU8FIh2dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmt7nO&md5=1846c419191a12469d1be35860c67cf9</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.dmpk.2017.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dmpk.2017.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DHosogi%26aufirst%3DJ.%26aulast%3DOhashi%26aufirst%3DR.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DFuse%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuwabara%26aufirst%3DT.%26atitle%3DMonoamine%2520Oxidase%2520B%2520Oxidizes%2520a%2520Novel%2520Multikinase%2520Inhibitor%2520Kw-2449%2520to%2520Its%2520Iminium%2520Ion%2520and%2520Aldehyde%2520Oxidase%2520Further%2520Converts%2520It%2520to%2520the%2520Oxo-Piperazine%2520Form%2520in%2520Human%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2017%26volume%3D32%26issue%3D5%26spage%3D255%26epage%3D264%26doi%3D10.1016%2Fj.dmpk.2017.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosogi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ushiki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, T.</span></span> <span> </span><span class="NLM_article-title">An Iminium Ion Metabolite Hampers the Production of the Pharmacologically Active Metabolite of a Multikinase Inhibitor Kw-2449 in Primates: Irreversible Inhibition of Aldehyde Oxidase and Covalent Binding with Endogenous Proteins</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1002/bdd.2123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fbdd.2123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29451686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlKjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2018&pages=164-174&issue=3&author=J.+Hosogiauthor=R.+Ohashiauthor=H.+Maedaauthor=K.+Fujitaauthor=J.+Ushikiauthor=T.+Kuwabaraauthor=Y.+Yamamotoauthor=T.+Imamura&title=An+Iminium+Ion+Metabolite+Hampers+the+Production+of+the+Pharmacologically+Active+Metabolite+of+a+Multikinase+Inhibitor+Kw-2449+in+Primates%3A+Irreversible+Inhibition+of+Aldehyde+Oxidase+and+Covalent+Binding+with+Endogenous+Proteins&doi=10.1002%2Fbdd.2123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">An iminium ion metabolite hampers the production of the pharmacologically active metabolite of a multikinase inhibitor KW-2449 in primates: irreversible inhibition of aldehyde oxidase and covalent binding with endogenous proteins</span></div><div class="casAuthors">Hosogi, Jun; Ohashi, Rui; Maeda, Hiroshi; Fujita, Kazuhiro; Ushiki, Junko; Kuwabara, Takashi; Yamamoto, Yorihiro; Imamura, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">We previously reported that KW-2449, (E)-1-{4-[2-(1H-Indazol-3-yl)vinyl]benzoyl}piperazine, a novel multikinase inhibitor developed for the treatment of leukemia patients, was oxidized to an iminium ion intermediate by monoamine oxidase B (MAO-B) and then converted to its oxo-piperazine form (M1) by aldehyde oxidase (AO).  However, it was found that the significant decrease in the pharmacol. active metabolite M1 following repeated administration of KW-2449 in primates might hamper the effectiveness of the drug.  The mechanism underlying this phenomenon was investigated and it was found that the AO activity was inhibited in a time-dependent manner in vitro under the co-incubation of KW-2449 and MAO-B, while neither KW-2449 nor M1 strongly inhibited MAO-B or AO activity.  These results clearly suggest that MAO-B catalyzed iminium ion metabolite inhibited AO, prompting us to investigate whether or not the iminium ion metabolite covalently binds to endogenous proteins, as has been reported with other reactive metabolites as a cause for idiosyncratic toxicity.  The assocn. of the radioactivity derived from 14C-KW-2449 with endogenous proteins both in vivo and in vitro was confirmed and it was verified that this covalent binding was inhibited by the addn. of sodium cyanide, an iminium ion-trapping reagent, and pargyline, a MAO-B inhibitor.  These findings strongly suggest that the iminium ion metabolite of KW-2449 is highly reactive in inhibiting AO irreversibly and binding to endogenous macromols. covalently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEopyNIUmjrrVg90H21EOLACvtfcHk0lhA2lU8FIh2dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlKjtbc%253D&md5=48e3fd0f51ef64b51943da8c4eb55d51</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fbdd.2123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.2123%26sid%3Dliteratum%253Aachs%26aulast%3DHosogi%26aufirst%3DJ.%26aulast%3DOhashi%26aufirst%3DR.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DUshiki%26aufirst%3DJ.%26aulast%3DKuwabara%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DImamura%26aufirst%3DT.%26atitle%3DAn%2520Iminium%2520Ion%2520Metabolite%2520Hampers%2520the%2520Production%2520of%2520the%2520Pharmacologically%2520Active%2520Metabolite%2520of%2520a%2520Multikinase%2520Inhibitor%2520Kw-2449%2520in%2520Primates%253A%2520Irreversible%2520Inhibition%2520of%2520Aldehyde%2520Oxidase%2520and%2520Covalent%2520Binding%2520with%2520Endogenous%2520Proteins%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D164%26epage%3D174%26doi%3D10.1002%2Fbdd.2123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Metabolism of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (Mptp) in Perfused Rat Liver: Involvement of Hepatic Aldehyde Oxidase as a Detoxification Enzyme</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">543</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10772632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVKgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=538-543&author=S.+Yoshiharaauthor=K.+Haradaauthor=S.+Ohta&title=Metabolism+of+1-Methyl-4-Phenyl-1%2C2%2C3%2C6-Tetrahydropyridine+%28Mptp%29+in+Perfused+Rat+Liver%3A+Involvement+of+Hepatic+Aldehyde+Oxidase+as+a+Detoxification+Enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in perfused rat liver: involvement of hepatic aldehyde oxidase as a detoxification enzyme</span></div><div class="casAuthors">Yoshihara, Shin'ichi; Harada, Keisuke; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-543</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">To elucidate the toxicol. relevance of hepatic aldehyde oxidase (AO) as a detoxification enzyme of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the authors studied the metab. and the hepatotoxicity of MPTP in intact rat livers exhibiting different AO activities by using a recirculating perfusion method.  In the perfusate during a 90-min recirculation of 1 mM MPTP, the perfused liver from Jcl:Wistar rat, a strain showing high AO activity, generated almost equal amts. of 1-methyl-4-phenylpyridinium species (MPP+) and 1-methyl-4-phenyl-5,6-dihydro-2-pyridone (MPTP lactam) as major metabolites, together with 4-phenyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-2-pyridone (MP 2-pyridone), and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine N-oxide.  However, a marked decrease of MPTP lactam as well as MP 2-pyridone and a concomitant increase of MPP+ were caused by coinfusion of 2-hydroxypyrimidine (2-OH PM), a competitive inhibitor of AO, into Jcl:Wistar rat liver.  A quite similar metabolic profile was obtained on perfusion of AO-deficient WKA/Sea rat liver.  Rather large amts. of MPP+ were retained in the liver in all the cases but esp. in Jcl:Wistar rat in the presence of 2-OH PM.  Lactate dehydrogenase leakage into the perfusate from rat liver perfused with 1 mM MPTP was greater in the strain with lower AO activity, WKA/Sea, than in that with higher AO activity, Jcl:Wistar.  Furthermore, inhibition of AO in Jcl:Wistar rat in the presence of 2-OH PM caused an enhancement of lactate dehydrogenase leakage.  These results suggest that hepatic AO is a key detoxification enzyme for MPTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYEw_mTvXmGrVg90H21EOLACvtfcHk0lhA2lU8FIh2dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVKgurk%253D&md5=7eff6a1e3c86c8396bf038088d0a7343</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshihara%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DMetabolism%2520of%25201-Methyl-4-Phenyl-1%252C2%252C3%252C6-Tetrahydropyridine%2520%2528Mptp%2529%2520in%2520Perfused%2520Rat%2520Liver%253A%2520Involvement%2520of%2520Hepatic%2520Aldehyde%2520Oxidase%2520as%2520a%2520Detoxification%2520Enzyme%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2000%26volume%3D28%26spage%3D538%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Involvement of Hepatic Aldehyde Oxidase in Conversion of 1-Methyl-4-Phenyl-2,3-Dihydropyridinium (Mpdp+) to 1-Methyl-4-Phenyl-5,6-Dihydro-2-Pyridone</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>360</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1006/abbi.1998.0925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1006%2Fabbi.1998.0925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9826433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFOku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=1998&pages=93-98&issue=1&author=S.+Yoshiharaauthor=S.+Ohta&title=Involvement+of+Hepatic+Aldehyde+Oxidase+in+Conversion+of+1-Methyl-4-Phenyl-2%2C3-Dihydropyridinium+%28Mpdp%2B%29+to+1-Methyl-4-Phenyl-5%2C6-Dihydro-2-Pyridone&doi=10.1006%2Fabbi.1998.0925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone</span></div><div class="casAuthors">Yoshihara, Shin'ichi; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-98</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">To obtain direct evidence of the involvement of aldehyde oxidase (AO), a cytosolic molybdoflavoenzyme, in the metab. of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the authors investigated the in vitro metab. of MPTP and the two-electron-oxidized 1-methyl-4-phenyl-2,3-dihydropyridinium species (MPDP+) by using mouse liver enzyme prepns.  Incubation of MPTP with mitochondrial fraction gave exclusively 1-methyl-4-phenylpyridinium (MPP+); this reaction was inhibited by deprenyl, a monoamine oxidase (MAO)-B inhibitor, and KCN.  When the mitochondrial fraction was combined with the cytosolic fraction, MPP+ formation was markedly decreased, while a large amt. of 1-methyl-4-phenyl-5,6-dihydro-2-pyridone (MPTP lactam) was newly formed.  Incubation of MPDP+ with the cytosolic fraction led to rapid formation of MPTP lactam with concomitant disappearance of the substrate.  The cytosol-dependent formation of MPTP lactam was inhibited by known AO inhibitors, such as menadione, norharman, and KCN.  The activity of cytosol in MPTP lactam formation was completely duplicated by purified mouse liver AO.  These results indicate that AO catalyzes the metabolic conversion of MPDP+, produced from MPTP by MAO-B, to MPTP lactam.  This metabolic pathway might be an important detoxification route, averting the formation of toxic MPP+.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yYA8zidMqbVg90H21EOLACvtfcHk0lhA2lU8FIh2dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFOku7o%253D&md5=6bcbee0b2e811b35b803021accda0f86</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1998.0925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1998.0925%26sid%3Dliteratum%253Aachs%26aulast%3DYoshihara%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DInvolvement%2520of%2520Hepatic%2520Aldehyde%2520Oxidase%2520in%2520Conversion%2520of%25201-Methyl-4-Phenyl-2%252C3-Dihydropyridinium%2520%2528Mpdp%252B%2529%2520to%25201-Methyl-4-Phenyl-5%252C6-Dihydro-2-Pyridone%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1998%26volume%3D360%26issue%3D1%26spage%3D93%26epage%3D98%26doi%3D10.1006%2Fabbi.1998.0925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al salhen, K. S.</span></span> <span> </span><span class="NLM_article-title">In Vitro Oxidation of Aldehyde Oxidase from Rabbit Liver: Specificity toward Endogenous Substrates</span>. <i>J. King Saud Univ., Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.jksus.2013.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.jksus.2013.09.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=67-74&issue=1&author=K.+S.+Al+salhen&title=In+Vitro+Oxidation+of+Aldehyde+Oxidase+from+Rabbit+Liver%3A+Specificity+toward+Endogenous+Substrates&doi=10.1016%2Fj.jksus.2013.09.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.jksus.2013.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jksus.2013.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2Bsalhen%26aufirst%3DK.%2BS.%26atitle%3DIn%2520Vitro%2520Oxidation%2520of%2520Aldehyde%2520Oxidase%2520from%2520Rabbit%2520Liver%253A%2520Specificity%2520toward%2520Endogenous%2520Substrates%26jtitle%3DJ.%2520King%2520Saud%2520Univ.%252C%2520Sci.%26date%3D2014%26volume%3D26%26issue%3D1%26spage%3D67%26epage%3D74%26doi%3D10.1016%2Fj.jksus.2013.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ambroziak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izaguirre, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietruszko, R.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Retinaldehyde and Other Aldehydes in Soluble Extracts of Human Liver and Kidney</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">33366</span>– <span class="NLM_lpage">33373</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.47.33366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.274.47.33366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10559215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXns1aqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=33366-33373&issue=47&author=W.+Ambroziakauthor=G.+Izaguirreauthor=R.+Pietruszko&title=Metabolism+of+Retinaldehyde+and+Other+Aldehydes+in+Soluble+Extracts+of+Human+Liver+and+Kidney&doi=10.1074%2Fjbc.274.47.33366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney</span></div><div class="casAuthors">Ambroziak, Wojciech; Izaguirre, Gonzalo; Pietruszko, Regina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">33366-33373</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Purifn. and characterization of enzymes metabolizing retinaldehyde, propionaldehyde, and octanaldehyde from four human livers and three kidneys were done to identify enzymes metabolizing retinaldehyde and their relationship to enzymes metabolizing other aldehydes.  The tissue fractionation patterns from human liver and kidney were the same, indicating presence of the same enzymes in human liver and kidney.  Moreover, in both organs the major NAD+-dependent retinaldehyde activity copurified with the propionaldehyde and octanaldehyde activities; in both organs the major NAD+-dependent retinaldehyde activity was assocd. with the E1 isoenzyme (coded for by aldh1 gene) of human aldehyde dehydrogenase.  A small amt. of NAD+-dependent retinaldehyde activity was assocd. with the E2 isoenzyme (product of aldh2 gene) of aldehyde dehydrogenase.  Some NAD+-independent retinaldehyde activity in both organs was assocd. with aldehyde oxidase, which could be easily sepd. from dehydrogenases.  Employing cellular retinoid-binding protein (CRBP), purified from human liver, demonstrated that E1 isoenzyme (but not E2 isoenzyme) could utilize CRBP-bound retinaldehyde as substrate, a feature thought to be specific to retinaldehyde dehydrogenases.  This is the first report of CRBP-bound retinaldehyde functioning as substrate for aldehyde dehydrogenase of broad substrate specificity.  Thus, it is concluded that in the human organism, retinaldehyde dehydrogenase (coded for by raldH1 gene) and broad substrate specificity E1 (a member of EC 1.2.1.3 aldehyde dehydrogenase family) are the same enzyme.  These results suggest that the E1 isoenzyme may be more important to alcoholism than the acetaldehyde-metabolizing enzyme, E2, because competition between acetaldehyde and retinaldehyde could result in abnormalities assocd. with vitamin A metab. and alcoholism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDFTFIAVDuTrVg90H21EOLACvtfcHk0liLVoXPdvgBJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1aqu78%253D&md5=65c6a7db0fa4b044c4544b229c017043</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.47.33366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.47.33366%26sid%3Dliteratum%253Aachs%26aulast%3DAmbroziak%26aufirst%3DW.%26aulast%3DIzaguirre%26aufirst%3DG.%26aulast%3DPietruszko%26aufirst%3DR.%26atitle%3DMetabolism%2520of%2520Retinaldehyde%2520and%2520Other%2520Aldehydes%2520in%2520Soluble%2520Extracts%2520of%2520Human%2520Liver%2520and%2520Kidney%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D47%26spage%3D33366%26epage%3D33373%26doi%3D10.1074%2Fjbc.274.47.33366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panoutsopoulos, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Isovanillin by Aldehyde Oxidase, Xanthine Oxidase, Aldehyde Dehydrogenase and Liver Slices</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1159/000082860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1159%2F000082860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15627845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislagtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=199-208&issue=4&author=G.+I.+Panoutsopoulosauthor=C.+Beedham&title=Metabolism+of+Isovanillin+by+Aldehyde+Oxidase%2C+Xanthine+Oxidase%2C+Aldehyde+Dehydrogenase+and+Liver+Slices&doi=10.1159%2F000082860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of Isovanillin by Aldehyde Oxidase, Xanthine Oxidase, Aldehyde Dehydrogenase and Liver Slices</span></div><div class="casAuthors">Panoutsopoulos, Georgios I.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-208</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Arom. aldehydes are good substrates of aldehyde dehydrogenase activity but are relatively poor substrates of aldehyde oxidase and xanthine oxidase.  However, the oxidn. of xenobiotic-derived arom. aldehydes by the latter enzymes was not studied to any great extent.  The present investigation compares the relative contribution of aldehyde dehydrogenase, aldehyde oxidase and xanthine oxidase activities in the oxidn. of isovanillin in sep. prepns. and also in freshly prepd. and cryopreserved liver slices.  The oxidn. of isovanillin was also examd. in the presence of specific inhibitors of each oxidizing enzyme.  Minimal transformation of isovanillin to isovanillic acid was obsd. in partially purified aldehyde oxidase, which is thought to be due to residual xanthine oxidase activity.  Isovanillin was rapidly metabolized to isovanillic acid by high amts. of purified xanthine oxidase, but only low amts. are present in guinea pig liver fraction.  Thus the contribution of xanthine oxidase to isovanillin oxidn. in guinea pig is very low.  In contrast, isovanillin was rapidly catalyzed to isovanillic acid by guinea pig liver aldehyde dehydrogenase activity.  The inhibitor studies revealed that isovanillin was predominantly metabolized by aldehyde dehydrogenase activity.  The oxidn. of xenobiotic-derived arom. aldehydes with freshly prepd. or cryopreserved liver slices was not previously reported.  In freshly prepd. liver slices, isovanillin was rapidly converted to isovanillic acid, whereas the conversion was very slow in cryopreserved liver slices due to low aldehyde dehydrogenase activity.  The formation of isovanillic acid was not altered by allopurinol, but considerably inhibited by disulfiram.  It is therefore concluded that isovanillin is predominantly metabolized by aldehyde dehydrogenase activity, with minimal contribution from either aldehyde oxidase or xanthine oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt0lr2kupZVbVg90H21EOLACvtfcHk0liLVoXPdvgBJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislagtL8%253D&md5=827159bda7971a989638eeae1fd5bf23</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1159%2F000082860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000082860%26sid%3Dliteratum%253Aachs%26aulast%3DPanoutsopoulos%26aufirst%3DG.%2BI.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DMetabolism%2520of%2520Isovanillin%2520by%2520Aldehyde%2520Oxidase%252C%2520Xanthine%2520Oxidase%252C%2520Aldehyde%2520Dehydrogenase%2520and%2520Liver%2520Slices%26jtitle%3DPharmacology%26date%3D2005%26volume%3D73%26issue%3D4%26spage%3D199%26epage%3D208%26doi%3D10.1159%2F000082860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panoutsopoulos, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouretas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Contribution of Aldehyde Oxidase, Xanthine Oxidase, and Aldehyde Dehydrogenase on the Oxidation of Aromatic Aldehydes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1368</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1021/tx030059u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx030059u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFaku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=1368-1376&issue=10&author=G.+I.+Panoutsopoulosauthor=D.+Kouretasauthor=C.+Beedham&title=Contribution+of+Aldehyde+Oxidase%2C+Xanthine+Oxidase%2C+and+Aldehyde+Dehydrogenase+on+the+Oxidation+of+Aromatic+Aldehydes&doi=10.1021%2Ftx030059u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes</span></div><div class="casAuthors">Panoutsopoulos, Georgios I.; Kouretas, Demetrios; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1368-1376</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aliph. aldehydes have a high affinity toward aldehyde dehydrogenase (ALDH) activity but are relatively poor substrates of aldehyde oxidase (AO) and xanthine oxidase (XO).  In addn., the oxidn. of xenobiotic-derived arom. aldehydes by the latter enzymes has not been studied to any great extent.  The present investigation compares the relative contribution of ALDH, AO, and XO activities in the oxidn. of substituted benzaldehydes in sep. prepns.  The incubation of vanillin, isovanillin, and protocatechuic aldehyde with either guinea pig liver AO, bovine milk XO, or guinea pig liver ALDH demonstrated that the 3 aldehyde-oxidizing enzymes had a complementary substrate specificity.  Incubations were also performed with specific inhibitors of each enzyme (isovanillin for AO, allopurinol for XO, and disulfiram for ALDH) to det. the relative contribution of each enzyme in the oxidn. of these aldehydes.  Under these conditions, vanillin was rapidly oxidized by AO, isovanillin was predominantly metabolized by ALDH, and protocatechuic aldehyde was slowly oxidized, possibly by all 3 enzymes.  Thus, AO may be a significant factor in the oxidn. of arom. aldehydes generated from amines and alkylbenzenes during drug metab.  In addn., this enzyme may also play a role in the catabolism of biogenic amines such as dopamine and noradrenaline where 3-methoxyphenylacetic acids are major metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7WrnGgzhlSbVg90H21EOLACvtfcHk0liLVoXPdvgBJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFaku7w%253D&md5=1658aee3159eaca6ca5f6a35d09fa93c</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Ftx030059u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx030059u%26sid%3Dliteratum%253Aachs%26aulast%3DPanoutsopoulos%26aufirst%3DG.%2BI.%26aulast%3DKouretas%26aufirst%3DD.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DContribution%2520of%2520Aldehyde%2520Oxidase%252C%2520Xanthine%2520Oxidase%252C%2520and%2520Aldehyde%2520Dehydrogenase%2520on%2520the%2520Oxidation%2520of%2520Aromatic%2520Aldehydes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26issue%3D10%26spage%3D1368%26epage%3D1376%26doi%3D10.1021%2Ftx030059u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panoutsopoulos, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Kinetics and Specificity of Guinea Pig Liver Aldehyde Oxidase and Bovine Milk Xanthine Oxidase Towards Substituted Benzaldehydes</span>. <i>Acta Biochim. Pol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.18388%2Fabp.2004_3550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15448727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSitr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2004&pages=649-663&author=G.+I.+Panoutsopoulosauthor=C.+Beedham&title=Kinetics+and+Specificity+of+Guinea+Pig+Liver+Aldehyde+Oxidase+and+Bovine+Milk+Xanthine+Oxidase+Towards+Substituted+Benzaldehydes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes</span></div><div class="casAuthors">Panoutsopoulos, Georgios I.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica Polonica</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-663</span>CODEN:
                <span class="NLM_cas:coden">ABPLAF</span>;
        ISSN:<span class="NLM_cas:issn">0001-527X</span>.
    
            (<span class="NLM_cas:orgname">Polish Biochemical Society</span>)
        </div><div class="casAbstract">Molybdenum-contg. enzymes, aldehyde oxidase and xanthine oxidase, are important in the oxidn. of N-heterocyclic xenobiotics.  However, the role of these enzymes in the oxidn. of drug-derived aldehydes has not been established.  The present investigation describes the interaction of eleven structurally related benzaldehydes with guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase, since they have similar substrate specificity to human molybdenum hydroxylases.  The compds. under test included mono-hydroxy and mono-methoxy benzaldehydes as well as 3,4-dihydroxy-, 3-hydroxy-4-methoxy-, 4-hydroxy-3-methoxy-, and 3,4-dimethoxy-benzaldehydes.  In addn., various amines and catechols were tested with the molybdenum hydroxylases as inhibitors of benzaldehyde oxidn.  The kinetic consts. have shown that hydroxy-, and methoxy-benzaldehydes are excellent substrates for aldehyde oxidase (Km values 5×10-6 M to 1×10-5 M) with lower affinities for xanthine oxidase (Km values around 10-4 M).  Therefore, aldehyde oxidase activity may be a significant factor in the oxidn. of the arom. aldehydes generated from amines and alkyl benzenes during drug metab.  Compds. with a 3-methoxy group showed relatively high Vmax values with aldehyde oxidase, whereas the presence of a 3-hydroxy group resulted in minimal Vmax values or no reaction.  In addn., amines acted as weak inhibitors, whereas catechols had a more pronounced inhibitory effect on the aldehyde oxidase activity.  It is therefore possible that aldehyde oxidase may be crit. in the oxidn. of the analogous phenylacetaldehydes derived from dopamine and noradrenaline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMffSeaalBPrVg90H21EOLACvtfcHk0liWjCcRs_ELYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSitr7E&md5=9a574cff56a42b3628a064323539e662</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.18388%2Fabp.2004_3550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18388%252Fabp.2004_3550%26sid%3Dliteratum%253Aachs%26aulast%3DPanoutsopoulos%26aufirst%3DG.%2BI.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DKinetics%2520and%2520Specificity%2520of%2520Guinea%2520Pig%2520Liver%2520Aldehyde%2520Oxidase%2520and%2520Bovine%2520Milk%2520Xanthine%2520Oxidase%2520Towards%2520Substituted%2520Benzaldehydes%26jtitle%3DActa%2520Biochim.%2520Pol.%26date%3D2004%26volume%3D51%26spage%3D649%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, S. M.</span></span> <span> </span><span class="NLM_article-title">International Regulatory Requirements for Genotoxicity Testing for Pharmaceuticals Used in Human Medicine, and Their Impurities and Metabolites</span>. <i>Environ. Mol. Mutagen</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1002/em.22077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fem.22077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28299826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlyrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=296-324&issue=5&author=S.+M.+Galloway&title=International+Regulatory+Requirements+for+Genotoxicity+Testing+for+Pharmaceuticals+Used+in+Human+Medicine%2C+and+Their+Impurities+and+Metabolites&doi=10.1002%2Fem.22077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolites</span></div><div class="casAuthors">Galloway, Sheila M.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental and Molecular Mutagenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">296-324</span>CODEN:
                <span class="NLM_cas:coden">EMMUEG</span>;
        ISSN:<span class="NLM_cas:issn">1098-2280</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The process of developing international (ICH) guidelines is described, and the main guidelines reviewed are the ICH S2(R1) guideline that includes the genotoxicity test battery for human pharmaceuticals, and the ICH M7 guideline for assessing and limiting potentially mutagenic impurities and degrdn. products in drugs.  Key aspects of the guidelines are reviewed in the context of drug development, for example the incorporation of genotoxicity assessment into non-clin. toxicity studies, and ways to develop and assess wt. of evidence.  In both guidelines, the existence of "thresholds" or non-linear dose responses for genotoxicity plays a part in the strategies.  Differences in ICH S2(R1) protocol recommendations from OECD guidelines are highlighted and rationales explained.  The use of genotoxicity data during clin. development and in assessment of carcinogenic potential is also described.  There are no international guidelines on assessment of potentially genotoxic metabolites, but some approaches to safety assessment are discussed for these.  Environ. Mol. Mutagen. 00:000-000, 2017. © 2017 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3K6IFtey1YbVg90H21EOLACvtfcHk0liWjCcRs_ELYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlyrs7o%253D&md5=98e29a2194e9fb54a64c4c6c63a9ed76</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1002%2Fem.22077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fem.22077%26sid%3Dliteratum%253Aachs%26aulast%3DGalloway%26aufirst%3DS.%2BM.%26atitle%3DInternational%2520Regulatory%2520Requirements%2520for%2520Genotoxicity%2520Testing%2520for%2520Pharmaceuticals%2520Used%2520in%2520Human%2520Medicine%252C%2520and%2520Their%2520Impurities%2520and%2520Metabolites%26jtitle%3DEnviron.%2520Mol.%2520Mutagen%26date%3D2017%26volume%3D58%26issue%3D5%26spage%3D296%26epage%3D324%26doi%3D10.1002%2Fem.22077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Enzymes Responsible for Nitrazepam Metabolism and Toxicity in Human</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.06.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2017.06.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28606603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVWrt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=150-160&author=K.+Konishiauthor=T.+Fukamiauthor=S.+Gotohauthor=M.+Nakajima&title=Identification+of+Enzymes+Responsible+for+Nitrazepam+Metabolism+and+Toxicity+in+Human&doi=10.1016%2Fj.bcp.2017.06.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of enzymes responsible for nitrazepam metabolism and toxicity in human</span></div><div class="casAuthors">Konishi, Keigo; Fukami, Tatsuki; Gotoh, Saki; Nakajima, Miki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">150-160</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nitrazepam (NZP) is a hypnotic agent that rarely causes liver injuries in humans and teratogenicity in rodents.  In humans, NZP is primarily metabolized to 7-aminonitrazepam (ANZP) by redn. and subsequently to 7-acetylamino nitrazepam (AANZP) by acetylation.  ANZP can be regenerated from AANZP by hydrolysis in rodents, but it is still unclear whether this reaction occurs in humans.  In rodents, AANZP may be assocd. with teratogenicity, while in humans, it is known that drug-induced liver injuries may be caused by NZP reactive metabolite(s).  In this study, we attempted to identify the enzymes responsible for NZP metab. to obtain a basic understanding of this process and the assocd. metabolite toxicities.  We found that the NZP reductase activity in human liver cytosol (HLC) was higher than that in human liver microsomes (HLM).  We purified the responsible enzyme(s) from HLC and found that the NZP reductase was aldehyde oxidase 1 (AOX1).  The role of AOX1 was confirmed by an obsd. increase in the NZP reductase activity upon addn. of N1-methylnicotinamide, an electron donor of AOX1, as well as inhibition of this activity in HLC in the presence of AOX1 inhibitors.  ANZP was acetylated to form AANZP by N-acetyltransferase (NAT) 2.  An expt. using recombinant esterases in an inhibition study using HLM revealed that AANZP is hydrolyzed by arylacetamide deacetylase (AADAC) in the human liver.  N-Hydroxylamino NZP, which is suspected to be a reactive metabolite, was detected as a conjugate with N-acetyl-L-cysteine through NZP redn. and ANZP hydroxylation reactions.  In the latter reaction, the conjugate was readily formed by recombinant CYP3A4 among the various P 450 isoforms tested.  In sum, we found that AOX1, NAT2, AADAC, and CYP3A4 are the determinants for the pharmacokinetics of NZP and that they confer interindividual variability in sensitivity to NZP side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP9ChCZdiNo7Vg90H21EOLACvtfcHk0liWjCcRs_ELYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVWrt7rE&md5=622995a5b19bf8575c5d9c1498d246b7</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.06.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.06.114%26sid%3Dliteratum%253Aachs%26aulast%3DKonishi%26aufirst%3DK.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DGotoh%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Enzymes%2520Responsible%2520for%2520Nitrazepam%2520Metabolism%2520and%2520Toxicity%2520in%2520Human%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D140%26spage%3D150%26epage%3D160%26doi%3D10.1016%2Fj.bcp.2017.06.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Chemical and Enzymatic Transformations of Nimesulide to Gsh Conjugates through Reductive and Oxidative Mechanisms</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2267</span>– <span class="NLM_lpage">2277</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.5b00290</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.5b00290" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGjurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=2267-2277&issue=12&author=L.+Zhouauthor=X.+Pangauthor=C.+Xieauthor=D.+Zhongauthor=X.+Chen&title=Chemical+and+Enzymatic+Transformations+of+Nimesulide+to+Gsh+Conjugates+through+Reductive+and+Oxidative+Mechanisms&doi=10.1021%2Facs.chemrestox.5b00290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and Enzymatic Transformations of Nimesulide to GSH Conjugates through Reductive and Oxidative Mechanisms</span></div><div class="casAuthors">Zhou, Lei; Pang, Xiaoyan; Xie, Cen; Zhong, Dafang; Chen, Xiaoyan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2277</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nimesulide (NIM) is a nonsteroidal anti-inflammatory drug, and clin. treatment with NIM has been assocd. with severe hepatotoxicity.  The bioactivation of nitro-reduced NIM (NIM-NH2), a major NIM metabolite, has been thought to be responsible for the hepatotoxicity of NIM.  However, we found that NIM-NH2 did not induce toxic effects in primary rat hepatocytes.  This study aimed to investigate other bioactivation pathways of NIM and evaluate their assocn. with hepatotoxicity.  After incubating NIM with NADPH- and GSH-supplemented human or rat liver microsomes, we identified two types of GSH conjugates: one was derived from the attachment of GSH to NIM-NH2 (NIM-NH2-GSH) and the other one was derived from a quinone-imine intermediate (NIM-OH-GSH).  NIM-NH2-GSH was generated not only by the oxidative activation of NIM-NH2 but also from the reductive activation of NIM.  Both NADPH and GSH could act as reducing agents.  Moreover, aldehyde oxidase also participated in the reductive activation of NIM.  NIM-OH-GSH was generated mainly from NIM via epoxidn. with CYP1A2 as the main catalyzing enzyme.  NIM was toxic to both primary human and rat hepatocytes, with IC50 values of 213 and 40 μM, resp.  Inhibition of the oxidative and reductive activation of NIM by the nonspecific CYP inhibitor 1-aminobenzotriazole and selective aldehyde oxidase inhibitor estradiol did not protect the cells from NIM-mediated toxicity.  Moreover, pretreating cells with L-buthionine-sulfoximine (a GSH depletor) did not affect the cytotoxicity of NIM.  These results suggested that oxidative and reductive activation of NIM did not cause the hepatotoxicity and that the parent drug concn. was assocd. with the cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruU3aQWFbXuLVg90H21EOLACvtfcHk0lh0PeR6WyHZKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGjurfF&md5=cd045b2ab836e5359a535cee27c87e87</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.5b00290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.5b00290%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DPang%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DChemical%2520and%2520Enzymatic%2520Transformations%2520of%2520Nimesulide%2520to%2520Gsh%2520Conjugates%2520through%2520Reductive%2520and%2520Oxidative%2520Mechanisms%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26issue%3D12%26spage%3D2267%26epage%3D2277%26doi%3D10.1021%2Facs.chemrestox.5b00290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanne, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Identification of Aldehyde Oxidase as the Neonicotinoid Nitroreductase</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1021/tx049737i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx049737i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnsVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=317-323&issue=2&author=R.+A.+Dickauthor=D.+B.+Kanneauthor=J.+E.+Casida&title=Identification+of+Aldehyde+Oxidase+as+the+Neonicotinoid+Nitroreductase&doi=10.1021%2Ftx049737i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Aldehyde Oxidase as the Neonicotinoid Nitroreductase</span></div><div class="casAuthors">Dick, Ryan A.; Kanne, David B.; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-323</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Imidacloprid (IMI), the prototypical neonicotinoid insecticide, is used worldwide for crop protection and flea control on pets.  It is both oxidatively metabolized by cytochrome P 450 enzymes and reduced at the nitroguanidine moiety by a previously unidentified cytosolic "neonicotinoid nitroreductase", the subject of this investigation.  Two major metabolites are detected on incubation of IMI with rabbit liver cytosol: the nitrosoguanidine (IMI-NO) and the aminoguanidine (IMI-NH2).  Three lines of evidence identify the molybdo-flavoenzyme aldehyde oxidase (AOX, EC 1.2.3.1) as the neonicotinoid nitroreductase.  First, classical AOX electron donor substrates (benzaldehyde, 2-hydroxypyrimidine, and N-methylnicotinamide) dramatically increase the rate of formation of IMI metabolites.  Allopurinol and diquat are also effective electron donors, while NADPH and xanthine are not.  Second, AOX inhibitors (potassium cyanide, menadione, and promethazine) inhibit metabolite formation when N-methylnicotinamide is utilized as an electron donor.  Without the addn. of an electron donor, rabbit liver cytosol reduces IMI only to IMI-NO at a slow rate.  This redn. is also inhibited by potassium cyanide, menadione, and promethazine, as well as by addnl. AOX inhibitors, cimetidine and chlorpromazine.  Finally, IMI nitroredn. by AOX is sensitive to an aerobic atm., but to a much lesser extent than cytochrome P 450 2D6.  Large species differences are obsd. in the IMI nitroreductive activity of liver cytosol.  While rabbit and monkey (Cynomolgus) give the highest levels of total metabolite formation, human, mouse, cow, and rat also metabolize IMI rapidly.  In contrast, dog, cat, and chicken liver cytosols do not reduce IMI at appreciable rates.  AOX, as a neonicotinoid nitroreductase, may limit the persistence of IMI, and possibly other neonicotinoids, in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEa6sAb7dPNrVg90H21EOLACvtfcHk0lh0PeR6WyHZKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnsVCqtw%253D%253D&md5=8057a5fddeb068c0e8e1f214259b9715</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Ftx049737i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx049737i%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DR.%2BA.%26aulast%3DKanne%26aufirst%3DD.%2BB.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DIdentification%2520of%2520Aldehyde%2520Oxidase%2520as%2520the%2520Neonicotinoid%2520Nitroreductase%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2005%26volume%3D18%26issue%3D2%26spage%3D317%26epage%3D323%26doi%3D10.1021%2Ftx049737i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maia, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, J. J.</span></span> <span> </span><span class="NLM_article-title">Nitrite Reduction by Molybdoenzymes: A New Class of Nitric Oxide-Forming Nitrite Reductases</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1007/s00775-014-1234-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00775-014-1234-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25589250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFWgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=403-433&issue=2&author=L.+B.+Maiaauthor=J.+J.+Moura&title=Nitrite+Reduction+by+Molybdoenzymes%3A+A+New+Class+of+Nitric+Oxide-Forming+Nitrite+Reductases&doi=10.1007%2Fs00775-014-1234-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases</span></div><div class="casAuthors">Maia, Luisa B.; Moura, Jose J. G.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-433</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  NO is a signaling mol. involved in several physiol. processes, in both prokaryotes and eukaryotes, and nitrite is being recognized as an NO source particularly relevant to cell signaling and survival under challenging conditions.  The "non-respiratory" nitrite redn. to NO is carried out by "non-dedicated" nitrite reductases, making use of metalloproteins present in cells to carry out other functions, such as several molybdoenzymes (a new class of nitric oxide-forming nitrite reductases).  Here, the authors highlight the physiol. relevance of Mo-dependent nitrite-derived NO formation in mammalian, plant, and bacterial signalling (and other) pathways.  The mammalian xanthine oxidase/xanthine dehydrogenase, aldehyde oxidase, mitochondrial amidoxime-reducing component, plant nitrate reductase, and bacterial aldehyde oxidoreductase and nitrate reductases are considered.  The nitrite reductase activity of each molybdoenzyme is described and the review is oriented to discuss the feasibility of the reactions from a (bio)chem. point of view.  In addn., the mol. mechanism proposed for the Mo-dependent nitrite redn. are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-oPWecs_W37Vg90H21EOLACvtfcHk0lh0PeR6WyHZKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFWgsA%253D%253D&md5=e213a017d9e0f7bc66278790ef558026</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1007%2Fs00775-014-1234-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-014-1234-2%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DL.%2BB.%26aulast%3DMoura%26aufirst%3DJ.%2BJ.%26atitle%3DNitrite%2520Reduction%2520by%2520Molybdoenzymes%253A%2520A%2520New%2520Class%2520of%2520Nitric%2520Oxide-Forming%2520Nitrite%2520Reductases%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2015%26volume%3D20%26issue%3D2%26spage%3D403%26epage%3D433%26doi%3D10.1007%2Fs00775-014-1234-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maia, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, J. J.</span></span> <span> </span><span class="NLM_article-title">Nitrite Reductase Activity of Rat and Human Xanthine Oxidase, Xanthine Dehydrogenase, and Aldehyde Oxidase: Evaluation of Their Contribution to No Formation in Vivo</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1021/bi500987w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi500987w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=685-710&issue=3&author=L.+B.+Maiaauthor=V.+Pereiraauthor=L.+Miraauthor=J.+J.+Moura&title=Nitrite+Reductase+Activity+of+Rat+and+Human+Xanthine+Oxidase%2C+Xanthine+Dehydrogenase%2C+and+Aldehyde+Oxidase%3A+Evaluation+of+Their+Contribution+to+No+Formation+in+Vivo&doi=10.1021%2Fbi500987w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrite reductase activity of rat and human xanthine oxidase, xanthine dehydrogenase, and aldehyde oxidase: Evaluation of their contribution to NO formation in vivo</span></div><div class="casAuthors">Maia, Luisa B.; Pereira, Vania; Mira, Lurdes; Moura, Jose J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">685-710</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nitrite is presently considered a NO "storage form" that can be made available, through its one-electron redn., to maintain NO formation under hypoxia/anoxia.  The molybdoenzymes, xanthine oxidase/dehydrogenase (XO/XD) and aldehyde oxidase (AO), are 2 of the most promising mammalian nitrite reductases, and in this work, the authors characterized NO formation by rat and human XO/XD and AO.  This is the 1st characterization of human enzymes, and the results support the employment of rat liver enzymes as suitable models of the human counterparts.  A comprehensive kinetic characterization of the effect of pH on XO- and AO-catalyzed nitrite redn. showed that the enzyme's specificity const. for nitrite increased 8-fold, while the KmNO2- decreased 6-fold, when the pH decreased from 7.4 to 6.3.  These results demonstrate that the ability of XO/AO to trigger NO formation would be greatly enhanced under the acidic conditions characteristic of ischemia.  The O2 inhibition was quantified, and the KiO2 values found (24.3-48.8 μM) suggested that in vivo NO formation would be fine-tuned by O2 availability.  The potential in vivo relative physiol. relevance of XO/XD/AO-dependent pathways of NO formation was evaluated using HepG2 and HMEC cell lines subjected to hypoxia.  NO formation by the cells was found to be pH-, nitrite-, and O2-dependent, and the relative contribution of XO/XD plus AO was found to be as high as 50%.  Collectively, these results supported the possibility that XO/XD and AO could contribute to NO generation under hypoxia inside a living human cell.  Furthermore, the mol. mechanism of XO/AO-catalyzed nitrite redn. was revised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqECP5pCAgPgLVg90H21EOLACvtfcHk0lgDtoMCmr2N9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrsLzO&md5=bab5f7ed51d1d4ef1dd6879ffb246132</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fbi500987w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi500987w%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DL.%2BB.%26aulast%3DPereira%26aufirst%3DV.%26aulast%3DMira%26aufirst%3DL.%26aulast%3DMoura%26aufirst%3DJ.%2BJ.%26atitle%3DNitrite%2520Reductase%2520Activity%2520of%2520Rat%2520and%2520Human%2520Xanthine%2520Oxidase%252C%2520Xanthine%2520Dehydrogenase%252C%2520and%2520Aldehyde%2520Oxidase%253A%2520Evaluation%2520of%2520Their%2520Contribution%2520to%2520No%2520Formation%2520in%2520Vivo%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26issue%3D3%26spage%3D685%26epage%3D710%26doi%3D10.1021%2Fbi500987w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span> <span> </span><span class="NLM_article-title">Involvement of Liver Aldehyde Oxidase in the Reduction of Nicotinamide N-Oxide</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(84)91297-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0006-291X%2884%2991297-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=6233971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2cXks1ygs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1984&pages=602-606&issue=2&author=S.+Kitamuraauthor=K.+Tatsumi&title=Involvement+of+Liver+Aldehyde+Oxidase+in+the+Reduction+of+Nicotinamide+N-Oxide&doi=10.1016%2F0006-291X%2884%2991297-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide</span></div><div class="casAuthors">Kitamura, Shigeyuki; Tatsumi, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">602-6</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Mammalian liver aldehyde oxidase was found to reduce nicotinamide N-oxide to nicotinamide.  Rabbit liver aldehyde oxidase supplemented with an electron donor exhibited a significant nicotinamide N-oxide reductase activity under anaerobic conditions.  Liver cytosols from rabbits, hogs, guinea pigs, hamsters, rats, and mice exhibited similar N-oxide reductase activities in the presence of an electron donor of aldehyde oxidase, but not xanthine oxidase.  The cytosolic N-oxide reductase activity was almost completely inhibited by menadione, an inhibitor of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobe1KAJWY-mbVg90H21EOLACvtfcHk0lgDtoMCmr2N9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1ygs7k%253D&md5=549bdd7d3ea9051944c6c6998ec14b6e</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2884%2991297-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252884%252991297-X%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DInvolvement%2520of%2520Liver%2520Aldehyde%2520Oxidase%2520in%2520the%2520Reduction%2520of%2520Nicotinamide%2520N-Oxide%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1984%26volume%3D120%26issue%3D2%26spage%3D602%26epage%3D606%26doi%3D10.1016%2F0006-291X%2884%2991297-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span> <span> </span><span class="NLM_article-title">N-Oxide Reduction of Quinoxaline-1,4-Dioxides Catalyzed by Porcine Aldehyde Oxidase Ssaox1</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.055418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.113.055418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24440959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVKqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=511-519&issue=4&author=P.+Muauthor=M.+Zhengauthor=M.+Xuauthor=Y.+Zhengauthor=X.+Tangauthor=Y.+Wangauthor=K.+Wuauthor=Q.+Chenauthor=L.+Wangauthor=Y.+Deng&title=N-Oxide+Reduction+of+Quinoxaline-1%2C4-Dioxides+Catalyzed+by+Porcine+Aldehyde+Oxidase+Ssaox1&doi=10.1124%2Fdmd.113.055418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">N-oxide reduction of quinoxaline-1,4-dioxides catalyzed by porcine aldehyde oxidase SsAOX1</span></div><div class="casAuthors">Mu, Peiqiang; Zheng, Ming; Xu, Ming; Zheng, Yuanming; Tang, Xianqing; Wang, Yufan; Wu, Kaixin; Chen, Qingmei; Wang, Lijuan; Deng, Yiqun</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-519, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Quinoxaline-1,4-dioxides (QdNOs) are a class of quinoxaline derivs. that are widely used in humans or animals as drugs or feed additives.  However, the metabolic mechanism, esp. the involved enzymes, has not been reported in detail.  In this study, the N-oxide redn. enzyme, porcine aldehyde oxidase SsAOX1 was identified and characterized.  The SsAOX1 gene was cloned from pig liver through reverse-transcription polymerase chain reaction using degenerate primers, which encode a 147-kDa protein with typical aldehyde oxidase motifs, two [2Fe-2S] centers, a FAD (FAD) binding domain, and a molybdenum cofactor domain.  After heterologous expression in a prokaryote, purified SsAOX1 formed a functional homodimer under native conditions.  Importantly, the SsAOX1 catalyzed the N-oxide redn. at the N1 position of three representative QdNOs (quinocetone, mequindox, and cyadox), which are commonly used as animal feed additives.  SsAOX1 has the highest activity toward quinocetone, followed by mequindox and cyadox, with kcat/Km values of 1.94 ± 0.04, 1.27 ± 0.15, and 0.43 ± 0.09 min-1 μM-1, resp.  However, SsAOX1 has the lowest substrate affinity for quinocetone, followed by the cyadox and mequindox, with Km values of 4.36 ± 0.56, 3.16 ± 0.48, and 2.96 ± 0.51 μM, resp.  In addn., using site-directed mutagenesis, we found that substitution of glycine 1019 with threonine endows SsAOX1 with N-oxide reductive activity at the N4 position.  The goal of this study was to identify and characterize the N-oxide redn. enzyme for a class of veterinary drugs, QdNOs, which will aid in the elucidation of the metabolic pathways of QdNOs and will provide a theor. basis for their administration and new veterinary drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo736HqsG6DhLVg90H21EOLACvtfcHk0lgDtoMCmr2N9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVKqtLg%253D&md5=3737fc8697d6abd12d20e8ba6bcbc752</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.055418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.055418%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DN-Oxide%2520Reduction%2520of%2520Quinoxaline-1%252C4-Dioxides%2520Catalyzed%2520by%2520Porcine%2520Aldehyde%2520Oxidase%2520Ssaox1%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D4%26spage%3D511%26epage%3D519%26doi%3D10.1124%2Fdmd.113.055418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span> <span> </span><span class="NLM_article-title">Involvement of Mammalian Liver Cytosols and Aldehyde Oxidase in Reductive Metabolism of Zonisamide</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8742231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28XhtFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1996&pages=199-202&author=K.+Sugiharaauthor=S.+Kitamuraauthor=K.+Tatsumi&title=Involvement+of+Mammalian+Liver+Cytosols+and+Aldehyde+Oxidase+in+Reductive+Metabolism+of+Zonisamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide</span></div><div class="casAuthors">Sugihara, Kazumi; Kitamura, Shigeyuki; Tatsumi, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-202</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Zonisamide (1,2-benzisoxazole-3-methansulfonamide), an anticonvulsant agent, is primarily metabolized to 2-sulfamoylacetylphenol by reductive cleavage of the 1,2-benzisoxazole ring.  Rabbit liver cytosol with an electron donor of aldehyde oxidase exhibited a significant zonisamide reductase activity that was sensitive to inhibition by menadione, an inhibitor of aldehyde oxidase.  The result suggested that the cytosolic activity is caused by aldehyde oxidase, a cytosolic enzyme.  In fact, rabbit and rat liver aldehyde oxidase had the ability to reduce zonisamide when supplemented with its electron donor.  Apparent KM and Vmax values of aldehyde oxidase for zonisamide were 217 μM and 42 nmol/10 min/mg protein in the case of the rabbit liver enzyme, and 542 μM and 382 nmol/10 min/mg protein in the case of the rat liver enzyme, resp.  In rabbits, hamsters, mice, and guinea pigs, zonisamide reductase activity of the liver cytosols with 2-hydroxypyrimidine, and electron donor of aldehyde oxidase, was much higher than that of the liver microsomes with NADPH.  In rats, zonisamide reductase activity was examd. with liver microsomes and cytosols from seven strains.  The 2-hydroxypyrimidine-dependent cytosolic activity exhibited marked strain differences, unlike the NADPH-dependent microsomal activity.  1,2-Benzisoxazole was also reduced to salicylaldehyde by rabbit liver cytosol and aldehyde oxidase in the presence of 2-hydroxypyrimidine.  Stoichiometric studies showed that 2-sulfamoylacetylphenol was formed accompanying nearly equimolar ammonia from zonisamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsj1fL0PqO4bVg90H21EOLACvtfcHk0lgDtoMCmr2N9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFCrs70%253D&md5=142cd72c5e1cc5024940b3d555499016</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DInvolvement%2520of%2520Mammalian%2520Liver%2520Cytosols%2520and%2520Aldehyde%2520Oxidase%2520in%2520Reductive%2520Metabolism%2520of%2520Zonisamide%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1996%26volume%3D24%26spage%3D199%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span> <span> </span><span class="NLM_article-title">Reduction and Methylation of Ziprasidone by Glutathione, Aldehyde Oxidase, and Thiol S-Methyltransferase in Humans: An in Vitro Study</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1057</span>, <span class="refDoi"> DOI: 10.3109/00498254.2012.683203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2012.683203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22559212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVCqtL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=1049-1057&issue=11&author=R.+S.+Obachauthor=C.+Prakashauthor=A.+M.+Kamel&title=Reduction+and+Methylation+of+Ziprasidone+by+Glutathione%2C+Aldehyde+Oxidase%2C+and+Thiol+S-Methyltransferase+in+Humans%3A+An+in+Vitro+Study&doi=10.3109%2F00498254.2012.683203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction and methylation of ziprasidone by glutathione, aldehyde oxidase, and thiol s-methyltransferase in humans: an in vitro study</span></div><div class="casAuthors">Obach, R. Scott; Prakash, Chandra; Kamel, Amin M.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1049-1057</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In humans, approx. two-thirds of the metabolic clearance of ziprasidone proceeds through redn. of the N-S bond of the benzisothiazole moiety, which is followed by methylation of the resulting thiophenol to the major metabolite S-methyldihydroziprasidone.  The objective of this study was to gain an understanding of the underlying mechanism of this clearance route.  Incubation of ziprasidone in human liver cytosol yielded the redn. product dihydroziprasidone.  Heating the cytosol prior to incubation prevented the reaction, and the reaction was saturable (KM = 3.9 μM; Vmax = 0.24 nmol/min/mg protein), supporting that it was enzyme catalyzed.  It was partially stimulated by 2-hydroxypyrimidine and inhibited by menadione, supporting a role for aldehyde oxidase in this reaction.  However, incubation of ziprasidone with reduced glutathione, even in the absence of cytosol, readily yielded dihydroziprasidone indicating that there is also a chem. redn. component to this clearance pathway.  The pathway was reversible because incubation of dihydroziprasidone in cytosol or with oxidized glutathione in buffer yielded ziprasidone.  The methylation of dihydroziprasidone was obsd. in human liver microsomes in the presence of S-adenosylmethionine (KM = 14 μM; Vmax = 0.032 nmol/min/mg protein).  This reaction was inhibited by 2,3-dichloro-α-methylbenzylamine supporting that thiol methyltransferase is the enzyme responsible for this reaction.  Thus, the main metabolic pathway for ziprasidone in humans occurs via chem. redn. and aldehyde oxidase catalyzed redn., followed by thiol methyltransferase catalyzed methylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFYh1Rs_L1_bVg90H21EOLACvtfcHk0liQebZL8soglQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVCqtL%252FN&md5=768e5709852f4035543b973fd7489dfd</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.3109%2F00498254.2012.683203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2012.683203%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DPrakash%26aufirst%3DC.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26atitle%3DReduction%2520and%2520Methylation%2520of%2520Ziprasidone%2520by%2520Glutathione%252C%2520Aldehyde%2520Oxidase%252C%2520and%2520Thiol%2520S-Methyltransferase%2520in%2520Humans%253A%2520An%2520in%2520Vitro%2520Study%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26issue%3D11%26spage%3D1049%26epage%3D1057%26doi%3D10.3109%2F00498254.2012.683203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishigai, M.</span></span> <span> </span><span class="NLM_article-title">Oxime-Metabolizing Activity of Liver Aldehyde Oxidase</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>253</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(87)90194-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0003-9861%2887%2990194-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3566284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2sXktF2rt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1987&pages=413-418&issue=2&author=K.+Tatsumiauthor=M.+Ishigai&title=Oxime-Metabolizing+Activity+of+Liver+Aldehyde+Oxidase&doi=10.1016%2F0003-9861%2887%2990194-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Oxime-metabolizing activity of liver aldehyde oxidase</span></div><div class="casAuthors">Tatsumi, Kiyoshi; Ishigai, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">413-18</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">Liver aldehyde oxidase in the presence of its electron donor exhibited a significant oxime-metabolizing activity toward some different types of oximes under anaerobic conditions.  Acetophenone oxime and salicylaldoxime were exclusively converted to the corresponding oxo compds., whereas benzamidoxime was converted to the corresponding ketimine.  With d-camphor oxime, the formation of both the corresponding oxo compd. and ketimine was obsd.  Stoichiometric studies showed that the formation of oxo compds. is accompanied by nearly equimolar NH3.  A mechanism of oxime biotransformation is proposed in which liver aldehyde oxidase catalyzes the redn. of oximes to the corresponding ketimines which in turn undergo, depending on their chem. stability, nonenzymic hydrolysis to the corresponding oxo compds. and NH3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJSKbnGY5yWrVg90H21EOLACvtfcHk0liQebZL8soglQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktF2rt78%253D&md5=a3522ad66bbba1f321f5b601fcafce02</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2887%2990194-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252887%252990194-9%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DIshigai%26aufirst%3DM.%26atitle%3DOxime-Metabolizing%2520Activity%2520of%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1987%26volume%3D253%26issue%3D2%26spage%3D413%26epage%3D418%26doi%3D10.1016%2F0003-9861%2887%2990194-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span> <span> </span><span class="NLM_article-title">Participation of Liver Aldehyde Oxidase in Reductive Metabolism of Hydroxamic Acids to Amides</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>247</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(86)90586-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0003-9861%2886%2990586-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3717945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL28XktValu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1986&pages=289-293&issue=2&author=K.+Sugiharaauthor=K.+Tatsumi&title=Participation+of+Liver+Aldehyde+Oxidase+in+Reductive+Metabolism+of+Hydroxamic+Acids+to+Amides&doi=10.1016%2F0003-9861%2886%2990586-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Participation of liver aldehyde oxidase in reductive metabolism of hydroxamic acids to amides</span></div><div class="casAuthors">Sugihara, Kazumi; Tatsumi, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-93</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The liver enzyme responsible for the redn. of arom. and heterocyclic hydroxamic acids to the corresponding amides was investigated with salicylhydroxamic acid, benzohydroxamic acid, anthranilohydroxamic acid, and nicotinohydroxamic acid.  Rabbit liver cytosol exhibited significant reductase activities toward the hydroxamic acids under anaerobic conditions when supplemented with an electron donor of aldehyde oxidase.  Similarly, rabbit liver aldehyde oxidase reduced these compds. to amides in the presence of its own electron donor, indicating that the reductase activities obsd. in the liver cytosol are due mainly to the cytosolic molybdoflavin enzyme.  Furthermore, a significant redn. of salicylhydroxamic acid and nicotinohydroxamic acid was also obsd. when an electron donor to aldehyde oxidase was incubated with liver cytosols from hamsters, guinea pigs, rats, and mice.  The cytosolic reductase activities toward salicylhydroxamic acid were markedly inhibited by menadione, an inhibitor of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy1GTZdY5VjLVg90H21EOLACvtfcHk0liQebZL8soglQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktValu7g%253D&md5=b8174de45f2ae58fbb4ff8d89d7ed0b4</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2886%2990586-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252886%252990586-2%26sid%3Dliteratum%253Aachs%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DParticipation%2520of%2520Liver%2520Aldehyde%2520Oxidase%2520in%2520Reductive%2520Metabolism%2520of%2520Hydroxamic%2520Acids%2520to%2520Amides%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1986%26volume%3D247%26issue%3D2%26spage%3D289%26epage%3D293%26doi%3D10.1016%2F0003-9861%2886%2990586-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, H.</span></span> <span> </span><span class="NLM_article-title">Involvement of Liver Aldehyde Oxidase in Sulfoxide Reduction</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4585</span>– <span class="NLM_lpage">4588</span>, <span class="refDoi"> DOI: 10.1248/cpb.30.4585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1248%2Fcpb.30.4585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7168878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL3sXhtVegtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1982&pages=4585-4588&issue=12&author=K.+Tatsumiauthor=S.+Kitamuraauthor=H.+Yamada&title=Involvement+of+Liver+Aldehyde+Oxidase+in+Sulfoxide+Reduction&doi=10.1248%2Fcpb.30.4585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of liver aldehyde oxidase in sulfoxide reduction</span></div><div class="casAuthors">Tatsumi, Kiyoshi; Kitamura, Shigeyuki; Yamada, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4585-8</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    </div><div class="casAbstract">Evidence is presented that guinea pig liver aldehyde oxidase, which is in the cytosolic fraction, in the presence of its electron donors such as aldehydes or N-heterocyclic compds., functions as a sulfoxide reductase toward sulindac and other sulfoxide compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrYMqdjgKaxbVg90H21EOLACvtfcHk0liQebZL8soglQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhtVegtrc%253D&md5=6a4cbd87147b57d043b32c18b2f365d7</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1248%2Fcpb.30.4585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.30.4585%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DH.%26atitle%3DInvolvement%2520of%2520Liver%2520Aldehyde%2520Oxidase%2520in%2520Sulfoxide%2520Reduction%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1982%26volume%3D30%26issue%3D12%26spage%3D4585%26epage%3D4588%26doi%3D10.1248%2Fcpb.30.4585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Human Liver Aldehyde Oxidase: Inhibition by 239 Drugs</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1177/0091270003260336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1177%2F0091270003260336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=14681337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Ojsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=7-19&issue=1&author=R.+S.+Obachauthor=P.+Huynhauthor=M.+C.+Allenauthor=C.+Beedham&title=Human+Liver+Aldehyde+Oxidase%3A+Inhibition+by+239+Drugs&doi=10.1177%2F0091270003260336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Human liver aldehyde oxidase: inhibition by 239 drugs</span></div><div class="casAuthors">Obach, R. Scott; Huynh, Phuong; Allen, Mary C.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-19</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The authors tested 239 frequently used drugs and other compds. for their potential to inhibit the drug-metabolizing enzyme, aldehyde oxidase, in human liver cytosol.  A sensitive, moderate throughput HPLC-MS assay was developed for 1-phthalazinone, the aldehyde oxidase-catalyzed product of phthalazine oxidn.  Inhibition of this activity was examd. for the 239 drugs and other compds. of interest at a test concn. of 50 μM.  Thirty-six compds. exhibited greater than 80% inhibition and were further examd. for measurement of IC50.  The most potent inhibitor obsd. was the selective estrogen receptor modulator, raloxifene (IC50 = 2.9 nM), and tamoxifen, estradiol, and ethinyl estradiol were also potent inhibitors.  Other classes of drugs that demonstrated inhibition of aldehyde oxidase included phenothiazines, tricyclic antidepressants, tricyclic atypical antipsychotic agents, and dihydropyridine calcium channel blockers, along with some other drugs, including loratadine, cyclobenzaprine, amodiaquine, maprotiline, ondansetron, propafenone, domperidone, quinacrine, ketoconazole, verapamil, tacrine, and salmeterol.  These findings are discussed in context to potential drug interactions that could be obsd. between these agents and drugs for which aldehyde oxidase is involved in metab. and warrant investigation of the possibility of clin. drug interactions mediated by inhibition of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxd8xFvCXbTLVg90H21EOLACvtfcHk0lh3oI7fa60Qnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Ojsg%253D%253D&md5=058765c4afeddb018ef9c1ca5a45d9b5</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1177%2F0091270003260336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270003260336%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DHuynh%26aufirst%3DP.%26aulast%3DAllen%26aufirst%3DM.%2BC.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DHuman%2520Liver%2520Aldehyde%2520Oxidase%253A%2520Inhibition%2520by%2520239%2520Drugs%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2004%26volume%3D44%26issue%3D1%26spage%3D7%26epage%3D19%26doi%3D10.1177%2F0091270003260336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase Importance in Vivo in Xenobiotic Metabolism: Imidacloprid Nitroreduction in Mice</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kft066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1093%2Ftoxsci%2Fkft066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23462233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1OhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=22-28&issue=1&author=T.+L.+Swensonauthor=J.+E.+Casida&title=Aldehyde+Oxidase+Importance+in+Vivo+in+Xenobiotic+Metabolism%3A+Imidacloprid+Nitroreduction+in+Mice&doi=10.1093%2Ftoxsci%2Fkft066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase importance in vivo in xenobiotic metabolism: Imidacloprid nitroreduction in mice</span></div><div class="casAuthors">Swenson, Tami L.; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-28</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) metabolizes many xenobiotics in vitro, but its importance in vivo is usually unknown relative to cytochrome P450s (CYPs) and other detoxification systems.  Currently, the most important insecticides are neonicotinoids, which are metabolized in vitro by AOX on redn. of the nitroimino group and by CYPs via oxidn. reactions.  The goal of this study was to establish the relative importance of AOX and CYPs in vivo using the mouse model.  The procedure was to reduce liver AOX activity by providing tungsten or hydralazine in the drinking water or to use the AOX-deficient DBA/2 mouse strain.  None of these approaches reduced CYP activity measured in vitro with an isoenzyme nonspecific substrate.  Liver AOX activity was reduced by 45% with tungsten and 61% with hydralazine and 81% in AOX-deficient mice relative to controls.  When mice were treated i.p. with the major neonicotinoid imidacloprid (IMI), metab. by CYP oxidn. reactions was not appreciably affected, whereas the AOX-generated nitrosoguanidine metabolite was decreased by 30% with tungsten and 56% with hydralazine and 86% in the AOX-deficient mice.  The other IMI nitroredn. metabolite, desnitro-IMI, was decreased by 55%, 65%, and 81% with tungsten, hydralazine, and in the AOX-deficient mice, resp.  Thus, decreasing liver AOX activity by three quite different procedures gave a corresponding decrease for in vivo reductive metabolites in the liver of IMI-treated mice.  Possible AOX involvement in IMI metab. in insects was evaluated using AOX-expressing and AOX-deficient Drosophila, but no differences were found in IMI nitroredn. or sensitivity between the two strains.  This is the first study to establish the in vivo relevance of AOX in neonicotinoid metab. in mammals and one of the first for xenobiotics in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO9w5zRrBAwrVg90H21EOLACvtfcHk0lh3oI7fa60Qnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1OhsbY%253D&md5=be011129c9602b126002a032f053621b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkft066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkft066%26sid%3Dliteratum%253Aachs%26aulast%3DSwenson%26aufirst%3DT.%2BL.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DAldehyde%2520Oxidase%2520Importance%2520in%2520Vivo%2520in%2520Xenobiotic%2520Metabolism%253A%2520Imidacloprid%2520Nitroreduction%2520in%2520Mice%26jtitle%3DToxicol.%2520Sci.%26date%3D2013%26volume%3D133%26issue%3D1%26spage%3D22%26epage%3D28%26doi%3D10.1093%2Ftoxsci%2Fkft066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lavaggi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerecetto, H.</span></span> <span> </span><span class="NLM_article-title">Differential Enzymatic Reductions Governing the Differential Hypoxia-Selective Cytotoxicities of Phenazine 5,10-Dioxides</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1900</span>– <span class="NLM_lpage">1906</span>, <span class="refDoi"> DOI: 10.1021/tx800199v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800199v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVGjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1900-1906&issue=9&author=M.+L.+Lavaggiauthor=M.+Cabreraauthor=M.+Gonzalezauthor=H.+Cerecetto&title=Differential+Enzymatic+Reductions+Governing+the+Differential+Hypoxia-Selective+Cytotoxicities+of+Phenazine+5%2C10-Dioxides&doi=10.1021%2Ftx800199v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Enzymatic Reductions Governing the Differential Hypoxia-Selective Cytotoxicities of Phenazine 5,10-Dioxides</span></div><div class="casAuthors">Lavaggi, Maria Laura; Cabrera, Mauricio; Gonzalez, Mercedes; Cerecetto, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1900-1906</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Some derivs. of phenazine 5,10-dioxide are selectively toxic to hypoxic cells commonly found in solid tumors.  Previous studies of the phenazine 5,10-dioxide mechanism of action indicated that a bioredn. process could be involved in its selective toxicities, maybe as result of its potential HO·-releasing capability in hypoxia.  The major unresolved aspect of the mechanism of phenazine 5,10-dioxides is the identity of the reductase(s) in the cell responsible for activating the drug to its toxic form and metabolites.  The authors have studied the metab. in both hypoxia and oxia of some selected 2-amino and 2-hydroxyphenazine 5,10-dioxides (I-V), using rat liver microsomal and cytosol fractions.  Differential hypoxic/oxic metab. was found to be correlated to a compd.'s cytotoxic selectivity but, in general, without metabolic differences between liver microsomal or cytosolic enzymes.  Dicoumarol and ketoconazole were found to inhibit the hypoxic metab. of the most selective phenazine 5,10-dioxide I, inferring a role for DT-diaphorase and cytochrome P 450.  The least hypoxic selective agents, IV and V, possess different hypoxia-metabolic profiles as compared to deriv. I explaining the differential cytotoxic biol. behavior.  The nonselective deriv. II suffered bioredn. in both conditions and, according to the inhibition studies with dicoumarol and ketoconazole, involves both DT-diaphorase and cytochrome P 450.  The nontoxic deriv. III showed poor bioreductive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoETx6VIJhjYLVg90H21EOLACvtfcHk0lh3oI7fa60Qnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVGjsLw%253D&md5=eaecbb6dac8c05d6d963f55b5a145267</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Ftx800199v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800199v%26sid%3Dliteratum%253Aachs%26aulast%3DLavaggi%26aufirst%3DM.%2BL.%26aulast%3DCabrera%26aufirst%3DM.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26atitle%3DDifferential%2520Enzymatic%2520Reductions%2520Governing%2520the%2520Differential%2520Hypoxia-Selective%2520Cytotoxicities%2520of%2520Phenazine%25205%252C10-Dioxides%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26issue%3D9%26spage%3D1900%26epage%3D1906%26doi%3D10.1021%2Ftx800199v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miceli, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Ziprasidone Metabolism, Aldehyde Oxidase, and Clinical Implications</span>. <i>J. Clin Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1097/01.jcp.0000084028.22282.f2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1097%2F01.jcp.0000084028.22282.f2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=12826984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFKjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=229-232&author=C.+Beedhamauthor=J.+J.+Miceliauthor=R.+S.+Obach&title=Ziprasidone+Metabolism%2C+Aldehyde+Oxidase%2C+and+Clinical+Implications&doi=10.1097%2F01.jcp.0000084028.22282.f2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Ziprasidone Metabolism, Aldehyde Oxidase, and Clinical Implications</span></div><div class="casAuthors">Beedham, Christine; Miceli, Jeffrey J.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-232</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Ziprasidone (Geodon, Zeldox), a recently approved atypical antipsychotic agent for the treatment of schizophrenia, undergoes extensive metab. in humans with very little (<5%) of the dose excreted as unchanged drug.  Two enzyme systems have been implicated in ziprasidone metab.: the cytosolic enzyme, aldehyde oxidase, catalyzes the predominant reductive pathway, and cytochrome P 4503A4 (CYP3A4) is responsible for two alternative oxidn. pathways.  The involvement of two competing pathways in ziprasidone metab. greatly reduces the potential for pharmacokinetic interactions between ziprasidone and other drugs.  Because CYP3A4 only mediates one third of ziprasidone metab., the likelihood of interactions between ziprasidone and CYP3A4 inhibitors/ substrates is low.  Furthermore, aldehyde oxidase activity does not appear to be altered when drugs or xenobiotics are coadministered.  Aldehyde oxidase, a molybdenum-contg. enzyme, catalyzes the oxidn. of N-heterocyclic drugs such as famciclovir and zaleplon, in addn. to reducing some agents such as zonisamide.  Both reactions can occur simultaneously.  Although in vitro inhibitors of aldehyde oxidase have been identified, there are no reported clin. interactions with aldehyde oxidase inhibitors or inducers.  There is no evidence of genetic polymorphism in aldehyde oxidase, and thus it is not surprising that ziprasidone exposure demonstrates unimodality in humans.  Aldehyde oxidase is unrelated to the similarly named enzyme aldehyde dehydrogenase, which is predominantly responsible for the oxidn. of acetaldehyde during ethanol metab.  Consequently, it is unlikely that there would be any pharmacokinetic interaction between ethanol and ziprasidone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaMcHVJ3jRXrVg90H21EOLACvtfcHk0lhURAk4Af8xpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFKjt7c%253D&md5=1a97e9ae5d19efabe87a67a384847d8f</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1097%2F01.jcp.0000084028.22282.f2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jcp.0000084028.22282.f2%26sid%3Dliteratum%253Aachs%26aulast%3DBeedham%26aufirst%3DC.%26aulast%3DMiceli%26aufirst%3DJ.%2BJ.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DZiprasidone%2520Metabolism%252C%2520Aldehyde%2520Oxidase%252C%2520and%2520Clinical%2520Implications%26jtitle%3DJ.%2520Clin%2520Psychopharmacol.%26date%3D2003%26volume%3D23%26spage%3D229%26epage%3D232%26doi%3D10.1097%2F01.jcp.0000084028.22282.f2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korzekwa, K. R.</span></span> <span> </span><span class="NLM_article-title">Predicting Intrinsic Clearance for Drugs and Drug Candidates Metabolized by Aldehyde Oxidase</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1268</span>, <span class="refDoi"> DOI: 10.1021/mp300568r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300568r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ajtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1262-1268&issue=4&author=J.+P.+Jonesauthor=K.+R.+Korzekwa&title=Predicting+Intrinsic+Clearance+for+Drugs+and+Drug+Candidates+Metabolized+by+Aldehyde+Oxidase&doi=10.1021%2Fmp300568r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting Intrinsic Clearance for Drugs and Drug Candidates Metabolized by Aldehyde Oxidase</span></div><div class="casAuthors">Jones, Jeffrey P.; Korzekwa, Kenneth R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1262-1268</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metab. by aldehyde oxidase (AO) has been responsible for a no. of drug failures in clin. trials.  The main reason is the clearance values for drugs metabolized by AO are underestimated by allometric scaling from preclin. species.  Furthermore, in vitro human data also underestimates clearance.  We have developed the first in silico models to predict both in vitro and in vivo human intrinsic clearance for 8 drugs with just two chem. descriptors.  These models explain a large amt. of the variance in the data using two computational ests. of the electronic and steric features of the reaction.  The in vivo computational models for human metab. are better than in vitro preclin. animal testing at predicting human intrinsic clearance.  Thus, it appears that AO is amenable to computational prediction of rates, which may be used to guide drug discovery, and predict pharmacokinetics for clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMe4imNUVqorVg90H21EOLACvtfcHk0lhURAk4Af8xpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ajtbc%253D&md5=b91f8487291a445d04cccd20fd9227a3</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fmp300568r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300568r%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26atitle%3DPredicting%2520Intrinsic%2520Clearance%2520for%2520Drugs%2520and%2520Drug%2520Candidates%2520Metabolized%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26issue%3D4%26spage%3D1262%26epage%3D1268%26doi%3D10.1021%2Fmp300568r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span> <span> </span><span class="NLM_article-title">Drug Metabolism in Drug Discovery and Development</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.apsb.2018.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30245961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3czhvVOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=721-732&issue=5&author=Z.+Zhangauthor=W.+Tang&title=Drug+Metabolism+in+Drug+Discovery+and+Development&doi=10.1016%2Fj.apsb.2018.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Drug metabolism in drug discovery and development</span></div><div class="casAuthors">Zhang Zhoupeng; Tang Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">721-732</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Drug metabolism as a discipline plays an important role in drug discovery and development and the effects of drug metabolism on pharmacokinetics (PK), pharmacodynamics (PD), and safety should be carefully considered.  This communication provides an overview of common strategies in the area of drug metabolism for improving PK/PD and safety profiles of drug candidates; these include, but are not limited to, collaboration with medicinal chemists on structure-activity relationships (SAR) to overcome high clearance, using deuterium replacement to further optimize a lead, prodrug approaches to circumvent formulation and delivery difficulties, and addressing issues such as species differences in metabolism, drug-drug interactions (DDI) and formation of reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzNUaecqdUJp6t8nS6Nc3fW6udTcc2eZ5oCsGLqqs_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhvVOisg%253D%253D&md5=6e4ab48f370b85d3605309ce21eded67</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DDrug%2520Metabolism%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26issue%3D5%26spage%3D721%26epage%3D732%26doi%3D10.1016%2Fj.apsb.2018.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schildknegt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripp, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span> <span> </span><span class="NLM_article-title">Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.042770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.042770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22190693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=625-634&issue=3&author=R.+Sharmaauthor=T.+J.+Strelevitzauthor=H.+Gaoauthor=A.+J.+Clarkauthor=K.+Schildknegtauthor=R.+S.+Obachauthor=S.+L.+Rippauthor=D.+K.+Spracklinauthor=L.+M.+Tremaineauthor=A.+D.+Vaz&title=Deuterium+Isotope+Effects+on+Drug+Pharmacokinetics.+I.+System-Dependent+Effects+of+Specific+Deuteration+with+Aldehyde+Oxidase+Cleared+Drugs&doi=10.1124%2Fdmd.111.042770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs</span></div><div class="casAuthors">Sharma, Raman; Strelevitz, Timothy J.; Gao, Hongying; Clark, Alan J.; Schildknegt, Klaas; Obach, R. Scott; Ripp, Sharon L.; Spracklin, Douglas K.; Tremaine, Larry M.; Vaz, Alfin D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The pharmacokinetic properties of drugs may be altered by kinetic deuterium isotope effects.  With specifically deuterated model substrates and drugs metabolized by aldehyde oxidase, we demonstrate how knowledge of the enzyme's reaction mechanism, species differences in the role played by other enzymes in a drug's metabolic clearance, and differences in systemic clearance mechanisms are critically important for the pharmacokinetic application of deuterium isotope effects.  Ex vivo methods to project the in vivo outcome using deuterated carbazeran and zoniporide with hepatic systems demonstrate the importance of establishing the extent to which other metabolic enzymes contribute to the metabolic clearance mechanism.  Differences in pharmacokinetic outcomes in guinea pig and rat, with the same metabolic clearance mechanism, show how species differences in the systemic clearance mechanism can affect the in vivo outcome.  Overall, to gain from the application of deuteration as a strategy to alter drug pharmacokinetics, these studies demonstrate the importance of understanding the systemic clearance mechanism and knowing the identity of the metabolic enzymes involved, the extent to which they contribute to metabolic clearance, and the extent to which metab. contributes to the systemic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCSMFZQoq7tbVg90H21EOLACvtfcHk0lioajLpq0vAnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsrc%253D&md5=8d94242f5ef844ab3f45cfe92275ecda</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042770%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DSchildknegt%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26aulast%3DVaz%26aufirst%3DA.%2BD.%26atitle%3DDeuterium%2520Isotope%2520Effects%2520on%2520Drug%2520Pharmacokinetics.%2520I.%2520System-Dependent%2520Effects%2520of%2520Specific%2520Deuteration%2520with%2520Aldehyde%2520Oxidase%2520Cleared%2520Drugs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D3%26spage%3D625%26epage%3D634%26doi%3D10.1124%2Fdmd.111.042770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futatsugi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D. N.</span></span> <span> </span><span class="NLM_article-title">Deuterium Isotope Effects in Drug Pharmacokinetics Ii: Substrate-Dependence of the Reaction Mechanism Influences Outcome for Cytochrome P450 Cleared Drugs</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">11</span>), <span class="NLM_elocation-id">e0206279</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0206279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1371%2Fjournal.pone.0206279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30427871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmsl2lsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&issue=11&author=H.+Sunauthor=D.+W.+Piotrowskiauthor=S.+T.+M.+Orrauthor=J.+S.+Warmusauthor=A.+C.+Wolfordauthor=S.+B.+Coffeyauthor=K.+Futatsugiauthor=Y.+Zhangauthor=A.+D.+N.+Vaz&title=Deuterium+Isotope+Effects+in+Drug+Pharmacokinetics+Ii%3A+Substrate-Dependence+of+the+Reaction+Mechanism+Influences+Outcome+for+Cytochrome+P450+Cleared+Drugs&doi=10.1371%2Fjournal.pone.0206279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects in drug pharmacokinetics II: substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs</span></div><div class="casAuthors">Sun, Hao; Piotrowski, David W.; Orr, Suvi T. M.; Warmus, Joseph S.; Wolford, Angela C.; Coffey, Steven B.; Futatsugi, Kentaro; Zhang, Yinsheng; Vaz, Alfin D. N.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e0206279/1-e0206279/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Two chemotypes were examd. in vitro with CYPs 3A4 and 2C19 by mol. docking, metabolic profiles, and intrinsic clearance deuterium isotope effects with specifically deuterated form to assess the potential for enhancement of pharmacokinetic parameters.  The results show the complexity of deuteration as an approach for pharmacokinetic enhancement when CYP enzymes are involved in metabolic clearance.  With CYP3A4 the rate limiting step was chemotype-dependent.  With one chemotype no intrinsic clearance deuterium isotope effect was obsd. with any deuterated form, whereas with the other chemotype the rate limiting step was isotopically sensitive, and the magnitude of the intrinsic clearance isotope effect was dependent on the position(s) and extent of deuteration.  Mol. docking and metabolic profiles aided in identifying sites for deuteration and predicted the possibility for metabolic switching.  However, the potential for an isotope effect on the intrinsic clearance cannot be predicted and must be established by examg. select deuterated versions of the chemotypes.  The results show how in a deuteration strategy mol. docking, in-vitro metabolic profiles, and intrinsic clearance assessments with select deuterated versions of new chem. entities can be applied to det. the potential for pharmacokinetic enhancement in a discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMi2y94MpYpbVg90H21EOLACvtfcHk0lioajLpq0vAnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmsl2lsr0%253D&md5=6c8e9623365c6f20b6732e946478d11b</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0206279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0206279%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DOrr%26aufirst%3DS.%2BT.%2BM.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DVaz%26aufirst%3DA.%2BD.%2BN.%26atitle%3DDeuterium%2520Isotope%2520Effects%2520in%2520Drug%2520Pharmacokinetics%2520Ii%253A%2520Substrate-Dependence%2520of%2520the%2520Reaction%2520Mechanism%2520Influences%2520Outcome%2520for%2520Cytochrome%2520P450%2520Cleared%2520Drugs%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26issue%3D11%26doi%3D10.1371%2Fjournal.pone.0206279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Hara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">A Simple Litmus Test for Aldehyde Oxidase Metabolism of Heteroarenes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1616</span>– <span class="NLM_lpage">1620</span>, <span class="refDoi"> DOI: 10.1021/jm4017976</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4017976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1616-1620&issue=4&author=F.+O%E2%80%99Haraauthor=A.+C.+Burnsauthor=M.+R.+Collinsauthor=D.+Dalvieauthor=M.+A.+Ornelasauthor=A.+D.+Vazauthor=Y.+Fujiwaraauthor=P.+S.+Baran&title=A+Simple+Litmus+Test+for+Aldehyde+Oxidase+Metabolism+of+Heteroarenes&doi=10.1021%2Fjm4017976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">A simple litmus test for aldehyde oxidase metabolism of heteroarenes</span></div><div class="casAuthors">O'Hara, Fionn; Burns, Aaron C.; Collins, Michael R.; Dalvie, Deepak; Ornelas, Martha A.; Vaz, Alfin D. N.; Fujiwara, Yuta; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1616-1620</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bioavailability of arom. azaheterocyclic drugs can be affected by the activity of aldehyde oxidase (AO).  Susceptibility to AO metab. is difficult to predict computationally and can be complicated in vivo by differences between species.  The authors report the use of bis(((difluoromethyl)sulfinyl)oxy)zinc (DFMS) as a source of CF2H radical for a rapid and inexpensive chem. "litmus test" for the early identification of heteroarom. drug candidates that have a high probability of metab. by AO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVg4s4JDwh8rVg90H21EOLACvtfcHk0lioajLpq0vAnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCmsro%253D&md5=f9f4aac781f7fd0966b8faa0469b37da</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fjm4017976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4017976%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hara%26aufirst%3DF.%26aulast%3DBurns%26aufirst%3DA.%2BC.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DOrnelas%26aufirst%3DM.%2BA.%26aulast%3DVaz%26aufirst%3DA.%2BD.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DA%2520Simple%2520Litmus%2520Test%2520for%2520Aldehyde%2520Oxidase%2520Metabolism%2520of%2520Heteroarenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D4%26spage%3D1616%26epage%3D1620%26doi%3D10.1021%2Fjm4017976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skipper, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wogan, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannenbaum, S. R.</span></span> <span> </span><span class="NLM_article-title">Monocyclic Aromatic Amines as Potential Human Carcinogens: Old Is New Again</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1093%2Fcarcin%2Fbgp267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=19887514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=50-58&issue=1&author=P.+L.+Skipperauthor=M.+Y.+Kimauthor=H.+L.+Sunauthor=G.+N.+Woganauthor=S.+R.+Tannenbaum&title=Monocyclic+Aromatic+Amines+as+Potential+Human+Carcinogens%3A+Old+Is+New+Again&doi=10.1093%2Fcarcin%2Fbgp267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Monocyclic aromatic amines as potential human carcinogens: old is new again</span></div><div class="casAuthors">Skipper, Paul L.; Kim, Min Young; Sun, H.-L. Patty; Wogan, Gerald N.; Tannenbaum, Steven R.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-58</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Alkylanilines are a group of chems. whose ubiquitous presence in the environment is a result of the multitude of sources from which they originate.  Exposure assessments indicate that most individuals experience lifelong exposure to these compds.  Many alkylanilines have biol. activity similar to that of the carcinogenic multi-ring arom. amines.  This review provides an overview of human exposure and biol. effects.  It also describes recent investigations into the biochem. mechanisms of action that lead to the assessment that they are most probably more complex than those of the more extensively investigated multi-ring arom. amines.  Not only is nitrenium ion chem. implicated in DNA damage by alkylanilines but also reactions involving quinone imines and perhaps reactive oxygen species.  Recent results described here indicate that alkylanilines can be potent genotoxins for cultured mammalian cells when activated by exogenous or endogenous phase I and phase II xenobiotic-metabolizing enzymes.  The nature of specific DNA damage products responsible for mutagenicity remains to be identified but evidence to date supports mechanisms of activation through obligatory N-hydroxylation as well as subsequent conjugation by sulfation and/or acetylation.  A fuller understanding of the mechanisms of alkylaniline genotoxicity is expected to provide important insights into the environmental and genetic origins of one or more human cancers and may reveal a substantial role for this group of compds. as potential human chem. carcinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu8jtJ_-C4s7Vg90H21EOLACvtfcHk0lh1xzgvimxc5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCnsw%253D%253D&md5=37e5a874a1ee9edf96acb3ad73ec2925</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp267%26sid%3Dliteratum%253Aachs%26aulast%3DSkipper%26aufirst%3DP.%2BL.%26aulast%3DKim%26aufirst%3DM.%2BY.%26aulast%3DSun%26aufirst%3DH.%2BL.%26aulast%3DWogan%26aufirst%3DG.%2BN.%26aulast%3DTannenbaum%26aufirst%3DS.%2BR.%26atitle%3DMonocyclic%2520Aromatic%2520Amines%2520as%2520Potential%2520Human%2520Carcinogens%253A%2520Old%2520Is%2520New%2520Again%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26issue%3D1%26spage%3D50%26epage%3D58%26doi%3D10.1093%2Fcarcin%2Fbgp267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascitti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preville, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohrt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, P.</span></span> <span> </span><span class="NLM_article-title">Intrinsic Electrophilicity of a 4-Substituted-5-Cyano-6-(2-Methylpyridin-3-Yloxy)Pyrimidine Derivative: Structural Characterization of Glutathione Conjugates in Vitro</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1021/tx100429x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx100429x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=269-278&issue=2&author=A.+S.+Kalgutkarauthor=V.+Mascittiauthor=R.+Sharmaauthor=G.+W.+Walkerauthor=T.+Ryderauthor=T.+S.+McDonaldauthor=Y.+Chenauthor=C.+Previlleauthor=A.+Basakauthor=K.+F.+McClureauthor=J.+T.+Kohrtauthor=R.+P.+Robinsonauthor=M.+J.+Munchhofauthor=P.+Cornelius&title=Intrinsic+Electrophilicity+of+a+4-Substituted-5-Cyano-6-%282-Methylpyridin-3-Yloxy%29Pyrimidine+Derivative%3A+Structural+Characterization+of+Glutathione+Conjugates+in+Vitro&doi=10.1021%2Ftx100429x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic Electrophilicity of a 4-Substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine Derivative: Structural Characterization of Glutathione Conjugates in Vitro</span></div><div class="casAuthors">Kalgutkar, Amit S.; Mascitti, Vincent; Sharma, Raman; Walker, Gregory W.; Ryder, Tim; McDonald, Thomas S.; Chen, Yue; Preville, Cathy; Basak, Arindrajit; McClure, Kim F.; Kohrt, Jeffrey T.; Robinson, Ralph P.; Munchhof, Michael J.; Cornelius, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-278</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iso-Pr 9-anti-[5-cyano-6-(2-methyl-pyridin-3-yloxy)-pyrimidin-4-yloxy]-3-oxa-7-aza-bicyclo[3.3.1]nonane-7-carboxylate (I) represents a prototypic compd. from a lead chem. series of G protein-coupled receptor 119 agonists, intended for treatment of type 2 diabetes.  A series of these compds. was synthesis and their metab. studies with GSH, β-NADPH, and GST from equine liver were undertaken.  This observation suggests that the electron-withdrawing potential of the C5 cyano group serves to increase the electrophilicity of the C6 carbon (via stabilization of the transition state) and favors reaction with the nucleophilic thiol.  The mechanistic insights gained from these studies should assist medicinal chem. efforts toward the design of analogs that retain primary pharmacol. but are latent toward reaction with biol. nucleophiles, thus mitigating the potential for toxicol. outcome due to adduction with glutathione or proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAN7rYvalUIbVg90H21EOLACvtfcHk0lh1xzgvimxc5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSitLo%253D&md5=b1b7d33bccecf36acd24ef5d0b707c3c</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Ftx100429x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx100429x%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DG.%2BW.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPreville%26aufirst%3DC.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DKohrt%26aufirst%3DJ.%2BT.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DCornelius%26aufirst%3DP.%26atitle%3DIntrinsic%2520Electrophilicity%2520of%2520a%25204-Substituted-5-Cyano-6-%25282-Methylpyridin-3-Yloxy%2529Pyrimidine%2520Derivative%253A%2520Structural%2520Characterization%2520of%2520Glutathione%2520Conjugates%2520in%2520Vitro%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26issue%3D2%26spage%3D269%26epage%3D278%26doi%3D10.1021%2Ftx100429x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1023/A:1012188625088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1023%2FA%3A1012188625088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9165525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=568-571&author=K.+Palmauthor=P.+Stenbergauthor=K.+Luthmanauthor=P.+Artursson&title=Polar+Molecular+Surface+Properties+Predict+the+Intestinal+Absorption+of+Drugs+in+Humans&doi=10.1023%2FA%3A1012188625088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface properties predict the intestinal absorption of drugs in humans</span></div><div class="casAuthors">Palm, Katrin; Stenberg, Patric; Luthman, Kristina; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">568-571</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">A theor. method was devised for prediction of drug absorption after oral administration to humans.  Twenty structurally diverse model drugs, ranging from 0.3 to 100% absorbed, were investigated.  The compds. also displayed diversity in physicochem. properties such as lipophilicity, hydrogen bonding potential and mol. size.  The dynamic mol. surface properties of the compds. were calcd., taking into account their 3-dimensional shape and flexibility.  An excellent sigmoidal relationship was established between the absorbed fraction after oral administration to humans (FA) and the dynamic polar mol. surface area (PSAd) (r2 = 0.94).  The relationship was stronger than those obtained for more established predictors of drug absorption.  Drugs that are completely absorbed (FA > 90%) had a PSAd ≤ 60 Å2 while drugs that are < 10% absorbed had a PSAd ≥ 140 Å2.  PSAd can be used to differentiate poorly absorbed drugs at an early stage of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPW66hupHIyLVg90H21EOLACvtfcHk0liFBAaBm0Nx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlSksrk%253D&md5=1394f0d1059e7d99ee02be977b92da8b</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1023%2FA%3A1012188625088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1012188625088%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DK.%26aulast%3DStenberg%26aufirst%3DP.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DPolar%2520Molecular%2520Surface%2520Properties%2520Predict%2520the%2520Intestinal%2520Absorption%2520of%2520Drugs%2520in%2520Humans%26jtitle%3DPharm.%2520Res.%26date%3D1997%26volume%3D14%26spage%3D568%26epage%3D571%26doi%3D10.1023%2FA%3A1012188625088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didziapetris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Japertas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrauskas, A.</span></span> <span> </span><span class="NLM_article-title">Classification Analysis of P-Glycoprotein Substrate Specificity</span>. <i>J. Drug Target</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1080/10611860310001648248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F10611860310001648248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15203928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=391-406&issue=7&author=R.+Didziapetrisauthor=P.+Japertasauthor=A.+Avdeefauthor=A.+Petrauskas&title=Classification+Analysis+of+P-Glycoprotein+Substrate+Specificity&doi=10.1080%2F10611860310001648248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Classification Analysis of P-Glycoprotein Substrate Specificity</span></div><div class="casAuthors">Didziapetris, Remigijus; Japertas, Pranas; Avdeef, Alex; Petrauskas, Alanas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">391-406</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Prediction of P-glycoprotein substrate specificity (SPGP) can be viewed as a constituent part of a compd.'s "pharmaceutical profiling" in drug design.  This task is difficult to achieve due to several factors that raised many contradictory opinions: (i) the disparity between the SPGP values obtained in different assays, (ii) the confusion between Pgp substrates and inhibitors, (iii) the confusion between lipophilicity and amphiphilicity of Pgp substrates, and (iv) the dilemma of describing class-specific relationships when Pgp has no binding sites of high ligand specificity.  In this work, the authors compiled SPGP data for 1000 compds.  All data were represented in a binary format, assigning SPGP = 1 for substrates and SPGP = 0 for nonsubstrates.  Each value was ranked according to the reliability of exptl. assay.  Two data sets were considered.  Set 1 included 220 compds. with SPGP from polarized transport across MDR1 transfected cell monolayers.  Set 2 included the entire list of 1000 compds., with SPGP values of generally lower reliability.  Both sets were analyzed using a stepwise classification structure-activity relationship (C-SAR) method, leading to derivation of simple rules for crude estn. of SPGP values.  The obtained rules are based on the following factors: (i) compd.'s size expressed through molar wt. or vol., (ii) H-accepting given by the Abraham's β (that can be crudely approximated by the sum of O and N atoms), and (iii) ionization given by the acid and base pKa values.  Very roughly, SPGP can be estd. by the "rule of fours".  Compds. with (N + O) ≥ 8, MW > 400 and acid pKa > 4 are likely to be Pgp substrates, whereas compds. with (N+O) ≤ 4, MW < 400 and base pKa < 8 are likely to be nonsubstrates.  The obtained results support the view that Pgp functioning can be compared to a complex "mini-pharmacokinetic" system with fuzzy specificity.  This system can be described by a probabilistic version of Abraham's solvation equation, suggesting a certain similarity between Pgp transport and chromatog. retention.  The chromatog. model does not work in the case of "marginal" compds. with properties close to the "global" physicochem. cut-offs.  In the latter case various class-specific rules must be considered.  These can be assocd. with the "amphiphilicity" and "biol. similarity" of compds.  The definition of class-specific effects entails construction of the knowledge base that can be very useful in ADME profiling of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsvKJmruZ7RLVg90H21EOLACvtfcHk0liFBAaBm0Nx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D&md5=5b7ea95eb2d9faded5645481c1330f03</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1080%2F10611860310001648248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860310001648248%26sid%3Dliteratum%253Aachs%26aulast%3DDidziapetris%26aufirst%3DR.%26aulast%3DJapertas%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DPetrauskas%26aufirst%3DA.%26atitle%3DClassification%2520Analysis%2520of%2520P-Glycoprotein%2520Substrate%2520Specificity%26jtitle%3DJ.%2520Drug%2520Target%26date%3D2003%26volume%3D11%26issue%3D7%26spage%3D391%26epage%3D406%26doi%3D10.1080%2F10611860310001648248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span> <span> </span><span class="NLM_article-title">Structural Modifications That Alter the P-Glycoprotein Efflux Properties of Compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4877</span>– <span class="NLM_lpage">4895</span>, <span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&issue=11&author=S.+A.+Hitchcock&title=Structural+Modifications+That+Alter+the+P-Glycoprotein+Efflux+Properties+of+Compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0liFBAaBm0Nx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520Modifications%2520That%2520Alter%2520the%2520P-Glycoprotein%2520Efflux%2520Properties%2520of%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D11%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nambu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran-Dube, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalaie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grodsky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (C-Met) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-Ylmethyl)-1h-[1,2,3]Triazolo[4,5-B]Pyrazin-6-Yl)-1h-Pyrazol-1 -Yl)Ethanol (Pf-04217903) for the Treatment of Cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8091</span>– <span class="NLM_lpage">8109</span>, <span class="refDoi"> DOI: 10.1021/jm300967g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300967g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8091-8109&issue=18&author=J.+J.+Cuiauthor=M.+McTigueauthor=M.+Nambuauthor=M.+Tran-Dubeauthor=M.+Pairishauthor=H.+Shenauthor=L.+Jiaauthor=H.+Chengauthor=J.+Hoffmanauthor=P.+Leauthor=M.+Jalaieauthor=G.+H.+Goetzauthor=K.+Ryanauthor=N.+Grodskyauthor=Y.+L.+Dengauthor=M.+Parkerauthor=S.+Timofeevskiauthor=B.+W.+Murrayauthor=S.+Yamazakiauthor=S.+Aguirreauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensen&title=Discovery+of+a+Novel+Class+of+Exquisitely+Selective+Mesenchymal-Epithelial+Transition+Factor+%28C-Met%29+Protein+Kinase+Inhibitors+and+Identification+of+the+Clinical+Candidate+2-%284-%281-%28Quinolin-6-Ylmethyl%29-1h-%5B1%2C2%2C3%5DTriazolo%5B4%2C5-B%5DPyrazin-6-Yl%29-1h-Pyrazol-1+-Yl%29Ethanol+%28Pf-04217903%29+for+the+Treatment+of+Cancer&doi=10.1021%2Fjm300967g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer</span></div><div class="casAuthors">Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dube, Michelle; Pairish, Mason; Shen, Hong; Jia, Lei; Cheng, Hengmiao; Hoffman, Jacqui; Le, Phuong; Jalaie, Mehran; Goetz, Gilles H.; Koenig, Marcel; Vojkovsky, Tomas; Zhang, Fang-Jie; Do, Steven; Botrous, Iriny; Ryan, Kevin; Grodsky, Neil; Deng, Ya-li; Parker, Max; Timofeevski, Sergei; Murray, Brion W.; Yamazaki, Shinji; Aguirre, Shirley; Li, Qiuhua; Zou, Helen; Christensen, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8091-8109</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The c-MET receptor tyrosine kinase is an attractive oncol. target because of its crit. role in human oncogenesis and tumor progression.  An oxindole hydrazide hit 6 (VI) was identified during a c-MET HTS campaign and subsequently demonstrated to have an unusual degree of selectivity against a broad array of other kinases.  The cocrystal structure of the related oxindole hydrazide c-MET inhibitor 10 (X) with a nonphosphorylated c-MET kinase domain revealed a unique binding mode assocd. with the exquisite selectivity profile.  The chem. labile oxindole hydrazide scaffold was replaced with a chem. and metabolically stable triazolopyrazine scaffold using structure based drug design.  Medicinal chem. lead optimization produced 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (2, II, PF-04217903), an extremely potent and exquisitely selective c-MET inhibitor.  2 Demonstrated effective tumor growth inhibition in c-MET dependent tumor models with good oral PK properties and an acceptable safety profile in preclin. studies.  2 Progressed to clin. evaluation in a Phase I oncol. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9sgnBFaSHLbVg90H21EOLACvtfcHk0liRazTLxs-WIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrrL&md5=3c3ecda1c9698f2f16f9ff7c95596105</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm300967g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300967g%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DParker%26aufirst%3DM.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAguirre%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Exquisitely%2520Selective%2520Mesenchymal-Epithelial%2520Transition%2520Factor%2520%2528C-Met%2529%2520Protein%2520Kinase%2520Inhibitors%2520and%2520Identification%2520of%2520the%2520Clinical%2520Candidate%25202-%25284-%25281-%2528Quinolin-6-Ylmethyl%2529-1h-%255B1%252C2%252C3%255DTriazolo%255B4%252C5-B%255DPyrazin-6-Yl%2529-1h-Pyrazol-1%2520-Yl%2529Ethanol%2520%2528Pf-04217903%2529%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D18%26spage%3D8091%26epage%3D8109%26doi%3D10.1021%2Fjm300967g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akabane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerst, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, K.</span></span> <span> </span><span class="NLM_article-title">A Quantitative Approach to Hepatic Clearance Prediction of Metabolism by Aldehyde Oxidase Using Custom Pooled Hepatocytes</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.3109/00498254.2012.670736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2012.670736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22448773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKisLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=863-871&issue=9&author=T.+Akabaneauthor=N.+Gerstauthor=J.+N.+Mastersauthor=K.+Tamura&title=A+Quantitative+Approach+to+Hepatic+Clearance+Prediction+of+Metabolism+by+Aldehyde+Oxidase+Using+Custom+Pooled+Hepatocytes&doi=10.3109%2F00498254.2012.670736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes</span></div><div class="casAuthors">Akabane, Takafumi; Gerst, Nicolas; Masters, Jeffrey N.; Tamura, Kouichi</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">863-871</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">We describe the usability of human pooled hepatocytes for non-CYP metab. evaluation and an in vivo-in vitro correlation anal. for aldehyde oxidase (AO) substrate compds. using pooled hepatocytes.  By comparing intrinsic clearance values of 18 compds. primarily metabolized by AO, UDP-glucuronosyltransferase, carbonyl/aldo-keto reductase, flavin-contg. monooxygenase, and monoamineoxidase in individual hepatocytes and pooled hepatocytes from the same individual donors, intrinsic clearance in the pooled hepatocytes was ±30% of the av. clearance value in individuals for 15 of 18 compds., suggesting that pooled hepatocytes maintained the av. activity of the individual hepatocytes.  Although the results of an in vivo-in vitro correlation anal. for AO substrate compds. showed a trend toward under-prediction, the underestimation ratios for all AO substrates were nevertheless comparable (7.2- to 14.9-fold), suggesting that hepatic clearance prediction for these compds. can be quantified using empirical scaling.  These observations enabled us to obtain specific pooled hepatocytes that showed the expected non-CYP enzyme activities by pre-characterization and to quantify hepatic clearance prediction for AO compds. using an empirical scaling factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_oKqnd67uxLVg90H21EOLACvtfcHk0liRazTLxs-WIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKisLzO&md5=c37efa2bb66e044b701ece9b606d8426</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.3109%2F00498254.2012.670736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2012.670736%26sid%3Dliteratum%253Aachs%26aulast%3DAkabane%26aufirst%3DT.%26aulast%3DGerst%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DJ.%2BN.%26aulast%3DTamura%26aufirst%3DK.%26atitle%3DA%2520Quantitative%2520Approach%2520to%2520Hepatic%2520Clearance%2520Prediction%2520of%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%2520Using%2520Custom%2520Pooled%2520Hepatocytes%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26issue%3D9%26spage%3D863%26epage%3D871%26doi%3D10.3109%2F00498254.2012.670736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Kinetic Deuterium Isotope Effects in Cytochrome P450 Oxidation Reactions</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">9−10</span>),  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fjlcr.3031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24285515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVemsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=428-431&issue=9%E2%88%9210&author=F.+P.+Guengerich&title=Kinetic+Deuterium+Isotope+Effects+in+Cytochrome+P450+Oxidation+Reactions&doi=10.1002%2Fjlcr.3031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic deuterium isotope effects in cytochrome P 450 oxidation reactions</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (P 450) isoforms account for ∼75% of the metab. of drugs.  Most of the reactions catalyzed by P 450 isoforms are mixed-function oxidns., and a C-H bond is (usually) broken.  The rate-limiting nature of this step can be analyzed using the kinetic isotope effect (KIE) approach.  The most relevant type of KIE is one termed intermol. noncompetitive, indicative of rate-limiting C-H bond breaking.  A plot of KIE vs. kcat for several P 450s showed a correlation coeff. (r2) of 0.62.  Deuterium substitution has been considered as a potential means of slowing drug metab. or redirecting sites of metab. in some cases, and several general points can be made regarding the potential for application of deuterium in drug design/development based on what is known about P 450 KIEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKzliIFqb7trVg90H21EOLACvtfcHk0liRazTLxs-WIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVemsbw%253D&md5=b06a7c3232f556435d16bf97b567199f</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3031%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DKinetic%2520Deuterium%2520Isotope%2520Effects%2520in%2520Cytochrome%2520P450%2520Oxidation%2520Reactions%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26issue%3D9%25E2%2588%259210%26spage%3D428%26epage%3D431%26doi%3D10.1002%2Fjlcr.3031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pue, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of Famciclovir in Man</span>. <i>Antivir. Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1177/09563202930040S602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1177%2F09563202930040S602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2cXitlGiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=47-55&author=M.+A.+Pueauthor=L.+Z.+Benet&title=Pharmacokinetics+of+Famciclovir+in+Man&doi=10.1177%2F09563202930040S602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of famciclovir in man</span></div><div class="casAuthors">Pue, M. A.; Benet, L. Z.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Chemistry & Chemotherapy</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">ACCHEH</span>;
        ISSN:<span class="NLM_cas:issn">0956-3202</span>.
    </div><div class="casAbstract">A review with 26 refs.  This review presents briefly the results of a no. of studies conducted in healthy volunteers, designed to investigate the pharmacokinetics of famciclovir, the oral form of the antiviral compd., penciclovir.  These studies have shown that famciclovir is absorbed rapidly and extensively following oral administration.  Extensive presystemic metab. of famciclovir occurs since compd.-related material in plasma consists almost entirely of deacetylated and oxidized metabolites.  Little or no parent compd. is detected in plasma or urine.  The major metabolite of famciclovir is penciclovir.  Max. plasma concns. of penciclovir are achieved rapidly following oral administration of famciclovir, and total systemic availability of penciclovir is high (77%).  Pharmacokinetic parameters for penciclovir are linear over the famciclovir oral dose range 125-75 mg and the penciclovir i.v. dose range 10-20 mg kg-1.  The distribution of penciclovir after i.v. administration is consistent with localization out of plasma and into tissues.  Penciclovir is eliminated rapidly and almost unchanged by net active tubular secretion and glomerular filtration in the kidneys.  The terminal phase elimination half-life of the compd. in healthy subjects is approx. 2 h.  A study in healthy elderly male subjects indicated no clin. significant effects of age on the pharmacokinetics of penciclovir following oral famciclovir administration.  Food appears to slow the rate of availability of penciclovir from oral famciclovir, but has no effects on the extent of availability of penciclovir.  These data indicate that famciclovir possesses excellent pharmacokinetic properties for the provision of clin. useful concns. of the antiviral agent penciclovir in the oral treatment of herpesviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCKJ8oqX1D47Vg90H21EOLACvtfcHk0liGwm-STZKikQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlGiu7w%253D&md5=b5f8a99ff882c36168a0048489faf478</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1177%2F09563202930040S602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F09563202930040S602%26sid%3Dliteratum%253Aachs%26aulast%3DPue%26aufirst%3DM.%2BA.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26atitle%3DPharmacokinetics%2520of%2520Famciclovir%2520in%2520Man%26jtitle%3DAntivir.%2520Chem.%2520Chemother.%26date%3D1993%26volume%3D4%26spage%3D47%26epage%3D55%26doi%3D10.1177%2F09563202930040S602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krenitsky, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miranda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteman, P. D.</span></span> <span> </span><span class="NLM_article-title">6-Deoxyacyclovir: A Xanthine Oxidase-Activated Prodrug of Acyclovir</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3209</span>– <span class="NLM_lpage">3213</span>, <span class="refDoi"> DOI: 10.1073/pnas.81.10.3209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1073%2Fpnas.81.10.3209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=6587347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2cXkvVenurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=3209-3213&issue=10&author=T.+A.+Krenitskyauthor=W.+W.+Hallauthor=P.+de+Mirandaauthor=L.+M.+Beauchampauthor=H.+J.+Schaefferauthor=P.+D.+Whiteman&title=6-Deoxyacyclovir%3A+A+Xanthine+Oxidase-Activated+Prodrug+of+Acyclovir&doi=10.1073%2Fpnas.81.10.3209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">6-Deoxyacyclovir:  a xanthine oxidase-activated prodrug of acyclovir</span></div><div class="casAuthors">Krenitsky, Thomas A.; Hall, Willard W.; De Miranda, Paulo; Beauchamp, Lilia M.; Schaeffer, Howard J.; Whiteman, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3209-13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">6-Deoxyacyclovir (I)  [84408-37-7] was synthesized and found to be 18 times more water sol. than acyclovir  [59277-89-3]; I was readily oxidized to acyclovir by xanthine oxidase (EC 1.2.3.2)  [9002-17-9].  It is also oxidized by aldehyde oxidase (EC 1.2.3.1)  [9029-07-6] largely to 8-hydroxy-6-deoxyacyclovir  [91503-60-5].  I and the major products of its oxidn. by aldehyde oxidase are devoid of appreciable activity against herpes simplex type I in vitro.  The success of I as a prodrug in vivo would depend upon how well its desired activation by xanthine oxidase competed with the nonactivating oxidns. by aldehyde oxidase.  In rats dosed orally with I, absorption was extensive and the major urinary metabolite was acyclovir.  In 2 human volunteers, urinary excretions of acyclovir were 5-6 times greater than those typically obsd. after administration of equiv. doses of acyclovir itself.  The areas under the plasma concn.-time curves for acyclovir were also 5-6 times greater.  Plasma levels of acyclovir peaked soon after ingestion of the prodrug, indicating rapid absorption and metabolic conversion.  Thus, 6-deoxyacyclovir may have clin. usefulness as a prodrug of acyclovir suitable for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwm6CfFXKAirVg90H21EOLACvtfcHk0liGwm-STZKikQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXkvVenurc%253D&md5=67a3e2a53095adeddbd1b22860300db0</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1073%2Fpnas.81.10.3209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.81.10.3209%26sid%3Dliteratum%253Aachs%26aulast%3DKrenitsky%26aufirst%3DT.%2BA.%26aulast%3DHall%26aufirst%3DW.%2BW.%26aulast%3Dde%2BMiranda%26aufirst%3DP.%26aulast%3DBeauchamp%26aufirst%3DL.%2BM.%26aulast%3DSchaeffer%26aufirst%3DH.%2BJ.%26aulast%3DWhiteman%26aufirst%3DP.%2BD.%26atitle%3D6-Deoxyacyclovir%253A%2520A%2520Xanthine%2520Oxidase-Activated%2520Prodrug%2520of%2520Acyclovir%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1984%26volume%3D81%26issue%3D10%26spage%3D3209%26epage%3D3213%26doi%3D10.1073%2Fpnas.81.10.3209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilsky, R. L.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Clinical Pharmacology of 5-Fluorouracil</span>. <i>Oncology (Williston Park)</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9830619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADyaK1M%252FkvVeisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=13-18&author=R.+L.+Schilsky&title=Biochemical+and+Clinical+Pharmacology+of+5-Fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and clinical pharmacology of 5-fluorouracil</span></div><div class="casAuthors">Schilsky R L</div><div class="citationInfo"><span class="NLM_cas:title">Oncology (Williston Park, N.Y.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10 Suppl 7</span>),
    <span class="NLM_cas:pages">13-8</span>
        ISSN:<span class="NLM_cas:issn">0890-9091</span>.
    </div><div class="casAbstract">The cellular and clinical pharmacology of fluoropyrimidines is characterized by marked interpatient variability in tumor response and patient tolerance.  Understanding the metabolic pathways followed by 5-fluorouracil (5-FU) has led to new strategies to optimize therapy with these important agents.  The "fluoropyrimidine phenotype" of tumor cells can be used to determine whether therapy with these agents is appropriate and, if so, whether one fluoropyrimidine may offer a particular advantage over another.  Combining a dihydropyrimidine dehydrogenase inhibitor with 5-FU offers the potential to minimize pharmacokinetic variability and, in that way, to improve oral bioavailability, facilitate dosage adjustment to achieve desired concentrations, and increase the likelihood of tumor response while minimizing the risk of severe toxicity to individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_qCHOqWTNfYMcDoIzZtNkfW6udTcc2eYMcCvMdaRAz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FkvVeisw%253D%253D&md5=8184a650c6ecd1be52ccade850415ce7</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchilsky%26aufirst%3DR.%2BL.%26atitle%3DBiochemical%2520and%2520Clinical%2520Pharmacology%2520of%25205-Fluorouracil%26jtitle%3DOncology%2520%2528Williston%2520Park%2529%26date%3D1998%26volume%3D12%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinderling, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karara, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span> <span> </span><span class="NLM_article-title">Systemic Availability of the Active Metabolite Hydroxy-Fasudil after Administration of Fasudil to Different Sites of the Human Gastrointestinal Tract</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1177/0091270006293767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1177%2F0091270006293767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=17192498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1altb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=19-25&issue=1&author=P.+H.+Hinderlingauthor=A.+H.+Kararaauthor=B.+Taoauthor=M.+Pawulaauthor=I.+Wildingauthor=M.+Lu&title=Systemic+Availability+of+the+Active+Metabolite+Hydroxy-Fasudil+after+Administration+of+Fasudil+to+Different+Sites+of+the+Human+Gastrointestinal+Tract&doi=10.1177%2F0091270006293767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic availability of the active metabolite hydroxy-fasudil after administration of fasudil to different sites of the human gastrointestinal tract</span></div><div class="casAuthors">Hinderling, Peter H.; Karara, Adel H.; Tao, Ben; Pawula, Maria; Wilding, Ian; Lu, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-25</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">This study evaluated the gastrointestinal absorption of fasudil, a novel Rho kinase inhibitor for the treatment of stable angina, at different sites using remote-controlled capsules and assessed the feasibility of developing an extended-release formulation.  Ten healthy male volunteers were enrolled, and 8 subjects completed this single-dose, open-label, randomized, 5-way crossover study.  Forty milligrams of fasudil HCl was administered as soln. to the distal ileum and ascending colon, as powder to the ascending colon, and orally as an immediate-release tablet and soln.  All treatments were well-tolerated and no serious adverse events were obsd.  The mean systemic availabilities of M3 relative to the oral soln. were 1.04 (distal ileum, soln.), 1.14 (ascending colon, soln.), 1.27 (ascending colon, powder) and 1.04 (oral tablet), indicating similar systemic availability of M3 after administration of fasudil HCl to different gastrointestinal sites.  The results suggest that development of a once-a-day extended-release formulation for fasudil HCl should be readily achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYRn_UaQvwZrVg90H21EOLACvtfcHk0liGwm-STZKikQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1altb0%253D&md5=a4654f0b409042d9faa61a0fdc57959c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1177%2F0091270006293767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270006293767%26sid%3Dliteratum%253Aachs%26aulast%3DHinderling%26aufirst%3DP.%2BH.%26aulast%3DKarara%26aufirst%3DA.%2BH.%26aulast%3DTao%26aufirst%3DB.%26aulast%3DPawula%26aufirst%3DM.%26aulast%3DWilding%26aufirst%3DI.%26aulast%3DLu%26aufirst%3DM.%26atitle%3DSystemic%2520Availability%2520of%2520the%2520Active%2520Metabolite%2520Hydroxy-Fasudil%2520after%2520Administration%2520of%2520Fasudil%2520to%2520Different%2520Sites%2520of%2520the%2520Human%2520Gastrointestinal%2520Tract%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2007%26volume%3D47%26issue%3D1%26spage%3D19%26epage%3D25%26doi%3D10.1177%2F0091270006293767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">Metabolomics Reveals the Formation of Aldehydes and Iminium in Gefitinib Metabolism</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2015.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2015.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26212543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Chsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=111-121&issue=1&author=X.+Liuauthor=Y.+Luauthor=X.+Guanauthor=B.+Dongauthor=H.+Chavanauthor=J.+Wangauthor=Y.+Zhangauthor=P.+Krishnamurthyauthor=F.+Li&title=Metabolomics+Reveals+the+Formation+of+Aldehydes+and+Iminium+in+Gefitinib+Metabolism&doi=10.1016%2Fj.bcp.2015.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism</span></div><div class="casAuthors">Liu, Xing; Lu, Yuanfu; Guan, Xinfu; Dong, Bingning; Chavan, Hemantkumar; Wang, Jin; Zhang, Yiqing; Krishnamurthy, Partha; Li, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-121</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gefitinib (GEF), an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, is widely used for the treatment of cancers, particularly non-small cell lung cancer.  However, its clin. use is limited by multiple adverse effects assocd. with GEF, such as liver and lung injuries, severe nausea, and diarrhea.  Although, the exact mechanism of GEF adverse effects are still unknown, xenobiotic-induced bioactivation is thought to play a significant role in GEF induced toxicity.  Using a metabolomic approach, we investigated the metabolic pathways of GEF in human and mouse liver microsomes.  Thirty four GEF metabolites and adducts were identified and half of them are novel.  The potential reactive metabolites, two aldehydes and one iminium, were identified for the first time.  The previously reported GSH adducts and primary amines were obsd. as well.  The aldehyde and iminium pathways were further confirmed by using methoxylamine and potassium cyanide as trapping reagents.  Using recombinant CYP450 isoforms, CYP3A4 inhibitor, and S9 from Cyp3a-null mice, we confirmed CYP3A is the major enzyme contributing to the formation of aldehydes, GSH adducts, and primary amines in liver.  Multiple enzymes contribute to the formation of iminium.  This study provided us more knowledge of GEF bioactivation and enzymes involved in metabolic pathways, which can be utilized for understanding the mechanism of adverse effects assocd. with GEF and predicting possible drug-drug interactions.  Further studies are suggested to det. the roles of these bioactivation pathways in GEF toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrViZ82Ih6lArVg90H21EOLACvtfcHk0lj7pYnn0OHmAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Chsb7M&md5=f95cbe2470bb41319e9e0fd1b5c3e25c</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DB.%26aulast%3DChavan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKrishnamurthy%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DMetabolomics%2520Reveals%2520the%2520Formation%2520of%2520Aldehydes%2520and%2520Iminium%2520in%2520Gefitinib%2520Metabolism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D97%26issue%3D1%26spage%3D111%26epage%3D121%26doi%3D10.1016%2Fj.bcp.2015.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of Tpn729 Metabolites in Humans Using Ultra-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.jpba.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26366939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2jtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=217-226&author=Y.+Zhuauthor=L.+Liauthor=P.+Dengauthor=X.+Chenauthor=D.+Zhong&title=Characterization+of+Tpn729+Metabolites+in+Humans+Using+Ultra-Performance+Liquid+Chromatography%2FQuadrupole+Time-of-Flight+Mass+Spectrometry&doi=10.1016%2Fj.jpba.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of TPN729 metabolites in humans using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry</span></div><div class="casAuthors">Zhu, Yunting; Li, Liang; Deng, Pan; Chen, Xiaoyan; Zhong, Dafang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">217-226</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">TPN729 has been reported as a novel phosphodiesterase type 5 (PDE5) inhibitor to treat erectile dysfunction, and is currently being tested in clin. trials.  In addn. to the potent inhibition against PDE5, TPN729 is regarded as a better alternative to provide fewer side effects and better patient compliance.  Given the potential therapeutic benefits of TPN729, it is of great importance to elucidate its metabolic characteristics in drug development.  This study is the first to investigate the metabolic fate of TPN729 in humans.  A rapid and reliable anal. method based on ultra-performance liq. chromatog./quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF MS) was established to investigate the metabolic profiles of TPN729 in human plasma, urine, and feces after its oral administration.  As a result, a total of 22 metabolites were identified, of which seven were confirmed in comparison with the ref. substances.  The incubations of the metabolite refs. in human hepatocytes and aldehyde trapping expt. were further conducted to investigate its metabolic pathways.  The results of the present study indicated the extensive metab. of TPN729 in humans, including oxidative deamination, oxidative ring opening, N-dealkylation, N-oxidn., hydroxylation, dehydrogenation, lactam formation, and glucuronidation.  M3 resulting from N-dealkylation was the major circulating substance detected in human plasma.  The principal metabolites detected in human feces were products of oxidative deamination and oxidative ring opening.  The parent drug was identified as the major component in urine.  Taken together, this study provided valuable information on the metabolic fate of TPN729 in humans, and applicable anal. strategies for rapid metabolic elucidation in complex matrix samples through the useful and reliable UPLC/Q-TOF MS technique.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVZMcV_WJUjrVg90H21EOLACvtfcHk0lj7pYnn0OHmAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2jtbfL&md5=c62f83995e393bbfb3f5ed259538ad9b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520Tpn729%2520Metabolites%2520in%2520Humans%2520Using%2520Ultra-Performance%2520Liquid%2520Chromatography%252FQuadrupole%2520Time-of-Flight%2520Mass%2520Spectrometry%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2016%26volume%3D117%26spage%3D217%26epage%3D226%26doi%3D10.1016%2Fj.jpba.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span> <span> </span><span class="NLM_article-title">Metabolism and Excretion of Imrecoxib in Rat</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.3109/00498250600595524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498250600595524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16854781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVCgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=441-455&issue=5&author=H.+Xuauthor=Y.+Zhangauthor=Y.+Sunauthor=P.+Zhangauthor=F.+Chuauthor=Z.+Guoauthor=H.+Zhangauthor=D.+Zhong&title=Metabolism+and+Excretion+of+Imrecoxib+in+Rat&doi=10.3109%2F00498250600595524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and excretion of imrecoxib in rat</span></div><div class="casAuthors">Xu, H.; Zhang, Y.; Sun, Y.; Zhang, P.; Chu, F.; Guo, Z.; Zhang, H.; Zhong, D.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">441-455</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The metab. and excretion of imrecoxib, a novel and moderately selective cyclooxygenase-II inhibitor, were investigated in rat.  The structures of metabolites were identified by mass spectrometry (MSn) and NMR.  Metabolic profiles of imrecoxib in urine, bile and feces were obtained by HPLC and LC/MSn, and cumulative excretion was detd. by LC/MSn.  Imrecoxib was extensively metabolized in rat after i.v. administration, with less than 2% of the dose excreted as parent drug in either urine or feces.  The major metabolic pathway was that the 4'-Me group of imrecoxib was first oxidized to the 4'-hydroxymethyl metabolite (M4), followed by addnl. oxidn. to 4'-carboxylic acid metabolite (M2).  The dihydroxylated metabolite, 4'-hydroxymethyl-5-hydroxyl imrecoxib (M3), was further oxidized to 4'-hydroxymethyl-5-carbonyl metabolite (M5), and glucuronide conjugates of M2-4 were formed.  After i.v. (5 mg kg-1) administration, the majority of the dose was recovered in the feces.  The dose was primarily excreted as the carboxylic acid metabolite in addn. to the 4'-hydroxymethyl metabolite.  The carboxylic acid metabolite was mainly excreted in feces, while the 4'-hydroxymethyl metabolite was mainly excreted in urine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL_PHJivoRSbVg90H21EOLACvtfcHk0lj7pYnn0OHmAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVCgtbY%253D&md5=a86e3c236b21fc11050f505eeb9a0fef</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.3109%2F00498250600595524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498250600595524%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DChu%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DD.%26atitle%3DMetabolism%2520and%2520Excretion%2520of%2520Imrecoxib%2520in%2520Rat%26jtitle%3DXenobiotica%26date%3D2006%26volume%3D36%26issue%3D5%26spage%3D441%26epage%3D455%26doi%3D10.3109%2F00498250600595524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D. F.</span></span> <span> </span><span class="NLM_article-title">Formation of 4’-Carboxyl Acid Metabolite of Imrecoxib by Rat Liver Microsomes</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1111/j.1745-7254.2006.00312.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1111%2Fj.1745-7254.2006.00312.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16539853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs12jt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=506-512&issue=4&author=H.+Y.+Xuauthor=P.+Zhangauthor=A.+S.+Gongauthor=Y.+M.+Sunauthor=F.+M.+Chuauthor=Z.+R.+Guoauthor=D.+F.+Zhong&title=Formation+of+4%E2%80%99-Carboxyl+Acid+Metabolite+of+Imrecoxib+by+Rat+Liver+Microsomes&doi=10.1111%2Fj.1745-7254.2006.00312.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes</span></div><div class="casAuthors">Xu, Hai-yan; Zhang, Peng; Gong, Ai-shen; Sun, Yu-ming; Chu, Feng-ming; Guo, Zong-ru; Zhong, Da-fang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">506-512</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Imrecoxib is a novel and moderately selective COX-2 inhibitor.  The aim of the present in vitro investigation was to study the formation of the major metabolite 4'-carboxylic acid imrecoxib (M2) and identify the enzyme(s) involved in the reaction.  The formation of M2 was studied in rat liver cytosol in the absence or presence of liver microsomes.  The formed metabolite was identified and quantified by LC/MSn.  In addn., to characterize the cytochrome P 450 (CYP) isoenzymes involved in M2 formation, the effects of typical CYP inhibitors (such as ketoconazle, quinine, α-naphthoflavone, methylpyrazole, and cimetidine) on the formation rate of M2 were investigated.  The formation of M2 from 4'-hydroxymethyl imrecoxib (M4) was completely dependent on rat liver microsomes and NADPH.  Enzyme kinetic studies demonstrated that the formation rate of M2 conformed to monophasic Michaelis-Menten kinetics.  Addnl. expts. showed that the formation of M2 was induced significantly by dexamethasone and lowered by ketoconazole strongly and concn.-dependently.  By comparison, other CYP inhibitors, such as α-naphthoflavone, cimetidine, quinine, and methylpyrazole had no inhibitory effects on this metabolic pathway.  These biotransformation studies of M4 and imrecoxib in rat liver at the subcellular level showed that the formation of M2 occurs in rat liver microsomes and is NADPH-dependent.  The reaction was mainly catalyzed by CYP 3A in untreated rats and in dexamethasone-induced rats.  Other CYP, such as CYP 1A, 2C, 2D, and 2E, seem unlikely to participate in this metabolic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2-0rMi82MtLVg90H21EOLACvtfcHk0ljTRk-ZSdyxEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs12jt78%253D&md5=27d8cd1e66a51c4276632f46d4ed4628</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7254.2006.00312.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7254.2006.00312.x%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%2BY.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DGong%26aufirst%3DA.%2BS.%26aulast%3DSun%26aufirst%3DY.%2BM.%26aulast%3DChu%26aufirst%3DF.%2BM.%26aulast%3DGuo%26aufirst%3DZ.%2BR.%26aulast%3DZhong%26aufirst%3DD.%2BF.%26atitle%3DFormation%2520of%25204%25E2%2580%2599-Carboxyl%2520Acid%2520Metabolite%2520of%2520Imrecoxib%2520by%2520Rat%2520Liver%2520Microsomes%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2006%26volume%3D27%26issue%3D4%26spage%3D506%26epage%3D512%26doi%3D10.1111%2Fj.1745-7254.2006.00312.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomgren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dambach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallion, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropf, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macaluso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheerens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, K. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Potent and Selective Bruton’s Tyrosine Kinase Inhibitors: Pyridazinone Analogs with Improved Metabolic Stability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2015.11.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26675441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvF2ms77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=575-579&issue=2&author=W.+B.+Youngauthor=J.+Barbosaauthor=P.+Blomgrenauthor=M.+C.+Bremerauthor=J.+J.+Crawfordauthor=D.+Dambachauthor=C.+Eigenbrotauthor=S.+Gallionauthor=A.+R.+Johnsonauthor=J.+E.+Kropfauthor=S.+H.+Leeauthor=L.+Liuauthor=J.+W.+Lubachauthor=J.+Macalusoauthor=P.+Maciejewskiauthor=S.+A.+Mitchellauthor=D.+F.+Ortwineauthor=J.+Di+Paoloauthor=K.+Reifauthor=H.+Scheerensauthor=A.+Schmittauthor=X.+Wangauthor=H.+Wongauthor=J.+M.+Xiongauthor=J.+Xuauthor=C.+Yuauthor=Z.+Zhaoauthor=K.+S.+Currie&title=Discovery+of+Highly+Potent+and+Selective+Bruton%E2%80%99s+Tyrosine+Kinase+Inhibitors%3A+Pyridazinone+Analogs+with+Improved+Metabolic+Stability&doi=10.1016%2Fj.bmcl.2015.11.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability</span></div><div class="casAuthors">Young, Wendy B.; Barbosa, James; Blomgren, Peter; Bremer, Meire C.; Crawford, James J.; Dambach, Donna; Eigenbrot, Charles; Gallion, Steve; Johnson, Adam R.; Kropf, Jeffrey E.; Lee, Seung H.; Liu, Lichuan; Lubach, Joseph W.; Macaluso, Jen; Maciejewski, Pat; Mitchell, Scott A.; Ortwine, Daniel F.; Di Paolo, Julie; Reif, Karin; Scheerens, Heleen; Schmitt, Aaron; Wang, Xiaojing; Wong, Harvey; Xiong, Jin-Ming; Xu, Jianjun; Yu, Christine; Zhao, Zhongdong; Currie, Kevin S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">575-579</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">BTK inhibitor GDC-0834 was found to be rapidly metabolized in human studies, resulting in a suspension of clin. trials.  The primary route of metab. was through cleavage of the acyclic amide bond connecting the terminal tetrahydrobenzothiophene with the central linker aryl ring.  SAR studies were focused on reducing metabolic cleavage of this amide, and resulted in the identification of several central aryl linker substituents that conferred improved stability.  The most promising substituted aryl linkers were then incorporated into an optimized pyridazinone scaffold, resulting in the identification of lead analog I, possessing improved potency, metabolic stability and preclin. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWhbh3H4N2ErVg90H21EOLACvtfcHk0ljTRk-ZSdyxEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2ms77M&md5=ff074fc16518d072ccb9b7b5d8520a03</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.076%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DW.%2BB.%26aulast%3DBarbosa%26aufirst%3DJ.%26aulast%3DBlomgren%26aufirst%3DP.%26aulast%3DBremer%26aufirst%3DM.%2BC.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DDambach%26aufirst%3DD.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGallion%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DKropf%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLubach%26aufirst%3DJ.%2BW.%26aulast%3DMacaluso%26aufirst%3DJ.%26aulast%3DMaciejewski%26aufirst%3DP.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DDi%2BPaolo%26aufirst%3DJ.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DScheerens%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DXiong%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%2520and%2520Selective%2520Bruton%25E2%2580%2599s%2520Tyrosine%2520Kinase%2520Inhibitors%253A%2520Pyridazinone%2520Analogs%2520with%2520Improved%2520Metabolic%2520Stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D575%26epage%3D579%26doi%3D10.1016%2Fj.bmcl.2015.11.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&issue=8&author=N.+A.+Meanwell&title=Synopsis+of+Some+Recent+Tactical+Application+of+Bioisosteres+in+Drug+Design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljTRk-ZSdyxEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520Some%2520Recent%2520Tactical%2520Application%2520of%2520Bioisosteres%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helmer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roffel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanteux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garratt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosje, T.</span></span> <span> </span><span class="NLM_article-title">A Dual-Administration Microtracer Technique to Characterize the Absorption, Distribution, Metabolism, and Excretion of [(14) C]Seletalisib (Ucb5857) in Healthy Subjects</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1582</span>– <span class="NLM_lpage">1590</span>, <span class="refDoi"> DOI: 10.1002/jcph.954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fjcph.954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28650526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslymsrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=1582-1590&issue=12&author=E.+Helmerauthor=J.+M.+Nicolasauthor=J.+Longauthor=A.+F.+Roffelauthor=E.+Jonesauthor=H.+Chanteuxauthor=N.+Diazauthor=H.+Garrattauthor=T.+Bosje&title=A+Dual-Administration+Microtracer+Technique+to+Characterize+the+Absorption%2C+Distribution%2C+Metabolism%2C+and+Excretion+of+%5B%2814%29+C%5DSeletalisib+%28Ucb5857%29+in+Healthy+Subjects&doi=10.1002%2Fjcph.954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A Dual-Administration Microtracer Technique to Characterize the Absorption, Distribution, Metabolism, and Excretion of [14C]Seletalisib (UCB5857) in Healthy Subjects</span></div><div class="casAuthors">Helmer, Eric; Nicolas, Jean-Marie; Long, Jeff; Roffel, Ad F.; Jones, Emma; Chanteux, Hugues; Diaz, Nieves; Garratt, Holly; Bosje, Tjerk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1582-1590</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphoinositide 3 kinases are targets for development of small-mol. inhibitors to disrupt progression of immune-inflammatory diseases.  This phase 1 open-label study (Eudract 2014-005353-39) evaluated the safety and relative bioavailability of 2 new seletalisib (UCB5857) formulations (A and B) compared with a ref. formulation.  Abs. bioavailability (period 1a, n = 6) and disposition and metab. (period 1b, n = 6) of the ref. formulation were evaluated: healthy subjects received 30 mg orally plus ∼20 μg of a 14C-labeled microtracer (i.v. in 1a, orally in 1b).  New formulations were evaluated: subjects from periods 1a and 1b were pooled and randomly distributed to receive a single oral dose (30 mg) of formulation A (n = 6) or B (n = 6) in periods 2 and 3, using a crossover design.  Abs. oral bioavailability of seletalisib was 97% (90% confidence interval 87, 107).  Unchanged [14C]seletalisib was the predominant radioactive component in plasma (94.8%).  After oral dosing, the radioactive dose was primarily recovered in feces (74.6%, geometric coeff. of variation [GeoCV] 18.1%), mostly as metabolites.  Seletalisib demonstrated a 24-h terminal half-life, vol. of distribution of 60.9 L (GeoCV 23.8%), and a total plasma clearance of 1.7 L/h (GeoCV 35.4%).  Formulations A and B displayed similar or even higher exposure compared with ref. seletalisib (areas under the concn.-time curves 19 337 [GeoCV 30.8%], 20 380 [GeoCV 37.7%], and 15 932 [GeoCV 36.4%] h·ng/mL, resp.).  New formulations A and B were bioequivalent with each other, and all 3 formulations showed acceptable safety profiles.  This radiolabeled microtracer approach successfully informed on the absorption, distribution, metab., and excretion of seletalisib and further guided the mechanistic pharmacokinetic modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG6cc05A-Y67Vg90H21EOLACvtfcHk0lgTwSDKYxIPIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslymsrnP&md5=b952ae852af8bb6c54001e76694cf55d</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1002%2Fjcph.954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.954%26sid%3Dliteratum%253Aachs%26aulast%3DHelmer%26aufirst%3DE.%26aulast%3DNicolas%26aufirst%3DJ.%2BM.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DRoffel%26aufirst%3DA.%2BF.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DChanteux%26aufirst%3DH.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DGarratt%26aufirst%3DH.%26aulast%3DBosje%26aufirst%3DT.%26atitle%3DA%2520Dual-Administration%2520Microtracer%2520Technique%2520to%2520Characterize%2520the%2520Absorption%252C%2520Distribution%252C%2520Metabolism%252C%2520and%2520Excretion%2520of%2520%255B%252814%2529%2520C%255DSeletalisib%2520%2528Ucb5857%2529%2520in%2520Healthy%2520Subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2017%26volume%3D57%26issue%3D12%26spage%3D1582%26epage%3D1590%26doi%3D10.1002%2Fjcph.954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renard, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arslan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbacki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leval, X.</span></span> <span> </span><span class="NLM_article-title">Pyridine Analogues of Nimesulide: Design, Synthesis, and in Vitro and in Vivo Pharmacological Evaluation as Promising Cyclooxygenase 1 and 2 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5864</span>– <span class="NLM_lpage">5871</span>, <span class="refDoi"> DOI: 10.1021/jm900702b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900702b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2jsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5864-5871&issue=19&author=J.+F.+Renardauthor=D.+Arslanauthor=N.+Garbackiauthor=B.+Pirotteauthor=X.+de+Leval&title=Pyridine+Analogues+of+Nimesulide%3A+Design%2C+Synthesis%2C+and+in+Vitro+and+in+Vivo+Pharmacological+Evaluation+as+Promising+Cyclooxygenase+1+and+2+Inhibitors&doi=10.1021%2Fjm900702b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridine Analogues of Nimesulide: Design, Synthesis, and in Vitro and in Vivo Pharmacological Evaluation as Promising Cyclooxygenase 1 and 2 Inhibitors</span></div><div class="casAuthors">Renard, Jean-Francois; Arslan, Deniz; Garbacki, Nancy; Pirotte, Bernard; de Leval, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5864-5871</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(arylamino)- and (cycloalkylamino)-substituted N-pyridinylsulfonamides I (R = F3C, Me, F3CCH2CH2; R1 = cyclopentyl, cyclohexyl, cycloheptyl, Ph, 2-ClC6H4, 3-ClC6H4, 4-ClC6H4, 3-BrC6H4, 4-BrC6H4, 2-MeC6H4, 3-MeC6H4, 4-MeC6H4, 2-EtC6H4, 3-EtC6H4, 4-EtC6H4, 2-MeOC6H4, 3-MeOC6H4, 4-MeOC6H4; in some cases isolated as hydrochloride salts) are prepd. as nimesulide analogs for use as potential COX-2-selective antiinflammatory agents.  Substitution of 3-bromo-4-nitropyridine 1-oxide, prepd. in two steps from 3-bromopyridine, with amines R1NH2, followed by iron-mediated redn. of the nitro group and the N-oxide and sulfonylation yields I.  I (R = F3C; R1 = 4-ClC6H4) shows selective binding to COX-2 over COX-1 in a human whole blood model, with IC50 values for COX-1 and COX-2 of 0.91 μM and 0.12 μM, resp.; in a rat carrageenan-induced pleurisy model, I (R = F3C; R1 = 4-ClC6H4) decreased the amt. of secretions from the lungs of the rats by 42-65% at doses of 5-20 mg/kg, with similar or better efficacy than nimesulide while avoiding the functionality in nimesulide that may be responsible for its toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsovt9qxEtILVg90H21EOLACvtfcHk0lgTwSDKYxIPIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2jsbnN&md5=6f2d163c857fba4fb382f13bcae993a1</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm900702b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900702b%26sid%3Dliteratum%253Aachs%26aulast%3DRenard%26aufirst%3DJ.%2BF.%26aulast%3DArslan%26aufirst%3DD.%26aulast%3DGarbacki%26aufirst%3DN.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3Dde%2BLeval%26aufirst%3DX.%26atitle%3DPyridine%2520Analogues%2520of%2520Nimesulide%253A%2520Design%252C%2520Synthesis%252C%2520and%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Pharmacological%2520Evaluation%2520as%2520Promising%2520Cyclooxygenase%25201%2520and%25202%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D19%26spage%3D5864%26epage%3D5871%26doi%3D10.1021%2Fjm900702b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Firestine, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davisson, V. J.</span></span> <span> </span><span class="NLM_article-title">A Tight Binding Inhibitor of 5-Aminoimidazole Ribonucleotide Carboxylase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">3484</span>– <span class="NLM_lpage">3486</span>, <span class="refDoi"> DOI: 10.1021/jm00074a033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00074a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK3sXms1Gitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3484-3486&issue=22&author=S.+M.+Firestineauthor=V.+J.+Davisson&title=A+Tight+Binding+Inhibitor+of+5-Aminoimidazole+Ribonucleotide+Carboxylase&doi=10.1021%2Fjm00074a033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">A tight binding inhibitor of 5-aminoimidazole ribonucleotide carboxylase</span></div><div class="casAuthors">Firestine, Steven M.; Davisson, V. Jo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3484-6</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">One carbon-carbon bond is made in the course of de novo biosynthesis of purine nucleotides and its formation is catalyzed by 5-aminoimidazole ribonucleotide carboxylase.  The limited no. of inhibitor design efforts for this enzyme has largely been due to a lack of information regarding its mechanism of action.  In this report, a tight binding inhibitor for the avian form of the enzyme is described.  The inhibitor 5-amino-1-(5'-phospho-β-D-ribofuranosyl)-4-nitroimidazole (I) which has an isoelectronic substitution of a nitro group for the carboxylic acid moiety in the normal enzymic product, binds to the enzyme in a reversible fashion with no covalent interactions.  Slow binding and release phases were detected under steady-state conditions, and progress curve analyses were used to establish a Ki of 0.34 nM.  This is the first example of a potent inhibitor targeted for this crit. enzyme.  The inhibitory binding of this simple isostere is consistent with the proposal that I is a mimic of a transition-state and provides the first evidence for a tetrahedral intermediate in the normal turnover process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqusQuuxziOZrVg90H21EOLACvtfcHk0lgTwSDKYxIPIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXms1Gitbg%253D&md5=c8c63204f9028a34add95ea2f910485e</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm00074a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00074a033%26sid%3Dliteratum%253Aachs%26aulast%3DFirestine%26aufirst%3DS.%2BM.%26aulast%3DDavisson%26aufirst%3DV.%2BJ.%26atitle%3DA%2520Tight%2520Binding%2520Inhibitor%2520of%25205-Aminoimidazole%2520Ribonucleotide%2520Carboxylase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D22%26spage%3D3484%26epage%3D3486%26doi%3D10.1021%2Fjm00074a033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagarathnam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murali Dhar, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzabadi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broten, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransom, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schorn, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendesky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrell, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluchowski, C.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Novel Alpha(1)(a) Adrenoceptor-Selective Antagonists. 1. Structure-Activity Relationship in Dihydropyrimidinones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">4764</span>– <span class="NLM_lpage">4777</span>, <span class="refDoi"> DOI: 10.1021/jm990200p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990200p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVSqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4764-4777&issue=23&author=D.+Nagarathnamauthor=S.+W.+Miaoauthor=B.+Laguauthor=G.+Chiuauthor=J.+Fangauthor=T.+G.+Murali+Dharauthor=J.+Zhangauthor=S.+Tyagarajanauthor=M.+R.+Marzabadiauthor=F.+Zhangauthor=W.+C.+Wongauthor=W.+Sunauthor=D.+Tianauthor=J.+M.+Wetzelauthor=C.+Forrayauthor=R.+S.+Changauthor=T.+P.+Brotenauthor=R.+W.+Ransomauthor=T.+W.+Schornauthor=T.+B.+Chenauthor=S.+O%E2%80%99Malleyauthor=P.+Klingauthor=K.+Schneckauthor=R.+Bendeskyauthor=C.+M.+Harrellauthor=K.+P.+Vyasauthor=C.+Gluchowski&title=Design+and+Synthesis+of+Novel+Alpha%281%29%28a%29+Adrenoceptor-Selective+Antagonists.+1.+Structure-Activity+Relationship+in+Dihydropyrimidinones&doi=10.1021%2Fjm990200p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel α1a Adrenoceptor-Selective Antagonists. 1. Structure-Activity Relationship in Dihydropyrimidinones</span></div><div class="casAuthors">Nagarathnam, Dhanapalan; Miao, Shou Wu; Lagu, Bharat; Chiu, George; Fang, James; Dhar, T. G. Murali; Zhang, Jack; Tyagarajan, Sriram; Marzabadi, Mohammad R.; Zhang, Fengqi; Wong, Wai C.; Sun, Wanying; Tian, Dake; Wetzel, John M.; Forray, Carlos; Chang, Raymond S. L.; Broten, Theodore P.; Ransom, Richard W.; Schorn, Terry W.; Chen, Tsing B.; O'Malley, Stacey; Kling, Paul; Schneck, Kathryn; Bendesky, Robert; Harrell, Charles M.; Vyas, Kamlesh P.; Gluchowski, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4764-4777</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dihydropyrimidinones such as compd. I exhibited high binding affinity and subtype selectivity for the cloned human α1a receptor.  Systematic modifications of I led to identification of highly potent and subtype-selective compds. with high binding affinity (Ki = 0.2 nM) for α1a receptor and greater than 1500-fold selectivity over α1b and α1d adrenoceptors.  The compds. were found to be functional antagonists in human, rat, and dog prostate tissues.  One of the compds. [(+)SNAP 6201] exhibited excellent selectively to inhibit intraurethral pressure (IUP) as compared to lowering diastolic blood pressure (DBP) in mongrel dogs (Kb(DBP)/Kb(IUP) = 40) suggesting uroselectivity for α1a-selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfso0m6xXmxbVg90H21EOLACvtfcHk0ljB_Bmzhm5zDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVSqtLk%253D&md5=af256a5faa2aa3c16b0c137b06ae49cb</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Fjm990200p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990200p%26sid%3Dliteratum%253Aachs%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DMiao%26aufirst%3DS.%2BW.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DChiu%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DMurali%2BDhar%26aufirst%3DT.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DMarzabadi%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DWong%26aufirst%3DW.%2BC.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DWetzel%26aufirst%3DJ.%2BM.%26aulast%3DForray%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DR.%2BS.%26aulast%3DBroten%26aufirst%3DT.%2BP.%26aulast%3DRansom%26aufirst%3DR.%2BW.%26aulast%3DSchorn%26aufirst%3DT.%2BW.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DKling%26aufirst%3DP.%26aulast%3DSchneck%26aufirst%3DK.%26aulast%3DBendesky%26aufirst%3DR.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DVyas%26aufirst%3DK.%2BP.%26aulast%3DGluchowski%26aufirst%3DC.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Novel%2520Alpha%25281%2529%2528a%2529%2520Adrenoceptor-Selective%2520Antagonists.%25201.%2520Structure-Activity%2520Relationship%2520in%2520Dihydropyrimidinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D23%26spage%3D4764%26epage%3D4777%26doi%3D10.1021%2Fjm990200p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gneuwuch, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, H. L.</span></span> <span> </span><span class="NLM_article-title">Pyridine Isosteres of The.Beta.-Adrenergic Antagonists, 2-(P-Nitrophenyl)-1-Isopropylamino-2-Ethanol and 3-(P-Nitrophenoxy)-1-Isopropylamino-2-Propanol</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1324</span>, <span class="refDoi"> DOI: 10.1021/jm00282a028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00282a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaE3sXjslyrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1321-1324&issue=12&author=C.+T.+Gneuwuchauthor=H.+L.+Friedman&title=Pyridine+Isosteres+of+The.Beta.-Adrenergic+Antagonists%2C+2-%28P-Nitrophenyl%29-1-Isopropylamino-2-Ethanol+and+3-%28P-Nitrophenoxy%29-1-Isopropylamino-2-Propanol&doi=10.1021%2Fjm00282a028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridine isosteres of the β-adrenergic antagonists, 2-(p-nitrophenyl)-1-isopropylamino-2-ethanol and 3-(p-nitrophenoxy)-1-isopropylamino-2-propanol</span></div><div class="casAuthors">Gneuwuch, C. Thomas; Friedman, Harris L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1321-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Although 2-(p-nitrophenyl)-1-isopropylamino-2-ethanol (INPEA) (I) [7413-36-7] had no β-adrenergic agonist activity (chronotropic activity on isolated spontaneously beating guinea pig atria), its o- and m-nitrophenyl isomers and all 3 1-pyridyl-2-isopropylaminoethanol isomers (α,β, and γ) showed agonist activity.  1-(4-Pyridyl)-2-isopropylaminoethanol-2HCl (II-2HCl) [36696-41-0], an isostere of I, behaved as both a partial agonist and a partial antagonist of the action of isoproterenol.  In the presence of 10-7M propranolol the dose-response curves for the pyridyl compds. were shifted to the right, indicating that these compds. acted on the β-receptors.  Isopropylamino-3-(4-pyridyloxy)-2-propanol-2HCl (III)-2HCl) [37764-36-6] was a pure antagonist 10 times as potent as I.  Evidently the basic N of the pyridine ring did not interfere with antagonist action and was not a site of attachment to the receptor.  To synthesize III, the known 4-allyloxypyridine was reacted with N-bromoacetamide in dilute H2SO4 to add HOBr across the double bond, forming a mixt. of isomers; the mixt. was converted to the epoxide and then to III as the single product using isopropylamine in KOH-EtOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNVWliZaZD_7Vg90H21EOLACvtfcHk0liqmhDkaZk5Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXjslyrsg%253D%253D&md5=5a2242341f78f591f1f5076e149c122d</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fjm00282a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00282a028%26sid%3Dliteratum%253Aachs%26aulast%3DGneuwuch%26aufirst%3DC.%2BT.%26aulast%3DFriedman%26aufirst%3DH.%2BL.%26atitle%3DPyridine%2520Isosteres%2520of%2520The.Beta.-Adrenergic%2520Antagonists%252C%25202-%2528P-Nitrophenyl%2529-1-Isopropylamino-2-Ethanol%2520and%25203-%2528P-Nitrophenoxy%2529-1-Isopropylamino-2-Propanol%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26issue%3D12%26spage%3D1321%26epage%3D1324%26doi%3D10.1021%2Fjm00282a028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mfuh, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larionov, O. V.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic N-Oxides - an Emerging Class of Therapeutic Agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">2819</span>– <span class="NLM_lpage">2857</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150619104007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.2174%2F0929867322666150619104007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26087764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWmsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=2819-2857&issue=24&author=A.+M.+Mfuhauthor=O.+V.+Larionov&title=Heterocyclic+N-Oxides+-+an+Emerging+Class+of+Therapeutic+Agents&doi=10.2174%2F0929867322666150619104007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents</span></div><div class="casAuthors">Mfuh, A. M.; Larionov, O. V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2819-2857</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Heterocyclic N-oxides have emerged as potent compds. with anticancer, antibacterial, antihypertensive, antiparasitic, anti-HIV, anti-inflammatory, herbicidal, neuroprotective, and procognitive activities.  The N-oxide motif has been successfully employed in a no. of recent drug development projects.  This review surveys the emergence of this scaffold in the mainstream medicinal chem. with a focus on the discovery of the heterocyclic N-oxide drugs, N-oxide-specific mechanisms of action, drug-receptor interactions and synthetic avenues to these compds.  As the first review on this subject that covers the developments since 1950s to date, it is expected that it will inspire wider implementation of the heterocyclic N-oxide motif in the rational design of new medicinal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOWS3-OhnTarVg90H21EOLACvtfcHk0liqmhDkaZk5Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWmsb%252FE&md5=dfbf6959196155dc9ad4dfe7a016d5d6</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150619104007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150619104007%26sid%3Dliteratum%253Aachs%26aulast%3DMfuh%26aufirst%3DA.%2BM.%26aulast%3DLarionov%26aufirst%3DO.%2BV.%26atitle%3DHeterocyclic%2520N-Oxides%2520-%2520an%2520Emerging%2520Class%2520of%2520Therapeutic%2520Agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26issue%3D24%26spage%3D2819%26epage%3D2857%26doi%3D10.2174%2F0929867322666150619104007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Veldhuizen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedillo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Till, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villasenor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zherebina, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span> <span> </span><span class="NLM_article-title">Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (Pi3k) Beta Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6858</span>– <span class="NLM_lpage">6868</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00797</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00797" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlantLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6858-6868&issue=15&author=J.+Chandrasekharauthor=R.+Dickauthor=J.+Van+Veldhuizenauthor=D.+Koditekauthor=E.+I.+Lepistauthor=M.+E.+McGrathauthor=L.+Patelauthor=G.+Phillipsauthor=K.+Sedilloauthor=J.+R.+Somozaauthor=J.+Therrienauthor=N.+A.+Tillauthor=J.+Treibergauthor=A.+G.+Villasenorauthor=Y.+Zherebinaauthor=S.+Perreault&title=Atropisomerism+by+Design%3A+Discovery+of+a+Selective+and+Stable+Phosphoinositide+3-Kinase+%28Pi3k%29+Beta+Inhibitor&doi=10.1021%2Facs.jmedchem.8b00797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor</span></div><div class="casAuthors">Chandrasekhar, Jayaraman; Dick, Ryan; Van Veldhuizen, Joshua; Koditek, David; Lepist, Eve-Irene; McGrath, Mary E.; Patel, Leena; Phillips, Gary; Sedillo, Kassandra; Somoza, John R.; Therrien, Joseph; Till, Nicholas A.; Treiberg, Jennifer; Villasenor, Armando G.; Zherebina, Yelena; Perreault, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6858-6868</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis.  In this manuscript, we report a case in which torsional scan studies guided the thoughtful creation of a restricted axis of rotation between two heteroarom. systems of a phosphoinositide 3-kinase (PI3K) β inhibitor, generating a pair of atropisomeric compds. with significantly different pharmacol. and pharmacokinetic profiles.  Emblematic of these differences, the metab. of inactive (M)-28 is primarily due to the cytosolic enzyme aldehyde oxidase, while active (P)-28 has lower affinity for aldehyde oxidase, resulting in substantially better metabolic stability.  Addnl., we report torsional scan and exptl. studies used to det. the barriers of rotation of this novel PI3Kβ inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM4lElYFK-4bVg90H21EOLACvtfcHk0liqmhDkaZk5Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlantLrK&md5=7bf851fb54cf73570f99635622ec9214</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00797%26sid%3Dliteratum%253Aachs%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DDick%26aufirst%3DR.%26aulast%3DVan%2BVeldhuizen%26aufirst%3DJ.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DLepist%26aufirst%3DE.%2BI.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DG.%26aulast%3DSedillo%26aufirst%3DK.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTill%26aufirst%3DN.%2BA.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DVillasenor%26aufirst%3DA.%2BG.%26aulast%3DZherebina%26aufirst%3DY.%26aulast%3DPerreault%26aufirst%3DS.%26atitle%3DAtropisomerism%2520by%2520Design%253A%2520Discovery%2520of%2520a%2520Selective%2520and%2520Stable%2520Phosphoinositide%25203-Kinase%2520%2528Pi3k%2529%2520Beta%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6858%26epage%3D6868%26doi%3D10.1021%2Facs.jmedchem.8b00797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanotta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Isolation and Characterization of the Human Aldehyde Oxidase Gene: Conservation of Intron/Exon Boundaries with the Xanthine Oxidoreductase Gene Indicates a Common Origin</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1042/bj3320383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1042%2Fbj3320383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9601067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1SqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=1998&pages=383-393&author=M.+Teraoauthor=M.+Kurosakiauthor=S.+Demontisauthor=S.+Zanottaauthor=E.+Garattini&title=Isolation+and+Characterization+of+the+Human+Aldehyde+Oxidase+Gene%3A+Conservation+of+Intron%2FExon+Boundaries+with+the+Xanthine+Oxidoreductase+Gene+Indicates+a+Common+Origin&doi=10.1042%2Fbj3320383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Demontis, Silvia; Zanotta, Stefania; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-393</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a molybdo-flavo enzyme involved in the metab. of various endogenous and exogenous N-heterocyclic compds. of pharmacol. and toxicol. importance.  The enzyme is the product of a gene which is implicated in the aetio-pathogenesis of familial recessive amyotrophic lateral sclerosis.  Here, the authors report the cloning and structural characterization of the human AO gene.  AO is a single copy gene approx. 85 kb long with 35 transcribed exons.  The transcription-initiation site and the sequence of the 5'-flanking region, contg. several putative regulatory elements, were detd.  The 5'-flanking region contains a functional promoter, as assessed by appropriate reporter constructs in transient transfection expts.  Comparison of the AO gene structure shows conservation of the position and type of exon/intron junctions relative to those obsd. in the gene coding for another molybdo-flavoprotein, i.e. xanthine oxidoreductase (XOR).  As the two genes code for proteins with a high level of amino acid identity, these results strongly suggest that the AO and XOR genetic loci arose as the consequence of a duplication event.  Southern blot anal. conducted on genomic DNA from various animal species with specific cDNA probes indicates that the AO gene is less conserved than the XOR gene during evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ECIWWYjPubVg90H21EOLACvtfcHk0lj2Rn0OEbC3hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1SqsLo%253D&md5=c16b9139af69ef8dd39d07ee76866f3f</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1042%2Fbj3320383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3320383%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DDemontis%26aufirst%3DS.%26aulast%3DZanotta%26aufirst%3DS.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520the%2520Human%2520Aldehyde%2520Oxidase%2520Gene%253A%2520Conservation%2520of%2520Intron%252FExon%2520Boundaries%2520with%2520the%2520Xanthine%2520Oxidoreductase%2520Gene%2520Indicates%2520a%2520Common%2520Origin%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D332%26spage%3D383%26epage%3D393%26doi%3D10.1042%2Fbj3320383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Trelles, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, F. J.</span></span> <span> </span><span class="NLM_article-title">Convergent Neofunctionalization by Positive Darwinian Selection after Ancient Recurrent Duplications of the Xanthine Dehydrogenase Gene</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">13413</span>– <span class="NLM_lpage">13417</span>, <span class="refDoi"> DOI: 10.1073/pnas.1835646100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1073%2Fpnas.1835646100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=14576276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFOisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13413-13417&issue=23&author=F.+Rodriguez-Trellesauthor=R.+Tarrioauthor=F.+J.+Ayala&title=Convergent+Neofunctionalization+by+Positive+Darwinian+Selection+after+Ancient+Recurrent+Duplications+of+the+Xanthine+Dehydrogenase+Gene&doi=10.1073%2Fpnas.1835646100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Convergent neofunctionalization by positive Darwinian selection after ancient recurrent duplications of the xanthine dehydrogenase gene</span></div><div class="casAuthors">Rodriguez-trelles, Francisco; Tarrio, Rosa; Ayala, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13413-13417</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Gene duplication is a primary source of mol. substrate for the emergence of evolutionary novelties.  The chances for redundant gene sequences to evolve new functions are small compared with the probability that the copies become disabled by deleterious mutations.  Functional divergence after gene duplication can result in two alternative evolutionary fates: one copy acquires a novel function (neofunctionalization), or each copy adopts part of the tasks of their parental gene (subfunctionalization).  The relative prevalence of each outcome is unknown.  Similarly unknown is the relative importance of pos. selection vs. random fixation of neutral mutations.  Aldehyde oxidase (Ao) and xanthine dehydrogenase (Xdh) genes encode two complex members of the xanthine oxidase family of molybdo-flavoenzymes that carry different functions.  Ao is known to have originated from a duplicate of an Xdh gene in eukaryotes, before the origin of multicellularity.  We show that (i) Ao evolved independently twice from two different Xdh paralogs, the second time in the chordates, before the diversification of vertebrates; (ii) after each duplication, the Ao duplicate underwent a period of rapid evolution during which identical sites across the two mols., involving the FAD and substrate-binding pockets, were subjected to intense pos. Darwinian selection; and (iii) the second Ao gene likely endured two periods of redundancy, initially as a duplicate of Xdh and later as a functional equiv. of the old Ao, which is currently absent from the vertebrate genome.  Caution is appropriate in structural genomics when using sequence similarity for assigning protein function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzgWuQxuLPQLVg90H21EOLACvtfcHk0lj2Rn0OEbC3hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFOisbo%253D&md5=b9ee535b2dee8d0bae93862a06c1f8d6</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1835646100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1835646100%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Trelles%26aufirst%3DF.%26aulast%3DTarrio%26aufirst%3DR.%26aulast%3DAyala%26aufirst%3DF.%2BJ.%26atitle%3DConvergent%2520Neofunctionalization%2520by%2520Positive%2520Darwinian%2520Selection%2520after%2520Ancient%2520Recurrent%2520Duplications%2520of%2520the%2520Xanthine%2520Dehydrogenase%2520Gene%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26issue%3D23%26spage%3D13413%26epage%3D13417%26doi%3D10.1073%2Fpnas.1835646100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perretta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Structure and Evolution of Vertebrate Aldehyde Oxidases: From Gene Duplication to Gene Suppression</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1807</span>– <span class="NLM_lpage">1830</span>, <span class="refDoi"> DOI: 10.1007/s00018-012-1229-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00018-012-1229-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23263164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsValt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=1807-1830&issue=10&author=M.+Kurosakiauthor=M.+Bolisauthor=M.+Fratelliauthor=M.+M.+Barzagoauthor=L.+Pattiniauthor=G.+Perrettaauthor=M.+Teraoauthor=E.+Garattini&title=Structure+and+Evolution+of+Vertebrate+Aldehyde+Oxidases%3A+From+Gene+Duplication+to+Gene+Suppression&doi=10.1007%2Fs00018-012-1229-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and evolution of vertebrate aldehyde oxidases: from gene duplication to gene suppression</span></div><div class="casAuthors">Kurosaki, Mami; Bolis, Marco; Fratelli, Maddalena; Barzago, Maria Monica; Pattini, Linda; Perretta, Gemma; Terao, Mineko; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1807-1830</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs) and xanthine dehydrogenases (XDHs) belong to the family of molybdo-flavoenzymes.  Although AOXs are not identifiable in fungi, these enzymes are represented in certain protists and the majority of plants and vertebrates.  The physiol. functions and substrates of AOXs are unknown.  Nevertheless, AOXs are major drug metabolizing enzymes, oxidizing a wide range of arom. aldehydes and heterocyclic compds. of medical/toxicol. importance.  Using genome sequencing data, we predict the structures of AOX genes and pseudogenes, reconstructing their evolution.  Fishes are the most primitive organisms with an AOX gene (AOXα), originating from the duplication of an ancestral XDH.  Further evolution of fishes resulted in the duplication of AOXα into AOXβ and successive pseudogenization of AOXα.  AOXβ is maintained in amphibians and it is the likely precursors of reptilian, avian, and mammalian AOX1.  Amphibian AOXγ is a duplication of AOXβ and the likely ancestor of reptilian and avian AOX2, which, in turn, gave rise to mammalian AOX3L1.  Subsequent gene duplications generated the two mammalian genes, AOX3 and AOX4.  The evolution of mammalian AOX genes is dominated by pseudogenization and deletion events.  Our anal. is relevant from a structural point of view, as it provides information on the residues characterizing the three domains of each mammalian AOX isoenzyme.  We cloned the cDNAs encoding the AOX proteins of guinea pig and cynomolgus monkeys, two unique species as to the evolution of this enzyme family.  We identify chimeric RNAs from the human AOX3 and AOX3L1 pseudogenes with potential to encode a novel microRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Ob09YlhEFLVg90H21EOLACvtfcHk0lh3UjDxCdZ22Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsValt7k%253D&md5=243e225973dec87b8df40beb63c7f583</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1007%2Fs00018-012-1229-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-012-1229-5%26sid%3Dliteratum%253Aachs%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DBolis%26aufirst%3DM.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DPattini%26aufirst%3DL.%26aulast%3DPerretta%26aufirst%3DG.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DStructure%2520and%2520Evolution%2520of%2520Vertebrate%2520Aldehyde%2520Oxidases%253A%2520From%2520Gene%2520Duplication%2520to%2520Gene%2520Suppression%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2013%26volume%3D70%26issue%3D10%26spage%3D1807%26epage%3D1830%26doi%3D10.1007%2Fs00018-012-1229-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Mammalian Aldehyde Oxidases: Genetics, Evolution and Biochemistry</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">7−8</span>),  <span class="NLM_fpage">1019</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1007/s00018-007-7398-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00018-007-7398-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=18066686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFynt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=1019-1048&issue=7%E2%88%928&author=E.+Garattiniauthor=M.+Fratelliauthor=M.+Terao&title=Mammalian+Aldehyde+Oxidases%3A+Genetics%2C+Evolution+and+Biochemistry&doi=10.1007%2Fs00018-007-7398-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian aldehyde oxidases: genetics, evolution and biochemistry</span></div><div class="casAuthors">Garattini, E.; Fratelli, M.; Terao, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1019-1048</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Mammalian aldehyde oxidases are a small group of proteins belonging to the larger family of molybdo-flavoenzymes along with xanthine oxidoreductase and other bacterial enzymes.  The 2 general types of reactions catalyzed by aldehyde oxidases are the hydroxylation of heterocycles and the oxidn. of aldehydes into the corresponding carboxylic acids.  Different animal species are characterized by a different complement of aldehyde oxidase genes.  Humans contain a single active gene, whereas marsupials and rodents are characterized by 4 such genes clustering at a short distance on the same chromosome.  At present, little is known about the physiol. relevance of aldehyde oxidases in humans and other mammals, although these enzymes are known to play a role in the metab. of drugs and compds. of toxicol. importance in the liver.  The present article provides an overview of the current knowledge of genetics, evolution, structure, enzymol., tissue distribution, and regulation of mammalian aldehyde oxidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsNZuLxV9pxLVg90H21EOLACvtfcHk0lh3UjDxCdZ22Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFynt70%253D&md5=1aa37435a1d77ca388180937902464dd</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7398-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7398-y%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DMammalian%2520Aldehyde%2520Oxidases%253A%2520Genetics%252C%2520Evolution%2520and%2520Biochemistry%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26issue%3D7%25E2%2588%25928%26spage%3D1019%26epage%3D1048%26doi%3D10.1007%2Fs00018-007-7398-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fagerberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallstrom, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oksvold, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kampf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djureinovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odeberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habuka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahmasebpoor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danielsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asplund, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjostedt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szigyarto, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skogs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takanen, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwenk, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindskog, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danielsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mardinoglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivertsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Feilitzen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwahlen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlen, M.</span></span> <span> </span><span class="NLM_article-title">Analysis of the Human Tissue-Specific Expression by Genome-Wide Integration of Transcriptomics and Antibody-Based Proteomics</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1074/mcp.M113.035600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fmcp.M113.035600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24309898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2nsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=397-406&issue=2&author=L.+Fagerbergauthor=B.+M.+Hallstromauthor=P.+Oksvoldauthor=C.+Kampfauthor=D.+Djureinovicauthor=J.+Odebergauthor=M.+Habukaauthor=S.+Tahmasebpoorauthor=A.+Danielssonauthor=K.+Edlundauthor=A.+Asplundauthor=E.+Sjostedtauthor=E.+Lundbergauthor=C.+A.+Szigyartoauthor=M.+Skogsauthor=J.+O.+Takanenauthor=H.+Berlingauthor=H.+Tegelauthor=J.+Mulderauthor=P.+Nilssonauthor=J.+M.+Schwenkauthor=C.+Lindskogauthor=F.+Danielssonauthor=A.+Mardinogluauthor=A.+Sivertssonauthor=K.+von+Feilitzenauthor=M.+Forsbergauthor=M.+Zwahlenauthor=I.+Olssonauthor=S.+Navaniauthor=M.+Hussauthor=J.+Nielsenauthor=F.+Pontenauthor=M.+Uhlen&title=Analysis+of+the+Human+Tissue-Specific+Expression+by+Genome-Wide+Integration+of+Transcriptomics+and+Antibody-Based+Proteomics&doi=10.1074%2Fmcp.M113.035600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics</span></div><div class="casAuthors">Fagerberg, Linn; Hallstroem, Bjoern M.; Oksvold, Per; Kampf, Caroline; Djureinovic, Dijana; Odeberg, Jacob; Habuka, Masato; Tahmasebpoor, Simin; Danielsson, Angelika; Edlund, Karolina; Asplund, Anna; Sjoestedt, Evelina; Lundberg, Emma; Al-Khalili Szigyarto, Cristina; Skogs, Marie; Takanen, Jenny Ottosson; Berling, Holger; Tegel, Hanna; Mulder, Jan; Nilsson, Peter; Schwenk, Jochen M.; Lindskog, Cecilia; Danielsson, Frida; Mardinoglu, Adil; Sivertsson, Aasa; von Feilitzen, Kalle; Forsberg, Mattias; Zwahlen, Martin; Olsson, IngMarie; Navani, Sanjay; Huss, Mikael; Nielsen, Jens; Ponten, Fredrik; Uhlen, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Global classification of the human proteins with regards to spatial expression patterns across organs and tissues is important for studies of human biol. and disease.  Here, we used a quant. transcriptomics anal. (RNA-Seq) to classify the tissue-specific expression of genes across a representative set of all major human organs and tissues and combined this anal. with antibody-based profiling of the same tissues.  To present the data, we launch a new version of the Human Protein Atlas that integrates RNA and protein expression data corresponding to ∼80% of the human protein-coding genes with access to the primary data for both the RNA and the protein anal. on an individual gene level.  We present a classification of all human protein-coding genes with regards to tissue-specificity and spatial expression pattern.  The integrative human expression map can be used as a starting point to explore the mol. constituents of the human body.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobQBz53bZwcrVg90H21EOLACvtfcHk0lijQcBb3ox9JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2nsrg%253D&md5=7f7946fac7e3108cde53e50f6eeda308</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M113.035600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M113.035600%26sid%3Dliteratum%253Aachs%26aulast%3DFagerberg%26aufirst%3DL.%26aulast%3DHallstrom%26aufirst%3DB.%2BM.%26aulast%3DOksvold%26aufirst%3DP.%26aulast%3DKampf%26aufirst%3DC.%26aulast%3DDjureinovic%26aufirst%3DD.%26aulast%3DOdeberg%26aufirst%3DJ.%26aulast%3DHabuka%26aufirst%3DM.%26aulast%3DTahmasebpoor%26aufirst%3DS.%26aulast%3DDanielsson%26aufirst%3DA.%26aulast%3DEdlund%26aufirst%3DK.%26aulast%3DAsplund%26aufirst%3DA.%26aulast%3DSjostedt%26aufirst%3DE.%26aulast%3DLundberg%26aufirst%3DE.%26aulast%3DSzigyarto%26aufirst%3DC.%2BA.%26aulast%3DSkogs%26aufirst%3DM.%26aulast%3DTakanen%26aufirst%3DJ.%2BO.%26aulast%3DBerling%26aufirst%3DH.%26aulast%3DTegel%26aufirst%3DH.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DNilsson%26aufirst%3DP.%26aulast%3DSchwenk%26aufirst%3DJ.%2BM.%26aulast%3DLindskog%26aufirst%3DC.%26aulast%3DDanielsson%26aufirst%3DF.%26aulast%3DMardinoglu%26aufirst%3DA.%26aulast%3DSivertsson%26aufirst%3DA.%26aulast%3Dvon%2BFeilitzen%26aufirst%3DK.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DZwahlen%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DI.%26aulast%3DNavani%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DJ.%26aulast%3DPonten%26aufirst%3DF.%26aulast%3DUhlen%26aufirst%3DM.%26atitle%3DAnalysis%2520of%2520the%2520Human%2520Tissue-Specific%2520Expression%2520by%2520Genome-Wide%2520Integration%2520of%2520Transcriptomics%2520and%2520Antibody-Based%2520Proteomics%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2014%26volume%3D13%26issue%3D2%26spage%3D397%26epage%3D406%26doi%3D10.1074%2Fmcp.M113.035600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Increasing Recognition of the Importance of Aldehyde Oxidase in Drug Development and Discovery</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.3109/03602532.2011.560606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F03602532.2011.560606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21428696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1ajtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=374-386&issue=3&author=E.+Garattiniauthor=M.+Terao&title=Increasing+Recognition+of+the+Importance+of+Aldehyde+Oxidase+in+Drug+Development+and+Discovery&doi=10.3109%2F03602532.2011.560606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing recognition of the importance of aldehyde oxidase in drug development and discovery</span></div><div class="casAuthors">Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">374-386</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidases are molybdoflavoenzymes with broad substrate specificity, oxidizing different types of aldehydes, and heterocyclic rings.  The physiol. function of aldehyde oxidases is largely unknown, although the enzymes play an important role in the metab. of numerous compds. of medicinal and toxicol. interest, as they oxidize a wide range of aldehydes and heterocyclic compds.  In this article, we review the significance of aldehyde oxidases for the design and development of new drugs and discuss assocd. problems.  These include species-specific differences in the complement of isoenzymes synthesized and general difficulties in studying the enzymic characteristics of purified or recombinant aldehyde oxidases.  We highlight the potential offered by human aldehyde oxidase targeting for the development of new pharmacol. agents, limiting our attention to the realms of antiobesity and anti-cancer drugs.  The last point is discussed in the context of the design of novel anticancer drugs, selectively activated or inactivated by this enzyme, with the final aim of achieving organ and/or tumor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr951BnlwtKZLVg90H21EOLACvtfcHk0ljZ_6mawQ07Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1ajtLo%253D&md5=4752bb8ee0ead1ff9e6413b1150a2c5e</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.3109%2F03602532.2011.560606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602532.2011.560606%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DIncreasing%2520Recognition%2520of%2520the%2520Importance%2520of%2520Aldehyde%2520Oxidase%2520in%2520Drug%2520Development%2520and%2520Discovery%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2011%26volume%3D43%26issue%3D3%26spage%3D374%26epage%3D386%26doi%3D10.3109%2F03602532.2011.560606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clancy, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repine, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brownstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, D.</span></span> <span> </span><span class="NLM_article-title">Analysis of Aldehyde Oxidase and Xanthine Dehydrogenase/Oxidase as Possible Candidate Genes for Autosomal Recessive Familial Amyotrophic Lateral Sclerosis</span>. <i>Somatic Cell Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1007/BF02255787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2FBF02255787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7570184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2MXot1aiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1995&pages=121-131&issue=2&author=R.+Bergerauthor=E.+Mezeyauthor=K.+P.+Clancyauthor=G.+Hartaauthor=R.+M.+Wrightauthor=J.+E.+Repineauthor=R.+H.+Brownauthor=M.+Brownsteinauthor=D.+Patterson&title=Analysis+of+Aldehyde+Oxidase+and+Xanthine+Dehydrogenase%2FOxidase+as+Possible+Candidate+Genes+for+Autosomal+Recessive+Familial+Amyotrophic+Lateral+Sclerosis&doi=10.1007%2FBF02255787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of aldehyde oxidase and xanthine dehydrogenase/oxidase as possible candidate genes for autosomal recessive familial amyotrophic lateral sclerosis</span></div><div class="casAuthors">Berger, Ralph; Mezey, Eva; Clancy, Kevin P.; Harta, Gyongyi; Wright, Richard M.; Repine, John E.; Brown, Robert H.; Brownstein, Michael; Patterson, David</div><div class="citationInfo"><span class="NLM_cas:title">Somatic Cell and Molecular Genetics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-31</span>CODEN:
                <span class="NLM_cas:coden">SCMGDN</span>;
        ISSN:<span class="NLM_cas:issn">0740-7750</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">Recently, point mutations in superoxide dismutase 1 (SOD1) have been shown to lead to a subset of autosomal dominantly inherited familial amyotrophic lateral sclerosis (ALS).  These findings have led to the hypothesis that defects in oxygen radical metab. may be involved in the pathogenesis of ALS.  Therefore, the authors decided to analyze other enzymes involved in oxygen radical metab. for possible involvement in other forms of ALS.  The authors report here anal. of two genes encoding the molybdenum hydroxylases aldehyde oxidase (AO) and xanthine dehydrogenase/oxidase (XDH) for involvement in ALS.  Of particular interest, one gene identified as encoding aldehyde oxidase is shown to map to 2q33, a region recently shown to contain a gene responsible for a familial form of ALS with autosomal recessive inheritance (FALS-AR).  The AO gene appears to be located within 280,000 bp of the simple sequence repeat marker D2S116, which shows no recombination with the FALs-AR locus.  The AO gene is highly expressed in glial cells of human spinal cord.  In addn., the authors mapped a gene for XDH to 2p22, a region previously shown to contain a highly homologous but different form of XDH.  Neither of these XDH genes appears to be highly expressed in human spinal cord.  This evidence suggests that AO may be a candidate gene for FALS-AR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVH8YkabRr_rVg90H21EOLACvtfcHk0ljZ_6mawQ07Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXot1aiurc%253D&md5=2d9a5f589da63767def5a43d20b3e80a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1007%2FBF02255787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02255787%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DMezey%26aufirst%3DE.%26aulast%3DClancy%26aufirst%3DK.%2BP.%26aulast%3DHarta%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DR.%2BM.%26aulast%3DRepine%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26aulast%3DBrownstein%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DD.%26atitle%3DAnalysis%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Dehydrogenase%252FOxidase%2520as%2520Possible%2520Candidate%2520Genes%2520for%2520Autosomal%2520Recessive%2520Familial%2520Amyotrophic%2520Lateral%2520Sclerosis%26jtitle%3DSomatic%2520Cell%2520Mol.%2520Genet.%26date%3D1995%26volume%3D21%26issue%3D2%26spage%3D121%26epage%3D131%26doi%3D10.1007%2FBF02255787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manevski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camenisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pognan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litherland, K.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase Activity in Fresh Human Skin</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2049</span>– <span class="NLM_lpage">2057</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.060368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.060368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25249692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFagsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=2049-2057&issue=12&author=N.+Manevskiauthor=K.+K.+Balavenkatramanauthor=B.+Bertschiauthor=P.+Swartauthor=M.+Wallesauthor=G.+Camenischauthor=H.+Schillerauthor=O.+Kretzauthor=B.+Lingauthor=R.+Wettsteinauthor=D.+J.+Schaeferauthor=F.+Pognanauthor=A.+Wolfauthor=K.+Litherland&title=Aldehyde+Oxidase+Activity+in+Fresh+Human+Skin&doi=10.1124%2Fdmd.114.060368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase activity in fresh human skin</span></div><div class="casAuthors">Manevski, Nenad; Balavenkatraman, Kamal Kumar; Bertschi, Barbara; Swart, Piet; Walles, Markus; Camenisch, Gian; Schiller, Hilmar; Kretz, Olivier; Ling, Barbara; Wettstein, Reto; Schaefer, Dirk J.; Pognan, Francois; Wolf, Armin; Litherland, Karine</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2049-2057, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Human aldehyde oxidase (AO) is a molybdoflavoenzyme that commonly oxidizes azaheterocycles in therapeutic drugs.  Although high metabolic clearance by AO resulted in several drug failures, existing in vitro-in vivo correlations are often poor and the extrahepatic role of AO practically unknown.  This study investigated enzymic activity of AO in fresh human skin, the largest organ of the body, frequently exposed to therapeutic drugs and xenobiotics.  Fresh, full-thickness human skin was obtained from 13 individual donors and assayed with two specific AO substrates: carbazeran and zoniporide.  Human skin explants from all donors metabolized carbazeran to 4-hydroxycarbazeran and zoniporide to 2-oxo-zoniporide.  Av. rates of carbazeran and zoniporide hydroxylations were 1.301 and 0.164 pmol × mg skin-1 × h-1, resulting in 13 and 2 % substrate turnover, resp., after 24 h of incubation with 10 μM substrate.  Hydroxylation activities for the two substrates were significantly correlated (r2 = 0.769), with interindividual variability ranging from 3-fold (zoniporide) to 6-fold (carbazeran).  Inclusion of hydralazine, an irreversible inhibitor of AO, resulted in concn.-dependent decrease of hydroxylation activities, exceeding 90% inhibition of carbazeran 4-hydroxylation at 100 μM inhibitor.  Reaction rates were linear up to 4 h and well described by Michaelis-Menten enzyme kinetics.  Comparison of carbazeran and zoniporide hydroxylation with rates of triclosan glucuronidation and sulfation and p-toluidine N-acetylation showed that cutaneous AO activity is comparable to tested phase II metabolic reactions, indicating a significant role of AO in cutaneous drug metab.  To our best knowledge, this is the first report of AO enzymic activity in human skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaynQ-Veyf0bVg90H21EOLACvtfcHk0lj6llNxXs7wlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFagsr7M&md5=ec72b646e63d9e7c429203baf1836337</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.060368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.060368%26sid%3Dliteratum%253Aachs%26aulast%3DManevski%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DSwart%26aufirst%3DP.%26aulast%3DWalles%26aufirst%3DM.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DKretz%26aufirst%3DO.%26aulast%3DLing%26aufirst%3DB.%26aulast%3DWettstein%26aufirst%3DR.%26aulast%3DSchaefer%26aufirst%3DD.%2BJ.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DLitherland%26aufirst%3DK.%26atitle%3DAldehyde%2520Oxidase%2520Activity%2520in%2520Fresh%2520Human%2520Skin%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D12%26spage%3D2049%26epage%3D2057%26doi%3D10.1124%2Fdmd.114.060368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hada, T.</span></span> <span> </span><span class="NLM_article-title">Widespread Cellular Distribution of Aldehyde Oxidase in Human Tissues Found by Immunohistochemistry Staining</span>. <i>Histol. Histopathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.14670/HH-16.745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.14670%2FHH-16.745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=11510964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmslyhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=745-753&author=Y.+Moriwakiauthor=T.+Yamamotoauthor=S.+Takahashiauthor=Z.+Tsutsumiauthor=T.+Hada&title=Widespread+Cellular+Distribution+of+Aldehyde+Oxidase+in+Human+Tissues+Found+by+Immunohistochemistry+Staining&doi=10.14670%2FHH-16.745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Widespread cellular distribution of aldehyde oxidase in human tissues found by immunohistochemistry staining</span></div><div class="casAuthors">Moriwaki, Y.; Yamamoto, T.; Takahashi, S.; Tsutsumi, Z.; Hada, T.</div><div class="citationInfo"><span class="NLM_cas:title">Histology and Histopathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-753</span>CODEN:
                <span class="NLM_cas:coden">HIHIES</span>;
        ISSN:<span class="NLM_cas:issn">0213-3911</span>.
    
            (<span class="NLM_cas:orgname">Histology and Histopathology</span>)
        </div><div class="casAbstract">Aldehyde oxidase (EC 1.2.3.1) (I) is a xenobiotic-metabolizing enzyme that catalyzes a variety of org. aldehydes and N-heterocyclic compds.  However, its precise pathophysiol. function in humans, other than its xenobiotic metab., remains unknown.  In order to gain a better understanding of the role of I, it was important to know its exact localization in human tissues.  Here, the authors investigated the distribution of I at the cellular level in a variety of human tissues by immunohistochem.  I was found to be widespread in respiratory, digestive, urogenital, and endocrine tissues, although a cell-specific localization in the various tissues studied was also obsd.  In the respiratory system, it was particularly abundant in epithelial cells from the trachea and bronchium, as well as alveolar cells.  In the digestive system, I was obsd. in surface epithelia of the small and large intestines, in addn. to hepatic cells.  Furthermore, the proximal, distal, and collecting tubules of the kidney were immunostained with various intensities, whereas glomerulus tissues were not.  In epididymis and prostate tissues, staining was obsd. in the ductuli epididymidis and glandular epithelia.  Moreover, the adrenal gland, cortex, and notably the zona reticularis, showed strong immunostaining.  This prevalent tissue distribution of I in humans suggests some addnl. pathophysiol. functions besides xenobiotic metab.  Accordingly, some possible roles were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw_iviNY40NrVg90H21EOLACvtfcHk0lj6llNxXs7wlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmslyhsr8%253D&md5=db271afdd0790738b94efec55ba58a7e</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.14670%2FHH-16.745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14670%252FHH-16.745%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DZ.%26aulast%3DHada%26aufirst%3DT.%26atitle%3DWidespread%2520Cellular%2520Distribution%2520of%2520Aldehyde%2520Oxidase%2520in%2520Human%2520Tissues%2520Found%2520by%2520Immunohistochemistry%2520Staining%26jtitle%3DHistol.%2520Histopathol.%26date%3D2001%26volume%3D16%26spage%3D745%26epage%3D753%26doi%3D10.14670%2FHH-16.745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yue, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breschi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vierstra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandstrom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervouchine, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djebali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurman, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaul, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rynes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirilusha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinov, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trout, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amrhein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher-Aylor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoshechkin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSalvo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fastuca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenkow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaleski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagarde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bussotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groudine, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCleary, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edsall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrissey, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cayting, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euskirchen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundaje, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malladi, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cline, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkup, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Learned, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbloom, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacerda de Sousa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pignatelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flicek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahveci, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James Kent, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalho Santos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notredame, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diegel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canfield, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabo, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilken, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reh, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giste, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutyavin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neph, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott Hansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bruijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selleri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudensky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josefowicz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichler, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orkin, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levasseur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papayannopoulou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoultchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disteche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treuting, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowdon, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feingold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortazavi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamatoyannopoulos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guigo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingeras, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardison, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, B.</span></span> <span> </span><span class="NLM_article-title">A Comparative Encyclopedia of DNA Elements in the Mouse Genome</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>515</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1038/nature13992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Fnature13992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25409824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGlt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=515&publication_year=2014&pages=355-364&author=F.+Yueauthor=Y.+Chengauthor=A.+Breschiauthor=J.+Vierstraauthor=W.+Wuauthor=T.+Rybaauthor=R.+Sandstromauthor=Z.+Maauthor=C.+Davisauthor=B.+D.+Popeauthor=Y.+Shenauthor=D.+D.+Pervouchineauthor=S.+Djebaliauthor=R.+E.+Thurmanauthor=R.+Kaulauthor=E.+Rynesauthor=A.+Kirilushaauthor=G.+K.+Marinovauthor=B.+A.+Williamsauthor=D.+Troutauthor=H.+Amrheinauthor=K.+Fisher-Aylorauthor=I.+Antoshechkinauthor=G.+DeSalvoauthor=L.-H.+Seeauthor=M.+Fastucaauthor=J.+Drenkowauthor=C.+Zaleskiauthor=A.+Dobinauthor=P.+Prietoauthor=J.+Lagardeauthor=G.+Bussottiauthor=A.+Tanzerauthor=O.+Denasauthor=K.+Liauthor=M.+A.+Benderauthor=M.+Zhangauthor=R.+Byronauthor=M.+T.+Groudineauthor=D.+McClearyauthor=L.+Phamauthor=Z.+Yeauthor=S.+Kuanauthor=L.+Edsallauthor=Y.-C.+Wuauthor=M.+D.+Rasmussenauthor=M.+S.+Bansalauthor=M.+Kellisauthor=C.+A.+Kellerauthor=C.+S.+Morrisseyauthor=T.+Mishraauthor=D.+Jainauthor=N.+Doganauthor=R.+S.+Harrisauthor=P.+Caytingauthor=T.+Kawliauthor=A.+P.+Boyleauthor=G.+Euskirchenauthor=A.+Kundajeauthor=S.+Linauthor=Y.+Linauthor=C.+Jansenauthor=V.+S.+Malladiauthor=M.+S.+Clineauthor=D.+T.+Ericksonauthor=V.+M.+Kirkupauthor=K.+Learnedauthor=C.+A.+Sloanauthor=K.+R.+Rosenbloomauthor=B.+Lacerda+de+Sousaauthor=K.+Bealauthor=M.+Pignatelliauthor=P.+Flicekauthor=J.+Lianauthor=T.+Kahveciauthor=D.+Leeauthor=W.+James+Kentauthor=M.+Ramalho+Santosauthor=J.+Herreroauthor=C.+Notredameauthor=A.+Johnsonauthor=S.+Vongauthor=K.+Leeauthor=D.+Batesauthor=F.+Neriauthor=M.+Diegelauthor=T.+Canfieldauthor=P.+J.+Saboauthor=M.+S.+Wilkenauthor=T.+A.+Rehauthor=E.+Gisteauthor=A.+Shaferauthor=T.+Kutyavinauthor=E.+Haugenauthor=D.+Dunnauthor=A.+P.+Reynoldsauthor=S.+Nephauthor=R.+Humbertauthor=R.+Scott+Hansenauthor=M.+De+Bruijnauthor=L.+Selleriauthor=A.+Rudenskyauthor=S.+Josefowiczauthor=R.+Samsteinauthor=E.+E.+Eichlerauthor=S.+H.+Orkinauthor=D.+Levasseurauthor=T.+Papayannopoulouauthor=K.-H.+Changauthor=A.+Skoultchiauthor=S.+Goshauthor=C.+Distecheauthor=P.+Treutingauthor=Y.+Wangauthor=M.+J.+Weissauthor=G.+A.+Blobelauthor=X.+Caoauthor=S.+Zhongauthor=T.+Wangauthor=P.+J.+Goodauthor=R.+F.+Lowdonauthor=L.+B.+Adamsauthor=X.-Q.+Zhouauthor=M.+J.+Pazinauthor=E.+A.+Feingoldauthor=B.+Woldauthor=J.+Taylorauthor=A.+Mortazaviauthor=S.+M.+Weissmanauthor=J.+A.+Stamatoyannopoulosauthor=M.+P.+Snyderauthor=R.+Guigoauthor=T.+R.+Gingerasauthor=D.+M.+Gilbertauthor=R.+C.+Hardisonauthor=M.+A.+Beerauthor=B.+Ren&title=A+Comparative+Encyclopedia+of+DNA+Elements+in+the+Mouse+Genome&doi=10.1038%2Fnature13992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative encyclopedia of DNA elements in the mouse genome</span></div><div class="casAuthors">Yue, Feng; Cheng, Yong; Breschi, Alessandra; Vierstra, Jeff; Wu, Weisheng; Ryba, Tyrone; Sandstrom, Richard; Ma, Zhihai; Davis, Carrie; Pope, Benjamin D.; Shen, Yin; Pervouchine, Dmitri D.; Djebali, Sarah; Thurman, Robert E.; Kaul, Rajinder; Rynes, Eric; Kirilusha, Anthony; Marinov, Georgi K.; Williams, Brian A.; Trout, Diane; Amrhein, Henry; Fisher-Aylor, Katherine; Antoshechkin, Igor; De Salvo, Gilberto; See, Lei-Hoon; Fastuca, Meagan; Drenkow, Jorg; Zaleski, Chris; Dobin, Alex; Prieto, Pablo; Lagarde, Julien; Bussotti, Giovanni; Tanzer, Andrea; Denas, Olgert; Li, Kanwei; Bender, M. A.; Zhang, Miaohua; Byron, Rachel; Groudine, Mark T.; McCleary, David; Pham, Long; Ye, Zhen; Kuan, Samantha; Edsall, Lee; Wu, Yi-Chieh; Rasmussen, Matthew D.; Bansal, Mukul S.; Kellis, Manolis; Keller, Cheryl A.; Morrissey, Christapher S.; Mishra, Tejaswini; Jain, Deepti; Dogan, Nergiz; Harris, Robert S.; Cayting, Philip; Kawli, Trupti; Boyle, Alan P.; Euskirchen, Ghia; Kundaje, Anshul; Lin, Shin; Lin, Yiing; Jansen, Camden; Malladi, Venkat S.; Cline, Melissa S.; Erickson, Drew T.; Kirkup, Vanessa M.; Learned, Katrina; Sloan, Cricket A.; Rosenbloom, Kate R.; Lacerda de Sousa, Beatriz; Beal, Kathryn; Pignatelli, Miguel; Flicek, Paul; Lian, Jin; Kahveci, Tamer; Lee, Dongwon; James Kent, W.; Ramalho Santos, Miguel; Herrero, Javier; Notredame, Cedric; Johnson, Audra; Vong, Shinny; Lee, Kristen; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Canfield, Theresa; Sabo, Peter J.; Wilken, Matthew S.; Reh, Thomas A.; Giste, Erika; Shafer, Anthony; Kutyavin, Tanya; Haugen, Eric; Dunn, Douglas; Reynolds, Alex P.; Neph, Shane; Humbert, Richard; Scott Hansen, R.; De Bruijn, Marella; Selleri, Licia; Rudensky, Alexander; Josefowicz, Steven; Samstein, Robert; Eichler, Evan E.; Orkin, Stuart H.; Levasseur, Dana; Papayannopoulou, Thalia; Chang, Kai-Hsin; Skoultchi, Arthur; Gosh, Srikanta; Disteche, Christine; Treuting, Piper; Wang, Yanli; Weiss, Mitchell J.; Blobel, Gerd A.; Cao, Xiaoyi; Zhong, Sheng; Wang, Ting; Good, Peter J.; Lowdon, Rebecca F.; Adams, Leslie B.; Zhou, Xiao-Qiao; Pazin, Michael J.; Feingold, Elise A.; Wold, Barbara; Taylor, James; Mortazavi, Ali; Weissman, Sherman M.; Stamatoyannopoulos, John A.; Snyder, Michael P.; Guigo, Roderic; Gingeras, Thomas R.; Gilbert, David M.; Hardison, Ross C.; Beer, Michael A.; Ren, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">515</span>
        (<span class="NLM_cas:issue">7527</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The lab. mouse shares the majority of its protein-coding genes with humans, making it the premier model organism in biomedical research, yet the two mammals differ in significant ways.  To gain greater insights into both shared and species-specific transcriptional and cellular regulatory programs in the mouse, the Mouse ENCODE Consortium has mapped transcription, DNase I hypersensitivity, transcription factor binding, chromatin modifications and replication domains throughout the mouse genome in diverse cell and tissue types.  By comparing with the human genome, we not only confirm substantial conservation in the newly annotated potential functional sequences, but also find a large degree of divergence of sequences involved in transcriptional regulation, chromatin state and higher order chromatin organization.  Our results illuminate the wide range of evolutionary forces acting on genes and their regulatory regions, and provide a general resource for research into mammalian biol. and mechanisms of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqifWSL34UuZrVg90H21EOLACvtfcHk0lhz62HD2_-r8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGlt7rI&md5=45adfc6779f3b152275db8bb471fe960</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1038%2Fnature13992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13992%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBreschi%26aufirst%3DA.%26aulast%3DVierstra%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DRyba%26aufirst%3DT.%26aulast%3DSandstrom%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DPope%26aufirst%3DB.%2BD.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DPervouchine%26aufirst%3DD.%2BD.%26aulast%3DDjebali%26aufirst%3DS.%26aulast%3DThurman%26aufirst%3DR.%2BE.%26aulast%3DKaul%26aufirst%3DR.%26aulast%3DRynes%26aufirst%3DE.%26aulast%3DKirilusha%26aufirst%3DA.%26aulast%3DMarinov%26aufirst%3DG.%2BK.%26aulast%3DWilliams%26aufirst%3DB.%2BA.%26aulast%3DTrout%26aufirst%3DD.%26aulast%3DAmrhein%26aufirst%3DH.%26aulast%3DFisher-Aylor%26aufirst%3DK.%26aulast%3DAntoshechkin%26aufirst%3DI.%26aulast%3DDeSalvo%26aufirst%3DG.%26aulast%3DSee%26aufirst%3DL.-H.%26aulast%3DFastuca%26aufirst%3DM.%26aulast%3DDrenkow%26aufirst%3DJ.%26aulast%3DZaleski%26aufirst%3DC.%26aulast%3DDobin%26aufirst%3DA.%26aulast%3DPrieto%26aufirst%3DP.%26aulast%3DLagarde%26aufirst%3DJ.%26aulast%3DBussotti%26aufirst%3DG.%26aulast%3DTanzer%26aufirst%3DA.%26aulast%3DDenas%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DBender%26aufirst%3DM.%2BA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DByron%26aufirst%3DR.%26aulast%3DGroudine%26aufirst%3DM.%2BT.%26aulast%3DMcCleary%26aufirst%3DD.%26aulast%3DPham%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DKuan%26aufirst%3DS.%26aulast%3DEdsall%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.-C.%26aulast%3DRasmussen%26aufirst%3DM.%2BD.%26aulast%3DBansal%26aufirst%3DM.%2BS.%26aulast%3DKellis%26aufirst%3DM.%26aulast%3DKeller%26aufirst%3DC.%2BA.%26aulast%3DMorrissey%26aufirst%3DC.%2BS.%26aulast%3DMishra%26aufirst%3DT.%26aulast%3DJain%26aufirst%3DD.%26aulast%3DDogan%26aufirst%3DN.%26aulast%3DHarris%26aufirst%3DR.%2BS.%26aulast%3DCayting%26aufirst%3DP.%26aulast%3DKawli%26aufirst%3DT.%26aulast%3DBoyle%26aufirst%3DA.%2BP.%26aulast%3DEuskirchen%26aufirst%3DG.%26aulast%3DKundaje%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DJansen%26aufirst%3DC.%26aulast%3DMalladi%26aufirst%3DV.%2BS.%26aulast%3DCline%26aufirst%3DM.%2BS.%26aulast%3DErickson%26aufirst%3DD.%2BT.%26aulast%3DKirkup%26aufirst%3DV.%2BM.%26aulast%3DLearned%26aufirst%3DK.%26aulast%3DSloan%26aufirst%3DC.%2BA.%26aulast%3DRosenbloom%26aufirst%3DK.%2BR.%26aulast%3DLacerda%2Bde%2BSousa%26aufirst%3DB.%26aulast%3DBeal%26aufirst%3DK.%26aulast%3DPignatelli%26aufirst%3DM.%26aulast%3DFlicek%26aufirst%3DP.%26aulast%3DLian%26aufirst%3DJ.%26aulast%3DKahveci%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DJames%2BKent%26aufirst%3DW.%26aulast%3DRamalho%2BSantos%26aufirst%3DM.%26aulast%3DHerrero%26aufirst%3DJ.%26aulast%3DNotredame%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DVong%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DBates%26aufirst%3DD.%26aulast%3DNeri%26aufirst%3DF.%26aulast%3DDiegel%26aufirst%3DM.%26aulast%3DCanfield%26aufirst%3DT.%26aulast%3DSabo%26aufirst%3DP.%2BJ.%26aulast%3DWilken%26aufirst%3DM.%2BS.%26aulast%3DReh%26aufirst%3DT.%2BA.%26aulast%3DGiste%26aufirst%3DE.%26aulast%3DShafer%26aufirst%3DA.%26aulast%3DKutyavin%26aufirst%3DT.%26aulast%3DHaugen%26aufirst%3DE.%26aulast%3DDunn%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DA.%2BP.%26aulast%3DNeph%26aufirst%3DS.%26aulast%3DHumbert%26aufirst%3DR.%26aulast%3DScott%2BHansen%26aufirst%3DR.%26aulast%3DDe%2BBruijn%26aufirst%3DM.%26aulast%3DSelleri%26aufirst%3DL.%26aulast%3DRudensky%26aufirst%3DA.%26aulast%3DJosefowicz%26aufirst%3DS.%26aulast%3DSamstein%26aufirst%3DR.%26aulast%3DEichler%26aufirst%3DE.%2BE.%26aulast%3DOrkin%26aufirst%3DS.%2BH.%26aulast%3DLevasseur%26aufirst%3DD.%26aulast%3DPapayannopoulou%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DK.-H.%26aulast%3DSkoultchi%26aufirst%3DA.%26aulast%3DGosh%26aufirst%3DS.%26aulast%3DDisteche%26aufirst%3DC.%26aulast%3DTreuting%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWeiss%26aufirst%3DM.%2BJ.%26aulast%3DBlobel%26aufirst%3DG.%2BA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGood%26aufirst%3DP.%2BJ.%26aulast%3DLowdon%26aufirst%3DR.%2BF.%26aulast%3DAdams%26aufirst%3DL.%2BB.%26aulast%3DZhou%26aufirst%3DX.-Q.%26aulast%3DPazin%26aufirst%3DM.%2BJ.%26aulast%3DFeingold%26aufirst%3DE.%2BA.%26aulast%3DWold%26aufirst%3DB.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DMortazavi%26aufirst%3DA.%26aulast%3DWeissman%26aufirst%3DS.%2BM.%26aulast%3DStamatoyannopoulos%26aufirst%3DJ.%2BA.%26aulast%3DSnyder%26aufirst%3DM.%2BP.%26aulast%3DGuigo%26aufirst%3DR.%26aulast%3DGingeras%26aufirst%3DT.%2BR.%26aulast%3DGilbert%26aufirst%3DD.%2BM.%26aulast%3DHardison%26aufirst%3DR.%2BC.%26aulast%3DBeer%26aufirst%3DM.%2BA.%26aulast%3DRen%26aufirst%3DB.%26atitle%3DA%2520Comparative%2520Encyclopedia%2520of%2520DNA%2520Elements%2520in%2520the%2520Mouse%2520Genome%26jtitle%3DNature%26date%3D2014%26volume%3D515%26spage%3D355%26epage%3D364%26doi%3D10.1038%2Fnature13992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning of the Cdna Coding for Mouse Aldehyde Oxidase: Tissue Distribution and Regulation in Vivo by Testosterone</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1042/bj3410071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1042%2Fbj3410071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10377246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=71-80&author=M.+Kurosakiauthor=S.+Demontisauthor=M.+M.+Barzagoauthor=E.+Garattiniauthor=M.+Terao&title=Molecular+Cloning+of+the+Cdna+Coding+for+Mouse+Aldehyde+Oxidase%3A+Tissue+Distribution+and+Regulation+in+Vivo+by+Testosterone&doi=10.1042%2Fbj3410071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of the cDNA coding for mouse aldehyde oxidase: tissue distribution and regulation in vivo by testosterone</span></div><div class="casAuthors">Kurosaki, Mami; Demontis, Silvia; Barzago, Maria Monica; Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-80</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The cDNA coding for mouse aldehyde oxidase (AO), a molybdoflavoprotein, has been isolated and characterized.  The cDNA is 4347 nt long and consists of an open reading frame predicting a polypeptide of 1333 amino acid residues, with 5' and 3' untranslated regions of 13 and 335 nt resp.  The apparent mol. mass of the translation product in vitro derived from the corresponding cRNA is consistent with that of the monomeric subunit of the AO holoenzyme.  The cDNA codes for a catalytically active form of AO, as demonstrated by transient transfection expts. conducted in the HC11 mouse mammary epithelial cell line.  The deduced primary structure of the AO protein contains consensus sequences for two distinct 2Fe2S redox centers and a molybdopterin-binding site.  The amino acid sequence of the mouse AO has a high degree of similarity with the human and bovine counterparts, and a significant degree of relatedness to AO proteins of plant origin.  Northern blot and in situ hybridization analyses demonstrate that hepatocytes, cardiocytes, lung endothelial or epithelial cells and esophagus epithelial cells express high levels of AO mRNA.  In the various tissues and organs considered, the level of AO mRNA expression is not strictly correlated with the amt. of the corresponding protein, suggesting that the synthesis of the AO enzyme is under translational or post-translational control.  In addn., we obsd. sex-related regulation of AO protein synthesis.  In the liver of male animals, despite similar amts. of AO mRNA, the levels of the AO enzyme and corresponding polypeptide are significantly higher than those in female animals.  Treatment of female mice with testosterone increases the amts. of AO mRNA and of the relative translation product to levels similar to those in male animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7FXG7lmMAKbVg90H21EOLACvtfcHk0ljlNqcht9oF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKisLY%253D&md5=041161a72629d21baf8397a774aa9011</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1042%2Fbj3410071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3410071%26sid%3Dliteratum%253Aachs%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DDemontis%26aufirst%3DS.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DMolecular%2520Cloning%2520of%2520the%2520Cdna%2520Coding%2520for%2520Mouse%2520Aldehyde%2520Oxidase%253A%2520Tissue%2520Distribution%2520and%2520Regulation%2520in%2520Vivo%2520by%2520Testosterone%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D341%26spage%3D71%26epage%3D80%26doi%3D10.1042%2Fbj3410071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bendotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosperini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Selective Localization of Mouse Aldehyde Oxidase Mrna in the Choroid Plexus and Motor Neurons</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9−10</span>),  <span class="NLM_fpage">2343</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1097/00001756-199707070-00048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1097%2F00001756-199707070-00048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9243637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1Wgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=2343-2349&issue=9%E2%88%9210&author=C.+Bendottiauthor=E.+Prosperiniauthor=M.+Kurosakiauthor=E.+Garattiniauthor=M.+Terao&title=Selective+Localization+of+Mouse+Aldehyde+Oxidase+Mrna+in+the+Choroid+Plexus+and+Motor+Neurons&doi=10.1097%2F00001756-199707070-00048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Selective localization of mouse aldehyde oxidase mRNA in the choroid plexus and motor neurons</span></div><div class="casAuthors">Bendotti, Caterina; Prosperini, Elena; Kurosaki, Mami; Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">2343-2349</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO), a protein involved in the catabolism of catecholamines, is the product of a gene potentially responsible for 1 of the familial forms of the motor neuron disease, amyotrophic lateral sclerosis (ALS).  Here, we report on the cloning of a partial cDNA coding for the mouse enzyme.  Using this cDNA as a probe, we demonstrate that the AO transcript is expressed in the epithelial component of the choroid plexus.  More importantly, in the gray matter, the mRNA is selectively localized in the large motor neurons of the nuclei of facial, motor trigemini and hypoglossus nerves and in the motor neurons of the anterior horns of the spinal cord.  This localization is consistent with a possible role of AO in the pathogenesis of ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4GKDiDr3VRrVg90H21EOLACvtfcHk0ljlNqcht9oF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1Wgt7s%253D&md5=2c5b0cb47a6666e63bb256270b068b28</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1097%2F00001756-199707070-00048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199707070-00048%26sid%3Dliteratum%253Aachs%26aulast%3DBendotti%26aufirst%3DC.%26aulast%3DProsperini%26aufirst%3DE.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DSelective%2520Localization%2520of%2520Mouse%2520Aldehyde%2520Oxidase%2520Mrna%2520in%2520the%2520Choroid%2520Plexus%2520and%2520Motor%2520Neurons%26jtitle%3DNeuroReport%26date%3D1997%26volume%3D8%26issue%3D9%25E2%2588%259210%26spage%3D2343%26epage%3D2349%26doi%3D10.1097%2F00001756-199707070-00048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Cloning of the Cdnas Coding for Two Novel Molybdo-Flavoproteins Showing High Similarity with Aldehyde Oxidase and Xanthine Oxidoreductase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">30690</span>– <span class="NLM_lpage">30700</span>, <span class="refDoi"> DOI: 10.1074/jbc.M005355200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M005355200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10893244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1agtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30690-30700&issue=39&author=M.+Teraoauthor=M.+Kurosakiauthor=G.+Saltiniauthor=S.+Demontisauthor=M.+Mariniauthor=M.+Salmonaauthor=E.+Garattini&title=Cloning+of+the+Cdnas+Coding+for+Two+Novel+Molybdo-Flavoproteins+Showing+High+Similarity+with+Aldehyde+Oxidase+and+Xanthine+Oxidoreductase&doi=10.1074%2Fjbc.M005355200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Saltini, Giuliana; Demontis, Silvia; Marini, Massimiliano; Salmona, Mario; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">30690-30700</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cDNAs coding for two novel mouse molybdo-flavoproteins, AOH1 and AOH2 (aldehyde oxidase homolog 1 and 2), were isolated.  The AOH1 and AOH2 cDNAs code for polypeptides of 1336 amino acids.  The two proteins have similar primary structure and show striking amino acid identity with aldehyde oxidase and xanthine oxidoreductase, two other molybdo-flavoenzymes.  AOH1 and AOH2 contain consensus sequences for a molybdopterin-binding site and two distinct 2Fe-2S redox centers.  In its native conformation, AOH1 has a mol. wt. consistent with a homotetrameric structure.  Transfection of the AOH1 and AOH2 cDNAs results in the prodn. of proteins with phenanthridine but not hypoxanthine oxidizing activity.  Furthermore, the AOH1 protein has benzaldehyde oxidizing activity with electrophoretic characteristics identical to those of a previously identified aldehyde oxidase isoenzyme.  The AOH1 transcript is expressed in the hepatocytes of the adult and fetal liver and in spermatogonia.  In liver, the AOH1 protein is synthesized in a gender-specific fashion.  The expression of AOH2 is limited to keratinized epithelia and the basal layer of the epidermis and hair folliculi.  The selective cell and tissue distribution of AOH1 and AOH2 mRNAs is consistent with the localization of the resp. protein products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPqzdTq52-i7Vg90H21EOLACvtfcHk0lj2oXIn1wTmkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1agtbw%253D&md5=4e030e708b88fa580c7a2a7a0fe49617</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M005355200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M005355200%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DSaltini%26aufirst%3DG.%26aulast%3DDemontis%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DM.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DCloning%2520of%2520the%2520Cdnas%2520Coding%2520for%2520Two%2520Novel%2520Molybdo-Flavoproteins%2520Showing%2520High%2520Similarity%2520with%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidoreductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D39%26spage%3D30690%26epage%3D30700%26doi%3D10.1074%2Fjbc.M005355200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardinello, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">The Aldehyde Oxidase Gene Cluster in Mice and Rats. Aldehyde Oxidase Homologue 3, a Novel Member of the Molybdo-Flavoenzyme Family with Selective Expression in the Olfactory Mucosa</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">50482</span>– <span class="NLM_lpage">50498</span>, <span class="refDoi"> DOI: 10.1074/jbc.M408734200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M408734200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15383531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWjsL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=50482-50498&issue=48&author=M.+Kurosakiauthor=M.+Teraoauthor=M.+M.+Barzagoauthor=A.+Bastoneauthor=D.+Bernardinelloauthor=M.+Salmonaauthor=E.+Garattini&title=The+Aldehyde+Oxidase+Gene+Cluster+in+Mice+and+Rats.+Aldehyde+Oxidase+Homologue+3%2C+a+Novel+Member+of+the+Molybdo-Flavoenzyme+Family+with+Selective+Expression+in+the+Olfactory+Mucosa&doi=10.1074%2Fjbc.M408734200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The Aldehyde Oxidase Gene Cluster in Mice and Rats: Aldehyde Oxidase Homologue 3, A Novel Member of the Molybdo-Flavoenzyme Family with Selective Expression in the Olfactory Mucosa</span></div><div class="casAuthors">Kurosaki, Mami; Terao, Mineko; Barzago, Maria Monica; Bastone, Antonio; Bernardinello, Davide; Salmona, Mario; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">50482-50498</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mammalian molybdo-flavoenzymes are oxidases requiring FAD and molybdopterin (molybdenum cofactor) for their catalytic activity.  This family of proteins was thought to consist of four members, xanthine oxidoreductase, aldehyde oxidase 1 (AOX1), and the aldehyde oxidase homologs 1 and 2 (AOH1 and AOH2, resp.).  Whereas the first two enzymes are present in humans and various other mammalian species, the last two proteins have been described only in mice.  Here, the authors report on the identification, in both mice and rats, of a novel molybdo-flavoenzyme, AOH3.  In addn., the authors have cloned the cDNAs coding for rat AOH1 and AOH2, demonstrating that this animal species has the same complement of molybdo-flavoproteins as the mouse.  The AOH3 cDNA is characterized by remarkable similarity to AOX1, AOH1, AOH2, and xanthine oxidoreductase cDNAs.  Mouse AOH3 is selectively expressed in Bowman's glands of the olfactory mucosa, although small amts. of the corresponding mRNA are present also in the skin.  In the former location, two alternatively spliced forms of the AOH3 transcript with different 3'-untranslated regions were identified.  The general properties of AOH3 were detd. by purifn. of mouse AOH3 from the olfactory mucosa.  The enzyme possesses aldehyde oxidase activity and oxidizes, albeit with low efficiency, exogenous substrates that are recognized by AOH1 and AOX1.  The Aoh3 gene maps to mouse chromosome 1 band c1 and rat chromosome 7 [sic] in close proximity to the Aox1, Aoh1, and Aoh2 loci and has an exon/intron structure almost identical to that of the other molybdo-flavoenzyme genes in the two species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr48cuzOskc97Vg90H21EOLACvtfcHk0lj2oXIn1wTmkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWjsL7N&md5=3a61fa5d905fcc7ffab3b1ac420dfdaf</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M408734200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M408734200%26sid%3Dliteratum%253Aachs%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DBernardinello%26aufirst%3DD.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DThe%2520Aldehyde%2520Oxidase%2520Gene%2520Cluster%2520in%2520Mice%2520and%2520Rats.%2520Aldehyde%2520Oxidase%2520Homologue%25203%252C%2520a%2520Novel%2520Member%2520of%2520the%2520Molybdo-Flavoenzyme%2520Family%2520with%2520Selective%2520Expression%2520in%2520the%2520Olfactory%2520Mucosa%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D48%26spage%3D50482%26epage%3D50498%26doi%3D10.1074%2Fjbc.M408734200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagnati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giudice, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanziani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiveron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Role of the Molybdoflavoenzyme Aldehyde Oxidase Homolog 2 in the Biosynthesis of Retinoic Acid: Generation and Characterization of a Knockout Mouse</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1128/MCB.01385-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1128%2FMCB.01385-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=18981221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=357-377&issue=2&author=M.+Teraoauthor=M.+Kurosakiauthor=M.+M.+Barzagoauthor=M.+Fratelliauthor=R.+Bagnatiauthor=A.+Bastoneauthor=C.+Giudiceauthor=E.+Scanzianiauthor=A.+Mancusoauthor=C.+Tiveronauthor=E.+Garattini&title=Role+of+the+Molybdoflavoenzyme+Aldehyde+Oxidase+Homolog+2+in+the+Biosynthesis+of+Retinoic+Acid%3A+Generation+and+Characterization+of+a+Knockout+Mouse&doi=10.1128%2FMCB.01385-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the molybdoflavoenzyme aldehyde oxidase homolog 2 in the biosynthesis of retinoic acid: generation and characterization of a knockout mouse</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Barzago, Maria Monica; Fratelli, Maddalena; Bagnati, Renzo; Bastone, Antonio; Giudice, Chiara; Scanziani, Eugenio; Mancuso, Alessandra; Tiveron, Cecilia; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-377</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mouse aldehyde oxidase AOH2 (aldehyde oxidase homolog 2) is a molybdoflavoenzyme.  Harderian glands are the richest source of AOH2, although the protein is detectable also in sebaceous glands, epidermis, and other keratinized epithelia.  The levels of AOH2 in the Harderian gland and skin are controlled by genetic background, being maximal in CD1 and C57BL/6 and minimal in DBA/2, CBA, and 129/Sv strains.  Testosterone is a neg. regulator of AOH2 in Harderian glands.  Purified AOH2 oxidizes retinaldehyde into retinoic acid, while it is devoid of pyridoxal-oxidizing activity.  Aoh2-/- mice, the first aldehyde oxidase knockout animals ever generated, are viable and fertile.  The data obtained for this knockout model indicate a significant role of AOH2 in the local synthesis and biodisposition of endogenous retinoids in the Harderian gland and skin.  The Harderian gland's transcriptome of knockout mice demonstrates overall downregulation of direct retinoid-dependent genes as well as perturbations in pathways controlling lipid homeostasis and cellular secretion, particularly in sexually immature animals.  The skin of knockout mice is characterized by thickening of the epidermis in basal conditions and after UV light exposure.  This has correlates in the corresponding transcriptome, which shows enrichment and overall upregulation of genes involved in hypertrophic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj5bWJ7gFLjLVg90H21EOLACvtfcHk0lj2oXIn1wTmkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChurw%253D&md5=c8903d17989a0a44f11511cb5c9f5f1e</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1128%2FMCB.01385-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01385-08%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DBagnati%26aufirst%3DR.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DGiudice%26aufirst%3DC.%26aulast%3DScanziani%26aufirst%3DE.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DTiveron%26aufirst%3DC.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DRole%2520of%2520the%2520Molybdoflavoenzyme%2520Aldehyde%2520Oxidase%2520Homolog%25202%2520in%2520the%2520Biosynthesis%2520of%2520Retinoic%2520Acid%253A%2520Generation%2520and%2520Characterization%2520of%2520a%2520Knockout%2520Mouse%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26issue%3D2%26spage%3D357%26epage%3D377%26doi%3D10.1128%2FMCB.01385-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanoni, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonetto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saccone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Purification of the Aldehyde Oxidase Homolog 1 (Aoh1) Protein and Cloning of the Aoh1 and Aldehyde Oxidase Homolog 2 (Aoh2) Genes. Identification of a Novel Molybdo-Flavoprotein Gene Cluster on Mouse Chromosome 1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">49</span>),  <span class="NLM_fpage">46347</span>– <span class="NLM_lpage">46363</span>, <span class="refDoi"> DOI: 10.1074/jbc.M105744200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M105744200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=11562361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVymtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=46347-46363&issue=49&author=M.+Teraoauthor=M.+Kurosakiauthor=M.+Mariniauthor=M.+A.+Vanoniauthor=G.+Saltiniauthor=V.+Bonettoauthor=A.+Bastoneauthor=C.+Federicoauthor=S.+Sacconeauthor=R.+Fanelliauthor=M.+Salmonaauthor=E.+Garattini&title=Purification+of+the+Aldehyde+Oxidase+Homolog+1+%28Aoh1%29+Protein+and+Cloning+of+the+Aoh1+and+Aldehyde+Oxidase+Homolog+2+%28Aoh2%29+Genes.+Identification+of+a+Novel+Molybdo-Flavoprotein+Gene+Cluster+on+Mouse+Chromosome+1&doi=10.1074%2Fjbc.M105744200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes: identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Marini, Massimiliano; Vanoni, Maria Antonietta; Saltini, Giuliana; Bonetto, Valentina; Bastone, Antonio; Federico, Concetta; Saccone, Salvatore; Fanelli, Roberto; Salmona, Mario; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">46347-46363</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We report the cloning of the AOH1 and AOH2 genes, which encode two novel mammalian molybdo-flavoproteins.  We have purified the AOH1 protein to homogeneity in its catalytically active form from mouse liver.  Twenty tryptic peptides, identified or directly sequenced by mass spectrometry, confirm the primary structure of the polypeptide deduced from the AOH1 gene.  The enzyme contains one mol. of FAD, one atom of molybdenum, and four atoms of iron per subunit and shows spectroscopic features similar to those of the prototypic molybdo-flavoprotein xanthine oxidoreductase.  The AOH1 and AOH2 genes are 98 and 60 kilobases long, resp., and consist of 35 coding exons.  The AOH1 gene has the potential to transcribe an extra leader non-coding exon, which is located downstream of exon 26, and is transcribed in the opposite orientation relative to all the other exons.  AOH1 and AOH2 map to chromosome 1 in close proximity to each other and to the aldehyde oxidase gene, forming a molybdo-flavoenzyme gene cluster.  Conservation in the position of exon/intron junctions among the mouse AOH1, AOH2, aldehyde oxidase, and xanthine oxidoreductase loci indicates that these genes are derived from the duplication of an ancestral precursor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwPMePV2jiBLVg90H21EOLACvtfcHk0ljheUISglDR4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVymtbg%253D&md5=93ee5bf46eb7bb5ac383c5380a81179b</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M105744200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M105744200%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DMarini%26aufirst%3DM.%26aulast%3DVanoni%26aufirst%3DM.%2BA.%26aulast%3DSaltini%26aufirst%3DG.%26aulast%3DBonetto%26aufirst%3DV.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DFederico%26aufirst%3DC.%26aulast%3DSaccone%26aufirst%3DS.%26aulast%3DFanelli%26aufirst%3DR.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DPurification%2520of%2520the%2520Aldehyde%2520Oxidase%2520Homolog%25201%2520%2528Aoh1%2529%2520Protein%2520and%2520Cloning%2520of%2520the%2520Aoh1%2520and%2520Aldehyde%2520Oxidase%2520Homolog%25202%2520%2528Aoh2%2529%2520Genes.%2520Identification%2520of%2520a%2520Novel%2520Molybdo-Flavoprotein%2520Gene%2520Cluster%2520on%2520Mouse%2520Chromosome%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D49%26spage%3D46347%26epage%3D46363%26doi%3D10.1074%2Fjbc.M105744200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuscoe, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannon, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancashire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moland, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branham, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfinger, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolsky, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerksen-Hughes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thierry-Mieg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thierry-Mieg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">A Rat Rna-Seq Transcriptomic Bodymap across 11 Organs and 4 Developmental Stages</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3230</span>, <span class="refDoi"> DOI: 10.1038/ncomms4230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Fncomms4230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24510058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BC2cvjsFChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3230&author=Y.+Yuauthor=J.+C.+Fuscoeauthor=C.+Zhaoauthor=C.+Guoauthor=M.+Jiaauthor=T.+Qingauthor=D.+I.+Bannonauthor=L.+Lancashireauthor=W.+Baoauthor=T.+Duauthor=H.+Luoauthor=Z.+Suauthor=W.+D.+Jonesauthor=C.+L.+Molandauthor=W.+S.+Branhamauthor=F.+Qianauthor=B.+Ningauthor=Y.+Liauthor=H.+Hongauthor=L.+Guoauthor=N.+Meiauthor=T.+Shiauthor=K.+Y.+Wangauthor=R.+D.+Wolfingerauthor=Y.+Nikolskyauthor=S.+J.+Walkerauthor=P.+Duerksen-Hughesauthor=C.+E.+Masonauthor=W.+Tongauthor=J.+Thierry-Miegauthor=D.+Thierry-Miegauthor=L.+Shiauthor=C.+Wang&title=A+Rat+Rna-Seq+Transcriptomic+Bodymap+across+11+Organs+and+4+Developmental+Stages&doi=10.1038%2Fncomms4230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages</span></div><div class="casAuthors">Yu Ying; Fuscoe James C; Zhao Chen; Jia Meiwen; Qing Tao; Du Tingting; Luo Heng; Guo Chao; Bannon Desmond I; Lancashire Lee; Nikolsky Yuri; Bao Wenjun; Wolfinger Russell D; Su Zhenqiang; Moland Carrie L; Branham William S; Qian Feng; Ning Baitang; Li Yan; Hong Huixiao; Guo Lei; Mei Nan; Tong Weida; Jones Wendell D; Shi Tieliu; Wang Kevin Y; Walker Stephen J; Duerksen-Hughes Penelope; Mason Christopher E; Thierry-Mieg Jean; Thierry-Mieg Danielle; Shi Leming; Wang Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3230</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The rat has been used extensively as a model for evaluating chemical toxicities and for understanding drug mechanisms.  However, its transcriptome across multiple organs, or developmental stages, has not yet been reported.  Here we show, as part of the SEQC consortium efforts, a comprehensive rat transcriptomic BodyMap created by performing RNA-Seq on 320 samples from 11 organs of both sexes of juvenile, adolescent, adult and aged Fischer 344 rats.  We catalogue the expression profiles of 40,064 genes, 65,167 transcripts, 31,909 alternatively spliced transcript variants and 2,367 non-coding genes/non-coding RNAs (ncRNAs) annotated in AceView.  We find that organ-enriched, differentially expressed genes reflect the known organ-specific biological activities.  A large number of transcripts show organ-specific, age-dependent or sex-specific differential expression patterns.  We create a web-based, open-access rat BodyMap database of expression profiles with crosslinks to other widely used databases, anticipating that it will serve as a primary resource for biomedical research using the rat model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqocd3VPk6-yA3UY9EwTNrfW6udTcc2ebxSlvgArEuZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvjsFChtA%253D%253D&md5=c07d485c0ef192adcc30404b3d539cab</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1038%2Fncomms4230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4230%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DFuscoe%26aufirst%3DJ.%2BC.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DQing%26aufirst%3DT.%26aulast%3DBannon%26aufirst%3DD.%2BI.%26aulast%3DLancashire%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DJones%26aufirst%3DW.%2BD.%26aulast%3DMoland%26aufirst%3DC.%2BL.%26aulast%3DBranham%26aufirst%3DW.%2BS.%26aulast%3DQian%26aufirst%3DF.%26aulast%3DNing%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DMei%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DK.%2BY.%26aulast%3DWolfinger%26aufirst%3DR.%2BD.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DWalker%26aufirst%3DS.%2BJ.%26aulast%3DDuerksen-Hughes%26aufirst%3DP.%26aulast%3DMason%26aufirst%3DC.%2BE.%26aulast%3DTong%26aufirst%3DW.%26aulast%3DThierry-Mieg%26aufirst%3DJ.%26aulast%3DThierry-Mieg%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DA%2520Rat%2520Rna-Seq%2520Transcriptomic%2520Bodymap%2520across%252011%2520Organs%2520and%25204%2520Developmental%2520Stages%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3230%26doi%3D10.1038%2Fncomms4230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span> <span> </span><span class="NLM_article-title">Comparative Localization of Aldehyde Oxidase and Xanthine Oxidoreductase Activity in Rat Tissues</span>. <i>Histochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1023/A:1003222831002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1023%2FA%3A1003222831002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10192546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1cXisVCns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=69-74&issue=2&author=Y.+Moriwakiauthor=T.+Yamamotoauthor=J.+Yamakitaauthor=S.+Takahashiauthor=K.+Higashino&title=Comparative+Localization+of+Aldehyde+Oxidase+and+Xanthine+Oxidoreductase+Activity+in+Rat+Tissues&doi=10.1023%2FA%3A1003222831002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative localization of aldehyde oxidase and xanthine oxidoreductase activity in rat tissues</span></div><div class="casAuthors">Moriwaki, Yuji; Yamamoto, Tetsuya; Yamakita, Jun-Ichi; Takahashi, Sumio; Higashino, Kazuya</div><div class="citationInfo"><span class="NLM_cas:title">Histochemical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-74</span>CODEN:
                <span class="NLM_cas:coden">HISJAE</span>;
        ISSN:<span class="NLM_cas:issn">0018-2214</span>.
    
            (<span class="NLM_cas:orgname">Chapman & Hall</span>)
        </div><div class="casAbstract">The distribution of aldehyde oxidase (I) activity was evaluated in unfixed cryostat sections from tissues of male Wistar rats using a tissue protectant, polyvinyl alc., with Tetra Nitro BT as a final electron acceptor.  The distribution of I activity was compared with that of xanthine oxidoreductase (II).  The enzyme histochem. method demonstrated I activity in the epithelium of the tongue, renal tubules, and bronchioles, as well as in the cytoplasm of liver cells.  Such activity was not detected in esophagus, stomach, spleen, adrenal glands, small or large intestine, or skeletal and heart muscle fibers.  In contrast, II activity was demonstrated in the tongue, renal tubules, bronchioles, esophageal, gastric, small and large intestinal epithelial cells, adrenal glands, spleen and liver cytoplasm, but not in skeletal and heart muscle fibers.  The significance of the ubiquitous distribution of I activity, esp. in surface epithelial cells from various tissues, except for the gastrointestinal tract, is unclear.  However, I may possess some physiol. activity other than in the metab. of N-heterocyclics or of certain drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6gPO2AWUBb7Vg90H21EOLACvtfcHk0lgUOoIUoks30A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVCns7w%253D&md5=3f2492fe3630405e5094a4f28aeccb42</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1023%2FA%3A1003222831002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1003222831002%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamakita%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26atitle%3DComparative%2520Localization%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidoreductase%2520Activity%2520in%2520Rat%2520Tissues%26jtitle%3DHistochem.%2520J.%26date%3D1998%26volume%3D30%26issue%3D2%26spage%3D69%26epage%3D74%26doi%3D10.1023%2FA%3A1003222831002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span> <span> </span><span class="NLM_article-title">Zonal Distribution of Allopurinol-Oxidizing Enzymes in Rat Liver</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>431</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1007/978-1-4615-5381-6_9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2F978-1-4615-5381-6_9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9598029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1cXls12hur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=1998&pages=47-50&author=Y.+Moriwakiauthor=T.+Yamamotoauthor=J.+Yamakitaauthor=S.+Takahashiauthor=Z.+Tsutsumiauthor=K.+Higashino&title=Zonal+Distribution+of+Allopurinol-Oxidizing+Enzymes+in+Rat+Liver&doi=10.1007%2F978-1-4615-5381-6_9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Zonal distribution of allopurinol-oxidizing enzymes in rat liver</span></div><div class="casAuthors">Moriwaki, Yuji; Yamamoto, Tetsuya; Yamakita, Jun-ichi; Takahashi, Sumio; Tsutsumi, Zenta; Higashino, Kazuya</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">431</span>
        (<span class="NLM_cas:issue">Purine and Pyrimidine Metabolism in Man IX, 1998</span>),
    <span class="NLM_cas:pages">47-50</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">We describe an enzymic histochem. localization of two allopurinol-oxidizing enzymes, xanthine oxidase and aldehyde oxidase in rat hepatic tissues.  This method is based on the tetrazolium salt procedures by use of a tissue protectant, polyvinyl alc., with tetra-nitro BT as the final electron acceptor.  The present study demonstrated that both oxidases are present in the cytoplasm of hepatic cells.  However, the distribution of the enzymes were uneven, being seen mainly in the pericentral rather than the periportal area.  When allopurinol was used as a substrate, the specific staining by xanthine oxidase was more prominent than that of aldehyde oxidase.  The results suggested that xanthine oxidase is more effective in oxidizing allopurinol than aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKDD7dHysSq7Vg90H21EOLACvtfcHk0lgUOoIUoks30A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls12hur0%253D&md5=98e64280f3c4320e09c7673b9279a50c</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1007%2F978-1-4615-5381-6_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4615-5381-6_9%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamakita%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DZ.%26aulast%3DHigashino%26aufirst%3DK.%26atitle%3DZonal%2520Distribution%2520of%2520Allopurinol-Oxidizing%2520Enzymes%2520in%2520Rat%2520Liver%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1998%26volume%3D431%26spage%3D47%26epage%3D50%26doi%3D10.1007%2F978-1-4615-5381-6_9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical Localization of Aldehyde and Xanthine Oxidase in Rat Tissues Using Polyclonal Antibodies</span>. <i>Histochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1007/BF01450880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2FBF01450880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8824908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28XkvVaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1996&pages=71-79&issue=1&author=Y.+Moriwakiauthor=T.+Yamamotoauthor=K.+Yamaguchiauthor=S.+Takahashiauthor=K.+Higashino&title=Immunohistochemical+Localization+of+Aldehyde+and+Xanthine+Oxidase+in+Rat+Tissues+Using+Polyclonal+Antibodies&doi=10.1007%2FBF01450880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies</span></div><div class="casAuthors">Moriwaki, Yuji; Yamamoto, Tetsuya; Yamaguchi, Kei; Takahashi, Sumio; Higashino, Kazuya</div><div class="citationInfo"><span class="NLM_cas:title">Histochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-9</span>CODEN:
                <span class="NLM_cas:coden">HCBIFP</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Tissues from male Wistar rats, fixed with 4% paraformaldehyde and embedded in paraffin, were studied with immunoperoxidase techniques using polyclonal antibodies raised against aldehyde oxidase (AO) or xanthine oxidase (XO) purified from rat liver.  Immunohistochem. studies demonstrated that AO-bearing cells were strongly stained in renal tubules, esophageal, gastric, intestinal and bronchial epithelium as well as liver cytoplasm.  Weak but pos. immunoreactivity was obsd. on the pulmonary alveolar epithelial cells, gastric glands and intestinal goblet cells.  In contrast, it was demonstrated that cells with XO were strongly stained in renal tubules, esophageal, gastric, and small and large intestinal and bronchial epithelia etc.  Pos. immunostaining was also found in adrenal gland, skeletal muscle, spleen and cerebral hippocampus.  Immunoreactivity against AO was not found in adrenal gland, spleen, mesentery, or aorta, whereas immunoreactivity against XO was not found in mesentery or aorta.  Although the significance of this ubiquitous and similar localization of AO and XO seems unclear at present, these results may provide a clue as to the full understanding of the pathophysiol. role of these oxidases in tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkrmijY6jYdbVg90H21EOLACvtfcHk0lhT80-dveQqMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvVaguw%253D%253D&md5=273c7eedc37ae05c11211f225114f567</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1007%2FBF01450880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01450880%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26atitle%3DImmunohistochemical%2520Localization%2520of%2520Aldehyde%2520and%2520Xanthine%2520Oxidase%2520in%2520Rat%2520Tissues%2520Using%2520Polyclonal%2520Antibodies%26jtitle%3DHistochem.%2520Cell%2520Biol.%26date%3D1996%26volume%3D105%26issue%3D1%26spage%3D71%26epage%3D79%26doi%3D10.1007%2FBF01450880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boldetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Avian and Canine Aldehyde Oxidases. Novel Insights into the Biology and Evolution of Molybdo-Flavoenzymes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">19748</span>– <span class="NLM_lpage">19761</span>, <span class="refDoi"> DOI: 10.1074/jbc.M600850200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M600850200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16672219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Gqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=19748-19761&issue=28&author=M.+Teraoauthor=M.+Kurosakiauthor=M.+M.+Barzagoauthor=E.+Varasanoauthor=A.+Boldettiauthor=A.+Bastoneauthor=M.+Fratelliauthor=E.+Garattini&title=Avian+and+Canine+Aldehyde+Oxidases.+Novel+Insights+into+the+Biology+and+Evolution+of+Molybdo-Flavoenzymes&doi=10.1074%2Fjbc.M600850200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Avian and Canine Aldehyde Oxidases: Novel insights into the biology and evolution of molybdo-flavoenzymes</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Barzago, Maria Monica; Varasano, Emanuela; Boldetti, Andrea; Bastone, Antonio; Fratelli, Maddalena; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">19748-19761</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aldehyde oxidases are molybdo-flavoenzymes structurally related to xanthine oxidoreductase.  They catalyze the oxidn. of aldehydes or N-heterocycles of physiol., pharmacol., and toxicol. relevance.  Rodents are characterized by four aldehyde oxidases as follows: AOX1 and aldehyde oxidase homologs 1-3 (AOH1, AOH2, and AOH3).  Humans synthesize a single functional aldehyde oxidase, AOX1.  Here we define the structure and the characteristics of the aldehyde oxidase genes and proteins in chicken and dog.  The avian genome contains two aldehyde oxidase genes, AOX1 and AOH, mapping to chromosome 7.  AOX1 and AOH are structurally very similar and code for proteins whose sequence was deduced from the corresponding cDNAs.  AOX1 is the ortholog of the same gene in mammals, whereas AOH represents the likely ancestor of rodent AOH1, AOH2, and AOH3.  The dog genome is endowed with two structurally conserved and active aldehyde oxidases clustering on chromosome 37.  Cloning of the corresponding cDNAs and tissue distribution studies demonstrate that they are the orthologs of rodent AOH2 and AOH3.  The vestiges of dog AOX1 and AOH1 are recognizable upstream of AOH2 and AOH3 on the same chromosome.  Comparison of the complement and the structure of the aldehyde oxidase and xanthine oxidoreductase genes in vertebrates and other animal species indicates that they evolved through a series of duplication and inactivation events.  Purifn. of the chicken AOX1 protein to homogeneity from kidney demonstrates that the enzyme possesses retinaldehyde oxidase activity.  Unlike humans and most other mammals, dog and chicken are devoid of liver aldehyde oxidase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgrgmQLkVMCLVg90H21EOLACvtfcHk0lhT80-dveQqMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Gqtrs%253D&md5=6614f74868cbc3ae79bb1a611cd55875</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M600850200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M600850200%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DVarasano%26aufirst%3DE.%26aulast%3DBoldetti%26aufirst%3DA.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DAvian%2520and%2520Canine%2520Aldehyde%2520Oxidases.%2520Novel%2520Insights%2520into%2520the%2520Biology%2520and%2520Evolution%2520of%2520Molybdo-Flavoenzymes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D28%26spage%3D19748%26epage%3D19761%26doi%3D10.1074%2Fjbc.M600850200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palpant, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parast, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzman, J.</span></span> <span> </span><span class="NLM_article-title">Statistically Based Splicing Detection Reveals Neural Enrichment and Tissue-Specific Induction of Circular Rna During Human Fetal Development</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">126</span>, <span class="refDoi"> DOI: 10.1186/s13059-015-0690-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1186%2Fs13059-015-0690-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26076956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BC2Mbjs12qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=126&author=L.+Szaboauthor=R.+Moreyauthor=N.+J.+Palpantauthor=P.+L.+Wangauthor=N.+Afariauthor=C.+Jiangauthor=M.+M.+Parastauthor=C.+E.+Murryauthor=L.+C.+Laurentauthor=J.+Salzman&title=Statistically+Based+Splicing+Detection+Reveals+Neural+Enrichment+and+Tissue-Specific+Induction+of+Circular+Rna+During+Human+Fetal+Development&doi=10.1186%2Fs13059-015-0690-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development</span></div><div class="casAuthors">Szabo Linda; Wang Peter L; Salzman Julia; Morey Robert; Afari Nastaran; Jiang Chuan; Laurent Louise C; Palpant Nathan J; Murry Charles E; Parast Mana M</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">126</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The pervasive expression of circular RNA is a recently discovered feature of gene expression in highly diverged eukaryotes, but the functions of most circular RNAs are still unknown.  Computational methods to discover and quantify circular RNA are essential.  Moreover, discovering biological contexts where circular RNAs are regulated will shed light on potential functional roles they may play.  RESULTS:  We present a new algorithm that increases the sensitivity and specificity of circular RNA detection by discovering and quantifying circular and linear RNA splicing events at both annotated and un-annotated exon boundaries, including intergenic regions of the genome, with high statistical confidence.  Unlike approaches that rely on read count and exon homology to determine confidence in prediction of circular RNA expression, our algorithm uses a statistical approach.  Using our algorithm, we unveiled striking induction of general and tissue-specific circular RNAs, including in the heart and lung, during human fetal development.  We discover regions of the human fetal brain, such as the frontal cortex, with marked enrichment for genes where circular RNA isoforms are dominant.  CONCLUSIONS:  The vast majority of circular RNA production occurs at major spliceosome splice sites; however, we find the first examples of developmentally induced circular RNAs processed by the minor spliceosome, and an enriched propensity of minor spliceosome donors to splice into circular RNA at un-annotated, rather than annotated, exons.  Together, these results suggest a potentially significant role for circular RNA in human development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQypielIS9HBQWRJ3OJdH_qfW6udTcc2eaEYjWPfpYFwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mbjs12qsQ%253D%253D&md5=ea95d2021bbd83fc5cca0b29f890a69a</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1186%2Fs13059-015-0690-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13059-015-0690-5%26sid%3Dliteratum%253Aachs%26aulast%3DSzabo%26aufirst%3DL.%26aulast%3DMorey%26aufirst%3DR.%26aulast%3DPalpant%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DP.%2BL.%26aulast%3DAfari%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DParast%26aufirst%3DM.%2BM.%26aulast%3DMurry%26aufirst%3DC.%2BE.%26aulast%3DLaurent%26aufirst%3DL.%2BC.%26aulast%3DSalzman%26aufirst%3DJ.%26atitle%3DStatistically%2520Based%2520Splicing%2520Detection%2520Reveals%2520Neural%2520Enrichment%2520and%2520Tissue-Specific%2520Induction%2520of%2520Circular%2520Rna%2520During%2520Human%2520Fetal%2520Development%26jtitle%3DGenome%2520Biol.%26date%3D2015%26volume%3D16%26spage%3D126%26doi%3D10.1186%2Fs13059-015-0690-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, D. A.</span></span> <span> </span><span class="NLM_article-title">Absolute Quantification of Aldehyde Oxidase Protein in Human Liver Using Liquid Chromatography-Tandem Mass Spectrometry</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3842</span>– <span class="NLM_lpage">3849</span>, <span class="refDoi"> DOI: 10.1021/mp4003046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp4003046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=3842-3849&issue=10&author=J.+T.+Barrauthor=J.+P.+Jonesauthor=C.+A.+Joswig-Jonesauthor=D.+A.+Rock&title=Absolute+Quantification+of+Aldehyde+Oxidase+Protein+in+Human+Liver+Using+Liquid+Chromatography-Tandem+Mass+Spectrometry&doi=10.1021%2Fmp4003046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute Quantification of Aldehyde Oxidase Protein in Human Liver Using Liquid Chromatography-Tandem Mass Spectrometry</span></div><div class="casAuthors">Barr, John T.; Jones, Jeffrey P.; Joswig-Jones, Carolyn A.; Rock, Dan A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3842-3849</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The function of the enzyme human aldehyde oxidase (AOX1) is uncertain; however, recent studies have implicated significant biochem. involvement in humans.  AOX1 has also rapidly become an important drug-metabolizing enzyme.  Until now, quantitation of AOX1 in complex matrixes such as tissue has not been achieved.  Herein, we developed and employed a trypsin digest and subsequent liq. chromatog.-tandem mass spectrometry anal. to det. abs. amts. of AOX1 in human liver.  E. coli expressed human purified AOX1 was used to validate the linearity, sensitivity, and selectivity of the method.  Overall, the method is highly efficient and sensitive for detn. of AOX1 in cytosolic liver fractions.  Using this method, we obsd. substantial batch-to-batch variation in AOX1 content (21-40 pmol AOX1/mg total protein) between various pooled human liver cytosol prepns.  We also obsd. interbatch variation in Vmax (3.3-4.9 nmol min-1 mg-1) and a modest correlation between enzyme concn. and activity.  In addn., we measured a large difference in kcat/Km, between purified (kcat/Km of 1.4) and human liver cytosol (kcat/Km of 15-20) indicating cytosol to be 11-14 times more efficient in the turnover of DACA than the E. coli expressed purified enzyme.  Finally, we discussed the future impact of this method for the development of drug metab. models and understanding the biochem. role of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdDihdSekMBLVg90H21EOLACvtfcHk0lgGCgFzXlpaMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtbvJ&md5=22a216a3f9acbea90ae6d8d6cf4948d9</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fmp4003046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp4003046%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DRock%26aufirst%3DD.%2BA.%26atitle%3DAbsolute%2520Quantification%2520of%2520Aldehyde%2520Oxidase%2520Protein%2520in%2520Human%2520Liver%2520Using%2520Liquid%2520Chromatography-Tandem%2520Mass%2520Spectrometry%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26issue%3D10%26spage%3D3842%26epage%3D3849%26doi%3D10.1021%2Fmp4003046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderstrom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase 1 (Aox1) in Human Liver Cytosols: Quantitative Characterization of Aox1 Expression Level and Activity Relationship</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1797</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.113.053082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23857892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVygtrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1797-1804&issue=10&author=C.+Fuauthor=L.+Diauthor=X.+Hanauthor=C.+Soderstromauthor=M.+Snyderauthor=M.+D.+Troutmanauthor=R.+S.+Obachauthor=H.+Zhang&title=Aldehyde+Oxidase+1+%28Aox1%29+in+Human+Liver+Cytosols%3A+Quantitative+Characterization+of+Aox1+Expression+Level+and+Activity+Relationship&doi=10.1124%2Fdmd.113.053082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase 1 (AOX1) in human liver cytosols: quantitative characterization of AOX1 expression level and activity relationship</span></div><div class="casAuthors">Fu, Cexiong; Di, Li; Han, Xiaogang; Soderstrom, Cathy; Snyder, Mark; Troutman, Matthew D.; Obach, R. Scott; Zhang, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1797-1804</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase 1 (AOX1) is a cytosolic enzyme highly expressed in liver and plays a key role in metabolizing drugs contg. arom. azaheterocyclic substituents.  Rapid metab. catalyzed by AOX1 can cause a drug to exhibit high clearance, low exposure, and hence decreased efficacy or even increased toxicity (if AOX1 generated metabolites are toxic).  There is a need to develop the correlation between AOX1 expression levels and AOX1-substrate clearance.  A fast, sensitive, and robust liq. chromatog.-tandem mass spectrometry (LC-MS/MS) method was developed to quantify AOX1 in human liver cytosol for the first time.  This LC-MS/MS method includes a straightforward ultrafiltration fractionation step and gives great selectivity and wide dynamic range (5.2 pM to 20.7 nM).  The AOX1 levels in human liver cytosols of 20 donors were quantified using this method to investigate individual differences in AOX1 expression.  No significant individual or gender differences in AOX1 levels were obsd., although male donors exhibited a broader distribution than female donors (0.74-2.30 pmol/mg vs. 0.74-1.69 pmol/mg, resp.).  The AOX1 protein levels measured by LC-MS/MS were consistent with those measured by an ELISA.  Several donors have a normal AOX1 protein level but low enzyme activity, which might be due to cofactor deficiency, single nucleotide polymorphism, or homodimer dissocn.  Cytosols from donors with chronic alc. consumption had low AOX1-catalyzed carbazeran oxidn. activities (<51 μl/min per mg compared with a median of 455 μl/min per mg), but preserved similar AOX1 protein expression levels (approx. 15% less than the median value).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB97GlLsl1vLVg90H21EOLACvtfcHk0lgGCgFzXlpaMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVygtrfF&md5=5f0ca934bbaaf65670abab7b2d44cf37</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053082%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DC.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DSoderstrom%26aufirst%3DC.%26aulast%3DSnyder%26aufirst%3DM.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DAldehyde%2520Oxidase%25201%2520%2528Aox1%2529%2520in%2520Human%2520Liver%2520Cytosols%253A%2520Quantitative%2520Characterization%2520of%2520Aox1%2520Expression%2520Level%2520and%2520Activity%2520Relationship%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26issue%3D10%26spage%3D1797%26epage%3D1804%26doi%3D10.1124%2Fdmd.113.053082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyward, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, T.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase Activity in Donor-Matched Fresh and Cryopreserved Human Hepatocytes and Assessment of Variability in 75 Donors</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1090</span>– <span class="NLM_lpage">1097</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.057984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.057984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24713130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKnt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1090-1097&issue=6&author=J.+M.+Hutzlerauthor=Y.+S.+Yangauthor=C.+Brownauthor=S.+Heywardauthor=T.+Moeller&title=Aldehyde+Oxidase+Activity+in+Donor-Matched+Fresh+and+Cryopreserved+Human+Hepatocytes+and+Assessment+of+Variability+in+75+Donors&doi=10.1124%2Fdmd.114.057984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase activity in donor-matched fresh and cryopreserved human hepatocytes and assessment of variability in 75 donors</span></div><div class="casAuthors">Hutzler, J. Matthew; Yang, Young-Sun; Brown, Caitlin; Heyward, Scott; Moeller, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1090-1097, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Studies were conducted to evaluate the impact of time and cryopreservation on aldehyde oxidase (AO) activity in human hepatocytes isolated from 10 donor livers, using O6-benzylguanine as a probe substrate.  In addn., variability in activity was assessed using cryopreserved hepatocytes from 75 donors.  Substantial donor-dependent loss in AO activity within 24 h after isolation of hepatocytes was obsd. (av. loss of 42%, range 15%-81%).  Meanwhile, AO activity in cryopreserved hepatocytes more closely represented the activity obsd. in fresh hepatocytes that were incubated immediately after isolation for the same donors (within 81% of fresh, range 48%-100%).  Activity of AO in cryopreserved hepatocytes from 75 donors varied by at least 17-fold (≤5.4 to 90 mL/min per kg of body wt.), with 63% of the donors having higher activity than a pooled 19-donor lot (34.2 mL/min per kg).  Comparison of demographics such as gender, body mass index, age, and ethnicity showed no statistically significant correlations with activity.  Evaluation of medical histories revealed that three of the five donors with no measurable activity had immediate histories of extensive alc. abuse.  Meanwhile, two single nucleotide polymorphisms (SNPs) for AOX1 (rs3731772 and rs55754655) were detected in our donor pool and showed allelic frequencies similar to those reported from other cohort studies.  However, these SNPs did not correlate with a statistically significant difference in intrinsic clearance compared with wild-type donors.  With a general lack of clarity about what causes highly variable AO activity, prescreening donors for AO activity and creating a custom high-activity pooled lot of cryopreserved hepatocytes are advised to minimize underpredictions of clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI1CETO4hEdrVg90H21EOLACvtfcHk0lgWIG4Ozax89g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKnt7%252FF&md5=21a11c73049d04fcace46fccf757c302</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.057984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.057984%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DHeyward%26aufirst%3DS.%26aulast%3DMoeller%26aufirst%3DT.%26atitle%3DAldehyde%2520Oxidase%2520Activity%2520in%2520Donor-Matched%2520Fresh%2520and%2520Cryopreserved%2520Human%2520Hepatocytes%2520and%2520Assessment%2520of%2520Variability%2520in%252075%2520Donors%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D6%26spage%3D1090%26epage%3D1097%26doi%3D10.1124%2Fdmd.114.057984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teutloff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfaro, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">The Impact of Single Nucleotide Polymorphisms on Human Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">856</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.043828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.043828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22279051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=856-864&issue=5&author=T.+Hartmannauthor=M.+Teraoauthor=E.+Garattiniauthor=C.+Teutloffauthor=J.+F.+Alfaroauthor=J.+P.+Jonesauthor=S.+Leimkuhler&title=The+Impact+of+Single+Nucleotide+Polymorphisms+on+Human+Aldehyde+Oxidase&doi=10.1124%2Fdmd.111.043828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of single nucleotide polymorphisms on human aldehyde oxidase</span></div><div class="casAuthors">Hartmann, Tobias; Terao, Mineko; Garattini, Enrico; Teutloff, Christian; Alfaro, Joshua F.; Jones, Jeffrey P.; Leimkuehler, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">856-864</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a complex molybdo-flavoprotein that belongs to the xanthine oxidase family.  AO is active as a homodimer, and each 150-kDa monomer binds 2 distinct [2Fe-2S] clusters, FAD, and the Mo cofactor.  AO plays an important role in the metab. of drugs based on its broad substrate specificity oxidizing arom. aza-heterocycles, e.g., N1-methylnicotinamide and N-methylphthalazinium, or aldehydes, such as benzaldehyde, retinal, and vanillin.  Sequencing the 35 coding exons of the human AOX1 gene in a sample of 180 Italian individuals led to the identification of relatively frequent, synonymous, missense, and nonsense single-nucleotide polymorphisms (SNPs).  Here, human aldehyde oxidase (hAOX1) was purified after heterologous expression in Escherichia coli.  The recombinant protein was obtained with a purity of 95% and a yield of 50 μg/L E. coli culture.  Site-directed mutagenesis of the hAOX1 cDNA allowed the purifn. of protein variants bearing amino acid changes R802C, R921H, N1135S, and H1297R, which corresponded to some of the identified SNPs.  The hAOX1 variants were purified and compared with the wild-type protein relative to activity, oligomerization state, and metal content.  The data showed that the mutation of each amino acid residue had a variable impact on the ability of hAOX1 to metabolize selected substrates.  Thus, the human population is characterized by the presence of functionally inactive hAOX1 allelic variants as well as variants encoding enzymes with different catalytic activities.  These results indicate that the presence of these allelic variants should be considered for the design of future drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPZuTJ_uSE37Vg90H21EOLACvtfcHk0lgWIG4Ozax89g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kgu7w%253D&md5=2f4880516d41161df95ef9a7b037bdd5</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.043828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.043828%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTeutloff%26aufirst%3DC.%26aulast%3DAlfaro%26aufirst%3DJ.%2BF.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DThe%2520Impact%2520of%2520Single%2520Nucleotide%2520Polymorphisms%2520on%2520Human%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D5%26spage%3D856%26epage%3D864%26doi%3D10.1124%2Fdmd.111.043828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorendorf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">A Single Nucleotide Polymorphism Causes Enhanced Radical Oxygen Species Production by Human Aldehyde Oxidase</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0182061</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0182061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1371%2Fjournal.pone.0182061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28750088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlaqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&issue=7&author=A.+Fotiauthor=F.+Dorendorfauthor=S.+Leimkuhler&title=A+Single+Nucleotide+Polymorphism+Causes+Enhanced+Radical+Oxygen+Species+Production+by+Human+Aldehyde+Oxidase&doi=10.1371%2Fjournal.pone.0182061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">A single nucleotide polymorphism causes enhanced radical oxygen species production by human aldehyde oxidase</span></div><div class="casAuthors">Foti, Alessandro; Dorendorf, Frank; Leimkuehler, Silke</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0182061/1-e0182061/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs) are molybdo-flavoenzymes characterized by broad substrate specificity, oxidizing arom./aliph. aldehydes into the corresponding carboxylic acids and hydroxylating various heteroarom. rings.  The enzymes use oxygen as the terminal electron acceptor and produce reduced oxygen species during turnover.  The physiol. function of mammalian AOX isoenzymes is still unclear, however, human AOX (hAOX1) is an emerging enzyme in phase-I drug metab.  Indeed, the no. of xenobiotics acting as hAOX1 substrates is increasing.  Further, numerous single-nucleotide polymorphisms (SNPs) have been identified within the hAOX1 gene.  SNPs are a major source of inter-individual variability in the human population, and SNP-based amino acid exchanges in hAOX1 reportedly modulate the catalytic function of the enzyme in either a pos. or neg. fashion.  In this report we selected ten novel SNPs resulting in amino acid exchanges in proximity to the FAD site of hAOX1 and characterized the purified enzymes after heterologous expression in Escherichia coli.  The hAOX1 variants were characterized carefully by quant. differences in their ability to produce superoxide radical.  ROS represent prominent key mols. in physiol. and pathol. conditions in the cell.  Our data reveal significant alterations in superoxide anion prodn. among the variants.  In particular the SNP-based amino acid exchange L438V in proximity to the isoalloxanzine ring of the FAD cofactor resulted in increased rate of superoxide radical prodn. of 75%.  Considering the high toxicity of the superoxide in the cell, the hAOX1-L438V SNP variant is an eventual candidate for crit. or pathol. roles of this natural variant within the human population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtSFZjw7z8bVg90H21EOLACvtfcHk0lgVuuj3Pnx4gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlaqurw%253D&md5=28472e1f132c811860fb71661edcac1b</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0182061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0182061%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DDorendorf%26aufirst%3DF.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DA%2520Single%2520Nucleotide%2520Polymorphism%2520Causes%2520Enhanced%2520Radical%2520Oxygen%2520Species%2520Production%2520by%2520Human%2520Aldehyde%2520Oxidase%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0182061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Simultaneous Determination of Idelalisib and Its Metabolite Gs-563117 in Dog Plasma by Lc-Ms/Ms: Application to a Pharmacokinetic Study</span>. <i>Biomed. Chromatogr.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e4511</span> <span class="refDoi"> DOI: 10.1002/bmc.4511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fbmc.4511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30773664" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&issue=5&author=C.+Wangauthor=F.+Jiaauthor=Y.+Zhang&title=Simultaneous+Determination+of+Idelalisib+and+Its+Metabolite+Gs-563117+in+Dog+Plasma+by+Lc-Ms%2FMs%3A+Application+to+a+Pharmacokinetic+Study&doi=10.1002%2Fbmc.4511"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1002%2Fbmc.4511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbmc.4511%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DSimultaneous%2520Determination%2520of%2520Idelalisib%2520and%2520Its%2520Metabolite%2520Gs-563117%2520in%2520Dog%2520Plasma%2520by%2520Lc-Ms%252FMs%253A%2520Application%2520to%2520a%2520Pharmacokinetic%2520Study%26jtitle%3DBiomed.%2520Chromatogr.%26date%3D2019%26volume%3D33%26issue%3D5%26doi%3D10.1002%2Fbmc.4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Mammalian Molybdo-Flavoenzymes, an Expanding Family of Proteins: Structure, Genetics, Regulation, Function and Pathophysiology</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1042/bj20030121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1042%2Fbj20030121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=12578558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2003&pages=15-32&author=E.+Garattiniauthor=R.+Mendelauthor=M.+J.+Romaoauthor=R.+Wrightauthor=M.+Terao&title=Mammalian+Molybdo-Flavoenzymes%2C+an+Expanding+Family+of+Proteins%3A+Structure%2C+Genetics%2C+Regulation%2C+Function+and+Pathophysiology&doi=10.1042%2Fbj20030121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology</span></div><div class="casAuthors">Garattini, Enrico; Mendel, Ralf; Romao, Maria Joao; Wright, Richard; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-32</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The molybdo-flavoenzymes are structurally related proteins that require a molybdopterin cofactor and FAD for their catalytic activity.  In mammals, four enzymes are known: xanthine oxidoreductase, aldehyde oxidase and two recently described mouse proteins known as aldehyde oxidase homolog 1 and aldehyde oxidase homolog 2.  The present review article summarizes current knowledge on the structure, enzymol., genetics, regulation and pathophysiol. of mammalian molybdo-flavoenzymes.  Molybdo-flavoenzymes are structurally complex oxidoreductases with an equally complex mechanism of catalysis.  Our knowledge has greatly increased due to the recent crystn. of two xanthine oxidoreductases and the detn. of the amino acid sequences of many members of the family.  The evolution of molybdo-flavoenzymes can now be traced, given the availability of the structures of the corresponding genes in many organisms.  The genes coding for molybdo-flavoenzymes are expressed in a cell-specific fashion and are controlled by endogenous and exogenous stimuli.  The recent cloning of the genes involved in the biosynthesis of the molybdenum cofactor has increased our knowledge on the assembly of the apo-forms of molybdo-flavoproteins into the corresponding holo-forms.  Xanthine oxidoreductase is the key enzyme in the catabolism of purines, although recent data suggest that the physiol. function of this enzyme is more complex than previously assumed.  The enzyme has been implicated in such diverse pathol. situations as organ ischemia, inflammation and infection.  At present, very little is known about the pathophysiol. relevance of aldehyde oxidase, aldehyde oxidase homolog 1 and aldehyde oxidase homolog 2, which do not as yet have an accepted endogenous substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF9AyORLkqFbVg90H21EOLACvtfcHk0lgVuuj3Pnx4gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFeitbg%253D&md5=3004079e3d63655d84db5df06656d339</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1042%2Fbj20030121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20030121%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DMendel%26aufirst%3DR.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DR.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DMammalian%2520Molybdo-Flavoenzymes%252C%2520an%2520Expanding%2520Family%2520of%2520Proteins%253A%2520Structure%252C%2520Genetics%252C%2520Regulation%252C%2520Function%2520and%2520Pathophysiology%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D372%26spage%3D15%26epage%3D32%26doi%3D10.1042%2Fbj20030121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kucukgoze, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">Direct Comparison of the Four Aldehyde Oxidase Enzymes Present in Mouse Gives Insight into Their Substrate Specificities</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e0191819</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0191819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1371%2Fjournal.pone.0191819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29370288" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&issue=1&author=G.+Kucukgozeauthor=S.+Leimkuhler&title=Direct+Comparison+of+the+Four+Aldehyde+Oxidase+Enzymes+Present+in+Mouse+Gives+Insight+into+Their+Substrate+Specificities&doi=10.1371%2Fjournal.pone.0191819"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0191819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0191819%26sid%3Dliteratum%253Aachs%26aulast%3DKucukgoze%26aufirst%3DG.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DDirect%2520Comparison%2520of%2520the%2520Four%2520Aldehyde%2520Oxidase%2520Enzymes%2520Present%2520in%2520Mouse%2520Gives%2520Insight%2520into%2520Their%2520Substrate%2520Specificities%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26issue%3D1%26doi%3D10.1371%2Fjournal.pone.0191819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotake, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effects of Drugs on the Metabolic Activity of Mouse and Human Aldehyde Oxidases and Influence on Drug-Drug Interactions</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2018.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29678521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFWjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=28-38&author=N.+Takaokaauthor=S.+Sanohauthor=K.+Okudaauthor=Y.+Kotakeauthor=G.+Sugaharaauthor=A.+Yanagiauthor=Y.+Ishidaauthor=C.+Tatenoauthor=Y.+Tayamaauthor=K.+Sugiharaauthor=S.+Kitamuraauthor=M.+Kurosakiauthor=M.+Teraoauthor=E.+Garattiniauthor=S.+Ohta&title=Inhibitory+Effects+of+Drugs+on+the+Metabolic+Activity+of+Mouse+and+Human+Aldehyde+Oxidases+and+Influence+on+Drug-Drug+Interactions&doi=10.1016%2Fj.bcp.2018.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions</span></div><div class="casAuthors">Takaoka, Naoki; Sanoh, Seigo; Okuda, Katsuhiro; Kotake, Yaichiro; Sugahara, Go; Yanagi, Ami; Ishida, Yuji; Tateno, Chise; Tayama, Yoshitaka; Sugihara, Kazumi; Kitamura, Shigeyuki; Kurosaki, Mami; Terao, Mineko; Garattini, Enrico; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28-38</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As aldehyde oxidase (AOX) plays an emerging role in drug metab., understanding its significance for drug-drug interactions (DDI) is important.  Therefore, we tested 10 compds. for species-specific and substrate-dependent differences in the inhibitory effect of AOX activity using genetically engineered HEK293 cells over-expressing human AOX1, mouse AOX1 or mouse AOX3.  The IC50 values of 10 potential inhibitors of the three AOX enzymes were detd. using phthalazine and O6-benzylguanine as substrates. 17β-Estradiol, menadione, norharmane and raloxifene exhibited marked differences in inhibitory effects between the human and mouse AOX isoforms when the phthalazine substrate was used.  Some of the compds. tested exhibited substrate-dependent differences in their inhibitory effects.  Docking simulations with human AOX1 and mouse AOX3 were conducted for six representative inhibitors.  The rank order of the min. binding energy reflected the order of the corresponding IC50 values.  We also evaluated the potential DDI between an AOX substrate (O6-benzylguanine) and an inhibitor (hydralazine) using chimeric mice with humanized livers.  Pretreatment of hydralazine increased the max. plasma concn. (Cmax) and the area under the plasma concn.-time curve (AUC0-24) of O6-benzylguanine compared to single administration.  Our in vitro data indicate species-specific and substrate-dependent differences in the inhibitory effects on AOX activity.  Our in vivo data demonstrate the existence of a DDI which may be of relevance in the clin. context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsgVzzBcETA7Vg90H21EOLACvtfcHk0lgrk3-Y9h2ZWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFWjsr0%253D&md5=5af239255a886296d31fded9ee1c10c3</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DTakaoka%26aufirst%3DN.%26aulast%3DSanoh%26aufirst%3DS.%26aulast%3DOkuda%26aufirst%3DK.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DSugahara%26aufirst%3DG.%26aulast%3DYanagi%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DY.%26aulast%3DTateno%26aufirst%3DC.%26aulast%3DTayama%26aufirst%3DY.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DInhibitory%2520Effects%2520of%2520Drugs%2520on%2520the%2520Metabolic%2520Activity%2520of%2520Mouse%2520and%2520Human%2520Aldehyde%2520Oxidases%2520and%2520Influence%2520on%2520Drug-Drug%2520Interactions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D154%26spage%3D28%26epage%3D38%26doi%3D10.1016%2Fj.bcp.2018.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">al-Tayib, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span> <span> </span><span class="NLM_article-title">Species Variation in Hepatic Aldehyde Oxidase Activity</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1007/BF03189919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2FBF03189919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3130251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVaksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1987&pages=307-310&issue=4&author=C.+Beedhamauthor=S.+E.+Bruceauthor=D.+J.+Critchleyauthor=Y.+al-Tayibauthor=D.+J.+Rance&title=Species+Variation+in+Hepatic+Aldehyde+Oxidase+Activity&doi=10.1007%2FBF03189919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Species variation in hepatic aldehyde oxidase activity</span></div><div class="casAuthors">Beedham, C.; Bruce, S. E.; Critchley, D. J.; Al-Tayib, Y.; Rance, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-10</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0398-7639</span>.
    </div><div class="casAbstract">The activity of hepatic aldehyde oxidase from rabbit, guinea pig, rat, marmoset, dog, baboon, and man was investigated in vitro with charged and uncharged N-heterocyclic substrates: Km and Vmax values were detd. for phthalazine, carbazeran, quinine, and quinidine.  The oxidn. of N-phenylquinolinium chloride to N-phenyl-2-quinolone and N-phenyl-4-quinolone was followed spectrophotometrically.  Rat or dog liver showed low and negligible enzyme activity, resp., whereas baboon liver contained a highly active aldehyde oxidase.  Enzyme from marmoset and guinea pig liver had the closest spectrum of activity to human liver aldehyde oxidase.  Unlike that from man, rabbit hepatic aldehyde oxidase was refractory toward carbazeran and converted N-phenylquinolinium chloride predominantly to the 2-quinolone.  N-Phenyl-4-quinolone was the major oxidn. product with enzyme from guinea pig, marmoset, baboon, and man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeSk-deE5ie7Vg90H21EOLACvtfcHk0lhjOg-zU7imRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVaksro%253D&md5=8f146a62d4462dfeb5daa121c4d5baab</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1007%2FBF03189919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03189919%26sid%3Dliteratum%253Aachs%26aulast%3DBeedham%26aufirst%3DC.%26aulast%3DBruce%26aufirst%3DS.%2BE.%26aulast%3DCritchley%26aufirst%3DD.%2BJ.%26aulast%3Dal-Tayib%26aufirst%3DY.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26atitle%3DSpecies%2520Variation%2520in%2520Hepatic%2520Aldehyde%2520Oxidase%2520Activity%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1987%26volume%3D12%26issue%3D4%26spage%3D307%26epage%3D310%26doi%3D10.1007%2FBF03189919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Molybdenum Hydroxylases: Biological Distribution and Substrate-Inhibitor Specificity</span>. <i>Prog. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1016/S0079-6468(08)70420-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2FS0079-6468%2808%2970420-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3332920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL1cXhtVyms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1987&pages=85-127&author=C.+Beedham&title=Molybdenum+Hydroxylases%3A+Biological+Distribution+and+Substrate-Inhibitor+Specificity&doi=10.1016%2FS0079-6468%2808%2970420-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Molybdenum hydroxylases:  biological distribution and substrate-inhibitor specificity</span></div><div class="casAuthors">Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-127</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    </div><div class="casAbstract">A review with 240 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_OHtxc9-yZLVg90H21EOLACvtfcHk0lhjOg-zU7imRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtVyms7w%253D&md5=6097afb5ac4830cffe9380e142816921</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970420-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970420-X%26sid%3Dliteratum%253Aachs%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DMolybdenum%2520Hydroxylases%253A%2520Biological%2520Distribution%2520and%2520Substrate-Inhibitor%2520Specificity%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D1987%26volume%3D24%26spage%3D85%26epage%3D127%26doi%3D10.1016%2FS0079-6468%2808%2970420-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyson, C. A.</span></span> <span> </span><span class="NLM_article-title">Variation of Hepatic Methotrexate 7-Hydroxylase Activity in Animals and Humans</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">611</span>, <span class="refDoi"> DOI: 10.1080/713803569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F713803569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10683765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1Wntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=607-611&author=S.+Kitamuraauthor=K.+Sugiharaauthor=K.+Nakataniauthor=S.+Ohtaauthor=T.+Ohharaauthor=S.+Ninomiyaauthor=C.+E.+Greenauthor=C.+A.+Tyson&title=Variation+of+Hepatic+Methotrexate+7-Hydroxylase+Activity+in+Animals+and+Humans&doi=10.1080%2F713803569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans</span></div><div class="casAuthors">Kitamura, Shigeyuki; Sugihara, Kazumi; Nakatani, Keiko; Ohta, Shigeru; Oh-hara, Toshinari; Ninomiya, Shin-ichi; Green, Carol E.; Tyson, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">607-611</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis</span>)
        </div><div class="casAbstract">This study deals with individual and species variations in the converting activity of methotrexate (MTX) to 7-hydroxymethotrexate in animals and humans.  When MTX 7-hydroxylase was assayed in six human liver cytosols, a 48-fold range of inter-subject variation of the activity was obsd.  The variations were correlated to the concns. of aldehyde oxidase activity in human subjects assayed with benzaldehyde as a substrate.  Species differences of liver MTX 7-hydroxylase activity were also obsd.  The activity was highest in rabbits, followed by rats, hamsters, and monkeys but was undetectable in dogs.  Strain differences of MTX 7-hydroxylase activity based on aldehyde oxidase activity were also obsd. in rats and mice.  The results suggest that aldehyde oxidase functions as MTX 7-hydroxylase in livers of animals and humans, and the obsd. differences of MTX 7-hydroxylase activity are due to variations in the amt. of aldehyde oxidase present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5SW80Ec5an7Vg90H21EOLACvtfcHk0lhjOg-zU7imRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1Wntw%253D%253D&md5=ed6aa79830882ac56611902083edeb09</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1080%2F713803569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F713803569%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DNakatani%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DOhhara%26aufirst%3DT.%26aulast%3DNinomiya%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DC.%2BE.%26aulast%3DTyson%26aufirst%3DC.%2BA.%26atitle%3DVariation%2520of%2520Hepatic%2520Methotrexate%25207-Hydroxylase%2520Activity%2520in%2520Animals%2520and%2520Humans%26jtitle%3DIUBMB%2520Life%26date%3D1999%26volume%3D48%26spage%3D607%26epage%3D611%26doi%3D10.1080%2F713803569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span> <span> </span><span class="NLM_article-title">Interspecies Variation in the Metabolism of Zoniporide by Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.3109/00498254.2012.727499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2012.727499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23046389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVOqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=399-408&issue=5&author=D.+Dalvieauthor=C.+Xiangauthor=P.+Kangauthor=S.+Zhou&title=Interspecies+Variation+in+the+Metabolism+of+Zoniporide+by+Aldehyde+Oxidase&doi=10.3109%2F00498254.2012.727499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Interspecies variation in the metabolism of zoniporide by aldehyde oxidase</span></div><div class="casAuthors">Dalvie, Deepak; Xiang, Cathie; Kang, Ping; Zhou, Sue</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-408</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">1. Aldehyde oxidase (AO) is a cytosolic enzyme that contributes to the Phase I metab. of xenobiotics in human and preclin. species.  2.Current studies explored in vitro metab. of zoniporide in various animal species and humans using S9 fractions.  The animal species included commonly used pharmacol. and toxicol. models and domestic animals such as the cat, cow or bull, pig and horse.  3. In addn., gender and strain differences in some species were also explored.  4. All animals except the dog and cat converted zoniporide to 2-oxozoniporide (M1).  5. Michael-Menten kinetic studies were conducted in species that turned over zoniporide to M1.6.  Marked differences in KM, Vmax and Clint were obsd. in the oxidn. of zoniporide.7.  Although the KM and Vmax of zoniporide oxidn. in male and female human S9 was similar, some gender difference was obsd. in animals esp., in Vmax.8.  The domestic animals also showed marked species differences in the AO activity and affinity toward zoniporide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnm9ba7EGMubVg90H21EOLACvtfcHk0ljx5VwL9RyKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVOqs70%253D&md5=aa979b370a1489c3570ea7a9510bd7c8</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.3109%2F00498254.2012.727499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2012.727499%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DXiang%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DS.%26atitle%3DInterspecies%2520Variation%2520in%2520the%2520Metabolism%2520of%2520Zoniporide%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2013%26volume%3D43%26issue%3D5%26spage%3D399%26epage%3D408%26doi%3D10.3109%2F00498254.2012.727499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">A Novel in Vitro Allometric Scaling Methodology for Aldehyde Oxidase Substrates to Enable Selection of Appropriate Species for Traditional Allometry</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1080/00498254.2017.1296208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498254.2017.1296208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28281401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFyksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=219-231&issue=3&author=R.+D.+Crouchauthor=J.+M.+Hutzlerauthor=J.+S.+Daniels&title=A+Novel+in+Vitro+Allometric+Scaling+Methodology+for+Aldehyde+Oxidase+Substrates+to+Enable+Selection+of+Appropriate+Species+for+Traditional+Allometry&doi=10.1080%2F00498254.2017.1296208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry</span></div><div class="casAuthors">Crouch, Rachel D.; Hutzler, J. Matthew; Daniels, J. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-231</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. Failure to predict human pharmacokinetics of aldehyde oxidase (AO) substrates using traditional allometry has been attributed to species differences in AO metab.2.  To identify appropriate species for predicting human in vivo clearance by single-species scaling (SSS) or multispecies allometry (MA), we scaled in vitro intrinsic clearance (CLint) of five AO substrates obtained from hepatic S9 of mouse, rat, guinea pig, monkey and minipig to human in vitro CLint.3.  When predicting human in vitro CLint, av. abs. fold-error was ≤2.0 by SSS with monkey, minipig and guinea pig (rat/mouse >3.0) and was <3.0 by most MA species combinations (including rat/mouse combinations).4.  Interspecies variables, including fraction metabolized by AO (Fm,AO) and hepatic extn. ratios (E) were estd. in vitro.  SSS prediction fold-errors correlated with the animal:human ratio of E (r2 = 0.6488), but not Fm,AO (r2 = 0.0051).5.  Using plasma clearance (CLp) from the literature, SSS with monkey was superior to rat or mouse at predicting human CLp of BIBX1382 and zoniporide, consistent with in vitro SSS assessments.6.  Evaluation of in vitro allometry, Fm,AO and E may prove useful to guide selection of suitable species for traditional allometry and prediction of human pharmacokinetics of AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqACaT1Bvbi47Vg90H21EOLACvtfcHk0ljx5VwL9RyKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFyksrs%253D&md5=824ee5fbec02c33e03f72007f16f4b1c</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1080%2F00498254.2017.1296208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2017.1296208%26sid%3Dliteratum%253Aachs%26aulast%3DCrouch%26aufirst%3DR.%2BD.%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DA%2520Novel%2520in%2520Vitro%2520Allometric%2520Scaling%2520Methodology%2520for%2520Aldehyde%2520Oxidase%2520Substrates%2520to%2520Enable%2520Selection%2520of%2520Appropriate%2520Species%2520for%2520Traditional%2520Allometry%26jtitle%3DXenobiotica%26date%3D2018%26volume%3D48%26issue%3D3%26spage%3D219%26epage%3D231%26doi%3D10.1080%2F00498254.2017.1296208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumeier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mages, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzbauer, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groschl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanidis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholmerich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, C.</span></span> <span> </span><span class="NLM_article-title">Small-Interference Rna-Mediated Knock-Down of Aldehyde Oxidase 1 in 3t3-L1 Cells Impairs Adipogenesis and Adiponectin Release</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>582</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2965</span>– <span class="NLM_lpage">2972</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2008.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.febslet.2008.07.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=18671973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpslSmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2008&pages=2965-2972&issue=19&author=J.+Weigertauthor=M.+Neumeierauthor=S.+Bauerauthor=W.+Magesauthor=A.+A.+Schnitzbauerauthor=A.+Obedauthor=B.+Groschlauthor=A.+Hartmannauthor=A.+Schafflerauthor=C.+Aslanidisauthor=J.+Scholmerichauthor=C.+Buechler&title=Small-Interference+Rna-Mediated+Knock-Down+of+Aldehyde+Oxidase+1+in+3t3-L1+Cells+Impairs+Adipogenesis+and+Adiponectin+Release&doi=10.1016%2Fj.febslet.2008.07.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release</span></div><div class="casAuthors">Weigert, Johanna; Neumeier, Markus; Bauer, Sabrina; Mages, Wolfgang; Schnitzbauer, Andreas A.; Obed, Aiman; Groeschl, Benedikt; Hartmann, Arndt; Schaeffler, Andreas; Aslanidis, Charalampos; Schoelmerich, Juergen; Buechler, Christa</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2965-2972</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidase 1 (AOX1) is highly abundant in the liver and oxidizes aldehydes thereby generating reactive oxygen species.  Enzymes involved in detoxification of aldehydes are expressed in adipocytes and alter adipogenesis, therefore the functional role of AOX1 in adipocytes was analyzed.  AOX1 mRNA was higher in visceral compared to s.c. human adipose tissue but AOX1 protein was detected in both fat depots.  AOX1 expression in adipocytes was confirmed by immunohistochem. and immunoblot.  AOX1 was induced during adipocytic differentiation and was downregulated by fenofibrate in differentiated cells.  Knock-down of AOX1 in preadipocytes led to impaired lipid storage and adiponectin release in the differentiated cells.  These data indicate that AOX1 is essential for adipogenesis and may link energy and drug metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEiK9kLbcXf7Vg90H21EOLACvtfcHk0lhfw4im96cAjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpslSmtrg%253D&md5=cb8f9009d488d3869c8dec146f0de4f9</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2008.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2008.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DWeigert%26aufirst%3DJ.%26aulast%3DNeumeier%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DMages%26aufirst%3DW.%26aulast%3DSchnitzbauer%26aufirst%3DA.%2BA.%26aulast%3DObed%26aufirst%3DA.%26aulast%3DGroschl%26aufirst%3DB.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DSchaffler%26aufirst%3DA.%26aulast%3DAslanidis%26aufirst%3DC.%26aulast%3DScholmerich%26aufirst%3DJ.%26aulast%3DBuechler%26aufirst%3DC.%26atitle%3DSmall-Interference%2520Rna-Mediated%2520Knock-Down%2520of%2520Aldehyde%2520Oxidase%25201%2520in%25203t3-L1%2520Cells%2520Impairs%2520Adipogenesis%2520and%2520Adiponectin%2520Release%26jtitle%3DFEBS%2520Lett.%26date%3D2008%26volume%3D582%26issue%3D19%26spage%3D2965%26epage%3D2972%26doi%3D10.1016%2Fj.febslet.2008.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sigruener, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracciano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncalli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornstein, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, G.</span></span> <span> </span><span class="NLM_article-title">Human Aldehyde Oxidase 1 Interacts with Atp-Binding Cassette Transporter-1 and Modulates Its Activity in Hepatocytes</span>. <i>Horm. Metab. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1055/s-2007-992129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1055%2Fs-2007-992129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=17992631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=781-789&issue=11&author=A.+Sigruenerauthor=C.+Buechlerauthor=E.+Orsoauthor=A.+Hartmannauthor=P.+J.+Wildauthor=L.+Terraccianoauthor=M.+Roncalliauthor=S.+R.+Bornsteinauthor=G.+Schmitz&title=Human+Aldehyde+Oxidase+1+Interacts+with+Atp-Binding+Cassette+Transporter-1+and+Modulates+Its+Activity+in+Hepatocytes&doi=10.1055%2Fs-2007-992129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes</span></div><div class="casAuthors">Sigruener, A.; Buechler, C.; Orso, E.; Hartmann, A.; Wild, P. J.; Terracciano, L.; Roncalli, M.; Bornstein, S. R.; Schmitz, G.</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and Metabolic Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">781-789</span>CODEN:
                <span class="NLM_cas:coden">HMMRA2</span>;
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">AOX1, a member of the cytosolic molybdenum hydroxylase family, has been identified by us earlier as an ABCA1-interacting protein.  AOX1 is well-described as xenobiotic metabolizing enzyme, which upon oxidn. of acetaldehyde and retinaldehyde to acetic acid and retinoic acid generates reactive oxygen species.  Here we show that knock-down of AOX1 in HepG2 by small interfering RNA significantly reduced ABCA1-dependent lipid efflux and enhanced phagocytic uptake of microspheres similar to ABCA1 deficiency, without affecting ABCA1 mRNA and protein levels.  ABCA1 and AOX1 are coexpressed in human hepatocytes, kidney proximal tubular epithelial cells, Leydig, and adrenocortical cells.  Expression of ABCA1 and AOX1 was investigated by immunohistochem. in liver tissue arrays.  A strong AOX1 expression was found in normal liver, and in cirrhosis.  In contrast, hepatocellular carcinomas showed either a complete loss or reduced expression of AOX1.  Significant correlations were found between reduced AOX1 expression and tumor stage, or metastatic or regional lymph node states.  Deregulation was also obsd. for ABCA1 expression but to a lesser extent.  Our findings show that the interaction of ABCA1 with AOX1 modulates ABCA1-linked cellular functions such as lipid efflux and phagocytosis in hepatocytes, and the reduced expression of AOX1 in malignant transformed hepatocytes supports the differentiation dependent upregulation of AOX1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHgXRNXB80xbVg90H21EOLACvtfcHk0lhfw4im96cAjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjsQ%253D%253D&md5=d2c7a135c094fd7209517cf5890810a4</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-992129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-992129%26sid%3Dliteratum%253Aachs%26aulast%3DSigruener%26aufirst%3DA.%26aulast%3DBuechler%26aufirst%3DC.%26aulast%3DOrso%26aufirst%3DE.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DWild%26aufirst%3DP.%2BJ.%26aulast%3DTerracciano%26aufirst%3DL.%26aulast%3DRoncalli%26aufirst%3DM.%26aulast%3DBornstein%26aufirst%3DS.%2BR.%26aulast%3DSchmitz%26aufirst%3DG.%26atitle%3DHuman%2520Aldehyde%2520Oxidase%25201%2520Interacts%2520with%2520Atp-Binding%2520Cassette%2520Transporter-1%2520and%2520Modulates%2520Its%2520Activity%2520in%2520Hepatocytes%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D2007%26volume%3D39%26issue%3D11%26spage%3D781%26epage%3D789%26doi%3D10.1055%2Fs-2007-992129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamli, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokharel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, I.</span></span> <span> </span><span class="NLM_article-title">Expressional Studies of the Aldehyde Oxidase (Aox1) Gene During Myogenic Differentiation in C2c12 Cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>450</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1296</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.06.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bbrc.2014.06.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24996175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyjtrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2014&pages=1291-1296&issue=4&author=M.+R.+Kamliauthor=J.+Kimauthor=S.+Pokharelauthor=A.+T.+Janauthor=E.+J.+Leeauthor=I.+Choi&title=Expressional+Studies+of+the+Aldehyde+Oxidase+%28Aox1%29+Gene+During+Myogenic+Differentiation+in+C2c12+Cells&doi=10.1016%2Fj.bbrc.2014.06.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Expressional studies of the aldehyde oxidase (AOX1) gene during myogenic differentiation in C2C12 cells</span></div><div class="casAuthors">Kamli, Majid Rasool; Kim, Jihoe; Pokharel, Smritee; Jan, Arif Tasleem; Lee, Eun Ju; Choi, Inho</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1291-1296</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs), which catalyze the hydroxylation of heterocycles and oxidn. of a wide variety of aldehydic compds., have been present throughout evolution from bacteria to humans.  While humans have only a single functional aldehyde oxidase (AOX1) gene, rodents are endowed with four AOXs; AOX1 and three aldehyde oxidase homologs (AOH1, AOH2 and AOH3).  In continuation of our previous study conducted to identify genes differentially expressed during myogenesis using a microarray approach, we investigated AOX1 with respect to its role in myogenesis to conceptualize how it is regulated in C2C12 cells.  The results obtained were validated by silencing of the AOX1 gene.  Anal. of their fusion index revealed that formation of myotubes showed a marked redn. of up to 40% in AOX1kd cells.  Expression of myogenin (MYOG), one of the marker genes used to study myogenesis, was also found to be reduced in AOX1kd cells.  AOX1 is an enzyme of pharmacol. and toxicol. importance that metabolizes numerous xenobiotics to their resp. carboxylic acids.  Hydrogen peroxide (H2O2) produced as a byproduct in this reaction is considered to be involved as a part of the signaling mechanism during differentiation.  An obsd. redn. in the level of H2O2 among AOX1kd cells confirmed prodn. of H2O2 in the reaction catalyzed by AOX1.  Taken together, these findings suggest that AOX1 acts as a contributor to the process of myogenesis by influencing the level of H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Odmy__Vx7LVg90H21EOLACvtfcHk0lhbQHlxPyEqQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyjtrfF&md5=d63a17f4939240d412043250587a45e4</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.06.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.06.126%26sid%3Dliteratum%253Aachs%26aulast%3DKamli%26aufirst%3DM.%2BR.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DPokharel%26aufirst%3DS.%26aulast%3DJan%26aufirst%3DA.%2BT.%26aulast%3DLee%26aufirst%3DE.%2BJ.%26aulast%3DChoi%26aufirst%3DI.%26atitle%3DExpressional%2520Studies%2520of%2520the%2520Aldehyde%2520Oxidase%2520%2528Aox1%2529%2520Gene%2520During%2520Myogenic%2520Differentiation%2520in%2520C2c12%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D450%26issue%3D4%26spage%3D1291%26epage%3D1296%26doi%3D10.1016%2Fj.bbrc.2014.06.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshita, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, S.</span></span> <span> </span><span class="NLM_article-title">Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Airway Epithelial Barrier Integrity</span>. <i>Allergol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">Suppl</span>),  <span class="NLM_fpage">S54</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.alit.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.alit.2015.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26344081" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=S54-63&issue=Suppl&author=Y.+Shintaniauthor=S.+Maruokaauthor=Y.+Gonauthor=D.+Koyamaauthor=A.+Yoshidaauthor=Y.+Kozuauthor=K.+Kurodaauthor=I.+Takeshitaauthor=E.+Tsuboiauthor=K.+Sodaauthor=S.+Hashimoto&title=Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Nrf2%29+Regulates+Airway+Epithelial+Barrier+Integrity&doi=10.1016%2Fj.alit.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1016%2Fj.alit.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.alit.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DShintani%26aufirst%3DY.%26aulast%3DMaruoka%26aufirst%3DS.%26aulast%3DGon%26aufirst%3DY.%26aulast%3DKoyama%26aufirst%3DD.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DKozu%26aufirst%3DY.%26aulast%3DKuroda%26aufirst%3DK.%26aulast%3DTakeshita%26aufirst%3DI.%26aulast%3DTsuboi%26aufirst%3DE.%26aulast%3DSoda%26aufirst%3DK.%26aulast%3DHashimoto%26aufirst%3DS.%26atitle%3DNuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Nrf2%2529%2520Regulates%2520Airway%2520Epithelial%2520Barrier%2520Integrity%26jtitle%3DAllergol.%2520Int.%26date%3D2015%26volume%3D64%26issue%3DSuppl%26spage%3DS54%26epage%3D63%26doi%3D10.1016%2Fj.alit.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaglia, F.</span></span> <span> </span><span class="NLM_article-title">Molybdenum Cofactor Deficiency</span>. <i>Mol. Genet. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1016/j.ymgme.2015.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.ymgme.2015.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26653176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFeqs7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=1-4&issue=1&author=P.+S.+Atwalauthor=F.+Scaglia&title=Molybdenum+Cofactor+Deficiency&doi=10.1016%2Fj.ymgme.2015.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Molybdenum cofactor deficiency</span></div><div class="casAuthors">Atwal, Paldeep S.; Scaglia, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Molybdenum cofactor deficiency (MoCD) is a severe autosomal recessive inborn error of metab. first described in 1978.  It is characterized by a neonatal presentation of intractable seizures, feeding difficulties, severe developmental delay, microcephaly with brain atrophy and coarse facial features.  MoCD results in deficiency of the molybdenum cofactor dependent enzymes sulfite oxidase, xanthine dehydrogenase, aldehyde oxidase and mitochondrial amidoxime reducing component.  The resultant accumulation of sulfite, taurine, S-sulfocysteine and thiosulfate contributes to the severe neurol. impairment.  Recently, initial evidence has demonstrated early treatment with cyclic PMP can turn MoCD type A from a previously neonatal lethal condition with only palliative options, to near normal neurol. outcomes in affected patients.  We review MoCD and focus on describing the currently published evidence of this exciting new therapeutic option for MoCD type A caused by pathogenic variants in MOCD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdWcfzQ6LNNbVg90H21EOLACvtfcHk0lhbQHlxPyEqQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFeqs7bJ&md5=57fbdc22e31d5676979094968caea933</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2015.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2015.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DP.%2BS.%26aulast%3DScaglia%26aufirst%3DF.%26atitle%3DMolybdenum%2520Cofactor%2520Deficiency%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2016%26volume%3D117%26issue%3D1%26spage%3D1%26epage%3D4%26doi%3D10.1016%2Fj.ymgme.2015.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokouchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, Y.</span></span> <span> </span><span class="NLM_article-title">Alleviation of Fatty Liver in a Rat Model by Enhancing N(1)-Methylnicotinamide Bioavailability through Aldehyde Oxidase Inhibition</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>507</i></span> (<span class="NLM_issue">1−4</span>),  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bbrc.2018.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30446221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyhtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2018&pages=203-210&issue=1%E2%88%924&author=K.+Takeuchiauthor=C.+Yokouchiauthor=H.+Gotoauthor=K.+Umeharaauthor=H.+Yamadaauthor=Y.+Ishii&title=Alleviation+of+Fatty+Liver+in+a+Rat+Model+by+Enhancing+N%281%29-Methylnicotinamide+Bioavailability+through+Aldehyde+Oxidase+Inhibition&doi=10.1016%2Fj.bbrc.2018.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Alleviation of fatty liver in a rat model by enhancing N1-methylnicotinamide bioavailability through aldehyde oxidase inhibition</span></div><div class="casAuthors">Takeuchi, Kenji; Yokouchi, Chie; Goto, Hirohiko; Umehara, Ken; Yamada, Hideyuki; Ishii, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">203-210</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nonalcoholic fatty liver disease (NAFLD) has increased worldwide in recent years.  NAFLD is classified into two types, nonalcoholic fatty liver (NAFL), with few complications, and nonalcoholic steatohepatitis (NASH), which leads to liver cirrhosis or cancer.  This study was based on previous reports that N1-methylnicotinamide (MNA) can stabilize sirtuin 1 protein, leading to decreased lipid levels in the liver.  We hypothesised that fatty liver improvement by MNA would be further enhanced by suppressing its rapid metab. by aldehyde oxidase in the liver.  To test this, hydralazine (HYD), a potent aldehyde oxidase inhibitor, was administered orally to NAFL model rats.  Liver triglyceride (TG) levels in the model were nearly unchanged by administration of MNA alone.  In contrast, TG levels were marked decreased in NAFL rats treated with a combination of MNA and HYD.  In addn., TG levels were decreased even in NAFL rats treated with only HYD.  These findings supported our hypothesis that maintaining MNA concns. in the liver, by suppressing MNA metab., would at least partially ameliorate fatty liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozCz2rGNA8YbVg90H21EOLACvtfcHk0liRXPS-e5XvPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyhtb3I&md5=318b9ce0e7a7f8c2d6f665c7084e97c5</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DYokouchi%26aufirst%3DC.%26aulast%3DGoto%26aufirst%3DH.%26aulast%3DUmehara%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DY.%26atitle%3DAlleviation%2520of%2520Fatty%2520Liver%2520in%2520a%2520Rat%2520Model%2520by%2520Enhancing%2520N%25281%2529-Methylnicotinamide%2520Bioavailability%2520through%2520Aldehyde%2520Oxidase%2520Inhibition%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D507%26issue%3D1%25E2%2588%25924%26spage%3D203%26epage%3D210%26doi%3D10.1016%2Fj.bbrc.2018.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marathe, P. H.</span></span> <span> </span><span class="NLM_article-title">Challenges and Opportunities with Non-Cyp Enzymes Aldehyde Oxidase, Carboxylesterase, and Udp-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1391</span>– <span class="NLM_lpage">1405</span>, <span class="refDoi"> DOI: 10.1208/s12248-016-9962-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1208%2Fs12248-016-9962-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27495117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCrt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=1391-1405&issue=6&author=U.+A.+Argikarauthor=P.+M.+Potterauthor=J.+M.+Hutzlerauthor=P.+H.+Marathe&title=Challenges+and+Opportunities+with+Non-Cyp+Enzymes+Aldehyde+Oxidase%2C+Carboxylesterase%2C+and+Udp-Glucuronosyltransferase%3A+Focus+on+Reaction+Phenotyping+and+Prediction+of+Human+Clearance&doi=10.1208%2Fs12248-016-9962-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance</span></div><div class="casAuthors">Argikar, Upendra A.; Potter, Philip M.; Hutzler, J. Matthew; Marathe, Punit H.</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1391-1405</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Over the years, significant progress has been made in reducing metabolic instability due to cytochrome P 450-mediated oxidn.  High-throughput metabolic stability screening has enabled the advancement of compds. with little to no oxidative metab.  Furthermore, high lipophilicity and low aq. soly. of presently pursued chemotypes reduces the probability of renal excretion.  As such, these low microsomal turnover compds. are often substrates for non-CYP-mediated metab.  UGTs, esterases, and aldehyde oxidase are major enzymes involved in catalyzing such metab.  Hepatocytes provide an excellent tool to identify such pathways including elucidation of major metabolites.  To predict human PK parameters for P 450-mediated metab., in vitro-in vivo extrapolation using hepatic microsomes, hepatocytes, and intestinal microsomes has been actively investigated.  However, such methods have not been sufficiently evaluated for non-P 450 enzymes.  In addn. to the involvement of the liver, extrahepatic enzymes (intestine, kidney, lung) are also likely to contribute to these pathways.  While there has been considerable progress in predicting metabolic pathways and clearance primarily mediated by the liver, progress in characterizing extrahepatic metab. and prediction of clearance has been slow.  Well-characterized in vitro systems or in vivo animal models to assess drug-drug interaction potential and intersubject variability due to polymorphism are not available.  Here we focus on the utility of appropriate in vitro studies to characterize non-CYP-mediated metab. and to understand the enzymes involved followed by pharmacokinetic studies in the appropriately characterized surrogate species.  The review will highlight progress made in establishing in vitro-in vivo correlation, predicting human clearance and avoiding costly clin. failures when non-CYP-mediated metabolic pathways are predominant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwZGibSne69rVg90H21EOLACvtfcHk0liRXPS-e5XvPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCrt77P&md5=968b8545e96e4a7aaed240d8efa71eae</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1208%2Fs12248-016-9962-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-016-9962-6%26sid%3Dliteratum%253Aachs%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DPotter%26aufirst%3DP.%2BM.%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26atitle%3DChallenges%2520and%2520Opportunities%2520with%2520Non-Cyp%2520Enzymes%2520Aldehyde%2520Oxidase%252C%2520Carboxylesterase%252C%2520and%2520Udp-Glucuronosyltransferase%253A%2520Focus%2520on%2520Reaction%2520Phenotyping%2520and%2520Prediction%2520of%2520Human%2520Clearance%26jtitle%3DAAPS%2520J.%26date%3D2016%26volume%3D18%26issue%3D6%26spage%3D1391%26epage%3D1405%26doi%3D10.1208%2Fs12248-016-9962-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santomango, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Ponce, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corlew, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">The Role of Aldehyde Oxidase and Xanthine Oxidase in the Biotransformation of a Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1834</span>– <span class="NLM_lpage">1845</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.046136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.046136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22711749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1834-1845&issue=9&author=R.+D.+Morrisonauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=T.+S.+Santomangoauthor=T.+M.+Bridgesauthor=D.+Stecauthor=K.+A.+Brewerauthor=R.+Sanchez-Ponceauthor=M.+M.+Corlewauthor=R.+Rushauthor=A.+S.+Feltsauthor=J.+Mankaauthor=B.+S.+Batesauthor=D.+F.+Venableauthor=A.+L.+Rodriguezauthor=C.+K.+Jonesauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=J.+S.+Daniels&title=The+Role+of+Aldehyde+Oxidase+and+Xanthine+Oxidase+in+the+Biotransformation+of+a+Novel+Negative+Allosteric+Modulator+of+Metabotropic+Glutamate+Receptor+Subtype+5&doi=10.1124%2Fdmd.112.046136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5</span></div><div class="casAuthors">Morrison, Ryan D.; Blobaum, Anna L.; Byers, Frank W.; Santomango, Tammy S.; Bridges, Thomas M.; Stec, Donald; Brewer, Katrina A.; Sanchez-Ponce, Raymundo; Corlew, Melany M.; Rush, Roger; Felts, Andrew S.; Manka, Jason; Bates, Brittney S.; Venable, Daryl F.; Rodriguez, Alice L.; Jones, Carrie K.; Niswender, Colleen M.; Conn, P. Jeffrey; Lindsley, Craig W.; Emmitte, Kyle A.; Daniels, J. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1834-1845</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neg. allosteric modulation (NAM) of metabotropic glutamate receptor subtype 5 (mGlu5) represents a therapeutic strategy for the treatment of childhood developmental disorders, such as fragile X syndrome and autism.  VU0409106 emerged as a lead compd. within a biaryl ether series, displaying potent and selective inhibition of mGlu5.  Despite its high clearance and short half-life, VU0409106 demonstrated efficacy in rodent models of anxiety after extravascular administration.  However, lack of a consistent correlation in rat between in vitro hepatic clearance and in vivo plasma clearance for the biaryl ether series prompted an investigation into the biotransformation of VU0409106 using hepatic subcellular fractions.  An in vitro appraisal in rat, monkey, and human liver S9 fractions indicated that the principal pathway was NADPH-independent oxidn. to metabolite M1 (+16 Da).  Both raloxifene (aldehyde oxidase inhibitor) and allopurinol (xanthine oxidase inhibitor) attenuated the formation of M1, thus implicating the contribution of both molybdenum hydroxylases in the biotransformation of VU0409106.  The use of 18O-labeled water in the S9 expts. confirmed the hydroxylase mechanism proposed, because 18O was incorporated into M1 (+18 Da) as well as in a secondary metabolite (M2; +36 Da), the formation of which was exclusively xanthine oxidase-mediated.  This unusual dual and sequential hydroxylase metab. was confirmed in liver S9 and hepatocytes of multiple species and correlated with in vivo data because M1 and M2 were the principal metabolites detected in rats administered VU0409106.  An in vitro-in vivo correlation of predicted hepatic and plasma clearance was subsequently established for VU0409106 in rats and nonhuman primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCTcWSe8Xod7Vg90H21EOLACvtfcHk0liRXPS-e5XvPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShtbfK&md5=6a1840588e53a456fc2f188f349bb730</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046136%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DSantomango%26aufirst%3DT.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DStec%26aufirst%3DD.%26aulast%3DBrewer%26aufirst%3DK.%2BA.%26aulast%3DSanchez-Ponce%26aufirst%3DR.%26aulast%3DCorlew%26aufirst%3DM.%2BM.%26aulast%3DRush%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DManka%26aufirst%3DJ.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520Role%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidase%2520in%2520the%2520Biotransformation%2520of%2520a%2520Novel%2520Negative%2520Allosteric%2520Modulator%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D9%26spage%3D1834%26epage%3D1845%26doi%3D10.1124%2Fdmd.112.046136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weidert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenborn, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantu-Medellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choughule, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, E. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Xanthine Oxidase by the Aldehyde Oxidase Inhibitor Raloxifene: Implications for Identifying Molybdopterin Nitrite Reductases</span>. <i>Nitric Oxide</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.niox.2013.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.niox.2013.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24406683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVOiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=41-45&author=E.+R.+Weidertauthor=S.+O.+Schoenbornauthor=N.+Cantu-Medellinauthor=K.+V.+Choughuleauthor=J.+P.+Jonesauthor=E.+E.+Kelley&title=Inhibition+of+Xanthine+Oxidase+by+the+Aldehyde+Oxidase+Inhibitor+Raloxifene%3A+Implications+for+Identifying+Molybdopterin+Nitrite+Reductases&doi=10.1016%2Fj.niox.2013.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: Implications for identifying molybdopterin nitrite reductases</span></div><div class="casAuthors">Weidert, E. R.; Schoenborn, S. O.; Cantu-Medellin, N.; Choughule, K. V.; Jones, J. P.; Kelley, E. E.</div><div class="citationInfo"><span class="NLM_cas:title">Nitric Oxide</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41-45</span>CODEN:
                <span class="NLM_cas:coden">NIOXF5</span>;
        ISSN:<span class="NLM_cas:issn">1089-8603</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sources of nitric oxide alternative to nitric oxide synthases are gaining significant traction as crucial mediators of vessel function under hypoxic inflammatory conditions.  For example, capacity to catalyze the one electron redn. of nitrite (NO-2) to ·NO has been reported for Hb, myoglobin and molybdopterin-contg. enzymes including xanthine oxidoreductase (XOR) and aldehyde oxidase (AO).  For XOR and AO, use of selective inhibition strategies is therefore crucial when attempting to assign relative contributions to nitrite-mediated ·NO formation in cells and tissue.  To this end, XOR inhibition has been accomplished with application of classic pyrazolopyrimidine-based inhibitors allo/oxypurinol or the newly FDA-approved XOR-specific inhibitor, Uloric (febuxostat).  Likewise, raloxifene, an estrogen receptor antagonist, has been identified as a potent (Ki = 1.0 nM) inhibitor of AO.  Herein, we characterize the inhibition kinetics of raloxifene for XOR and describe the resultant effects on inhibiting XO-catalyzed ·NO formation.  Exposure of purified XO to raloxifene (PBS, pH 7.4) resulted in a dose-dependent (12.5-100 μM) inhibition of xanthine oxidn. to uric acid.  Dixon plot anal. revealed a competitive inhibition process with a Ki = 13 μM.  This inhibitory process was more effective under acidic pH; similar to values encountered under hypoxic/inflammatory conditions.  In addn., raloxifene also inhibited anoxic XO-catalyzed redn. of NO-2 to NO (EC50 = 64 μM).  In contrast to having no effect on XO-catalyzed uric acid prodn., the AO inhibitor menadione demonstrated potent inhibition of XO-catalyzed NO-2 redn. (EC50 = 60 nM); somewhat similar to the XO-specific inhibitor, febuxostat (EC50 = 4 nM).  Importantly, febuxostat was found to be a very poor inhibitor of human AO (EC50 = 613 μM) suggesting its usefulness for validating XO-dependent contributions to NO-2 redn. in biol. systems.  Combined, these data indicate care should be taken when choosing inhibition strategies as well as inhibitor concns. when assigning relative NO-2 reductase activity of AO and XOR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqicWXInWyd6rVg90H21EOLACvtfcHk0lgW-DzbWS3aEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVOiurw%253D&md5=a118eb46dba38456b25aaca3da192d01</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2013.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2013.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DWeidert%26aufirst%3DE.%2BR.%26aulast%3DSchoenborn%26aufirst%3DS.%2BO.%26aulast%3DCantu-Medellin%26aufirst%3DN.%26aulast%3DChoughule%26aufirst%3DK.%2BV.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DKelley%26aufirst%3DE.%2BE.%26atitle%3DInhibition%2520of%2520Xanthine%2520Oxidase%2520by%2520the%2520Aldehyde%2520Oxidase%2520Inhibitor%2520Raloxifene%253A%2520Implications%2520for%2520Identifying%2520Molybdopterin%2520Nitrite%2520Reductases%26jtitle%3DNitric%2520Oxide%26date%3D2014%26volume%3D37%26spage%3D41%26epage%3D45%26doi%3D10.1016%2Fj.niox.2013.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paragas, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Ecoao: A Simple System for the Study of Human Aldehyde Oxidases Role in Drug Metabolism</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4820</span>– <span class="NLM_lpage">4827</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b01054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b01054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKisb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=4820-4827&issue=8&author=E.+M.+Paragasauthor=S.+C.+Humphreysauthor=J.+Minauthor=C.+A.+Joswig-Jonesauthor=S.+Leimkuhlerauthor=J.+P.+Jones&title=Ecoao%3A+A+Simple+System+for+the+Study+of+Human+Aldehyde+Oxidases+Role+in+Drug+Metabolism&doi=10.1021%2Facsomega.7b01054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">ecoAO: A Simple System for the Study of Human Aldehyde Oxidases Role in Drug Metabolism</span></div><div class="casAuthors">Paragas, Erickson M.; Humphreys, Sara C.; Min, Joshua; Joswig-Jones, Carolyn A.; Leimkuhler, Silke; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4820-4827</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">AO metabolite stds. are often difficult to synthesize due to the chemo- and regio-selectivity of the enzyme, precluding metabolic studies.  Furthermore, human aldehyde oxidase (AO) is recalcitrant to study because established in vitro AO systems such as liver cytosol, S9 fractions, and primary hepatocytes, lack specificity and/or display variability in their AO expression and activity profiles.  Here, the authors describe a practical E. coli-based system---ecoAO---that addresses these issues simultaneously. ecoAO is a cell paste of Moco-producing E. coli strain TP1017 expressing human AO. ecoAO exhibits specific AO activity with the known substrates zoniporide, DACA, O6-benzylguanine, and zaleplon as well as 3-aminoquinoline, simplifying detn. of metabolic parameters such as Km and kcat/Km.  Furthermore, it has utility as a biocatalyst, yielding mg quantities of AO metabolites of each of these substrates.  Accordingly, ecoAO promises to provide easy access to metabolites with the potential to improve pharmacokinetic clearance predictions and guide drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQNFZ-z437XrVg90H21EOLACvtfcHk0lgW-DzbWS3aEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKisb%252FJ&md5=37ba9d707d4ff3842362858a5b1016d5</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b01054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b01054%26sid%3Dliteratum%253Aachs%26aulast%3DParagas%26aufirst%3DE.%2BM.%26aulast%3DHumphreys%26aufirst%3DS.%2BC.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DEcoao%253A%2520A%2520Simple%2520System%2520for%2520the%2520Study%2520of%2520Human%2520Aldehyde%2520Oxidases%2520Role%2520in%2520Drug%2520Metabolism%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26issue%3D8%26spage%3D4820%26epage%3D4827%26doi%3D10.1021%2Facsomega.7b01054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide Polymorphisms</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.068395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.115.068395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26842593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1277-1285&issue=8&author=A.+Fotiauthor=T.+Hartmannauthor=C.+Coelhoauthor=T.+Santos-Silvaauthor=M.+J.+Romaoauthor=S.+Leimkuhler&title=Optimization+of+the+Expression+of+Human+Aldehyde+Oxidase+for+Investigations+of+Single-Nucleotide+Polymorphisms&doi=10.1124%2Fdmd.115.068395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the expression of human aldehyde oxidase for investigations of single-nucleotide polymorphisms</span></div><div class="casAuthors">Foti, Alessandro; Hartmann, Tobias; Coelho, Catarina; Santos-Silva, Teresa; Romao, Maria Joao; Leimkuehler, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1277-1285</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX1) is an enzyme with broad substrate specificity, catalyzing the oxidn. of a wide range of endogenous and exogenous aldehydes as well as N-heterocyclic arom. compds.  In humans, the enzyme's role in phase I drug metab. has been established and its importance is now emerging.  However, the true physiol. function of AOX1 in mammals is still unknown.  Further, numerous single-nucleotide polymorphisms (SNPs) have been identified in human AOX1.  SNPs are a major source of interindividual variability in the human population, and SNP-based amino acid exchanges in AOX1 reportedly modulate the catalytic function of the enzyme in either a pos. or neg. fashion.  For the reliable anal. of the effect of amino acid exchanges in human proteins, the existence of reproducible expression systems for the prodn. of active protein in ample amts. for kinetic, spectroscopic, and crystallog. studies is required.  In our study we report an optimized expression system for hAOX1 in Escherichia coli using a codon-optimized construct.  The codon-optimization resulted in an up to 15-fold increase of protein prodn. and a simplified purifn. procedure.  The optimized expression system was used to study three SNPs that result in amino acid changes C44W, G1269R, and S1271L.  In addn., the crystal structure of the S1271L SNP was solved.  We demonstrate that the recombinant enzyme can be used for future studies to exploit the role of AOX in drug metab., and for the identification and synthesis of new drugs targeting AOX when combined with crystallog. and modeling studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO20NfuioFBLVg90H21EOLACvtfcHk0ljnNsC2pR8Zew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurrO&md5=3e33e7bf0cf356549e3b47cbf91e9b00</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.068395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.068395%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DOptimization%2520of%2520the%2520Expression%2520of%2520Human%2520Aldehyde%2520Oxidase%2520for%2520Investigations%2520of%2520Single-Nucleotide%2520Polymorphisms%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1277%26epage%3D1285%26doi%3D10.1124%2Fdmd.115.068395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saburulla, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Carbazeran 4-Oxidation and O (6)-Benzylguanine 8-Oxidation as Catalytic Markers of Human Aldehyde Oxidase: Impact of Cytosolic Contamination of Liver Microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.082099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.118.082099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30337443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVGisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=26-37&issue=1&author=J.+Xieauthor=N.+F.+Saburullaauthor=S.+Chenauthor=S.+Y.+Wongauthor=Z.+P.+Yapauthor=L.+H.+Zhangauthor=A.+J.+Lau&title=Evaluation+of+Carbazeran+4-Oxidation+and+O+%286%29-Benzylguanine+8-Oxidation+as+Catalytic+Markers+of+Human+Aldehyde+Oxidase%3A+Impact+of+Cytosolic+Contamination+of+Liver+Microsomes&doi=10.1124%2Fdmd.118.082099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of carbazeran 4-oxidation and O6-benzylguanine 8-oxidation as catalytic markers of human aldehyde oxidase: impact of cytosolic contamination of liver microsomes</span></div><div class="casAuthors">Xie, Jiarong; Saburulla, Nur Fazilah; Chen, Shiyan; Wong, Siew Ying; Yap, Ze Ping; Zhang, Linghua Harris; Lau, Aik Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-37</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study investigated the contribution of microsomal cytochrome P 450 and cytosolic aldehyde oxidase-1 (AOX-1) to carbazeran 4-oxidn. and O6-benzylguanine 8-oxidn. in human liver microsomal, cytosolic, and S9 fractions.  Incubations contg. carbazeran and human liver microsomes with or without exogenously added NADPH yielded comparable levels of 4-oxo-carbazeran.  O6-Benzylguanine 8-oxidn. occurred in microsomal incubations, and the extent was increased by NADPH.  Human recombinant CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 did not catalyze carbazeran 4-oxidn., whereas CYP1A2 was highly active in O6-benzylguanine 8-oxidn. 1-Aminobenzotriazole, a pan-cytochrome P 450 inhibitor, decreased O6-benzylguanine 8-oxidn., but not carbazeran 4-oxidn., in microsomal incubations, whereas 1-aminobenzotriazole and furafylline (a CYP1A2-selective inhibitor) did not inhibit carbazeran 4-oxidn. or O6-benzylguanine 8-oxidn. in human liver S9 fraction.  Carbazeran 4-oxidn. in incubations contg. human liver microsomes (from multiple donors and com. suppliers) was attributed to microsomal prepns. contaminated with AOX-1, as suggested by liver microsomal expts. indicating a decrease in carbazeran 4-oxidn. by an AOX-1 inhibitor (hydralazine), and to detection of AOX-1 protein (at one-third the level of that in liver cytosol).  Cytosolic contamination of liver microsomes was further demonstrated by the formation of dehydroepiandrosterone sulfate (catalyzed by cytosolic sulfotransferases) in liver microsomal incubations contg. dehydroepiandrosterone.  In conclusion, carbazeran 4-oxidn. and O6-benzylguanine 8-oxidn. are enzyme-selective catalytic markers of human AOX-1, as shown in human liver S9 fraction expressing cytochrome P 450 and AOX-1.  This study highlights the neg. impact of cytosolic contamination of liver microsomes on the interpretation of reaction phenotyping data collected in an in vitro study performed in microsomal fractions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruul-70K9zeLVg90H21EOLACvtfcHk0ljnNsC2pR8Zew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVGisrc%253D&md5=a6936ce3e69422b1181c7e098bb36260</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.082099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.082099%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DSaburulla%26aufirst%3DN.%2BF.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DS.%2BY.%26aulast%3DYap%26aufirst%3DZ.%2BP.%26aulast%3DZhang%26aufirst%3DL.%2BH.%26aulast%3DLau%26aufirst%3DA.%2BJ.%26atitle%3DEvaluation%2520of%2520Carbazeran%25204-Oxidation%2520and%2520O%2520%25286%2529-Benzylguanine%25208-Oxidation%2520as%2520Catalytic%2520Markers%2520of%2520Human%2520Aldehyde%2520Oxidase%253A%2520Impact%2520of%2520Cytosolic%2520Contamination%2520of%2520Liver%2520Microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2019%26volume%3D47%26issue%3D1%26spage%3D26%26epage%3D37%26doi%3D10.1124%2Fdmd.118.082099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Human Carboxylesterases: A Comprehensive Review</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.apsb.2018.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30245959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=699-712&issue=5&author=D.+Wangauthor=L.+Zouauthor=Q.+Jinauthor=J.+Houauthor=G.+Geauthor=L.+Yang&title=Human+Carboxylesterases%3A+A+Comprehensive+Review&doi=10.1016%2Fj.apsb.2018.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Human carboxylesterases: a comprehensive review</span></div><div class="casAuthors">Wang Dandan; Zou Liwei; Jin Qiang; Ge Guangbo; Yang Ling; Hou Jie</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">699-712</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Mammalian carboxylesterases (CEs) are key enzymes from the serine hydrolase superfamily.  In the human body, two predominant carboxylesterases (CES1 and CES2) have been identified and extensively studied over the past decade.  These two enzymes play crucial roles in the metabolism of a wide variety of endogenous esters, ester-containing drugs and environmental toxicants.  The key roles of CES in both human health and xenobiotic metabolism arouse great interest in the discovery of potent CES modulators to regulate endobiotic metabolism or to improve the efficacy of ester drugs.  This review covers the structural and catalytic features of CES, tissue distributions, biological functions, genetic polymorphisms, substrate specificities and inhibitor properties of CES1 and CES2, as well as the significance and recent progress on the discovery of CES modulators.  The information presented here will help pharmacologists explore the relevance of CES to human diseases or to assign the contribution of certain CES in xenobiotic metabolism.  It will also facilitate medicinal chemistry efforts to design prodrugs activated by a given CES isoform, or to develop potent and selective modulators of CES for potential biomedical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzNUaecqdULHHuJhbyicZfW6udTcc2eas5sJxcgTembntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D&md5=4c0b70b0208577496c8e0270af5eda8e</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DHuman%2520Carboxylesterases%253A%2520A%2520Comprehensive%2520Review%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26issue%3D5%26spage%3D699%26epage%3D712%26doi%3D10.1016%2Fj.apsb.2018.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Human Liver Aldehyde Oxidase: Implications for Potential Drug-Drug Interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2381</span>– <span class="NLM_lpage">2386</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.041806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.041806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21940905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCru77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=2381-2386&issue=12&author=J.+T.+Barrauthor=J.+P.+Jones&title=Inhibition+of+Human+Liver+Aldehyde+Oxidase%3A+Implications+for+Potential+Drug-Drug+Interactions&doi=10.1124%2Fdmd.111.041806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions</span></div><div class="casAuthors">Barr, John T.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2381-2386</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">During the course of our research efforts to understand the kinetics of human aldehyde oxidase as a xenobiotic-clearing enzyme, we investigated the effect of eight different inhibitors on the oxidn. of the probe substrate phthalazine.  Satn. kinetic parameters for phthalazine oxidn. in human liver cytosol were found to be the following: Km = 8.0 ± 0.4 μM and Vmax = 4.3 ± 0.1 nmol · min-1 · mg protein-1.  Inhibitory potency of the inhibitors tested ranged from 0.1 to 5 μM.  Of the eight different inhibitor compds. tested, seven were obsd. to inhibit through a mixed mode and one through a strictly competitive mode.  A ratio of the Kii and Kis values was used to assess the relative competitiveness of each inhibitor.  For the mixed inhibitors, the mode of inhibition varied from mostly uncompetitive to predominantly competitive (Kii/Kis values ranging from 0.1 to 15).  The implications for potential drug-drug interactions and inhibition mechanism are discussed.  We found two inhibitors, clozapine and chlorpromazine, that have a moderate predicted risk of drug-drug interactions based on the Ki value relative to the inhibitor concn. in human plasma, having a calcd. [I]/Ki value of 0.4 and 0.8, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS6gGC3rD4U7Vg90H21EOLACvtfcHk0ljxqnUbhcJxpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCru77F&md5=1113e63fdb48c3f8ed07c5ca4ae8cf24</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.041806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.041806%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520Human%2520Liver%2520Aldehyde%2520Oxidase%253A%2520Implications%2520for%2520Potential%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26issue%3D12%26spage%3D2381%26epage%3D2386%26doi%3D10.1124%2Fdmd.111.041806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuneo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barosi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danesi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagiuoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poletti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viale, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinzani, P. L.</span></span> <span> </span><span class="NLM_article-title">Management of Adverse Events Associated with Idelalisib Treatment in Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Multidisciplinary Position Paper</span>. <i>Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1002/hon.2540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fhon.2540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30187496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3c3mtVGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=3-14&issue=1&author=A.+Cuneoauthor=G.+Barosiauthor=R.+Danesiauthor=S.+Fagiuoliauthor=P.+Ghiaauthor=A.+Marzanoauthor=M.+Montilloauthor=V.+Polettiauthor=P.+Vialeauthor=P.+L.+Zinzani&title=Management+of+Adverse+Events+Associated+with+Idelalisib+Treatment+in+Chronic+Lymphocytic+Leukemia+and+Follicular+Lymphoma%3A+A+Multidisciplinary+Position+Paper&doi=10.1002%2Fhon.2540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper</span></div><div class="casAuthors">Cuneo Antonio; Barosi Giovanni; Danesi Romano; Fagiuoli Stefano; Ghia Paolo; Marzano Alfredo; Montillo Marco; Poletti Venerino; Poletti Venerino; Viale Pierluigi; Zinzani Pier Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Hematological oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The introduction of new therapeutic agents in chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL), including the new kinase inhibitor idelalisib, has changed the therapeutic landscape of these diseases.  However, the use of idelalisib is associated with a peculiar profile of side effects, which require an optimization of the current approach to prophylaxis and supportive treatment.  Moving from the recognition that the abovementioned issue represents an unmet need in CLL and FL, a multidisciplinary panel of experts was convened to produce a consensus document aiming to provide practical recommendations for the management of the side effects during idelalisib therapy for CLL and FL.  The present publication represents a consensus document from a series of meetings held during 2017.  The Panel generated clinical key questions using the criterion of clinical relevance through a Delphi process and explored 4 domains, ie, diarrhea/colitis, transaminitis, pneumonitis, and infectious complications.  Using the consensus method, the Panel was able to shape recommendations which may assist hematologist to minimize adverse events and guarantee adherence to treatment in patients with CLL and FL candidate to receive idelalisib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReSzyGASKhvxFwe7cAcrfPfW6udTcc2eZLgPGKFJoXKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3mtVGjsw%253D%253D&md5=0766c852e9cb404ce6c8d7769ce8ac58</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1002%2Fhon.2540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhon.2540%26sid%3Dliteratum%253Aachs%26aulast%3DCuneo%26aufirst%3DA.%26aulast%3DBarosi%26aufirst%3DG.%26aulast%3DDanesi%26aufirst%3DR.%26aulast%3DFagiuoli%26aufirst%3DS.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DMarzano%26aufirst%3DA.%26aulast%3DMontillo%26aufirst%3DM.%26aulast%3DPoletti%26aufirst%3DV.%26aulast%3DViale%26aufirst%3DP.%26aulast%3DZinzani%26aufirst%3DP.%2BL.%26atitle%3DManagement%2520of%2520Adverse%2520Events%2520Associated%2520with%2520Idelalisib%2520Treatment%2520in%2520Chronic%2520Lymphocytic%2520Leukemia%2520and%2520Follicular%2520Lymphoma%253A%2520A%2520Multidisciplinary%2520Position%2520Paper%26jtitle%3DHematol.%2520Oncol.%26date%3D2019%26volume%3D37%26issue%3D1%26spage%3D3%26epage%3D14%26doi%3D10.1002%2Fhon.2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, K.</span></span> <span> </span><span class="NLM_article-title">Reaction Phenotyping: Advances in the Experimental Strategies Used to Characterize the Contribution of Drug-Metabolizing Enzymes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.058750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.058750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25297949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOlu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=163-181&issue=1&author=M.+A.+Zientekauthor=K.+Youdim&title=Reaction+Phenotyping%3A+Advances+in+the+Experimental+Strategies+Used+to+Characterize+the+Contribution+of+Drug-Metabolizing+Enzymes&doi=10.1124%2Fdmd.114.058750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes</span></div><div class="casAuthors">Zientek, Michael A.; Youdim, Kuresh</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163-181, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  During the process of drug discovery, the pharmaceutical industry is faced with numerous challenges.  One challenge is the successful prediction of the major routes of human clearance of new medications.  For compds. cleared by metab., accurate predictions help provide an early risk assessment of their potential to exhibit significant interpatient differences in pharmacokinetics via routes of metab. catalyzed by functionally polymorphic enzymes and/or clin. significant metabolic drug-drug interactions.  This review details the most recent and emerging in vitro strategies used by drug metab. and pharmacokinetic scientists to better det. rates and routes of metabolic clearance and how to translate these parameters to est. the amt. these routes contribute to overall clearance, commonly referred to as fraction metabolized.  The enzymes covered in this review include cytochrome P450s together with other enzymic pathways whose involvement in metabolic clearance has become increasingly important as efforts to mitigate cytochrome P 450 clearance are successful.  Advances in the prediction of the fraction metabolized include newly developed methods to differentiate CYP3A4 from the polymorphic enzyme CYP3A5, scaling tools for UDP-glucuronosyltranferase, and estn. of fraction metabolized for substrates of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphbnT5ibiuKrVg90H21EOLACvtfcHk0lheesMaOKYaTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOlu7jJ&md5=cf94d4e64207e9b56120570bfa74a2ac</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.058750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.058750%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%2BA.%26aulast%3DYoudim%26aufirst%3DK.%26atitle%3DReaction%2520Phenotyping%253A%2520Advances%2520in%2520the%2520Experimental%2520Strategies%2520Used%2520to%2520Characterize%2520the%2520Contribution%2520of%2520Drug-Metabolizing%2520Enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26issue%3D1%26spage%3D163%26epage%3D181%26doi%3D10.1124%2Fdmd.114.058750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M. A.</span></span> <span> </span><span class="NLM_article-title">Strategies for a Comprehensive Understanding of Metabolism by Aldehyde Oxidase</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1517/17425255.2013.738668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1517%2F17425255.2013.738668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23231678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFGmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=153-168&issue=2&author=J.+M.+Hutzlerauthor=R.+S.+Obachauthor=D.+Dalvieauthor=M.+A.+Zientek&title=Strategies+for+a+Comprehensive+Understanding+of+Metabolism+by+Aldehyde+Oxidase&doi=10.1517%2F17425255.2013.738668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for a comprehensive understanding of metabolism by aldehyde oxidase</span></div><div class="casAuthors">Hutzler, James Matthew; Obach, Ronald Scott; Dalvie, Deepak; Zientek, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-168</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Aldehyde oxidase (AO) is a drug-metabolizing molybdo-flavoenzyme with profound species differences in expression and activity toward various substrates.  The contribution of this enzyme to the metab. and clearance of heterocyclic-contg. xenobiotics appears to have increased in recent years, but has not always been identified prior to clin. studies.  As a result, drug candidates have been neg. impacted in development.Areas covered: This review provides the most recent in vitro and in vivo strategies for the drug metab.-pharmacokinetic (DMPK) scientist.  The review details approaches for confirmation of AO as an operable metabolic pathway, estg. clearance and fraction of total metab., and identification of an appropriate surrogate species for human AO activity for evaluating safety of clin. relevant metabolites.Expert opinion: As the role of AO in metab. of new drug mols. continues to emerge, it is crit. that DMPK scientists have the most updated methodologies to enable formulation of a thorough exptl. plan to understand the potential implications of this metabolic pathway.  Whether it is higher-than-expected clearance, contributing to an unfavorable half-life, or the formation of an AO-derived disproportionate human metabolite (DHM), such a plan would serve to minimize complications or attrition of drug candidates due to unforeseen issues in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIyqFAKQ_oc7Vg90H21EOLACvtfcHk0lheesMaOKYaTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFGmt70%253D&md5=b8c7e4fe65773a2c5e40d4556b3b5eb5</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1517%2F17425255.2013.738668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2013.738668%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DZientek%26aufirst%3DM.%2BA.%26atitle%3DStrategies%2520for%2520a%2520Comprehensive%2520Understanding%2520of%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2013%26volume%3D9%26issue%3D2%26spage%3D153%26epage%3D168%26doi%3D10.1517%2F17425255.2013.738668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullenwider, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmenk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of Aldehyde Oxidase Enzyme Activity in Cryopreserved Human Hepatocytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.042861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.042861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22031625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=267-275&issue=2&author=J.+M.+Hutzlerauthor=Y.+S.+Yangauthor=D.+Albaughauthor=C.+L.+Fullenwiderauthor=J.+Schmenkauthor=M.+B.+Fisher&title=Characterization+of+Aldehyde+Oxidase+Enzyme+Activity+in+Cryopreserved+Human+Hepatocytes&doi=10.1124%2Fdmd.111.042861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes</span></div><div class="casAuthors">Hutzler, J. Matthew; Yang, Young-Sun; Albaugh, Daniel; Fullenwider, Cody L.; Schmenk, Jennifer; Fisher, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Substrates of aldehyde oxidase (AO), for which human clin. pharmacokinetics are reported, were selected and evaluated in pooled mixed-gender cryopreserved human hepatocytes in an effort to quant. characterize AO activity.  Estd. hepatic clearance (Clh) for BIBX1382, carbazeran, O6-benzylguanine, zaleplon, and XK-469 using cryopreserved hepatocytes was 18, 17, 12, <4.3, and <4.3 mL · min-1 · kg-1, resp.  The obsd. metabolic clearance in cryopreserved hepatocytes was confirmed to be a result of AO-mediated metab. via two approaches.  Metabolite identification after incubations in the presence of H218O confirmed that the predominant oxidative metabolite was generated by AO, as expected isotope patterns in mass spectra were obsd. after anal. by high-resoln. mass spectrometry.  Second, clearance values were efficiently attenuated upon coincubation with hydralazine, an inhibitor of AO.  The low exposure after oral doses of BIBX1382 and carbazeran (∼5% F) would have been fairly well predicted using simple hepatic extn. (fh) values derived from cryopreserved hepatocytes.  In addn., the estd. hepatic clearance value for O6-benzylguanine was within ∼80% of the obsd. total clearance in humans after i.v. administration (15 mL · min-1 · kg-1), indicating a reasonable level of quant. activity from this in vitro system.  However, a 3.5-fold underprediction of total clearance was obsd. for zaleplon, despite the 5-oxo metabolite being clearly obsd.  These data taken together suggest that the use of cryopreserved hepatocytes may be a practical approach for assessing AO-mediated metab. in discovery and potentially useful for predicting hepatic clearance of AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9RVqtqeCaRrVg90H21EOLACvtfcHk0lheesMaOKYaTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsL8%253D&md5=efa4198748bd5990222f53121a4c196c</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042861%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DAlbaugh%26aufirst%3DD.%26aulast%3DFullenwider%26aufirst%3DC.%2BL.%26aulast%3DSchmenk%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26atitle%3DCharacterization%2520of%2520Aldehyde%2520Oxidase%2520Enzyme%2520Activity%2520in%2520Cryopreserved%2520Human%2520Hepatocytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D2%26spage%3D267%26epage%3D275%26doi%3D10.1124%2Fdmd.111.042861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Hydralazine as a Selective Probe Inactivator of Aldehyde Oxidase in Human Hepatocytes: Estimation of the Contribution of Aldehyde Oxidase to Metabolic Clearance</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1441</span>– <span class="NLM_lpage">1448</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.045195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.045195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22522748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrs7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1441-1448&issue=7&author=T.+J.+Strelevitzauthor=C.+C.+Orozcoauthor=R.+S.+Obach&title=Hydralazine+as+a+Selective+Probe+Inactivator+of+Aldehyde+Oxidase+in+Human+Hepatocytes%3A+Estimation+of+the+Contribution+of+Aldehyde+Oxidase+to+Metabolic+Clearance&doi=10.1124%2Fdmd.112.045195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance</span></div><div class="casAuthors">Strelevitz, Timothy J.; Orozco, Christine C.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1441-1448</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) metab. could lead to significant underestimation of clearance in prediction of human pharmacokinetics as well as unanticipated exposure to AO-generated metabolites, if not accounted for early in drug research.  We report a method using cryopreserved human hepatocytes and the time-dependent AO inhibitor hydralazine (KI = 83 ± 27 μM, kintact = 0.063 ± 0.007 min-1), which ests. the contribution of AO metab. relative to total hepatic clearance.  Using zaleplon as a probe substrate and simultaneously monitoring the AO-catalyzed formation of oxozaleplon and the CYP3A-catalyzed formation of desethyzaleplon in the presence of a range of hydralazine concns., it was detd. that >90% inhibition of the AO activity with minimal effect on the CYP3A activity could be achieved with 25 to 50 μM hydralazine.  This method was used to est. the fraction metabolized due to AO [fm(AO)] for six compds. with clearance attributed to AO along with four other drugs not metabolized by AO.  The fm(AO) values for the AO substrates ranged between 0.49 and 0.83.  Differences in estd. fm(AO) between two batches of pooled human hepatocytes suggest that sensitivity to hydralazine varies slightly with hepatocyte prepns.  Substrates with a CYP2D6 contribution to clearance were affected by hydralazine to a minor extent, because of weak inhibition of this enzyme.  Overall, these findings demonstrate that hydralazine, at a concn. of 25 to 50 μM, can be used in human hepatocyte incubations to est. the contribution of AO to the hepatic clearance of drugs and other compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBKznnCiG-LVg90H21EOLACvtfcHk0liMn9sgJj-JKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrs7vJ&md5=6237313df0fe4ded2d2f37e55c3d4b03</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.045195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.045195%26sid%3Dliteratum%253Aachs%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DOrozco%26aufirst%3DC.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DHydralazine%2520as%2520a%2520Selective%2520Probe%2520Inactivator%2520of%2520Aldehyde%2520Oxidase%2520in%2520Human%2520Hepatocytes%253A%2520Estimation%2520of%2520the%2520Contribution%2520of%2520Aldehyde%2520Oxidase%2520to%2520Metabolic%2520Clearance%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D7%26spage%3D1441%26epage%3D1448%26doi%3D10.1124%2Fdmd.112.045195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toselli, F.</span>; <span class="NLM_string-name">Golding, M.</span>; <span class="NLM_string-name">Manevski, N.</span>; <span class="NLM_string-name">King, L.</span>; <span class="NLM_string-name">Nicolaï, J.</span>; <span class="NLM_string-name">Gillent, E.</span>; <span class="NLM_string-name">Delatour, C.</span>; <span class="NLM_string-name">Isin, E. M.</span>; <span class="NLM_string-name">Henshall, J.</span>; <span class="NLM_string-name">Chanteux, H.</span>; <span class="NLM_string-name">Ungell, A. L.</span></span> In  <i>Aldehyde Oxidase: A New Foe in Drug Discovery?</i>; <span class="NLM_publisher-name">DMDG-SPS Joint Meeting, October 16−18, 2018, Gothenburg, Sweden</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=F.+Toselli&author=M.+Golding&author=N.+Manevski&author=L.+King&author=J.+Nicola%C3%AF&author=E.+Gillent&author=C.+Delatour&author=E.+M.+Isin&author=J.+Henshall&author=H.+Chanteux&author=A.+L.+Ungell&title=Aldehyde+Oxidase%3A+A+New+Foe+in+Drug+Discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DToselli%26aufirst%3DF.%26jtitle%3DAldehyde%2520Oxidase%253A%2520A%2520New%2520Foe%2520in%2520Drug%2520Discovery%253F%26pub%3DDMDG-SPS%2520Joint%2520Meeting%252C%2520October%252016%25E2%2588%259218%252C%25202018%252C%2520Gothenburg%252C%2520Sweden%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1630</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2018.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.xphs.2018.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30448524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVejtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2019&pages=1627-1630&issue=4&author=X.+Yangauthor=N.+Johnsonauthor=L.+Di&title=Evaluation+of+Cytochrome+P450+Selectivity+for+Hydralazine+as+an+Aldehyde+Oxidase+Inhibitor+for+Reaction+Phenotyping&doi=10.1016%2Fj.xphs.2018.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping</span></div><div class="casAuthors">Yang, Xin; Johnson, Nathaniel; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences (Philadelphia, PA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1627-1630</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hydralazine has been reported as a selective mechanism-based inactivator of aldehyde oxidase (AO) and it is widely used in the pharmaceutical industry for reaction phenotyping to est. fraction metabolized by AO and to identify AO substrates.  In this study, however, hydralazine was found to inhibit CYP1A2, 2B6, 2D6, and 3A in human suspension hepatocytes under reaction phenotyping assay conditions, at concns. that chem. knocked out most of the AO activities (≥50 μM).  Furthermore, hydralazine is a time-dependent inhibitor of CYP1A2.  Based on these findings, precautions need to be taken when using hydralazine as an AO inhibitor for in vitro studies because fraction metabolized by AO is likely to be overestimated and the likelihood of false positives in identifying AO substrates increases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgqUrRsY_No7Vg90H21EOLACvtfcHk0liMn9sgJj-JKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVejtb4%253D&md5=4445e552c958712215442f3b648c9ec1</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2018.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2018.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DJohnson%26aufirst%3DN.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DEvaluation%2520of%2520Cytochrome%2520P450%2520Selectivity%2520for%2520Hydralazine%2520as%2520an%2520Aldehyde%2520Oxidase%2520Inhibitor%2520for%2520Reaction%2520Phenotyping%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2019%26volume%3D108%26issue%3D4%26spage%3D1627%26epage%3D1630%26doi%3D10.1016%2Fj.xphs.2018.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Potent Inhibition of Human Liver Aldehyde Oxidase by Raloxifene</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1124/dmd.32.1.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.32.1.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=14709625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFWqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=89-97&issue=1&author=R.+S.+Obach&title=Potent+Inhibition+of+Human+Liver+Aldehyde+Oxidase+by+Raloxifene&doi=10.1124%2Fdmd.32.1.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Potent inhibition of human liver aldehyde oxidase by raloxifene</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The selective estrogen receptor modulator, raloxifene, has been demonstrated as a potent uncompetitive inhibitor of human liver aldehyde oxidase-catalyzed oxidn. of phthalazine, vanillin, and nicotine-Δ1'(5')-iminium ion, with Ki values of 0.87 to 1.4 nM.  Inhibition was not time-dependent.  Raloxifene has also been shown to be a noncompetitive inhibitor of an aldehyde oxidase-catalyzed redn. reaction of a hydroxamic acid-contg. compd., with a Ki of 51 nM.  However, raloxifene had only small effects on xanthine oxidase, an enzyme related to aldehyde oxidase.  In addn., several other compds. of the same therapeutic class as raloxifene were examd. for their potential to inhibit aldehyde oxidase.  However, none were as potent as raloxifene, since IC50 values were orders of magnitude higher and ranged from 0.29 to 57 μM.  In an examn. of analogs of raloxifene, it was shown that the bisphenol structure with a hydrophobic group on the 3-position of the benzothiophene ring system was the most important element that imparts inhibitory potency.  The relevance of these data to the mechanistic understanding of aldehyde oxidase catalysis, as well as to the potential for raloxifene to cause drug interactions with agents for which aldehyde oxidase-mediated metab. is important, such as zaleplon or famciclovir, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6iDLIEl8GgrVg90H21EOLACvtfcHk0liMn9sgJj-JKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFWqs7w%253D&md5=a693f57077e2d685eea25a998f4603d7</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.1.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.1.89%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPotent%2520Inhibition%2520of%2520Human%2520Liver%2520Aldehyde%2520Oxidase%2520by%2520Raloxifene%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26issue%3D1%26spage%3D89%26epage%3D97%26doi%3D10.1124%2Fdmd.32.1.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandikere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanamarlapudi, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnamaneni, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, A. K.</span></span> <span> </span><span class="NLM_article-title">Identification of a Suitable and Selective Inhibitor Towards Aldehyde Oxidase Catalyzed Reactions</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.3109/00498254.2013.819594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2013.819594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24156774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=197-204&issue=3&author=R.+Nirogiauthor=V.+Kandikereauthor=R.+C.+Palacharlaauthor=G.+Bhyrapuneniauthor=V.+B.+Kanamarlapudiauthor=R.+K.+Ponnamaneniauthor=A.+K.+Manoharan&title=Identification+of+a+Suitable+and+Selective+Inhibitor+Towards+Aldehyde+Oxidase+Catalyzed+Reactions&doi=10.3109%2F00498254.2013.819594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions</span></div><div class="casAuthors">Nirogi, Ramakrishna; Kandikere, Vishwottam; Palacharla, Raghava Choudary; Bhyrapuneni, Gopinadh; Kanamarlapudi, Vijaya Bhargava; Ponnamaneni, Ranjith Kumar; Manoharan, Arun Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-204</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">1. Aldehyde oxidase (AO) is a liver cytosolic molybdoflavoprotein enzyme whose importance in drug metab. is gaining in the recent.  The objective of this work is to find a potent and selective inhibitor for AO activity using phthalazine oxidn. as a marker reaction.  2. Among org. solvents tested, it was identified that methanol was not a suitable choice for AO activity even at concns. less than 0.2% vol./vol.  Acetonitrile and DMSO did not show any effect till 0.5% vol./vol. but thereafter activities tend to decrease.  3. For selectivity, 23 compds. were selected and evaluated for their effects on AO and nine CYP450 enzymes.  Among the tested compds. chlorpromazine, estradiol, hydralazine, quetiapine and raloxifene were selected based on their potency of inhibition towards AO activity.  4. Raloxifene was found to be a non-specific inhibitor of all major tested CYP450 enzymes and was excluded as a selective inhibitor for AO.  Quetiapine also showed a degree of inhibition towards the major CYP450 tested.  Hydralazine used as a specific inhibitor during the past for AO activity demonstrated a stimulation of AO activity at high and low concns. resp. and the inhibition noted to be time dependent while inhibiting other enzymes like monoamine oxidase.  5. Estradiol showed no inhibition towards the tested CYP450 enzymes and thus proved to be a selective and specific inhibitor for AO activity with an uncompetitive mode of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1yYD_spWMv7Vg90H21EOLACvtfcHk0lja2ymor3eC4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyntr0%253D&md5=46c6e4947b4296da9e6e30d319bdc7a2</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.3109%2F00498254.2013.819594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2013.819594%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DKanamarlapudi%26aufirst%3DV.%2BB.%26aulast%3DPonnamaneni%26aufirst%3DR.%2BK.%26aulast%3DManoharan%26aufirst%3DA.%2BK.%26atitle%3DIdentification%2520of%2520a%2520Suitable%2520and%2520Selective%2520Inhibitor%2520Towards%2520Aldehyde%2520Oxidase%2520Catalyzed%2520Reactions%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26issue%3D3%26spage%3D197%26epage%3D204%26doi%3D10.3109%2F00498254.2013.819594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span> <span> </span><span class="NLM_article-title">The Effects of Drug Metabolizing Enzyme Inhibitors on Hepatic Efflux and Uptake Transporters</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.2174/1872312811666171010101248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.2174%2F1872312811666171010101248" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=111-118&issue=2&author=J.+Cheongauthor=J.+S.+Halladayauthor=E.+Pliseauthor=J.+K.+Sodhiauthor=L.+Salphati&title=The+Effects+of+Drug+Metabolizing+Enzyme+Inhibitors+on+Hepatic+Efflux+and+Uptake+Transporters&doi=10.2174%2F1872312811666171010101248"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.2174%2F1872312811666171010101248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1872312811666171010101248%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DSodhi%26aufirst%3DJ.%2BK.%26aulast%3DSalphati%26aufirst%3DL.%26atitle%3DThe%2520Effects%2520of%2520Drug%2520Metabolizing%2520Enzyme%2520Inhibitors%2520on%2520Hepatic%2520Efflux%2520and%2520Uptake%2520Transporters%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2018%26volume%3D11%26issue%3D2%26spage%3D111%26epage%3D118%26doi%3D10.2174%2F1872312811666171010101248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin-Muttitt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, J. G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A. J.</span></span> <span> </span><span class="NLM_article-title">In Vitro and in Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1124/jpet.119.259267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fjpet.119.259267" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=S.+Chenauthor=K.+Austin-Muttittauthor=L.+H.+Zhangauthor=J.+G.+L.+Mullinsauthor=A.+J.+Lau&title=In+Vitro+and+in+Silico+Analyses+of+the+Inhibition+of+Human+Aldehyde+Oxidase+by+Bazedoxifene%2C+Lasofoxifene%2C+and+Structural+Analogues&doi=10.1124%2Fjpet.119.259267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1124%2Fjpet.119.259267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.119.259267%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DAustin-Muttitt%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%2BH.%26aulast%3DMullins%26aufirst%3DJ.%2BG.%2BL.%26aulast%3DLau%26aufirst%3DA.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Silico%2520Analyses%2520of%2520the%2520Inhibition%2520of%2520Human%2520Aldehyde%2520Oxidase%2520by%2520Bazedoxifene%252C%2520Lasofoxifene%252C%2520and%2520Structural%2520Analogues%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2019%26doi%3D10.1124%2Fjpet.119.259267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishimuta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bando, K.</span></span> <span> </span><span class="NLM_article-title">Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from in Vivo Monkey Pharmacokinetics Study and in Vitro Metabolic Stability Tests Using Hepatocytes</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">20</span>, <span class="refDoi"> DOI: 10.1208/s12248-019-0294-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1208%2Fs12248-019-0294-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30673906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3cjksVyjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=20&author=H.+Nishimutaauthor=T.+Watanabeauthor=K.+Bando&title=Quantitative+Prediction+of+Human+Hepatic+Clearance+for+P450+and+Non-P450+Substrates+from+in+Vivo+Monkey+Pharmacokinetics+Study+and+in+Vitro+Metabolic+Stability+Tests+Using+Hepatocytes&doi=10.1208%2Fs12248-019-0294-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes</span></div><div class="casAuthors">Nishimuta Haruka; Watanabe Takao; Bando Kiyoko</div><div class="citationInfo"><span class="NLM_cas:title">The AAPS journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Accurate prediction of human pharmacokinetics for drugs remains challenging, especially for non-cytochrome P450 (P450) substrates.  Hepatocytes might be suitable for predicting hepatic intrinsic clearance (CLint) of new chemical entities, because they can be applied to various compounds regardless of the metabolic enzymes.  However, it was reported that hepatic CLint is underestimated in hepatocytes.  The purpose of the present study was to confirm the predictability of human hepatic clearance for P450 and non-P450 substrates in hepatocytes and the utility of animal scaling factors for the prediction using hepatocytes.  CLint values for 30 substrates of P450, UDP-glucuronosyltransferase, flavin-containing monooxygenase, esterases, reductases, and aldehyde oxidase in human microsomes, human S9 and human, rat, and monkey hepatocytes were estimated.  Hepatocytes were incubated in serum of each species.  Furthermore, CLint values in human hepatocytes were corrected with empirical, monkey, and rat scaling factors.  CLint values in hepatocytes for most compounds were underestimated compared to observed values regardless of the metabolic enzyme, and the predictability was improved by using the scaling factors.  The prediction using human hepatocytes corrected with monkey scaling factor showed the highest predictability for both P450 and non-P450 substrates among the predictions using liver microsomes, liver S9, and hepatocytes with or without scaling factors.  CLint values by this method for 80% and 90% of all compounds were within 2- and 3-fold of observed values, respectively.  This method is accurate and useful for estimating new chemical entities, with no need to care about cofactors, localization of metabolic enzymes, or protein binding in plasma and incubation mixture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQ1ByXKj3fVN-cVm4E2RlLfW6udTcc2eZWVExziIPva7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjksVyjsg%253D%253D&md5=7b095a8ea124c39d49a722c3b08f82ff</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1208%2Fs12248-019-0294-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-019-0294-1%26sid%3Dliteratum%253Aachs%26aulast%3DNishimuta%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DBando%26aufirst%3DK.%26atitle%3DQuantitative%2520Prediction%2520of%2520Human%2520Hepatic%2520Clearance%2520for%2520P450%2520and%2520Non-P450%2520Substrates%2520from%2520in%2520Vivo%2520Monkey%2520Pharmacokinetics%2520Study%2520and%2520in%2520Vitro%2520Metabolic%2520Stability%2520Tests%2520Using%2520Hepatocytes%26jtitle%3DAAPS%2520J.%26date%3D2019%26volume%3D21%26spage%3D20%26doi%3D10.1208%2Fs12248-019-0294-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase-Catalyzed Metabolism of N1-Methylnicotinamide in Vivo and in Vitro in Chimeric Mice with Humanized Liver</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1202</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.019075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.107.019075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=18332084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotVegur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=1202-1205&issue=7&author=S.+Kitamuraauthor=K.+Nittaauthor=Y.+Tayamaauthor=C.+Tanoueauthor=K.+Sugiharaauthor=T.+Inoueauthor=T.+Horieauthor=S.+Ohta&title=Aldehyde+Oxidase-Catalyzed+Metabolism+of+N1-Methylnicotinamide+in+Vivo+and+in+Vitro+in+Chimeric+Mice+with+Humanized+Liver&doi=10.1124%2Fdmd.107.019075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver</span></div><div class="casAuthors">Kitamura, Shigeyuki; Nitta, Kayoko; Tayama, Yoshitaka; Tanoue, Chiaki; Sugihara, Kazumi; Inoue, Tae; Horie, Toru; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1202-1205</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase-mediated oxidn. of N1-methylnicotinamide to N1-methyl-2-pyridine-5-carboxamide (2-PY) and N1-methyl-4-pyridone-5-carboxamide (4-PY) in chimeric mice constructed by transplanting human hepatocytes into urokinase-type plasminogen activator-transgenic severe combined immunodeficient mice was examd. in vivo and in vitro.  The activity in liver cytosol of chimeric mice with a high replacement index was approx. 4-fold higher than that in control mice.  Furthermore, the oxidn. products in control mice were 2-PY and 4-PY, whereas, in chimeric mice, the major product was 2-PY, as in humans.  The aldehyde oxidase in chimeric mouse liver was confirmed to be of human type by immunoblotting anal.  The ratio of pyridones (2-PY/4-PY) excreted in the urine of chimeric mice was closer to that of humans than to that of control mice.  Thus, the aldehyde oxidase in chimeric mice has human-type functional characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOv9qznxXoY7Vg90H21EOLACvtfcHk0lhQeGq8mC8y2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotVegur4%253D&md5=14985abbc5c43cbc4bd31c2cd98c4e8b</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.019075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.019075%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNitta%26aufirst%3DK.%26aulast%3DTayama%26aufirst%3DY.%26aulast%3DTanoue%26aufirst%3DC.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DHorie%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DAldehyde%2520Oxidase-Catalyzed%2520Metabolism%2520of%2520N1-Methylnicotinamide%2520in%2520Vivo%2520and%2520in%2520Vitro%2520in%2520Chimeric%2520Mice%2520with%2520Humanized%2520Liver%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26issue%3D7%26spage%3D1202%26epage%3D1205%26doi%3D10.1124%2Fdmd.107.019075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotake, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohshita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Prediction of in Vivo Hepatic Clearance and Half-Life of Drug Candidates in Human Using Chimeric Mice with Humanized Liver</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.040923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.040923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22048522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=322-328&issue=2&author=S.+Sanohauthor=A.+Horiguchiauthor=K.+Sugiharaauthor=Y.+Kotakeauthor=Y.+Tayamaauthor=H.+Ohshitaauthor=C.+Tatenoauthor=T.+Horieauthor=S.+Kitamuraauthor=S.+Ohta&title=Prediction+of+in+Vivo+Hepatic+Clearance+and+Half-Life+of+Drug+Candidates+in+Human+Using+Chimeric+Mice+with+Humanized+Liver&doi=10.1124%2Fdmd.111.040923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver</span></div><div class="casAuthors">Sanoh, Seigo; Horiguchi, Aya; Sugihara, Kazumi; Kotake, Yaichiro; Tayama, Yoshitaka; Ohshita, Hiroki; Tateno, Chise; Horie, Toru; Kitamura, Shigeyuki; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">322-328</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Accurate prediction of pharmacokinetics (PK) parameters in humans from animal data is difficult for various reasons, including species differences.  However, chimeric mice with humanized liver (PXB mice; urokinase-type plasminogen activator/severe combined immunodeficiency mice repopulated with approx. 80% human hepatocytes) have been developed.  The expression levels and metabolic activities of cytochrome P 450 (P 450) and non-P 450 enzymes in the livers of PXB mice are similar to those in humans.  In this study, we examd. the predictability for human PK parameters from data obtained in PXB mice.  Elimination of selected drugs involves multiple metabolic pathways mediated not only by P 450 but also by non-P 450 enzymes, such as UDP-glucuronosyltransferase, sulfotransferase, and aldehyde oxidase in liver.  Direct comparison between in vitro intrinsic clearance (CLint,in vitro) in PXB mice hepatocytes and in vivo intrinsic clearance (CLint,in vivo) in humans, calcd. based on a well stirred model, showed a moderate correlation (r2 = 0.475, p = 0.009).  However, when CLint,in vivo values in humans and PXB mice were compared similarly, there was a good correlation (r2 = 0.754, p = 1.174 × 10-4).  Elimination half-life (t1/2) after i.v. administration also showed a good correlation (r2 = 0.886, p = 1.506 × 10-4) between humans and PXB mice.  The rank order of CL and t1/2 in human could be predicted at least, although it may not be possible to predict abs. values due to rather large prediction errors.  Our results indicate that in vitro and in vivo expts. with PXB mice should be useful at least for semiquant. prediction of the PK characteristics of candidate drugs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJRoBSzD2uXLVg90H21EOLACvtfcHk0lhQeGq8mC8y2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsb0%253D&md5=b139c1e654c4d21752aea5112aa167c6</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.040923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.040923%26sid%3Dliteratum%253Aachs%26aulast%3DSanoh%26aufirst%3DS.%26aulast%3DHoriguchi%26aufirst%3DA.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DTayama%26aufirst%3DY.%26aulast%3DOhshita%26aufirst%3DH.%26aulast%3DTateno%26aufirst%3DC.%26aulast%3DHorie%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DPrediction%2520of%2520in%2520Vivo%2520Hepatic%2520Clearance%2520and%2520Half-Life%2520of%2520Drug%2520Candidates%2520in%2520Human%2520Using%2520Chimeric%2520Mice%2520with%2520Humanized%2520Liver%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D2%26spage%3D322%26epage%3D328%26doi%3D10.1124%2Fdmd.111.040923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teramura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Prediction of Human Metabolism of Fk3453 by Aldehyde Oxidase Using Chimeric Mice Transplanted with Human or Rat Hepatocytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.041954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.041954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21984595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=76-82&issue=1&author=S.+Sanohauthor=K.+Nozakiauthor=H.+Muraiauthor=S.+Terashitaauthor=T.+Teramuraauthor=S.+Ohta&title=Prediction+of+Human+Metabolism+of+Fk3453+by+Aldehyde+Oxidase+Using+Chimeric+Mice+Transplanted+with+Human+or+Rat+Hepatocytes&doi=10.1124%2Fdmd.111.041954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes</span></div><div class="casAuthors">Sanoh, Seigo; Nozaki, Kazuyoshi; Murai, Hidetsugu; Terashita, Shigeyuki; Teramura, Toshio; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-82</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">During drug development, it is important to predict the activities of multiple metabolic enzymes, not only cytochrome P 450 (P 450) but also non-P 450 enzymes, such as conjugative enzymes and aldehyde oxidase (AO).  In this study, we focused on prediction of AO-mediated human metab. and pharmacokinetics (PK) of 6-(2-amino-4-phenylpyrimidine-5-yl)-2-isopropylpyridazin-3(2H)-one (FK3453) (Astollas Pharma Inc.), the development of which was suspended due to extremely low exposure in human, despite good oral bioavailability in rat and dog.  We examd. species difference in oxidative metab. of the aminopyrimidine moiety of FK3453, catalyzed by AO, using human-chimeric mice with humanized liver (h-PXB mice) and rat-chimeric mice (r-PXB mice) transplanted with rat hepatocytes.  AO activity of h-PXB mouse hepatocytes was higher than that of r-PXB mouse hepatocytes.  Moreover, higher concns. of human-specific AO-generated FK3453 metabolite A-M were detected in urine and feces after administration of FK3453 to h-PXB mice vs. r-PXB mice.  The total clearance of h-PXB mice was 2-fold higher than that of r-PXB mice.  These results agreed reasonably well with the metab. and PK profiles of FK3453 in human and rat.  Our results indicated that h-PXB mice should be helpful for predicting the metabolic profile of drugs in humans, and the use of both h-PXB and r-PXB mice should be helpful for evaluation of species differences of AO metabolic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOPbv2yx-v07Vg90H21EOLACvtfcHk0liDDO9yofZvDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajtb8%253D&md5=3b0b8dbf8a5065f76d86b7820f8990e1</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.041954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.041954%26sid%3Dliteratum%253Aachs%26aulast%3DSanoh%26aufirst%3DS.%26aulast%3DNozaki%26aufirst%3DK.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DTeramura%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DPrediction%2520of%2520Human%2520Metabolism%2520of%2520Fk3453%2520by%2520Aldehyde%2520Oxidase%2520Using%2520Chimeric%2520Mice%2520Transplanted%2520with%2520Human%2520or%2520Rat%2520Hepatocytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D1%26spage%3D76%26epage%3D82%26doi%3D10.1124%2Fdmd.111.041954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittelmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camattari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glieder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lütz, S.</span></span> <span> </span><span class="NLM_article-title">Production of Recombinant Human Aldehyde Oxidase in Escherichia Coli and Optimization of Its Application for the Preparative Synthesis of Oxidized Drug Metabolites</span>. <i>ChemCatChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1028</span>– <span class="NLM_lpage">1042</span>, <span class="refDoi"> DOI: 10.1002/cctc.201301094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fcctc.201301094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFKrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1028-1042&issue=4&author=D.+Rodriguesauthor=M.+Kittelmannauthor=F.+Eggimannauthor=T.+Bachlerauthor=S.+Abadauthor=A.+Camattariauthor=A.+Gliederauthor=M.+Winklerauthor=S.+L%C3%BCtz&title=Production+of+Recombinant+Human+Aldehyde+Oxidase+in+Escherichia+Coli+and+Optimization+of+Its+Application+for+the+Preparative+Synthesis+of+Oxidized+Drug+Metabolites&doi=10.1002%2Fcctc.201301094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Production of Recombinant Human Aldehyde Oxidase in Escherichia coli and Optimization of Its Application for the Preparative Synthesis of Oxidized Drug Metabolites</span></div><div class="casAuthors">Rodrigues, Diogo; Kittelmann, Matthias; Eggimann, Fabian; Bachler, Thorsten; Abad, Sandra; Camattari, Andrea; Glieder, Anton; Winkler, Margit; Luetz, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">ChemCatChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1028-1042</span>CODEN:
                <span class="NLM_cas:coden">CHEMK3</span>;
        ISSN:<span class="NLM_cas:issn">1867-3880</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Recombinant human aldehyde oxidase (AO) was expressed in Escherichia coli.  Different cell disruption methods and conditions of cell culture in shake flasks and bioreactors and of biotransformation on an anal. scale were tested to optimize the synthesis of oxidized AO drug metabolites.  The volumetric productivity was increased 24-fold by optimizing the cell culture conditions.  The highest yield was achieved in a 25 L stirred tank bioreactor under non-oxygen-limited conditions and high lactose feed rate.  Suspensions of highly concd. and well-aerated whole cells at neutral pH and relatively low temps. led to the best conversion.  The solvent for the substrate and the buffering agent for the biotransformation had an important effect.  In a biotransformation with AO, 210 mg of famciclovir was converted to in a yield of 82 %.  The optimized protocol represents a viable method for the preparative synthesis of oxidized AO metabolites of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy384rQSslSrVg90H21EOLACvtfcHk0liDDO9yofZvDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFKrs7w%253D&md5=2791e07f54c683f4b567f22485c97afa</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1002%2Fcctc.201301094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcctc.201301094%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DD.%26aulast%3DKittelmann%26aufirst%3DM.%26aulast%3DEggimann%26aufirst%3DF.%26aulast%3DBachler%26aufirst%3DT.%26aulast%3DAbad%26aufirst%3DS.%26aulast%3DCamattari%26aufirst%3DA.%26aulast%3DGlieder%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DL%25C3%25BCtz%26aufirst%3DS.%26atitle%3DProduction%2520of%2520Recombinant%2520Human%2520Aldehyde%2520Oxidase%2520in%2520Escherichia%2520Coli%2520and%2520Optimization%2520of%2520Its%2520Application%2520for%2520the%2520Preparative%2520Synthesis%2520of%2520Oxidized%2520Drug%2520Metabolites%26jtitle%3DChemCatChem%26date%3D2014%26volume%3D6%26issue%3D4%26spage%3D1028%26epage%3D1042%26doi%3D10.1002%2Fcctc.201301094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jairaj, M.</span></span> <span> </span><span class="NLM_article-title">Introduction of a Routine Quan/Qual Approach into Research Dmpk: Experiences and Evolving Strategies</span>. <i>Bioanalysis</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3337</span>– <span class="NLM_lpage">3348</span>, <span class="refDoi"> DOI: 10.4155/bio.14.233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.4155%2Fbio.14.233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25534790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFaqtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=3337-3348&issue=24&author=L.+Kingauthor=A.+Kotianauthor=M.+Jairaj&title=Introduction+of+a+Routine+Quan%2FQual+Approach+into+Research+Dmpk%3A+Experiences+and+Evolving+Strategies&doi=10.4155%2Fbio.14.233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of a routine quan/qual approach into research DMPK: experiences and evolving strategies</span></div><div class="casAuthors">King, Lloyd; Kotian, Apoorva; Jairaj, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Bioanalysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3337-3348</span>CODEN:
                <span class="NLM_cas:coden">BIOAB4</span>;
        ISSN:<span class="NLM_cas:issn">1757-6180</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The application of liq. chromatog. high-resoln. mass spectrometry for simultaneous quant. and qual. (quan/qual) anal. has gained momentum across a range of different scientific arenas in recent years.  The ability to acquire high quality quant. data, while also capturing qual. data for either parallel or retrospective anal., is a powerful resource, esp. in view of ever-reducing cycle times, lab. space and budgets.  The quan/qual approach employing a Q-Exactive® Orbitrap high-resoln. mass spectrometer has been successfully introduced into UCB's research DMPK department.  This article describes our experiences in introducing quan/qual, issues that we discovered in establishing this new working paradigm, the evolution of the strategy and its future potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTqLFIfyyXvLVg90H21EOLACvtfcHk0liU7EnIC6Qz3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFaqtbbO&md5=70e3ff7cfe9e9b773d25d42e7bb1b980</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.4155%2Fbio.14.233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fbio.14.233%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DL.%26aulast%3DKotian%26aufirst%3DA.%26aulast%3DJairaj%26aufirst%3DM.%26atitle%3DIntroduction%2520of%2520a%2520Routine%2520Quan%252FQual%2520Approach%2520into%2520Research%2520Dmpk%253A%2520Experiences%2520and%2520Evolving%2520Strategies%26jtitle%3DBioanalysis%26date%3D2014%26volume%3D6%26issue%3D24%26spage%3D3337%26epage%3D3348%26doi%3D10.4155%2Fbio.14.233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muenster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L.</span></span> <span> </span><span class="NLM_article-title">Quantitative-Qualitative Data Acquisition Using a Benchtop Orbitrap Mass Spectrometer</span>. <i>J. Am. Soc. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1441</span>– <span class="NLM_lpage">1450</span>, <span class="refDoi"> DOI: 10.1016/j.jasms.2009.03.002</span> </span><div class="citationLinks">[<a href="/doi/10.1016/j.jasms.2009.03.002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptV2msLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1441-1450&issue=8&author=K.+P.+Batemanauthor=M.+Kellmannauthor=H.+Muensterauthor=R.+Pappauthor=L.+Taylor&title=Quantitative-Qualitative+Data+Acquisition+Using+a+Benchtop+Orbitrap+Mass+Spectrometer&doi=10.1016%2Fj.jasms.2009.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative-Qualitative Data Acquisition Using a Benchtop Orbitrap Mass Spectrometer</span></div><div class="casAuthors">Bateman, Kevin P.; Kellmann, Markus; Muenster, Helmut; Papp, Robert; Taylor, Lester</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society for Mass Spectrometry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1441-1450</span>CODEN:
                <span class="NLM_cas:coden">JAMSEF</span>;
        ISSN:<span class="NLM_cas:issn">1044-0305</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Current approaches to discovery-stage drug metab. studies (pharmacokinetics, microsomal stability, etc.) typically use triple-quadrupole-based approaches for quant. anal.  This necessitates the optimization of parameters such as Q1 and Q3 m/z values, collision energy, and interface voltages.  These studies detect only the specified compd. and information about other components, such as metabolites, is lost.  The ability to perform full-scan acquisition for quant. anal. would eliminate the need for compd. optimization while enabling the detection of metabolites and other non-drug-related endogenous components.  Such an instrument would have to provide sensitivity, selectivity, dynamic range, and scan speed suitable for discovery-stage quant. studies.  In this study, a prototype benchtop Orbitrap-based mass analyzer was used to collect both quant. and qual. data from human microsomal incubation samples as well as rat plasma from pharmacokinetic studies.  Instrumental parameters such as scan speed, resoln., and mass accuracy are discussed in relation to the requirements for a quant.-qual. workflow.  The ability to perform highly selective quant. anal. while simultaneously characterizing metabolites from both in vitro and in vivo studies is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEoT2w34dt0rVg90H21EOLACvtfcHk0liU7EnIC6Qz3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptV2msLo%253D&md5=1801c665bea72d2904d6709545de9ab6</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1016%2Fj.jasms.2009.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jasms.2009.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DK.%2BP.%26aulast%3DKellmann%26aufirst%3DM.%26aulast%3DMuenster%26aufirst%3DH.%26aulast%3DPapp%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DL.%26atitle%3DQuantitative-Qualitative%2520Data%2520Acquisition%2520Using%2520a%2520Benchtop%2520Orbitrap%2520Mass%2520Spectrometer%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D2009%26volume%3D20%26issue%3D8%26spage%3D1441%26epage%3D1450%26doi%3D10.1016%2Fj.jasms.2009.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramagiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humpreys, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfmacher, W. A.</span></span> <span> </span><span class="NLM_article-title">It Is Time for a Paradigm Shift in Drug Discovery Bioanalysis: From Srm to Hrms</span>. <i>J. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1002/jms.1921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fjms.1921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21630388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFChtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=595-601&issue=6&author=R.+Ramanathanauthor=M.+Jemalauthor=S.+Ramagiriauthor=Y.+Q.+Xiaauthor=W.+G.+Humpreysauthor=T.+Olahauthor=W.+A.+Korfmacher&title=It+Is+Time+for+a+Paradigm+Shift+in+Drug+Discovery+Bioanalysis%3A+From+Srm+to+Hrms&doi=10.1002%2Fjms.1921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS</span></div><div class="casAuthors">Ramanathan, Ragu; Jemal, Mohammed; Ramagiri, Suma; Xia, Yuan-Qing; Humpreys, W. Griffith; Olah, Timothy; Korfmacher, Walter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Mass Spectrometry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-601</span>CODEN:
                <span class="NLM_cas:coden">JMSPFJ</span>;
        ISSN:<span class="NLM_cas:issn">1076-5174</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  It can be argued that the last true paradigm shift in the bioanal. (BA) arena was the shift from high-performance liq. chromatog. (HPLC) with UV detection to HPLC with tandem mass spectrometry (MS/MS) detection after the commercialization of the triple quadrupole mass spectrometer in the 1990s.  HPLC-MS/MS anal. based on selected reaction monitoring (SRM) has become the gold std. for BA assays and is used by all the major pharmaceutical companies for the quant. anal. of new drug entities (NCEs) as part of the new drug discovery and development process.  While LC-MS/MS continues to be the best tool for drug discovery bioanal., a new paradigm involving high-resoln. mass spectrometry (HRMS) and ultrahigh-pressure liq. chromatog. (uHPLC) is starting to make inroads into the pharmaceutical industry.  The ability to collect full scan spectra, with excellent mass accuracy, mass resoln., 10-250 ms scan speeds and no NCE-related MS parameter optimization, makes the uHPLC-HRMS techniques suitable for quant. anal. of NCEs while preserving max. qual. information about other drug-related and endogenous components such as metabolites, degradants, biomarkers and formulation materials.  In this perspective article, we provide some insight into the evolution of the hybrid quadrupole-time-of-flight (Qq-TOF) mass spectrometer and propose some of the desirable specifications that such HRMS systems should have to be integrated into the drug discovery bioanal. workflow for performing integrated qual. and quant. bioanal. of drugs and related components.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUJ1FXoDKA7bVg90H21EOLACvtfcHk0lhIbp28nDievA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFChtL4%253D&md5=34bb55be25538d3b18ed198b5f04ebb5</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1002%2Fjms.1921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjms.1921%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DR.%26aulast%3DJemal%26aufirst%3DM.%26aulast%3DRamagiri%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DY.%2BQ.%26aulast%3DHumpreys%26aufirst%3DW.%2BG.%26aulast%3DOlah%26aufirst%3DT.%26aulast%3DKorfmacher%26aufirst%3DW.%2BA.%26atitle%3DIt%2520Is%2520Time%2520for%2520a%2520Paradigm%2520Shift%2520in%2520Drug%2520Discovery%2520Bioanalysis%253A%2520From%2520Srm%2520to%2520Hrms%26jtitle%3DJ.%2520Mass%2520Spectrom.%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D595%26epage%3D601%26doi%3D10.1002%2Fjms.1921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, A. E.</span></span> <span> </span><span class="NLM_article-title">Online Hydrogen-Deuterium Exchange and a Tandem-Quadrupole Time-of-Flight Mass Spectrometer Coupled with Liquid Chromatography for Metabolite Identification in Drug Metabolism</span>. <i>J. Chromatogr. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1093/chromsci/41.8.398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1093%2Fchromsci%2F41.8.398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=14558931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Sgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2003&pages=398-404&issue=8&author=A.+E.+Nassar&title=Online+Hydrogen-Deuterium+Exchange+and+a+Tandem-Quadrupole+Time-of-Flight+Mass+Spectrometer+Coupled+with+Liquid+Chromatography+for+Metabolite+Identification+in+Drug+Metabolism&doi=10.1093%2Fchromsci%2F41.8.398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Online Hydrogen-Deuterium Exchange and a Tandem-Quadrupole Time-of-Flight Mass Spectrometer Coupled with Liquid Chromatography for Metabolite Identification in Drug Metabolism</span></div><div class="casAuthors">Nassar, A.-E. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatographic Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">398-404</span>CODEN:
                <span class="NLM_cas:coden">JCHSBZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-9665</span>.
    
            (<span class="NLM_cas:orgname">Preston Publications</span>)
        </div><div class="casAbstract">A method for metabolite identification in drug discovery and development utilizing online hydrogen-deuterium (H-D) exchange and a tandem-quadrupole time-of-flight mass spectrometer coupled with liq. chromatog. has been developed for the first time.  For purposes of evaluating this method, nimodipine is incubated with rat, dog, monkey, and human hepatic microsomes over a 60-min period.  This procedure involves the replacement of H2O with D2O in the mobile phase.  The equilibration time required to change (switch) from H2O in the mobile phase into D2O is approx. 10 min.  There is no significant difference between the retention times in H2O or D2O mobile phase.  The results show that the sepns. of nimodipine and its metabolites and the subsequent H-D exchanges were achieved online.  This leads to the identification of nimodipine metabolites formed in vitro.  Five metabolites of nimodipine are identified and characterized.  These metabolites are formed by dehydrogenation, demethylation of methoxy group, cleavage of the ester groups by hydrolysis or oxidn., and hydroxylation of Me groups.  The combination of the H-D exchange process and the assay system is a powerful tool for the study of metabolite identification.  The method appears to be highly desirable for identification of metabolites produced by dehydrogenation, oxidn., and dealkylation, which are discussed herein.  This method also greatly enhances throughput, which in turn facilitates the ability to rapidly provide metabolite elucidation.  (c) 2003 Preston Publications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkvoX1gRdVGLVg90H21EOLACvtfcHk0lhIbp28nDievA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Sgu7c%253D&md5=3c15037601d67033539128241b882a74</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1093%2Fchromsci%2F41.8.398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fchromsci%252F41.8.398%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.%2BE.%26atitle%3DOnline%2520Hydrogen-Deuterium%2520Exchange%2520and%2520a%2520Tandem-Quadrupole%2520Time-of-Flight%2520Mass%2520Spectrometer%2520Coupled%2520with%2520Liquid%2520Chromatography%2520for%2520Metabolite%2520Identification%2520in%2520Drug%2520Metabolism%26jtitle%3DJ.%2520Chromatogr.%2520Sci.%26date%3D2003%26volume%3D41%26issue%3D8%26spage%3D398%26epage%3D404%26doi%3D10.1093%2Fchromsci%2F41.8.398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munson, B.</span></span> <span> </span><span class="NLM_article-title">Collisionally-Induced Dissociation of Purine Antiviral Agents: Mechanisms of Ion Formation Using Gas Phase Hydrogen/Deuterium Exchange and Electrospray Ionization Tandem Mass Spectrometry</span>. <i>Eur. J. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1255/ejms.538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1255%2Fejms.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15103102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVamtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=239-257&issue=2&author=A.+M.+Kamelauthor=B.+Munson&title=Collisionally-Induced+Dissociation+of+Purine+Antiviral+Agents%3A+Mechanisms+of+Ion+Formation+Using+Gas+Phase+Hydrogen%2FDeuterium+Exchange+and+Electrospray+Ionization+Tandem+Mass+Spectrometry&doi=10.1255%2Fejms.538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Collision-induced dissociation of purine antiviral agents: mechanisms of ion formation using gas-phase hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry</span></div><div class="casAuthors">Kamel, Amin M.; Munson, Burnaby</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-257</span>CODEN:
                <span class="NLM_cas:coden">EJMSCL</span>;
        ISSN:<span class="NLM_cas:issn">1469-0667</span>.
    
            (<span class="NLM_cas:orgname">IM Publications</span>)
        </div><div class="casAbstract">Electrospray ionization (ESI) and collision-induced dissocn. (CID) mass spectra were obtained for two purine nucleoside antiviral agents (acycloguanosine and vidarabine) and one purine nucleotide (vidarabine monophosphate) and for the corresponding compds. in which the labile hydrogens were replaced by deuterium gas-phase exchange.  The no. of labile hydrogens, x, was detd. from a comparison of ESI spectra obtained with N2 and with ND3 as the nebulizer gas.  CID mass spectra were obtained for [M+H]+ and [M-H]- ions and the exchanged analogs, [M(Dx)+D]+ and [M(Dx)-D]-, produced by ESI using a Sciex API-IIIplus mass spectrometer.  Compns. of product ions were detd. and mechanisms of decompn. elucidated by comparison of the CID mass spectra of the un-deuterated and deuterated species.  Protonated purine antiviral agents dissoc. through rearrangement decompns. of base-protonated [M+H]+ ions by cleavage of the glycosidic bonds to give the protonated bases with a sugar moiety as the neutral fragment.  Cleavage of the same bonds with charge retention on the sugar moiety gives low abundance ions, due to the low proton affinity of the sugar moiety compared with that of the purine base.  CID of protonated purine bases [B+H]+ occurs through two major pathways: (1) elimination of NH3 (ND3) and (2) loss of NH2CN (ND2CN).  Minor pathways include elimination of HNCO (DNCO), loss of CO and loss of HCN (DCN).  Deprotonated acycloguanosine and vidarabine exhibit the deprotonated base [B-H]- as a major fragment from glycosidic bond cleavage and charge delocalization on the base.  Deprotonated vidarabine monophosphate, however, shows predominantly phosphate-related product ions.  CID of deprotonated guanine shows two principal pathways: (1) elimination of NH3 (ND3) and (2) loss of NH2CN (ND2CN).  Minor pathways include elimination of HNCO (DNCO), loss of CO and loss of HCN (DCN).  The dissocn. reactions of deprotonated adenine, however, proceed by elimination of HCN and elimination of NCHNH (NCHND).  The mass spectra of the antiviral agents studied in this paper may be useful in predicting reaction pathways in other heteroarom. ring decompns. of nucleosides and nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVD35ob8XOWbVg90H21EOLACvtfcHk0ljwvh7Po-bMcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVamtL8%253D&md5=96299e7946c81e1a944612a3df7e9e10</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1255%2Fejms.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1255%252Fejms.538%26sid%3Dliteratum%253Aachs%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DMunson%26aufirst%3DB.%26atitle%3DCollisionally-Induced%2520Dissociation%2520of%2520Purine%2520Antiviral%2520Agents%253A%2520Mechanisms%2520of%2520Ion%2520Formation%2520Using%2520Gas%2520Phase%2520Hydrogen%252FDeuterium%2520Exchange%2520and%2520Electrospray%2520Ionization%2520Tandem%2520Mass%2520Spectrometry%26jtitle%3DEur.%2520J.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D10%26issue%3D2%26spage%3D239%26epage%3D257%26doi%3D10.1255%2Fejms.538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span> <span> </span><span class="NLM_article-title">Oxidative Metabolism of a Quinoxaline Derivative by Xanthine Oxidase in Rodent Plasma</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2207</span>– <span class="NLM_lpage">2216</span>, <span class="refDoi"> DOI: 10.1021/tx200329k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200329k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GgtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=2207-2216&issue=12&author=R.+Sharmaauthor=H.+Engauthor=G.+S.+Walkerauthor=G.+Barreiroauthor=A.+F.+Stepanauthor=K.+F.+McClureauthor=A.+Wolfordauthor=P.+D.+Boninauthor=P.+Corneliusauthor=A.+S.+Kalgutkar&title=Oxidative+Metabolism+of+a+Quinoxaline+Derivative+by+Xanthine+Oxidase+in+Rodent+Plasma&doi=10.1021%2Ftx200329k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Metabolism of a Quinoxaline Derivative by Xanthine Oxidase in Rodent Plasma</span></div><div class="casAuthors">Sharma, Raman; Eng, Heather; Walker, Gregory S.; Barreiro, Gabriela; Stepan, Antonia F.; McClure, Kim F.; Wolford, Angela; Bonin, Paul D.; Cornelius, Peter; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2207-2216</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of efforts directed at the G protein-coupled receptor 119 agonist program for type 2 diabetes, a series of cyanopyridine derivs. exemplified by isopropyl-4-(3-cyano-5-(quinoxalin-6-yl)pyridine-2-yl)piperazine-1-carboxylate (1) were identified as novel chemotypes worthy of further hit-to-lead optimization.  Compd. 1, however, was found to be unstable in plasma (37 °C, pH 7.4) from rat (T1/2 = 16 min), mouse (T1/2 = 61 min), and guinea pig (T1/2 = 4 min).  Lowering the temp. of plasma incubations (4-25 °C) attenuated the degrdn. of 1, implicating the involvement of an enzyme-mediated process.  Failure to detect any appreciable amt. of 1 in plasma samples from protein binding and pharmacokinetic studies in rats was consistent with its labile nature in plasma.  Instability noted in rodent plasma was not obsd. in plasma from dogs, monkeys, and humans (T1/2 > 370 min at 37 °C, pH 7.4).  Metabolite identification studies in rodent plasma revealed the formation of a single metabolite (M1), which was 16 Da higher than the mol. wt. of 1 (compd. 1, MH+ = 403; M1, MH+ = 419).  Pretreatment of rat plasma with allopurinol, but not raloxifene, abolished the conversion of 1 to M1, suggesting that xanthine oxidase (XO) was responsible for the oxidative instability.  Consistent with the known catalytic mechanism of XO, the source of oxygen incorporated in M1 was derived from water rather than mol. oxygen.  The formation of M1 was also demonstrated in incubations of 1 with purified bovine XO.  The structure of M1 was detd. by NMR anal. to be isopropyl-4-(3-cyano-5-(3-oxo-3,4-dihydroquinoxalin-6-yl)pyridine-2-yl)piperazine-1-carboxylate.  The regiochem. of quinoxaline ring oxidn. in 1 was consistent with ab initio calcns. and mol. docking studies using a published crystal structure of bovine XO.  A close-in analog of 1, which lacked the quinoxaline motif (e.g., 5-(4-cyano-3-methylphenyl)-2-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)nicotinitrile (2)) was stable in rat plasma and possessed substantially improved GPR119 agonist properties.  To the best of our knowledge, our studies constitute the first report on the involvement of rodent XO in oxidative drug metab. in plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqifhwdppp75LVg90H21EOLACvtfcHk0ljwvh7Po-bMcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GgtbvN&md5=859662ffb3a9f9989b9be9a1b33b6a33</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1021%2Ftx200329k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200329k%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DWolford%26aufirst%3DA.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DCornelius%26aufirst%3DP.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DOxidative%2520Metabolism%2520of%2520a%2520Quinoxaline%2520Derivative%2520by%2520Xanthine%2520Oxidase%2520in%2520Rodent%2520Plasma%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26issue%3D12%26spage%3D2207%26epage%3D2216%26doi%3D10.1021%2Ftx200329k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Hara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackmond, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Radical-Based Regioselective C-H Functionalization of Electron-Deficient Heteroarenes: Scope, Tunability, and Predictability</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">32</span>),  <span class="NLM_fpage">12122</span>– <span class="NLM_lpage">12134</span>, <span class="refDoi"> DOI: 10.1021/ja406223k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja406223k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=12122-12134&issue=32&author=F.+O%E2%80%99Haraauthor=D.+G.+Blackmondauthor=P.+S.+Baran&title=Radical-Based+Regioselective+C-H+Functionalization+of+Electron-Deficient+Heteroarenes%3A+Scope%2C+Tunability%2C+and+Predictability&doi=10.1021%2Fja406223k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Radical-Based Regioselective C-H Functionalization of Electron-Deficient Heteroarenes: Scope, Tunability, and Predictability</span></div><div class="casAuthors">O'Hara, Fionn; Blackmond, Donna G.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">12122-12134</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Radical addn. processes can be ideally suited for the direct functionalization of heteroarom. bases, yet these processes are only sparsely used due to the perception of poor or unreliable control of regiochem.  A systematic investigation of factors affecting the regiochem. of radical functionalization of heterocycles using alkylsulfinate salts revealed that certain types of substituents exert consistent and additive effects on the regioselectivity of substitution.  This allowed us to establish guidelines for predicting regioselectivity on complex π-deficient heteroarenes, including pyridines, pyrimidines, pyridazines, and pyrazines.  Since the relative contribution from opposing directing factors was dependent on solvent and pH, it was sometimes possible to tune the regiochem. to a desired result by modifying reaction conditions.  This methodol. was applied to the direct, regioselective introduction of iso-Pr groups into complex, biol. active mols., such as diflufenican (I; R = H → R = iso-Pr) and nevirapine (II; R = H → R = iso-Pr).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEOGesZTIMOrVg90H21EOLACvtfcHk0lgAYqPNlEwuug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3M&md5=e12331edd20ef03aafe3c7a7145a8f6e</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1021%2Fja406223k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja406223k%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hara%26aufirst%3DF.%26aulast%3DBlackmond%26aufirst%3DD.%2BG.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DRadical-Based%2520Regioselective%2520C-H%2520Functionalization%2520of%2520Electron-Deficient%2520Heteroarenes%253A%2520Scope%252C%2520Tunability%252C%2520and%2520Predictability%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D32%26spage%3D12122%26epage%3D12134%26doi%3D10.1021%2Fja406223k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Christian Gampe, <span class="NLM_string-name hlFld-ContribAuthor">Vishal A. Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14357-14381. <a href="https://doi.org/10.1021/acs.jmedchem.0c01177" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01177%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurse%252Bor%252BCure%25253F%252BA%252BPerspective%252Bon%252Bthe%252BDevelopability%252Bof%252BAldehydes%252Bas%252BActive%252BPharmaceutical%252BIngredients%26aulast%3DGampe%26aufirst%3DChristian%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D29092020%26date%3D11092020%26volume%3D63%26issue%3D23%26spage%3D14357%26epage%3D14381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Julia Shanu-Wilson, Liam Evans, Stephen Wrigley, Jonathan Steele, James Atherton, <span class="NLM_string-name hlFld-ContribAuthor">Jason Boer</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation: Impact and Application of Metabolism in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2087-2107. <a href="https://doi.org/10.1021/acsmedchemlett.0c00202" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00202%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBiotransformation%25253A%252BImpact%252Band%252BApplication%252Bof%252BMetabolism%252Bin%252BDrug%252BDiscovery%26aulast%3DShanu-Wilson%26aufirst%3DJulia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D13082020%26date%3D28082020%26volume%3D11%26issue%3D11%26spage%3D2087%26epage%3D2107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laura Goracci, Jenny Desantis, Aurora Valeri, Beatrice Castellani, Michela Eleuteri, <span class="NLM_string-name hlFld-ContribAuthor">Gabriele Cruciani</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11615-11638. <a href="https://doi.org/10.1021/acs.jmedchem.0c00793" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00793%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnderstanding%252Bthe%252BMetabolism%252Bof%252BProteolysis%252BTargeting%252BChimeras%252B%252528PROTACs%252529%25253A%252BThe%252BNext%252BStep%252Btoward%252BPharmaceutical%252BApplications%26aulast%3DGoracci%26aufirst%3DLaura%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11052020%26date%3D07102020%26volume%3D63%26issue%3D20%26spage%3D11615%26epage%3D11638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Li Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Synergy between Experiments and Computations: A Green Channel for Revealing Metabolic Mechanism of Xenobiotics in Chemical Toxicology. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2020,</strong> <em>33 </em>
                                    (7)
                                     , 1539-1550. <a href="https://doi.org/10.1021/acs.chemrestox.9b00448" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.9b00448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.9b00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.9b00448%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DSynergy%252Bbetween%252BExperiments%252Band%252BComputations%25253A%252BA%252BGreen%252BChannel%252Bfor%252BRevealing%252BMetabolic%252BMechanism%252Bof%252BXenobiotics%252Bin%252BChemical%252BToxicology%26aulast%3DJi%26aufirst%3DLi%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D04112019%26date%3D10042020%26date%3D27032020%26volume%3D33%26issue%3D7%26spage%3D1539%26epage%3D1550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jihui Zhao, Rongrong Cui, Lihao Wang, Yingjia Chen, Zunyun Fu, Xiaoyu Ding, Chen Cui, Tianbiao Yang, Xutong Li, Yuan Xu, Kaixian Chen, Xiaomin Luo, Hualiang Jiang, <span class="NLM_string-name hlFld-ContribAuthor">Mingyue Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: An Improved Computational Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6523-6537. <a href="https://doi.org/10.1021/acs.jmedchem.9b01895" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01895%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevisiting%252BAldehyde%252BOxidase%252BMediated%252BMetabolism%252Bin%252BDrug-like%252BMolecules%25253A%252BAn%252BImproved%252BComputational%252BModel%26aulast%3DZhao%26aufirst%3DJihui%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D14112019%26date%3D31032020%26date%3D19032020%26volume%3D63%26issue%3D12%26spage%3D6523%26epage%3D6537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stephane Perreault, Fatima Arjmand, Jayaraman Chandrasekhar, Jia Hao, Kathleen S. Keegan, David Koditek, Eve-Irene Lepist, Clinton K. Matson, Mary E. McGrath, Leena Patel, Kassandra Sedillo, Joseph Therrien, Nicholas A. Till, Adrian Tomkinson, Jennifer Treiberg, Yelena Zherebina, <span class="NLM_string-name hlFld-ContribAuthor">Gary Phillips</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an Atropisomeric PI3Kβ Selective Inhibitor through Optimization of the Hinge Binding Motif. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1236-1243. <a href="https://doi.org/10.1021/acsmedchemlett.0c00095" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00095%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ban%252BAtropisomeric%252BPI3K%2525CE%2525B2%252BSelective%252BInhibitor%252Bthrough%252BOptimization%252Bof%252Bthe%252BHinge%252BBinding%252BMotif%26aulast%3DPerreault%26aufirst%3DStephane%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22022020%26date%3D13042020%26date%3D15042020%26date%3D13042020%26volume%3D11%26issue%3D6%26spage%3D1236%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Frederick W. Goldberg, M. Raymond V. Finlay, Attilla K. T. Ting, David Beattie, Gillian M. Lamont, Charlene Fallan, Gail L. Wrigley, Marianne Schimpl, Martin R. Howard, Beth Williamson, Mercedes Vazquez-Chantada, Derek G. Barratt, Barry R. Davies, Elaine B. Cadogan, Antonio Ramos-Montoya, <span class="NLM_string-name hlFld-ContribAuthor">Emma Dean</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (7)
                                     , 3461-3471. <a href="https://doi.org/10.1021/acs.jmedchem.9b01684" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01684%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252B7-Methyl-2-%25255B%2525287-methyl%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridin-6-yl%252529amino%25255D-9-%252528tetrahydro-2H-pyran-4-yl%252529-7%25252C9-dihydro-8H-purin-8-one%252B%252528AZD7648%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BDNA-Dependent%252BProtein%252BKinase%252B%252528DNA-PK%252529%252BInhibitor%26aulast%3DGoldberg%26aufirst%3DFrederick%2BW.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11102019%26date%3D15012020%26date%3D18122019%26volume%3D63%26issue%3D7%26spage%3D3461%26epage%3D3471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gilles Ouvry, Laurence Clary, Loïc Tomas, Michèle Aurelly, Laetitia Bonnary, Emilie Borde, Claire Bouix-Peter, Laurent Chantalat, Claire Defoin-Platel, Sophie Deret, Mathieu Forissier, Craig S. Harris, Tatiana Isabet, Laurent Lamy, Anne-Pascale Luzy, Jonathan Pascau, Catherine Soulet, Alessandro Taddei, Nathalie Taquet, Etienne Thoreau, Emeric Varvier, Emmanuel Vial, <span class="NLM_string-name hlFld-ContribAuthor">Laurent F. Hennequin</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (11)
                                     , 1561-1567. <a href="https://doi.org/10.1021/acsmedchemlett.9b00401" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00401%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImpact%252Bof%252BMinor%252BStructural%252BModifications%252Bon%252BProperties%252Bof%252Ba%252BSeries%252Bof%252BmTOR%252BInhibitors%26aulast%3DOuvry%26aufirst%3DGilles%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30082019%26date%3D04102019%26date%3D08102019%26date%3D04102019%26volume%3D10%26issue%3D11%26spage%3D1561%26epage%3D1567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Somaieh  Soltani</span>, <span class="hlFld-ContribAuthor ">Somayeh  Hallaj-Nezhadi</span>, <span class="hlFld-ContribAuthor ">Mohammad Reza  Rashidi</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review of in silico approaches for the prediction and modulation of aldehyde oxidase-mediated drug metabolism: The current features, challenges and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113559. <a href="https://doi.org/10.1016/j.ejmech.2021.113559" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113559%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bof%252Bin%252Bsilico%252Bapproaches%252Bfor%252Bthe%252Bprediction%252Band%252Bmodulation%252Bof%252Baldehyde%252Boxidase-mediated%252Bdrug%252Bmetabolism%25253A%252BThe%252Bcurrent%252Bfeatures%25252C%252Bchallenges%252Band%252Bfuture%252Bperspectives%26aulast%3DSoltani%26aufirst%3DSomaieh%26date%3D2021%26volume%3D222%26spage%3D113559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elias Carvalho  Padilha</span>, <span class="hlFld-ContribAuthor ">Pranav  Shah</span>, <span class="hlFld-ContribAuthor ">Ganesha  Rai</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">NOX2 inhibitor GSK2795039 metabolite identification towards drug optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2021,</strong> <em>201 </em>, 114102. <a href="https://doi.org/10.1016/j.jpba.2021.114102" title="DOI URL">https://doi.org/10.1016/j.jpba.2021.114102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2021.114102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2021.114102%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DNOX2%252Binhibitor%252BGSK2795039%252Bmetabolite%252Bidentification%252Btowards%252Bdrug%252Boptimization%26aulast%3DPadilha%26aufirst%3DElias%2BCarvalho%26date%3D2021%26volume%3D201%26spage%3D114102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subramanyam  Vankadara</span>, <span class="hlFld-ContribAuthor ">Yun  Xuan Wong</span>, <span class="hlFld-ContribAuthor ">Boping  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Yang See</span>, <span class="hlFld-ContribAuthor ">Li  Hong Tan</span>, <span class="hlFld-ContribAuthor ">Qian  Wen Tan</span>, <span class="hlFld-ContribAuthor ">Gang  Wang</span>, <span class="hlFld-ContribAuthor ">Ratna  Karuna</span>, <span class="hlFld-ContribAuthor ">Xue  Guo</span>, <span class="hlFld-ContribAuthor ">Shu  Ting Tan</span>, <span class="hlFld-ContribAuthor ">Jia  Yi Fong</span>, <span class="hlFld-ContribAuthor ">Joma  Joy</span>, <span class="hlFld-ContribAuthor ">C.S.  Brian Chia</span>. </span><span class="cited-content_cbyCitation_article-title">A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>382 </em>, 128263. <a href="https://doi.org/10.1016/j.bmcl.2021.128263" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128263%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bhead-to-head%252Bcomparison%252Bof%252Bthe%252Binhibitory%252Bactivities%252Bof%252B15%252Bpeptidomimetic%252BSARS-CoV-2%252B3CLpro%252Binhibitors%26aulast%3DVankadara%26aufirst%3DSubramanyam%26date%3D2021%26volume%3D382%26spage%3D128263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepak K.  Dalvie</span>, <span class="hlFld-ContribAuthor ">Bernard  Testa</span>. </span><span class="cited-content_cbyCitation_article-title">Principles of Drug Metabolism. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-139. <a href="https://doi.org/10.1002/0471266949.bmc033.pub3" title="DOI URL">https://doi.org/10.1002/0471266949.bmc033.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc033.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc033.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DPrinciples%252Bof%252BDrug%252BMetabolism%26aulast%3DDalvie%26aufirst%3DDeepak%2BK.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D139%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhilesh V.  Dhuria</span>, <span class="hlFld-ContribAuthor ">Bianka  Haro</span>, <span class="hlFld-ContribAuthor ">Amit  Kapadia</span>, <span class="hlFld-ContribAuthor ">Khadjia A.  Lobo</span>, <span class="hlFld-ContribAuthor ">Bernice  Matusow</span>, <span class="hlFld-ContribAuthor ">Mary A.  Schleiff</span>, <span class="hlFld-ContribAuthor ">Christina  Tantoy</span>, <span class="hlFld-ContribAuthor ">Jasleen K.  Sodhi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in predicting CYP-independent metabolism. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2021,</strong> <em>53 </em>
                                    (2)
                                     , 188-206. <a href="https://doi.org/10.1080/03602532.2021.1923728" title="DOI URL">https://doi.org/10.1080/03602532.2021.1923728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03602532.2021.1923728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03602532.2021.1923728%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DRecent%252Bdevelopments%252Bin%252Bpredicting%252BCYP-independent%252Bmetabolism%26aulast%3DDhuria%26aufirst%3DNikhilesh%2BV.%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D2%26spage%3D188%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ciarán N.  Cronin</span>, <span class="hlFld-ContribAuthor ">JianHua  Liu</span>, <span class="hlFld-ContribAuthor ">Nicole  Grable</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Strelevitz</span>, <span class="hlFld-ContribAuthor ">R. Scott  Obach</span>, <span class="hlFld-ContribAuthor ">Anthony  Carlo</span>. </span><span class="cited-content_cbyCitation_article-title">Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay. </span><span class="cited-content_cbyCitation_journal-name">Protein Expression and Purification</span><span> <strong>2021,</strong> <em>177 </em>, 105749. <a href="https://doi.org/10.1016/j.pep.2020.105749" title="DOI URL">https://doi.org/10.1016/j.pep.2020.105749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pep.2020.105749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pep.2020.105749%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Expression%2520and%2520Purification%26atitle%3DProduction%252Bof%252Bactive%252Brecombinant%252Bhuman%252Baldehyde%252Boxidase%252B%252528AOX%252529%252Bin%252Bthe%252Bbaculovirus%252Bexpression%252Bvector%252Bsystem%252B%252528BEVS%252529%252Band%252Bdeployment%252Bin%252Ba%252Bpre-clinical%252Bfraction-of-control%252BAOX%252Bcompound%252Bexposure%252Bassay%26aulast%3DCronin%26aufirst%3DCiar%25C3%25A1n%2BN.%26date%3D2021%26volume%3D177%26spage%3D105749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erickson M.  Paragas</span>, <span class="hlFld-ContribAuthor ">Kanika  Choughule</span>, <span class="hlFld-ContribAuthor ">Jeffrey P.  Jones</span>, <span class="hlFld-ContribAuthor ">John T.  Barr</span>. </span><span class="cited-content_cbyCitation_article-title">Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde Oxidase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 257-284. <a href="https://doi.org/10.1007/978-1-0716-1554-6_10" title="DOI URL">https://doi.org/10.1007/978-1-0716-1554-6_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-0716-1554-6_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-0716-1554-6_10%26sid%3Dliteratum%253Aachs%26atitle%3DEnzyme%252BKinetics%25252C%252BPharmacokinetics%25252C%252Band%252BInhibition%252Bof%252BAldehyde%252BOxidase%26aulast%3DParagas%26aufirst%3DErickson%2BM.%26date%3D2021%26date%3D2021%26spage%3D257%26epage%3D284%26pub%3DSpringer%2520US%26atitle%3DEnzyme%252BKinetics%252Bin%252BDrug%252BMetabolism%26aulast%3DNagar%26aufirst%3DSwati%26date%3D2021%26volume%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien L.  Degorce</span>, <span class="hlFld-ContribAuthor ">Anna  Aagaard</span>, <span class="hlFld-ContribAuthor ">Rana  Anjum</span>, <span class="hlFld-ContribAuthor ">Iain A.  Cumming</span>, <span class="hlFld-ContribAuthor ">Coura R.  Diène</span>, <span class="hlFld-ContribAuthor ">Charlene  Fallan</span>, <span class="hlFld-ContribAuthor ">Tony  Johnson</span>, <span class="hlFld-ContribAuthor ">Karl-Johan  Leuchowius</span>, <span class="hlFld-ContribAuthor ">Alexandra L.  Orton</span>, <span class="hlFld-ContribAuthor ">Stuart  Pearson</span>, <span class="hlFld-ContribAuthor ">Graeme R.  Robb</span>, <span class="hlFld-ContribAuthor ">Alan  Rosen</span>, <span class="hlFld-ContribAuthor ">Graeme B.  Scarfe</span>, <span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">James M.  Smith</span>, <span class="hlFld-ContribAuthor ">Oliver R.  Steward</span>, <span class="hlFld-ContribAuthor ">Ina  Terstiege</span>, <span class="hlFld-ContribAuthor ">Michael J.  Tucker</span>, <span class="hlFld-ContribAuthor ">Paul  Turner</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Gail L.  Wrigley</span>, <span class="hlFld-ContribAuthor ">Yafeng  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (23)
                                     , 115815. <a href="https://doi.org/10.1016/j.bmc.2020.115815" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115815%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DImproving%252Bmetabolic%252Bstability%252Band%252Bremoving%252Baldehyde%252Boxidase%252Bliability%252Bin%252Ba%252B5-azaquinazoline%252Bseries%252Bof%252BIRAK4%252Binhibitors%26aulast%3DDegorce%26aufirst%3DS%25C3%25A9bastien%2BL.%26date%3D2020%26volume%3D28%26issue%3D23%26spage%3D115815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masato  Ooka</span>, <span class="hlFld-ContribAuthor ">Caitlin  Lynch</span>, <span class="hlFld-ContribAuthor ">Menghang  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Application of In Vitro Metabolism Activation in High-Throughput Screening. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 8182. <a href="https://doi.org/10.3390/ijms21218182" title="DOI URL">https://doi.org/10.3390/ijms21218182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21218182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21218182%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DApplication%252Bof%252BIn%252BVitro%252BMetabolism%252BActivation%252Bin%252BHigh-Throughput%252BScreening%26aulast%3DOoka%26aufirst%3DMasato%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D8182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsuki  Nagata</span>, <span class="hlFld-ContribAuthor ">Yasushi  Obora</span>. </span><span class="cited-content_cbyCitation_article-title">Transition‐Metal‐Mediated/Catalyzed Synthesis of Pyridines, Pyrimidines, and Triazines by [2+2+2] Cycloaddition Reactions. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>9 </em>
                                    (10)
                                     , 1532-1547. <a href="https://doi.org/10.1002/ajoc.202000240" title="DOI URL">https://doi.org/10.1002/ajoc.202000240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000240%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTransition%2525E2%252580%252590Metal%2525E2%252580%252590Mediated%25252FCatalyzed%252BSynthesis%252Bof%252BPyridines%25252C%252BPyrimidines%25252C%252Band%252BTriazines%252Bby%252B%25255B2%25252B2%25252B2%25255D%252BCycloaddition%252BReactions%26aulast%3DNagata%26aufirst%3DTatsuki%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D10%26spage%3D1532%26epage%3D1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yin‐Xiao  Du</span>, <span class="hlFld-ContribAuthor ">Xiao‐Ping  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>108 </em>
                                    (2)
                                     , 242-247. <a href="https://doi.org/10.1002/cpt.1844" title="DOI URL">https://doi.org/10.1002/cpt.1844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.1844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.1844%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DFavipiravir%25253A%252BPharmacokinetics%252Band%252BConcerns%252BAbout%252BClinical%252BTrials%252Bfor%252B2019%2525E2%252580%252590nCoV%252BInfection%26aulast%3DDu%26aufirst%3DYin%25E2%2580%2590Xiao%26date%3D2020%26date%3D2020%26volume%3D108%26issue%3D2%26spage%3D242%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kei  Irie</span>, <span class="hlFld-ContribAuthor ">Atsushi  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Hirotoshi  Fujita</span>, <span class="hlFld-ContribAuthor ">Ryo  Tamura</span>, <span class="hlFld-ContribAuthor ">Masaaki  Eto</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Ikesue</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Muroi</span>, <span class="hlFld-ContribAuthor ">Keisuke  Tomii</span>, <span class="hlFld-ContribAuthor ">Tohru  Hashida</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Science</span><span> <strong>2020,</strong> <em>23 </em><a href="https://doi.org/10.1111/cts.12827" title="DOI URL">https://doi.org/10.1111/cts.12827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cts.12827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcts.12827%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Science%26atitle%3DPharmacokinetics%252Bof%252BFavipiravir%252Bin%252BCritically%252BIll%252BPatients%252BWith%252BCOVID%2525E2%252580%25259019%26aulast%3DIrie%26aufirst%3DKei%26date%3D2020%26date%3D2020%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yixue  Qiao</span>, <span class="hlFld-ContribAuthor ">Kaushik  Maiti</span>, <span class="hlFld-ContribAuthor ">Zakia  Sultana</span>, <span class="hlFld-ContribAuthor ">Lei  Fu</span>, <span class="hlFld-ContribAuthor ">Roger  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of vertebrate aldehyde oxidase as a therapeutic treatment for cancer, obesity, aging and amyotrophic lateral sclerosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111948. <a href="https://doi.org/10.1016/j.ejmech.2019.111948" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111948%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252Bvertebrate%252Baldehyde%252Boxidase%252Bas%252Ba%252Btherapeutic%252Btreatment%252Bfor%252Bcancer%25252C%252Bobesity%25252C%252Baging%252Band%252Bamyotrophic%252Blateral%252Bsclerosis%26aulast%3DQiao%26aufirst%3DYixue%26date%3D2020%26volume%3D187%26spage%3D111948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liam  Evans</span>, <span class="hlFld-ContribAuthor ">Richard  Phipps</span>, <span class="hlFld-ContribAuthor ">Julia  Shanu-Wilson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Steele</span>, <span class="hlFld-ContribAuthor ">Stephen  Wrigley</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for metabolite generation and characterization by NMR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 119-150. <a href="https://doi.org/10.1016/B978-0-12-820018-6.00004-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-820018-6.00004-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820018-6.00004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820018-6.00004-1%26sid%3Dliteratum%253Aachs%26atitle%3DMethods%252Bfor%252Bmetabolite%252Bgeneration%252Band%252Bcharacterization%252Bby%252BNMR%26aulast%3DEvans%26aufirst%3DLiam%26date%3D2020%26spage%3D119%26epage%3D150%26pub%3DElsevier%26atitle%3DIdentification%252Band%252BQuantification%252Bof%252BDrugs%25252C%252BMetabolites%25252C%252BDrug%252BMetabolizing%252BEnzymes%25252C%252Band%252BTransporters%26date%3D2020%26volume%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0030.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Factors influencing AO-mediated metabolism and drug design. Representation of AO-catalyzed sites of oxidation on quinazoline is prepared based on transition state energies calculated in Montefiori et al. 2017.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Drawings of human body and mouse are authored by Mikael Häggström and David Liao, respectively, and are freely provided for reuse under the Creative Commons license. Drug disappearance and metabolite appearance curves are simulated with GraphPad Prism 8.1 (GraphPad Software). Representation of AO active site is prepared based on published cocrystal structure of human AO (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UHX">4UHX</a>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> using the PyMOL 2.3 software (Schrödinger, Inc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of human AO (A) and its MoCo active site (B). Representations are prepared based on published cocrystal structure of human AO (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UHX">4UHX</a>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> using the PyMOL 2.3 software (Schrödinger, Inc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed concerted catalytic mechanisms of AO-catalyzed oxidations<a onclick="showRef(event, 'ref40 ref41 ref45'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref45">(40,41,45)</a> (A) and amide hydrolysis<a onclick="showRef(event, 'ref9 ref28'); return false;" href="javascript:void(0);" class="ref ref9 ref28">(9,28)</a> (B). Amino acid residues are numbered according to the human AO sequence.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Examples of aromatic azaheterocycles oxidized by AO. Star denotes the site of oxidation by AO, if reported in the literature. See <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> for the list of published AO substrates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Examples of nonaromatic azaheterocycles oxidized by AO, often in combination with other oxidative drug-metabolizing enzymes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Examples of aldehyde oxidations catalyzed by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Examples of amide hydrolysis catalyzed by AO. (A) GDC-0834 was the first reported example of amide hydrolysis by AO.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (B) Modifications of amine moiety affected rates of amide hydrolysis, with EDGs in the ortho position giving the highest propensity toward hydrolysis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (C) Modifications of acyl moiety had less impact, with most tested compounds being AO substrates.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Examples of nitro reductions catalyzed by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Example of mechanistically important and simultaneous oxidation/reduction of 5-nitroquinoline catalyzed by AO. Prepared based on results from Paragas et al.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Examples of <i>N</i>-oxide reductions catalyzed by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Examples of various reductions catalyzed by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Options to manage AO-catalyzed oxidations in the context of drug discovery.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Examples of kinetic deuterium isotope effect (KDIE) in AO-catalyzed oxidations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Application of AO metabolites as novel scaffolds or prodrugs in drug discovery.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Example of disubstituted 1,6-naphthyridines and isoquinolines. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on Mallinger et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Example of pyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one analogues. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on Hayes et al.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Examples of azaindole analogues. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on results from refs <a onclick="showRef(event, 'ref25 ref51 ref93'); return false;" href="javascript:void(0);" class="ref ref25 ref51 ref93">(25,51,and93)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Example of imidazoquinoline analogues. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on results from Glatthar et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Example of 1,5-naphthyridine analogues. Asterisk denotes the site of AO-catalyzed oxidations. Prepared based on results from Cheng et al.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Examples of pyridine analogues. Prepared based on results from Pryde et al.<a onclick="showRef(event, 'ref7 ref65'); return false;" href="javascript:void(0);" class="ref ref7 ref65">(7,65)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Example of imidazo[1,2-<i>a</i>]pyrimidine analogues. Prepared based on results from Linton et al.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Example of naphthyridine analogues in azetidinyl ketolides. Prepared based on results from Magee et al.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Exact sites of AO oxidation were not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Example of quinoline analogues (zoniporide series). Prepared based on results from Dalvie et al.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Example of quinoline analogues (c-Met inhibitors). Prepared based on results from Zhang et al.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Example of atropisomerism affecting the rate of AO metabolism of the quinoline analogues. Asterisk denotes the site of AO oxidation. Prepared based on results from Chandrasekhar et al. 2018.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Applications of the chemical “Litmus test”. Prepared based on results from O’Hara et al.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/medium/jm9b00875_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Example of HSQC <sup>1</sup>H−<sup>13</sup>C of litmus test reaction in an NMR tube. The HSQC spectra of the reaction mixtures show the <sup>1</sup>H−<sup>13</sup>C correlation before (A) and after (B) addition of the litmus test reagent, TBHP. The unreacted pyridyl C−H correlations (signals 1 and 2) can be seen to split into two peaks (1a/b and 2a/b) due to the shift effect of the addition of the CHF<sub>2</sub> on a neighboring carbon. C−H (3) is still a single signal as this represents unreacted starting material with the product no longer having a C−H in this position.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00875/20191219/images/large/jm9b00875_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00875&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 240 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltani, S.</span></span> <span> </span><span class="NLM_article-title">An Overview of Aldehyde Oxidase: An Enzyme of Emerging Importance in Novel Drug Discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1080/17460441.2017.1284198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F17460441.2017.1284198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28095715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Cis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=305-316&issue=3&author=M.+R.+Rashidiauthor=S.+Soltani&title=An+Overview+of+Aldehyde+Oxidase%3A+An+Enzyme+of+Emerging+Importance+in+Novel+Drug+Discovery&doi=10.1080%2F17460441.2017.1284198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery</span></div><div class="casAuthors">Rashidi, Mohammad-Reza; Soltani, Somaieh</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-316</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Given the rising trend in medicinal chem. strategy to reduce cytochrome P 450-dependent metab., aldehyde oxidase (AOX) has recently gained increased attention in drug discovery programs and the no. of drug candidates that are metabolized by AOX is steadily growing.  Despite the emerging importance of AOX in drug discovery, there are certain major recognized problems assocd. with AOX-mediated metab. of drugs.  Intra- and inter-species variations in AOX activity, the lack of reliable and predictive animal models using the common exptl. animals, and failure in the predictions of in vivo metabolic activity of AOX using traditional in vitro methods are among these issues that are covered in this article.  A comprehensive review of computational human AOX (hAOX) related studies are also provided.  Following the recent progress in the stem cell field, the authors recommend the application of organoids technol. as an effective tool to solve the fundamental problems assocd. with the evaluation of AOX in drug discovery.  The recent success in resolving the hAOX crystal structure can too be another valuable data source for the study of AOX-catalyzed metab. of new drug candidates, using computer-aided drug discovery methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqNIV9RHOPk7Vg90H21EOLACvtfcHk0lhzOOronT8pDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Cis7c%253D&md5=fa5242a96053f718c70369a15621db95</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1284198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1284198%26sid%3Dliteratum%253Aachs%26aulast%3DRashidi%26aufirst%3DM.%2BR.%26aulast%3DSoltani%26aufirst%3DS.%26atitle%3DAn%2520Overview%2520of%2520Aldehyde%2520Oxidase%253A%2520An%2520Enzyme%2520of%2520Emerging%2520Importance%2520in%2520Novel%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26issue%3D3%26spage%3D305%26epage%3D316%26doi%3D10.1080%2F17460441.2017.1284198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for the Role of Mammalian Aldehyde Oxidases in the Metabolism of Drugs and Xenobiotics</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2017.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.cbpa.2017.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28126656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=39-47&author=M.+J.+Romaoauthor=C.+Coelhoauthor=T.+Santos-Silvaauthor=A.+Fotiauthor=M.+Teraoauthor=E.+Garattiniauthor=S.+Leimkuhler&title=Structural+Basis+for+the+Role+of+Mammalian+Aldehyde+Oxidases+in+the+Metabolism+of+Drugs+and+Xenobiotics&doi=10.1016%2Fj.cbpa.2017.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the role of mammalian aldehyde oxidases in the metabolism of drugs and xenobiotics</span></div><div class="casAuthors">Romao, Maria Joao; Coelho, Catarina; Santos-Silva, Teresa; Foti, Alessandro; Terao, Mineko; Garattini, Enrico; Leimkehler, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-47</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs) are molybdo-flavoenzymes characterized by broad substrate specificity, oxidizing arom./aliph. aldehydes into the corresponding carboxylic acids and hydroxylating various heteroarom. rings.  Mammals are characterized by a complement of species-specific AOX isoenzymes, that varies from one in humans (AOX1) to four in rodents (AOX1, AOX2, AOX3 and AOX4).  The physiol. function of mammalian AOX isoenzymes is unknown, although human AOX1 is an emerging enzyme in phase-I drug metab.  Indeed, the no. of therapeutic mols. under development which act as AOX substrates is increasing.  The recent crystn. and structure detn. of human AOX1 as well as mouse AOX3 has brought new insights into the mechanisms underlying substrate/inhibitor binding as well as the catalytic activity of this class of enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm_agFEt6t-7Vg90H21EOLACvtfcHk0lhl_tbBWmPZtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKjsLg%253D&md5=87985d602479342e0c5cb9b63512b951</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2017.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Role%2520of%2520Mammalian%2520Aldehyde%2520Oxidases%2520in%2520the%2520Metabolism%2520of%2520Drugs%2520and%2520Xenobiotics%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D37%26spage%3D39%26epage%3D47%26doi%3D10.1016%2Fj.cbpa.2017.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkühler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romão, M. J.</span></span> <span> </span><span class="NLM_article-title">Critical Overview on the Structure and Metabolism of Human Aldehyde Oxidase and Its Role in Pharmacokinetics</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2018.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.ccr.2018.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFGrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2018&pages=35-59&author=C.+Motaauthor=C.+Coelhoauthor=S.+Leimk%C3%BChlerauthor=E.+Garattiniauthor=M.+Teraoauthor=T.+Santos-Silvaauthor=M.+J.+Rom%C3%A3o&title=Critical+Overview+on+the+Structure+and+Metabolism+of+Human+Aldehyde+Oxidase+and+Its+Role+in+Pharmacokinetics&doi=10.1016%2Fj.ccr.2018.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Critical overview on the structure and metabolism of human aldehyde oxidase and its role in pharmacokinetics</span></div><div class="casAuthors">Mota, Cristiano; Coelho, Catarina; Leimkuhler, Silke; Garattini, Enrico; Terao, Mineko; Santos-Silva, Teresa; Romao, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-59</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidases are molybdenum and flavin dependent enzymes characterized by a very wide substrate specificity and performing diverse reactions that include oxidns. (e.g., aldehydes and aza-heterocycles), hydrolysis of amide bonds, and redns. (e.g., nitro, S-oxides and N-oxides).  Oxidn. reactions and amide hydrolysis occur at the molybdenum site while the redns. are proposed to occur at the flavin site.  AOX activity affects the metab. of different drugs and xenobiotics, some of which designed to resist other liver metabolizing enzymes (e.g., cytochrome P 450 monooxygenase isoenzymes), raising its importance in drug development.  This work consists of a comprehensive overview on aldehyde oxidases, concerning the genetic evolution of AOX, its diversity among the human population, the crystal structures available, the known catalytic reactions and the consequences in pre-clin. pharmacokinetic and pharmacodynamic studies.  Anal. of the different animal models generally used for pre-clin. trials and comparison between the human (hAOX1), mouse homologs as well as the related xanthine oxidase (XOR) are extensively considered.  The data reviewed also include a systematic anal. of representative classes of mols. that are hAOX1 substrates as well as of typical and well characterized hAOX1 inhibitors.  The considerations made on the basis of a structural and functional anal. are correlated with reported kinetic and metabolic data for typical classes of drugs, searching for potential structural determinants that may dictate substrate and/or inhibitor specificities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYNjsJXx2C1bVg90H21EOLACvtfcHk0lhl_tbBWmPZtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFGrt70%253D&md5=269eec7a7e99e17af05ad73fc126d4cd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2018.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2018.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DMota%26aufirst%3DC.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DLeimk%25C3%25BChler%26aufirst%3DS.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DRom%25C3%25A3o%26aufirst%3DM.%2BJ.%26atitle%3DCritical%2520Overview%2520on%2520the%2520Structure%2520and%2520Metabolism%2520of%2520Human%2520Aldehyde%2520Oxidase%2520and%2520Its%2520Role%2520in%2520Pharmacokinetics%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2018%26volume%3D368%26spage%3D35%26epage%3D59%26doi%3D10.1016%2Fj.ccr.2018.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Mammalian Aldehyde Oxidases</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1007/s00204-016-1683-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00204-016-1683-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26920149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1Ort7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=753-780&issue=4&author=M.+Teraoauthor=M.+J.+Romaoauthor=S.+Leimkuhlerauthor=M.+Bolisauthor=M.+Fratelliauthor=C.+Coelhoauthor=T.+Santos-Silvaauthor=E.+Garattini&title=Structure+and+Function+of+Mammalian+Aldehyde+Oxidases&doi=10.1007%2Fs00204-016-1683-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of mammalian aldehyde oxidases</span></div><div class="casAuthors">Terao, Mineko; Romao, Maria Joao; Leimkuhler, Silke; Bolis, Marco; Fratelli, Maddalena; Coelho, Catarina; Santos-Silva, Teresa; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-780</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Mammalian aldehyde oxidases (AOXs; EC1.2.3.1) are a group of conserved proteins belonging to the family of molybdo-flavoenzymes along with the structurally related xanthine dehydrogenase enzyme.  AOXs are characterized by broad substrate specificity, oxidizing not only arom. and aliph. aldehydes into the corresponding carboxylic acids, but also hydroxylating a series of heteroarom. rings.  The no. of AOX isoenzymes expressed in different vertebrate species is variable.  The two extremes are represented by humans, which express a single enzyme (AOX1) in many organs and mice or rats which are characterized by tissue-specific expression of four isoforms (AOX1, AOX2, AOX3, and AOX4).  In vertebrates each AOX isoenzyme is the product of a distinct gene consisting of 35 highly conserved exons.  The extant species-specific complement of AOX isoenzymes is the result of a complex evolutionary process consisting of a first phase characterized by a series of asynchronous gene duplications and a second phase where the pseudogenization and gene deletion events prevail.  In the last few years remarkable advances in the elucidation of the structural characteristics and the catalytic mechanisms of mammalian AOXs have been made thanks to the successful crystn. of human AOX1 and mouse AOX3.  Much less is known about the physiol. function and physiol. substrates of human AOX1 and other mammalian AOX isoenzymes, although the importance of these proteins in xenobiotic metab. is fairly well established and their relevance in drug development is increasing.  This review article provides an overview and a discussion of the current knowledge on mammalian AOX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS5HLUCQFuwrVg90H21EOLACvtfcHk0lhnjFBceWnVGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1Ort7s%253D&md5=9b1267ba46528c89ccbaf26dbd0e36cf</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00204-016-1683-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-016-1683-1%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DBolis%26aufirst%3DM.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DStructure%2520and%2520Function%2520of%2520Mammalian%2520Aldehyde%2520Oxidases%26jtitle%3DArch.%2520Toxicol.%26date%3D2016%26volume%3D90%26issue%3D4%26spage%3D753%26epage%3D780%26doi%3D10.1007%2Fs00204-016-1683-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase and Its Role as a Drug Metabolizing Enzyme</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.pharmthera.2019.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=31128989" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=D.+Dalvieauthor=L.+Di&title=Aldehyde+Oxidase+and+Its+Role+as+a+Drug+Metabolizing+Enzyme&doi=10.1016%2Fj.pharmthera.2019.05.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DAldehyde%2520Oxidase%2520and%2520Its%2520Role%2520as%2520a%2520Drug%2520Metabolizing%2520Enzyme%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26doi%3D10.1016%2Fj.pharmthera.2019.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battelli, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, A.</span></span> <span> </span><span class="NLM_article-title">Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">4027</span>– <span class="NLM_lpage">4036</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160725091915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.2174%2F0929867323666160725091915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27458036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVOhu7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=4027-4036&issue=35&author=M.+G.+Battelliauthor=L.+Politoauthor=M.+Bortolottiauthor=A.+Bolognesi&title=Xanthine+Oxidoreductase+in+Drug+Metabolism%3A+Beyond+a+Role+as+a+Detoxifying+Enzyme&doi=10.2174%2F0929867323666160725091915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme</span></div><div class="casAuthors">Battelli, Maria Giulia; Polito, Letizia; Bortolotti, Massimo; Bolognesi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">4027-4036</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The enzyme xanthine oxidoreductase (XOR) catalyzes the last two steps of purine catabolism in the highest uricotelic primates.  XOR is an enzyme with dehydrogenase activity that, in mammals, may be converted into oxidase activity under a variety of pathophysiol. conditions.  XOR activity is highly regulated at the transcriptional and post-translational levels and may generate reactive oxygen and nitrogen species, which trigger different consequences, ranging from cytotoxicity to inflammation.  The low specificity for substrates allows XOR to metabolize a no. of endogenous metabolites and a variety of exogenous compds., including drugs.  The present review focuses on the role of XOR as a drug-metabolizing enzyme, specifically for drugs with anticancer, antimicrobial, antiviral, immunosuppressive or vasodilator activities, as well as drugs acting on metab. or inducing XOR expression.  XOR has an activating role that is essential to the pharmacol. action of quinone drugs, cyadox, antiviral nucleoside analogs, allopurinol, nitrate and nitrite.  XOR activity has a degrdn. function toward thiopurine nucleotides, pyrazinoic acid, methylxanthines and tolbutamide, whose half-life may be prolonged by the use of XOR inhibitors.  In conclusion, to avoid potential drug interaction risks, such as a toxic excess of drug bioavailability or a loss of drug efficacy, caution is suggested in the use of XOR inhibitors, as in the case of hyperuricemic patients affected by gout or tumor lysis syndrome, when it is necessary to simultaneously administer therapeutic substances that are activated or degraded by the drug-metabolizing activity of XOR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlrIvvW2UuYbVg90H21EOLACvtfcHk0lhnjFBceWnVGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVOhu7bE&md5=f90b40a1cea0b863f6226aefcc6e1bd9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160725091915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160725091915%26sid%3Dliteratum%253Aachs%26aulast%3DBattelli%26aufirst%3DM.%2BG.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DBortolotti%26aufirst%3DM.%26aulast%3DBolognesi%26aufirst%3DA.%26atitle%3DXanthine%2520Oxidoreductase%2520in%2520Drug%2520Metabolism%253A%2520Beyond%2520a%2520Role%2520as%2520a%2520Detoxifying%2520Enzyme%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26issue%3D35%26spage%3D4027%26epage%3D4036%26doi%3D10.2174%2F0929867323666160725091915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckworth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry Approaches to Avoid Aldehyde Oxidase Metabolism</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2856</span>– <span class="NLM_lpage">2860</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2012.02.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22429467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2856-2860&issue=8&author=D.+C.+Prydeauthor=T.+D.+Tranauthor=P.+Jonesauthor=J.+Duckworthauthor=M.+Howardauthor=I.+Gardnerauthor=R.+Hylandauthor=R.+Websterauthor=T.+Wenhamauthor=S.+Bagalauthor=K.+Omotoauthor=R.+P.+Schneiderauthor=J.+Lin&title=Medicinal+Chemistry+Approaches+to+Avoid+Aldehyde+Oxidase+Metabolism&doi=10.1016%2Fj.bmcl.2012.02.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry approaches to avoid aldehyde oxidase metabolism</span></div><div class="casAuthors">Pryde, David C.; Tran, Thien-Duc; Jones, Peter; Duckworth, Jonathan; Howard, Martin; Gardner, Iain; Hyland, Ruth; Webster, Rob; Wenham, Tracey; Bagal, Sharan; Omoto, Kiyoyuki; Schneider, Richard P.; Lin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2856-2860</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a molybdenum-contg. enzyme distributed throughout the animal kingdom and capable of metabolising a wide range of aldehydes and N-heterocyclic compds.  Although metab. by this enzyme in man is recognized to have significant clin. impact where human AO activity was not predicted by screening in preclin. species, there is very little reported literature offering real examples where drug discoverers have successfully designed away from AO oxidn.  This article reports on some strategies adopted in the Pfizer TLR7 agonist program to successfully switch off AO metab. that was seen principally in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZKVEe9ZUzMbVg90H21EOLACvtfcHk0liQa8odfFXdJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSitbs%253D&md5=4c4c68b64f1c7013ad978408add0b09a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.069%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DTran%26aufirst%3DT.%2BD.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DDuckworth%26aufirst%3DJ.%26aulast%3DHoward%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DHyland%26aufirst%3DR.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWenham%26aufirst%3DT.%26aulast%3DBagal%26aufirst%3DS.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DR.%2BP.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DMedicinal%2520Chemistry%2520Approaches%2520to%2520Avoid%2520Aldehyde%2520Oxidase%2520Metabolism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2856%26epage%3D2860%26doi%3D10.1016%2Fj.bmcl.2012.02.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Differences in the in Vivo and in Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1320</span>– <span class="NLM_lpage">1328</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.081182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.118.081182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29980580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFGgt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=1320-1328&issue=9&author=X.+Houauthor=J.+Zhouauthor=S.+Yuauthor=L.+Zhouauthor=Y.+Zhangauthor=D.+Zhongauthor=X.+Chen&title=Differences+in+the+in+Vivo+and+in+Vitro+Metabolism+of+Imrecoxib+in+Humans%3A+Formation+of+the+Rate-Limiting+Aldehyde+Intermediate&doi=10.1124%2Fdmd.118.081182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in the in vivo and in vitro metabolism of imrecoxib in humans: formation of the rate-limiting aldehyde intermediate</span></div><div class="casAuthors">Hou, Xiangyu; Zhou, Jialan; Yu, Songda; Zhou, Lei; Zhang, Yifan; Zhong, Dafang; Chen, Xiaoyan</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1320-1328,S1-S6</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Imrecoxib is a typical cyclooxygenase-2 inhibitor and the benzylic carbon motif is its major site of oxidative metab., producing a hydroxymethyl metabolite (M1) and a carboxylic acid metabolite (M2).  The plasma exposure of M2 is four times higher than those of both M0 and M1 in humans.  However, this metabolite is rarely formed in in vitro expts.  Therefore, this study aims to investigate the formation mechanism of M2 and to further elucidate the reason for the discrepancy between in vitro and in vivo metabolic data.  By employing human hepatocytes, human liver microsomes (HLMs), human liver cytosols (HLCs), recombinant enzymes, and selective enzyme inhibitors, the metabolic map of imrecoxib was elaborated as follows: the parent drug was initially hydroxylated to form M1 in HLMs, mainly mediated by CYP3A4 and CYP2D6, and to subsequently form aldehyde imrecoxib (M-CHO) in HLMs and HLCs.  The latter process is the rate-limiting step in generating the end-product M2.  In further M-CHO metab., two opposite reactions (namely, rapid oxidn. catalyzed by CYP3A4, CYP2D6, and cytosolic aldehyde oxidase to form M2 vs. redn. to regenerate M1 mediated by NADPH-dependent reductases in HLMs and HLCs, such as cytochrome P 450 reductase) led to marked underestimation of the M2 amt. in static in vitro incubations.  The findings provided a possible explanation for the difference between in vitro and in vivo metab. of imrecoxib, suggesting that the effect of competitive redn. on the static oxidn. metab. in in vitro metabolic expts. should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpKb_-F2d-KLVg90H21EOLACvtfcHk0liQa8odfFXdJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFGgt77N&md5=2c96fffd86f1159e31e54a0cdb280103</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.081182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.081182%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DDifferences%2520in%2520the%2520in%2520Vivo%2520and%2520in%2520Vitro%2520Metabolism%2520of%2520Imrecoxib%2520in%2520Humans%253A%2520Formation%2520of%2520the%2520Rate-Limiting%2520Aldehyde%2520Intermediate%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26issue%3D9%26spage%3D1320%26epage%3D1328%26doi%3D10.1124%2Fdmd.118.081182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J. S.</span></span> <span> </span><span class="NLM_article-title">A Novel Reaction Mediated by Human Aldehyde Oxidase: Amide Hydrolysis of Gdc-0834</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.061804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.061804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25845827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlCrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=908-915&issue=6&author=J.+K.+Sodhiauthor=S.+Wongauthor=D.+S.+Kirkpatrickauthor=L.+Liuauthor=S.+C.+Khojastehauthor=C.+E.+Hopauthor=J.+T.+Barrauthor=J.+P.+Jonesauthor=J.+S.+Halladay&title=A+Novel+Reaction+Mediated+by+Human+Aldehyde+Oxidase%3A+Amide+Hydrolysis+of+Gdc-0834&doi=10.1124%2Fdmd.114.061804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834</span></div><div class="casAuthors">Sodhi, Jasleen K.; Wong, Susan; Kirkpatrick, Donald S.; Liu, Lichuan; Khojasteh, S. Cyrus; Hop, Cornelis E. C. A.; Barr, John T.; Jones, Jeffrey P.; Halladay, Jason S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">908-915</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">GDC-0834, a Bruton's tyrosine kinase inhibitor investigated as a potential treatment of rheumatoid arthritis, was previously reported to be extensively metabolized by amide hydrolysis such that no measurable levels of this compd. were detected in human circulation after oral administration.  In vitro studies in human liver cytosol detd. that GDC-0834 (R)-N-(3-(6-(4-(1,4-dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide was rapidly hydrolyzed with a CLint of 0.511 mL/min per mg of protein.  Aldehyde oxidase (AO) and carboxylesterase (CES) were putatively identified as the enzymes responsible after cytosolic fractionation and mass spectrometry-proteomics anal. of the enzymically active fractions.  Results were confirmed by a series of kinetic expts. with inhibitors of AO, CES, and xanthine oxidase (XO), which implicated AO and CES, but not XO, as mediating GDC-0834 amide hydrolysis.  Further supporting the interaction between GDC-0834 and AO, GDC-0834 was shown to be a potent reversible inhibitor of six known AO substrates with IC50 values ranging from 0.86 to 1.87 μM.  Addnl., in silico modeling studies suggest that GDC-0834 is capable of binding in the active site of AO with the amide bond of GDC-0834 near the molybdenum cofactor (MoCo), orientated in such a way to enable potential nucleophilic attack on the carbonyl of the amide bond by the hydroxyl of MoCo.  Together, the in vitro and in silico results suggest the involvement of AO in the amide hydrolysis of GDC-0834.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAO_iWKyUVLVg90H21EOLACvtfcHk0lisqzC1FIVSTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlCrtrw%253D&md5=4cf67605bc094945de8229be5c9cacae</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.061804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.061804%26sid%3Dliteratum%253Aachs%26aulast%3DSodhi%26aufirst%3DJ.%2BK.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26aulast%3DHop%26aufirst%3DC.%2BE.%26aulast%3DBarr%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26atitle%3DA%2520Novel%2520Reaction%2520Mediated%2520by%2520Human%2520Aldehyde%2520Oxidase%253A%2520Amide%2520Hydrolysis%2520of%2520Gdc-0834%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26issue%3D6%26spage%3D908%26epage%3D915%26doi%3D10.1124%2Fdmd.114.061804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paragas, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">The Two Faces of Aldehyde Oxidase: Oxidative and Reductive Transformations of 5-Nitroquinoline</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2017.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28888950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKltbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2017&pages=210-217&author=E.+M.+Paragasauthor=S.+C.+Humphreysauthor=J.+Minauthor=C.+A.+Joswig-Jonesauthor=J.+P.+Jones&title=The+Two+Faces+of+Aldehyde+Oxidase%3A+Oxidative+and+Reductive+Transformations+of+5-Nitroquinoline&doi=10.1016%2Fj.bcp.2017.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline</span></div><div class="casAuthors">Paragas, Erickson M.; Humphreys, Sara C.; Min, Joshua; Joswig-Jones, Carolyn A.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">210-217</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is a cytosolic enzyme responsible for the metab. of some drugs and drug candidates.  AOX catalyzes the oxidative hydroxylation of substrates including several aliph. and arom. aldehydes, and nitrogen-contg. heterocyclic compds.  AOX is also reported to catalyze the reductive metab. of nitro-compds., N-oxides, sulfoxides, isoxazoles, isothiazoles, nitrite and hydroxamic acids.  These reductive transformations are not well understood and are generally believed to only occur at low oxygen concns.  In this study, we used 5-nitroquinoline (5NQ) as a substrate to further understand both the oxidative and the reductive transformations catalyzed by AOX.  In vitro reaction of 5NQ with AOX under aerobic conditions generated the oxidized (2-oxo-5-nitroquinoline, 2-oxo-5NQ), the reduced (5-aminoquinoline, 5AQ) and the oxidized/reduced (2-oxo-5-aminoquinoline, 2-oxo-5AQ) metabolites.  Interestingly, in human liver cytosol, co-incubation of 5NQ and known AOX oxidative substrates DACA and phthalazine significantly increased the yield of the reduced metabolite, while oxidized metabolites prodn. decreased.  These data indicate that 5NQ can be reduced at atm. oxygen concns. and that the reductive transformation occurs at a second site that is kinetically distinct from the oxidative site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEP7SDjFQWZ7Vg90H21EOLACvtfcHk0lisqzC1FIVSTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKltbfE&md5=4a2acff32f835e365bdb5a079c291eab</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DParagas%26aufirst%3DE.%2BM.%26aulast%3DHumphreys%26aufirst%3DS.%2BC.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520Two%2520Faces%2520of%2520Aldehyde%2520Oxidase%253A%2520Oxidative%2520and%2520Reductive%2520Transformations%2520of%25205-Nitroquinoline%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D145%26spage%3D210%26epage%3D217%26doi%3D10.1016%2Fj.bcp.2017.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogiso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span> <span> </span><span class="NLM_article-title">Substrate Selectivity of Human Aldehyde Oxidase 1 in Reduction of Nitroaromatic Drugs</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>659</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2018.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.abb.2018.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30367827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCktL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=659&publication_year=2018&pages=85-92&author=T.+Ogisoauthor=T.+Fukamiauthor=K.+Mishiroauthor=K.+Konishiauthor=J.+P.+Jonesauthor=M.+Nakajima&title=Substrate+Selectivity+of+Human+Aldehyde+Oxidase+1+in+Reduction+of+Nitroaromatic+Drugs&doi=10.1016%2Fj.abb.2018.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate selectivity of human aldehyde oxidase 1 in reduction of nitroaromatic drugs</span></div><div class="casAuthors">Ogiso, Takuo; Fukami, Tatsuki; Mishiro, Kenji; Konishi, Keigo; Jones, Jeffrey P.; Nakajima, Miki</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">659</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-92</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human aldehyde oxidase 1 (AOX1) catalyzes the oxidn. of various drugs and endogenous compds.  Recently, we found that AOX1 catalyzed the redn. of drugs such as nitrazepam and dantrolene.  In this study, we aimed to clarify the substrate selectivity of human AOX1 for the redn. of nitroarom. drugs to obtain helpful information for drug development.  We investigated whether 11 nitroarom. drugs were reduced by AOX1 using recombinant AOX1 and human liver cytosol (HLC) in the presence of N1-methylnicotinamide, an electron donor to AOX1.  We found that clonazepam, flunitrazepam, flutamide, nilutamide, nimesulide, and nimetazepam were substantially reduced by recombinant AOX1 and HLC, whereas azelnidipine, nifedipine, and nimodipine were slightly reduced and metronidazole and tolcapone were not reduced.  Via structural anal., we obsd. that nitroarom. drugs reduced by AOX1 possessed a relatively electron-deficient nitro group.  Since the addn. of NADPH to human liver microsomes (HLM) did not increase the reductase activities of the drugs that were reduced by recombinant AOX1, it was detd. that NADPH-dependent enzymes in microsomes, such as cytochrome P 450, were not involved in this process.  Inhibition studies using known AOX1 inhibitors supported the role of AOX1 in the redn. of drugs in HLC.  In conclusion, this provides new information related to the substrate selectivity of human AOX1 for the redn. of nitroarom. drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcrsu5gv3v-rVg90H21EOLACvtfcHk0lj8vNAmFw4Izg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCktL%252FM&md5=3a2759d9a707a3b25f4c372970cdbed9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2018.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2018.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DOgiso%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DMishiro%26aufirst%3DK.%26aulast%3DKonishi%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DNakajima%26aufirst%3DM.%26atitle%3DSubstrate%2520Selectivity%2520of%2520Human%2520Aldehyde%2520Oxidase%25201%2520in%2520Reduction%2520of%2520Nitroaromatic%2520Drugs%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2018%26volume%3D659%26spage%3D85%26epage%3D92%26doi%3D10.1016%2Fj.abb.2018.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offerman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillis, W. S.</span></span> <span> </span><span class="NLM_article-title">A Species Difference in the Presystemic Metabolism of Carbazeran in Dog and Man</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.3109/00498258409151492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498258409151492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=6531941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2MXhsVaksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1984&pages=935-945&issue=12&author=B.+Kayeauthor=J.+L.+Offermanauthor=J.+L.+Reidauthor=H.+L.+Elliottauthor=W.+S.+Hillis&title=A+Species+Difference+in+the+Presystemic+Metabolism+of+Carbazeran+in+Dog+and+Man&doi=10.3109%2F00498258409151492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A species difference in the presystemic metabolism of carbazeran in dog and man</span></div><div class="casAuthors">Kaye, B.; Offerman, J. L.; Reid, J. L.; Elliott, H. L.; Hillis, W. S.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">935-45</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    </div><div class="casAbstract">The bioavailability of carbazeran (I)  [70724-25-3] and the metab. of 14C-labeled I were studied in the dog and man following oral administration.  The drug was moderately well absorbed in both species, but there was a marked difference in bioavailability and in routes of metab.  In the dog, systemic bioavailability was approx. 68% and biotransformation involved mainly O-demethylation.  In man, bioavailability was not measurable and carbazeran was almost completely cleared via 4-hydroxylation of the phthalazine moiety.  Thus, the lack of detectable pharmacol. effect in man following oral administration of the drug appears to be due to presystemic metab. by a particularly active pathway not found in the dog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDeBO_IO2xVLVg90H21EOLACvtfcHk0lj8vNAmFw4Izg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhsVaksbo%253D&md5=7725513a84c38d58065c31ce84624a23</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3109%2F00498258409151492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498258409151492%26sid%3Dliteratum%253Aachs%26aulast%3DKaye%26aufirst%3DB.%26aulast%3DOfferman%26aufirst%3DJ.%2BL.%26aulast%3DReid%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DH.%2BL.%26aulast%3DHillis%26aufirst%3DW.%2BS.%26atitle%3DA%2520Species%2520Difference%2520in%2520the%2520Presystemic%2520Metabolism%2520of%2520Carbazeran%2520in%2520Dog%2520and%2520Man%26jtitle%3DXenobiotica%26date%3D1984%26volume%3D14%26issue%3D12%26spage%3D935%26epage%3D945%26doi%3D10.3109%2F00498258409151492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerny, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilpin, K.</span></span> <span> </span><span class="NLM_article-title">Cynomolgus Monkey as a Surrogate for Human Aldehyde Oxidase Metabolism of the Egfr Inhibitor Bibx1382</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1760</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.059030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.059030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25035284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12jsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1751-1760&issue=10&author=J.+M.+Hutzlerauthor=M.+A.+Cernyauthor=Y.+S.+Yangauthor=C.+Asherauthor=D.+Wongauthor=K.+Frederickauthor=K.+Gilpin&title=Cynomolgus+Monkey+as+a+Surrogate+for+Human+Aldehyde+Oxidase+Metabolism+of+the+Egfr+Inhibitor+Bibx1382&doi=10.1124%2Fdmd.114.059030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382</span></div><div class="casAuthors">Hutzler, J. Matthew; Cerny, Matthew A.; Yang, Young-Sun; Asher, Constance; Wong, Diane; Frederick, Kosea; Gilpin, Kyle</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1751-1760, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">BIBX1382 was an epidermal growth factor receptor inhibitor under clin. investigation for treatment of cancer.  This candidate possessed an attractive preclin. absorption, distribution, metab., and excretion profile, yet failed in clin. studies due in part to poor oral exposure, resulting from extensive metab. by aldehyde oxidase (AO).  In vitro metab. studies were performed in liver cytosol and cryopreserved hepatocytes from multiple species.  In addn., a pharmacokinetic study was performed in cynomolgus monkey for comparison with the reported human pharmacokinetics of BIBX1382.  Estd. hepatic clearance of BIBX1382 in rhesus (42 mL/min per kg) and cynomolgus monkey (43 mL/min per kg) liver cytosol was comparable to human (≥93% of liver blood flow).  Metabolite identification after incubation of BIBX1382 in liver cytosol fortified with the AO inhibitor raloxifene confirmed that AO is involved in the formation of the predominant metabolite (BIBU1476, M1) in cynomolgus monkey.  After i.v. and oral administration of BIBX1382 to cynomolgus monkeys, high plasma clearance (118 mL/min per kg) and low oral exposure (Cmax = 12.7 nM and 6% oral bioavailability) was obsd., with the exposure of M1 exceeding BIBX1382 after oral dosing.  This pharmacokinetic profile compared favorably with the human clin. data of BIBX1382 (plasma clearance 25-55 mL/min per kg and 5% oral bioavailability).  Thus, it appears that cynomolgus monkey represents a suitable surrogate for the obsd. human AO metab. of BIBX1382.  To circumvent clin. failures due to uncharacterized metab. by AO, in vitro studies in the appropriate subcellular fraction, followed by pharmacokinetic and toxicokinetic studies in the appropriately characterized surrogate species should be conducted for substrates of AO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmMUPaJpQsG7Vg90H21EOLACvtfcHk0lj8vNAmFw4Izg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12jsbrI&md5=ccb9a5ee98921b41bae55a73e7198b22</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.059030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.059030%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DCerny%26aufirst%3DM.%2BA.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DAsher%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DFrederick%26aufirst%3DK.%26aulast%3DGilpin%26aufirst%3DK.%26atitle%3DCynomolgus%2520Monkey%2520as%2520a%2520Surrogate%2520for%2520Human%2520Aldehyde%2520Oxidase%2520Metabolism%2520of%2520the%2520Egfr%2520Inhibitor%2520Bibx1382%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D10%26spage%3D1751%26epage%3D1760%26doi%3D10.1124%2Fdmd.114.059030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilausen, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thale, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasena, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, M.</span></span> <span> </span><span class="NLM_article-title">Lack of Exposure in a First-in-Man Study Due to Aldehyde Oxidase Metabolism: Investigated by Use of 14c-Microdose, Humanized Mice, Monkey Pharmacokinetics, and in Vitro Methods</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.072793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.116.072793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27737930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlSkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=68-75&issue=1&author=K.+G.+Jensenauthor=A.+M.+Jacobsenauthor=C.+Bundgaardauthor=D.+O.+Nilausenauthor=Z.+Thaleauthor=G.+Chandrasenaauthor=M.+Jorgensen&title=Lack+of+Exposure+in+a+First-in-Man+Study+Due+to+Aldehyde+Oxidase+Metabolism%3A+Investigated+by+Use+of+14c-Microdose%2C+Humanized+Mice%2C+Monkey+Pharmacokinetics%2C+and+in+Vitro+Methods&doi=10.1124%2Fdmd.116.072793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of exposure in a first-in-man study due to aldehyde oxidase metabolism: investigated by use of 14C-microdose, humanized mice, monkey pharmacokinetics, and in vitro methods</span></div><div class="casAuthors">Jensen, Klaus Gjervig; Jacobsen, Anne-Marie; Bundgaard, Christoffer; Nilausen, Dorrit Oestergaard; Thale, Zia; Chandrasena, Gamini; Joergensen, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-75</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inclusion of a microdose of 14C-labeled drug in the first-in-man study of new investigational drugs and subsequent anal. by accelerator mass spectrometry has become an integrated part of drug development at Lundbeck.  It has been found to be highly informative with regard to investigations of the routes and rates of excretion of the drug and the human metabolite profiles according to metabolites in safety testing guidance and also when addnl. metab.-related issues needed to be addressed.  In the first-in-man study with the NCE Lu AF09535, contrary to anticipated, surprisingly low exposure was obsd. when measuring the parent compd. using conventional bioanal.  Parallel accelerator mass spectrometry anal. revealed that the low exposure was almost exclusively attributable to extensive metab.  The metab. obsd. in humans was mediated via a human specific metabolic pathway, whereas an equiv. extent of metab. was not obsd. in preclin. species.  In vitro, incubation studies in human liver cytosol revealed involvement of aldehyde oxidase (AO) in the biotransformation of Lu AF09535.  In vivo, substantially lower plasma exposure of Lu AF09535 was obsd. in chimeric mice with humanized livers compared with control animals.  In addn., Lu AF09535 exhibited very low oral bioavailability in monkeys despite relatively low clearance after i.v. administration in contrast to the pharmacokinetics in rats and dogs, both showing low clearance and high bioavailability.  The in vitro and in vivo methods applied were proved useful for identifying and evaluating AO-dependent metab.  Different strategies to integrate these methods for prediction of in vivo human clearance of AO substrates were evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMEbOS64YnLVg90H21EOLACvtfcHk0lik6XGAldqtLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlSkt7s%253D&md5=670770579f69820969ad76dfa153156e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.072793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.072793%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DK.%2BG.%26aulast%3DJacobsen%26aufirst%3DA.%2BM.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DNilausen%26aufirst%3DD.%2BO.%26aulast%3DThale%26aufirst%3DZ.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DM.%26atitle%3DLack%2520of%2520Exposure%2520in%2520a%2520First-in-Man%2520Study%2520Due%2520to%2520Aldehyde%2520Oxidase%2520Metabolism%253A%2520Investigated%2520by%2520Use%2520of%252014c-Microdose%252C%2520Humanized%2520Mice%252C%2520Monkey%2520Pharmacokinetics%252C%2520and%2520in%2520Vitro%2520Methods%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2017%26volume%3D45%26issue%3D1%26spage%3D68%26epage%3D75%26doi%3D10.1124%2Fdmd.116.072793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hvenegaard, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang-Andersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalgaard, L.</span></span> <span> </span><span class="NLM_article-title">Identification of the Cytochrome P450 and Other Enzymes Involved in the in Vitro Oxidative Metabolism of a Novel Antidepressant, Lu Aa21004</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.044610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.044610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22496396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrs73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1357-1365&issue=7&author=M.+G.+Hvenegaardauthor=B.+Bang-Andersenauthor=H.+Pedersenauthor=M.+Jorgensenauthor=A.+Puschlauthor=L.+Dalgaard&title=Identification+of+the+Cytochrome+P450+and+Other+Enzymes+Involved+in+the+in+Vitro+Oxidative+Metabolism+of+a+Novel+Antidepressant%2C+Lu+Aa21004&doi=10.1124%2Fdmd.112.044610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004</span></div><div class="casAuthors">Hvenegaard, Mette G.; Bang-Andersen, Benny; Pedersen, Henrik; Joergensen, Morten; Puschl, Ask; Dalgaard, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1357-1365</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]-piperazine (Lu AA21004) is a novel antidepressant that is currently in late-stage clin. development for major depressive disorder.  In the present study, the metab. of Lu AA21004 was investigated using human liver microsomes (HLM), human liver S9 fraction, and recombinant enzymes.  Lu AA21004 was found in vitro to be oxidized to a 4-hydroxy-Ph metabolite, a sulfoxide, an N-hydroxylated piperazine, and a benzylic alc., which was further oxidized to the corresponding benzoic acid [3-methyl-4-(2-piperazin-1-yl-phenysulfanyl)-benzoic acid (Lu AA34443)].  The formation of the 4-hydroxy-Ph metabolite was catalyzed by CYP2D6 with some contribution from CYP2C9, whereas the formation of the sulfoxide was mediated by CYP3A4/5 and CYP2A6.  CYP2C9 and CYP2C19 were the primary enzymes responsible for formation of the N-hydroxylated metabolite.  The benzylic alc. was formed by CYP2D6 only.  The oxidn. of the benzylic alc. to the corresponding benzoic acid of Lu AA21004 was catalyzed by alc. dehydrogenase and aldehyde dehydrogenase, with some contribution from aldehyde oxidase.  CYP2D6 was also capable of catalyzing the formation of the benzoic acid of Lu AA21004; however, its overall contribution to this pathway was negligible.  Enzyme kinetic parameters revealed that the rate-limiting step in the formation of the benzoic acid from Lu AA21004 is the formation of the corresponding alc.  Thus, the intrinsic clearance (Vmax/Km) in HLM for metab. of Lu AA21004 to the benzylic alc. was 1.13 × 10-6 l · min-1 · mg-1, whereas the subsequent metab. of the benzylic alc. to the benzoic acid of Lu AA21004 is characterized by an intrinsic clearance (Vmax/Km) in S9 fraction of 922 × 10-6 l · min-1 · mg-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztxSrnmvMrLVg90H21EOLACvtfcHk0lik6XGAldqtLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrs73O&md5=d8c7d282b8a8433f4fee14dbd3da34c3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.044610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.044610%26sid%3Dliteratum%253Aachs%26aulast%3DHvenegaard%26aufirst%3DM.%2BG.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DPedersen%26aufirst%3DH.%26aulast%3DJorgensen%26aufirst%3DM.%26aulast%3DPuschl%26aufirst%3DA.%26aulast%3DDalgaard%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520the%2520Cytochrome%2520P450%2520and%2520Other%2520Enzymes%2520Involved%2520in%2520the%2520in%2520Vitro%2520Oxidative%2520Metabolism%2520of%2520a%2520Novel%2520Antidepressant%252C%2520Lu%2520Aa21004%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D7%26spage%3D1357%26epage%3D1365%26doi%3D10.1124%2Fdmd.112.044610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vardavas, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozcagli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragkiadaki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stivaktakis, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzatzarakis, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegakis, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilaki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaloudis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsiaoussis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouretas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsitsimpikou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsatsakis, A. M.</span></span> <span> </span><span class="NLM_article-title">The Metabolism of Imidacloprid by Aldehyde Oxidase Contributes to Its Clastogenic Effect in New Zealand Rabbits</span>. <i>Mutat. Res., Genet. Toxicol. Environ. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>829−830</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.mrgentox.2018.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.mrgentox.2018.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29704990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslKltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=829%E2%88%92830&publication_year=2018&pages=26-32&author=A.+I.+Vardavasauthor=E.+Ozcagliauthor=P.+Fragkiadakiauthor=P.+D.+Stivaktakisauthor=M.+N.+Tzatzarakisauthor=A.+K.+Alegakisauthor=F.+Vasilakiauthor=K.+Kaloudisauthor=J.+Tsiaoussisauthor=D.+Kouretasauthor=C.+Tsitsimpikouauthor=F.+Carvalhoauthor=A.+M.+Tsatsakis&title=The+Metabolism+of+Imidacloprid+by+Aldehyde+Oxidase+Contributes+to+Its+Clastogenic+Effect+in+New+Zealand+Rabbits&doi=10.1016%2Fj.mrgentox.2018.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of imidacloprid by aldehyde oxidase contributes to its clastogenic effect in New Zealand rabbits</span></div><div class="casAuthors">Vardavas, Alexander I.; Ozcagli, Eren; Fragkiadaki, Persefoni; Stivaktakis, Polychronis D.; Tzatzarakis, Manolis N.; Alegakis, Athanasios K.; Vasilaki, Fotini; Kaloudis, Kostas; Tsiaoussis, John; Kouretas, Dimitrios; Tsitsimpikou, Christina; Carvalho, Felix; Tsatsakis, Aristidis M.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology and Environmental Mutagenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">829-830</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-32</span>CODEN:
                <span class="NLM_cas:coden">MRGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1383-5718</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Imidacloprid (IMI) is a systemic, chloro-nicotinyl insecticide classified in Regulation N° 1272/2008 of the European Commision as "harmful if swallowed and very toxic to aquatic life, with long-lasting effects".  IMI is metabolized in vitro both by aldehyde oxidase (AOX) (redn.) and by cytochrome P450s enzymes (CYPs).  In the present study, the AOX inhibitor sodium tungstate dihydrate (ST) was used to elucidate the relative contribution of CYP 450 and AOX metabolic pathways on IMI metab., in male rabbits exposed to IMI for two months.  To evaluate the inhibition effectiveness, various metabolite concns. in the IMI and IMI+ST exposed groups were monitored.  DNA damage was also evaluated in micronucleus (MN) and single cell electrophoresis (SCGC) assays in both groups, along with oxidative stress (OS) with the inflammatory status of the exposed animals, in order to clarify which metabolic pathway is more detrimental in this exptl. setting.  A significant increase in the frequency of binucleated cells with MN (BNMN, 105%) and micronuclei (MN, 142%) was obsd. after exposure to IMI (p<0.001).  The increase in the ST co-exposed animals was less pronounced (BNMN 75%, MN 95%).  The Cytokinesis Block Proliferation Index (CBPI) showed no significant difference between controls and exposed animals at any time of exposure (p>0.05), which indicates no cytotoxic effect.  Similarly, comet results show that the IMI group exhibited the highest achieved tail intensity, which reached 70.7% over the control groups, whereas in the IMI+ST groups the increase remained at 48.5%.  No differences were obsd. between all groups for oxidative-stress biomarkers.  The results indicate that the AOX metabolic pathway plays a more important role in the systemic toxicity of IMI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMa0IXCzmcdbVg90H21EOLACvtfcHk0li0yN6ZZdoLwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslKltL8%253D&md5=b71dad717a62caf31143566177c3bbeb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.mrgentox.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrgentox.2018.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DVardavas%26aufirst%3DA.%2BI.%26aulast%3DOzcagli%26aufirst%3DE.%26aulast%3DFragkiadaki%26aufirst%3DP.%26aulast%3DStivaktakis%26aufirst%3DP.%2BD.%26aulast%3DTzatzarakis%26aufirst%3DM.%2BN.%26aulast%3DAlegakis%26aufirst%3DA.%2BK.%26aulast%3DVasilaki%26aufirst%3DF.%26aulast%3DKaloudis%26aufirst%3DK.%26aulast%3DTsiaoussis%26aufirst%3DJ.%26aulast%3DKouretas%26aufirst%3DD.%26aulast%3DTsitsimpikou%26aufirst%3DC.%26aulast%3DCarvalho%26aufirst%3DF.%26aulast%3DTsatsakis%26aufirst%3DA.%2BM.%26atitle%3DThe%2520Metabolism%2520of%2520Imidacloprid%2520by%2520Aldehyde%2520Oxidase%2520Contributes%2520to%2520Its%2520Clastogenic%2520Effect%2520in%2520New%2520Zealand%2520Rabbits%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D2018%26volume%3D829%25E2%2588%2592830%26spage%3D26%26epage%3D32%26doi%3D10.1016%2Fj.mrgentox.2018.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akabane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teramura, T.</span></span> <span> </span><span class="NLM_article-title">Case Report of Extensive Metabolism by Aldehyde Oxidase in Humans: Pharmacokinetics and Metabolite Profile of Fk3453 in Rats, Dogs, and Humans</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.3109/00498254.2010.549970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2010.549970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21385103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=372-384&issue=5&author=T.+Akabaneauthor=K.+Tanakaauthor=M.+Irieauthor=S.+Terashitaauthor=T.+Teramura&title=Case+Report+of+Extensive+Metabolism+by+Aldehyde+Oxidase+in+Humans%3A+Pharmacokinetics+and+Metabolite+Profile+of+Fk3453+in+Rats%2C+Dogs%2C+and+Humans&doi=10.3109%2F00498254.2010.549970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Case report of extensive metabolism by aldehyde oxidase in humans: Pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans</span></div><div class="casAuthors">Akabane, Takafumi; Tanaka, Kohichiro; Irie, Megumi; Terashita, Shigeyuki; Teramura, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-384</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The in vitro and in vivo pharmacokinetic profiles of FK3453 [6-(2-amino-4-phenylpyrimidin-5-yl)-2-isopropylpyridazin-3(2H)-one] in rats, dogs, and humans were described, and the mechanism responsible for poor oral exposure of FK3453 in humans was investigated.  FK3453 showed favorable profiles in preclin. pharmacokinetic studies, including satisfactory abs. bioavailability and total body clearance in animals (30.5-41.4%, 54.7-68.2%, and 71.3-93.4% and 10.8-17.6, 1.9-17.1, and 5.0 mL/min/kg in male rats, female rats, and dogs, resp.), and good metabolic stability in liver microsomes (42.3, 14.5, and 1.1 mL/min/kg in male rats, dogs, and humans, resp.).  However, despite these promising preclin. findings, plasma concns. of FK3453 in humans were extremely low, with the oxidative metabolite of the aminopyrimidine moiety (M4) identified as a major metabolite.  Given that aldehyde oxidase (AO) and xanthine oxidase (XO) were presumed to be the enzymes responsible for M4 formation, the mechanism of M4 formation was studied using human liver subcellular fractions.  M4 was detected in the incubation mixt. with S9 and cytosol but not with microsomes, and M4 formation was inhibited by AO inhibitors (menadione, isovanillin) but not by cytochrome P 450 inhibitor (1-aminobenzotriazole) or XO inhibitor (allopurinol).  These results suggest that M4 formation is catalyzed by AO, and therefore, its poor exposure in humans was attributed to extensive AO metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRrHt4c8_yd7Vg90H21EOLACvtfcHk0li0yN6ZZdoLwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wnsr8%253D&md5=7ba62d51a4213f8c37472bb182f2687f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3109%2F00498254.2010.549970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2010.549970%26sid%3Dliteratum%253Aachs%26aulast%3DAkabane%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DIrie%26aufirst%3DM.%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DTeramura%26aufirst%3DT.%26atitle%3DCase%2520Report%2520of%2520Extensive%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%2520in%2520Humans%253A%2520Pharmacokinetics%2520and%2520Metabolite%2520Profile%2520of%2520Fk3453%2520in%2520Rats%252C%2520Dogs%252C%2520and%2520Humans%26jtitle%3DXenobiotica%26date%3D2011%26volume%3D41%26issue%3D5%26spage%3D372%26epage%3D384%26doi%3D10.3109%2F00498254.2010.549970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monshouwer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peltz, G.</span></span> <span> </span><span class="NLM_article-title">In Silico and in Vitro Pharmacogenetics: Aldehyde Oxidase Rapidly Metabolizes a P38 Kinase Inhibitor</span>. <i>Pharmacogenomics J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1038/tpj.2010.8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Ftpj.2010.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=20177421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlaisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=15-24&issue=1&author=X.+Zhangauthor=H.+H.+Liuauthor=P.+Wellerauthor=M.+Zhengauthor=W.+Taoauthor=J.+Wangauthor=G.+Liaoauthor=M.+Monshouwerauthor=G.+Peltz&title=In+Silico+and+in+Vitro+Pharmacogenetics%3A+Aldehyde+Oxidase+Rapidly+Metabolizes+a+P38+Kinase+Inhibitor&doi=10.1038%2Ftpj.2010.8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor</span></div><div class="casAuthors">Zhang, X.; Liu, H.-H.; Weller, P.; Zheng, M.; Tao, W.; Wang, J.; Liao, G.; Monshouwer, M.; Peltz, G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenomics Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">PJHOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1470-269X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. development of a candidate p38 kinase inhibitor was terminated because of its unexpectedly rapid clearance in human subjects.  Its short half-life and metabolic profile in human beings were vastly different from that in rats, dogs, and monkeys characterized during routine pre-clin. studies.  Mice generated the predominant drug (4-hydroxylated) metabolite produced in human beings, which was not found in other species.  The data from a murine in vitro drug biotransformation assay that used liver exts. from 14 inbred mouse strains were analyzed by haplotype-based computational genetic anal.  This led to the identification of aldehyde oxidase-1 (AOX1) as the enzyme responsible for the rapid metab. of this drug.  Specific enzyme inhibitors and expressed recombinant enzymes were used to confirm that AOX catalyzed the formation of the 4-hydroxylated drug metabolite in mouse and man.  Genetic variation within Aox1 regulated the level of hepatic Aox1 mRNA, AOX1 protein, and enzyme activity among the inbred strains.  Thus, computational murine pharmacogenetic anal. can facilitate the identification and characterization of drug metab. pathways that are differentially utilized by humans and other species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqwWgdlWC4zrVg90H21EOLACvtfcHk0li0yN6ZZdoLwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlaisLo%253D&md5=f440e4ef770c2d78eeb90ff6458896a1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Ftpj.2010.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftpj.2010.8%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%2BH.%26aulast%3DWeller%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DMonshouwer%26aufirst%3DM.%26aulast%3DPeltz%26aufirst%3DG.%26atitle%3DIn%2520Silico%2520and%2520in%2520Vitro%2520Pharmacogenetics%253A%2520Aldehyde%2520Oxidase%2520Rapidly%2520Metabolizes%2520a%2520P38%2520Kinase%2520Inhibitor%26jtitle%3DPharmacogenomics%2520J.%26date%3D2011%26volume%3D11%26issue%3D1%26spage%3D15%26epage%3D24%26doi%3D10.1038%2Ftpj.2010.8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolkema, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohets, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkenau, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lampo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jonge, M. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doorn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellemans, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskens, F.</span></span> <span> </span><span class="NLM_article-title">The C-Met Tyrosine Kinase Inhibitor Jnj-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2297</span>– <span class="NLM_lpage">2304</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1158%2F1078-0432.CCR-14-3258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25745036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXoslOktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2297-2304&issue=10&author=M.+P.+Lolkemaauthor=H.+H.+Bohetsauthor=H.+T.+Arkenauauthor=A.+Lampoauthor=E.+Baraleauthor=M.+J.+A.+de+Jongeauthor=L.+van+Doornauthor=P.+Hellemansauthor=J.+S.+de+Bonoauthor=F.+Eskens&title=The+C-Met+Tyrosine+Kinase+Inhibitor+Jnj-38877605+Causes+Renal+Toxicity+through+Species-Specific+Insoluble+Metabolite+Formation&doi=10.1158%2F1078-0432.CCR-14-3258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation</span></div><div class="casAuthors">Lolkema, Martijn P.; Bohets, Hilde H.; Arkenau, Hendrik-Tobias; Lampo, Ann; Barale, Erio; de Jonge, Maja J. A.; van Doorn, Leni; Hellemans, Peter; de Bono, Johann S.; Eskens, Ferry A. L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2297-2304</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The receptor tyrosine kinase c-Met plays an important role in tumorigenesis and is a novel target for anticancer treatment.  This phase I, first-in-human trial, explored safety, pharmacokinetics, pharmacodynamics, and initial antitumor activity of JNJ-38877605, a potent and selective c-Met inhibitor.  Exptl. Design: We performed a phase I dose-escalation study according to the std. 3+3 design.  Results: Even at subtherapeutic doses, mild though recurrent renal toxicity was obsd. in virtually all patients.  Renal toxicity had not been obsd. in preclin. studies in rats and dogs.  Addnl. preclin. studies pointed toward the rabbit as a suitable toxicol. model, as the formation of the M10 metabolite of JNJ-38877605 specifically occurred in rabbits and humans.  Addnl. toxicol. studies in rabbits clearly demonstrated that JNJ-38877605 induced species-specific renal toxicity.  Histopathol. evaluation in rabbits revealed renal crystal formation with degenerative and inflammatory changes.  Identification of the components of these renal crystals revealed M1/3 and M5/6 metabolites.  Accordingly, it was found that humans and rabbits showed significantly increased systemic exposure to these metabolites relative to other species.  These main culprit insol. metabolites were generated by aldehyde oxidase activity.  Alternative dosing schedules of JNJ-3877605 and concomitant probenecid administration in rabbits failed to prevent renal toxicity at dose levels that could be pharmacol. active.  Conclusions: Combined clin. and correlative preclin. studies suggest that renal toxicity of JNJ-38877605 is caused by the formation of species-specific insol. metabolites.  These observations preclude further clin. development of JNJ-38877605.  Clin Cancer Res; 21(10); 2297-304. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro1cpkCcM_IbVg90H21EOLACvtfcHk0liph20F0kX-_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXoslOktbc%253D&md5=9900b077fbb0766d9c26b3908e7ee1c4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3258%26sid%3Dliteratum%253Aachs%26aulast%3DLolkema%26aufirst%3DM.%2BP.%26aulast%3DBohets%26aufirst%3DH.%2BH.%26aulast%3DArkenau%26aufirst%3DH.%2BT.%26aulast%3DLampo%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DE.%26aulast%3Dde%2BJonge%26aufirst%3DM.%2BJ.%2BA.%26aulast%3Dvan%2BDoorn%26aufirst%3DL.%26aulast%3DHellemans%26aufirst%3DP.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DEskens%26aufirst%3DF.%26atitle%3DThe%2520C-Met%2520Tyrosine%2520Kinase%2520Inhibitor%2520Jnj-38877605%2520Causes%2520Renal%2520Toxicity%2520through%2520Species-Specific%2520Insoluble%2520Metabolite%2520Formation%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26issue%3D10%26spage%3D2297%26epage%3D2304%26doi%3D10.1158%2F1078-0432.CCR-14-3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span> <span> </span><span class="NLM_article-title">Unexpected Renal Toxicity Associated with Sgx523, a Small Molecule Inhibitor of Met</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1007/s10637-012-9823-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs10637-012-9823-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22547164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsleis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=363-369&issue=2&author=J.+R.+Infanteauthor=T.+Ruggauthor=M.+Gordonauthor=I.+Rooneyauthor=L.+Rosenauthor=K.+Zehauthor=R.+Liuauthor=H.+A.+Burrisauthor=R.+K.+Ramanathan&title=Unexpected+Renal+Toxicity+Associated+with+Sgx523%2C+a+Small+Molecule+Inhibitor+of+Met&doi=10.1007%2Fs10637-012-9823-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of MET</span></div><div class="casAuthors">Infante, Jeffrey R.; Rugg, Terence; Gordon, Michael; Rooney, Isabelle; Rosen, Lee; Zeh, Karin; Liu, Raymond; Burris, Howard A.; Ramanathan, Ramesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">363-369</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose SGX523 is an orally bio-available, ATP competitive, small mol. inhibitor of MET, binding the kinase domain active site in a novel mode.  Two phase 1, open-label, dose-escalation studies of SGX523 were conducted to evaluate both interrupted and continuous dosing schedules.  Methods Thirty-six patients per study were planned to be enrolled.  The first study explored a 21-day cycle with SGX523 administered on an intermittent schedule at a starting dose of 60 mg PO BID for 14 days followed by 7 days of rest.  The second protocol explored a continuous 28-day dosing schedule with SGX523 administered at a starting dose of 20 mg PO BID for 28 days without rest.  Results A total of 10 patients were enrolled, 2 on the intermittent dosing protocol and 8 on the continuous dosing protocol.  All 6 patients that received daily doses of ≥ 80 mg developed unexpected renal failure manifested by an early rise of serum blood urea nitrogen and creatinine.  Human PK anal. revealed the formation of two insol. metabolites at levels not seen in the rat or dog preclin. toxicol. studies.  Subsequent primate toxicol. and toxicokinetic evaluation replicated human findings, and histol. examn. of the monkey kidneys revealed the formation of crystals both within the renal tubules and within giant cell macrophages.  Conclusion Two-species toxicol. studies of SGX523 did not predict the occurrence of renal toxicity in the human.  Subsequent primate toxicol. studies suggest the cause of the renal failure seen in humans was a crystal nephropathy secondary to insol. metabolites.  SGX523 is no longer in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ewYHwc5RhrVg90H21EOLACvtfcHk0liph20F0kX-_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsleis7g%253D&md5=fe939cff3ba4a95ca7c21ff5744d043f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs10637-012-9823-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-012-9823-9%26sid%3Dliteratum%253Aachs%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DRugg%26aufirst%3DT.%26aulast%3DGordon%26aufirst%3DM.%26aulast%3DRooney%26aufirst%3DI.%26aulast%3DRosen%26aufirst%3DL.%26aulast%3DZeh%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26atitle%3DUnexpected%2520Renal%2520Toxicity%2520Associated%2520with%2520Sgx523%252C%2520a%2520Small%2520Molecule%2520Inhibitor%2520of%2520Met%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26issue%3D2%26spage%3D363%26epage%3D369%26doi%3D10.1007%2Fs10637-012-9823-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maduskuie, T. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falahatpisheh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeleswaram, S.</span></span> <span> </span><span class="NLM_article-title">Species-Specific Metabolism of Sgx523 by Aldehyde Oxidase and the Toxicological Implications</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.032375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.110.032375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=20421447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1277-1285&issue=8&author=S.+Diamondauthor=J.+Boerauthor=T.+P.+Maduskuieauthor=N.+Falahatpishehauthor=Y.+Liauthor=S.+Yeleswaram&title=Species-Specific+Metabolism+of+Sgx523+by+Aldehyde+Oxidase+and+the+Toxicological+Implications&doi=10.1124%2Fdmd.110.032375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications</span></div><div class="casAuthors">Diamond, Sharon; Boer, Jason; Maduskuie, Thomas P., Jr.; Falahatpisheh, Nikoo; Li, Yu; Yeleswaram, Swamy</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1277-1285</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">An investigation was conducted to follow up on the apparent species-dependent toxicity reported for 6-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio]quinoline (SGX523), a mesenchymal-epithelial transition factor (c-MET) inhibitor that entered clin. development for the treatment of solid tumors.  Patients treated with SGX523 exhibited compromised renal function presumably resulting from crystal deposits in renal tubules.  Our independent metabolite profiling of SGX523 indicates that a major NADPH-independent, late-eluting metabolite [6-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio)quinolin-2(1H)-one (M11)] was generated by monkey and human liver S-9, and to a lesser extent by rat S-9, whereas M11 was absent in dog S-9 incubations.  We confirmed the identity of M11 as 2-quinolinone-SGX523.  Expts. with various molybdenum hydroxylase inhibitors showed that aldehyde oxidase (AO), and not xanthine oxidase, metabolized SGX523 to M11 in monkey and human liver cytosol.  In addn., the oxygen incorporated into M11 was derived from water rather than atm. oxygen, corroborating M11 formation via AO.  After oral dosing in monkeys, metabolite profiling of plasma and urine showed that SGX523 was indeed metabolized to M11 and its N-demethyl analog (M8).  In urine, M11 levels were ∼70-fold greater than that of SGX523, and the soly. of M11 in urine was only 3% of that of SGX523.  In summary, SGX523 is metabolized by AO in a species-specific manner to a markedly less-sol. metabolite, M11.  We propose that M11 is likely involved in the obsd. obstructive nephropathy reported in clin. studies.  Moreover, this study illustrates the need to conduct thorough metabolic evaluations early in drug development to select the most relevant nonclin. species for toxicol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryx8buDjc41LVg90H21EOLACvtfcHk0lj10QWrJtJVlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjM&md5=27450436ad7a69d72d4cc8ae9860ccd9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.032375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.032375%26sid%3Dliteratum%253Aachs%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DMaduskuie%26aufirst%3DT.%2BP.%26aulast%3DFalahatpisheh%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYeleswaram%26aufirst%3DS.%26atitle%3DSpecies-Specific%2520Metabolism%2520of%2520Sgx523%2520by%2520Aldehyde%2520Oxidase%2520and%2520the%2520Toxicological%2520Implications%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D8%26spage%3D1277%26epage%3D1285%26doi%3D10.1124%2Fdmd.110.032375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warr, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorehead, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemenway, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, J. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical Development</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1124/dmd.117.078899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.117.078899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29311136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsV2ktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=237-247&issue=3&author=J.+Zhengauthor=Y.+Xinauthor=J.+Zhangauthor=R.+Subramanianauthor=B.+P.+Murrayauthor=J.+A.+Whitneyauthor=M.+R.+Warrauthor=J.+Lingauthor=L.+Mooreheadauthor=E.+Kwanauthor=J.+Hemenwayauthor=B.+J.+Smithauthor=J.+A.+Silverman&title=Pharmacokinetics+and+Disposition+of+Momelotinib+Revealed+a+Disproportionate+Human+Metabolite-Resolution+for+Clinical+Development&doi=10.1124%2Fdmd.117.078899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and disposition of momelotinib revealed a disproportionate human metabolite-resolution for clinical development</span></div><div class="casAuthors">Zheng, Jim; Xin, Yan; Zhang, Jingyu; Subramanian, Raju; Murray, Bernard P.; Whitney, J. Andrew; Warr, Matthew R.; Ling, John; Moorehead, Lisa; Kwan, Ellen; Hemenway, Jeffrey; Smith, Bill J.; Silverman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-247,S1-S28</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Momelotinib (MMB), a small-mol. inhibitor of Janus kinase (JAK)1/2 and of activin A receptor type 1 (ACVR1), is in clin. development for the treatment of myeloproliferative neoplasms.  The pharmacokinetics and disposition of [14C]MMB were characterized in a single-dose, human mass-balance study.  Metab. and the pharmacol. activity of key metabolites were elucidated in multiple in vitro and in vivo expts.  MMB was rapidly absorbed following oral dosing with approx. 97% of the radioactivity recovered, primarily in feces with urine as a secondary route.  Mean blood-to-plasma [14C] area under the plasma concn.-time curve ratio was 0.72, suggesting low assocn. of MMB and metabolites with blood cells. [14C]MMB-derived radioactivity was detectable in blood for ≤48 h, suggesting no irreversible binding of MMB or its metabolites.  The major circulating human metabolite, M21 (a morpholino lactam), is a potent inhibitor of JAK1/2 and ACVR1 in vitro.  Estn. of pharmacol. activity index suggests M21 contributes significantly to the pharmacol. activity of MMB for the inhibition of both JAK1/2 and ACVR1.  M21 was obsd. in disproportionately higher amts. in human plasma than in rat or dog, the rodent and nonrodent species used for the general nonclin. safety assessment of this mol.  This discrepancy was resolved with addnl. nonclin. studies wherein the circulating metabolites and drug-drug interactions were further characterized.  The human metab. of MMB was mediated primarily by multiple cytochrome P 450 enzymes, whereas M21 formation involved initial P 450 oxidn. of the morpholine ring followed by metab. via aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGdMwZyk81C7Vg90H21EOLACvtfcHk0lj10QWrJtJVlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsV2ktb8%253D&md5=cf73dce851338a404b11a90fe2287ca4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fdmd.117.078899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.117.078899%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DB.%2BP.%26aulast%3DWhitney%26aufirst%3DJ.%2BA.%26aulast%3DWarr%26aufirst%3DM.%2BR.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DMoorehead%26aufirst%3DL.%26aulast%3DKwan%26aufirst%3DE.%26aulast%3DHemenway%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DSilverman%26aufirst%3DJ.%2BA.%26atitle%3DPharmacokinetics%2520and%2520Disposition%2520of%2520Momelotinib%2520Revealed%2520a%2520Disproportionate%2520Human%2520Metabolite-Resolution%2520for%2520Clinical%2520Development%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26issue%3D3%26spage%3D237%26epage%3D247%26doi%3D10.1124%2Fdmd.117.078899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitcher-Johnstone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D. J.</span></span> <span> </span><span class="NLM_article-title">Metabolic Switching of Bilr 355 in the Presence of Ritonavir. Ii. Uncovering Novel Contributions by Gut Bacteria and Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1130</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.044362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.044362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22393121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlWnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1130-1137&issue=6&author=Y.+Liauthor=J.+Xuauthor=W.+G.+Laiauthor=A.+Whitcher-Johnstoneauthor=D.+J.+Tweedie&title=Metabolic+Switching+of+Bilr+355+in+the+Presence+of+Ritonavir.+Ii.+Uncovering+Novel+Contributions+by+Gut+Bacteria+and+Aldehyde+Oxidase&doi=10.1124%2Fdmd.111.044362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic switching of BILR 355 in the presence of ritonavir. II. Uncovering novel contributions by gut bacteria and aldehyde oxidase</span></div><div class="casAuthors">Li, Yongmei; Xu, Jun; Lai, W. George; Whitcher-Johnstone, Andrea; Tweedie, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1130-1137</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ritonavir (RTV) was used as a boosting agent to increase the clin. exposure of 11-ethyl-5,11-dihydro-5-methyl-8-[2-[(1-oxido-4-quinolinyl)oxy]ethyl]-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one (BILR 355), an inhibitor of the human immunodeficiency virus, by inhibiting the CYP3A-mediated metab. of BILR 355.  However, although the levels of BILR 355 increased upon concomitant administration of RTV, a metabolite of BILR 355, BILR 516, which was not detected previously in humans dosed with BILR 355 alone, became a disproportionate human metabolite with levels exceeding the parent levels at steady state.  This was an unusual finding based on the in vitro and in vivo metabolic profiles of BILR 355 available at that time.  Our studies reveal that BILR 355 is reduced to an intermediate, BILR 402, by gut bacteria and the reduced metabolite (BILR 402) is then oxidized by aldehyde oxidase to form BILR 516, the disproportionate human metabolite.  The role of aldehyde oxidase helped to explain the some-what unique formation of BILR 516 in humans compared with preclin. animal species.  This article underlines the increasing importance of two individually atypical enzymes in drug development, gut bacterial biotransformation and aldehyde oxidase, which in combination provided a unique metabolic pathway.  In addn., this article clearly elucidates an example of novel metabolic switching and, it is hoped, raises awareness of the potential for metabolic switching in combination drug therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot96hVZ6iS27Vg90H21EOLACvtfcHk0lj10QWrJtJVlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlWnsrY%253D&md5=4373d80f720051a930c5348391148923</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.044362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.044362%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DW.%2BG.%26aulast%3DWhitcher-Johnstone%26aufirst%3DA.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26atitle%3DMetabolic%2520Switching%2520of%2520Bilr%2520355%2520in%2520the%2520Presence%2520of%2520Ritonavir.%2520Ii.%2520Uncovering%2520Novel%2520Contributions%2520by%2520Gut%2520Bacteria%2520and%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D6%26spage%3D1130%26epage%3D1137%26doi%3D10.1124%2Fdmd.111.044362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glatthar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troxler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beerli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gassmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druckes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fendrich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny-Baron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornfeld, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peel, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparrer, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (Cot) Kinase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7544</span>– <span class="NLM_lpage">7560</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSms7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7544-7560&issue=16&author=R.+Glattharauthor=A.+Stojanovicauthor=T.+Troxlerauthor=H.+Mattesauthor=H.+Mobitzauthor=R.+Beerliauthor=J.+Blanzauthor=E.+Gassmannauthor=P.+Druckesauthor=G.+Fendrichauthor=S.+Gutmannauthor=G.+Martiny-Baronauthor=F.+Spenceauthor=J.+Hornfeldauthor=J.+E.+Peelauthor=H.+Sparrer&title=Discovery+of+Imidazoquinolines+as+a+Novel+Class+of+Potent%2C+Selective%2C+and+in+Vivo+Efficacious+Cancer+Osaka+Thyroid+%28Cot%29+Kinase+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors</span></div><div class="casAuthors">Glatthar, Ralf; Stojanovic, Aleksandar; Troxler, Thomas; Mattes, Henri; Mobitz, Henrik; Beerli, Rene; Blanz, Joachim; Gassmann, Ernst; Druckes, Peter; Fendrich, Gabriele; Gutmann, Sascha; Martiny-Baron, Georg; Spence, Fiona; Hornfeld, Jeff; Peel, John Edmonson; Sparrer, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7544-7560</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages.  Thus, pharmacol. inhibition of COT should be a valid approach to therapeutically intervene in the pathogenesis of macrophage-driven inflammatory diseases such as rheumatoid arthritis.  We report the discovery and chem. optimization of a novel series of COT kinase inhibitors, with unprecedented nanomolar potency for the inhibition of TNFα.  Pharmacol. profiling in vivo revealed a high metab. of these compds. in rats which was demonstrated to be predominantly attributed to aldehyde oxidase.  Due to the very low activity of hepatic AO in the dog, the selected candidate 32 displayed significant blood exposure in dogs which resulted in a clear prevention of inflammation-driven lameness.  Taken together, the described compds. both potently and selectively inhibit COT kinase in primary human cells and ameliorate inflammatory pathologies in vivo, supporting the notion that COT is an appropriate therapeutic target for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHVRjwV5VvurVg90H21EOLACvtfcHk0lg9l5qH9BKUpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSms7nN&md5=26f882f203e21bf78d9c9e5090f8fc5b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00598%26sid%3Dliteratum%253Aachs%26aulast%3DGlatthar%26aufirst%3DR.%26aulast%3DStojanovic%26aufirst%3DA.%26aulast%3DTroxler%26aufirst%3DT.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DMobitz%26aufirst%3DH.%26aulast%3DBeerli%26aufirst%3DR.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DGassmann%26aufirst%3DE.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DGutmann%26aufirst%3DS.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DSpence%26aufirst%3DF.%26aulast%3DHornfeld%26aufirst%3DJ.%26aulast%3DPeel%26aufirst%3DJ.%2BE.%26aulast%3DSparrer%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520Imidazoquinolines%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%252C%2520Selective%252C%2520and%2520in%2520Vivo%2520Efficacious%2520Cancer%2520Osaka%2520Thyroid%2520%2528Cot%2529%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D16%26spage%3D7544%26epage%3D7560%26doi%3D10.1021%2Facs.jmedchem.6b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zetterberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakilam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hariparsad, N.</span></span> <span> </span><span class="NLM_article-title">Vx-509 (Decernotinib)-Mediated Cyp3a Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1286</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.071100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.116.071100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27298338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1286-1295&issue=8&author=C.+Zetterbergauthor=F.+Maltaisauthor=L.+Laitinenauthor=S.+Liaoauthor=H.+Tsaoauthor=A.+Chakilamauthor=N.+Hariparsad&title=Vx-509+%28Decernotinib%29-Mediated+Cyp3a+Time-Dependent+Inhibition%3A+An+Aldehyde+Oxidase+Metabolite+as+a+Perpetrator+of+Drug-Drug+Interactions&doi=10.1124%2Fdmd.116.071100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">VX-509 (Decernotinib)-mediated CYP3A time-dependent inhibition: an aldehyde oxidase metabolite as a perpetrator of drug-drug interactions</span></div><div class="casAuthors">Zetterberg, Craig; Maltais, Francois; Laitinen, Leena; Liao, Shengkai; Tsao, Hong; Chakilam, Ananthsrinivas; Hariparsad, Niresh</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1286-1295</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(R)-2-((2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2- methyl-N-(2,2,2-trifluoroethyl)butanamide (VX-509, decernotinib) is an oral Janus kinase 3 inhibitor that has been studied in patients with rheumatoid arthritis.  Patients with rheumatoid arthritis often receive multiple medications, such as statins and steroids, to manage the signs and symptoms of comorbidities, which increases the chances of drug-drug interactions (DDIs).  Mechanism-based inhibition is a subset of time-dependent inhibition (TDI) and occurswhen amol. forms a reactive metabolite which irreversibly binds and inactivates drug-metabolizing enzymes, potentially increasing the systemic load to toxic concns.  Traditionally, perpetrating compds. are screened using human liver microsomes (HLMs); however, this system may be inadequate when the precipitant is activated by a non-cytochrome P 450 (P 450)-mediated pathway.  Even though studies assessing competitive inhibition and TDI using HLM suggested a low risk for CYP3A4-mediated DDI in the clinic, VX-509 increased the area under the curve of midazolam, atorvastatin, and methyl-prednisolone by approx. 12.0-, 2.7-, and 4.3-fold, resp.  Metabolite identification studies using human liver cytosol indicated that VX-509 is converted to an oxidative metabolite,which is the perpetrator of the DDIs obsd. in the clinic.  As opposed to HLM, hepatocytes contain the full complement of drug-metabolizing enzymes and transporters and can be used to assess TDI arising from non-P 450-mediated metabolic pathways.  In the current study, we highlight the role of aldehyde oxidase in the formation of the hydroxylmetabolite of VX-509, which is involved in clin. significant TDIbased DDIs and represents an addnl. example in which a system-dependent prediction of TDI would be evident.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR_yvvbiu6ybVg90H21EOLACvtfcHk0lg9l5qH9BKUpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurjE&md5=82ee148002f4dba2d8ddb495988e64f4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.071100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.071100%26sid%3Dliteratum%253Aachs%26aulast%3DZetterberg%26aufirst%3DC.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DLaitinen%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DH.%26aulast%3DChakilam%26aufirst%3DA.%26aulast%3DHariparsad%26aufirst%3DN.%26atitle%3DVx-509%2520%2528Decernotinib%2529-Mediated%2520Cyp3a%2520Time-Dependent%2520Inhibition%253A%2520An%2520Aldehyde%2520Oxidase%2520Metabolite%2520as%2520a%2520Perpetrator%2520of%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1286%26epage%3D1295%26doi%3D10.1124%2Fdmd.116.071100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogiso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Enzymes Responsible for Dantrolene Metabolism in the Human Liver: A Clue to Uncover the Cause of Liver Injury</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2018.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29522712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkt1Gltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=69-78&author=T.+Amanoauthor=T.+Fukamiauthor=T.+Ogisoauthor=D.+Hiroseauthor=J.+P.+Jonesauthor=T.+Taniguchiauthor=M.+Nakajima&title=Identification+of+Enzymes+Responsible+for+Dantrolene+Metabolism+in+the+Human+Liver%3A+A+Clue+to+Uncover+the+Cause+of+Liver+Injury&doi=10.1016%2Fj.bcp.2018.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injury</span></div><div class="casAuthors">Amano, Takayuki; Fukami, Tatsuki; Ogiso, Takuo; Hirose, Daisuke; Jones, Jeffrey P.; Taniguchi, Tsuyoshi; Nakajima, Miki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-78</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dantrolene is used for malignant hyperthermia during anesthesia, and it sometimes causes severe liver injury as a side effect.  Dantrolene is metabolized to acetylaminodantrolene, which is formed via the redn. of dantrolene to aminodantrolene and subsequent acetylation.  Formation of hydroxylamine during the metabolic process may be assocd. with liver injury.  We identified the enzymes responsible for dantrolene metab. in humans to elucidate the mechanism of liver injury.  Dantrolene reductase activity was not detected in human liver microsomes, but it was detected in cytosol.  Formation was increased in the presence of N1-methylnicotineamide, which is an electron donor to aldehyde oxidase 1 (AOX1).  Potent inhibitors of AOX1 and a correlation study with a marker of AOX1 activity, namely phthalazine oxidase activity, in a panel of 28 human liver cytosol samples supported the role of AOX1 in dantrolene redn.  Acetylaminodantrolene formation from aminodantrolene was highly detected in recombinant N-acetyltransferase (NAT) 2 rather than NAT1.  A glutathione trapping assay revealed the formation of hydroxylamine via an AOX1-dependent redn. of dantrolene but not via hydroxylation of aminodantrolene.  In conclusion, we found that AOX1 and NAT2 were responsible for dantrolene metab. in humans and that AOX1-dependent metab. dets. dantrolene-induced liver injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozmdPV3PSsEbVg90H21EOLACvtfcHk0lg2svluTtLzCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkt1Gltro%253D&md5=f3ae6b3c787604e998bee8f10b9c7d89</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DAmano%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DOgiso%26aufirst%3DT.%26aulast%3DHirose%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DNakajima%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Enzymes%2520Responsible%2520for%2520Dantrolene%2520Metabolism%2520in%2520the%2520Human%2520Liver%253A%2520A%2520Clue%2520to%2520Uncover%2520the%2520Cause%2520of%2520Liver%2520Injury%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D151%26spage%3D69%26epage%3D78%26doi%3D10.1016%2Fj.bcp.2018.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. C.</span></span>, <span> </span><span class="NLM_article-title">Aldehyde Oxidase Metabolism in Drug Discovery</span>. In  <i>Medicinal Chemistry Reviews</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J. J.</span></span>, Ed.; <span class="NLM_publisher-name">American Chemical Society</span>, <span class="NLM_publisher-loc">Washington, D.C.</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">52</span>, Chapter 21.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+C.+Burnsauthor=J.+J.+Bronson&title=Medicinal+Chemistry+Reviews"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DA.%2BC.%26atitle%3DAldehyde%2520Oxidase%2520Metabolism%2520in%2520Drug%2520Discovery%26btitle%3DMedicinal%2520Chemistry%2520Reviews%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2017%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goracci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span> <span> </span><span class="NLM_article-title">Structure-Metabolism Relationships in Human-Aox: Chemical Insights from a Large Database of Aza-Aromatic and Amide Compounds</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">E3178</span>– <span class="NLM_lpage">E3187</span>, <span class="refDoi"> DOI: 10.1073/pnas.1618881114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1073%2Fpnas.1618881114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28373537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsV2nsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E3178-E3187&issue=16&author=S.+Lepriauthor=M.+Ceccarelliauthor=N.+Milaniauthor=S.+Tortorellaauthor=A.+Cuccoauthor=A.+Valeriauthor=L.+Goracciauthor=A.+Brinkauthor=G.+Cruciani&title=Structure-Metabolism+Relationships+in+Human-Aox%3A+Chemical+Insights+from+a+Large+Database+of+Aza-Aromatic+and+Amide+Compounds&doi=10.1073%2Fpnas.1618881114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds.</span></div><div class="casAuthors">Lepri, Susan; Ceccarelli, Martina; Milani, Nicolo; Tortorella, Sara; Cucco, Andrea; Valeri, Aurora; Goracci, Laura; Brink, Andreas; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">E3178-E3187</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is a metabolic enzyme catalyzing the oxidn. of aldehyde and aza-arom. compds. and the hydrolysis of amides, moieties frequently shared by the majority of drugs.  Despite its key role in human metab., to date only fragmentary information about the chem. features responsible for AOX susceptibility are reported and only "very local" structure-metab. relationships based on a small no. of similar compds. have been developed.  This study reports a more comprehensive coverage of the chem. space of structures with a high risk of AOX phase I metab. in humans.  More than 270 compds. were studied to identify the site of metab. and the metabolite(s).  Both electronic [supported by d. functional theory (DFT) calcns.] and exposure effects were considered when rationalizing the structure-metab. relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotA9C1TVn-9bVg90H21EOLACvtfcHk0lg2svluTtLzCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsV2nsb8%253D&md5=81cd013f7b63399e10d950e30377dbc0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1618881114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1618881114%26sid%3Dliteratum%253Aachs%26aulast%3DLepri%26aufirst%3DS.%26aulast%3DCeccarelli%26aufirst%3DM.%26aulast%3DMilani%26aufirst%3DN.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DCucco%26aufirst%3DA.%26aulast%3DValeri%26aufirst%3DA.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DBrink%26aufirst%3DA.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DStructure-Metabolism%2520Relationships%2520in%2520Human-Aox%253A%2520Chemical%2520Insights%2520from%2520a%2520Large%2520Database%2520of%2520Aza-Aromatic%2520and%2520Amide%2520Compounds%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26issue%3D16%26spage%3DE3178%26epage%3DE3187%26doi%3D10.1073%2Fpnas.1618881114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sejberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for Cdk8/19</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=573-578&issue=6&author=A.+Mallingerauthor=K.+Schiemannauthor=C.+Rinkauthor=J.+Sejbergauthor=M.+A.+Honeyauthor=P.+Czodrowskiauthor=M.+Stubbsauthor=O.+Poeschkeauthor=M.+Buschauthor=R.+Schneiderauthor=D.+Schwarzauthor=D.+Musilauthor=R.+Burkeauthor=K.+Urbahnsauthor=P.+Workmanauthor=D.+Wienkeauthor=P.+A.+Clarkeauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=C.+Esdarauthor=F.+Rohdichauthor=J.+Blagg&title=2%2C8-Disubstituted-1%2C6-Naphthyridines+and+4%2C6-Disubstituted-Isoquinolines+with+Potent%2C+Selective+Affinity+for+Cdk8%2F19&doi=10.1021%2Facsmedchemlett.6b00022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19</span></div><div class="casAuthors">Mallinger, Aurelie; Schiemann, Kai; Rink, Christian; Sejberg, Jimmy; Honey, Mark A.; Czodrowski, Paul; Stubbs, Mark; Poeschke, Oliver; Busch, Michael; Schneider, Richard; Schwarz, Daniel; Musil, Djordje; Burke, Rosemary; Urbahns, Klaus; Workman, Paul; Wienke, Dirk; Clarke, Paul A.; Raynaud, Florence I.; Eccles, Suzanne A.; Esdar, Christina; Rohdich, Felix; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">573-578</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We demonstrate a designed scaffold-hop approach to the discovery of 2,8-disubstituted-1,6-naphthyridine- and 4,6-disubstituted-isoquinoline-based dual CDK8/19 ligands.  Optimized compds. in both series exhibited rapid aldehyde oxidase-mediated metab., which could be abrogated by introduction of an amino substituent at C5 of the 1,6-naphthyridine scaffold or at C1 of the isoquinoline scaffold.  Compds. 51 and 59 were progressed to in vivo pharmacokinetic studies, and 51 also demonstrated sustained inhibition of STAT1SER727 phosphorylation, a biomarker of CDK8 inhibition, in an SW620 colorectal carcinoma human tumor xenograft model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcHD7cu5uM2rVg90H21EOLACvtfcHk0ljAairuSKvzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCrs70%253D&md5=20854b532b81db1be40afcd811ac5731</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00022%26sid%3Dliteratum%253Aachs%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DRink%26aufirst%3DC.%26aulast%3DSejberg%26aufirst%3DJ.%26aulast%3DHoney%26aufirst%3DM.%2BA.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3D2%252C8-Disubstituted-1%252C6-Naphthyridines%2520and%25204%252C6-Disubstituted-Isoquinolines%2520with%2520Potent%252C%2520Selective%2520Affinity%2520for%2520Cdk8%252F19%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D6%26spage%3D573%26epage%3D578%26doi%3D10.1021%2Facsmedchemlett.6b00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellriegel, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, P.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Identification and Human Exposure Prediction of Two Aldehyde Oxidase-Mediated Metabolites of a Methylquinoline-Containing Drug Candidate</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1080/00498254.2018.1444815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498254.2018.1444815" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29473769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1OjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2019&pages=302-312&issue=3&author=A.+C.+Liauthor=D.+Cuiauthor=E.+Yuauthor=K.+Dobsonauthor=E.+T.+Hellriegelauthor=P.+Robertson&title=Identification+and+Human+Exposure+Prediction+of+Two+Aldehyde+Oxidase-Mediated+Metabolites+of+a+Methylquinoline-Containing+Drug+Candidate&doi=10.1080%2F00498254.2018.1444815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and human exposure prediction of two aldehyde oxidase-mediated metabolites of a methylquinoline-containing drug candidate</span></div><div class="casAuthors">Li, Austin C.; Cui, Donghui; Yu, Erya; Dobson, Kyle; Hellriegel, Edward T.; Robertson Jr, Philmore</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">302-312</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. Aldehyde oxidase (AO enzymes)-mediated oxidn. predominantly occurs at a carbon atom adjacent to the nitrogen on arom. azaheterocycles.  In the current report, we identified that AO enzymes oxidn. took place at both the C-2 and C-4 positions of the methylquinoline moiety of Compd. A based on data from mass spectrometric anal., AO enzymes "litmus" test, and comparison with authentic stds.2.  To assess the potential for inadequate coverage for these two AO enzyme-mediated metabolites in nonclin. safety studies, given concerns due to differences in AO enzymes expression between preclin. species and humans, the human circulating levels of the two AO enzyme-mediated metabolites were predicted prospectively using in vitro and in vivo models.  Both formation clearance and elimination clearance of the two metabolites were predicted based on in vitro to in vivo correlation and comparison with in vivo data from rats.3.  The result showed that the 4-OH metabolite of Compd. A would account for less than 3% of the total drug-related exposure in human plasma, while the exposure to the 2-oxo metabolite would be relatively high (∼70%).4.  The predicted human exposure levels for the two metabolites are in similar ranges as those obsd. in monkeys.  These data taken together support the advancement to clin. development of Compd. A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUVUnEkPWCa7Vg90H21EOLACvtfcHk0ljAairuSKvzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1OjtL4%253D&md5=2a22b0830ecba7adcf1bd05b4e99145d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F00498254.2018.1444815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2018.1444815%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.%2BC.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DE.%26aulast%3DDobson%26aufirst%3DK.%26aulast%3DHellriegel%26aufirst%3DE.%2BT.%26aulast%3DRobertson%26aufirst%3DP.%26atitle%3DIdentification%2520and%2520Human%2520Exposure%2520Prediction%2520of%2520Two%2520Aldehyde%2520Oxidase-Mediated%2520Metabolites%2520of%2520a%2520Methylquinoline-Containing%2520Drug%2520Candidate%26jtitle%3DXenobiotica%26date%3D2019%26volume%3D49%26issue%3D3%26spage%3D302%26epage%3D312%26doi%3D10.1080%2F00498254.2018.1444815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Triazolopyridazines Substituted with Methylisoquinolinone as Selective C-Met Kinase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">7185</span>– <span class="NLM_lpage">7188</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2011.09.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22001029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7185-7188&issue=23&author=J.+W.+Ryuauthor=S.+Y.+Hanauthor=J.+I.+Yunauthor=S.+U.+Choiauthor=H.+Jungauthor=J.+D.+Haauthor=S.+Y.+Choauthor=C.+O.+Leeauthor=N.+S.+Kangauthor=J.+S.+Kohauthor=H.+R.+Kimauthor=J.+Lee&title=Design+and+Synthesis+of+Triazolopyridazines+Substituted+with+Methylisoquinolinone+as+Selective+C-Met+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2011.09.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors</span></div><div class="casAuthors">Ryu, Jae Wook; Han, Sun-Young; Yun, Jeong In; Choi, Sang-Un; Jung, Heejung; Ha, Jae Du; Cho, Sung Yun; Lee, Chong Ock; Kang, Nam Sook; Koh, Jong Sung; Kim, Hyoung Rae; Lee, Jongkook</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7185-7188</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of triazolopyridazines substituted with methylisoquinolinone, e.g. I (R = Ph, pyrrolidin-1-yl, thiazol-3-yl, 3-FC6H4), were designed and synthesized.  Some of the triazolopyridazines strongly inhibited c-Met kinase and showed good anti-proliferative activity against a panel of c-Met-amplified gastric cancer cell lines (MKN-45, SNU-5 and Hs746T).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooR--kJy29qbVg90H21EOLACvtfcHk0ljAairuSKvzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7F&md5=d0416a66a0bfc8c1e3564f306704a1d4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.066%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DJ.%2BW.%26aulast%3DHan%26aufirst%3DS.%2BY.%26aulast%3DYun%26aufirst%3DJ.%2BI.%26aulast%3DChoi%26aufirst%3DS.%2BU.%26aulast%3DJung%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DJ.%2BD.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DC.%2BO.%26aulast%3DKang%26aufirst%3DN.%2BS.%26aulast%3DKoh%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Triazolopyridazines%2520Substituted%2520with%2520Methylisoquinolinone%2520as%2520Selective%2520C-Met%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D23%26spage%3D7185%26epage%3D7188%26doi%3D10.1016%2Fj.bmcl.2011.09.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner-Tung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzorno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. C.</span></span> <span> </span><span class="NLM_article-title">5-Fluoro-2-Pyrimidinone, a Liver Aldehyde Oxidase-Activated Prodrug of 5-Fluorouracil</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1111</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(95)98508-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0006-2952%2895%2998508-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7748192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2MXltl2rsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=1111-1116&issue=8&author=X.+Guoauthor=M.+Lerner-Tungauthor=H.+X.+Chenauthor=C.+N.+Changauthor=J.+L.+Zhuauthor=C.+P.+Changauthor=G.+Pizzornoauthor=T.+S.+Linauthor=Y.+C.+Cheng&title=5-Fluoro-2-Pyrimidinone%2C+a+Liver+Aldehyde+Oxidase-Activated+Prodrug+of+5-Fluorouracil&doi=10.1016%2F0006-2952%2895%2998508-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">5-Fluoro-2-pyramidinone, a liver aldehyde oxidase-activated prodrug of 5-fluorouracil</span></div><div class="casAuthors">Guo, Xin; Lerner-Tung, Mary; Chen, Hong-Xing; Chang, Chien-Neng; Zhu, Ju-Liang; Chang, Chia-Ping; Pizzorno, Giuseppe; Lin, Tai-Shun; Cheng, Yung-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1111-16</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">5-Fluorouracil (5-FU) is an effective antitumor agent used in treating various cancers.  Because of its metab. by intestinal and other cells, 5-FU has an inconsistent bioavailability that limits its oral use.  5-Fluoro-2-pyramidinone (5-FP) a 5-FU prodrug, was synthesized and converted to 5-FU by aldehyde oxidase, an enzyme present in high concns. in the livers of mice and humans but not in the gastrointestinal tract.  Using BDF1 mice, the pharmacokinetics of 5-FP were studied and compared with those of 5-FU.  The bioavailability of 5-FP given orally was 100% at a dosage of 25 μg/kg and 78% at a dosage of 50 mg/kg.  The half-lives of both doses of 5-FP were at least 2-fold longer than the half-lives of the same doses of 5-FU, and the clearance rates of 5-FP were 3-fold slower.  5-FP was converted rapidly to 5-FU in vivo.  The resulting 5-FU was measured at a steady-state level of 40-70 μM in plasma, at a dosage of 25 mg/kg, that was sustained for at least 4 h.  Also, when given orally, 5-FP was shown to have potent activity against Colon 38 tumor cells and P388 leukemia cells in mice.  The therapeutic index of 5-FP was similar to that of 5-FU in these mouse tumor models.  The potential clin. use of 5-FP as a prodrug of 5-FU should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqibLmX9x1QmLVg90H21EOLACvtfcHk0liQITJOk8A0tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltl2rsbs%253D&md5=8a8b747501650cce544fa2dd59bb99f1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2998508-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252998508-7%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DLerner-Tung%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%2BX.%26aulast%3DChang%26aufirst%3DC.%2BN.%26aulast%3DZhu%26aufirst%3DJ.%2BL.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DPizzorno%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DT.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BC.%26atitle%3D5-Fluoro-2-Pyrimidinone%252C%2520a%2520Liver%2520Aldehyde%2520Oxidase-Activated%2520Prodrug%2520of%25205-Fluorouracil%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26issue%3D8%26spage%3D1111%26epage%3D1116%26doi%3D10.1016%2F0006-2952%2895%2998508-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">In Vitro Oxidation of Famciclovir and 6-Deoxypenciclovir by Aldehyde Oxidase from Human, Guinea Pig, Rabbit, and Rat Liver</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9224775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFCgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=805-813&issue=7&author=M.+R.+Rashidiauthor=J.+A.+Smithauthor=S.+E.+Clarkeauthor=C.+Beedham&title=In+Vitro+Oxidation+of+Famciclovir+and+6-Deoxypenciclovir+by+Aldehyde+Oxidase+from+Human%2C+Guinea+Pig%2C+Rabbit%2C+and+Rat+Liver"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver</span></div><div class="casAuthors">Rashidi, Mohammad R.; Smith, John A.; Clarke, Stephen E.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">805-813</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Famciclovir, a 9-substituted guanine deriv., is a new antiviral agent which undergoes rapid hydrolysis and oxidn. in man to yield the active antiherpes agent, penciclovir.  Studies with human liver cytosol have indicated that the oxidn. of the penultimate metabolite, 6-deoxypenciclovir, to penciclovir is catalyzed by the molybdenum hydroxylase, aldehyde oxidase.  In the present study the oxidn. of famciclovir and 6-deoxypenciclovir with partially purified molybdenum hydroxylases from human, guinea pig, rabbit, and rat livers and bovine milk xanthine oxidase has been investigated.  Famciclovir and 6-deoxypenciclovir were oxidized predominantly to 6-oxo-famciclovir and penciclovir, resp., by human, guinea pig, and rat liver aldehyde oxidase.  Small amts. of 8-oxo and 6,8-dioxo-metabolites were also formed from each substrate.  Famciclovir and 6-deoxypenciclovir were good substrates for rabbit liver aldehyde oxidase but, in each case, two major metabolites were formed.  6-Deoxypenciclovir was converted to penciclovir and 8-oxo-6-deoxypenciclovir in approx. equal quantities; famciclovir was oxidized to 6-oxo-famciclovir and a second metabolite which, on the basis of chromatog. and UV spectral data, was thought to be 8-oxo-famciclovir.  Two groups of Sprague Dawley rats were identified; those contg. hepatic aldehyde oxidase and xanthine oxidase and those with only xanthine oxidase.  These have been designated AO-active and AO-inactive rats, resp.  Famciclovir was not oxidized by enzyme from AO-inactive rats or bovine milk xanthine oxidase although 6-deoxypenciclovir was slowly converted to penciclovir by rat liver or milk xanthine oxidase.  Inhibitor studies showed in human, guinea pig, and rabbit liver that xanthine oxidase did not contribute to the oxidn. of famciclovir and 6-deoxypenciclovir; thus it is proposed that drug activation in vivo would be catalyzed solely by aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq-gDS733rprVg90H21EOLACvtfcHk0liQITJOk8A0tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFCgur4%253D&md5=c719a9ec021d9001e396ecea39957364</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRashidi%26aufirst%3DM.%2BR.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DIn%2520Vitro%2520Oxidation%2520of%2520Famciclovir%2520and%25206-Deoxypenciclovir%2520by%2520Aldehyde%2520Oxidase%2520from%2520Human%252C%2520Guinea%2520Pig%252C%2520Rabbit%252C%2520and%2520Rat%2520Liver%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D25%26issue%3D7%26spage%3D805%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takayasu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikegaki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, T.</span></span> <span> </span><span class="NLM_article-title">Antivasospastic Effects of Hydroxyfasudil, a Rho-Kinase Inhibitor, after Subarachnoid Hemorrhage</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1254/jphs.11075FP</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1254%2Fjphs.11075FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22186620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ygsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2012&pages=92-98&issue=1&author=S.+Satohauthor=M.+Takayasuauthor=K.+Kawasakiauthor=I.+Ikegakiauthor=A.+Hitomiauthor=K.+Yanoauthor=M.+Shibuyaauthor=T.+Asano&title=Antivasospastic+Effects+of+Hydroxyfasudil%2C+a+Rho-Kinase+Inhibitor%2C+after+Subarachnoid+Hemorrhage&doi=10.1254%2Fjphs.11075FP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage</span></div><div class="casAuthors">Satoh, Shin-ichi; Takayasu, Masakazu; Kawasaki, Koh; Ikegaki, Ichiro; Hitomi, Asako; Yano, Kazuo; Shibuya, Masato; Asano, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-98</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">We investigated the anti-vasospastic potential of fasudil's active metabolite, hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage (SAH) and also its effect on hemorheol. abnormalities following cerebral ischemia.  Chronic cerebral vasospasm was produced using a two-hemorrhage canine model.  On day 7, angiog. vasospasm was obsd. in all animals, and i.v. administration of hydroxyfasudil (3 mg·kg-1·30 min-1) significantly reversed the vasospasm (predose diam. of the basilar artery, 57.9% ± 2.0% of the baseline before the injection of blood; postdose diam., 64.5% ± 1.9%).  The viscosity of whole blood was significantly increased 24 h after 1 h middle cerebral artery occlusion in rats.  Hydroxyfasudil (3 and 10 mg/kg, i.p.) significantly decreased blood viscosity.  The specificity of hydroxyfasudil was examd. against a panel of 17 protein kinases using ELISA anal.  Hydroxyfasudil inhibited Rho-kinase α and β at a concn. of 10 μM by 97.6% and 97.7%, resp.  No other protein kinase was inhibited with 10 μM hydroxyfasudil by over 40%.  The present results indicate hydroxyfasudil is a selective inhibitor of Rho-kinase.  The results also suggest that hydroxyfasudil contributes to the potency of fasudil to prevent cerebral vasospasm and hyperviscosity and suggest the potential utility of hydroxyfasudil as a therapeutic agent for patients with SAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomBZxR6Kp1xrVg90H21EOLACvtfcHk0lgEbfl_dwUZ8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ygsbw%253D&md5=1ba639cc41eb9ba63437a4dad5cbb15e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1254%2Fjphs.11075FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.11075FP%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DS.%26aulast%3DTakayasu%26aufirst%3DM.%26aulast%3DKawasaki%26aufirst%3DK.%26aulast%3DIkegaki%26aufirst%3DI.%26aulast%3DHitomi%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DK.%26aulast%3DShibuya%26aufirst%3DM.%26aulast%3DAsano%26aufirst%3DT.%26atitle%3DAntivasospastic%2520Effects%2520of%2520Hydroxyfasudil%252C%2520a%2520Rho-Kinase%2520Inhibitor%252C%2520after%2520Subarachnoid%2520Hemorrhage%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D118%26issue%3D1%26spage%3D92%26epage%3D98%26doi%3D10.1254%2Fjphs.11075FP" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6421</span>– <span class="NLM_lpage">6467</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6421-6467&issue=15&author=R.+J.+Youngauthor=P.+D.+Leeson&title=Mapping+the+Efficiency+and+Physicochemical+Trajectories+of+Successful+Optimizations&doi=10.1021%2Facs.jmedchem.8b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span></div><div class="casAuthors">Young, Robert J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6421-6467</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The practices and tactics employed in successful optimizations are examd., judged from the trajectories of ligand efficiency and property evolution.  A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technol.) and types of mols., including those beyond the rule of five.  The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable.  What is clear is that while targets are different, successful mols. are almost invariably among the most efficient for their target, even at the extremes.  Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQtcLKSk7q7Vg90H21EOLACvtfcHk0lgEbfl_dwUZ8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D&md5=f040ef02d161e070bb5021fde1585e66</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DMapping%2520the%2520Efficiency%2520and%2520Physicochemical%2520Trajectories%2520of%2520Successful%2520Optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467%26doi%3D10.1021%2Facs.jmedchem.8b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jørgensen, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4237</span>– <span class="NLM_lpage">4244</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b00658</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b00658" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ohtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=4237-4244&issue=8&author=M.+Montefioriauthor=F.+S.+J%C3%B8rgensenauthor=L.+Olsen&title=Aldehyde+Oxidase%3A+Reaction+Mechanism+and+Prediction+of+Site+of+Metabolism&doi=10.1021%2Facsomega.7b00658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism</span></div><div class="casAuthors">Montefiori, Marco; Joergensen, Flemming Steen; Olsen, Lars</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4237-4244</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a Mo-contg. enzyme involved in the clearance of drug compds. contg. aldehydes and N-contg. heterocyclic fragments.  AO has gained considerable interest in recent years because of examples of too fast clearance of drug compds. in development.  Thus, it is important to be able to predict AO-mediated drug metab.  Therefore, we characterized the structural and energetic aspects of different mechanisms with DFT using the Mo cofactor (MoCo) as model for the reactive part of the enzyme.  For a series of 6-substituted 4-quinazolinones, the trend in activation energies was the same for 3 tested reaction mechanisms.  Using the concerted mechanism as model for the enzymic reaction, the transition states for formation of all possible metabolites for a series of known AO substrates were detd.  The lowest activation energies corresponded in all cases to the exptl. obsd. sites of metab. (SOMs).  Various mol. properties were calcd. and investigated as more easily determinable markers for reactivity.  Both the stabilities of the intermediates and products correlated to some extent with the transition state energies, and may be used to predict the SOM.  The electrostatic potential (ESP)-derived charges were also good markers for prediction of the exptl. SOMs for this set of compds. and may pave the way for the development of fast methods for prediction of SOMs for AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWMl-me1-SlbVg90H21EOLACvtfcHk0lgEbfl_dwUZ8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ohtr3J&md5=5aa9f790b1ff0f28cb270322618de06c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b00658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b00658%26sid%3Dliteratum%253Aachs%26aulast%3DMontefiori%26aufirst%3DM.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DF.%2BS.%26aulast%3DOlsen%26aufirst%3DL.%26atitle%3DAldehyde%2520Oxidase%253A%2520Reaction%2520Mechanism%2520and%2520Prediction%2520of%2520Site%2520of%2520Metabolism%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26issue%3D8%26spage%3D4237%26epage%3D4244%26doi%3D10.1021%2Facsomega.7b00658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into Xenobiotic and Inhibitor Binding to Human Aldehyde Oxidase</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">783</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Fnchembio.1895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26322824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlylsrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=779-783&issue=10&author=C.+Coelhoauthor=A.+Fotiauthor=T.+Hartmannauthor=T.+Santos-Silvaauthor=S.+Leimkuhlerauthor=M.+J.+Romao&title=Structural+Insights+into+Xenobiotic+and+Inhibitor+Binding+to+Human+Aldehyde+Oxidase&doi=10.1038%2Fnchembio.1895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase</span></div><div class="casAuthors">Coelho, Catarina; Foti, Alessandro; Hartmann, Tobias; Santos-Silva, Teresa; Leimkuhler, Silke; Romao, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">779-783</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is a xanthine oxidase (XO)-related enzyme with emerging importance due to its role in the metab. of drugs and xenobiotics.  We report the first crystal structures of human AOX1, substrate free (2.6-Å resoln.) and in complex with the substrate phthalazine and the inhibitor thioridazine (2.7-Å resoln.).  Anal. of the protein active site combined with steady-state kinetic studies highlight the unique features, including binding and substrate orientation at the active site, that characterize human AOX1 as an important drug-metabolizing enzyme.  Structural anal. of the complex with the noncompetitive inhibitor thioridazine revealed a new, unexpected and fully occupied inhibitor-binding site that is structurally conserved among mammalian AOXs and XO.  The new structural insights into the catalytic and inhibition mechanisms of human AOX that we now report will be of great value for the rational anal. of clin. drug interactions involving inhibition of AOX1 and for the prediction and design of AOX-stable putative drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbH6qUJJ5AMbVg90H21EOLACvtfcHk0lhOGUoNy5pNvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlylsrnJ&md5=2053b7ec132f3e4ed7a82d011a46072a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1895%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26atitle%3DStructural%2520Insights%2520into%2520Xenobiotic%2520and%2520Inhibitor%2520Binding%2520to%2520Human%2520Aldehyde%2520Oxidase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D10%26spage%3D779%26epage%3D783%26doi%3D10.1038%2Fnchembio.1895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esmaeeli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span> <span> </span><span class="NLM_article-title">Human Aldehyde Oxidase (Haox1): Structure Determination of the Moco-Free Form of the Natural Variant G1269r and Biophysical Studies of Single Nucleotide Polymorphisms</span>. <i>FEBS Open Bio</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1002/2211-5463.12617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2F2211-5463.12617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30985987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlKqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=925-934&issue=5&author=C.+Motaauthor=M.+Esmaeeliauthor=C.+Coelhoauthor=T.+Santos-Silvaauthor=M.+Wolffauthor=A.+Fotiauthor=S.+Leimkuhlerauthor=M.+J.+Romao&title=Human+Aldehyde+Oxidase+%28Haox1%29%3A+Structure+Determination+of+the+Moco-Free+Form+of+the+Natural+Variant+G1269r+and+Biophysical+Studies+of+Single+Nucleotide+Polymorphisms&doi=10.1002%2F2211-5463.12617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Human aldehyde oxidase (hAOX1): structure determination of the Moco-free form of the natural variant G1269R and biophysical studies of single nucleotide polymorphisms</span></div><div class="casAuthors">Mota, Cristiano; Esmaeeli, Mariam; Coelho, Catarina; Santos-Silva, Teresa; Wolff, Martin; Foti, Alessandro; Leimkuehler, Silke; Romao, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Open Bio</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">925-934</span>CODEN:
                <span class="NLM_cas:coden">FOBEB3</span>;
        ISSN:<span class="NLM_cas:issn">2211-5463</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human aldehyde oxidase (hAOX1) is a molybdenum enzyme with high toxicol. importance, but its physiol. role is still unknown. hAOX1 metabolizes different classes of xenobiotics and is one of the main drug-metabolizing enzymes in the liver, along with cytochrome P 450. hAOX1 oxidizes and inactivates a large no. of drug mols. and has been responsible for the failure of several phase I clin. trials.  The interindividual variability of drug-metabolizing enzymes caused by single nucleotide polymorphisms (SNPs) is highly relevant in pharmaceutical treatments.  In this study, we present the crystal structure of the inactive variant G1269R, revealing the first structure of a molybdenum cofactor (Moco)-free form of hAOX1.  These data allowed to model, for the first time, the flexible Gate 1 that controls access to the active site.  Furthermore, we inspected the thermostability of wild-type hAOX1 and hAOX1 with various SNPs (L438V, R1231H, G1269R or S1271L) by CD spectroscopy and ThermoFAD, revealing that amino acid exchanges close to the Moco site can impact protein stability up to 10 °C.  These results correlated with biochem. and structural data and enhance our understanding of hAOX1 and the effect of SNPs in the gene encoding this enzyme in the human population.  Enzymes : Aldehyde oxidase (); xanthine dehydrogenase (); xanthine oxidase ().  Databases : Structural data are available in the Protein Data Bank under the accession no. 6Q6Q.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK4IebI-h967Vg90H21EOLACvtfcHk0lhOGUoNy5pNvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlKqsLo%253D&md5=96642bd514af80a301962a4a83b7a1f1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F2211-5463.12617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F2211-5463.12617%26sid%3Dliteratum%253Aachs%26aulast%3DMota%26aufirst%3DC.%26aulast%3DEsmaeeli%26aufirst%3DM.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26atitle%3DHuman%2520Aldehyde%2520Oxidase%2520%2528Haox1%2529%253A%2520Structure%2520Determination%2520of%2520the%2520Moco-Free%2520Form%2520of%2520the%2520Natural%2520Variant%2520G1269r%2520and%2520Biophysical%2520Studies%2520of%2520Single%2520Nucleotide%2520Polymorphisms%26jtitle%3DFEBS%2520Open%2520Bio%26date%3D2019%26volume%3D9%26issue%3D5%26spage%3D925%26epage%3D934%26doi%3D10.1002%2F2211-5463.12617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyngholm-Kjærby, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jørgensen, F. S.</span></span> <span> </span><span class="NLM_article-title">Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism</span>. <i>Comput. Struct. Biotechnol. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.csbj.2019.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.csbj.2019.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30949305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlt12jsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=345-351&author=M.+Montefioriauthor=C.+Lyngholm-Kj%C3%A6rbyauthor=A.+Longauthor=L.+Olsenauthor=F.+S.+J%C3%B8rgensen&title=Fast+Methods+for+Prediction+of+Aldehyde+Oxidase-Mediated+Site-of-Metabolism&doi=10.1016%2Fj.csbj.2019.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism</span></div><div class="casAuthors">Montefiori, Marco; Lyngholm-Kjaerby, Casper; Long, Anthony; Olsen, Lars; Joergensen, Flemming Steen</div><div class="citationInfo"><span class="NLM_cas:title">Computational and Structural Biotechnology Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">345-351</span>CODEN:
                <span class="NLM_cas:coden">CSBJAC</span>;
        ISSN:<span class="NLM_cas:issn">2001-0370</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde Oxidase (AO) is an enzyme involved in the metab. of aldehydes and N-contg. heterocyclic compds.  Many drug compds. contain heterocyclic moieties, and AO metab. has lead to failure of several late-stage drug candidates.  Therefore, it is important to take AO-mediated metab. into account early in the drug discovery process, and thus, to have fast and reliable models to predict the site of metab. (SOM).  We have collected a dataset of 78 substrates of human AO with a total of 89 SOMs and 347 non-SOMs and detd. at. descriptors for each compd.  The descriptors comprise NMR shielding and ESP charges from d. functional theory (DFT), NMR chem. shift from ChemBioDraw, and Gasteiger charges from RDKit.  Addnl., at. accessibility was considered using 2D-SASA and relative span descriptors from SMARTCyp.  Finally, stability of the product, the metabolite, was detd. with DFT and also used as a descriptor.  All descriptors have AUC larger than 0.75.  In particular, descriptors related to the chem. shielding and chem. shift (AUC = 0.96) and ESP charges (AUC = 0.96) proved to be good descriptors.  We recommend two simple methods to identify the SOM for a given mol.: (1) use ChemBioDraw to calc. the chem. shift or (2) calc. ESP charges or chem. shift using DFT.  The first approach is fast but somewhat difficult to automate, while the second is more time-consuming, but can easily be automated.  The two methods predict correctly 93% and 91%, resp., of the 89 exptl. obsd. SOMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8QYgsDr8OrLVg90H21EOLACvtfcHk0lhOGUoNy5pNvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlt12jsLw%253D&md5=8a01ea8667b1bfcccc7ab59570df6739</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.csbj.2019.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.csbj.2019.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DMontefiori%26aufirst%3DM.%26aulast%3DLyngholm-Kj%25C3%25A6rby%26aufirst%3DC.%26aulast%3DLong%26aufirst%3DA.%26aulast%3DOlsen%26aufirst%3DL.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DF.%2BS.%26atitle%3DFast%2520Methods%2520for%2520Prediction%2520of%2520Aldehyde%2520Oxidase-Mediated%2520Site-of-Metabolism%26jtitle%3DComput.%2520Struct.%2520Biotechnol.%2520J.%26date%3D2019%26volume%3D17%26spage%3D345%26epage%3D351%26doi%3D10.1016%2Fj.csbj.2019.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korzekwa, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMasters, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Use of Density Functional Calculations to Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4642</span>– <span class="NLM_lpage">4647</span>, <span class="refDoi"> DOI: 10.1021/jm0703690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0703690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4642-4647&issue=19&author=R.+A.+Torresauthor=K.+R.+Korzekwaauthor=D.+R.+McMastersauthor=C.+M.+Fandozziauthor=J.+P.+Jones&title=Use+of+Density+Functional+Calculations+to+Predict+the+Regioselectivity+of+Drugs+and+Molecules+Metabolized+by+Aldehyde+Oxidase&doi=10.1021%2Fjm0703690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Density Functional Calculations To Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase</span></div><div class="casAuthors">Torres, Rhonda A.; Korzekwa, Kenneth R.; McMasters, Daniel R.; Fandozzi, Christine M.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4642-4647</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase is a molybdenum hydroxylase that catalyzes the oxidn. of aldehydes and nitrogen-contg. heterocycles.  The enzyme plays a dual role in the metab. of physiol. important endogenous compds. and the biotransformation of xenobiotics.  Using d. functional theory methods, geometry optimization of tetrahedral intermediates of drugs and druglike compds. was examd. to predict the likely metabolites of aldehyde oxidase.  The calcns. suggest that the lowest energy tetrahedral intermediate resulting from the initial substrate corresponds to the obsd. metabolite ≥90% of the time.  Addnl. calcns. were performed on a series of heterocyclic compds. where the products resulting from metab. by xanthine oxidase and aldehyde oxidase differ in many instances.  Again, the lowest energy tetrahedral intermediate corresponded to the obsd. product of aldehyde oxidase metab. ≥90% for the compds. examd., while the obsd. products of xanthine oxidase were not well predicted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmnIR2Ha4_oLVg90H21EOLACvtfcHk0li4hNih8xkTRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D&md5=514ee5703f306287a3b7315fc5cea434</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0703690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703690%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DR.%2BA.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DUse%2520of%2520Density%2520Functional%2520Calculations%2520to%2520Predict%2520the%2520Regioselectivity%2520of%2520Drugs%2520and%2520Molecules%2520Metabolized%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D19%26spage%3D4642%26epage%3D4647%26doi%3D10.1021%2Fjm0703690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alfaro, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Studies on the Mechanism of Aldehyde Oxidase and Xanthine Oxidase</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9469</span>– <span class="NLM_lpage">9472</span>, <span class="refDoi"> DOI: 10.1021/jo801053u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo801053u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGku7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=9469-9472&issue=23&author=J.+F.+Alfaroauthor=J.+P.+Jones&title=Studies+on+the+Mechanism+of+Aldehyde+Oxidase+and+Xanthine+Oxidase&doi=10.1021%2Fjo801053u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the Mechanism of Aldehyde Oxidase and Xanthine Oxidase</span></div><div class="casAuthors">Alfaro, Joshua F.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9469-9472</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DFT calcns. support a concerted mechanism for xanthine oxidase and aldehyde oxidase hydride displacement from the sp2 carbon of 6-substituted 4-quinazolinones.  The variations in transition state structure show that C-O bond formation is nearly complete in the transition state and the transition state changes are anti-Hammond with the C-H and C-O bond lengths being more product-like for the faster reactions.  The C-O bond length in the transition state is around 90% formed.  However, the C-H bond is only about 80% broken.  This leads to a very tetrahedral transition state with an O-C-N angle of 109°.  Thus, while the mechanism is concerted, the antibonding orbital of the C-H bond that is broken is not directly attacked by the nucleophile and instead hydride displacement occurs after almost complete tetrahedral transition state formation.  In support of this the C=N bond is lengthened in the transition state indicating that attack on the electrophilic carbon occurs by addn. to the C=N bond with neg. charge increasing on the nitrogen.  Differences in exptl. reaction rates are accurately reproduced by these calcns. and tend to support this mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrK9tmdy1IwLVg90H21EOLACvtfcHk0li4hNih8xkTRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGku7vI&md5=188f70b1454b3e6bfd19301aafae2908</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo801053u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801053u%26sid%3Dliteratum%253Aachs%26aulast%3DAlfaro%26aufirst%3DJ.%2BF.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DStudies%2520on%2520the%2520Mechanism%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26issue%3D23%26spage%3D9469%26epage%3D9472%26doi%3D10.1021%2Fjo801053u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryde, U.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Active-Site Design of Molybdenum Oxo-Transfer Enzymes by Quantum Mechanical Calculations</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">11913</span>– <span class="NLM_lpage">11924</span>, <span class="refDoi"> DOI: 10.1021/ic5010837</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic5010837" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=11913-11924&issue=22&author=J.+Liauthor=U.+Ryde&title=Comparison+of+the+Active-Site+Design+of+Molybdenum+Oxo-Transfer+Enzymes+by+Quantum+Mechanical+Calculations&doi=10.1021%2Fic5010837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the Active-Site Design of Molybdenum Oxo-Transfer Enzymes by Quantum Mechanical Calculations</span></div><div class="casAuthors">Li, Jilai; Ryde, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11913-11924</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are three families of mononuclear molybdenum enzymes that catalyze oxygen atom transfer (OAT) reactions, named after a typical example from each family, viz., DMSO reductase (DMSOR), sulfite oxidase (SO), and xanthine oxidase (XO).  These families differ in the construction of their active sites, with two molybdopterin (MPT) groups in the DMSOR family, two oxy groups in the SO family, and a sulfido group in the XO family.  We have employed d. functional theory calcns. on cluster models of the active sites to understand the selection of molybdenum ligands in the three enzyme families.  Our calcns. show that the DMSOR active site has a much stronger oxidative power than the other two sites, owing to the extra molybdopterin ligand.  However, the active sites do not seem to have been constructed to make the OAT reaction as exergonic as possible, but instead to keep the reaction free energy close to zero (to avoid excessive loss of energy), thereby making the reoxidn. (SO and XO) or reredn. of the active sites (DMSOR) after the OAT reaction facile.  We also show that active-site models of the three enzyme families can all catalyze the redn. of DMSO and that the DMSOR model does not give the lowest activation barrier.  Likewise, all three models can catalyze the oxidn. of sulfite, provided that the Coulombic repulsion between the substrate and the enzyme model can be overcome, but for this harder reaction, the SO model gives the lowest activation barrier, although the differences are not large.  However, only the XO model can catalyze the oxidn. of xanthine, owing to its sulfido ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWu06wRwr8LrVg90H21EOLACvtfcHk0li4hNih8xkTRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrsLbM&md5=384e5cf521267956acf0b9cee807e2c7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fic5010837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic5010837%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DRyde%26aufirst%3DU.%26atitle%3DComparison%2520of%2520the%2520Active-Site%2520Design%2520of%2520Molybdenum%2520Oxo-Transfer%2520Enzymes%2520by%2520Quantum%2520Mechanical%2520Calculations%26jtitle%3DInorg.%2520Chem.%26date%3D2014%26volume%3D53%26issue%3D22%26spage%3D11913%26epage%3D11924%26doi%3D10.1021%2Fic5010837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, W.</span></span> <span> </span><span class="NLM_article-title">A Combined Qm/Mm Study on the Reductive Half-Reaction of Xanthine Oxidase: Substrate Orientation and Mechanism</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">14885</span>– <span class="NLM_lpage">14902</span>, <span class="refDoi"> DOI: 10.1021/ja9045394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9045394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=14885-14902&issue=41&author=S.+Metzauthor=W.+Thiel&title=A+Combined+Qm%2FMm+Study+on+the+Reductive+Half-Reaction+of+Xanthine+Oxidase%3A+Substrate+Orientation+and+Mechanism&doi=10.1021%2Fja9045394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A Combined QM/MM Study on the Reductive Half-Reaction of Xanthine Oxidase: Substrate Orientation and Mechanism</span></div><div class="casAuthors">Metz, Sebastian; Thiel, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">14885-14902</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quantum mech./mol. mech. (QM/MM) methods were used to investigate the conversion of xanthine to uric acid in xanthine oxidase.  Seven mechanistic variants were considered with different tautomeric forms of xanthine, different protonation states of the active-site residues, and different substrate orientations.  The most favorable pathway (setup G) has a B3LYP/MM barrier of about 14 kcal mol-1, consistent with the available exptl. data.  This multistep mechanism starts with Glu1261 deprotonating the xanthine at the N3 position followed by a proton transfer from the cofactor to the N9 atom of xanthine; the thus activated cofactor and substrate then react to form a tetrahedral intermediate, and a subsequent rate-limiting hydride transfer generates the product.  The substrate orientation that has commonly been assumed in the literature leads to the most stable reactant complex, but the opposite orientation ("upside down") is computed to be the most favorable one during the reaction (setup G).  In the "upside down" conformation, the Arg880 residue can best stabilize the reactive xanthine species with the neg. charged N3 atom, esp. the tetrahedral intermediate and the following transition state for hydride transfer which is generally the highest point on the computed energy profiles.  QM-only calcns. for a minimal gas-phase model and for larger cluster models are performed for comparison, in particular for establishing intrinsic reactivities and a common energy scale.  An anal. of the computational results provides detailed insight into the essential mechanistic role of the active-site residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-z1Egy9O7xLVg90H21EOLACvtfcHk0limGbTdBDaiwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltLjM&md5=55c9e18fc825b1b019b7a65ab8040a6a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja9045394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9045394%26sid%3Dliteratum%253Aachs%26aulast%3DMetz%26aufirst%3DS.%26aulast%3DThiel%26aufirst%3DW.%26atitle%3DA%2520Combined%2520Qm%252FMm%2520Study%2520on%2520the%2520Reductive%2520Half-Reaction%2520of%2520Xanthine%2520Oxidase%253A%2520Substrate%2520Orientation%2520and%2520Mechanism%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26issue%3D41%26spage%3D14885%26epage%3D14902%26doi%3D10.1021%2Fja9045394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hille, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velayutham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweier, J. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of Superoxide Production from Aldehyde Oxidase: An Important Source of Oxidants in Biological Tissues</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>460</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2006.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.abb.2006.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=17353002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjslSlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2007&pages=113-121&issue=1&author=T.+K.+Kunduauthor=R.+Hilleauthor=M.+Velayuthamauthor=J.+L.+Zweier&title=Characterization+of+Superoxide+Production+from+Aldehyde+Oxidase%3A+An+Important+Source+of+Oxidants+in+Biological+Tissues&doi=10.1016%2Fj.abb.2006.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of superoxide production from aldehyde oxidase: An important source of oxidants in biological tissues</span></div><div class="casAuthors">Kundu, Tapan Kumar; Hille, Russ; Velayutham, Murugesan; Zweier, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO), a molybdoflavoenzyme that plays an important role in aldehyde biotransformation, requires oxygen as substrate and produces reduced oxygen species.  However, little information is available regarding its importance in cellular redox stress.  Therefore, studies were undertaken to characterize its superoxide and hydrogen peroxide prodn.  Aldehyde oxidase was purified to >98% purity and exhibited a single band at ∼290 kDa on native polyacrylamide gradient gel electrophoresis.  Superoxide generation was measured and quantitated by cytochrome c redn. and EPR spin trapping with p-dimethyl aminocinnamaldehyde as reducing substrate.  Prominent superoxide generation was obsd. with an initial rate of 295 nmol min-1 mg-1.  Electrochem. measurements of oxygen consumption and hydrogen peroxide formation yielded values of 650 and 355 nmol min-1 mg-1.  In view of the ubiquitous distribution of aldehydes in tissues, aldehyde oxidase can be an important basal source of superoxide that would be enhanced in disease settings where cellular aldehyde levels are increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRlJ1RBG6al7Vg90H21EOLACvtfcHk0limGbTdBDaiwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjslSlsrs%253D&md5=087d50b1d52b072e7775613d9848a0d6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2006.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2006.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DKundu%26aufirst%3DT.%2BK.%26aulast%3DHille%26aufirst%3DR.%26aulast%3DVelayutham%26aufirst%3DM.%26aulast%3DZweier%26aufirst%3DJ.%2BL.%26atitle%3DCharacterization%2520of%2520Superoxide%2520Production%2520from%2520Aldehyde%2520Oxidase%253A%2520An%2520Important%2520Source%2520of%2520Oxidants%2520in%2520Biological%2520Tissues%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2007%26volume%3D460%26issue%3D1%26spage%3D113%26epage%3D121%26doi%3D10.1016%2Fj.abb.2006.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trincao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span> <span> </span><span class="NLM_article-title">The First Mammalian Aldehyde Oxidase Crystal Structure: Insights into Substrate Specificity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">40690</span>– <span class="NLM_lpage">40702</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.390419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M112.390419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23019336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslantr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=40690-40702&issue=48&author=C.+Coelhoauthor=M.+Mahroauthor=J.+Trincaoauthor=A.+T.+Carvalhoauthor=M.+J.+Ramosauthor=M.+Teraoauthor=E.+Garattiniauthor=S.+Leimkuhlerauthor=M.+J.+Romao&title=The+First+Mammalian+Aldehyde+Oxidase+Crystal+Structure%3A+Insights+into+Substrate+Specificity&doi=10.1074%2Fjbc.M112.390419"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The First Mammalian Aldehyde Oxidase Crystal Structure</span></div><div class="casAuthors">Coelho, Catarina; Mahro, Martin; Trincao, Jose; Carvalho, Alexandra T. P.; Ramos, Maria Joao; Terao, Mineko; Garattini, Enrico; Leimkuehler, Silke; Romao, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">40690-40702</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs) are homodimeric proteins belonging to the xanthine oxidase family of molybdenum-contg. enzymes.  Each 150-kDa monomer contains a FAD redox cofactor, two spectroscopically distinct [2Fe-2S] clusters, and a molybdenum cofactor located within the protein active site.  AOXs are characterized by broad range substrate specificity, oxidizing different aldehydes and arom. N-heterocycles.  Despite increasing recognition of its role in the metab. of drugs and xenobiotics, the physiol. function of the protein is still largely unknown.  We have crystd. and solved the crystal structure of mouse liver aldehyde oxidase 3 to 2.9 Å.  This is the first mammalian AOX whose structure has been solved.  The structure provides important insights into the protein active center and further evidence on the catalytic differences characterizing AOX and xanthine oxidoreductase.  The mouse liver aldehyde oxidase 3 three-dimensional structure combined with kinetic, mutagenesis data, mol. docking, and mol. dynamics studies make a decisive contribution to understand the mol. basis of its rather broad substrate specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJhbcCiD1gB7Vg90H21EOLACvtfcHk0limGbTdBDaiwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslantr7L&md5=df014384e84736af9a937fd383f24523</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.390419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.390419%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DMahro%26aufirst%3DM.%26aulast%3DTrincao%26aufirst%3DJ.%26aulast%3DCarvalho%26aufirst%3DA.%2BT.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520First%2520Mammalian%2520Aldehyde%2520Oxidase%2520Crystal%2520Structure%253A%2520Insights%2520into%2520Substrate%2520Specificity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D48%26spage%3D40690%26epage%3D40702%26doi%3D10.1074%2Fjbc.M112.390419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Cytochrome P450 Substrate Oxidation: Minireview</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1002/jbt.20174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fjbt.20174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=17936929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGjtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=163-168&issue=4&author=F.+P.+Guengerich&title=Mechanisms+of+Cytochrome+P450+Substrate+Oxidation%3A+Minireview&doi=10.1002%2Fjbt.20174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of cytochrome P 450 substrate oxidation</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Molecular Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">163-168</span>CODEN:
                <span class="NLM_cas:coden">JBMTFQ</span>;
        ISSN:<span class="NLM_cas:issn">1095-6670</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (P 450) isoforms catalyze a variety of oxidn. reactions and some redn. reactions, collectively involving thousands of substrates.  A general chem. mechanism can be used to rationalize most of the oxidns. and involves a perferryl intermediate (FeO3+) and odd-electron chem., i.e., abstraction of a H atom or electron followed by O rebound and sometimes rearrangement.  This general mechanism can explain C atom hydroxylation, heteroatom oxygenation and dealkylation, epoxidn., desatn., heme destruction, and other reactions.  Another approach to understanding catalysis involves anal. of the more general catalytic cycle, including substrate specificity, because complex patterns of cooperativity are obsd. with several P 450s.  Some of the complexity is due to slow conformational changes in the proteins that occur on the same timescale as other steps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCChTcULy-L7Vg90H21EOLACvtfcHk0lieYByrU8MCxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGjtLrN&md5=9d9c6d02db1a91dcdc167d0b4a05e6e9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fjbt.20174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbt.20174%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DMechanisms%2520of%2520Cytochrome%2520P450%2520Substrate%2520Oxidation%253A%2520Minireview%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D2007%26volume%3D21%26issue%3D4%26spage%3D163%26epage%3D168%26doi%3D10.1002%2Fjbt.20174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Visser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, S.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3947</span>– <span class="NLM_lpage">3980</span>, <span class="refDoi"> DOI: 10.1021/cr020443g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr020443g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=3947-3980&issue=9&author=B.+Meunierauthor=S.+P.+de+Visserauthor=S.+Shaik&title=Mechanism+of+Oxidation+Reactions+Catalyzed+by+Cytochrome+P450+Enzymes&doi=10.1021%2Fcr020443g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes</span></div><div class="casAuthors">Meunier, Bernard; de Visser, Samueel P.; Shaik, Sason</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3947-3980</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The exact nature of the active species in cytochrome P 450 enzymes (the putative high-valent iron-oxo intermediate) is still a matter of intensive debates.  Site-directed mutagenesis studies in conjunction with structural studies allowed different hypotheses to be checked.  Theor. calcns. became available and enabled various hypotheses to be tested and new solns. to be offered.  All these studies have enriched the knowledge on mol. enzymol. and the coordination chem. of metal-peroxo and high-valent metal-oxo species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR8qIfDs6uAbVg90H21EOLACvtfcHk0lieYByrU8MCxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVejtr8%253D&md5=d10f62537d0af7d3895217ee91a5119b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcr020443g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020443g%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DB.%26aulast%3Dde%2BVisser%26aufirst%3DS.%2BP.%26aulast%3DShaik%26aufirst%3DS.%26atitle%3DMechanism%2520of%2520Oxidation%2520Reactions%2520Catalyzed%2520by%2520Cytochrome%2520P450%2520Enzymes%26jtitle%3DChem.%2520Rev.%26date%3D2004%26volume%3D104%26issue%3D9%26spage%3D3947%26epage%3D3980%26doi%3D10.1021%2Fcr020443g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shephard, E. A.</span></span> <span> </span><span class="NLM_article-title">Drug Metabolism by Flavin-Containing Monooxygenases of Human and Mouse</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1239718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F17425255.2017.1239718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27678284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1eiur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=167-181&issue=2&author=I.+R.+Phillipsauthor=E.+A.+Shephard&title=Drug+Metabolism+by+Flavin-Containing+Monooxygenases+of+Human+and+Mouse&doi=10.1080%2F17425255.2017.1239718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Drug metabolism by flavin-containing monooxygenases of human and mouse</span></div><div class="casAuthors">Phillips, Ian R.; Shephard, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-181</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Flavin-contg. monooxygenases (FMOs) play an important role in drug metab.: We focus on the role of FMOs in the metab. of drugs in human and mouse.  We describe FMO genes and proteins of human and mouse; the catalytic mechanism of FMOs and their significance for drug metab.; differences between FMOs and CYPs; factors contributing to potential underestimation of the contribution of FMOs to drug metab.; the developmental and tissue-specific expression of FMO genes and differences between human and mouse; and factors that induce or inhibit FMOs.  We discuss the contribution of FMOs of human and mouse to the metab. of drugs and how genetic variation of FMOs affects drug metab.  Finally, we discuss the utility of animal models for FMO-mediated drug metab. in humans.: The contribution of FMOs to drug metab. may be underestimated.  As FMOs are not readily induced or inhibited and their reactions are generally detoxifications, the design of drugs that are metabolized predominantly by FMOs offers clin. advantages.  Fmo1(-/-),Fmo2(-/-),Fmo4(-/-) mice provide a good animal model for FMO-mediated drug metab. in humans.  Identification of roles for FMO1 and FMO5 in endogenous metab. has implications for drug therapy and initiates an exciting area of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJQXt-nCk13LVg90H21EOLACvtfcHk0lieYByrU8MCxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1eiur7K&md5=82ffec82f5438321d8211ff0482e7dbd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1239718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1239718%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26aulast%3DShephard%26aufirst%3DE.%2BA.%26atitle%3DDrug%2520Metabolism%2520by%2520Flavin-Containing%2520Monooxygenases%2520of%2520Human%2520and%2520Mouse%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26issue%3D2%26spage%3D167%26epage%3D181%26doi%3D10.1080%2F17425255.2017.1239718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korzekwa, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschel, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, M. E.</span></span> <span> </span><span class="NLM_article-title">Human Liver Oxidative Metabolism of O6-Benzylguanine</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1385</span>– <span class="NLM_lpage">1389</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(95)02019-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0006-2952%2895%2902019-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7503788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2MXpslOisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=1385-1389&issue=9&author=S.+K.+Royauthor=K.+R.+Korzekwaauthor=F.+J.+Gonzalezauthor=R.+C.+Moschelauthor=M.+E.+Dolan&title=Human+Liver+Oxidative+Metabolism+of+O6-Benzylguanine&doi=10.1016%2F0006-2952%2895%2902019-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Human liver oxidative metabolism of O6-benzylguanine</span></div><div class="casAuthors">Roy, Sandip K.; Korzekwa, Kenneth R.; Gonzalez, Frank J.; Moschel, Robert C.; Dolan, M. Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1385-9</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The oxidn. of O6-benzylguanine, an inactivator of O6-alkylguaine-DNA alkyltransferase, was examd. using human liver cytosol, microsomes, and several P 450 isoforms.  Incubation of O6-benzylguanine with human liver cytosol resulted in the formation of O6-benzyl-8-oxoguanine, which was inhibited by menadione, a potent inhibitor of aldehyde oxidase.  Inhibition by allopurinol, a xanthine oxidase inhibitor, was less dramatic.  Oxidn. of O6-benzylguanine also occurred with pooled human liver microsomes and was inhibited by both furafylline and troleandomycin, selective inhibitors of CYPIA2 and CYP3A4, resp.  Human P450s, CYPIA2, CYP2B6, CYP2C8, CYP2C9, CYP2E1, and CYP3A4 expressed in Hep G2 hepatoma cells using vaccinia virus vectors were incubated with 10 or 200 μM O6-benzylguanine.  At 10 μM, O6-benzylguanine was oxidized primarily by CYP1A2 and to a lesser extent by CYP3A4.  However, an appreciable increase in CYP3A4 contribution was noted at 200 μM.  CYP1A2 exhibited a more than 200-fold higher relative catalytic activity (Vmax/Km) compared with CYP3A4.  Therefore, at therapeutically relevant concns. of O6-benzylguanine, CYP1A2 could be primarily involved in its oxidn. since it shows a much lower Km value (1.3 μM) than CYP3A4 (52.2 μM) and cytosol (81.5 μM).  However, one would expect interindividual variation in the extent of oxidn. of O6-benzylguanine depending on the levels of aldehyde oxidase, CYP1A2, and CYP3A4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdpuhyULK3OrVg90H21EOLACvtfcHk0lieYByrU8MCxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslOisr0%253D&md5=1c356de65d29834d1f1f916e4eb1cc71</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2902019-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252902019-5%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%2BK.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26atitle%3DHuman%2520Liver%2520Oxidative%2520Metabolism%2520of%2520O6-Benzylguanine%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26issue%3D9%26spage%3D1385%26epage%3D1389%26doi%3D10.1016%2F0006-2952%2895%2902019-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hille, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, P.</span></span> <span> </span><span class="NLM_article-title">The Mononuclear Molybdenum Enzymes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3963</span>– <span class="NLM_lpage">4038</span>, <span class="refDoi"> DOI: 10.1021/cr400443z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400443z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=3963-4038&issue=7&author=R.+Hilleauthor=J.+Hallauthor=P.+Basu&title=The+Mononuclear+Molybdenum+Enzymes&doi=10.1021%2Fcr400443z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Mononuclear Molybdenum Enzymes</span></div><div class="casAuthors">Hille, Russ; Hall, James; Basu, Partha</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3963-4038</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Molybdenum is the only second-row transition metal required by most living organisms and is nearly universally distributed in biol.  Enzymes contg. molybdenum in their active sites have long been recognized, and many have been characterized structurally and biochem.  Furthermore, it is now well-established that with the exception of nitrogenase (in which molybdenum is incorporated into a [MoFe7S9] active site cluster) all mononuclear molybdenum-contg. enzymes fall into one of three large and mutually exclusive families.  The enzymes xanthine oxidase, sulfite oxidase, and DMSO reductase, each of which represents a good example of one of the three molybdenum-contg. enzyme families, are the focus of the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaH5_H7dhwRLVg90H21EOLACvtfcHk0ljUenm7R9Vb7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCnu74%253D&md5=698a13bf02d700be36c3ce2f1e951b22</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcr400443z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400443z%26sid%3Dliteratum%253Aachs%26aulast%3DHille%26aufirst%3DR.%26aulast%3DHall%26aufirst%3DJ.%26aulast%3DBasu%26aufirst%3DP.%26atitle%3DThe%2520Mononuclear%2520Molybdenum%2520Enzymes%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26issue%3D7%26spage%3D3963%26epage%3D4038%26doi%3D10.1021%2Fcr400443z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barsanti, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aversa, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramurthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taricani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Q.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (Abi) as Atr Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/ml500352s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500352s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVelurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=42-46&issue=1&author=P.+A.+Barsantiauthor=Y.+Panauthor=Y.+Luauthor=R.+Jainauthor=M.+Coxauthor=R.+J.+Aversaauthor=M.+P.+Dillonauthor=R.+Ellingauthor=C.+Huauthor=X.+Jinauthor=M.+Knappauthor=J.+Lanauthor=S.+Ramurthyauthor=P.+Rudewiczauthor=L.+Settiauthor=S.+Subramanianauthor=M.+Mathurauthor=L.+Taricaniauthor=G.+Thomasauthor=L.+Xiaoauthor=Q.+Yue&title=Structure-Based+Drug+Design+of+Novel%2C+Potent%2C+and+Selective+Azabenzimidazoles+%28Abi%29+as+Atr+Inhibitors&doi=10.1021%2Fml500352s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR Inhibitors</span></div><div class="casAuthors">Barsanti, Paul A.; Pan, Yue; Lu, Yipin; Jain, Rama; Cox, Matthew; Aversa, Robert J.; Dillon, Michael P.; Elling, Robert; Hu, Cheng; Jin, Xianming; Knapp, Mark; Lan, Jiong; Ramurthy, Savithri; Rudewicz, Patrick; Setti, Lina; Subramanian, Sharadha; Mathur, Michelle; Taricani, Lorena; Thomas, George; Xiao, Linda; Yue, Qin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-46</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compd. I was discovered through morphing of the ATR biochem. HTS hit I.  The ABI series was potent and selective for ATR.  Incorporation of a 6-azaindole afforded a marked increase in cellular potency but was assocd. with poor PK and hERG ion channel inhibition.  DMPK expts. established that CYP P 450 and AO metab. in conjunction with Pgp and BCRP efflux were major causative mechanisms for the obsd. PK.  The series also harbored the CYP3A4 TDI liability driven by the presence of both a morpholine and an indole moiety.  Incorporation of an adjacent fluorine or nitrogen into the 6-azaindole addressed many of the various medicinal chem. issues encountered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDC1_FhPys3rVg90H21EOLACvtfcHk0ljUenm7R9Vb7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVelurvN&md5=0af868d4812510335fe92b74d34a8910</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml500352s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500352s%26sid%3Dliteratum%253Aachs%26aulast%3DBarsanti%26aufirst%3DP.%2BA.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DCox%26aufirst%3DM.%26aulast%3DAversa%26aufirst%3DR.%2BJ.%26aulast%3DDillon%26aufirst%3DM.%2BP.%26aulast%3DElling%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DKnapp%26aufirst%3DM.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DRamurthy%26aufirst%3DS.%26aulast%3DRudewicz%26aufirst%3DP.%26aulast%3DSetti%26aufirst%3DL.%26aulast%3DSubramanian%26aufirst%3DS.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DTaricani%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DYue%26aufirst%3DQ.%26atitle%3DStructure-Based%2520Drug%2520Design%2520of%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Azabenzimidazoles%2520%2528Abi%2529%2520as%2520Atr%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D1%26spage%3D42%26epage%3D46%26doi%3D10.1021%2Fml500352s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilworth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athersuch, T. J.</span></span> <span> </span><span class="NLM_article-title">Metabolic Hydrolysis of Aromatic Amides in Selected Rat, Minipig, and Human in Vitro Systems</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2405</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-20464-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Fs41598-018-20464-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29402925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BC1MvnsFyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=2405&author=P.+R.+Bradshawauthor=I.+D.+Wilsonauthor=R.+U.+Gillauthor=P.+J.+Butlerauthor=C.+Dilworthauthor=T.+J.+Athersuch&title=Metabolic+Hydrolysis+of+Aromatic+Amides+in+Selected+Rat%2C+Minipig%2C+and+Human+in+Vitro+Systems&doi=10.1038%2Fs41598-018-20464-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Hydrolysis of Aromatic Amides in Selected Rat, Minipig, and Human In Vitro Systems</span></div><div class="casAuthors">Bradshaw Peter R; Wilson Ian D; Athersuch Toby J; Gill Rachel Upcott; Butler Philip J; Dilworth Clive; Athersuch Toby J</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2405</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The release of aromatic amines from drugs and other xenobiotics resulting from the hydrolysis of metabolically labile amide bonds presents a safety risk through several mechanisms, including geno-, hepato- and nephrotoxicity.  Whilst multiple in vitro systems used for studying metabolic stability display serine hydrolase activity, responsible for the hydrolysis of amide bonds, they vary in their efficiency and selectivity.  Using a range of amide-containing probe compounds (0.5-10 μM), we have investigated the hydrolytic activity of several rat, minipig and human-derived in vitro systems - including Supersomes, microsomes, S9 fractions and hepatocytes - with respect to their previously observed human in vivo metabolism.  In our hands, human carboxylesterase Supersomes and rat S9 fractions systems showed relatively poor prediction of human in vivo metabolism.  Rat S9 fractions, which are commonly utilised in the Ames test to assess mutagenicity, may be limited in the detection of genotoxic metabolites from aromatic amides due to their poor concordance with human in vivo amide hydrolysis.  In this study, human liver microsomes and minipig subcellular fractions provided more representative models of human in vivo hydrolytic metabolism of the aromatic amide compounds tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMzpsIkzpxmRcr74wzj5o5fW6udTcc2ebkjjFFJGhnbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvnsFyrsA%253D%253D&md5=9f1f65ed68d8a58788dda69bb41cd7d3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-20464-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-20464-4%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DP.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26aulast%3DGill%26aufirst%3DR.%2BU.%26aulast%3DButler%26aufirst%3DP.%2BJ.%26aulast%3DDilworth%26aufirst%3DC.%26aulast%3DAthersuch%26aufirst%3DT.%2BJ.%26atitle%3DMetabolic%2520Hydrolysis%2520of%2520Aromatic%2520Amides%2520in%2520Selected%2520Rat%252C%2520Minipig%252C%2520and%2520Human%2520in%2520Vitro%2520Systems%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D2405%26doi%3D10.1038%2Fs41598-018-20464-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B. M. J. M.</span></span> <i>Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology</i>; <span class="NLM_publisher-name">Verlag Helvetica Chimica Acta</span>, <span class="NLM_publisher-loc">Zürich</span>, <span class="NLM_year">2006</span>; <span class="refDoi"> DOI: 10.1002/9783906390444</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2F9783906390444" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=B.+M.+J.+M.+Testa&title=Hydrolysis+in+Drug+and+Prodrug+Metabolism%3A+Chemistry%2C+Biochemistry%2C+and+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2F9783906390444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783906390444%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%2BM.%2BJ.%2BM.%26btitle%3DHydrolysis%2520in%2520Drug%2520and%2520Prodrug%2520Metabolism%253A%2520Chemistry%252C%2520Biochemistry%252C%2520and%2520Enzymology%26pub%3DVerlag%2520Helvetica%2520Chimica%2520Acta%26date%3D2006%26doi%3D10.1002%2F9783906390444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narai, N.</span></span> <span> </span><span class="NLM_article-title">Reductive Metabolism of Aromatic Nitro Compounds Including Carcinogens by Rabbit Liver Preparations</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1089</span>– <span class="NLM_lpage">1093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3943085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL28XhvVWnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=1089-1093&author=K.+Tatsumiauthor=S.+Kitamuraauthor=N.+Narai&title=Reductive+Metabolism+of+Aromatic+Nitro+Compounds+Including+Carcinogens+by+Rabbit+Liver+Preparations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations</span></div><div class="casAuthors">Tatsumi, Kiyoshi; Kitamura, Shigeyuki; Narai, Noriko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1089-93</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Reductive metab. of arom. nitro compds. was examd. with rabbit liver prepns.  Under anaerobic conditions, carcinogenic 2-nitrofluorene (I)  [607-57-8], 4-nitrobiphenyl  [92-93-3] and 1-nitronaphthalene  [86-57-7] were reduced to the corresponding hydroxylamines and amines, whereas the carcinogenic 1-nitropyrene  [5522-43-0] was reduced only to the corresponding amine by liver cytosol in the presence of 2-hydroxypyrimidine  [557-01-7], an electron donor of aldehyde oxidase  [9029-07-6].  Both liver microsomes and cytosol catalyzed the redn. of these arom. nitro compds. in varying degrees.  The microsomes required reduced pyridine nucleotides for occurrence of the nitroreductase activities.  In this case, NADPH  [53-57-6] was more effective than NADH  [58-68-4] as an electron donor.  The cytosol by itself exhibited some nitroreductase  [9037-41-6] activities, which were markedly enhanced by addn. of an electron donor of aldehyde oxidase, i.e., N1-methylnicotinamide  [3106-60-3] or 2-hydroxypyrimidine.  The full activities of the cytosol with the electron donor were much higher than those of the microsomes with the reduced pyridine nucleotide.  Purified liver aldehyde oxidase, like the cytosol, exhibited significant nitroreductase activities in the presence of its electron donor.  Evidently cytosolic aldehyde oxidase functions as a major enzyme responsible for the redn. of arom. nitro compds. including carcinogens in rabbit liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3zkVEW2OV27Vg90H21EOLACvtfcHk0lhDLhX0pUgOSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvVWnu7s%253D&md5=f25b77244a97c6192fb51ad20b0d3b6a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNarai%26aufirst%3DN.%26atitle%3DReductive%2520Metabolism%2520of%2520Aromatic%2520Nitro%2520Compounds%2520Including%2520Carcinogens%2520by%2520Rabbit%2520Liver%2520Preparations%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D1089%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span> <span> </span><span class="NLM_article-title">Reduction of Tertiary Amine N-Oxides by Liver Preparations: Function of Aldehyde Oxidase as a Major N-Oxide Reductase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(84)90742-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0006-291X%2884%2990742-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=6743317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2cXltVKgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1984&pages=749-754&issue=3&author=S.+Kitamuraauthor=K.+Tatsumi&title=Reduction+of+Tertiary+Amine+N-Oxides+by+Liver+Preparations%3A+Function+of+Aldehyde+Oxidase+as+a+Major+N-Oxide+Reductase&doi=10.1016%2F0006-291X%2884%2990742-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of tertiary amine N-oxides by liver preparations:  function of aldehyde oxidase as a major N-oxide reductase</span></div><div class="casAuthors">Kitamura, Shigeyuki; Tatsumi, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">749-54</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The redn. of tertiary amine N-oxides to the corresponding amines by liver prepns. was investigated with imipramine N-oxide and cyclobenzaprine N-oxide under anaerobic conditions.  Rabbit liver cytosol in the presence of an electron donor of aldehyde oxidase exhibited a significant N-oxide reductase activity which was comparable to the activity of the liver microsomes supplemented with NADPH.  Rabbit liver aldehyde oxidase also exhibited the N-oxide reductase activity in the presence of its electron donor, indicating that the activity obsd. in the liver cytosol was due to this cytosolic enzyme.  Furthermore, the tertiary amine N-oxide reductase activity of liver cytosols from rats, mice, hamsters, and hogs was demonstrated by comparison with that of liver microsomes from these mammalian species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWJVbhTVDm0bVg90H21EOLACvtfcHk0lhT0X7HQZ47gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVKgtr8%253D&md5=734ebab5cd63c6ada04df82a2155239e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2884%2990742-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252884%252990742-3%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DReduction%2520of%2520Tertiary%2520Amine%2520N-Oxides%2520by%2520Liver%2520Preparations%253A%2520Function%2520of%2520Aldehyde%2520Oxidase%2520as%2520a%2520Major%2520N-Oxide%2520Reductase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1984%26volume%3D121%26issue%3D3%26spage%3D749%26epage%3D754%26doi%3D10.1016%2F0006-291X%2884%2990742-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase and Its Importance in Novel Drug Discovery: Present and Future Challenges</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1517/17460441.2013.788497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1517%2F17460441.2013.788497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23565746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFynsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=641-654&issue=6&author=E.+Garattiniauthor=M.+Terao&title=Aldehyde+Oxidase+and+Its+Importance+in+Novel+Drug+Discovery%3A+Present+and+Future+Challenges&doi=10.1517%2F17460441.2013.788497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase and its importance in novel drug discovery: present and future challenges</span></div><div class="casAuthors">Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">641-654</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Aldehyde oxidases (AOXs) are molybdo-flavoenzymes that oxidize arom. aldehydes into the corresponding carboxylic acids and heterocycles into hydroxylated derivs.  AOXs have broad substrate specificity and are present in the liver of humans and many exptl. animals.  These enzymes play an important role in Phase I metab. of drugs and xenobiotics of toxicol. interest.  Areas covered: Preclin. studies on the AOX-dependent metab. of new drug candidates are problematic.  Furthermore, there is a general lack of reliable in silico methodologies to predict whether a new org. mol. is an AOX substrate.  In vitro systems, for the design of high- or medium-throughput screening tests, to identify AOX substrates have many limitations.  In vivo studies on AOX-dependent metab. in animal models, on the other hand, are difficult because the complement of liver AOXs in humans and popular exptl. animals is different.  The authors discuss the possible ways to overcome all these problems.  Expert opinion: The significance of AOXs as drug-metabolizing enzymes is increasing, as the current strategies of org. synthesis designed to avoid cytochrome P 450 (CYP450)-dependent metab. tend to enrich for new chem. structures efficiently oxidized by these enzymes.  There is need for reliable methods to screen for, predict, and validate AOX-dependent metab. of new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTholvCIK88LVg90H21EOLACvtfcHk0lhT0X7HQZ47gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFynsbg%253D&md5=c1829fd49bb8c76f518231105105708c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.788497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.788497%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DAldehyde%2520Oxidase%2520and%2520Its%2520Importance%2520in%2520Novel%2520Drug%2520Discovery%253A%2520Present%2520and%2520Future%2520Challenges%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D641%26epage%3D654%26doi%3D10.1517%2F17460441.2013.788497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. D.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8441</span>– <span class="NLM_lpage">8460</span>, <span class="refDoi"> DOI: 10.1021/jm100888d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&issue=24&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.+D.+Tran&title=Aldehyde+Oxidase%3A+An+Enzyme+of+Emerging+Importance+in+Drug+Discovery&doi=10.1021%2Fjm100888d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0lhT0X7HQZ47gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.%2BD.%26atitle%3DAldehyde%2520Oxidase%253A%2520An%2520Enzyme%2520of%2520Emerging%2520Importance%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D24%26spage%3D8441%26epage%3D8460%26doi%3D10.1021%2Fjm100888d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutowo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cibrian-Uhalte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magarinos, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadatos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span> <span> </span><span class="NLM_article-title">The Chembl Database in 2017</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D945</span>– <span class="NLM_lpage">D954</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1093%2Fnar%2Fgkw1074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27899562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D945-D954&issue=D1&author=A.+Gaultonauthor=A.+Herseyauthor=M.+Nowotkaauthor=A.+P.+Bentoauthor=J.+Chambersauthor=D.+Mendezauthor=P.+Mutowoauthor=F.+Atkinsonauthor=L.+J.+Bellisauthor=E.+Cibrian-Uhalteauthor=M.+Daviesauthor=N.+Dedmanauthor=A.+Karlssonauthor=M.+P.+Magarinosauthor=J.+P.+Overingtonauthor=G.+Papadatosauthor=I.+Smitauthor=A.+R.+Leach&title=The+Chembl+Database+in+2017&doi=10.1093%2Fnar%2Fgkw1074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The ChEMBL database in 2017</span></div><div class="casAuthors">Gaulton, Anna; Hersey, Anne; Nowotka, Micha-l; Bento, A. Patricia; Chambers, Jon; Mendez, David; Mutowo, Prudence; Atkinson, Francis; Bellis, Louisa J.; Cibrian-Uhalte, Elena; Davies, Mark; Dedman, Nathan; Karlsson, Anneli; Magarinos, Maria Paula; Overington, John P.; Papadatos, George; Smit, Ines; Leach, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D945-D954</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 and 2014 Nucleic Acids Research Database Issues.  Since then, alongside the continued extn. of data from the medicinal chem. literature, new sources of bioactivity data have also been added to the database.  These include: deposited data sets from neglected disease screening; crop protection data; drug metab. and disposition data and bioactivity data from patents.  A no. of improvements and new features have also been incorporated.  These include the annotation of assays and targets using ontologies, the inclusion of targets and indications for clin. candidates, addn. of metabolic pathways for drugs and calcn. of structural alerts.  The ChEMBL data can be accessed via a web-interface, RDF distribution, data downloads and RESTful web-services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB0IuNShSHIrVg90H21EOLACvtfcHk0lghWzqt4UQ-zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D&md5=1dcbb641f8c2d11410663f97505a4911</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1074%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNowotka%26aufirst%3DM.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DMendez%26aufirst%3DD.%26aulast%3DMutowo%26aufirst%3DP.%26aulast%3DAtkinson%26aufirst%3DF.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DCibrian-Uhalte%26aufirst%3DE.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DDedman%26aufirst%3DN.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DMagarinos%26aufirst%3DM.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DPapadatos%26aufirst%3DG.%26aulast%3DSmit%26aufirst%3DI.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26atitle%3DThe%2520Chembl%2520Database%2520in%25202017%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26issue%3DD1%26spage%3DD945%26epage%3DD954%26doi%3D10.1093%2Fnar%2Fgkw1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stubley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stell, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieson, D. W.</span></span> <span> </span><span class="NLM_article-title">The Oxidation of Azaheterocycles with Mammalian Liver Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.3109/00498257909087261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498257909087261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=516790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL3cXhtVKgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1979&pages=475-484&issue=8&author=C.+Stubleyauthor=J.+G.+Stellauthor=D.+W.+Mathieson&title=The+Oxidation+of+Azaheterocycles+with+Mammalian+Liver+Aldehyde+Oxidase&doi=10.3109%2F00498257909087261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The oxidation of azaheterocycles with mammalian liver aldehyde oxidase</span></div><div class="casAuthors">Stubley, C.; Stell, J. G. P.; Mathieson, D. W.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">475-84</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    </div><div class="casAbstract">Rabbit liver aldehyde oxidase (EC 1.2.3.1.) (I) oxidized isoquinoline, cinnoline, quinoxaline, quinazoline, and phthalazine to 1-hydroxyisoquinoline, 4-hydroxycinnoline, 2-hydroxy- and 2,3-dihydroxyquinoxaline, 4-hydroxy- and 2,4-dihydroxyquinazoline, and 1-hydroxyphthalazine, resp.  Michaelis-Menten consts. were detd. for the action of I on each of these compds. and showed that these compds. were among the most efficient substrates yet described for rabbit liver I.  Incubation of these compds. with bovine milk xanthine oxidase yielded significant amts. of metabolites only with quinazoline and phthalazine, for which the Km values were detd.  Incubation of the compds. with 100,000-g supernatant from rat liver gave qual. the same results as with rabbit liver, but smaller amts. of the oxidn. products were detected.  The substrate specificities of the enzymes are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLJEfWfGpohrVg90H21EOLACvtfcHk0lghWzqt4UQ-zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhtVKgt70%253D&md5=6a8f77c49aa3838d7372a7094a4b5464</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3109%2F00498257909087261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498257909087261%26sid%3Dliteratum%253Aachs%26aulast%3DStubley%26aufirst%3DC.%26aulast%3DStell%26aufirst%3DJ.%2BG.%26aulast%3DMathieson%26aufirst%3DD.%2BW.%26atitle%3DThe%2520Oxidation%2520of%2520Azaheterocycles%2520with%2520Mammalian%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D1979%26volume%3D9%26issue%3D8%26spage%3D475%26epage%3D484%26doi%3D10.3109%2F00498257909087261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Evidence for Substrate-Dependent Inhibition Profiles for Human Liver Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.048546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.048546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22996261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=24-29&issue=1&author=J.+T.+Barrauthor=J.+P.+Jones&title=Evidence+for+Substrate-Dependent+Inhibition+Profiles+for+Human+Liver+Aldehyde+Oxidase&doi=10.1124%2Fdmd.112.048546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase</span></div><div class="casAuthors">Barr, John T.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-29</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The goal of this study was to provide a reasonable assessment of how probe substrate selection may impact the results of in vitro aldehyde oxidase (I) inhibition expts.  Here, the authors used a previously studied set of 7 known I inhibitors to probe the inhibition profile of a pharmacol. relevant substrate, N-[(2-dimethylamino)ethyl]acridine-4-carboxamide (DACA).  DACA oxidn. by I in human liver cytosol was characterized with a measured Vmax of 2.3 nmol product/min/mg and a Km of 6.3 μM.  The Kii and Kis values describing the inhibition of DACA oxidn. by the panel of 7 inhibitors were tabulated and compared with previous findings with phthalazine as substrate.  In every case, the inhibition profile shifted to a much less uncompetitive mode of inhibition for DACA relative to phthalazine.  With the exception of one inhibitor, raloxifene, this change in inhibition profile appeared to be a result of a decrease in the uncompetitive mode of inhibition (an affected Kii value), whereas the competitive mode (Kis) appeared to be relatively consistent between substrates.  Raloxifene was found to inhibit competitively when using DACA as a probe, and a previous report showed that raloxifene inhibited uncompetitively with other substrates.  The relevance of these data to the mechanistic understanding of I inhibition and potential implications on drug-drug interactions was discussed.  Overall, it appears that the choice in substrate may be crit. when conducting mechanistic inhibition or in vitro drug-drug interactions prediction studies with I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWZ7cJVqkp_bVg90H21EOLACvtfcHk0lghWzqt4UQ-zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1OjsQ%253D%253D&md5=8980b8d7b3951f27ec63023706cb3188</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.048546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.048546%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DEvidence%2520for%2520Substrate-Dependent%2520Inhibition%2520Profiles%2520for%2520Human%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26issue%3D1%26spage%3D24%26epage%3D29%26doi%3D10.1124%2Fdmd.112.048546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stell, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelhouse, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, C. W.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Cryptolepine and 2-Fluorocryptolepine by Aldehyde Oxidase</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.2011.01408.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1111%2Fj.2042-7158.2011.01408.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22221099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVSisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=237-243&issue=2&author=J.+G.+Stellauthor=R.+T.+Wheelhouseauthor=C.+W.+Wright&title=Metabolism+of+Cryptolepine+and+2-Fluorocryptolepine+by+Aldehyde+Oxidase&doi=10.1111%2Fj.2042-7158.2011.01408.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of cryptolepine and 2-fluorocryptolepine by aldehyde oxidase</span></div><div class="casAuthors">Stell, J. Godfrey P.; Wheelhouse, Richard T.; Wright, Colin W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">237-243</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives To investigate the metab. of cryptolepine and some cryptolepine analogs by aldehyde oxidase, and to assess the implications of the results on the potential of cryptolepine analogs as antimalarial agents.  Methods The products resulting from the oxidn. of cryptolepine and 2-fluorocryptolepine by a rabbit liver prepn. of aldehyde oxidase were isolated and identified using chromatog. and spectroscopic techniques.  The antiplasmodial activity of cryptolepine-11-one was assessed against Plasmodium falciparum using the parasite lactate dehydrogenase assay.  Key findings Cryptolepine was oxidized by aldehyde oxidase give cryptolepine-11-one.  Although 2-fluorocryptolepine was found to have less affinity for the enzyme than cryptolepine, it was a better substrate for aldehyde oxidase than the parent compd.  In contrast, quindoline, the 11-chloro-, 2,7-dibromo- and 2-methoxy analogs of cryptolepine were not readily oxidized.  Cryptolepine-11-one was found to be inactive against P. falciparum in vitro raising the possibility that the effectiveness of cryptolepine as an antimalarial, may be compromised by metab. to an inactive metabolite by liver aldehyde oxidase.  Conclusions Cryptolepine and 2-fluorocryptolepine are substrates for aldehyde oxidase.  This may have implications for the design and development of cryptolepine analogs as antimalarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS7nWldURg1LVg90H21EOLACvtfcHk0lghWzqt4UQ-zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVSisLY%253D&md5=42fc6fc32d2f38ce0247b6c28ea04b7b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2011.01408.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2011.01408.x%26sid%3Dliteratum%253Aachs%26aulast%3DStell%26aufirst%3DJ.%2BG.%26aulast%3DWheelhouse%26aufirst%3DR.%2BT.%26aulast%3DWright%26aufirst%3DC.%2BW.%26atitle%3DMetabolism%2520of%2520Cryptolepine%2520and%25202-Fluorocryptolepine%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2012%26volume%3D64%26issue%3D2%26spage%3D237%26epage%3D243%26doi%3D10.1111%2Fj.2042-7158.2011.01408.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magee, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripp, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chupak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finegan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granskog, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardink, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huband, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamicker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knickerbocker, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzien, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, U. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait-Kamradt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whipple, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widlicka, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishka, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkowski, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">7446</span>– <span class="NLM_lpage">7457</span>, <span class="refDoi"> DOI: 10.1021/jm900729s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900729s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKktLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7446-7457&issue=23&author=T.+V.+Mageeauthor=S.+L.+Rippauthor=B.+Liauthor=R.+A.+Buzonauthor=L.+Chupakauthor=T.+J.+Doughertyauthor=S.+M.+Fineganauthor=D.+Girardauthor=A.+E.+Hagenauthor=M.+J.+Falconeauthor=K.+A.+Farleyauthor=K.+Granskogauthor=J.+R.+Hardinkauthor=M.+D.+Hubandauthor=B.+J.+Kamickerauthor=T.+Kanekoauthor=M.+J.+Knickerbockerauthor=J.+L.+Lirasauthor=A.+Marraauthor=I.+Medinaauthor=T.+T.+Nguyenauthor=M.+C.+Noeauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnellauthor=J.+B.+Penzienauthor=U.+D.+Reillyauthor=J.+R.+Schaferauthor=Y.+Shenauthor=G.+G.+Stoneauthor=T.+J.+Strelevitzauthor=J.+Sunauthor=A.+Tait-Kamradtauthor=A.+D.+Vazauthor=D.+A.+Whippleauthor=D.+W.+Widlickaauthor=D.+G.+Wishkaauthor=J.+P.+Wolkowskiauthor=M.+E.+Flanagan&title=Discovery+of+Azetidinyl+Ketolides+for+the+Treatment+of+Susceptible+and+Multidrug+Resistant+Community-Acquired+Respiratory+Tract+Infections&doi=10.1021%2Fjm900729s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections</span></div><div class="casAuthors">Magee, Thomas V.; Ripp, Sharon L.; Li, Bryan; Buzon, Richard A.; Chupak, Lou; Dougherty, Thomas J.; Finegan, Steven M.; Girard, Dennis; Hagen, Anne E.; Falcone, Michael J.; Farley, Kathleen A.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Kamicker, Barbara J.; Kaneko, Takushi; Knickerbocker, Michael J.; Liras, Jennifer L.; Marra, Andrea; Medina, Ivy; Nguyen, Thuy-Trinh; Noe, Mark C.; Obach, R. Scott; O'Donnell, John P.; Penzien, Joseph B.; Reilly, Usa Datta; Schafer, John R.; Shen, Yue; Stone, Gregory G.; Strelevitz, Timothy J.; Sun, Jianmin; Tait-Kamradt, Amelia; Vaz, Alfin D. N.; Whipple, David A.; Widlicka, Daniel W.; Wishka, Donn G.; Wolkowski, Joanna P.; Flanagan, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7446-7457</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Respiratory tract bacterial strains are becoming increasingly resistant to currently marketed macrolide antibiotics.  The current alternative telithromycin (1) from the newer ketolide class of macrolides addresses resistance but is hampered by serious safety concerns, hepatotoxicity in particular.  We have discovered a novel series of azetidinyl ketolides that focus on mitigation of hepatotoxicity by minimizing hepatic turnover and time-dependent inactivation of CYP3A isoforms in the liver without compromising the potency and efficacy of 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7QWmxQD6817Vg90H21EOLACvtfcHk0lgmwepDcz9G6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKktLbJ&md5=af3db30db1415fb477bffd6b5a2bab7c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm900729s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900729s%26sid%3Dliteratum%253Aachs%26aulast%3DMagee%26aufirst%3DT.%2BV.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DBuzon%26aufirst%3DR.%2BA.%26aulast%3DChupak%26aufirst%3DL.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DFinegan%26aufirst%3DS.%2BM.%26aulast%3DGirard%26aufirst%3DD.%26aulast%3DHagen%26aufirst%3DA.%2BE.%26aulast%3DFalcone%26aufirst%3DM.%2BJ.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DGranskog%26aufirst%3DK.%26aulast%3DHardink%26aufirst%3DJ.%2BR.%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DKamicker%26aufirst%3DB.%2BJ.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DKnickerbocker%26aufirst%3DM.%2BJ.%26aulast%3DLiras%26aufirst%3DJ.%2BL.%26aulast%3DMarra%26aufirst%3DA.%26aulast%3DMedina%26aufirst%3DI.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DPenzien%26aufirst%3DJ.%2BB.%26aulast%3DReilly%26aufirst%3DU.%2BD.%26aulast%3DSchafer%26aufirst%3DJ.%2BR.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DStone%26aufirst%3DG.%2BG.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTait-Kamradt%26aufirst%3DA.%26aulast%3DVaz%26aufirst%3DA.%2BD.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DWidlicka%26aufirst%3DD.%2BW.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DWolkowski%26aufirst%3DJ.%2BP.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520Azetidinyl%2520Ketolides%2520for%2520the%2520Treatment%2520of%2520Susceptible%2520and%2520Multidrug%2520Resistant%2520Community-Acquired%2520Respiratory%2520Tract%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D23%26spage%3D7446%26epage%3D7457%26doi%3D10.1021%2Fjm900729s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R. A.</span></span> <span> </span><span class="NLM_article-title">Refinement of in Vitro Methods for Identification of Aldehyde Oxidase Substrates Reveals Novel Metabolites of Kinase Inhibitors</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.080960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.118.080960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29615437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWlsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=846-859&issue=6&author=R.+A.+Dick&title=Refinement+of+in+Vitro+Methods+for+Identification+of+Aldehyde+Oxidase+Substrates+Reveals+Novel+Metabolites+of+Kinase+Inhibitors&doi=10.1124%2Fdmd.118.080960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of in vitro methods for identification of aldehyde oxidase substrates reveals metabolites of kinase inhibitors</span></div><div class="casAuthors">Dick, Ryan A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">846-859</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">To identify aldehyde oxidase (AO) substrates, an assay procedure was developed that leverages the capabilities of high-resoln. mass spectrometry to simultaneously monitor parent loss and formation of hydroxylated metabolite over time in incubations with liver cytosol.  By incorporating metabolite monitoring, false positives resulting from metab. by other cytosolic enzymes or processes were decreased.  A diverse set of 34 kinase inhibitors contg. AO-substrate motifs was screened, and 35% of the compds. were identified as human AO substrates.  Confirmation was obtained through detn. of the site of metab.  Human AO substrates identified contained unsubstituted diazanaphthalene moieties (A77-01, INCB 28060, ML-347, LDN-193189, and SB-525334), 4-aminoquinazoline cores (lapatinib, lapatinib M1, and CL-387785), and terminal pyridine and pyrimidine groups (imatinib, bafetinib, and AMG 900).  Rat and cynomolgus monkey AO displayed substrate specificities that overlapped moderately with human; rates of metab. were often higher and lower for cynomolgus monkey and rat, resp., compared with human.  A subset of novel AO substrates identified in this study was also subjected to two other methods for AO substrate detn.: comparison of human liver microsome and hepatocyte stability, and the effect of hydralazine, an AO-specific inhibitor, on hepatocyte stability.  These methods appeared to correlate and be capable of identifying AO substrates when more than one-third of metab. in hepatocytes was AO-mediated; however, significant limitations exist.  Considering the sensitivity, efficiency, and definitiveness of the cytosol assay with metabolite monitoring, its use is recommended as a primary screen for AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlGGJzSPQLDbVg90H21EOLACvtfcHk0lgmwepDcz9G6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWlsb7M&md5=0b08ae43f93b6a9874f10b40422d93b2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.080960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.080960%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DR.%2BA.%26atitle%3DRefinement%2520of%2520in%2520Vitro%2520Methods%2520for%2520Identification%2520of%2520Aldehyde%2520Oxidase%2520Substrates%2520Reveals%2520Novel%2520Metabolites%2520of%2520Kinase%2520Inhibitors%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26issue%3D6%26spage%3D846%26epage%3D859%26doi%3D10.1124%2Fdmd.118.080960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, T.</span></span> <span> </span><span class="NLM_article-title">Oxidative Metabolic Pathway of Lenvatinib Mediated by Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1326</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.058073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.058073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24914245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKntbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1326-1333&issue=8&author=K.+Inoueauthor=H.+Mizuoauthor=S.+Kawaguchiauthor=K.+Fukudaauthor=K.+Kusanoauthor=T.+Yoshimura&title=Oxidative+Metabolic+Pathway+of+Lenvatinib+Mediated+by+Aldehyde+Oxidase&doi=10.1124%2Fdmd.114.058073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase</span></div><div class="casAuthors">Inoue, Kazuko; Mizuo, Hitoshi; Kawaguchi, Shinki; Fukuda, Katsuyuki; Kusano, Kazutomi; Yoshimura, Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1326-1333, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lenvatinib is a multityrosine kinase inhibitor that inhibits vascular endothelial growth factor receptors, and is being developed as an anticancer drug.  P450s are involved in one of the elimination pathways of lenvatinib, and mono-oxidized metabolites, such as N-oxide (M3) and desmethylated metabolite (M2), form in rats, dogs, monkeys, and humans.  Meanwhile, two other oxidative metabolites are produced only in monkey and human liver S9 fractions, and their structures have been identified using high-resoln. mass spectrometry as a quinolinone form of lenvatinib (M3') and a quinolinone form of desmethylated lenvatinib (M2').  The formation of M3' from lenvatinib occurred independently of NADPH and was effectively inhibited by typical inhibitors of aldehyde oxidase, indicating the involvement of aldehyde oxidase, but not P450s, in this pathway.  M2' was a dioxidized metabolite arising from a combination of mono-oxidn. and desmethylation and could only be produced from M2 in a NADPH-independent manner; M2' could not be generated from M3 or M3'.  These results suggested that M2' is formed from lenvatinib by a unique two-step pathway through M2.  Although both lenvatinib and M2 were substrates for aldehyde oxidase, an enzyme kinetic study indicated that M2 was a much more favorable substrate than lenvatinib.  No inhibitory activities of lenvatinib, M2', or M3' and no significant inhibitory activities of M2 or M3 on aldehyde oxidase were obsd., suggesting a low possibility of drug-drug interactions in combination therapy with substrates of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor7zodBgKGsLVg90H21EOLACvtfcHk0lh-AX_dGuq9SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKntbzE&md5=c8b203525c5d1fdf2157d95784d88b53</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.058073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.058073%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DMizuo%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DS.%26aulast%3DFukuda%26aufirst%3DK.%26aulast%3DKusano%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DT.%26atitle%3DOxidative%2520Metabolic%2520Pathway%2520of%2520Lenvatinib%2520Mediated%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D8%26spage%3D1326%26epage%3D1333%26doi%3D10.1124%2Fdmd.114.058073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bish, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaramella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckworth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horscroft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laxton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span> <span> </span><span class="NLM_article-title">Design and Optimisation of Orally Active Tlr7 Agonists for the Treatment of Hepatitis C Virus Infection</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2389</span>– <span class="NLM_lpage">2393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2011.02.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21419626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12ku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2389-2393&issue=8&author=T.+D.+Tranauthor=D.+C.+Prydeauthor=P.+Jonesauthor=F.+M.+Adamauthor=N.+Bensonauthor=G.+Bishauthor=F.+Caloauthor=G.+Ciaramellaauthor=R.+Dixonauthor=J.+Duckworthauthor=D.+N.+Foxauthor=D.+A.+Hayauthor=J.+Hitchinauthor=N.+Horscroftauthor=M.+Howardauthor=I.+Gardnerauthor=H.+M.+Jonesauthor=C.+Laxtonauthor=T.+Parkinsonauthor=G.+Parsonsauthor=K.+Proctorauthor=M.+C.+Smithauthor=N.+Smithauthor=A.+Thomas&title=Design+and+Optimisation+of+Orally+Active+Tlr7+Agonists+for+the+Treatment+of+Hepatitis+C+Virus+Infection&doi=10.1016%2Fj.bmcl.2011.02.092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization of orally active TLR7 agonists for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Tran, Thien-Duc; Pryde, David C.; Jones, Peter; Adam, Fiona M.; Benson, Neil; Bish, Gerwyn; Calo, Frederick; Ciaramella, Guiseppe; Dixon, Rachel; Duckworth, Jonathan; Fox, David N. A.; Hay, Duncan A.; Hitchin, James; Horscroft, Nigel; Howard, Martin; Gardner, Iain; Jones, Hannah M.; Laxton, Carl; Parkinson, Tanya; Parsons, Gemma; Proctor, Katie; Smith, Mya C.; Smith, Nicholas; Thomas, Amy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2389-2393</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationships of a series of novel interferon inducers are described.  Pharmacokinetic studies and efficacy assessment of a series of 8-oxo-3-deazapurine analogs led to the identification of compd. I, a potent and selective agonist of the TLR7 receptor with an excellent in vivo efficacy profile in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq2lV4cNSHv7Vg90H21EOLACvtfcHk0lh-AX_dGuq9SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12ku74%253D&md5=49e8d72575cf93b1e9cc8ecc69ddd035</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.092%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BD.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DAdam%26aufirst%3DF.%2BM.%26aulast%3DBenson%26aufirst%3DN.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DCalo%26aufirst%3DF.%26aulast%3DCiaramella%26aufirst%3DG.%26aulast%3DDixon%26aufirst%3DR.%26aulast%3DDuckworth%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DD.%2BN.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DHitchin%26aufirst%3DJ.%26aulast%3DHorscroft%26aufirst%3DN.%26aulast%3DHoward%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DLaxton%26aufirst%3DC.%26aulast%3DParkinson%26aufirst%3DT.%26aulast%3DParsons%26aufirst%3DG.%26aulast%3DProctor%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%2BC.%26aulast%3DSmith%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DA.%26atitle%3DDesign%2520and%2520Optimisation%2520of%2520Orally%2520Active%2520Tlr7%2520Agonists%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D8%26spage%3D2389%26epage%3D2393%26doi%3D10.1016%2Fj.bmcl.2011.02.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wickremsinhe, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmieri, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmel, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, K. C.</span></span> <span> </span><span class="NLM_article-title">Disposition and Metabolism of Ly2603618, a Chk-1 Inhibitor Following Intravenous Administration in Patients with Advanced and/or Metastatic Solid Tumors</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.3109/00498254.2014.900589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2014.900589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24666335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GntL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=827-841&issue=9&author=E.+R.+Wickremsinheauthor=S.+M.+Hynesauthor=M.+D.+Palmieriauthor=M.+I.+Mitchellauthor=T.+L.+Abrahamauthor=J.+F.+Rehmelauthor=E.+Chanaauthor=L.+M.+Jostauthor=K.+C.+Cassidy&title=Disposition+and+Metabolism+of+Ly2603618%2C+a+Chk-1+Inhibitor+Following+Intravenous+Administration+in+Patients+with+Advanced+and%2For+Metastatic+Solid+Tumors&doi=10.3109%2F00498254.2014.900589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Disposition and metabolism of LY2603618, a Chk-1 inhibitor following intravenous administration in patients with advanced and/or metastatic solid tumors</span></div><div class="casAuthors">Wickremsinhe, Enaksha R.; Hynes, Scott M.; Palmieri, Margo D.; Mitchell, Malcolm I.; Abraham, Trent L.; Rehmel, Jessica Fayer; Chana, Emilie; Jost, Lorenz M.; Cassidy, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">827-841</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">1. The disposition and metab. of a Chk-1 inhibitor (LY2603618) was characterized following a 1-h i.v. administration of a single 250-mg dose of [14C]LY2603618 (50 μCi) to patients with advanced or metastatic solid tumors.  2. LY2603618 was well tolerated with no clin. significant adverse events.  Study was limited to three patients due to challenges of conducting ADME studies in patients with advanced cancer.  Plasma, urine and feces were analyzed for radioactivity, LY2603618 and metabolites.  LY2603618 had a half-life of 10.5 h and was the most abundant entity in plasma, accounting for approx. 69% of total plasma radioactivity.  The second most abundant metabolites, H2 and H5, accounted for <10% of total circulating radioactivity.  The major route of clearance was via CYP450 metab.  The mean total recovery of radioactivity was 83%, with approx. 72% of the radioactivity recovered in the feces and approx. 11% in the urine.  LY2603618 represented approx. 6% and 3% of the administered dose in feces and urine, resp.  3. A total of 12 metabolites were identified.  In vitro phenotyping indicated that CYP3A4 was predominantly responsible for the metabolic clearance of LY2603618.  Addnl., aldehyde oxidase was involved in the formation of a unique human and non-human primate metabolite, H5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Q8Zu_a3bF7Vg90H21EOLACvtfcHk0lh-AX_dGuq9SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GntL7J&md5=6306e281d6757c7a804f2a3d68da6783</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3109%2F00498254.2014.900589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2014.900589%26sid%3Dliteratum%253Aachs%26aulast%3DWickremsinhe%26aufirst%3DE.%2BR.%26aulast%3DHynes%26aufirst%3DS.%2BM.%26aulast%3DPalmieri%26aufirst%3DM.%2BD.%26aulast%3DMitchell%26aufirst%3DM.%2BI.%26aulast%3DAbraham%26aufirst%3DT.%2BL.%26aulast%3DRehmel%26aufirst%3DJ.%2BF.%26aulast%3DChana%26aufirst%3DE.%26aulast%3DJost%26aufirst%3DL.%2BM.%26aulast%3DCassidy%26aufirst%3DK.%2BC.%26atitle%3DDisposition%2520and%2520Metabolism%2520of%2520Ly2603618%252C%2520a%2520Chk-1%2520Inhibitor%2520Following%2520Intravenous%2520Administration%2520in%2520Patients%2520with%2520Advanced%2520and%252For%2520Metastatic%2520Solid%2520Tumors%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26issue%3D9%26spage%3D827%26epage%3D841%26doi%3D10.3109%2F00498254.2014.900589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adusumalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamwal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leggio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhlaghi, F.</span></span> <span> </span><span class="NLM_article-title">Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist Pf-5190457: A Reverse Translational Bed-to-Bench Approach</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1124/dmd.119.087015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.119.087015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=31182423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSgtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=874-882&issue=8&author=S.+Adusumalliauthor=R.+Jamwalauthor=R.+S.+Obachauthor=T.+F.+Ryderauthor=L.+Leggioauthor=F.+Akhlaghi&title=Role+of+Molybdenum-Containing+Enzymes+in+the+Biotransformation+of+the+Novel+Ghrelin+Receptor+Inverse+Agonist+Pf-5190457%3A+A+Reverse+Translational+Bed-to-Bench+Approach&doi=10.1124%2Fdmd.119.087015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Role of molybdenum-containing enzymes in the biotransformation of the novel ghrelin receptor inverse agonist PF-5190457: a reverse translational bed-to-bench approach</span></div><div class="casAuthors">Adusumalli, Sravani; Jamwal, Rohitash; Obach, R. Scott; Ryder, Tim F.; Leggio, Lorenzo; Akhlaghi, Fatemeh</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">874-882</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(R)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)-1-(2-(5-(6-methylpyrimidin- 4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonan-7-yl)ethan- 1-one (PF-5190457) was identified as a potent and selective inverse agonist of the ghrelin receptor [growth hormone secretagogue receptor 1a (GHS-R1a)].  The present translational bed-to-bench work characterizes the biotransformation of this compd. in vivo and then further explores in vitro metab. in fractions of human liver and primary hepatocytes.  Following oral administration of PF-5190457 in a phase 1b clin. study, hydroxyl metabolites of the compd. were obsd., including one that had not been obsd. in previously performed human liver microsomal incubations.  PF-6870961 or (R)-1-(2-(5-(2-hydroxy-6-methylpyrimidin- 4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonan-7-yl)-2- (2-methylimidazo[2,1-b]thiazol-6-yl)ethan-1-one was biosynthesized using liver cytosol, and the site of hydroxylation was shown to be on the pyrimidine using NMR spectroscopy.  The aldehyde oxidase (AO) inhibitor raloxifene and the xanthine oxidase inhibitor febuxostat inhibited the formation of PF-6870961 in human liver cytosol, suggesting both enzymes were involved in the metab. of the drug.  However, greater inhibition was obsd. with raloxifene, indicating AO is a dominant enzyme in the biotransformation.  The intrinsic clearance of the drug in human liver cytosol was estd. to be 0.002 mL/min per mg protein.  This study provides important novel information at three levels: 1) it provides addnl. new information on the recently developed novel compd. PF-5190457, the first GHS-R1a blocker that has moved to development in humans; 2) it provides an example of a reverse translational approach where a discovery in humans was brought back, validated, and further investigated at the bench level; and 3) it demonstrates the importance of considering the molybdenumcontaining oxidases during the development of new drug entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS5C1istD71LVg90H21EOLACvtfcHk0liYQIV-JEONfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSgtr7I&md5=c23536428f968c1479374385a5f7b185</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1124%2Fdmd.119.087015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.119.087015%26sid%3Dliteratum%253Aachs%26aulast%3DAdusumalli%26aufirst%3DS.%26aulast%3DJamwal%26aufirst%3DR.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DLeggio%26aufirst%3DL.%26aulast%3DAkhlaghi%26aufirst%3DF.%26atitle%3DRole%2520of%2520Molybdenum-Containing%2520Enzymes%2520in%2520the%2520Biotransformation%2520of%2520the%2520Novel%2520Ghrelin%2520Receptor%2520Inverse%2520Agonist%2520Pf-5190457%253A%2520A%2520Reverse%2520Translational%2520Bed-to-Bench%2520Approach%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2019%26volume%3D47%26issue%3D8%26spage%3D874%26epage%3D882%26doi%3D10.1124%2Fdmd.119.087015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">1303</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.068338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.115.068338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26936972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1296-1303&issue=8&author=R.+D.+Crouchauthor=R.+D.+Morrisonauthor=F.+W.+Byersauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=J.+S.+Daniels&title=Evaluating+the+Disposition+of+a+Mixed+Aldehyde+Oxidase%2FCytochrome+P450+Substrate+in+Rats+with+Attenuated+P450+Activity&doi=10.1124%2Fdmd.115.068338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating the disposition of a mixed aldehyde oxidase/cytochrome P450 substrate in rats with attenuated P450 activity</span></div><div class="casAuthors">Crouch, Rachel D.; Morrison, Ryan D.; Byers, Frank W.; Lindsley, Craig W.; Emmitte, Kyle A.; Daniels, J. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1296-1303</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Marketed drugs cleared by aldehyde oxidase (AO) are few, with no known clin. relevant pharmacokinetic drug interactions assocd. with AO inhibition, whereas cytochrome P 450 (P 450) inhibition or induction mediates a no. of clin. drug interactions.  Little attention has been given to the consequences of coadministering a P 450 inhibitor with a compd. metabolized by both AO and P 450.  Upon discovering that VU0409106 (1) was metabolized by AO (to M1) and P 450 enzymes (to M4-M6), we sought to evaluate the in vivo disposition of 1 and its metabolites in rats with attenuated P 450 activity.  Male rats were orally pretreated with the pan-P 450 inactivator, 1-aminobenzotriazole (ABT), before an i.p. dose of 1.  Interestingly, the plasma area under the curve (AUC) of M1 was increased 15-fold in ABT-treated rats, indicating a metabolic shunt toward AO resulted from the drug interaction condition.  The AUC of 1 also increased 7.8- fold.  Accordingly, plasma clearance of 1 decreased from 53.5 to 15.3 mL/min per kilogramin ABT-pretreated rats receiving an i.v. dose of 1.  Consistentwith these data,M1 formation in hepatic S9 increased with NADPH-exclusion to eliminate P 450 activity (50% over reactions contg. NADPH).  These studies reflect possible consequences of a drug interaction between P 450 inhibitors and compds. cleared by both AO and P 450 enzymes.  Notably, increased exposure to an AO metabolite may hold clin. relevance for active metabolites or those mediating toxicity at elevated concns.  The recent rise in clin. drug candidates metabolized by AO underscores the importance of these findings and the need for clin. studies to fully understand these risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof5dGfI2A47bVg90H21EOLACvtfcHk0lgWEapF7-4tdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurrK&md5=a8435edfa1bba3e71112e468d731d76f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.068338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.068338%26sid%3Dliteratum%253Aachs%26aulast%3DCrouch%26aufirst%3DR.%2BD.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DEvaluating%2520the%2520Disposition%2520of%2520a%2520Mixed%2520Aldehyde%2520Oxidase%252FCytochrome%2520P450%2520Substrate%2520in%2520Rats%2520with%2520Attenuated%2520P450%2520Activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1296%26epage%3D1303%26doi%3D10.1124%2Fdmd.115.068338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing Mglu5-Negative Allosteric Modulator Vu0424238 (Auglurant)</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1259</span>, <span class="refDoi"> DOI: 10.1124/dmd.117.077552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.117.077552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28939686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVansL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=1245-1259&issue=12&author=R.+D.+Crouchauthor=A.+L.+Blobaumauthor=A.+S.+Feltsauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Species-Specific+Involvement+of+Aldehyde+Oxidase+and+Xanthine+Oxidase+in+the+Metabolism+of+the+Pyrimidine-Containing+Mglu5-Negative+Allosteric+Modulator+Vu0424238+%28Auglurant%29&doi=10.1124%2Fdmd.117.077552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Species-specific involvement of aldehyde oxidase and xanthine oxidase in the metabolism of the pyrimidine-containing mGlu5-negative allosteric modulator VU0424238 (auglurant)</span></div><div class="casAuthors">Crouch, Rachel D.; Blobaum, Anna L.; Felts, Andrew S.; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1245-1259</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) and xanthine oxidase (XO) are molybdo-flavoenzymes that catalyze oxidn. of arom. azaheterocycles.  Differences in AO activity have been reported among various species, including rats, humans, and monkeys.  Herein we report a species difference in the enzymes responsible for the metab. of the neg. allosteric modulator of metabotropic glutamate receptor subtype 5 (mGlu5 NAM) VU0424238 (VU238, auglurant).  Hepatic S9 incubations with AO and XO specific inhibitors hydralazine and allopurinol indicated that rats and cynomolgus monkeys both oxidized VU238 to the 6-oxopyrimidine metabolite M1 via an AO-mediated pathway, whereas secondary oxidn. to the 2,6-dioxopyrimidine metabolite M2 was mediated predominantly by AO in monkeys and XO in rats.  Despite differences in enzymic pathways, intrinsic clearance (CLint) of M1 was similar between species (cynomolgus and rat CLint = 2.00 ± 0.040 and 2.19 ± 0.201 μl/min per mg of protein, resp.).  Inhibitor studies in the S9 of multiple species indicated that oxidn. of VU238 to M1 was mediated predominantly by AO in humans, cynomolgus and rhesus monkeys, rats, mice, guinea pigs, and minipigs.  Oxidn. of M1 to M2 was mediated predominantly by XO in rats and mice and by AO in monkeys and guinea pigs, whereas low turnover prevented enzyme phenotyping in humans and minipigs.  Addnl., inhibitor expts. indicated that oxidn. at the 2-position of the pyrimidine ring of the known AO substrate, BIBX1382, was mediated by AO in all species, although prodn. of this metabolite was comparatively low in rats and mice.  These data may suggest low reactivity of rat AO toward 2-oxidn. of pyrimidine-contg. compds. and highlight the importance of thoroughly characterizing AO-metabolized drug candidates in multiple preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVGvcWaoRLN7Vg90H21EOLACvtfcHk0lgWEapF7-4tdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVansL8%253D&md5=5d60074965ff047ad77a1e4619db143d</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1124%2Fdmd.117.077552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.117.077552%26sid%3Dliteratum%253Aachs%26aulast%3DCrouch%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSpecies-Specific%2520Involvement%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidase%2520in%2520the%2520Metabolism%2520of%2520the%2520Pyrimidine-Containing%2520Mglu5-Negative%2520Allosteric%2520Modulator%2520Vu0424238%2520%2528Auglurant%2529%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2017%26volume%3D45%26issue%3D12%26spage%3D1245%26epage%3D1259%26doi%3D10.1124%2Fdmd.117.077552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klecker, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cysyk, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. M.</span></span> <span> </span><span class="NLM_article-title">Zebularine Metabolism by Aldehyde Oxidase in Hepatic Cytosol from Humans, Monkeys, Dogs, Rats, and Mice: Influence of Sex and Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmc.2005.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16143537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1egsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=62-66&issue=1&author=R.+W.+Kleckerauthor=R.+L.+Cysykauthor=J.+M.+Collins&title=Zebularine+Metabolism+by+Aldehyde+Oxidase+in+Hepatic+Cytosol+from+Humans%2C+Monkeys%2C+Dogs%2C+Rats%2C+and+Mice%3A+Influence+of+Sex+and+Inhibitors&doi=10.1016%2Fj.bmc.2005.07.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: Influence of sex and inhibitors</span></div><div class="casAuthors">Klecker, Raymond W.; Cysyk, Richard L.; Collins, Jerry M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-66</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To aid in the clin. evaluation of zebularine, a potential oral antitumor agent, we initiated studies on the metab. of zebularine in liver cytosol from humans and other mammals.  Metab. by aldehyde oxidase (AO, EC 1.2.3.1) was the major catabolic route, yielding uridine as the primary metabolite, which was metabolized further to uracil by uridine phosphorylase.  The inhibition of zebularine metab. was studied using raloxifene, a known potent inhibitor of AO, and 5-benzylacyclouridine (BAU), a previously undescribed inhibitor of AO.  The Michaelis-Menten kinetics of aldehyde oxidase and its inhibition by raloxifene and BAU were highly variable between species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3KI53bTnEBbVg90H21EOLACvtfcHk0lgBMLSvJ2lX4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1egsLjP&md5=73ead144a54a542635ec99008699688f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DKlecker%26aufirst%3DR.%2BW.%26aulast%3DCysyk%26aufirst%3DR.%2BL.%26aulast%3DCollins%26aufirst%3DJ.%2BM.%26atitle%3DZebularine%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%2520in%2520Hepatic%2520Cytosol%2520from%2520Humans%252C%2520Monkeys%252C%2520Dogs%252C%2520Rats%252C%2520and%2520Mice%253A%2520Influence%2520of%2520Sex%2520and%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26issue%3D1%26spage%3D62%26epage%3D66%26doi%3D10.1016%2Fj.bmc.2005.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasaki, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masubuchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span> <span> </span><span class="NLM_article-title">Species Differences in Enantioselective 2-Oxidations of Rs-8359, a Selective and Reversible Mao-a Inhibitor, and Cinchona Alkaloids by Aldehyde Oxidase</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1002/bdd.494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fbdd.494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16400710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28XktlGhu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=133-139&issue=3&author=K.+Itohauthor=M.+Yamamuraauthor=W.+Takasakiauthor=T.+Sasakiauthor=A.+Masubuchiauthor=Y.+Tanaka&title=Species+Differences+in+Enantioselective+2-Oxidations+of+Rs-8359%2C+a+Selective+and+Reversible+Mao-a+Inhibitor%2C+and+Cinchona+Alkaloids+by+Aldehyde+Oxidase&doi=10.1002%2Fbdd.494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase</span></div><div class="casAuthors">Itoh, Kunio; Yamamura, Mayumi; Takasaki, Wataru; Sasaki, Takamitsu; Masubuchi, Akiko; Tanaka, Yorihisa</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-139</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The 2-oxidn. activity on the pyrimidine ring of RS-8359, a MAO-A inhibitor, is the major metabolic pathway catalyzed by aldehyde oxidase.  This study investigated the species differences in the 2-oxidn. activity by liver cytosolic fractions from rats, mice, guinea-pigs, rabbits, dogs, monkeys, and humans.  The Vmax/Km value for the (S)-enantiomer of RS-8359 was extremely high in monkeys and humans, moderate in guinea-pigs, and low in rats and mice.  Dogs were deficient in 2-oxidn. activity.  The (R)-enantiomer was only oxidized at a very low rate in guinea-pigs, monkeys, and humans, and not oxidized in rats, mice, and rabbits.  Thus, marked species differences and enantioselectivity were obvious for the 2-oxidn. of the (S)-enantiomer of RS-8359.  The in vitro results were in good accordance with previously reported in vivo excretion data of the 2-keto metabolite and the non-detectable blood plasma concns. of the (S)-enantiomer in monkeys and humans after administration of racemic RS-8359.  Enantioselectivity was also obsd. for the oxidn. of cinchona alkaloids catalyzed by aldehyde oxidase.  Among the 4 cinchona alkaloids studied, the oxidn. activity of cinchonidine, which has no substituents at the 6-hydroxy group but bears (8S,9R)-configurations, was highest.  As opposed to the (S)-enantiomer, an extremely high catalytic activity of cinchonidine was confirmed in rabbits, but not in monkeys or humans.  Rabbit liver aldehyde oxidase was suggested to have characteristic properties around the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIB8y7bWsMdLVg90H21EOLACvtfcHk0lgBMLSvJ2lX4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktlGhu7c%253D&md5=064c2f816decbfe6ea01debdf3f7afb7</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fbdd.494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.494%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DM.%26aulast%3DTakasaki%26aufirst%3DW.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DMasubuchi%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DSpecies%2520Differences%2520in%2520Enantioselective%25202-Oxidations%2520of%2520Rs-8359%252C%2520a%2520Selective%2520and%2520Reversible%2520Mao-a%2520Inhibitor%252C%2520and%2520Cinchona%2520Alkaloids%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2006%26volume%3D27%26issue%3D3%26spage%3D133%26epage%3D139%26doi%3D10.1002%2Fbdd.494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masubuchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span> <span> </span><span class="NLM_article-title">Stereospecific Oxidation of the (S)-Enantiomer of Rs-8359, a Selective and Reversible Monoamine Oxidase a (Mao-a) Inhibitor, by Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1080/00498250500202106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498250500202106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16192108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWitLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=561-573&issue=6&author=K.+Itohauthor=M.+Yamamuraauthor=S.+Muramatsuauthor=K.+Hoshinoauthor=A.+Masubuchiauthor=T.+Sasakiauthor=Y.+Tanaka&title=Stereospecific+Oxidation+of+the+%28S%29-Enantiomer+of+Rs-8359%2C+a+Selective+and+Reversible+Monoamine+Oxidase+a+%28Mao-a%29+Inhibitor%2C+by+Aldehyde+Oxidase&doi=10.1080%2F00498250500202106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase</span></div><div class="casAuthors">Itoh, K.; Yamamura, M.; Muramatsu, S.; Hoshino, K.; Masubuchi, A.; Sasaki, T.; Tanaka, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">561-573</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">In a previous paper by the authors on RS-8359, a new selective and reversible monoamine oxidase A (MAO-A) inhibitor, it was reported that the (S)-enantiomer of RS-8359 is rapidly eliminated from rats, monkeys and humans as a result of the formation of a 2-oxidative metabolite.  The present study investigates the properties of the enzyme responsible for the 2-oxidn. of RS-8359.  Subcellular localization, cofactor requirement and the inhibitory effects of typical compds. were studied using rat liver prepns.  In addn., the enzyme was purified from rat liver cytosol for further characterization.  The enzyme activity was localized in the cytosolic fraction without the need for any cofactor and was extensively inhibited by menadione, chlorpromazine and quinacrine.  The purified enzyme was also a homodimer with a monomeric mol. wt. of 140 kDa and it had an A280/A450 ratio of 5.1 in the absorption spectrum.  The results suggest that the enzyme responsible for the biotransformation of RS-8359 to give the 2-keto deriv. is aldehyde oxidase (EC 1.2.3.1).  The reaction of aldehyde oxidase is highly stereoselective for the (S)-configuration of RS-8359 and the (9R)-configuration of cinchona alkaloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvGEK_uJKiTrVg90H21EOLACvtfcHk0lgBMLSvJ2lX4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWitLbF&md5=22611faf87ab18a56761afceaa02f666</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1080%2F00498250500202106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250500202106%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DM.%26aulast%3DMuramatsu%26aufirst%3DS.%26aulast%3DHoshino%26aufirst%3DK.%26aulast%3DMasubuchi%26aufirst%3DA.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DStereospecific%2520Oxidation%2520of%2520the%2520%2528S%2529-Enantiomer%2520of%2520Rs-8359%252C%2520a%2520Selective%2520and%2520Reversible%2520Monoamine%2520Oxidase%2520a%2520%2528Mao-a%2529%2520Inhibitor%252C%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2005%26volume%3D35%26issue%3D6%26spage%3D561%26epage%3D573%26doi%3D10.1080%2F00498250500202106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolarek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loi, C. M.</span></span> <span> </span><span class="NLM_article-title">Cross-Species Comparison of the Metabolism and Excretion of Zoniporide: Contribution of Aldehyde Oxidase to Interspecies Differences</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.030783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.109.030783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=20040581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOgsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=641-654&issue=4&author=D.+Dalvieauthor=C.+Zhangauthor=W.+Chenauthor=T.+Smolarekauthor=R.+S.+Obachauthor=C.+M.+Loi&title=Cross-Species+Comparison+of+the+Metabolism+and+Excretion+of+Zoniporide%3A+Contribution+of+Aldehyde+Oxidase+to+Interspecies+Differences&doi=10.1124%2Fdmd.109.030783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences</span></div><div class="casAuthors">Dalvie, Deepak; Zhang, Chenghong; Chen, Weichao; Smolarek, Teresa; Obach, R. Scott; Loi, Cho-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-654</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Excretion and metab. of zoniporide were investigated in humans after i.v. infusion of [14C]zoniporide at an 80-mg dose.  Bile was the primary route of excretion because 57% of dose was recovered in the feces after i.v. infusion.  Zoniporide was primarily cleared via metab. in humans.  2-Oxozoniporide (M1) was the major excretory and circulating metabolite in humans and was catalyzed by aldehyde oxidase (Km of 3.4 μM and Vmax of 74 pmol/min/mg protein).  Metabolites M2 (17% of the dose) and M3 (6.4% of circulating radioactivity), in which the guanidine moiety was hydrolyzed to a carboxylic acid, were also detected in human feces and plasma, resp., suggesting that hydrolysis was another route of metab. of zoniporide in humans.  The metab. and excretion of [14C]zoniporide in rats and dogs were also evaluated.  As in humans, bile was the primary route of excretion of the radiolabeled material in both species, and metab. was the primary route of clearance.  A comparison of plasma metabolites showed that for M3, rats had a higher concn. than human or dog.  M1 was absent in dog and present in human and rat plasma at comparable levels, whereas comparison of excreta showed that the total body burden of M1 was greater in rat than that in human.  No further evaluation of M2 was considered because it was detected only in the human fecal exts.  Hence, no further toxicol. evaluation of the three human metabolites was undertaken.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogaZ5SY2KDrbVg90H21EOLACvtfcHk0lgeNvgRWRc-8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOgsrnK&md5=0a9ab410a5296bc500b3a37133def090</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.030783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.030783%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSmolarek%26aufirst%3DT.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DLoi%26aufirst%3DC.%2BM.%26atitle%3DCross-Species%2520Comparison%2520of%2520the%2520Metabolism%2520and%2520Excretion%2520of%2520Zoniporide%253A%2520Contribution%2520of%2520Aldehyde%2520Oxidase%2520to%2520Interspecies%2520Differences%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D4%26spage%3D641%26epage%3D654%26doi%3D10.1124%2Fdmd.109.030783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padilha, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKew, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peccinini, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Application of in Vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (Fop)</span>. <i>Front Pharmacol</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">234</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3389%2Ffphar.2019.00234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=31068801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3M7jslymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=234&author=E.+C.+Padilhaauthor=J.+Wangauthor=E.+Kernsauthor=A.+Leeauthor=W.+Huangauthor=J.+K.+Jiangauthor=J.+McKewauthor=A.+Mutlibauthor=R.+G.+Peccininiauthor=P.+B.+Yuauthor=P.+Sandersonauthor=X.+Xu&title=Application+of+in+Vitro+Drug+Metabolism+Studies+in+Chemical+Structure+Optimization+for+the+Treatment+of+Fibrodysplasia+Ossificans+Progressiva+%28Fop%29&doi=10.3389%2Ffphar.2019.00234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)</span></div><div class="casAuthors">Padilha Elias C; Kerns Ed; Lee Arthur; Huang Wenwei; Jiang Jian-Kang; McKew John; Sanderson Philip; Xu Xin; Padilha Elias C; Peccinini Rosangela G; Wang Jianyao; Wang Jianyao; Mutlib Abdul; Yu Paul B</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Currently no approved treatment exists for fibrodysplasia ossificans progressiva (FOP) patients, and disease progression results in severe restriction of joint function and premature mortality.  LDN-193189 has been demonstrated to be efficacious in a mouse FOP disease model after oral administration.  To support species selection for drug safety evaluation and to guide structure optimization for back-up compounds, in vitro metabolism of LDN-193189 was investigated in liver microsome and cytosol fractions of mouse, rat, dog, rabbit, monkey and human.  Metabolism studies included analysis of reactive intermediate formation using glutathione and potassium cyanide (KCN) and analysis of non-P450 mediated metabolites in cytosol fractions of various species.  Metabolite profiles and metabolic soft spots of LDN-193189 were elucidated using LC/UV and mass spectral techniques.  The in vitro metabolism of LDN-193189 was significantly dependent on aldehyde oxidase, with formation of the major NIH-Q55 metabolite.  The piperazinyl moiety of LDN-193189 was liable to NADPH-dependent metabolism which generated reactive iminium intermediates, as confirmed through KCN trapping experiments, and aniline metabolites (M337 and M380), which brought up potential drug safety concerns.  Subsequently, strategies were employed to avoid metabolic liabilities leading to the synthesis of Compounds 1, 2, and 3.  This study demonstrated the importance of metabolite identification for the discovery of novel and safe drug candidates for the treatment of FOP and helped medicinal chemists steer away from potential metabolic liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ95Ts_1DsHYpdYoSR9eyvsfW6udTcc2ebnyxleYDsdC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7jslymtQ%253D%253D&md5=d207950bcb621c76cc2239b79da23008</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00234%26sid%3Dliteratum%253Aachs%26aulast%3DPadilha%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKerns%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DJ.%2BK.%26aulast%3DMcKew%26aufirst%3DJ.%26aulast%3DMutlib%26aufirst%3DA.%26aulast%3DPeccinini%26aufirst%3DR.%2BG.%26aulast%3DYu%26aufirst%3DP.%2BB.%26aulast%3DSanderson%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DApplication%2520of%2520in%2520Vitro%2520Drug%2520Metabolism%2520Studies%2520in%2520Chemical%2520Structure%2520Optimization%2520for%2520the%2520Treatment%2520of%2520Fibrodysplasia%2520Ossificans%2520Progressiva%2520%2528Fop%2529%26jtitle%3DFront%2520Pharmacol%26date%3D2019%26volume%3D10%26spage%3D234%26doi%3D10.3389%2Ffphar.2019.00234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Xenobiotics by Aldehyde Oxidase</span>. <i>Curr. Protoc Toxicol</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4.41.1</span>– <span class="NLM_lpage">4.41.13</span>, <span class="refDoi"> DOI: 10.1002/0471140856.tx0441s63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2F0471140856.tx0441s63" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=4.41.1-4.41.13&author=D.+Dalvieauthor=M.+Zientek&title=Metabolism+of+Xenobiotics+by+Aldehyde+Oxidase&doi=10.1002%2F0471140856.tx0441s63"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2F0471140856.tx0441s63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471140856.tx0441s63%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DZientek%26aufirst%3DM.%26atitle%3DMetabolism%2520of%2520Xenobiotics%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DCurr.%2520Protoc%2520Toxicol%26date%3D2015%26volume%3D63%26spage%3D4.41.1%26epage%3D4.41.13%26doi%3D10.1002%2F0471140856.tx0441s63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shardlow, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thewlis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayrton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of the Novel, High-Affinity and Selective Dopamine D3 Receptor Antagonist Sb-277011 in Rat, Dog and Monkey: In Vitro/in Vivo Correlation and the Role of Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">8−9</span>),  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1080/00498250110056531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498250110056531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=11569533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvF2ltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=677-686&issue=8%E2%88%929&author=N.+E.+Austinauthor=S.+J.+Baldwinauthor=L.+Cutlerauthor=N.+Deeksauthor=P.+J.+Kellyauthor=M.+Nashauthor=C.+E.+Shardlowauthor=G.+Stempauthor=K.+Thewlisauthor=A.+Ayrtonauthor=P.+Jeffrey&title=Pharmacokinetics+of+the+Novel%2C+High-Affinity+and+Selective+Dopamine+D3+Receptor+Antagonist+Sb-277011+in+Rat%2C+Dog+and+Monkey%3A+In+Vitro%2Fin+Vivo+Correlation+and+the+Role+of+Aldehyde+Oxidase&doi=10.1080%2F00498250110056531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog, and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase</span></div><div class="casAuthors">Austin, N. E.; Baldwin, S. J.; Cutler, L.; Deeks, N.; Kelly, P. J.; Nash, M.; Shardlow, C. E.; Stemp, G.; Thewlis, K.; Ayrton, A.; Jeffrey, P.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8/9</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. In vitro studies with the selective dopamine D3 receptor antagonist SB-277011 were conducted in liver microsomes and homogenates from rat, dog, cynomolgus monkey, and human to correlate the rate of metab. with the in vivo pharmacokinetics of the compd. in rat, dog, and cynomolgus monkey.  2. In the presence of NADPH, SB-277011 was relatively stable in the presence of liver microsomes from rat, dog, cynomolgus monkey, and human with an intrinsic clearance (CLi) of < 2 mL min-1 g-1 liver for all species.  In total liver homogenates, SB-277011 was metabolized at a similar rate in rat and dog (CLi < 2 mL min-1 g-1 liver) to that in liver microsomes but in cynomolgus monkey and human (CLi = 9.9 and 45 mL min-1 g-1 liver, resp.) the intrinsic clearance was ∼6- and 35-fold higher, resp., than that in liver microsomes.  3. In the absence of NADPH, SB-277011 was rapidly cleared in liver homogenates from cynomolgus monkey and human (CLi = 7.4 and 27 mL min-1 g-1 liver, resp.) demonstrating that a significant pathway of metab. of this compd. was via an NADPH-independent non-microsomal oxidative route.  This pathway was sensitive to inhibition with isovanillin suggesting that the enzyme responsible was aldehyde oxidase.  4. The in vivo pharmacokinetics showed that the plasma clearance of SB-277011 was low in rat (20 mL min-1 kg-1), moderate in dog (14 mL min-1 kg-1) and high in cynomolgus monkey (58 mL min-1 kg-1), which is consistent with the in vitro findings and demonstrated a greater capacity for the monkey to metabolize this compd.  The oral bioavailability of SB-277011 in rat, dog, and cynomolgus monkey was 35, 43 and 2%, resp.  Given the high clearance of this compd. in cynomolgus monkey, the low oral bioavailability is probably as a result of high 1st-pass elimination, specifically by aldehyde oxidase, rather than poor absorption.  5. The high in vitro clearance of SB-277011 in human liver homogenates and the involvement of aldehyde oxidase in the metab. of SB-277011 indicates that the bioavailability of the compd. is likely to be low in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRX0OtLzrYkbVg90H21EOLACvtfcHk0lj_yrBvi4va1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvF2ltL4%253D&md5=c7795b7b9bdd0a71b64de549a4622199</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1080%2F00498250110056531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250110056531%26sid%3Dliteratum%253Aachs%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBaldwin%26aufirst%3DS.%2BJ.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DP.%2BJ.%26aulast%3DNash%26aufirst%3DM.%26aulast%3DShardlow%26aufirst%3DC.%2BE.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%26aulast%3DAyrton%26aufirst%3DA.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520of%2520the%2520Novel%252C%2520High-Affinity%2520and%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonist%2520Sb-277011%2520in%2520Rat%252C%2520Dog%2520and%2520Monkey%253A%2520In%2520Vitro%252Fin%2520Vivo%2520Correlation%2520and%2520the%2520Role%2520of%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2001%26volume%3D31%26issue%3D8%25E2%2588%25929%26spage%3D677%26epage%3D686%26doi%3D10.1080%2F00498250110056531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. Y. J.</span></span> <span> </span><span class="NLM_article-title">Metabolism of C-Met Kinase Inhibitors Containing Quinoline by Aldehyde Oxidase, Electron Donating and Steric Hindrance Effect</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1855</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.081919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.118.081919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30209037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1Onsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=1847-1855&issue=12&author=J.+W.+Zhangauthor=W.+Xiaoauthor=Z.+T.+Gaoauthor=Z.+T.+Yuauthor=J.+Y.+J.+Zhang&title=Metabolism+of+C-Met+Kinase+Inhibitors+Containing+Quinoline+by+Aldehyde+Oxidase%2C+Electron+Donating+and+Steric+Hindrance+Effect&doi=10.1124%2Fdmd.118.081919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of c-Met kinase inhibitors containing quinoline by aldehyde oxidase, electron donating, and steric hindrance effect</span></div><div class="casAuthors">Zhang, Jiang Wei; Xiao, Wen; Gao, Zhen Ting; Yu, Zheng Tian; Zhang, Ji Yue Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1847-1855</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Some quinoline-contg. c-Met kinase inhibitors are aldehyde oxidase (AO) substrates. 3-Substituted quinoline triazolopyridine analogs were synthesized to understand the electron-donating and steric hindrance effects on AO-mediated metab.  Metabolic stability studies for these quinoline analogs were carried out in liver cytosol from mice, rats, cynomolgus monkeys, and humans.  Several 3-N-substituted analogs were found to be unstable in monkey liver cytosolic incubations (half-life, <10 min), and five of them (63, 53, 51, 11, and 71) were chosen for addnl. mechanistic studies.  Mono-oxygenation on the quinoline ring was identified by liq. chromatog. tandem mass spectrometry.  Metabolite formation was inhibited by the AO inhibitors menadione and raloxifene, but not by the xanthine oxidase inhibitor allopurinol.  It was found that small electron-donating groups at the 3-quinoline moiety made the analogs more susceptible to AO metab., whereas large 3-substituents could reverse the trend.  Although species differences were obsd., this trend was applicable to all species tested.  Small electron-donating substituents at the 3-quinoline moiety increased both affinity (decreased Michaelis const.) and Vmax max. velocity toward AO in kinetic studies, whereas large substituents decreased both parameters probably as a result of steric hindrance.  Based on our anal., a common structural feature with high AO liability was proposed.  Our finding could provide useful information for chemists to minimize potential AO liability when designing quinoline analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkGiQQGWoG1bVg90H21EOLACvtfcHk0lj_yrBvi4va1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1Onsbk%253D&md5=87b1321378c2b70c2e2490e23263b3fa</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.081919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.081919%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BW.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DZ.%2BT.%26aulast%3DYu%26aufirst%3DZ.%2BT.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%2BJ.%26atitle%3DMetabolism%2520of%2520C-Met%2520Kinase%2520Inhibitors%2520Containing%2520Quinoline%2520by%2520Aldehyde%2520Oxidase%252C%2520Electron%2520Donating%2520and%2520Steric%2520Hindrance%2520Effect%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26issue%3D12%26spage%3D1847%26epage%3D1855%26doi%3D10.1124%2Fdmd.118.081919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Deuterium-Labeled Jnj38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1218</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.8b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.8b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVChtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=1213-1218&issue=11&author=Z.+Zhanauthor=X.+Pengauthor=Y.+Sunauthor=J.+Aiauthor=W.+Duan&title=Evaluation+of+Deuterium-Labeled+Jnj38877605%3A+Pharmacokinetic%2C+Metabolic%2C+and+in+Vivo+Antitumor+Profiles&doi=10.1021%2Facs.chemrestox.8b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Deuterium-Labeled JNJ38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles</span></div><div class="casAuthors">Zhan, Zhengsheng; Peng, Xia; Sun, Yiming; Ai, Jing; Duan, Wenhu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1213-1218</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C-Met inhibitor JNJ38877605 has proven curative as an antitumor agent, while its clin. study was terminated due to renal toxicity.  It was reported that the renal toxicity was caused by the poor soly. of its aldehyde oxidase (AO) metabolites.  Therefore, blocking AO oxidn. of JNJ38877605 might diminish the toxic metabolites and overcome the renal toxicity.  Compd. 3, the AO metabolic site deuterated JNJ38877605, was then synthesized as the target mol.  In vitro monkey liver S9 fraction incubation of 3 manifested that the renal toxic metabolite M2-2 was significantly reduced, which connoted that this deuteration has partly blocked AO oxidn.  After po. nasal gavage to cynomolgus monkeys, compd. 3 revealed decreased AO metabolites M2-2 and M3-2 in the plasma as well as 1.88-fold AUC and 1.56-fold Cmax compared with JNJ38877605, indicating that deuterium replacement significantly blocked AO metab. in vivo.  Besides, metabolic profiles of 3 were investigated by anal. of the plasma and the urine of the po. administrated cynomolgus monkeys.  Moreover, after oral administration to the EBC-1 tumor-bearing nude mice, compd. 3 exhibited a better antitumor efficacy than JNJ38877605.  In conclusion, deuteration on the AO metabolic site of JNJ38877605 improved its AO metab., oral exposure, as well as in vivo antitumor efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbsjIia0zdsbVg90H21EOLACvtfcHk0lj_yrBvi4va1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVChtrbM&md5=a9e66686424cd885998b17b603827313</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.8b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.8b00191%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DW.%26atitle%3DEvaluation%2520of%2520Deuterium-Labeled%2520Jnj38877605%253A%2520Pharmacokinetic%252C%2520Metabolic%252C%2520and%2520in%2520Vivo%2520Antitumor%2520Profiles%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26issue%3D11%26spage%3D1213%26epage%3D1218%26doi%3D10.1021%2Facs.chemrestox.8b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase Mediated Metabolism in Drug-Like Molecules: A Combined Computational and Experimental Study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2973</span>– <span class="NLM_lpage">2982</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjslyitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2973-2982&issue=7&author=Y.+Xuauthor=L.+Liauthor=Y.+Wangauthor=J.+Xingauthor=L.+Zhouauthor=D.+Zhongauthor=X.+Luoauthor=H.+Jiangauthor=K.+Chenauthor=M.+Zhengauthor=P.+Dengauthor=X.+Chen&title=Aldehyde+Oxidase+Mediated+Metabolism+in+Drug-Like+Molecules%3A+A+Combined+Computational+and+Experimental+Study&doi=10.1021%2Facs.jmedchem.7b00019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: A Combined Computational and Experimental Study</span></div><div class="casAuthors">Xu, Yuan; Li, Liang; Wang, Yulan; Xing, Jing; Zhou, Lei; Zhong, Dafang; Luo, Xiaomin; Jiang, Hualiang; Chen, Kaixian; Zheng, Mingyue; Deng, Pan; Chen, Xiaoyan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2973-2982</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is an important drug-metabolizing enzyme.  However, the current in vitro models for evaluating AOX metab. are sometimes misleading, and preclin. animal models generally fail to predict human AOX-mediated metab.  In this study, the authors report a combined computational and exptl. investigation of drug-like mols. that are potential aldehyde oxidase substrates, of which multiple sites of metab. (SOMs) mediated by AOX and their preferences for the reaction can be unambiguously identified.  In addn., the proposed strategy was used to evaluate the metab. of newly designed c-Met inhibitors, and a success switch-off of AOX metab. was obsd.  Overall, this study provide useful information to guide lead optimization and drug discovery based on AOX-mediated metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPvn1B_ge-grVg90H21EOLACvtfcHk0ligDP1PU_OqrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjslyitLc%253D&md5=2cb27d8a575dacef529f20cfe32cf8dc</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00019%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DAldehyde%2520Oxidase%2520Mediated%2520Metabolism%2520in%2520Drug-Like%2520Molecules%253A%2520A%2520Combined%2520Computational%2520and%2520Experimental%2520Study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D7%26spage%3D2973%26epage%3D2982%26doi%3D10.1021%2Facs.jmedchem.7b00019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, H.</span></span> <span> </span><span class="NLM_article-title">Species Differences in Metabolism of Ripasudil (K-115) Are Attributed to Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.3109/00498254.2015.1096981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2015.1096981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26678038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGgtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2016&pages=579-590&author=T.+Isobeauthor=M.+Ohtaauthor=Y.+Kanekoauthor=H.+Kawai&title=Species+Differences+in+Metabolism+of+Ripasudil+%28K-115%29+Are+Attributed+to+Aldehyde+Oxidase&doi=10.3109%2F00498254.2015.1096981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase</span></div><div class="casAuthors">Isobe, Tomoyuki; Ohta, Masayuki; Kaneko, Yoshio; Kawai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. We examd. the metab. of ripasudil (K-115), a selective and potent Rho-assocd. coiled coil-contg. protein kinase (ROCK) inhibitor, by in vitro and in vivo studies.2.  First, we identified metabolites and metabolic enzymes involved in ripasudil metab.  Species differences were obsd. in metabolic clearance and profiles of metabolites in liver S9 fraction and hepatocytes.  In addn., ripasudil was metabolised in humans and monkey S9 without NADP (NADPH).  Studies using specific inhibitors and human recombinant enzyme systems showed that M1 (main metabolite in humans) formation is mediated by aldehyde oxidase (AO).3.  Therefore, we developed ripasudil as an ophthalmic agent.  First, we compared the pharmacokinetic profiles of ripasudil in humans and rats.  The results indicated rapid disappearance of ripasudil from the circulation after instillation in humans and its level remained relatively high only in M1.  In contrast, we found six metabolites from M1 to M6 in plasma after oral administration to rats.4.  Anal. of enzyme kinetics using S9 showed that the formation of M1 is the major metabolic pathway of ripasudil in humans even though CYP3A4/3A5 and CYP2C8/3A4/3A5 were assocd. with the formation of M2 and M4, resp.  In conclusion, AO causes differences in ripasudil metab. between species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ83vnSAoNYrVg90H21EOLACvtfcHk0ligDP1PU_OqrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGgtrzF&md5=178a4bb59973d4be6ce3245100f532e7</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.3109%2F00498254.2015.1096981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2015.1096981%26sid%3Dliteratum%253Aachs%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DY.%26aulast%3DKawai%26aufirst%3DH.%26atitle%3DSpecies%2520Differences%2520in%2520Metabolism%2520of%2520Ripasudil%2520%2528K-115%2529%2520Are%2520Attributed%2520to%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2016%26volume%3D46%26spage%3D579%26epage%3D590%26doi%3D10.3109%2F00498254.2015.1096981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, X.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase-Dependent Species Difference in Hepatic Metabolism of Fasudil to Hydroxyfasudil</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1080/00498254.2017.1292016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498254.2017.1292016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28166443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Gksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=170-177&issue=2&author=Z.+Maoauthor=Y.+Wuauthor=Q.+Liauthor=X.+Wangauthor=Y.+Liuauthor=X.+Di&title=Aldehyde+Oxidase-Dependent+Species+Difference+in+Hepatic+Metabolism+of+Fasudil+to+Hydroxyfasudil&doi=10.1080%2F00498254.2017.1292016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase-dependent species difference in hepatic metabolism of fasudil to hydroxyfasudil</span></div><div class="casAuthors">Mao, Zhengsheng; Wu, Yali; Li, Qiuying; Wang, Xin; Liu, Youping; Di, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-177</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">An investigation on the metabolic mechanism of fasudil to hydroxyfasudil was conducted in vitro using liver subcellular fractions of different species.  Hydroxyfasudil was generated in large amts. by rat liver S9 and to a similar extent by human liver S9 but was not detected in dog liver S9 incubations.  Studies with various molybdenum hydroxylase inhibitors demonstrated that aldehyde oxidase (AO), but not xanthine oxidase (XO), selectively catalyzed fasudil to hydroxyfasudil in both rat and human liver cytosol.  In addn., the oxygen atom incorporated into hydroxyfasudil was derived from water rather than atm. oxygen, which further corroborated AO involvement.  Enzyme kinetics expts. revealed that fasudil had a higher affinity to human hepatic AO than to rat hepatic AO.  Besides, significantly different in vivo pharmacokinetic parameters obsd. between male and female rats indicated that the AO activity in rats was gender-dependent.  The present study provided first evidences that AO causes differences in fasudil metab. between species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLweM3FIR00rVg90H21EOLACvtfcHk0ligDP1PU_OqrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Gksbk%253D&md5=03b6d2441e74bc60045e1fdcb192a0ec</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1080%2F00498254.2017.1292016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2017.1292016%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDi%26aufirst%3DX.%26atitle%3DAldehyde%2520Oxidase-Dependent%2520Species%2520Difference%2520in%2520Hepatic%2520Metabolism%2520of%2520Fasudil%2520to%2520Hydroxyfasudil%26jtitle%3DXenobiotica%26date%3D2018%26volume%3D48%26issue%3D2%26spage%3D170%26epage%3D177%26doi%3D10.1080%2F00498254.2017.1292016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span> <span> </span><span class="NLM_article-title">Substrate Specificity of Human Liver Aldehyde Oxidase toward Substituted Quinazolines and Phthalazines: A Comparison with Hepatic Enzyme from Guinea Pig, Rabbit, and Baboon</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>319</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1006/abbi.1995.1320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1006%2Fabbi.1995.1320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7786031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Sht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1995&pages=481-490&issue=2&author=C.+Beedhamauthor=D.+J.+Critchleyauthor=D.+J.+Rance&title=Substrate+Specificity+of+Human+Liver+Aldehyde+Oxidase+toward+Substituted+Quinazolines+and+Phthalazines%3A+A+Comparison+with+Hepatic+Enzyme+from+Guinea+Pig%2C+Rabbit%2C+and+Baboon&doi=10.1006%2Fabbi.1995.1320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon</span></div><div class="casAuthors">Beedham, Christine; Critchley, David J. P.; Rance, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">481-90</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Partially purified aldehyde oxidase (EC 1.2.3.1) has been prepd. from human, rabbit, guinea pig, and baboon liver by heat treatment and pptn. with ammonium sulfate.  The interaction of 35 substituted quinazolines and phthalazines with human liver enzyme has been studied using a spectrophotometric assay.  Fifteen quinazoline and 14 phthalazine derivs. were substrates for human liver aldehyde oxidase with Km values ranging from 5 to 500 μM.  The substrate specificity of the quinazolines toward rabbit, guinea pig, and baboon liver aldehyde oxidase has also been investigated; the reaction of substituted phthalazines with mammalian liver enzyme has been reported previously.  Oxidn. products of 2-substituted (4-substituted) quinazolines with rabbit liver aldehyde oxidase were identified by MS as 4-oxo (2-oxo)-quinazolines, resp.  In all cases, unsubstituted compds. gave the highest oxidn. rates and the presence of lipophilic substituents presumably facilitated hydrophobic binding to the enzymes.  However, there were marked differences in substrate specificity between human liver aldehyde oxidase and hepatic enzyme from rabbit, guinea pig, and baboon with the size of substrate being the differentiating factor.  The mol. sizes of the substrates, estd. using calcd. molar refractivities, ranked the size of the binding site of aldehyde oxidase in the order rabbit < guinea pig < baboon < man.  Isoelec. points of the different aldehyde oxidase isoenzymes ranged from pH 5.10 for rabbit to 6.40 for the human liver isoenzyme.  These results indicate that rabbit liver aldehyde oxidase shows marked differences from the human liver enzyme in its handling of quinazoline and phthalazine substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcAxLqZIp9GLVg90H21EOLACvtfcHk0ligDP1PU_OqrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Sht7w%253D&md5=23598ccf3235f610bb941e5840f90ac2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1995.1320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1995.1320%26sid%3Dliteratum%253Aachs%26aulast%3DBeedham%26aufirst%3DC.%26aulast%3DCritchley%26aufirst%3DD.%2BJ.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26atitle%3DSubstrate%2520Specificity%2520of%2520Human%2520Liver%2520Aldehyde%2520Oxidase%2520toward%2520Substituted%2520Quinazolines%2520and%2520Phthalazines%253A%2520A%2520Comparison%2520with%2520Hepatic%2520Enzyme%2520from%2520Guinea%2520Pig%252C%2520Rabbit%252C%2520and%2520Baboon%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1995%26volume%3D319%26issue%3D2%26spage%3D481%26epage%3D490%26doi%3D10.1006%2Fabbi.1995.1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghafourian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M. R.</span></span> <span> </span><span class="NLM_article-title">Quantitative Study of the Structural Requirements of Phthalazine/Quinazoline Derivatives for Interaction with Human Liver Aldehyde Oxidase</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1071</span>, <span class="refDoi"> DOI: 10.1248/cpb.49.1066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1248%2Fcpb.49.1066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=11558587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=1066-1071&issue=9&author=T.+Ghafourianauthor=M.+R.+Rashidi&title=Quantitative+Study+of+the+Structural+Requirements+of+Phthalazine%2FQuinazoline+Derivatives+for+Interaction+with+Human+Liver+Aldehyde+Oxidase&doi=10.1248%2Fcpb.49.1066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative study of the structural requirements of phthalazine/quinazoline derivatives for interaction with human liver aldehyde oxidase</span></div><div class="casAuthors">Ghafourian, Taravat; Rashidi, Mohammad Reza</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Aldehyde oxidase is a molybdenum-contg. enzyme distributed throughout the animal kingdom.  Although this enzyme is capable of metabolizing a wide range of aldehydes and N-heterocyclic compds., there is no reported detailed study of physicochem. requirements of the enzyme-substrate interactions.  The aim of this study, therefore, was to investigate quant. the relationships between the kinetic consts. of aldehyde oxidase-catalyzed oxidn. of some phthalazine and quinazoline derivs. (as substrates) and their structural parameters.  Multiple regression and stepwise regression analyses showed that polarity of phthalazines (expressed as dipole moment μ, cohesive energy d. δT and an indicator variable for hydrogen-bond acceptor ability of R1 substituent, HBA) had a neg. effect on the enzyme activity (leading to the redn. of Vmax and increase of Km).  Electron withdrawing substituents in the quinazoline series are favorable for interaction with the enzyme.  This finding and also the relationships of 1/Km of phthalazines with the energy of the LUMO and log Vmax/logKm of phthalazines with degree of bonding of the two nitrogen atoms in the mols. are consistent with the mechanism of action.  The reaction involves a nucleophilic attack on an electron-deficient sp2-hybridized carbon atom and formation of an epoxide intermediate following the disruption of the arom. structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo84zHPCsYJ9rVg90H21EOLACvtfcHk0ljX54t1g7z6PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFyksb4%253D&md5=29f52036a2c36909fc841e5c2cd0741f</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1248%2Fcpb.49.1066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.49.1066%26sid%3Dliteratum%253Aachs%26aulast%3DGhafourian%26aufirst%3DT.%26aulast%3DRashidi%26aufirst%3DM.%2BR.%26atitle%3DQuantitative%2520Study%2520of%2520the%2520Structural%2520Requirements%2520of%2520Phthalazine%252FQuinazoline%2520Derivatives%2520for%2520Interaction%2520with%2520Human%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2001%26volume%3D49%26issue%3D9%26spage%3D1066%26epage%3D1071%26doi%3D10.1248%2Fcpb.49.1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klecker, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katki, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parchment, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boinpally, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoRusso, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivy, S. P.</span></span> <span> </span><span class="NLM_article-title">Metabolic Profile of Xk469 (2(R)-[4-(7-Chloro-2-Quinoxalinyl)Oxyphenoxy]-Propionic Acid; Nsc698215) in Patients and in Vitro: Low Potential for Active or Toxic Metabolites or for Drug-Drug Interactions</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1007/s00280-004-0962-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00280-004-0962-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15895233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFKksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=351-357&issue=4&author=L.+W.+Andersonauthor=J.+M.+Collinsauthor=R.+W.+Kleckerauthor=A.+G.+Katkiauthor=R.+E.+Parchmentauthor=R.+R.+Boinpallyauthor=P.+M.+LoRussoauthor=S.+P.+Ivy&title=Metabolic+Profile+of+Xk469+%282%28R%29-%5B4-%287-Chloro-2-Quinoxalinyl%29Oxyphenoxy%5D-Propionic+Acid%3B+Nsc698215%29+in+Patients+and+in+Vitro%3A+Low+Potential+for+Active+or+Toxic+Metabolites+or+for+Drug-Drug+Interactions&doi=10.1007%2Fs00280-004-0962-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug-drug interactions</span></div><div class="casAuthors">Anderson, Lawrence W.; Collins, Jerry M.; Klecker, Raymond W.; Katki, Aspandiar G.; Parchment, Ralph E.; Boinpally, Ramesh R.; LoRusso, Patricia M.; Ivy, S. Percy</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-357</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">As part of an ongoing phase 1 study, we studied the excretion of XK469 and its metab. in patients and in vitro.  Five primary metabolites were identified by HPLC/MS/MS.  An oxidized product formed by cytosolic aldehyde oxidase was the predominant species both in urine and human hepatocytes in vitro.  Conjugates of XK469 with glycine, taurine, and glucuronic acid, as well as the microsomal product, 4-oxo-XK469, were also found in urine and in vitro, but none were major contributors to the mass balance for XK469 elimination.  Based upon the relative concns. circulating in plasma, systemic exposure to parent drug was 100-fold higher than for the metabolites.  Thus, both toxicity and efficacy of XK469 are most likely to be produced by the parent mol., rather than the metabolites.  Urinary recovery of parent drug was low (2% of dose in 24 h), partly because of the long half-life of XK469 (approx. 3 days).  In addn., the metabolite profile in urine indicates that only 25% of the XK469-derived material was unchanged drug.  Thus, urinary excretion was not a major factor in XK469 elimination.  Variations in systemic exposure to XK469 will be strongly influenced by factors that alter the activity of aldehyde oxidase, including pharmacogenetics, enzyme inhibition, and enzyme induction, but no specific modifiers have been reported.  The multiday half-life of XK469 hampered our ability to obtain a complete mass balance, and the possibility exists that other routes, such as biliary excretion, may also play a substantial role in XK469 disposition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYlfZnoAoC4LVg90H21EOLACvtfcHk0ljX54t1g7z6PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFKksrs%253D&md5=803b71cb18ef3664a3e752f5993b3ef3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0962-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0962-3%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DL.%2BW.%26aulast%3DCollins%26aufirst%3DJ.%2BM.%26aulast%3DKlecker%26aufirst%3DR.%2BW.%26aulast%3DKatki%26aufirst%3DA.%2BG.%26aulast%3DParchment%26aufirst%3DR.%2BE.%26aulast%3DBoinpally%26aufirst%3DR.%2BR.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26aulast%3DIvy%26aufirst%3DS.%2BP.%26atitle%3DMetabolic%2520Profile%2520of%2520Xk469%2520%25282%2528R%2529-%255B4-%25287-Chloro-2-Quinoxalinyl%2529Oxyphenoxy%255D-Propionic%2520Acid%253B%2520Nsc698215%2529%2520in%2520Patients%2520and%2520in%2520Vitro%253A%2520Low%2520Potential%2520for%2520Active%2520or%2520Toxic%2520Metabolites%2520or%2520for%2520Drug-Drug%2520Interactions%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D56%26issue%3D4%26spage%3D351%26epage%3D357%26doi%3D10.1007%2Fs00280-004-0962-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acheampong, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usansky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harcourt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang-Liu, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of Brimonidine Metabolism with Rat, Rabbit, Dog, Monkey and Human Liver Fractions and Rabbit Liver Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1055</span>, <span class="refDoi"> DOI: 10.3109/00498259609167421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498259609167421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8905918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28Xmt12hsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=1035-1055&issue=10&author=A.+A.+Acheampongauthor=D.+S.+Chienauthor=S.+Lamauthor=S.+Vekichauthor=A.+Breauauthor=J.+Usanskyauthor=D.+Harcourtauthor=S.+A.+Munkauthor=H.+Nguyenauthor=M.+Garstauthor=D.+Tang-Liu&title=Characterization+of+Brimonidine+Metabolism+with+Rat%2C+Rabbit%2C+Dog%2C+Monkey+and+Human+Liver+Fractions+and+Rabbit+Liver+Aldehyde+Oxidase&doi=10.3109%2F00498259609167421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase</span></div><div class="casAuthors">Acheampong, A. A.; Chien, D. -S.; Lam, S.; Vekich, S.; Breau, A.; Usansky, J.; Harcourt, D.; Munk, S. A.; Nguyen, H.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1035-1055</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis</span>)
        </div><div class="casAbstract">The in vitro metab. of [14C]brimonidine by rat, rabbit, dog, monkey and human liver fractions was studied to assess any species differences.  In vitro metab. by rabbit liver aldehyde oxidase and human liver slices, and in vivo metab. in rats were also investigated.  The hepatic and urinary metabolites were characterized by liq. chromatog. and mass spectrometry.  Up to 7, 6, 11 and 14 metabolites were detected in rat liver S9 fraction, human liver S9 fraction, human liver slices and rat urine, resp.  Rabbit liver aldehyde oxidase catalyzed the metab. of brimonidine to 2-oxobrimonidine and 3-oxobrimonidine, and further oxidn. to 2,3-dioxobrimonidine.  Menadione inhibited the liver aldehyde oxidase-mediated oxidn.  Hepatic oxidn. of brimonidine to 2-oxobrimonidine, 3-oxobrimonidine, and 2,3-dioxobrimonidine was a major pathway in all the species studied, except the dog, whose prominent metabolites were 4',5'-dehydrobrimonidine and 5-bromo-6-guanidinoquinoxaline.  These results indicate extensive hepatic metab. of brimonidine and provide evidence for aldehyde oxidase involvement in brimonidine metab.  The species differences in hepatic brimonidine metab. are likely related to the low activity of dog liver aldehyde oxidase.  The principal metabolic pathways of brimonidine are α(N)-oxidn. to 2,3-dioxobrimonidine, and oxidative cleavage of the imidazoline ring to give 5-bromo-6-guanidinoquinoxaline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZf8_3eajv8bVg90H21EOLACvtfcHk0ljX54t1g7z6PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmt12hsro%253D&md5=2185d4cdae5aabc1bd9f221124350f72</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3109%2F00498259609167421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498259609167421%26sid%3Dliteratum%253Aachs%26aulast%3DAcheampong%26aufirst%3DA.%2BA.%26aulast%3DChien%26aufirst%3DD.%2BS.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DVekich%26aufirst%3DS.%26aulast%3DBreau%26aufirst%3DA.%26aulast%3DUsansky%26aufirst%3DJ.%26aulast%3DHarcourt%26aufirst%3DD.%26aulast%3DMunk%26aufirst%3DS.%2BA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DGarst%26aufirst%3DM.%26aulast%3DTang-Liu%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520Brimonidine%2520Metabolism%2520with%2520Rat%252C%2520Rabbit%252C%2520Dog%252C%2520Monkey%2520and%2520Human%2520Liver%2520Fractions%2520and%2520Rabbit%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D1996%26volume%3D26%26issue%3D10%26spage%3D1035%26epage%3D1055%26doi%3D10.3109%2F00498259609167421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knighton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walls, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Highly Potent Pi3k/Mtor Dual Inhibitor Pf-04979064 through Structure-Based Drug Design</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1021/ml300309h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300309h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Cksr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=91-97&issue=1&author=H.+Chengauthor=C.+Liauthor=S.+Baileyauthor=S.+M.+Baxiauthor=L.+Gouletauthor=L.+Guoauthor=J.+Hoffmanauthor=Y.+Jiangauthor=T.+O.+Johnsonauthor=T.+W.+Johnsonauthor=D.+R.+Knightonauthor=J.+Liauthor=K.+K.+Liuauthor=Z.+Liuauthor=M.+A.+Marxauthor=M.+Wallsauthor=P.+A.+Wellsauthor=M.+J.+Yinauthor=J.+Zhuauthor=M.+Zientek&title=Discovery+of+the+Highly+Potent+Pi3k%2FMtor+Dual+Inhibitor+Pf-04979064+through+Structure-Based+Drug+Design&doi=10.1021%2Fml300309h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design</span></div><div class="casAuthors">Cheng, Hengmiao; Li, Chunze; Bailey, Simon; Baxi, Sangita M.; Goulet, Lance; Guo, Lisa; Hoffman, Jacqui; Jiang, Ying; Johnson, Theodore Otto; Johnson, Ted W.; Knighton, Daniel R.; Li, John; Liu, Kevin K.-C.; Liu, Zhengyu; Marx, Matthew A.; Walls, Marlena; Wells, Peter A.; Yin, Min-Jean; Zhu, Jinjiang; Zientek, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-97</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PI3K, AKT, and mTOR are key kinases from PI3K signaling pathway being extensively pursued to treat a variety of cancers in oncol.  To search for a structurally differentiated back-up candidate to PF-04691502, which is currently in phase I/II clin. trials for treating solid tumors, a lead optimization effort was carried out with a tricyclic imidazo[1,5]naphthyridine series.  Integration of structure-based drug design and phys. properties-based optimization yielded a potent and selective PI3K/mTOR dual kinase inhibitor PF-04979064 (I).  This manuscript discusses the lead optimization for the tricyclic series, which both improved the in vitro potency and addressed a no. of ADMET issues including high metabolic clearance mediated by both P 450 and aldehyde oxidase (AO), poor permeability, and poor soly.  An empirical scaling tool was developed to predict human clearance from in vitro human liver S9 assay data for tricyclic derivs. that were AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQSJqL-ssP7Vg90H21EOLACvtfcHk0ljevXEFanK8cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Cksr7I&md5=0059c9c220419aad748b4fcde92c28bb</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fml300309h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300309h%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBaxi%26aufirst%3DS.%2BM.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DKnighton%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%2BK.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DWalls%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYin%26aufirst%3DM.%2BJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZientek%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520the%2520Highly%2520Potent%2520Pi3k%252FMtor%2520Dual%2520Inhibitor%2520Pf-04979064%2520through%2520Structure-Based%2520Drug%2520Design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D1%26spage%3D91%26epage%3D97%26doi%3D10.1021%2Fml300309h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">In Vitro-in Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.033555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.110.033555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=20444863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1322-1327&issue=8&author=M.+Zientekauthor=Y.+Jiangauthor=K.+Youdimauthor=R.+S.+Obach&title=In+Vitro-in+Vivo+Correlation+for+Intrinsic+Clearance+for+Drugs+Metabolized+by+Human+Aldehyde+Oxidase&doi=10.1124%2Fdmd.110.033555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase</span></div><div class="casAuthors">Zientek, Michael; Jiang, Ying; Youdim, Kuresh; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1322-1327</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability to predict in vivo clearance from in vitro intrinsic clearance for compds. metabolized by aldehyde oxidase has not been demonstrated.  To date, there is no established scaling method for predicting aldehyde oxidase-mediated clearance using in vitro or animal data.  This challenge is exacerbated by the fact that rats and dogs, two of the lab. animal species commonly used to develop in vitro-in vivo correlations of clearance, differ from humans with regard to expression of aldehyde oxidase.  The objective of this investigation was to develop an in vitro-in vivo correlation of intrinsic clearance for aldehyde oxidase, using 11 drugs known to be metabolized by this enzyme.  The set consisted of methotrexate, XK-469, (±-4-(4-cyanoanilino)-5,6-dihydro-7-hydroxy-7H-cyclopenta[d]pyrimidine (RS-8359), zaleplon, 6-deoxypenciclovir, zoniporide, O6-benzylguanine, N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA), carbazeran, PF-4217903, and PF-945863.  These compds. were assayed using two in vitro systems (pooled human liver cytosol and liver S-9 fractions) to calc. scaled unbound intrinsic clearance, and they were then compared with calcd. in vivo unbound intrinsic clearance.  The investigation provided a relative scale that can be used for in vitro-in vivo correlation of aldehyde oxidase clearance and suggests limits as to when a potential new drug candidate that is metabolized by this enzyme will possess acceptable human clearance, or when structural modification is required to reduce aldehyde oxidase catalyzed metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFkx3d5zxrd7Vg90H21EOLACvtfcHk0ljevXEFanK8cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjJ&md5=296ee366707d82b416e70eb8161f923b</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033555%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DIn%2520Vitro-in%2520Vivo%2520Correlation%2520for%2520Intrinsic%2520Clearance%2520for%2520Drugs%2520Metabolized%2520by%2520Human%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D8%26spage%3D1322%26epage%3D1327%26doi%3D10.1124%2Fdmd.110.033555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanigan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sejberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bihan, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span> <span> </span><span class="NLM_article-title">Pyrido[3,4-D]Pyrimidin-4(3h)-One Metabolism Mediated by Aldehyde Oxidase Is Blocked by C2-Substitution</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1080/00498254.2016.1230245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498254.2016.1230245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27618572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCntb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=771-777&issue=9&author=A.+Hayesauthor=N.+Y.+Mokauthor=M.+Liuauthor=C.+Thaiauthor=A.+T.+Henleyauthor=B.+Atrashauthor=R.+M.+Laniganauthor=J.+Sejbergauthor=Y.+V.+Le+Bihanauthor=V.+Bavetsiasauthor=J.+Blaggauthor=F.+I.+Raynaud&title=Pyrido%5B3%2C4-D%5DPyrimidin-4%283h%29-One+Metabolism+Mediated+by+Aldehyde+Oxidase+Is+Blocked+by+C2-Substitution&doi=10.1080%2F00498254.2016.1230245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by aldehyde oxidase is blocked by C2-substitution</span></div><div class="casAuthors">Hayes, Angela; Mok, N. Yi; Liu, Manjuan; Thai, Ching; Henley, Alan T.; Atrash, Butrus; Lanigan, Rachel M.; Sejberg, Jemmy; Le Bihan, Yann-Vai; Bavetsias, Vassilios; Blagg, Julian; Raynaud, Florence I.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">771-777</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">We have previously described C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-one derivs. as cell permeable inhibitors of the KDM4 and KDM5 subfamilies of JmjC histone lysine demethylases.  Although exemplar compd. exhibited moderate clearance in mouse liver microsomes, it was highly cleared in vivo due to metab. by aldehyde oxidase (AO).  Similar human and mouse AO-mediated metab. was obsd. with the pyrido[3,4-d]pyrimidin-4(3H)-one scaffold and other C8-substituted derivs.  We identified the C2-position as the oxidn. site by LC-MS and 1H-NMR and showed that C2-substituted derivs. are no longer AO substrates.  In addn. to the exptl. data, these observations are supported by mol. modeling studies in the human AO protein crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpSd3R2GorubVg90H21EOLACvtfcHk0ljWF0tN2K_9tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCntb3J&md5=0a06863e46be75e1d0353641054d2687</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1080%2F00498254.2016.1230245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2016.1230245%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DMok%26aufirst%3DN.%2BY.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DThai%26aufirst%3DC.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DLanigan%26aufirst%3DR.%2BM.%26aulast%3DSejberg%26aufirst%3DJ.%26aulast%3DLe%2BBihan%26aufirst%3DY.%2BV.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26atitle%3DPyrido%255B3%252C4-D%255DPyrimidin-4%25283h%2529-One%2520Metabolism%2520Mediated%2520by%2520Aldehyde%2520Oxidase%2520Is%2520Blocked%2520by%2520C2-Substitution%26jtitle%3DXenobiotica%26date%3D2017%26volume%3D47%26issue%3D9%26spage%3D771%26epage%3D777%26doi%3D10.1080%2F00498254.2016.1230245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choughule, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Interspecies Differences in the Metabolism of Methotrexate: An Insight into the Active Site Differences between Human and Rabbit Aldehyde Oxidase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2015.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2015.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26032640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=288-295&issue=3&author=K.+V.+Choughuleauthor=C.+A.+Joswig-Jonesauthor=J.+P.+Jones&title=Interspecies+Differences+in+the+Metabolism+of+Methotrexate%3A+An+Insight+into+the+Active+Site+Differences+between+Human+and+Rabbit+Aldehyde+Oxidase&doi=10.1016%2Fj.bcp.2015.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase</span></div><div class="casAuthors">Choughule, Kanika V.; Joswig-Jones, Carolyn A.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">288-295</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several drug compds. have failed in clin. trials due to extensive biotransformation by aldehyde oxidase (AOX) (EC 1.2.3.1).  One of the main reasons is the difficulty in scaling clearance for drugs metabolized by AOX, from preclin. species to human.  Using methotrexate as a probe substrate, we evaluated AOX metab. in liver cytosol from human and commonly used lab. species such as guinea pig, monkey, rat and rabbit.  We found that the metab. of methotrexate in rabbit liver cytosol was several orders of magnitude higher than any of the other species tested.  The results of protein quantitation revealed that the amt. of AOX1 in human liver was similar to rabbit liver.  To understand if the obsd. differences in activity were due to structural differences, we modelled rabbit AOX1 using the previously generated human AOX1 homol. model.  Mol. docking of methotrexate into the active site of the enzyme led to the identification of important residues that could potentially be involved in substrate binding and account for the obsd. differences.  In order to study the impact of these residue changes on enzyme activity, we used site directed mutagenesis to construct mutant AOX1 cDNAs by substituting nucleotides of human AOX1 with relevant ones of rabbit AOX1.  AOX1 mutant proteins were expressed in Escherichia coli.  Differences in the kinetic properties of these mutants have been presented in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnFnLMbgAZrVg90H21EOLACvtfcHk0ljWF0tN2K_9tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOktr0%253D&md5=2d6c39da8eb19c0a09dcc2076410b63c</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DChoughule%26aufirst%3DK.%2BV.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DInterspecies%2520Differences%2520in%2520the%2520Metabolism%2520of%2520Methotrexate%253A%2520An%2520Insight%2520into%2520the%2520Active%2520Site%2520Differences%2520between%2520Human%2520and%2520Rabbit%2520Aldehyde%2520Oxidase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D96%26issue%3D3%26spage%3D288%26epage%3D295%26doi%3D10.1016%2Fj.bcp.2015.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laljee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase-Catalysed Oxidation of Methotrexate in the Liver of Guinea-Pig, Rabbit and Man</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1211/0022357991772619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1211%2F0022357991772619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10385213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXjsVOlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=411-418&issue=4&author=C.+G.+Jordanauthor=M.+R.+Rashidiauthor=H.+Laljeeauthor=S.+E.+Clarkeauthor=J.+E.+Brownauthor=C.+Beedham&title=Aldehyde+Oxidase-Catalysed+Oxidation+of+Methotrexate+in+the+Liver+of+Guinea-Pig%2C+Rabbit+and+Man&doi=10.1211%2F0022357991772619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase-catalyzed oxidation of methotrexate in the liver of guinea pig, rabbit and man</span></div><div class="casAuthors">Jordan, C. Geraldine M.; Rashidi, Mohammed R.; Laljee, Hussain; Clarke, Stephen E.; Brown, John E.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-418</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">Although 7-hydroxymethotrexate is a major metabolite of methotrexate during high-dose therapy, negligible methotrexate-oxidizing activity has been found in-vitro in the liver in man.  The goals of this study were to det. the role of aldehyde oxidase in the metab. of methotrexate to 7-hydroxymethotrexate in the liver and to study the effects of inhibitors and other substrates on the metab. of methotrexate.  Methotrexate, (±)-methotrexate and (-)-methotrexate were incubated with partially purified aldehyde oxidase from the liver of rabbit, guinea-pig and man and the products analyzed by HPLC.  Rabbit liver aldehyde oxidase was used for purposes of comparison.  In-vitro aldehyde oxidase from the liver of man catalyzes the oxidn. of methotrexate to 7-hydroxymethotrexate, but the turnover is low.  However, formation of 7-hydroxymethotrexate from all forms of methotrexate by the liver in guinea-pig and man was significantly inhibited in the presence of 100 μM menadione and chlorpromazine, potent inhibitors of aldehyde oxidase.  Allopurinol (100 μM) had a negligible inhibitory effect on liver aldehyde oxidase from guinea-pig and man.  Allopurinol is a xanthine oxidase inhibitor.  The prodn. of 7-hydroxymethotrexate was enhanced in the presence of allopurinol.  Although aldehyde oxidase is also responsible for some of this conversion, it is also possible that the closely related xanthine oxidase is responsible for the formation of 7-hydroxymethotrexate.  By employing potent selective inhibitors of aldehyde oxidase, menadione and chlorpromazine, we have demonstrated for the first time that liver aldehyde oxidase from man is minimally involved in methotrexate oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC0SziaiQX67Vg90H21EOLACvtfcHk0ljWF0tN2K_9tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsVOlt78%253D&md5=7541b8594155ae83b4407177055f255a</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1211%2F0022357991772619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357991772619%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DC.%2BG.%26aulast%3DRashidi%26aufirst%3DM.%2BR.%26aulast%3DLaljee%26aufirst%3DH.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26aulast%3DBrown%26aufirst%3DJ.%2BE.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DAldehyde%2520Oxidase-Catalysed%2520Oxidation%2520of%2520Methotrexate%2520in%2520the%2520Liver%2520of%2520Guinea-Pig%252C%2520Rabbit%2520and%2520Man%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1999%26volume%3D51%26issue%3D4%26spage%3D411%26epage%3D418%26doi%3D10.1211%2F0022357991772619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, E. J.</span></span> <span> </span><span class="NLM_article-title">Role of Aldehyde Oxidase in the Hepatic in Vitro Metabolism of 3-Methylindole in Pigs</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1021/jf990805u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf990805u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVWjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=833-837&issue=3&author=G.+J.+Diazauthor=E.+J.+Squires&title=Role+of+Aldehyde+Oxidase+in+the+Hepatic+in+Vitro+Metabolism+of+3-Methylindole+in+Pigs&doi=10.1021%2Fjf990805u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Aldehyde Oxidase in the Hepatic in Vitro Metabolism of 3-Methylindole in Pigs</span></div><div class="casAuthors">Diaz, Gonzalo J.; Squires, E. James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">833-837</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metab. of 3-hydroxy-3-methylindolenine (HMI), a recently discovered metabolite of 3-methylindole (3MI, skatole) produced by porcine liver microsomes, was investigated in vitro using porcine liver cytosol.  HMI was rapidly metabolized to a single product, 3-hydroxy-3-methyloxindole (HMOI), by porcine cytosol.  By the use of the selective inhibitors menadione and quinacrine, it was shown that the enzyme responsible for the oxidn. of HMI into HMOI was aldehyde oxidase (AO; aldehyde:oxygen oxidoreductase, EC 1.2.3.1).  The activity of AO in the conversion of HMI to HMOI was measured in a population of pigs (n = 30) with a wide range of 3MI levels in back fat (0.07-0.30 mg/kg).  AO activity was found to be neg. correlated (r = -0.70; P < 0.001) with the level of 3MI in fat.  The results of the present study suggest that AO plays an important role in the metab. of 3MI in the pig and that its catalytic activity is related to an adequate 3MI clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJEVr91Lr387Vg90H21EOLACvtfcHk0lgR9Mi3jZZjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVWjtrY%253D&md5=d6978ef1e3ed62e65419a760fa51d167</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjf990805u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf990805u%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DSquires%26aufirst%3DE.%2BJ.%26atitle%3DRole%2520of%2520Aldehyde%2520Oxidase%2520in%2520the%2520Hepatic%2520in%2520Vitro%2520Metabolism%2520of%25203-Methylindole%2520in%2520Pigs%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2000%26volume%3D48%26issue%3D3%26spage%3D833%26epage%3D837%26doi%3D10.1021%2Fjf990805u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, P.</span></span> <span> </span><span class="NLM_article-title">Effect of Structural Variation on Aldehyde Oxidase-Catalyzed Oxidation of Zoniporide</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1575</span>– <span class="NLM_lpage">1587</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.045823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.045823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22587988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2iurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1575-1587&issue=8&author=D.+Dalvieauthor=H.+Sunauthor=C.+Xiangauthor=Q.+Huauthor=Y.+Jiangauthor=P.+Kang&title=Effect+of+Structural+Variation+on+Aldehyde+Oxidase-Catalyzed+Oxidation+of+Zoniporide&doi=10.1124%2Fdmd.112.045823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide</span></div><div class="casAuthors">Dalvie, Deepak; Sun, Hao; Xiang, Cathie; Hu, Qiyue; Jiang, Ying; Kang, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1575-1587</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Current studies explored the effect of structural changes on the aldehyde oxidase (AO)-mediated metab. of zoniporide (1).  Zoniporide analogs with modifications of the acylguanidine moiety, the cyclopropyl group on the pyrazole ring, and the quinoline ring were studied for their AO-catalyzed metab. using the human S9 fraction.  Anal. of the half-lives suggested that subtle changes in the structure of 1 influenced its metab. and that the guanidine and the quinoline moieties were prerequisites for AO-catalyzed oxidn. to 2-oxozoniporide (M1).  In contrast, replacement of the cyclopropyl group with other alkyl groups was tolerated.  The effect of structural variation on AO properties was rationalized by docking 1 and its analogs into the human AO homol. model.  These studies indicated the importance of electrostatic, π-π stacking and hydrophobic interactions of the three motifs with residues in the active site.  Differences in substrate properties were also rationalized by comparing their half-lives with cLogD, electrophilicity parameters [electrostatic potential (ESP) charges and energy of lowest unoccupied MOs (ELUMO)], and the energies of formation of tetrahedral intermediates.  Whereas the success of energetics in predicting the AO substrate properties of analogs was 87%, the predictive ability of other descriptors was none (cLogD) to 60% (ESP charges and ELUMO).  Overall, the structure-metab. relationship could be rationalized using a combination of both the energy calcns. and docking studies.  This combination method can be incorporated into a strategy for mitigating AO liabilities obsd. in the lead candidate or studying structure-metab. relationships of other AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCkVhA55F__bVg90H21EOLACvtfcHk0lgR9Mi3jZZjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2iurbK&md5=b3ec4f1916d516092e72156dd63304a5</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.045823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.045823%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DP.%26atitle%3DEffect%2520of%2520Structural%2520Variation%2520on%2520Aldehyde%2520Oxidase-Catalyzed%2520Oxidation%2520of%2520Zoniporide%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D8%26spage%3D1575%26epage%3D1587%26doi%3D10.1124%2Fdmd.112.045823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bandarage, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledeboer, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrn, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nti Addae, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memmott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span> <span> </span><span class="NLM_article-title">Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00487</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00487" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1KmtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=261-265&issue=2&author=U.+K.+Bandarageauthor=M.+P.+Clarkauthor=E.+Perolaauthor=H.+Gaoauthor=M.+D.+Jacobsauthor=A.+Tsaiauthor=J.+Gillespieauthor=J.+M.+Kennedyauthor=F.+Maltaisauthor=M.+W.+Ledeboerauthor=I.+Daviesauthor=W.+Guauthor=R.+A.+Byrnauthor=K.+Nti+Addaeauthor=H.+Bennettauthor=J.+R.+Leemanauthor=S.+M.+Jonesauthor=C.+O%E2%80%99Brienauthor=C.+Memmottauthor=Y.+Bennaniauthor=P.+S.+Charifson&title=Novel+2-Substituted+7-Azaindole+and+7-Azaindazole+Analogues+as+Potential+Antiviral+Agents+for+the+Treatment+of+Influenza&doi=10.1021%2Facsmedchemlett.6b00487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza</span></div><div class="casAuthors">Bandarage, Upul K.; Clark, Michael P.; Perola, Emanuele; Gao, Huai; Jacobs, Marc D.; Tsai, Alice; Gillespie, Jeffery; Kennedy, Joseph M.; Maltais, Francois; Ledeboer, Mark W.; Davies, Ioana; Gu, Wenxin; Byrn, Randal A.; Nti Addae, Kwame; Bennett, Hamilton; Leeman, Joshua R.; Jones, Steven M.; O'Brien, Colleen; Memmott, Christine; Bennani, Youssef; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-265</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">JNJ-63623872 (2) is a first-in-class, orally bioavailable compd. that offers significant potential for the treatment of pandemic and seasonal influenza.  Early lead optimization efforts in our 7-azaindole series focused on 1,3-diaminocyclohexyl amide and urea substitutions on the pyrimidine-7-azaindole motif.  In this work, we explored two strategies to eliminate obsd. aldehyde oxidase (AO)-mediated metab. at the 2-position of these 7-azaindole analogs.  Substitution at the 2-position of the azaindole ring generated somewhat less potent analogs, but reduced AO-mediated metab.  Incorporation of a ring nitrogen generated 7-azaindazole analogs that were equipotent to the parent 2-H-7-azaindole, but surprisingly, did not appear to improve AO-mediated metab.  Overall, we identified multiple 2-substituted 7-azaindole analogs with enhanced AO stability and we present data for one such compd. (12) that demonstrate a favorable oral pharmacokinetic profile in rodents.  These analogs have the potential to be further developed as anti-influenza agents for the treatment of influenza.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp21HItUy6aabVg90H21EOLACvtfcHk0lgR9Mi3jZZjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1KmtL4%253D&md5=8ada3c238e2932e95b938ecced26d8f1</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00487%26sid%3Dliteratum%253Aachs%26aulast%3DBandarage%26aufirst%3DU.%2BK.%26aulast%3DClark%26aufirst%3DM.%2BP.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DTsai%26aufirst%3DA.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DJ.%2BM.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DLedeboer%26aufirst%3DM.%2BW.%26aulast%3DDavies%26aufirst%3DI.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DNti%2BAddae%26aufirst%3DK.%26aulast%3DBennett%26aufirst%3DH.%26aulast%3DLeeman%26aufirst%3DJ.%2BR.%26aulast%3DJones%26aufirst%3DS.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%26aulast%3DMemmott%26aufirst%3DC.%26aulast%3DBennani%26aufirst%3DY.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DNovel%25202-Substituted%25207-Azaindole%2520and%25207-Azaindazole%2520Analogues%2520as%2520Potential%2520Antiviral%2520Agents%2520for%2520the%2520Treatment%2520of%2520Influenza%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D261%26epage%3D265%26doi%3D10.1021%2Facsmedchemlett.6b00487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chopko, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregro, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engers, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poslusney, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamsal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnetz-Boutaud, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stec, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandon, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B. J.</span></span> <span> </span><span class="NLM_article-title">Sar Inspired by Aldehyde Oxidase (Ao) Metabolism: Discovery of Novel, Cns Penetrant Tricyclic M4 Pams</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2019.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=31248774" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=T.+C.+Chopkoauthor=C.+Hanauthor=A.+R.+Gregroauthor=D.+W.+Engersauthor=A.+S.+Feltsauthor=M.+S.+Poslusneyauthor=K.+A.+Bollingerauthor=R.+D.+Morrisonauthor=M.+Bubserauthor=A.+Lamsalauthor=V.+B.+Luscombeauthor=H.+P.+Choauthor=N.+C.+Schnetz-Boutaudauthor=A.+L.+Rodriguezauthor=S.+Changauthor=J.+S.+Danielsauthor=D.+F.+Stecauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=M.+R.+Woodauthor=M.+W.+Woodauthor=M.+E.+Dugganauthor=N.+J.+Brandonauthor=P.+J.+Connauthor=T.+M.+Bridgesauthor=C.+W.+Lindsleyauthor=B.+J.+Melancon&title=Sar+Inspired+by+Aldehyde+Oxidase+%28Ao%29+Metabolism%3A+Discovery+of+Novel%2C+Cns+Penetrant+Tricyclic+M4+Pams&doi=10.1016%2Fj.bmcl.2019.06.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DChopko%26aufirst%3DT.%2BC.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DGregro%26aufirst%3DA.%2BR.%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DPoslusney%26aufirst%3DM.%2BS.%26aulast%3DBollinger%26aufirst%3DK.%2BA.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DLamsal%26aufirst%3DA.%26aulast%3DLuscombe%26aufirst%3DV.%2BB.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DSchnetz-Boutaud%26aufirst%3DN.%2BC.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DStec%26aufirst%3DD.%2BF.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BW.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26atitle%3DSar%2520Inspired%2520by%2520Aldehyde%2520Oxidase%2520%2528Ao%2529%2520Metabolism%253A%2520Discovery%2520of%2520Novel%252C%2520Cns%2520Penetrant%2520Tricyclic%2520M4%2520Pams%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26doi%3D10.1016%2Fj.bmcl.2019.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span> <span> </span><span class="NLM_article-title">Systematic Structure Modifications of Imidazo[1,2-a]Pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (Ao)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7705</span>– <span class="NLM_lpage">7712</span>, <span class="refDoi"> DOI: 10.1021/jm2010942</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010942" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ynu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7705-7712&issue=21&author=A.+Lintonauthor=P.+Kangauthor=M.+Ornelasauthor=S.+Kephartauthor=Q.+Huauthor=M.+Pairishauthor=Y.+Jiangauthor=C.+Guo&title=Systematic+Structure+Modifications+of+Imidazo%5B1%2C2-a%5DPyrimidine+to+Reduce+Metabolism+Mediated+by+Aldehyde+Oxidase+%28Ao%29&doi=10.1021%2Fjm2010942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Structure Modifications of Imidazo[1,2-a]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO)</span></div><div class="casAuthors">Linton, Angelica; Kang, Ping; Ornelas, Martha; Kephart, Susan; Hu, Qiyue; Pairish, Mason; Jiang, Ying; Guo, Chuangxing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7705-7712</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-{trans-3-[(5-Cyano-6-methylpyridin-2-yl)oxy]-2,2,4,4-tetramethylcyclobutyl}imidazo[1,2-a]pyrimidine-3-carboxamide (I) was recently identified as a full antagonist of the androgen receptor, demonstrating excellent in vivo tumor growth inhibition in castration-resistant prostate cancer (CRPC).  However, the imidazo[1,2-a]pyrimidine moiety is rapidly metabolized by aldehyde oxidase (AO).  The present paper describes a no. of medicinal chem. strategies taken to avoid the AO-mediated oxidn. of this particular system.  Guided by an AO protein structure-based model, the investigation revealed the most probable site of AO oxidn. and the observation that altering the heterocycle or blocking the reactive site are two of the more effective strategies for reducing AO metab.  These strategies may be useful for other drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQMDVJxz6g_bVg90H21EOLACvtfcHk0lgwhuOZw9ETcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ynu7bL&md5=b6da895d38c71f90eb4f83716f1060f0</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm2010942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010942%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DSystematic%2520Structure%2520Modifications%2520of%2520Imidazo%255B1%252C2-a%255DPyrimidine%2520to%2520Reduce%2520Metabolism%2520Mediated%2520by%2520Aldehyde%2520Oxidase%2520%2528Ao%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D21%26spage%3D7705%26epage%3D7712%26doi%3D10.1021%2Fjm2010942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekeres, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott-Stevens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macleod, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, B.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase and Its Contribution to the Metabolism of a Structurally Novel, Functionally Selective Gabaa Alpha5-Subtype Inverse Agonist</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1080/00498250600567903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498250600567903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16684711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVGnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=315-330&issue=4&author=D.+O%E2%80%99Connorauthor=P.+Jonesauthor=M.+S.+Chambersauthor=R.+Maxeyauthor=H.+J.+Szekeresauthor=N.+Szetoauthor=P.+Scott-Stevensauthor=A.+M.+Macleodauthor=M.+Braunauthor=B.+Cato&title=Aldehyde+Oxidase+and+Its+Contribution+to+the+Metabolism+of+a+Structurally+Novel%2C+Functionally+Selective+Gabaa+Alpha5-Subtype+Inverse+Agonist&doi=10.1080%2F00498250600567903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase and its contribution to the metabolism of a structurally novel, functionally selective GABAA α5-subtype inverse agonist</span></div><div class="casAuthors">O'Connor, D.; Jones, P.; Chambers, M. S.; Maxey, R.; Szekeres, H. J.; Szeto, N.; Scott-Stevens, P.; Macleod, A. M.; Braun, M.; Cato, B.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">315-330</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Compd. (I) was recently identified as a functionally selective, inverse agonist at the benzodiazepine site of GABAA α5-contg. receptors, which enhances performance in animal models of cognition.  The routes of metab. of I in rat, dog, rhesus monkey and human in vitro systems, and in vivo in rat, dog and rhesus monkey have been characterized.  The current study demonstrates that both a cytosolic oxidative reaction and cytochrome P 450 play important roles in the metab. of I.  Chem. inhibition studies showed the oxidn. in human cytosol to be catalyzed predominantly by aldehyde oxidase rather than the related enzyme, xanthine oxidase.  The aldehyde oxidase-mediated metabolites were present in vitro and in vivo in both rat and rhesus monkey, and also in vitro in man.  They were absent both in vitro and in vivo in dog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgcCJQg0f0hrVg90H21EOLACvtfcHk0lgwhuOZw9ETcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVGnu7c%253D&md5=273b3ad51a76a8ff473d1b9fffa69b65</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1080%2F00498250600567903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250600567903%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DChambers%26aufirst%3DM.%2BS.%26aulast%3DMaxey%26aufirst%3DR.%26aulast%3DSzekeres%26aufirst%3DH.%2BJ.%26aulast%3DSzeto%26aufirst%3DN.%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DMacleod%26aufirst%3DA.%2BM.%26aulast%3DBraun%26aufirst%3DM.%26aulast%3DCato%26aufirst%3DB.%26atitle%3DAldehyde%2520Oxidase%2520and%2520Its%2520Contribution%2520to%2520the%2520Metabolism%2520of%2520a%2520Structurally%2520Novel%252C%2520Functionally%2520Selective%2520Gabaa%2520Alpha5-Subtype%2520Inverse%2520Agonist%26jtitle%3DXenobiotica%26date%3D2006%26volume%3D36%26issue%3D4%26spage%3D315%26epage%3D330%26doi%3D10.1080%2F00498250600567903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekeres, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wafford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLeod, A. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and Metabolism Studies on (3-Tert-Butyl-7-(5-Methylisoxazol-3-Yl)-2-(1-Methyl-1h-1,2,4-Triazol-5-Ylmethoxy) Pyrazolo[1,5-D][1,2,4]Triazine, a Functionally Selective Gaba(a) Alpha5 Inverse Agonist for Cognitive Dysfunction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">872</span>– <span class="NLM_lpage">875</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2005.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16303300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1Gkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=872-875&issue=4&author=P.+Jonesauthor=J.+R.+Atackauthor=M.+P.+Braunauthor=B.+P.+Catoauthor=M.+S.+Chambersauthor=D.+O%E2%80%99Connorauthor=S.+M.+Cookauthor=S.+C.+Hobbsauthor=R.+Maxeyauthor=H.+J.+Szekeresauthor=N.+Szetoauthor=K.+A.+Waffordauthor=A.+M.+MacLeod&title=Pharmacokinetics+and+Metabolism+Studies+on+%283-Tert-Butyl-7-%285-Methylisoxazol-3-Yl%29-2-%281-Methyl-1h-1%2C2%2C4-Triazol-5-Ylmethoxy%29+Pyrazolo%5B1%2C5-D%5D%5B1%2C2%2C4%5DTriazine%2C+a+Functionally+Selective+Gaba%28a%29+Alpha5+Inverse+Agonist+for+Cognitive+Dysfunction&doi=10.1016%2Fj.bmcl.2005.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)pyrazolo[1,5-d][1,2,4]triazine), a functionally selective GABAA α5 inverse agonist for cognitive dysfunction</span></div><div class="casAuthors">Jones, Philip; Atack, John R.; Braun, Matthew P.; Cato, Brian P.; Chambers, Mark S.; O'Connor, Desmond; Cook, Susan M.; Hobbs, Sarah C.; Maxey, Robert; Szekeres, Helen J.; Szeto, Nicola; Wafford, Keith A.; MacLeod, Angus M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">872-875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">3-Tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)pyrazolo[1,5-d][1,2,4]triazine (1) was recently identified as a functionally selective, inverse agonist at the benzodiazepine site of GABAA α5 receptors and enhances performance in animal models of cognition.  The routes of metab. of this compd. in vivo in rat have been well characterized, the identities of the major metabolites are confirmed by synthesis and their biol. profiles were evaluated.  An unusual oxidn. of the pyrazolo[1,5-d][1,2,4]triazine core to the corresponding pyrazolo[1,5-d][1,2,4]triazin-4(5H)-one scaffold by aldehyde oxidase has been obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3Kn6ffipmLVg90H21EOLACvtfcHk0ljWWIRiJuRgvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1Gkuw%253D%253D&md5=7b78b6895ef7b3c494fbea1fda5fdee0</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DBraun%26aufirst%3DM.%2BP.%26aulast%3DCato%26aufirst%3DB.%2BP.%26aulast%3DChambers%26aufirst%3DM.%2BS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%26aulast%3DCook%26aufirst%3DS.%2BM.%26aulast%3DHobbs%26aufirst%3DS.%2BC.%26aulast%3DMaxey%26aufirst%3DR.%26aulast%3DSzekeres%26aufirst%3DH.%2BJ.%26aulast%3DSzeto%26aufirst%3DN.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DMacLeod%26aufirst%3DA.%2BM.%26atitle%3DPharmacokinetics%2520and%2520Metabolism%2520Studies%2520on%2520%25283-Tert-Butyl-7-%25285-Methylisoxazol-3-Yl%2529-2-%25281-Methyl-1h-1%252C2%252C4-Triazol-5-Ylmethoxy%2529%2520Pyrazolo%255B1%252C5-D%255D%255B1%252C2%252C4%255DTriazine%252C%2520a%2520Functionally%2520Selective%2520Gaba%2528a%2529%2520Alpha5%2520Inverse%2520Agonist%2520for%2520Cognitive%2520Dysfunction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D4%26spage%3D872%26epage%3D875%26doi%3D10.1016%2Fj.bmcl.2005.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. Y. J.</span></span> <span> </span><span class="NLM_article-title">In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for C-Met Inhibitor Met401</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1007/s13318-019-00557-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs13318-019-00557-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=J.+W.+Zhangauthor=H.+B.+Dengauthor=C.+Y.+Zhangauthor=J.+Q.+Daiauthor=Q.+Liauthor=Q.+G.+Zhengauthor=H.+X.+Wanauthor=H.+P.+Yuauthor=F.+Heauthor=Y.+C.+Xuauthor=S.+Zhaoauthor=J.+Y.+J.+Zhang&title=In+Vitro+Metabolism+by+Aldehyde+Oxidase+Leads+to+Poor+Pharmacokinetic+Profile+in+Rats+for+C-Met+Inhibitor+Met401&doi=10.1007%2Fs13318-019-00557-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1007%2Fs13318-019-00557-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-019-00557-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BW.%26aulast%3DDeng%26aufirst%3DH.%2BB.%26aulast%3DZhang%26aufirst%3DC.%2BY.%26aulast%3DDai%26aufirst%3DJ.%2BQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DQ.%2BG.%26aulast%3DWan%26aufirst%3DH.%2BX.%26aulast%3DYu%26aufirst%3DH.%2BP.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%2BC.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%2BJ.%26atitle%3DIn%2520Vitro%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%2520Leads%2520to%2520Poor%2520Pharmacokinetic%2520Profile%2520in%2520Rats%2520for%2520C-Met%2520Inhibitor%2520Met401%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2019%26doi%3D10.1007%2Fs13318-019-00557-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanoue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uramaru, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span> <span> </span><span class="NLM_article-title">Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.2174/1872312810666161227145358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.2174%2F1872312810666161227145358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28029084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FpvFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=278-285&issue=4&author=C.+Tanoueauthor=K.+Sugiharaauthor=Y.+Tayamaauthor=N.+Uramaruauthor=Y.+Watanabeauthor=S.+Ohtaauthor=S.+Kitamura&title=Variability+of+Zaleplon+5-Oxidase+Activity+in+Mice+and+Humans%2C+and+Inhibition+by+Raloxifene&doi=10.2174%2F1872312810666161227145358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene</span></div><div class="casAuthors">Tanoue Chiaki; Ohta Shigeru; Sugihara Kazumi; Tayama Yoshitaka; Uramaru Naoto; Watanabe Yoko; Kitamura Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Drug metabolism letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">278-285</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Zaleplon (ZAL) is a sedative-hypnotic agent, which is mainly metabolized to inactive 5-oxidized zaleplon (5-oxo-ZAL) and N-des-ethylated ZAL (des-ethyl-ZAL) in mice and humans.  The former reaction is considered to be catalyzed by aldehyde oxidase present in liver cytosol.  METHODS:  Here, we examined sex and strain differences of ZAL metabolism to 5-oxo-ZAL among four strains of mice, as well as the inter-individual variation in humans, in order to evaluate the variability of 5-oxo-ZAL-forming activity and its relationship with aldehyde oxidase activity.  In mice, the activity in C57BL/6J strain was the highest, followed by C3H/He and BALB/c.  The activity in DBA/2J was the lowest, being 2.3-fold lower than that of C57BL/6J mice.  The activity of male mice was higher than that of female mice.  Large inter-individual variations were observed among humans, with a range of 10- fold.  Raloxifene, an inhibitor of aldehyde oxidase, markedly decreased the formation of 5-oxo-ZAL by liver cytosol of mice and humans.  Further, the plasma level of 5-oxo-ZAL in mice was decreased when raloxifene was co-administered with ZAL.  RESULTS:  Our results indicate that the formation of 5-oxo-ZAL from ZAL is mainly catalyzed by aldehyde oxidase in mice and humans, and the variability of 5-oxo-ZAL formation is due primarily to differences of aldehyde oxidase activity.  CONCLUSION:  High inter-individual variability of ZAL 5-oxidase activity and potential for interaction of ZAL with other medicines that are inhibitors of aldehyde oxidase should be taken into consideration in clinical usage of ZAL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCBScGEmrCpIvKgEt20y1XfW6udTcc2ebX9PixCzpmDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FpvFWhuw%253D%253D&md5=3b7cdc7b7e66a9cd11e761e94fdf81da</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.2174%2F1872312810666161227145358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1872312810666161227145358%26sid%3Dliteratum%253Aachs%26aulast%3DTanoue%26aufirst%3DC.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DTayama%26aufirst%3DY.%26aulast%3DUramaru%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DKitamura%26aufirst%3DS.%26atitle%3DVariability%2520of%2520Zaleplon%25205-Oxidase%2520Activity%2520in%2520Mice%2520and%2520Humans%252C%2520and%2520Inhibition%2520by%2520Raloxifene%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2017%26volume%3D10%26issue%3D4%26spage%3D278%26epage%3D285%26doi%3D10.2174%2F1872312810666161227145358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lake, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renwick, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatina, J. A.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Zaleplon by Human Liver: Evidence for Involvement of Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1080/00498250210158915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498250210158915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=12419014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFCktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=835-847&issue=10&author=B.+G.+Lakeauthor=S.+E.+Ballauthor=J.+Kaoauthor=A.+B.+Renwickauthor=R.+J.+Priceauthor=J.+A.+Scatina&title=Metabolism+of+Zaleplon+by+Human+Liver%3A+Evidence+for+Involvement+of+Aldehyde+Oxidase&doi=10.1080%2F00498250210158915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase</span></div><div class="casAuthors">Lake, B. G.; Ball, S. E.; Kao, J.; Renwick, A. B.; Price, R. J.; Scatina, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">835-847</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. The metab. of Zaleplon (CL-284,846; ZAL) was studied in precision-cut human liver slices and liver cytosol prepns.  2. Human liver slices metabolized ZAL to a no. of products including 5-oxo-ZAL (M2), N-desethyl-5-oxo-ZAL (M1), and N-desethyl-ZAL (DZAL), the latter metabolite being known to be formed by CYP3A forms.  3. Human liver cytosol prepns. catalyzed the metab. of ZAL to M2.  Kinetic anal. of 3 cytosol prepns. revealed mean Km and Vmax of 93 mm and 317 pmol/min/mg protein, resp.  4. Using 16 individual human liver cytosol prepns. a 33-fold variability in the metab. of 80 μM ZAL to M2 was obsd.  Correlations were obsd. between M2 formation and the metab. of the aldehyde oxidase substrates phenanthridine (r2 = 0.774) and phthalazine (r2 = 0.460).  5. The metab. of 80 μM ZAL to M2 in liver cytosol prepns. was markedly inhibited by the aldehyde oxidase inhibitors chlorpromazine, promethazine, hydralazine, and menadione.  Addnl. kinetic anal. suggested that chlorpromazine and promethazine were non-competitive inhibitors of M2 formation with Ki of 2.3 and 1.9 μM, resp.  ZAL metab. to M2 was also inhibited by cimetidine.  6. Incubations conducted with human liver cytosol and H218O demonstrated that the oxygen atom incorporated into ZAL and DZAL to form M2 and M1, resp., was derived from water and not from mol. oxygen.  7. In summary, by correlation anal., chem. inhibition and H218O incorporation studies, ZAL metab. to M2 in human liver appears to be catalyzed by aldehyde oxidase.  With human liver slices, ZAL was metabolized to products dependent on both aldehyde oxidase and CYP3A forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokS2P9qpmL0rVg90H21EOLACvtfcHk0li8v9ugUGAbzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFCktbw%253D&md5=1c2287b2cd01a2290085e707af3a93ad</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1080%2F00498250210158915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250210158915%26sid%3Dliteratum%253Aachs%26aulast%3DLake%26aufirst%3DB.%2BG.%26aulast%3DBall%26aufirst%3DS.%2BE.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DRenwick%26aufirst%3DA.%2BB.%26aulast%3DPrice%26aufirst%3DR.%2BJ.%26aulast%3DScatina%26aufirst%3DJ.%2BA.%26atitle%3DMetabolism%2520of%2520Zaleplon%2520by%2520Human%2520Liver%253A%2520Evidence%2520for%2520Involvement%2520of%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2002%26volume%3D32%26issue%3D10%26spage%3D835%26epage%3D847%26doi%3D10.1080%2F00498250210158915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of (S)-1-(1-(Imidazo[1,2-a]Pyridin-6-Yl)Ethyl)-6-(1-Methyl-1h-Pyrazol-4-Yl)-1h-[1,2, 3]Triazolo[4,5-B]Pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (C-Met) Inhibitor in Clinical Development for Treatment of Cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7577</span>– <span class="NLM_lpage">7589</span>, <span class="refDoi"> DOI: 10.1021/jm500510f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500510f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7577-7589&issue=18&author=H.+Jiaauthor=G.+Daiauthor=J.+Wengauthor=Z.+Zhangauthor=Q.+Wangauthor=F.+Zhouauthor=L.+Jiaoauthor=Y.+Cuiauthor=Y.+Renauthor=S.+Fanauthor=J.+Zhouauthor=W.+Qingauthor=Y.+Guauthor=J.+Wangauthor=Y.+Saiauthor=W.+Su&title=Discovery+of+%28S%29-1-%281-%28Imidazo%5B1%2C2-a%5DPyridin-6-Yl%29Ethyl%29-6-%281-Methyl-1h-Pyrazol-4-Yl%29-1h-%5B1%2C2%2C+3%5DTriazolo%5B4%2C5-B%5DPyrazine+%28Volitinib%29+as+a+Highly+Potent+and+Selective+Mesenchymal-Epithelial+Transition+Factor+%28C-Met%29+Inhibitor+in+Clinical+Development+for+Treatment+of+Cancer&doi=10.1021%2Fjm500510f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer</span></div><div class="casAuthors">Jia, Hong; Dai, Guangxiu; Weng, Jianyang; Zhang, Zhulin; Wang, Qing; Zhou, Feng; Jiao, Longxian; Cui, Yumin; Ren, Yongxin; Fan, Shiming; Zhou, Jinghong; Qing, Weiguo; Gu, Yi; Wang, Jian; Sai, Yang; Su, Weiguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7577-7589</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HGF/c-Met signaling has been implicated in human cancers.  Herein we describe the invention of a series of novel triazolopyrazine c-Met inhibitors.  The structure-activity relation of these compds. was investigated, leading to the identification of Volitinib (I), which demonstrated favorable pharmacokinetic properties in mice and good antitumor activities in the human glioma xenograft model in athymic nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJmuzIGrPGZbVg90H21EOLACvtfcHk0li8v9ugUGAbzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7jN&md5=aced38bbd7431f5ac01b6698e8657261</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm500510f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500510f%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DQing%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%2528S%2529-1-%25281-%2528Imidazo%255B1%252C2-a%255DPyridin-6-Yl%2529Ethyl%2529-6-%25281-Methyl-1h-Pyrazol-4-Yl%2529-1h-%255B1%252C2%252C%25203%255DTriazolo%255B4%252C5-B%255DPyrazine%2520%2528Volitinib%2529%2520as%2520a%2520Highly%2520Potent%2520and%2520Selective%2520Mesenchymal-Epithelial%2520Transition%2520Factor%2520%2528C-Met%2529%2520Inhibitor%2520in%2520Clinical%2520Development%2520for%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D18%26spage%3D7577%26epage%3D7589%26doi%3D10.1021%2Fjm500510f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, G. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span> <span> </span><span class="NLM_article-title">Identification of 3-Substituted-6-(1-(1h-[1,2,3]Triazolo[4,5-B]Pyrazin-1-Yl)Ethyl)Quinoline Derivatives as Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (C-Met) Inhibitors Via Metabolite Profiling-Based Structural Optimization</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.ejmech.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28411455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFGht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=147-158&author=F.+Zhaoauthor=L.+D.+Zhangauthor=Y.+Haoauthor=N.+Chenauthor=R.+Baiauthor=Y.+J.+Wangauthor=C.+C.+Zhangauthor=G.+S.+Liauthor=L.+J.+Haoauthor=C.+Shiauthor=J.+Zhangauthor=Y.+Maoauthor=Y.+Fanauthor=G.+X.+Xiaauthor=J.+X.+Yuauthor=Y.+J.+Liu&title=Identification+of+3-Substituted-6-%281-%281h-%5B1%2C2%2C3%5DTriazolo%5B4%2C5-B%5DPyrazin-1-Yl%29Ethyl%29Quinoline+Derivatives+as+Highly+Potent+and+Selective+Mesenchymal-Epithelial+Transition+Factor+%28C-Met%29+Inhibitors+Via+Metabolite+Profiling-Based+Structural+Optimization&doi=10.1016%2Fj.ejmech.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization</span></div><div class="casAuthors">Zhao, Fei; Zhang, Le-Duo; Hao, Yu; Chen, Na; Bai, Rui; Wang, Yu-Ji; Zhang, Chun-Chun; Li, Gong-Sheng; Hao, Li-Jun; Shi, Chen; Zhang, Jing; Mao, Yu; Fan, Yi; Xia, Guang-Xin; Yu, Jian-Xin; Liu, Yan-Jun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">C-Met/HGF signaling pathway plays an important role in cancer progression, and it was considered to be related to poor prognosis and drug resistance.  Based on metabolite profiling of (S)-7-fluoro-6-(1-(6-(1-methyl-1H-pyrazol-4-yl)-1H-imidazo[4,5-b]pyrazin-1-yl)ethyl)quinoline, a series of 2-substituted or 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivs. was rationally designed and evaluated.  Most of the 3-substituted derivs. not only exhibited potent activities in both enzymic and cellular assays, but also were stable in liver microsomes among different species (human, rat and monkey).  SAR investigation revealed that introducing of N-methyl-1H-pyrazol-4-yl group at the 3-position of quinoline moiety is beneficial to improve the inhibitory potency, esp. in the cellular assays.  The influence of fluorine atom at 7-position or 5, 7-position of quinoline moiety and substituents at the 6-position of triazolo[4,5-b]pyrazine core on overall activity is not very significant.  Racemate I, an extremely potent and exquisitely selective c-Met inhibitor, demonstrated favorable pharmacokinetic properties in rats, no significant AO metab., and effective tumor growth inhibition in c-Met overexpressed NSCLC (H1993 cell line) and gastric cancer (SNU-5 cell line) xenograft models.  Docking anal. indicated that besides the typical interactions of most selective c-Met inhibitors, the intramol. halogen bond and addnl. hydrogen bond interactions with kinase are beneficial to the binding.  These results may provide deep insight into potential structural modifications for developing potent c-Met inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgyqGUbEUV5LVg90H21EOLACvtfcHk0li8v9ugUGAbzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFGht78%253D&md5=baf9368a3f9c4c7638c53c532686206f</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DL.%2BD.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DG.%2BS.%26aulast%3DHao%26aufirst%3DL.%2BJ.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DG.%2BX.%26aulast%3DYu%26aufirst%3DJ.%2BX.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26atitle%3DIdentification%2520of%25203-Substituted-6-%25281-%25281h-%255B1%252C2%252C3%255DTriazolo%255B4%252C5-B%255DPyrazin-1-Yl%2529Ethyl%2529Quinoline%2520Derivatives%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Mesenchymal-Epithelial%2520Transition%2520Factor%2520%2528C-Met%2529%2520Inhibitors%2520Via%2520Metabolite%2520Profiling-Based%2520Structural%2520Optimization%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D147%26epage%3D158%26doi%3D10.1016%2Fj.ejmech.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robeson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics, Metabolism and Excretion of Idelalisib</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">5570</span>– <span class="NLM_lpage">5570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1182%2Fblood.V122.21.5570.5570" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=5570-5570&issue=21&author=M.+Robesonauthor=H.+Zhouauthor=E.+Kwanauthor=S.+Ramanathan&title=Pharmacokinetics%2C+Metabolism+and+Excretion+of+Idelalisib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1182%2Fblood.V122.21.5570.5570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V122.21.5570.5570%26sid%3Dliteratum%253Aachs%26aulast%3DRobeson%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKwan%26aufirst%3DE.%26aulast%3DRamanathan%26aufirst%3DS.%26atitle%3DPharmacokinetics%252C%2520Metabolism%2520and%2520Excretion%2520of%2520Idelalisib%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26issue%3D21%26spage%3D5570%26epage%3D5570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kearney, B. P.</span></span> <span> </span><span class="NLM_article-title">Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0304-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs40262-015-0304-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26242379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=33-45&issue=1&author=S.+Ramanathanauthor=F.+Jinauthor=S.+Sharmaauthor=B.+P.+Kearney&title=Clinical+Pharmacokinetic+and+Pharmacodynamic+Profile+of+Idelalisib&doi=10.1007%2Fs40262-015-0304-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib</span></div><div class="casAuthors">Ramanathan, Srinivasan; Jin, Feng; Sharma, Shringi; Kearney, Brian P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-45</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Idelalisib is a potent and selective phosphatidylinositol 3-kinase-δ inhibitor, which is a first-in-class agent to be approved for the treatment of relapsed chronic lymphocytic leukemia, follicular B cell non-Hodgkin's lymphoma and small lymphocytic lymphoma.  In dose-ranging studies, idelalisib exposure increased in a less than dose-proportional manner, likely because of soly.-limited absorption.  The approved starting dose of 150 mg twice daily was supported by extensive exposure-response evaluations, with dose redn. to 100 mg twice daily being allowed for specific toxicities.  Idelalisib may be administered without regard to food on the basis of the absence of clin. relevant food effects, and was accordingly dosed in primary efficacy/safety studies.  Idelalisib is metabolized primarily via aldehyde oxidase (AO) and, to a lesser extent, via cytochrome P 450 (CYP) 3A.  Coadministration with the strong CYP3A inhibitor ketoconazole 400 mg once daily resulted in a ∼79 % increase in the idelalisib area under the plasma concn.-time curve (AUC).  Administration with the potent inducer rifampin resulted in a 75 % decrease in idelalisib exposure (AUC) and, as such, coadministration with strong inducers should be avoided.  GS-563117 is an inactive primary circulating metabolite of idelalisib formed mainly via AO.  Unlike idelalisib, GS-563117 is a mechanism-based inhibitor of CYP3A.  Accordingly, idelalisib 150 mg twice-daily dosing increases the midazolam AUC 5.4-fold.  Clin., idelalisib is not an inhibitor of the transporters P-glycoprotein, breast cancer resistance protein, org. anion-transporting polypeptide (OATP) 1B1 or OAPT1B3.  In a population pharmacokinetic model, no meaningful impact on idelalisib pharmacokinetics was noted for any of the covariates tested.  Idelalisib exposure was ∼60 % higher with moderate/severe hepatic impairment; no relevant changes were obsd. with severe renal impairment.  This article reviews a comprehensive pharmacol. program, including drug-drug interaction studies and mechanistic and special population studies, which has allowed a thorough understanding of idelalisib clin. pharmacokinetics and their impact on clin. safety and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprSL8hV_Gha7Vg90H21EOLACvtfcHk0ljtg1Wr0qeKiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSit7o%253D&md5=df1082fcbb0e1a9aa941769ade9fe962</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0304-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0304-0%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DF.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKearney%26aufirst%3DB.%2BP.%26atitle%3DClinical%2520Pharmacokinetic%2520and%2520Pharmacodynamic%2520Profile%2520of%2520Idelalisib%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26issue%3D1%26spage%3D33%26epage%3D45%26doi%3D10.1007%2Fs40262-015-0304-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choughule, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaba, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">In Vitro Oxidative Metabolism of 6-Mercaptopurine in Human Liver: Insights into the Role of the Molybdoflavoenzymes Aldehyde Oxidase, Xanthine Oxidase, and Xanthine Dehydrogenase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1334</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.058107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.058107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24824603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFentrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1334-1340&issue=8&author=K.+V.+Choughuleauthor=C.+Barnabaauthor=C.+A.+Joswig-Jonesauthor=J.+P.+Jones&title=In+Vitro+Oxidative+Metabolism+of+6-Mercaptopurine+in+Human+Liver%3A+Insights+into+the+Role+of+the+Molybdoflavoenzymes+Aldehyde+Oxidase%2C+Xanthine+Oxidase%2C+and+Xanthine+Dehydrogenase&doi=10.1124%2Fdmd.114.058107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase and xanthine dehydrogenase</span></div><div class="casAuthors">Choughule, Kanika V.; Barnaba, Carlo; Joswig-Jones, Carolyn A.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1334-1340, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Anticancer agent 6-mercaptopurine (6MP) has been in use since 1953 for the treatment of childhood acute lymphoblastic leukemia (ALL) and inflammatory bowel disease.  Despite being available for 60 years, several aspects of 6MP drug metab. and pharmacokinetics in humans are unknown.  Molybdoflavoenzymes such as aldehyde oxidase (AO) and xanthine oxidase (XO) have previously been implicated in the metab. of this drug.  In this study, the authors investigated the in vitro metab. of 6MP to 6-thiouric acid (6TUA) in pooled human liver cytosol.  The authors discovered that 6MP is metabolized to 6TUA through sequential metab. via the 6-thioxanthine (6TX) intermediate.  The role of human AO and XO in the metab. of 6MP was established using the specific inhibitors raloxifene and febuxostat.  Both AO and XO were involved in the metab. of the 6TX intermediate, whereas only XO was responsible for the conversion of 6TX to 6TUA.  These findings were further confirmed using purified human AO and Escherichia coli lysate contg. expressed recombinant human XO.  Xanthine dehydrogenase (XDH), which belongs to the family of xanthine oxidoreductases and preferentially reduces NAD (NAD+), was shown to contribute to the overall prodn. of the 6TX intermediate as well as the final product 6TUA in the presence of NAD+ in human liver cytosol.  In conclusion, the authors present evidence that three enzymes, AO, XO and XDH, contribute to the prodn. of 6TX intermediate, whereas only XO and XDH are involved in the conversion of 6TX to 6TUA in pooled HLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLcFznxA1HqLVg90H21EOLACvtfcHk0ljtg1Wr0qeKiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFentrfP&md5=97c192f3b6cb6a91a9a1fd06e3948607</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.058107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.058107%26sid%3Dliteratum%253Aachs%26aulast%3DChoughule%26aufirst%3DK.%2BV.%26aulast%3DBarnaba%26aufirst%3DC.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DIn%2520Vitro%2520Oxidative%2520Metabolism%2520of%25206-Mercaptopurine%2520in%2520Human%2520Liver%253A%2520Insights%2520into%2520the%2520Role%2520of%2520the%2520Molybdoflavoenzymes%2520Aldehyde%2520Oxidase%252C%2520Xanthine%2520Oxidase%252C%2520and%2520Xanthine%2520Dehydrogenase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D8%26spage%3D1334%26epage%3D1340%26doi%3D10.1124%2Fdmd.114.058107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, C.</span></span> <span> </span><span class="NLM_article-title">Metabolism and Excretion of 6-Chloro-9-(4-Methoxy-3,5-Dimethylpyridin-2-Ylmethyl)-9h-Purin-2-Ylamine, an Hsp90 Inhibitor, in Rats and Dogs and Assessment of Its Metabolic Profile in Plasma of Humans</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2133</span>– <span class="NLM_lpage">2147</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.054023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.113.054023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24046333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=2133-2147&issue=12&author=L.+Xuauthor=C.+Woodwardauthor=J.+Daiauthor=C.+Prakash&title=Metabolism+and+Excretion+of+6-Chloro-9-%284-Methoxy-3%2C5-Dimethylpyridin-2-Ylmethyl%29-9h-Purin-2-Ylamine%2C+an+Hsp90+Inhibitor%2C+in+Rats+and+Dogs+and+Assessment+of+Its+Metabolic+Profile+in+Plasma+of+Humans&doi=10.1124%2Fdmd.113.054023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and excretion of 6-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine, an HSP90 inhibitor, in rats and dogs and assessment of its metabolic profile in plasma of humans</span></div><div class="casAuthors">Xu, Lin; Woodward, Caroline; Dai, Jing; Prakash, Chandra</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2133-2147</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">6-Chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine (BIIB021), a synthetic HSP90 inhibitor, exhibited promising antitumor activity in preclin. models and was in development for the treatment of breast cancer.  The metab. and excretion of BIIB021 was investigated in rats and dogs after oral administration of [14C]BIIB021.  The administered radioactive dose was quant. recovered in both species, and feces/bile was the major route of excretion.  Metabolic profiling revealed that BIIB021 is extensively metabolized primarily via hydroxylation of the Me group (M7), O-demethylation (M2), and to a lesser extent by glutathione conjugation (M8 and M9).  M7 was further metabolized to form the carboxylic acid (M3) and glucuronide conjugate (M4).  Human plasma obtained from the phase I study in cancer patients were also analyzed to assess the metab. of BIIB021 in humans and to ensure that selected animal species were exposed to all human major metabolites.  Results suggested that BIIB021 is metabolized via hydroxylation followed by carboxylation and glucuronidation in humans consistent with rat and dog; however, an addnl. dominant circulating metabolite, hydroxylation at the purine ring (M10), was identified in humans.  Preliminary in vitro studies using liver cytosolic fractions indicated that M10 formation is primarily catalyzed by aldehyde oxidase (AO).  AO catalytic activity for M10 formation was the highest in the monkey, followed by mouse, human, and rat.  The apparent Km and Vmax values of M10 formation were 174 ± 8 μM and 14.0 ± 0.3 pmol•min-1•mg protein-1 in human and 132 ± 9 μM and 131 ± 4 pmol•min-1•mg protein-1 in monkey, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfFSIHj4horbVg90H21EOLACvtfcHk0lj5pu0JwZDV2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbjK&md5=656da9292fac38b27edbb95c7a9c83a5</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.054023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.054023%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DPrakash%26aufirst%3DC.%26atitle%3DMetabolism%2520and%2520Excretion%2520of%25206-Chloro-9-%25284-Methoxy-3%252C5-Dimethylpyridin-2-Ylmethyl%2529-9h-Purin-2-Ylamine%252C%2520an%2520Hsp90%2520Inhibitor%252C%2520in%2520Rats%2520and%2520Dogs%2520and%2520Assessment%2520of%2520Its%2520Metabolic%2520Profile%2520in%2520Plasma%2520of%2520Humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26issue%3D12%26spage%3D2133%26epage%3D2147%26doi%3D10.1124%2Fdmd.113.054023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, M. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of O6-Benzylguanine in Rats and Its Metabolism by Rat Liver Microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1394</span>– <span class="NLM_lpage">1399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8689950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28XhvF2nug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=1394-1399&issue=12&author=S.+K.+Royauthor=E.+Guptaauthor=M.+E.+Dolan&title=Pharmacokinetics+of+O6-Benzylguanine+in+Rats+and+Its+Metabolism+by+Rat+Liver+Microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of O6-benzylguanine in rats and its metabolism by Rat liver microsomes</span></div><div class="casAuthors">Roy, Sandip K.; Gupta, Elora; Dolan, M. Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1394-9</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">O6-benzylguanine is an effective inhibitor of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase, and enhances the effectiveness of 1,3-bis(2-chloroethyl)-1-nitrosourea in cells in culture and animal tumor models.  To prep. O6-benzylguanine for clin. trials and to det. the availability and disposition of O6-benzyl-7,8-dihydro-8-oxoguanine (O6-benzyl-8-oxoguanine), its major metabolite, pharmacokinetic parameters of these compds. were investigated in male Sprague-Dawley rats.  Noncompartmental pharmacokinetic parameters were detd. following i.v. administration of O6-benzylguanine or O6-benzyl-8-oxoguanine in rats.  Half-life, clearance, and vol. of distribution were resp., 1.6 h, 160 mL/h/kg, and 405 g/kg for O6-benzylguanine, and 1.2 h, 312 mL/h/kg, and 405 mL/kg for O6-benzylguanine, and 1.2 h, 312 mL/h/kg, and 507 mL/kg for O6-benzyl-8-oxoguanine.  At least 37% of O6-benzylguanine was converted to O6-benzyl-8-oxoguanine after administration of O6-benzylguanine.  Renal excretion accounted for 8 and 62% of the administered O6-benzyl-8-oxoguanine after administration of O6-benzylguanine,resp.  Administration of phenobarbital to rats before O6-benzylguanine resulted in a 17- to 19-fold increase in the amt. of oxidized product in the urine.  Kinetic consts., KM and Vmax were estd. as 19.6 μM and 0.02 nmol/min/mg protein and 13.4 μM and 0.96 nmol/min/mg protein, for un-induced and induced rat liver microsomes, resp.  The use of inhibitors of cytosolic enzymes, xanthine oxidase, and aldehyde oxidase indicated that aldehyde oxidase is primarily involved in the cytosolic oxidn. of O6-benzylguanine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNzndL4iv85rVg90H21EOLACvtfcHk0lj5pu0JwZDV2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvF2nug%253D%253D&md5=d4aa6ace9f95bea963bf1371a211751a</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%2BK.%26aulast%3DGupta%26aufirst%3DE.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26atitle%3DPharmacokinetics%2520of%2520O6-Benzylguanine%2520in%2520Rats%2520and%2520Its%2520Metabolism%2520by%2520Rat%2520Liver%2520Microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1995%26volume%3D23%26issue%3D12%26spage%3D1394%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitchen, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balis, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widemann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, P. C.</span></span> <span> </span><span class="NLM_article-title">Thioguanine Administered as a Continuous Intravenous Infusion to Pediatric Patients Is Metabolized to the Novel Metabolite 8-Hydroxy-Thioguanine</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">870</span>– <span class="NLM_lpage">874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10525111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXntFChu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1999&pages=870-874&issue=2&author=B.+J.+Kitchenauthor=A.+Moserauthor=E.+Loweauthor=F.+M.+Balisauthor=B.+Widemannauthor=L.+Andersonauthor=J.+Strongauthor=S.+M.+Blaneyauthor=S.+L.+Bergauthor=M.+O%E2%80%99Brienauthor=P.+C.+Adamson&title=Thioguanine+Administered+as+a+Continuous+Intravenous+Infusion+to+Pediatric+Patients+Is+Metabolized+to+the+Novel+Metabolite+8-Hydroxy-Thioguanine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxythioguanine</span></div><div class="casAuthors">Kitchen, Brenda J.; Moser, Asher; Lowe, Elizabeth; Balis, Frank M.; Widemann, Brigitte; Anderson, Lawrence; Strong, John; Blaney, Susan M.; Berg, Stacey L.; O'Brien, Michelle; Adamson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">870-874</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thiopurine antimetabolites have been in clin. use for more than 40 yr, yet the metab. of thiopurines remains only partially understood.  Data from our previous pediatric phase 1 trial of continuous i.v. infusion of thioguanine (CIVI-TG) suggested that TG was eliminated by saturable mechanism, with conversion of the drug to an unknown metabolite.  In this study we have identified this metabolite as 8-hydroxythioguanine (8-OH-TG).  The metabolite coeluted with the 8-OH-TG std. on HPLC and had an identical UV spectrum, with a λmax of 350 nm.  On mass spectroscopy, the pos. ion, single quad scan of 8-OH-TG yielded a protonated mol. ion at 184 Da and contained diagnostic ions at m/z 167, 156, 142, and 125 Da.  Incubation of TG in vitro with partially purified aldehyde oxidase resulted in 8-OH-TG formation.  8-OH-TG is the predominant circulating metabolite found in patients receiving CIVI-TG and is likely generated by the action of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcB3qraig1kbVg90H21EOLACvtfcHk0lj5pu0JwZDV2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFChu7g%253D&md5=6af192138b458d31826c203f251c89de</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitchen%26aufirst%3DB.%2BJ.%26aulast%3DMoser%26aufirst%3DA.%26aulast%3DLowe%26aufirst%3DE.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26aulast%3DWidemann%26aufirst%3DB.%26aulast%3DAnderson%26aufirst%3DL.%26aulast%3DStrong%26aufirst%3DJ.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DBerg%26aufirst%3DS.%2BL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DAdamson%26aufirst%3DP.%2BC.%26atitle%3DThioguanine%2520Administered%2520as%2520a%2520Continuous%2520Intravenous%2520Infusion%2520to%2520Pediatric%2520Patients%2520Is%2520Metabolized%2520to%2520the%2520Novel%2520Metabolite%25208-Hydroxy-Thioguanine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D291%26issue%3D2%26spage%3D870%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philip, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y. Z.</span></span> <span> </span><span class="NLM_article-title">A Novel Ring Oxidation of 4- or 5-Substituted 2h-Oxazole to Corresponding 2-Oxazolone Catalyzed by Cytosolic Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1676</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.044545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.044545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22621803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1668-1676&issue=9&author=V.+K.+Aroraauthor=T.+Philipauthor=S.+Huangauthor=Y.+Z.+Shu&title=A+Novel+Ring+Oxidation+of+4-+or+5-Substituted+2h-Oxazole+to+Corresponding+2-Oxazolone+Catalyzed+by+Cytosolic+Aldehyde+Oxidase&doi=10.1124%2Fdmd.112.044545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">A novel ring oxidation of 4- or 5-substituted 2H-oxazole to corresponding 2-oxazolone catalyzed by cytosolic aldehyde oxidase</span></div><div class="casAuthors">Arora, Vinod K.; Philip, Thomas; Huang, Stella; Shu, Yue-Zhong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1668-1676</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ring oxidn. of 2H-oxazole, or C2-unsubstituted oxazole, to 2-oxazolone, a cyclic carbamate, was obsd. on various 4- or 5-substituted oxazoles.  Using 5-(3-bromophenyl)oxazole as a model compd., its 2-oxazolone metabolite M1 was fully characterized by liq. chromatog./tandem mass spectrometry and NMR.  The reaction mainly occurred in the liver cytosolic fraction without the requirement of cytochrome P 450 enzymes and cofactor NADPH.  Investigations into the mechanism of formation of 2-oxazolone using various chem. inhibitors indicated that the reaction was primarily catalyzed by aldehyde oxidase and not by xanthine oxidase.  In addn., cytosol incubation of 5-(3-bromophenyl)oxazole in the medium contg. H218O led to the 18O incorporation into M1, substantiating the reaction mechanism of a typical molybdenum hydroxylase.  The rank order of liver cytosols for the 2-oxazolone formation was mouse > monkey >> rat and human liver cytosol, whereas M1 was not formed in dog liver cytosol.  Because the reaction was obsd. with a no. of 4- or 5-substituted 2H-oxazoles in mouse liver cytosols, 2H-oxazoles represent a new substrate chemotype for ring oxidn. catalyzed by aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcTnuHHmEkLVg90H21EOLACvtfcHk0ljwIOJTHqwP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShtbjM&md5=b2849d6f5d1ac5a35ac330ab225cf1e7</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.044545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.044545%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DPhilip%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DShu%26aufirst%3DY.%2BZ.%26atitle%3DA%2520Novel%2520Ring%2520Oxidation%2520of%25204-%2520or%25205-Substituted%25202h-Oxazole%2520to%2520Corresponding%25202-Oxazolone%2520Catalyzed%2520by%2520Cytosolic%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D9%26spage%3D1668%26epage%3D1676%26doi%3D10.1124%2Fdmd.112.044545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chissick, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K.</span></span> <span> </span><span class="NLM_article-title">The Role of Aldehyde Oxidase in the in Vivo Metabolism of Benzothiazole</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">604S</span>, <span class="refDoi"> DOI: 10.1042/bst023604s</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1042%2Fbst023604s" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8654789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28XhtVWktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=604S&issue=4&author=A.+M.+Fowlerauthor=H.+H.+Chissickauthor=M.+J.+Frearsonauthor=K.+Wilson&title=The+Role+of+Aldehyde+Oxidase+in+the+in+Vivo+Metabolism+of+Benzothiazole&doi=10.1042%2Fbst023604s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The role of aldehyde oxidase in the in vivo metabolism of benzothiazole</span></div><div class="casAuthors">Fowler, A. Michelle; Chissick, Harvey H.; Frearson, Martin J.; Wilson, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">604S</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press</span>)
        </div><div class="casAbstract">Benzothiazole and 2-hydroxybenzothiazole were metabolized to 2-methylmercaptoaniline, 2-methylsulfinylaniline, and 2-methylsulfonylaniline in guinea pigs indicating that aldehyde oxidase may have a key role in the in vivo metab. of benzothiazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Grn-EPTTTLVg90H21EOLACvtfcHk0ljwIOJTHqwP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtVWktLo%253D&md5=b013e109d3e20c3c04e5ef3aab869b60</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1042%2Fbst023604s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst023604s%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DA.%2BM.%26aulast%3DChissick%26aufirst%3DH.%2BH.%26aulast%3DFrearson%26aufirst%3DM.%2BJ.%26aulast%3DWilson%26aufirst%3DK.%26atitle%3DThe%2520Role%2520of%2520Aldehyde%2520Oxidase%2520in%2520the%2520in%2520Vivo%2520Metabolism%2520of%2520Benzothiazole%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D1995%26volume%3D23%26issue%3D4%26spage%3D604S%26doi%3D10.1042%2Fbst023604s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cesarini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyrakis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosconi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goracci, L.</span></span> <span> </span><span class="NLM_article-title">From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01552</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01552" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOru7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=360-371&issue=1&author=G.+Crucianiauthor=N.+Milaniauthor=P.+Benedettiauthor=S.+Lepriauthor=L.+Cesariniauthor=M.+Baroniauthor=F.+Spyrakisauthor=S.+Tortorellaauthor=E.+Mosconiauthor=L.+Goracci&title=From+Experiments+to+a+Fast+Easy-to-Use+Computational+Methodology+to+Predict+Human+Aldehyde+Oxidase+Selectivity+and+Metabolic+Reactions&doi=10.1021%2Facs.jmedchem.7b01552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions</span></div><div class="casAuthors">Cruciani, Gabriele; Milani, Nicolo; Benedetti, Paolo; Lepri, Susan; Cesarini, Lucia; Baroni, Massimo; Spyrakis, Francesca; Tortorella, Sara; Mosconi, Edoardo; Goracci, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">360-371</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) is a molibdo-flavoenzyme that raised great interest in recent years, since its contribution in xenobiotics metab. has not always been identified before clin. trials, with consequent neg. effects on the fate of new potential drugs.  The fundamental role of AOX in metabolizing xenobiotics is also due to the attempt of medicinal chemists to stabilize candidates toward cytochrome P 450 activity, which increases the risk for new compds. to be susceptible to AOX nucleophile attack.  Therefore, novel strategies to predict the potential liability of new entities towards AOX enzyme are urgently needed to increase effectiveness, reduce costs, and prioritize exptl. studies.  In the present work, we present the most up-to-date computational method to predict liability towards human AOX, for applications in drug design and pharmacokinetic optimization.  The method was developed using a large dataset of homogeneous exptl. data, which is also disclosed as supplementary material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_Tnrnus317Vg90H21EOLACvtfcHk0ljwIOJTHqwP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOru7fK&md5=23c7fd8a5abcba87e7fc065d5e6dafc6</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01552%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DMilani%26aufirst%3DN.%26aulast%3DBenedetti%26aufirst%3DP.%26aulast%3DLepri%26aufirst%3DS.%26aulast%3DCesarini%26aufirst%3DL.%26aulast%3DBaroni%26aufirst%3DM.%26aulast%3DSpyrakis%26aufirst%3DF.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DMosconi%26aufirst%3DE.%26aulast%3DGoracci%26aufirst%3DL.%26atitle%3DFrom%2520Experiments%2520to%2520a%2520Fast%2520Easy-to-Use%2520Computational%2520Methodology%2520to%2520Predict%2520Human%2520Aldehyde%2520Oxidase%2520Selectivity%2520and%2520Metabolic%2520Reactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D1%26spage%3D360%26epage%3D371%26doi%3D10.1021%2Facs.jmedchem.7b01552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosogi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, T.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase B Oxidizes a Novel Multikinase Inhibitor Kw-2449 to Its Iminium Ion and Aldehyde Oxidase Further Converts It to the Oxo-Piperazine Form in Human</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/j.dmpk.2017.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.dmpk.2017.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28751116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=255-264&issue=5&author=J.+Hosogiauthor=R.+Ohashiauthor=H.+Maedaauthor=S.+Tashiroauthor=E.+Fuseauthor=Y.+Yamamotoauthor=T.+Kuwabara&title=Monoamine+Oxidase+B+Oxidizes+a+Novel+Multikinase+Inhibitor+Kw-2449+to+Its+Iminium+Ion+and+Aldehyde+Oxidase+Further+Converts+It+to+the+Oxo-Piperazine+Form+in+Human&doi=10.1016%2Fj.dmpk.2017.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase B oxidizes a novel multikinase inhibitor KW-2449 to its iminium ion and aldehyde oxidase further converts it to the oxo-piperazine form in human</span></div><div class="casAuthors">Hosogi, Jun; Ohashi, Rui; Maeda, Hiroshi; Tashiro, Satoshi; Fuse, Eiichi; Yamamoto, Yorihiro; Kuwabara, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">255-264</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">(E)-1-{4-[2-(1H-Indazol-3-yl)vinyl]benzoyl}piperazine (KW-2449) is a novel multikinase inhibitor.  During our clin. study, we found that KW-2449 is mainly metabolized to its oxo-piperazine form (M1).  An inhibition study suggested that monoamine oxidase-B (MAO-B) oxidizes KW-2449 to an iminium (intermediate) and aldehyde oxidase (AO) then metabolizes the intermediate to M1.  The conversion of KW-2449 to the iminium (intermediate) by MAO-B was confirmed by the formation of its cyanide adduct.  This cooperative metabolic pathway by MAO-B and AO was newly identified in the metab. of piperazine.  The clearance of KW-2449 by MAO-B and AO in human was estd. based on the kinetic anal. with in vitro-in vivo extrapolation.  The systemic clearance in human was similar to the calcd. value, indicating that the extrapolation approach was applicable to KW-2449 metab.  Finally, we found that (E)-3-amino-1-{4-[2-(1H-Indazol-3-yl)vinyl]benzoyl}-pyrrolidine (Compd. A) as a stable compd. against MAO-B and AO.  The total body clearance of Compd. A was reduced to one tenth of KW-2449, demonstrating that preventing the metab. of MAO and AO led to more preferable pharmacokinetic profiles.  As piperazine is often introduced to drug candidates to improve lipophilicity of the compd. to get more hydrophilic nature, the results of this study provide useful information for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2fKwc369Ix7Vg90H21EOLACvtfcHk0lg93_ld1lAy3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmt7nO&md5=1846c419191a12469d1be35860c67cf9</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.dmpk.2017.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dmpk.2017.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DHosogi%26aufirst%3DJ.%26aulast%3DOhashi%26aufirst%3DR.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DFuse%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuwabara%26aufirst%3DT.%26atitle%3DMonoamine%2520Oxidase%2520B%2520Oxidizes%2520a%2520Novel%2520Multikinase%2520Inhibitor%2520Kw-2449%2520to%2520Its%2520Iminium%2520Ion%2520and%2520Aldehyde%2520Oxidase%2520Further%2520Converts%2520It%2520to%2520the%2520Oxo-Piperazine%2520Form%2520in%2520Human%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2017%26volume%3D32%26issue%3D5%26spage%3D255%26epage%3D264%26doi%3D10.1016%2Fj.dmpk.2017.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosogi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ushiki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, T.</span></span> <span> </span><span class="NLM_article-title">An Iminium Ion Metabolite Hampers the Production of the Pharmacologically Active Metabolite of a Multikinase Inhibitor Kw-2449 in Primates: Irreversible Inhibition of Aldehyde Oxidase and Covalent Binding with Endogenous Proteins</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1002/bdd.2123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fbdd.2123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29451686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlKjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2018&pages=164-174&issue=3&author=J.+Hosogiauthor=R.+Ohashiauthor=H.+Maedaauthor=K.+Fujitaauthor=J.+Ushikiauthor=T.+Kuwabaraauthor=Y.+Yamamotoauthor=T.+Imamura&title=An+Iminium+Ion+Metabolite+Hampers+the+Production+of+the+Pharmacologically+Active+Metabolite+of+a+Multikinase+Inhibitor+Kw-2449+in+Primates%3A+Irreversible+Inhibition+of+Aldehyde+Oxidase+and+Covalent+Binding+with+Endogenous+Proteins&doi=10.1002%2Fbdd.2123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">An iminium ion metabolite hampers the production of the pharmacologically active metabolite of a multikinase inhibitor KW-2449 in primates: irreversible inhibition of aldehyde oxidase and covalent binding with endogenous proteins</span></div><div class="casAuthors">Hosogi, Jun; Ohashi, Rui; Maeda, Hiroshi; Fujita, Kazuhiro; Ushiki, Junko; Kuwabara, Takashi; Yamamoto, Yorihiro; Imamura, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">We previously reported that KW-2449, (E)-1-{4-[2-(1H-Indazol-3-yl)vinyl]benzoyl}piperazine, a novel multikinase inhibitor developed for the treatment of leukemia patients, was oxidized to an iminium ion intermediate by monoamine oxidase B (MAO-B) and then converted to its oxo-piperazine form (M1) by aldehyde oxidase (AO).  However, it was found that the significant decrease in the pharmacol. active metabolite M1 following repeated administration of KW-2449 in primates might hamper the effectiveness of the drug.  The mechanism underlying this phenomenon was investigated and it was found that the AO activity was inhibited in a time-dependent manner in vitro under the co-incubation of KW-2449 and MAO-B, while neither KW-2449 nor M1 strongly inhibited MAO-B or AO activity.  These results clearly suggest that MAO-B catalyzed iminium ion metabolite inhibited AO, prompting us to investigate whether or not the iminium ion metabolite covalently binds to endogenous proteins, as has been reported with other reactive metabolites as a cause for idiosyncratic toxicity.  The assocn. of the radioactivity derived from 14C-KW-2449 with endogenous proteins both in vivo and in vitro was confirmed and it was verified that this covalent binding was inhibited by the addn. of sodium cyanide, an iminium ion-trapping reagent, and pargyline, a MAO-B inhibitor.  These findings strongly suggest that the iminium ion metabolite of KW-2449 is highly reactive in inhibiting AO irreversibly and binding to endogenous macromols. covalently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEopyNIUmjrrVg90H21EOLACvtfcHk0lg93_ld1lAy3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlKjtbc%253D&md5=48e3fd0f51ef64b51943da8c4eb55d51</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fbdd.2123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.2123%26sid%3Dliteratum%253Aachs%26aulast%3DHosogi%26aufirst%3DJ.%26aulast%3DOhashi%26aufirst%3DR.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DUshiki%26aufirst%3DJ.%26aulast%3DKuwabara%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DImamura%26aufirst%3DT.%26atitle%3DAn%2520Iminium%2520Ion%2520Metabolite%2520Hampers%2520the%2520Production%2520of%2520the%2520Pharmacologically%2520Active%2520Metabolite%2520of%2520a%2520Multikinase%2520Inhibitor%2520Kw-2449%2520in%2520Primates%253A%2520Irreversible%2520Inhibition%2520of%2520Aldehyde%2520Oxidase%2520and%2520Covalent%2520Binding%2520with%2520Endogenous%2520Proteins%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D164%26epage%3D174%26doi%3D10.1002%2Fbdd.2123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Metabolism of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (Mptp) in Perfused Rat Liver: Involvement of Hepatic Aldehyde Oxidase as a Detoxification Enzyme</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">543</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10772632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVKgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=538-543&author=S.+Yoshiharaauthor=K.+Haradaauthor=S.+Ohta&title=Metabolism+of+1-Methyl-4-Phenyl-1%2C2%2C3%2C6-Tetrahydropyridine+%28Mptp%29+in+Perfused+Rat+Liver%3A+Involvement+of+Hepatic+Aldehyde+Oxidase+as+a+Detoxification+Enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in perfused rat liver: involvement of hepatic aldehyde oxidase as a detoxification enzyme</span></div><div class="casAuthors">Yoshihara, Shin'ichi; Harada, Keisuke; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-543</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">To elucidate the toxicol. relevance of hepatic aldehyde oxidase (AO) as a detoxification enzyme of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the authors studied the metab. and the hepatotoxicity of MPTP in intact rat livers exhibiting different AO activities by using a recirculating perfusion method.  In the perfusate during a 90-min recirculation of 1 mM MPTP, the perfused liver from Jcl:Wistar rat, a strain showing high AO activity, generated almost equal amts. of 1-methyl-4-phenylpyridinium species (MPP+) and 1-methyl-4-phenyl-5,6-dihydro-2-pyridone (MPTP lactam) as major metabolites, together with 4-phenyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-2-pyridone (MP 2-pyridone), and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine N-oxide.  However, a marked decrease of MPTP lactam as well as MP 2-pyridone and a concomitant increase of MPP+ were caused by coinfusion of 2-hydroxypyrimidine (2-OH PM), a competitive inhibitor of AO, into Jcl:Wistar rat liver.  A quite similar metabolic profile was obtained on perfusion of AO-deficient WKA/Sea rat liver.  Rather large amts. of MPP+ were retained in the liver in all the cases but esp. in Jcl:Wistar rat in the presence of 2-OH PM.  Lactate dehydrogenase leakage into the perfusate from rat liver perfused with 1 mM MPTP was greater in the strain with lower AO activity, WKA/Sea, than in that with higher AO activity, Jcl:Wistar.  Furthermore, inhibition of AO in Jcl:Wistar rat in the presence of 2-OH PM caused an enhancement of lactate dehydrogenase leakage.  These results suggest that hepatic AO is a key detoxification enzyme for MPTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYEw_mTvXmGrVg90H21EOLACvtfcHk0lg93_ld1lAy3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVKgurk%253D&md5=7eff6a1e3c86c8396bf038088d0a7343</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshihara%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DMetabolism%2520of%25201-Methyl-4-Phenyl-1%252C2%252C3%252C6-Tetrahydropyridine%2520%2528Mptp%2529%2520in%2520Perfused%2520Rat%2520Liver%253A%2520Involvement%2520of%2520Hepatic%2520Aldehyde%2520Oxidase%2520as%2520a%2520Detoxification%2520Enzyme%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2000%26volume%3D28%26spage%3D538%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Involvement of Hepatic Aldehyde Oxidase in Conversion of 1-Methyl-4-Phenyl-2,3-Dihydropyridinium (Mpdp+) to 1-Methyl-4-Phenyl-5,6-Dihydro-2-Pyridone</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>360</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1006/abbi.1998.0925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1006%2Fabbi.1998.0925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9826433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFOku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=1998&pages=93-98&issue=1&author=S.+Yoshiharaauthor=S.+Ohta&title=Involvement+of+Hepatic+Aldehyde+Oxidase+in+Conversion+of+1-Methyl-4-Phenyl-2%2C3-Dihydropyridinium+%28Mpdp%2B%29+to+1-Methyl-4-Phenyl-5%2C6-Dihydro-2-Pyridone&doi=10.1006%2Fabbi.1998.0925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone</span></div><div class="casAuthors">Yoshihara, Shin'ichi; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-98</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">To obtain direct evidence of the involvement of aldehyde oxidase (AO), a cytosolic molybdoflavoenzyme, in the metab. of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the authors investigated the in vitro metab. of MPTP and the two-electron-oxidized 1-methyl-4-phenyl-2,3-dihydropyridinium species (MPDP+) by using mouse liver enzyme prepns.  Incubation of MPTP with mitochondrial fraction gave exclusively 1-methyl-4-phenylpyridinium (MPP+); this reaction was inhibited by deprenyl, a monoamine oxidase (MAO)-B inhibitor, and KCN.  When the mitochondrial fraction was combined with the cytosolic fraction, MPP+ formation was markedly decreased, while a large amt. of 1-methyl-4-phenyl-5,6-dihydro-2-pyridone (MPTP lactam) was newly formed.  Incubation of MPDP+ with the cytosolic fraction led to rapid formation of MPTP lactam with concomitant disappearance of the substrate.  The cytosol-dependent formation of MPTP lactam was inhibited by known AO inhibitors, such as menadione, norharman, and KCN.  The activity of cytosol in MPTP lactam formation was completely duplicated by purified mouse liver AO.  These results indicate that AO catalyzes the metabolic conversion of MPDP+, produced from MPTP by MAO-B, to MPTP lactam.  This metabolic pathway might be an important detoxification route, averting the formation of toxic MPP+.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yYA8zidMqbVg90H21EOLACvtfcHk0lg93_ld1lAy3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFOku7o%253D&md5=6bcbee0b2e811b35b803021accda0f86</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1998.0925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1998.0925%26sid%3Dliteratum%253Aachs%26aulast%3DYoshihara%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DInvolvement%2520of%2520Hepatic%2520Aldehyde%2520Oxidase%2520in%2520Conversion%2520of%25201-Methyl-4-Phenyl-2%252C3-Dihydropyridinium%2520%2528Mpdp%252B%2529%2520to%25201-Methyl-4-Phenyl-5%252C6-Dihydro-2-Pyridone%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1998%26volume%3D360%26issue%3D1%26spage%3D93%26epage%3D98%26doi%3D10.1006%2Fabbi.1998.0925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al salhen, K. S.</span></span> <span> </span><span class="NLM_article-title">In Vitro Oxidation of Aldehyde Oxidase from Rabbit Liver: Specificity toward Endogenous Substrates</span>. <i>J. King Saud Univ., Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.jksus.2013.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.jksus.2013.09.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=67-74&issue=1&author=K.+S.+Al+salhen&title=In+Vitro+Oxidation+of+Aldehyde+Oxidase+from+Rabbit+Liver%3A+Specificity+toward+Endogenous+Substrates&doi=10.1016%2Fj.jksus.2013.09.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.jksus.2013.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jksus.2013.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2Bsalhen%26aufirst%3DK.%2BS.%26atitle%3DIn%2520Vitro%2520Oxidation%2520of%2520Aldehyde%2520Oxidase%2520from%2520Rabbit%2520Liver%253A%2520Specificity%2520toward%2520Endogenous%2520Substrates%26jtitle%3DJ.%2520King%2520Saud%2520Univ.%252C%2520Sci.%26date%3D2014%26volume%3D26%26issue%3D1%26spage%3D67%26epage%3D74%26doi%3D10.1016%2Fj.jksus.2013.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ambroziak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izaguirre, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietruszko, R.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Retinaldehyde and Other Aldehydes in Soluble Extracts of Human Liver and Kidney</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">33366</span>– <span class="NLM_lpage">33373</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.47.33366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.274.47.33366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10559215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXns1aqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=33366-33373&issue=47&author=W.+Ambroziakauthor=G.+Izaguirreauthor=R.+Pietruszko&title=Metabolism+of+Retinaldehyde+and+Other+Aldehydes+in+Soluble+Extracts+of+Human+Liver+and+Kidney&doi=10.1074%2Fjbc.274.47.33366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney</span></div><div class="casAuthors">Ambroziak, Wojciech; Izaguirre, Gonzalo; Pietruszko, Regina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">33366-33373</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Purifn. and characterization of enzymes metabolizing retinaldehyde, propionaldehyde, and octanaldehyde from four human livers and three kidneys were done to identify enzymes metabolizing retinaldehyde and their relationship to enzymes metabolizing other aldehydes.  The tissue fractionation patterns from human liver and kidney were the same, indicating presence of the same enzymes in human liver and kidney.  Moreover, in both organs the major NAD+-dependent retinaldehyde activity copurified with the propionaldehyde and octanaldehyde activities; in both organs the major NAD+-dependent retinaldehyde activity was assocd. with the E1 isoenzyme (coded for by aldh1 gene) of human aldehyde dehydrogenase.  A small amt. of NAD+-dependent retinaldehyde activity was assocd. with the E2 isoenzyme (product of aldh2 gene) of aldehyde dehydrogenase.  Some NAD+-independent retinaldehyde activity in both organs was assocd. with aldehyde oxidase, which could be easily sepd. from dehydrogenases.  Employing cellular retinoid-binding protein (CRBP), purified from human liver, demonstrated that E1 isoenzyme (but not E2 isoenzyme) could utilize CRBP-bound retinaldehyde as substrate, a feature thought to be specific to retinaldehyde dehydrogenases.  This is the first report of CRBP-bound retinaldehyde functioning as substrate for aldehyde dehydrogenase of broad substrate specificity.  Thus, it is concluded that in the human organism, retinaldehyde dehydrogenase (coded for by raldH1 gene) and broad substrate specificity E1 (a member of EC 1.2.1.3 aldehyde dehydrogenase family) are the same enzyme.  These results suggest that the E1 isoenzyme may be more important to alcoholism than the acetaldehyde-metabolizing enzyme, E2, because competition between acetaldehyde and retinaldehyde could result in abnormalities assocd. with vitamin A metab. and alcoholism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDFTFIAVDuTrVg90H21EOLACvtfcHk0liAv6n7ZNnqUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1aqu78%253D&md5=65c6a7db0fa4b044c4544b229c017043</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.47.33366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.47.33366%26sid%3Dliteratum%253Aachs%26aulast%3DAmbroziak%26aufirst%3DW.%26aulast%3DIzaguirre%26aufirst%3DG.%26aulast%3DPietruszko%26aufirst%3DR.%26atitle%3DMetabolism%2520of%2520Retinaldehyde%2520and%2520Other%2520Aldehydes%2520in%2520Soluble%2520Extracts%2520of%2520Human%2520Liver%2520and%2520Kidney%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D47%26spage%3D33366%26epage%3D33373%26doi%3D10.1074%2Fjbc.274.47.33366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panoutsopoulos, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Isovanillin by Aldehyde Oxidase, Xanthine Oxidase, Aldehyde Dehydrogenase and Liver Slices</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1159/000082860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1159%2F000082860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15627845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislagtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=199-208&issue=4&author=G.+I.+Panoutsopoulosauthor=C.+Beedham&title=Metabolism+of+Isovanillin+by+Aldehyde+Oxidase%2C+Xanthine+Oxidase%2C+Aldehyde+Dehydrogenase+and+Liver+Slices&doi=10.1159%2F000082860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of Isovanillin by Aldehyde Oxidase, Xanthine Oxidase, Aldehyde Dehydrogenase and Liver Slices</span></div><div class="casAuthors">Panoutsopoulos, Georgios I.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-208</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Arom. aldehydes are good substrates of aldehyde dehydrogenase activity but are relatively poor substrates of aldehyde oxidase and xanthine oxidase.  However, the oxidn. of xenobiotic-derived arom. aldehydes by the latter enzymes was not studied to any great extent.  The present investigation compares the relative contribution of aldehyde dehydrogenase, aldehyde oxidase and xanthine oxidase activities in the oxidn. of isovanillin in sep. prepns. and also in freshly prepd. and cryopreserved liver slices.  The oxidn. of isovanillin was also examd. in the presence of specific inhibitors of each oxidizing enzyme.  Minimal transformation of isovanillin to isovanillic acid was obsd. in partially purified aldehyde oxidase, which is thought to be due to residual xanthine oxidase activity.  Isovanillin was rapidly metabolized to isovanillic acid by high amts. of purified xanthine oxidase, but only low amts. are present in guinea pig liver fraction.  Thus the contribution of xanthine oxidase to isovanillin oxidn. in guinea pig is very low.  In contrast, isovanillin was rapidly catalyzed to isovanillic acid by guinea pig liver aldehyde dehydrogenase activity.  The inhibitor studies revealed that isovanillin was predominantly metabolized by aldehyde dehydrogenase activity.  The oxidn. of xenobiotic-derived arom. aldehydes with freshly prepd. or cryopreserved liver slices was not previously reported.  In freshly prepd. liver slices, isovanillin was rapidly converted to isovanillic acid, whereas the conversion was very slow in cryopreserved liver slices due to low aldehyde dehydrogenase activity.  The formation of isovanillic acid was not altered by allopurinol, but considerably inhibited by disulfiram.  It is therefore concluded that isovanillin is predominantly metabolized by aldehyde dehydrogenase activity, with minimal contribution from either aldehyde oxidase or xanthine oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt0lr2kupZVbVg90H21EOLACvtfcHk0liAv6n7ZNnqUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislagtL8%253D&md5=827159bda7971a989638eeae1fd5bf23</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1159%2F000082860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000082860%26sid%3Dliteratum%253Aachs%26aulast%3DPanoutsopoulos%26aufirst%3DG.%2BI.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DMetabolism%2520of%2520Isovanillin%2520by%2520Aldehyde%2520Oxidase%252C%2520Xanthine%2520Oxidase%252C%2520Aldehyde%2520Dehydrogenase%2520and%2520Liver%2520Slices%26jtitle%3DPharmacology%26date%3D2005%26volume%3D73%26issue%3D4%26spage%3D199%26epage%3D208%26doi%3D10.1159%2F000082860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panoutsopoulos, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouretas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Contribution of Aldehyde Oxidase, Xanthine Oxidase, and Aldehyde Dehydrogenase on the Oxidation of Aromatic Aldehydes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1368</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1021/tx030059u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx030059u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFaku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=1368-1376&issue=10&author=G.+I.+Panoutsopoulosauthor=D.+Kouretasauthor=C.+Beedham&title=Contribution+of+Aldehyde+Oxidase%2C+Xanthine+Oxidase%2C+and+Aldehyde+Dehydrogenase+on+the+Oxidation+of+Aromatic+Aldehydes&doi=10.1021%2Ftx030059u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes</span></div><div class="casAuthors">Panoutsopoulos, Georgios I.; Kouretas, Demetrios; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1368-1376</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aliph. aldehydes have a high affinity toward aldehyde dehydrogenase (ALDH) activity but are relatively poor substrates of aldehyde oxidase (AO) and xanthine oxidase (XO).  In addn., the oxidn. of xenobiotic-derived arom. aldehydes by the latter enzymes has not been studied to any great extent.  The present investigation compares the relative contribution of ALDH, AO, and XO activities in the oxidn. of substituted benzaldehydes in sep. prepns.  The incubation of vanillin, isovanillin, and protocatechuic aldehyde with either guinea pig liver AO, bovine milk XO, or guinea pig liver ALDH demonstrated that the 3 aldehyde-oxidizing enzymes had a complementary substrate specificity.  Incubations were also performed with specific inhibitors of each enzyme (isovanillin for AO, allopurinol for XO, and disulfiram for ALDH) to det. the relative contribution of each enzyme in the oxidn. of these aldehydes.  Under these conditions, vanillin was rapidly oxidized by AO, isovanillin was predominantly metabolized by ALDH, and protocatechuic aldehyde was slowly oxidized, possibly by all 3 enzymes.  Thus, AO may be a significant factor in the oxidn. of arom. aldehydes generated from amines and alkylbenzenes during drug metab.  In addn., this enzyme may also play a role in the catabolism of biogenic amines such as dopamine and noradrenaline where 3-methoxyphenylacetic acids are major metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7WrnGgzhlSbVg90H21EOLACvtfcHk0lgpr8lEs4xyEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFaku7w%253D&md5=1658aee3159eaca6ca5f6a35d09fa93c</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Ftx030059u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx030059u%26sid%3Dliteratum%253Aachs%26aulast%3DPanoutsopoulos%26aufirst%3DG.%2BI.%26aulast%3DKouretas%26aufirst%3DD.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DContribution%2520of%2520Aldehyde%2520Oxidase%252C%2520Xanthine%2520Oxidase%252C%2520and%2520Aldehyde%2520Dehydrogenase%2520on%2520the%2520Oxidation%2520of%2520Aromatic%2520Aldehydes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26issue%3D10%26spage%3D1368%26epage%3D1376%26doi%3D10.1021%2Ftx030059u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panoutsopoulos, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Kinetics and Specificity of Guinea Pig Liver Aldehyde Oxidase and Bovine Milk Xanthine Oxidase Towards Substituted Benzaldehydes</span>. <i>Acta Biochim. Pol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.18388%2Fabp.2004_3550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15448727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSitr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2004&pages=649-663&author=G.+I.+Panoutsopoulosauthor=C.+Beedham&title=Kinetics+and+Specificity+of+Guinea+Pig+Liver+Aldehyde+Oxidase+and+Bovine+Milk+Xanthine+Oxidase+Towards+Substituted+Benzaldehydes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes</span></div><div class="casAuthors">Panoutsopoulos, Georgios I.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica Polonica</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-663</span>CODEN:
                <span class="NLM_cas:coden">ABPLAF</span>;
        ISSN:<span class="NLM_cas:issn">0001-527X</span>.
    
            (<span class="NLM_cas:orgname">Polish Biochemical Society</span>)
        </div><div class="casAbstract">Molybdenum-contg. enzymes, aldehyde oxidase and xanthine oxidase, are important in the oxidn. of N-heterocyclic xenobiotics.  However, the role of these enzymes in the oxidn. of drug-derived aldehydes has not been established.  The present investigation describes the interaction of eleven structurally related benzaldehydes with guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase, since they have similar substrate specificity to human molybdenum hydroxylases.  The compds. under test included mono-hydroxy and mono-methoxy benzaldehydes as well as 3,4-dihydroxy-, 3-hydroxy-4-methoxy-, 4-hydroxy-3-methoxy-, and 3,4-dimethoxy-benzaldehydes.  In addn., various amines and catechols were tested with the molybdenum hydroxylases as inhibitors of benzaldehyde oxidn.  The kinetic consts. have shown that hydroxy-, and methoxy-benzaldehydes are excellent substrates for aldehyde oxidase (Km values 5×10-6 M to 1×10-5 M) with lower affinities for xanthine oxidase (Km values around 10-4 M).  Therefore, aldehyde oxidase activity may be a significant factor in the oxidn. of the arom. aldehydes generated from amines and alkyl benzenes during drug metab.  Compds. with a 3-methoxy group showed relatively high Vmax values with aldehyde oxidase, whereas the presence of a 3-hydroxy group resulted in minimal Vmax values or no reaction.  In addn., amines acted as weak inhibitors, whereas catechols had a more pronounced inhibitory effect on the aldehyde oxidase activity.  It is therefore possible that aldehyde oxidase may be crit. in the oxidn. of the analogous phenylacetaldehydes derived from dopamine and noradrenaline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMffSeaalBPrVg90H21EOLACvtfcHk0lgpr8lEs4xyEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSitr7E&md5=9a574cff56a42b3628a064323539e662</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.18388%2Fabp.2004_3550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18388%252Fabp.2004_3550%26sid%3Dliteratum%253Aachs%26aulast%3DPanoutsopoulos%26aufirst%3DG.%2BI.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DKinetics%2520and%2520Specificity%2520of%2520Guinea%2520Pig%2520Liver%2520Aldehyde%2520Oxidase%2520and%2520Bovine%2520Milk%2520Xanthine%2520Oxidase%2520Towards%2520Substituted%2520Benzaldehydes%26jtitle%3DActa%2520Biochim.%2520Pol.%26date%3D2004%26volume%3D51%26spage%3D649%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, S. M.</span></span> <span> </span><span class="NLM_article-title">International Regulatory Requirements for Genotoxicity Testing for Pharmaceuticals Used in Human Medicine, and Their Impurities and Metabolites</span>. <i>Environ. Mol. Mutagen</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1002/em.22077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fem.22077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28299826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlyrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=296-324&issue=5&author=S.+M.+Galloway&title=International+Regulatory+Requirements+for+Genotoxicity+Testing+for+Pharmaceuticals+Used+in+Human+Medicine%2C+and+Their+Impurities+and+Metabolites&doi=10.1002%2Fem.22077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolites</span></div><div class="casAuthors">Galloway, Sheila M.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental and Molecular Mutagenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">296-324</span>CODEN:
                <span class="NLM_cas:coden">EMMUEG</span>;
        ISSN:<span class="NLM_cas:issn">1098-2280</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The process of developing international (ICH) guidelines is described, and the main guidelines reviewed are the ICH S2(R1) guideline that includes the genotoxicity test battery for human pharmaceuticals, and the ICH M7 guideline for assessing and limiting potentially mutagenic impurities and degrdn. products in drugs.  Key aspects of the guidelines are reviewed in the context of drug development, for example the incorporation of genotoxicity assessment into non-clin. toxicity studies, and ways to develop and assess wt. of evidence.  In both guidelines, the existence of "thresholds" or non-linear dose responses for genotoxicity plays a part in the strategies.  Differences in ICH S2(R1) protocol recommendations from OECD guidelines are highlighted and rationales explained.  The use of genotoxicity data during clin. development and in assessment of carcinogenic potential is also described.  There are no international guidelines on assessment of potentially genotoxic metabolites, but some approaches to safety assessment are discussed for these.  Environ. Mol. Mutagen. 00:000-000, 2017. © 2017 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3K6IFtey1YbVg90H21EOLACvtfcHk0lgpr8lEs4xyEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlyrs7o%253D&md5=98e29a2194e9fb54a64c4c6c63a9ed76</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1002%2Fem.22077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fem.22077%26sid%3Dliteratum%253Aachs%26aulast%3DGalloway%26aufirst%3DS.%2BM.%26atitle%3DInternational%2520Regulatory%2520Requirements%2520for%2520Genotoxicity%2520Testing%2520for%2520Pharmaceuticals%2520Used%2520in%2520Human%2520Medicine%252C%2520and%2520Their%2520Impurities%2520and%2520Metabolites%26jtitle%3DEnviron.%2520Mol.%2520Mutagen%26date%3D2017%26volume%3D58%26issue%3D5%26spage%3D296%26epage%3D324%26doi%3D10.1002%2Fem.22077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Enzymes Responsible for Nitrazepam Metabolism and Toxicity in Human</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.06.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2017.06.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28606603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVWrt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=150-160&author=K.+Konishiauthor=T.+Fukamiauthor=S.+Gotohauthor=M.+Nakajima&title=Identification+of+Enzymes+Responsible+for+Nitrazepam+Metabolism+and+Toxicity+in+Human&doi=10.1016%2Fj.bcp.2017.06.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of enzymes responsible for nitrazepam metabolism and toxicity in human</span></div><div class="casAuthors">Konishi, Keigo; Fukami, Tatsuki; Gotoh, Saki; Nakajima, Miki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">150-160</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nitrazepam (NZP) is a hypnotic agent that rarely causes liver injuries in humans and teratogenicity in rodents.  In humans, NZP is primarily metabolized to 7-aminonitrazepam (ANZP) by redn. and subsequently to 7-acetylamino nitrazepam (AANZP) by acetylation.  ANZP can be regenerated from AANZP by hydrolysis in rodents, but it is still unclear whether this reaction occurs in humans.  In rodents, AANZP may be assocd. with teratogenicity, while in humans, it is known that drug-induced liver injuries may be caused by NZP reactive metabolite(s).  In this study, we attempted to identify the enzymes responsible for NZP metab. to obtain a basic understanding of this process and the assocd. metabolite toxicities.  We found that the NZP reductase activity in human liver cytosol (HLC) was higher than that in human liver microsomes (HLM).  We purified the responsible enzyme(s) from HLC and found that the NZP reductase was aldehyde oxidase 1 (AOX1).  The role of AOX1 was confirmed by an obsd. increase in the NZP reductase activity upon addn. of N1-methylnicotinamide, an electron donor of AOX1, as well as inhibition of this activity in HLC in the presence of AOX1 inhibitors.  ANZP was acetylated to form AANZP by N-acetyltransferase (NAT) 2.  An expt. using recombinant esterases in an inhibition study using HLM revealed that AANZP is hydrolyzed by arylacetamide deacetylase (AADAC) in the human liver.  N-Hydroxylamino NZP, which is suspected to be a reactive metabolite, was detected as a conjugate with N-acetyl-L-cysteine through NZP redn. and ANZP hydroxylation reactions.  In the latter reaction, the conjugate was readily formed by recombinant CYP3A4 among the various P 450 isoforms tested.  In sum, we found that AOX1, NAT2, AADAC, and CYP3A4 are the determinants for the pharmacokinetics of NZP and that they confer interindividual variability in sensitivity to NZP side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP9ChCZdiNo7Vg90H21EOLACvtfcHk0lgpr8lEs4xyEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVWrt7rE&md5=622995a5b19bf8575c5d9c1498d246b7</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.06.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.06.114%26sid%3Dliteratum%253Aachs%26aulast%3DKonishi%26aufirst%3DK.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DGotoh%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Enzymes%2520Responsible%2520for%2520Nitrazepam%2520Metabolism%2520and%2520Toxicity%2520in%2520Human%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D140%26spage%3D150%26epage%3D160%26doi%3D10.1016%2Fj.bcp.2017.06.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Chemical and Enzymatic Transformations of Nimesulide to Gsh Conjugates through Reductive and Oxidative Mechanisms</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2267</span>– <span class="NLM_lpage">2277</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.5b00290</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.5b00290" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGjurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=2267-2277&issue=12&author=L.+Zhouauthor=X.+Pangauthor=C.+Xieauthor=D.+Zhongauthor=X.+Chen&title=Chemical+and+Enzymatic+Transformations+of+Nimesulide+to+Gsh+Conjugates+through+Reductive+and+Oxidative+Mechanisms&doi=10.1021%2Facs.chemrestox.5b00290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and Enzymatic Transformations of Nimesulide to GSH Conjugates through Reductive and Oxidative Mechanisms</span></div><div class="casAuthors">Zhou, Lei; Pang, Xiaoyan; Xie, Cen; Zhong, Dafang; Chen, Xiaoyan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2277</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nimesulide (NIM) is a nonsteroidal anti-inflammatory drug, and clin. treatment with NIM has been assocd. with severe hepatotoxicity.  The bioactivation of nitro-reduced NIM (NIM-NH2), a major NIM metabolite, has been thought to be responsible for the hepatotoxicity of NIM.  However, we found that NIM-NH2 did not induce toxic effects in primary rat hepatocytes.  This study aimed to investigate other bioactivation pathways of NIM and evaluate their assocn. with hepatotoxicity.  After incubating NIM with NADPH- and GSH-supplemented human or rat liver microsomes, we identified two types of GSH conjugates: one was derived from the attachment of GSH to NIM-NH2 (NIM-NH2-GSH) and the other one was derived from a quinone-imine intermediate (NIM-OH-GSH).  NIM-NH2-GSH was generated not only by the oxidative activation of NIM-NH2 but also from the reductive activation of NIM.  Both NADPH and GSH could act as reducing agents.  Moreover, aldehyde oxidase also participated in the reductive activation of NIM.  NIM-OH-GSH was generated mainly from NIM via epoxidn. with CYP1A2 as the main catalyzing enzyme.  NIM was toxic to both primary human and rat hepatocytes, with IC50 values of 213 and 40 μM, resp.  Inhibition of the oxidative and reductive activation of NIM by the nonspecific CYP inhibitor 1-aminobenzotriazole and selective aldehyde oxidase inhibitor estradiol did not protect the cells from NIM-mediated toxicity.  Moreover, pretreating cells with L-buthionine-sulfoximine (a GSH depletor) did not affect the cytotoxicity of NIM.  These results suggested that oxidative and reductive activation of NIM did not cause the hepatotoxicity and that the parent drug concn. was assocd. with the cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruU3aQWFbXuLVg90H21EOLACvtfcHk0lgBL5joTukq3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGjurfF&md5=cd045b2ab836e5359a535cee27c87e87</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.5b00290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.5b00290%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DPang%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DChemical%2520and%2520Enzymatic%2520Transformations%2520of%2520Nimesulide%2520to%2520Gsh%2520Conjugates%2520through%2520Reductive%2520and%2520Oxidative%2520Mechanisms%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26issue%3D12%26spage%3D2267%26epage%3D2277%26doi%3D10.1021%2Facs.chemrestox.5b00290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanne, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Identification of Aldehyde Oxidase as the Neonicotinoid Nitroreductase</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1021/tx049737i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx049737i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnsVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=317-323&issue=2&author=R.+A.+Dickauthor=D.+B.+Kanneauthor=J.+E.+Casida&title=Identification+of+Aldehyde+Oxidase+as+the+Neonicotinoid+Nitroreductase&doi=10.1021%2Ftx049737i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Aldehyde Oxidase as the Neonicotinoid Nitroreductase</span></div><div class="casAuthors">Dick, Ryan A.; Kanne, David B.; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-323</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Imidacloprid (IMI), the prototypical neonicotinoid insecticide, is used worldwide for crop protection and flea control on pets.  It is both oxidatively metabolized by cytochrome P 450 enzymes and reduced at the nitroguanidine moiety by a previously unidentified cytosolic "neonicotinoid nitroreductase", the subject of this investigation.  Two major metabolites are detected on incubation of IMI with rabbit liver cytosol: the nitrosoguanidine (IMI-NO) and the aminoguanidine (IMI-NH2).  Three lines of evidence identify the molybdo-flavoenzyme aldehyde oxidase (AOX, EC 1.2.3.1) as the neonicotinoid nitroreductase.  First, classical AOX electron donor substrates (benzaldehyde, 2-hydroxypyrimidine, and N-methylnicotinamide) dramatically increase the rate of formation of IMI metabolites.  Allopurinol and diquat are also effective electron donors, while NADPH and xanthine are not.  Second, AOX inhibitors (potassium cyanide, menadione, and promethazine) inhibit metabolite formation when N-methylnicotinamide is utilized as an electron donor.  Without the addn. of an electron donor, rabbit liver cytosol reduces IMI only to IMI-NO at a slow rate.  This redn. is also inhibited by potassium cyanide, menadione, and promethazine, as well as by addnl. AOX inhibitors, cimetidine and chlorpromazine.  Finally, IMI nitroredn. by AOX is sensitive to an aerobic atm., but to a much lesser extent than cytochrome P 450 2D6.  Large species differences are obsd. in the IMI nitroreductive activity of liver cytosol.  While rabbit and monkey (Cynomolgus) give the highest levels of total metabolite formation, human, mouse, cow, and rat also metabolize IMI rapidly.  In contrast, dog, cat, and chicken liver cytosols do not reduce IMI at appreciable rates.  AOX, as a neonicotinoid nitroreductase, may limit the persistence of IMI, and possibly other neonicotinoids, in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEa6sAb7dPNrVg90H21EOLACvtfcHk0lgBL5joTukq3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnsVCqtw%253D%253D&md5=8057a5fddeb068c0e8e1f214259b9715</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Ftx049737i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx049737i%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DR.%2BA.%26aulast%3DKanne%26aufirst%3DD.%2BB.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DIdentification%2520of%2520Aldehyde%2520Oxidase%2520as%2520the%2520Neonicotinoid%2520Nitroreductase%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2005%26volume%3D18%26issue%3D2%26spage%3D317%26epage%3D323%26doi%3D10.1021%2Ftx049737i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maia, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, J. J.</span></span> <span> </span><span class="NLM_article-title">Nitrite Reduction by Molybdoenzymes: A New Class of Nitric Oxide-Forming Nitrite Reductases</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1007/s00775-014-1234-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00775-014-1234-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25589250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFWgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=403-433&issue=2&author=L.+B.+Maiaauthor=J.+J.+Moura&title=Nitrite+Reduction+by+Molybdoenzymes%3A+A+New+Class+of+Nitric+Oxide-Forming+Nitrite+Reductases&doi=10.1007%2Fs00775-014-1234-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases</span></div><div class="casAuthors">Maia, Luisa B.; Moura, Jose J. G.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-433</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  NO is a signaling mol. involved in several physiol. processes, in both prokaryotes and eukaryotes, and nitrite is being recognized as an NO source particularly relevant to cell signaling and survival under challenging conditions.  The "non-respiratory" nitrite redn. to NO is carried out by "non-dedicated" nitrite reductases, making use of metalloproteins present in cells to carry out other functions, such as several molybdoenzymes (a new class of nitric oxide-forming nitrite reductases).  Here, the authors highlight the physiol. relevance of Mo-dependent nitrite-derived NO formation in mammalian, plant, and bacterial signalling (and other) pathways.  The mammalian xanthine oxidase/xanthine dehydrogenase, aldehyde oxidase, mitochondrial amidoxime-reducing component, plant nitrate reductase, and bacterial aldehyde oxidoreductase and nitrate reductases are considered.  The nitrite reductase activity of each molybdoenzyme is described and the review is oriented to discuss the feasibility of the reactions from a (bio)chem. point of view.  In addn., the mol. mechanism proposed for the Mo-dependent nitrite redn. are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-oPWecs_W37Vg90H21EOLACvtfcHk0lgBL5joTukq3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFWgsA%253D%253D&md5=e213a017d9e0f7bc66278790ef558026</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1007%2Fs00775-014-1234-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-014-1234-2%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DL.%2BB.%26aulast%3DMoura%26aufirst%3DJ.%2BJ.%26atitle%3DNitrite%2520Reduction%2520by%2520Molybdoenzymes%253A%2520A%2520New%2520Class%2520of%2520Nitric%2520Oxide-Forming%2520Nitrite%2520Reductases%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2015%26volume%3D20%26issue%3D2%26spage%3D403%26epage%3D433%26doi%3D10.1007%2Fs00775-014-1234-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maia, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, J. J.</span></span> <span> </span><span class="NLM_article-title">Nitrite Reductase Activity of Rat and Human Xanthine Oxidase, Xanthine Dehydrogenase, and Aldehyde Oxidase: Evaluation of Their Contribution to No Formation in Vivo</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1021/bi500987w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi500987w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=685-710&issue=3&author=L.+B.+Maiaauthor=V.+Pereiraauthor=L.+Miraauthor=J.+J.+Moura&title=Nitrite+Reductase+Activity+of+Rat+and+Human+Xanthine+Oxidase%2C+Xanthine+Dehydrogenase%2C+and+Aldehyde+Oxidase%3A+Evaluation+of+Their+Contribution+to+No+Formation+in+Vivo&doi=10.1021%2Fbi500987w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrite reductase activity of rat and human xanthine oxidase, xanthine dehydrogenase, and aldehyde oxidase: Evaluation of their contribution to NO formation in vivo</span></div><div class="casAuthors">Maia, Luisa B.; Pereira, Vania; Mira, Lurdes; Moura, Jose J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">685-710</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nitrite is presently considered a NO "storage form" that can be made available, through its one-electron redn., to maintain NO formation under hypoxia/anoxia.  The molybdoenzymes, xanthine oxidase/dehydrogenase (XO/XD) and aldehyde oxidase (AO), are 2 of the most promising mammalian nitrite reductases, and in this work, the authors characterized NO formation by rat and human XO/XD and AO.  This is the 1st characterization of human enzymes, and the results support the employment of rat liver enzymes as suitable models of the human counterparts.  A comprehensive kinetic characterization of the effect of pH on XO- and AO-catalyzed nitrite redn. showed that the enzyme's specificity const. for nitrite increased 8-fold, while the KmNO2- decreased 6-fold, when the pH decreased from 7.4 to 6.3.  These results demonstrate that the ability of XO/AO to trigger NO formation would be greatly enhanced under the acidic conditions characteristic of ischemia.  The O2 inhibition was quantified, and the KiO2 values found (24.3-48.8 μM) suggested that in vivo NO formation would be fine-tuned by O2 availability.  The potential in vivo relative physiol. relevance of XO/XD/AO-dependent pathways of NO formation was evaluated using HepG2 and HMEC cell lines subjected to hypoxia.  NO formation by the cells was found to be pH-, nitrite-, and O2-dependent, and the relative contribution of XO/XD plus AO was found to be as high as 50%.  Collectively, these results supported the possibility that XO/XD and AO could contribute to NO generation under hypoxia inside a living human cell.  Furthermore, the mol. mechanism of XO/AO-catalyzed nitrite redn. was revised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqECP5pCAgPgLVg90H21EOLACvtfcHk0liPr_ofgf_Kmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrsLzO&md5=bab5f7ed51d1d4ef1dd6879ffb246132</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fbi500987w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi500987w%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DL.%2BB.%26aulast%3DPereira%26aufirst%3DV.%26aulast%3DMira%26aufirst%3DL.%26aulast%3DMoura%26aufirst%3DJ.%2BJ.%26atitle%3DNitrite%2520Reductase%2520Activity%2520of%2520Rat%2520and%2520Human%2520Xanthine%2520Oxidase%252C%2520Xanthine%2520Dehydrogenase%252C%2520and%2520Aldehyde%2520Oxidase%253A%2520Evaluation%2520of%2520Their%2520Contribution%2520to%2520No%2520Formation%2520in%2520Vivo%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26issue%3D3%26spage%3D685%26epage%3D710%26doi%3D10.1021%2Fbi500987w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span> <span> </span><span class="NLM_article-title">Involvement of Liver Aldehyde Oxidase in the Reduction of Nicotinamide N-Oxide</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(84)91297-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0006-291X%2884%2991297-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=6233971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2cXks1ygs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1984&pages=602-606&issue=2&author=S.+Kitamuraauthor=K.+Tatsumi&title=Involvement+of+Liver+Aldehyde+Oxidase+in+the+Reduction+of+Nicotinamide+N-Oxide&doi=10.1016%2F0006-291X%2884%2991297-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide</span></div><div class="casAuthors">Kitamura, Shigeyuki; Tatsumi, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">602-6</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Mammalian liver aldehyde oxidase was found to reduce nicotinamide N-oxide to nicotinamide.  Rabbit liver aldehyde oxidase supplemented with an electron donor exhibited a significant nicotinamide N-oxide reductase activity under anaerobic conditions.  Liver cytosols from rabbits, hogs, guinea pigs, hamsters, rats, and mice exhibited similar N-oxide reductase activities in the presence of an electron donor of aldehyde oxidase, but not xanthine oxidase.  The cytosolic N-oxide reductase activity was almost completely inhibited by menadione, an inhibitor of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobe1KAJWY-mbVg90H21EOLACvtfcHk0liPr_ofgf_Kmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1ygs7k%253D&md5=549bdd7d3ea9051944c6c6998ec14b6e</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2884%2991297-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252884%252991297-X%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DInvolvement%2520of%2520Liver%2520Aldehyde%2520Oxidase%2520in%2520the%2520Reduction%2520of%2520Nicotinamide%2520N-Oxide%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1984%26volume%3D120%26issue%3D2%26spage%3D602%26epage%3D606%26doi%3D10.1016%2F0006-291X%2884%2991297-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span> <span> </span><span class="NLM_article-title">N-Oxide Reduction of Quinoxaline-1,4-Dioxides Catalyzed by Porcine Aldehyde Oxidase Ssaox1</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.055418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.113.055418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24440959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVKqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=511-519&issue=4&author=P.+Muauthor=M.+Zhengauthor=M.+Xuauthor=Y.+Zhengauthor=X.+Tangauthor=Y.+Wangauthor=K.+Wuauthor=Q.+Chenauthor=L.+Wangauthor=Y.+Deng&title=N-Oxide+Reduction+of+Quinoxaline-1%2C4-Dioxides+Catalyzed+by+Porcine+Aldehyde+Oxidase+Ssaox1&doi=10.1124%2Fdmd.113.055418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">N-oxide reduction of quinoxaline-1,4-dioxides catalyzed by porcine aldehyde oxidase SsAOX1</span></div><div class="casAuthors">Mu, Peiqiang; Zheng, Ming; Xu, Ming; Zheng, Yuanming; Tang, Xianqing; Wang, Yufan; Wu, Kaixin; Chen, Qingmei; Wang, Lijuan; Deng, Yiqun</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-519, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Quinoxaline-1,4-dioxides (QdNOs) are a class of quinoxaline derivs. that are widely used in humans or animals as drugs or feed additives.  However, the metabolic mechanism, esp. the involved enzymes, has not been reported in detail.  In this study, the N-oxide redn. enzyme, porcine aldehyde oxidase SsAOX1 was identified and characterized.  The SsAOX1 gene was cloned from pig liver through reverse-transcription polymerase chain reaction using degenerate primers, which encode a 147-kDa protein with typical aldehyde oxidase motifs, two [2Fe-2S] centers, a FAD (FAD) binding domain, and a molybdenum cofactor domain.  After heterologous expression in a prokaryote, purified SsAOX1 formed a functional homodimer under native conditions.  Importantly, the SsAOX1 catalyzed the N-oxide redn. at the N1 position of three representative QdNOs (quinocetone, mequindox, and cyadox), which are commonly used as animal feed additives.  SsAOX1 has the highest activity toward quinocetone, followed by mequindox and cyadox, with kcat/Km values of 1.94 ± 0.04, 1.27 ± 0.15, and 0.43 ± 0.09 min-1 μM-1, resp.  However, SsAOX1 has the lowest substrate affinity for quinocetone, followed by the cyadox and mequindox, with Km values of 4.36 ± 0.56, 3.16 ± 0.48, and 2.96 ± 0.51 μM, resp.  In addn., using site-directed mutagenesis, we found that substitution of glycine 1019 with threonine endows SsAOX1 with N-oxide reductive activity at the N4 position.  The goal of this study was to identify and characterize the N-oxide redn. enzyme for a class of veterinary drugs, QdNOs, which will aid in the elucidation of the metabolic pathways of QdNOs and will provide a theor. basis for their administration and new veterinary drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo736HqsG6DhLVg90H21EOLACvtfcHk0liPr_ofgf_Kmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVKqtLg%253D&md5=3737fc8697d6abd12d20e8ba6bcbc752</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.055418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.055418%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DN-Oxide%2520Reduction%2520of%2520Quinoxaline-1%252C4-Dioxides%2520Catalyzed%2520by%2520Porcine%2520Aldehyde%2520Oxidase%2520Ssaox1%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D4%26spage%3D511%26epage%3D519%26doi%3D10.1124%2Fdmd.113.055418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span> <span> </span><span class="NLM_article-title">Involvement of Mammalian Liver Cytosols and Aldehyde Oxidase in Reductive Metabolism of Zonisamide</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8742231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28XhtFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1996&pages=199-202&author=K.+Sugiharaauthor=S.+Kitamuraauthor=K.+Tatsumi&title=Involvement+of+Mammalian+Liver+Cytosols+and+Aldehyde+Oxidase+in+Reductive+Metabolism+of+Zonisamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide</span></div><div class="casAuthors">Sugihara, Kazumi; Kitamura, Shigeyuki; Tatsumi, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-202</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Zonisamide (1,2-benzisoxazole-3-methansulfonamide), an anticonvulsant agent, is primarily metabolized to 2-sulfamoylacetylphenol by reductive cleavage of the 1,2-benzisoxazole ring.  Rabbit liver cytosol with an electron donor of aldehyde oxidase exhibited a significant zonisamide reductase activity that was sensitive to inhibition by menadione, an inhibitor of aldehyde oxidase.  The result suggested that the cytosolic activity is caused by aldehyde oxidase, a cytosolic enzyme.  In fact, rabbit and rat liver aldehyde oxidase had the ability to reduce zonisamide when supplemented with its electron donor.  Apparent KM and Vmax values of aldehyde oxidase for zonisamide were 217 μM and 42 nmol/10 min/mg protein in the case of the rabbit liver enzyme, and 542 μM and 382 nmol/10 min/mg protein in the case of the rat liver enzyme, resp.  In rabbits, hamsters, mice, and guinea pigs, zonisamide reductase activity of the liver cytosols with 2-hydroxypyrimidine, and electron donor of aldehyde oxidase, was much higher than that of the liver microsomes with NADPH.  In rats, zonisamide reductase activity was examd. with liver microsomes and cytosols from seven strains.  The 2-hydroxypyrimidine-dependent cytosolic activity exhibited marked strain differences, unlike the NADPH-dependent microsomal activity.  1,2-Benzisoxazole was also reduced to salicylaldehyde by rabbit liver cytosol and aldehyde oxidase in the presence of 2-hydroxypyrimidine.  Stoichiometric studies showed that 2-sulfamoylacetylphenol was formed accompanying nearly equimolar ammonia from zonisamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsj1fL0PqO4bVg90H21EOLACvtfcHk0liQanqRNWyWyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFCrs70%253D&md5=142cd72c5e1cc5024940b3d555499016</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DInvolvement%2520of%2520Mammalian%2520Liver%2520Cytosols%2520and%2520Aldehyde%2520Oxidase%2520in%2520Reductive%2520Metabolism%2520of%2520Zonisamide%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1996%26volume%3D24%26spage%3D199%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span> <span> </span><span class="NLM_article-title">Reduction and Methylation of Ziprasidone by Glutathione, Aldehyde Oxidase, and Thiol S-Methyltransferase in Humans: An in Vitro Study</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1057</span>, <span class="refDoi"> DOI: 10.3109/00498254.2012.683203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2012.683203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22559212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVCqtL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=1049-1057&issue=11&author=R.+S.+Obachauthor=C.+Prakashauthor=A.+M.+Kamel&title=Reduction+and+Methylation+of+Ziprasidone+by+Glutathione%2C+Aldehyde+Oxidase%2C+and+Thiol+S-Methyltransferase+in+Humans%3A+An+in+Vitro+Study&doi=10.3109%2F00498254.2012.683203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction and methylation of ziprasidone by glutathione, aldehyde oxidase, and thiol s-methyltransferase in humans: an in vitro study</span></div><div class="casAuthors">Obach, R. Scott; Prakash, Chandra; Kamel, Amin M.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1049-1057</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In humans, approx. two-thirds of the metabolic clearance of ziprasidone proceeds through redn. of the N-S bond of the benzisothiazole moiety, which is followed by methylation of the resulting thiophenol to the major metabolite S-methyldihydroziprasidone.  The objective of this study was to gain an understanding of the underlying mechanism of this clearance route.  Incubation of ziprasidone in human liver cytosol yielded the redn. product dihydroziprasidone.  Heating the cytosol prior to incubation prevented the reaction, and the reaction was saturable (KM = 3.9 μM; Vmax = 0.24 nmol/min/mg protein), supporting that it was enzyme catalyzed.  It was partially stimulated by 2-hydroxypyrimidine and inhibited by menadione, supporting a role for aldehyde oxidase in this reaction.  However, incubation of ziprasidone with reduced glutathione, even in the absence of cytosol, readily yielded dihydroziprasidone indicating that there is also a chem. redn. component to this clearance pathway.  The pathway was reversible because incubation of dihydroziprasidone in cytosol or with oxidized glutathione in buffer yielded ziprasidone.  The methylation of dihydroziprasidone was obsd. in human liver microsomes in the presence of S-adenosylmethionine (KM = 14 μM; Vmax = 0.032 nmol/min/mg protein).  This reaction was inhibited by 2,3-dichloro-α-methylbenzylamine supporting that thiol methyltransferase is the enzyme responsible for this reaction.  Thus, the main metabolic pathway for ziprasidone in humans occurs via chem. redn. and aldehyde oxidase catalyzed redn., followed by thiol methyltransferase catalyzed methylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFYh1Rs_L1_bVg90H21EOLACvtfcHk0liQanqRNWyWyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVCqtL%252FN&md5=768e5709852f4035543b973fd7489dfd</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.3109%2F00498254.2012.683203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2012.683203%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DPrakash%26aufirst%3DC.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26atitle%3DReduction%2520and%2520Methylation%2520of%2520Ziprasidone%2520by%2520Glutathione%252C%2520Aldehyde%2520Oxidase%252C%2520and%2520Thiol%2520S-Methyltransferase%2520in%2520Humans%253A%2520An%2520in%2520Vitro%2520Study%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26issue%3D11%26spage%3D1049%26epage%3D1057%26doi%3D10.3109%2F00498254.2012.683203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishigai, M.</span></span> <span> </span><span class="NLM_article-title">Oxime-Metabolizing Activity of Liver Aldehyde Oxidase</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>253</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(87)90194-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0003-9861%2887%2990194-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3566284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2sXktF2rt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1987&pages=413-418&issue=2&author=K.+Tatsumiauthor=M.+Ishigai&title=Oxime-Metabolizing+Activity+of+Liver+Aldehyde+Oxidase&doi=10.1016%2F0003-9861%2887%2990194-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Oxime-metabolizing activity of liver aldehyde oxidase</span></div><div class="casAuthors">Tatsumi, Kiyoshi; Ishigai, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">413-18</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">Liver aldehyde oxidase in the presence of its electron donor exhibited a significant oxime-metabolizing activity toward some different types of oximes under anaerobic conditions.  Acetophenone oxime and salicylaldoxime were exclusively converted to the corresponding oxo compds., whereas benzamidoxime was converted to the corresponding ketimine.  With d-camphor oxime, the formation of both the corresponding oxo compd. and ketimine was obsd.  Stoichiometric studies showed that the formation of oxo compds. is accompanied by nearly equimolar NH3.  A mechanism of oxime biotransformation is proposed in which liver aldehyde oxidase catalyzes the redn. of oximes to the corresponding ketimines which in turn undergo, depending on their chem. stability, nonenzymic hydrolysis to the corresponding oxo compds. and NH3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJSKbnGY5yWrVg90H21EOLACvtfcHk0liQanqRNWyWyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktF2rt78%253D&md5=a3522ad66bbba1f321f5b601fcafce02</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2887%2990194-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252887%252990194-9%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DIshigai%26aufirst%3DM.%26atitle%3DOxime-Metabolizing%2520Activity%2520of%2520Liver%2520Aldehyde%2520Oxidase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1987%26volume%3D253%26issue%3D2%26spage%3D413%26epage%3D418%26doi%3D10.1016%2F0003-9861%2887%2990194-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span> <span> </span><span class="NLM_article-title">Participation of Liver Aldehyde Oxidase in Reductive Metabolism of Hydroxamic Acids to Amides</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>247</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(86)90586-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2F0003-9861%2886%2990586-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3717945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL28XktValu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1986&pages=289-293&issue=2&author=K.+Sugiharaauthor=K.+Tatsumi&title=Participation+of+Liver+Aldehyde+Oxidase+in+Reductive+Metabolism+of+Hydroxamic+Acids+to+Amides&doi=10.1016%2F0003-9861%2886%2990586-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Participation of liver aldehyde oxidase in reductive metabolism of hydroxamic acids to amides</span></div><div class="casAuthors">Sugihara, Kazumi; Tatsumi, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-93</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The liver enzyme responsible for the redn. of arom. and heterocyclic hydroxamic acids to the corresponding amides was investigated with salicylhydroxamic acid, benzohydroxamic acid, anthranilohydroxamic acid, and nicotinohydroxamic acid.  Rabbit liver cytosol exhibited significant reductase activities toward the hydroxamic acids under anaerobic conditions when supplemented with an electron donor of aldehyde oxidase.  Similarly, rabbit liver aldehyde oxidase reduced these compds. to amides in the presence of its own electron donor, indicating that the reductase activities obsd. in the liver cytosol are due mainly to the cytosolic molybdoflavin enzyme.  Furthermore, a significant redn. of salicylhydroxamic acid and nicotinohydroxamic acid was also obsd. when an electron donor to aldehyde oxidase was incubated with liver cytosols from hamsters, guinea pigs, rats, and mice.  The cytosolic reductase activities toward salicylhydroxamic acid were markedly inhibited by menadione, an inhibitor of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy1GTZdY5VjLVg90H21EOLACvtfcHk0lgmz4Z9vWISTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktValu7g%253D&md5=b8174de45f2ae58fbb4ff8d89d7ed0b4</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2886%2990586-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252886%252990586-2%26sid%3Dliteratum%253Aachs%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DParticipation%2520of%2520Liver%2520Aldehyde%2520Oxidase%2520in%2520Reductive%2520Metabolism%2520of%2520Hydroxamic%2520Acids%2520to%2520Amides%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1986%26volume%3D247%26issue%3D2%26spage%3D289%26epage%3D293%26doi%3D10.1016%2F0003-9861%2886%2990586-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatsumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, H.</span></span> <span> </span><span class="NLM_article-title">Involvement of Liver Aldehyde Oxidase in Sulfoxide Reduction</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4585</span>– <span class="NLM_lpage">4588</span>, <span class="refDoi"> DOI: 10.1248/cpb.30.4585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1248%2Fcpb.30.4585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7168878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL3sXhtVegtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1982&pages=4585-4588&issue=12&author=K.+Tatsumiauthor=S.+Kitamuraauthor=H.+Yamada&title=Involvement+of+Liver+Aldehyde+Oxidase+in+Sulfoxide+Reduction&doi=10.1248%2Fcpb.30.4585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of liver aldehyde oxidase in sulfoxide reduction</span></div><div class="casAuthors">Tatsumi, Kiyoshi; Kitamura, Shigeyuki; Yamada, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4585-8</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    </div><div class="casAbstract">Evidence is presented that guinea pig liver aldehyde oxidase, which is in the cytosolic fraction, in the presence of its electron donors such as aldehydes or N-heterocyclic compds., functions as a sulfoxide reductase toward sulindac and other sulfoxide compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrYMqdjgKaxbVg90H21EOLACvtfcHk0lgmz4Z9vWISTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhtVegtrc%253D&md5=6a4cbd87147b57d043b32c18b2f365d7</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1248%2Fcpb.30.4585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.30.4585%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DH.%26atitle%3DInvolvement%2520of%2520Liver%2520Aldehyde%2520Oxidase%2520in%2520Sulfoxide%2520Reduction%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1982%26volume%3D30%26issue%3D12%26spage%3D4585%26epage%3D4588%26doi%3D10.1248%2Fcpb.30.4585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Human Liver Aldehyde Oxidase: Inhibition by 239 Drugs</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1177/0091270003260336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1177%2F0091270003260336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=14681337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Ojsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=7-19&issue=1&author=R.+S.+Obachauthor=P.+Huynhauthor=M.+C.+Allenauthor=C.+Beedham&title=Human+Liver+Aldehyde+Oxidase%3A+Inhibition+by+239+Drugs&doi=10.1177%2F0091270003260336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Human liver aldehyde oxidase: inhibition by 239 drugs</span></div><div class="casAuthors">Obach, R. Scott; Huynh, Phuong; Allen, Mary C.; Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-19</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The authors tested 239 frequently used drugs and other compds. for their potential to inhibit the drug-metabolizing enzyme, aldehyde oxidase, in human liver cytosol.  A sensitive, moderate throughput HPLC-MS assay was developed for 1-phthalazinone, the aldehyde oxidase-catalyzed product of phthalazine oxidn.  Inhibition of this activity was examd. for the 239 drugs and other compds. of interest at a test concn. of 50 μM.  Thirty-six compds. exhibited greater than 80% inhibition and were further examd. for measurement of IC50.  The most potent inhibitor obsd. was the selective estrogen receptor modulator, raloxifene (IC50 = 2.9 nM), and tamoxifen, estradiol, and ethinyl estradiol were also potent inhibitors.  Other classes of drugs that demonstrated inhibition of aldehyde oxidase included phenothiazines, tricyclic antidepressants, tricyclic atypical antipsychotic agents, and dihydropyridine calcium channel blockers, along with some other drugs, including loratadine, cyclobenzaprine, amodiaquine, maprotiline, ondansetron, propafenone, domperidone, quinacrine, ketoconazole, verapamil, tacrine, and salmeterol.  These findings are discussed in context to potential drug interactions that could be obsd. between these agents and drugs for which aldehyde oxidase is involved in metab. and warrant investigation of the possibility of clin. drug interactions mediated by inhibition of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxd8xFvCXbTLVg90H21EOLACvtfcHk0lgmz4Z9vWISTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Ojsg%253D%253D&md5=058765c4afeddb018ef9c1ca5a45d9b5</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1177%2F0091270003260336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270003260336%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DHuynh%26aufirst%3DP.%26aulast%3DAllen%26aufirst%3DM.%2BC.%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DHuman%2520Liver%2520Aldehyde%2520Oxidase%253A%2520Inhibition%2520by%2520239%2520Drugs%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2004%26volume%3D44%26issue%3D1%26spage%3D7%26epage%3D19%26doi%3D10.1177%2F0091270003260336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase Importance in Vivo in Xenobiotic Metabolism: Imidacloprid Nitroreduction in Mice</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kft066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1093%2Ftoxsci%2Fkft066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23462233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1OhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=22-28&issue=1&author=T.+L.+Swensonauthor=J.+E.+Casida&title=Aldehyde+Oxidase+Importance+in+Vivo+in+Xenobiotic+Metabolism%3A+Imidacloprid+Nitroreduction+in+Mice&doi=10.1093%2Ftoxsci%2Fkft066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase importance in vivo in xenobiotic metabolism: Imidacloprid nitroreduction in mice</span></div><div class="casAuthors">Swenson, Tami L.; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-28</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX) metabolizes many xenobiotics in vitro, but its importance in vivo is usually unknown relative to cytochrome P450s (CYPs) and other detoxification systems.  Currently, the most important insecticides are neonicotinoids, which are metabolized in vitro by AOX on redn. of the nitroimino group and by CYPs via oxidn. reactions.  The goal of this study was to establish the relative importance of AOX and CYPs in vivo using the mouse model.  The procedure was to reduce liver AOX activity by providing tungsten or hydralazine in the drinking water or to use the AOX-deficient DBA/2 mouse strain.  None of these approaches reduced CYP activity measured in vitro with an isoenzyme nonspecific substrate.  Liver AOX activity was reduced by 45% with tungsten and 61% with hydralazine and 81% in AOX-deficient mice relative to controls.  When mice were treated i.p. with the major neonicotinoid imidacloprid (IMI), metab. by CYP oxidn. reactions was not appreciably affected, whereas the AOX-generated nitrosoguanidine metabolite was decreased by 30% with tungsten and 56% with hydralazine and 86% in the AOX-deficient mice.  The other IMI nitroredn. metabolite, desnitro-IMI, was decreased by 55%, 65%, and 81% with tungsten, hydralazine, and in the AOX-deficient mice, resp.  Thus, decreasing liver AOX activity by three quite different procedures gave a corresponding decrease for in vivo reductive metabolites in the liver of IMI-treated mice.  Possible AOX involvement in IMI metab. in insects was evaluated using AOX-expressing and AOX-deficient Drosophila, but no differences were found in IMI nitroredn. or sensitivity between the two strains.  This is the first study to establish the in vivo relevance of AOX in neonicotinoid metab. in mammals and one of the first for xenobiotics in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO9w5zRrBAwrVg90H21EOLACvtfcHk0lgSxg6Q8SwQ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1OhsbY%253D&md5=be011129c9602b126002a032f053621b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkft066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkft066%26sid%3Dliteratum%253Aachs%26aulast%3DSwenson%26aufirst%3DT.%2BL.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DAldehyde%2520Oxidase%2520Importance%2520in%2520Vivo%2520in%2520Xenobiotic%2520Metabolism%253A%2520Imidacloprid%2520Nitroreduction%2520in%2520Mice%26jtitle%3DToxicol.%2520Sci.%26date%3D2013%26volume%3D133%26issue%3D1%26spage%3D22%26epage%3D28%26doi%3D10.1093%2Ftoxsci%2Fkft066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lavaggi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerecetto, H.</span></span> <span> </span><span class="NLM_article-title">Differential Enzymatic Reductions Governing the Differential Hypoxia-Selective Cytotoxicities of Phenazine 5,10-Dioxides</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1900</span>– <span class="NLM_lpage">1906</span>, <span class="refDoi"> DOI: 10.1021/tx800199v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800199v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVGjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1900-1906&issue=9&author=M.+L.+Lavaggiauthor=M.+Cabreraauthor=M.+Gonzalezauthor=H.+Cerecetto&title=Differential+Enzymatic+Reductions+Governing+the+Differential+Hypoxia-Selective+Cytotoxicities+of+Phenazine+5%2C10-Dioxides&doi=10.1021%2Ftx800199v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Enzymatic Reductions Governing the Differential Hypoxia-Selective Cytotoxicities of Phenazine 5,10-Dioxides</span></div><div class="casAuthors">Lavaggi, Maria Laura; Cabrera, Mauricio; Gonzalez, Mercedes; Cerecetto, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1900-1906</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Some derivs. of phenazine 5,10-dioxide are selectively toxic to hypoxic cells commonly found in solid tumors.  Previous studies of the phenazine 5,10-dioxide mechanism of action indicated that a bioredn. process could be involved in its selective toxicities, maybe as result of its potential HO·-releasing capability in hypoxia.  The major unresolved aspect of the mechanism of phenazine 5,10-dioxides is the identity of the reductase(s) in the cell responsible for activating the drug to its toxic form and metabolites.  The authors have studied the metab. in both hypoxia and oxia of some selected 2-amino and 2-hydroxyphenazine 5,10-dioxides (I-V), using rat liver microsomal and cytosol fractions.  Differential hypoxic/oxic metab. was found to be correlated to a compd.'s cytotoxic selectivity but, in general, without metabolic differences between liver microsomal or cytosolic enzymes.  Dicoumarol and ketoconazole were found to inhibit the hypoxic metab. of the most selective phenazine 5,10-dioxide I, inferring a role for DT-diaphorase and cytochrome P 450.  The least hypoxic selective agents, IV and V, possess different hypoxia-metabolic profiles as compared to deriv. I explaining the differential cytotoxic biol. behavior.  The nonselective deriv. II suffered bioredn. in both conditions and, according to the inhibition studies with dicoumarol and ketoconazole, involves both DT-diaphorase and cytochrome P 450.  The nontoxic deriv. III showed poor bioreductive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoETx6VIJhjYLVg90H21EOLACvtfcHk0lgSxg6Q8SwQ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVGjsLw%253D&md5=eaecbb6dac8c05d6d963f55b5a145267</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Ftx800199v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800199v%26sid%3Dliteratum%253Aachs%26aulast%3DLavaggi%26aufirst%3DM.%2BL.%26aulast%3DCabrera%26aufirst%3DM.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26atitle%3DDifferential%2520Enzymatic%2520Reductions%2520Governing%2520the%2520Differential%2520Hypoxia-Selective%2520Cytotoxicities%2520of%2520Phenazine%25205%252C10-Dioxides%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26issue%3D9%26spage%3D1900%26epage%3D1906%26doi%3D10.1021%2Ftx800199v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miceli, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Ziprasidone Metabolism, Aldehyde Oxidase, and Clinical Implications</span>. <i>J. Clin Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1097/01.jcp.0000084028.22282.f2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1097%2F01.jcp.0000084028.22282.f2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=12826984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFKjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=229-232&author=C.+Beedhamauthor=J.+J.+Miceliauthor=R.+S.+Obach&title=Ziprasidone+Metabolism%2C+Aldehyde+Oxidase%2C+and+Clinical+Implications&doi=10.1097%2F01.jcp.0000084028.22282.f2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Ziprasidone Metabolism, Aldehyde Oxidase, and Clinical Implications</span></div><div class="casAuthors">Beedham, Christine; Miceli, Jeffrey J.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-232</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Ziprasidone (Geodon, Zeldox), a recently approved atypical antipsychotic agent for the treatment of schizophrenia, undergoes extensive metab. in humans with very little (<5%) of the dose excreted as unchanged drug.  Two enzyme systems have been implicated in ziprasidone metab.: the cytosolic enzyme, aldehyde oxidase, catalyzes the predominant reductive pathway, and cytochrome P 4503A4 (CYP3A4) is responsible for two alternative oxidn. pathways.  The involvement of two competing pathways in ziprasidone metab. greatly reduces the potential for pharmacokinetic interactions between ziprasidone and other drugs.  Because CYP3A4 only mediates one third of ziprasidone metab., the likelihood of interactions between ziprasidone and CYP3A4 inhibitors/ substrates is low.  Furthermore, aldehyde oxidase activity does not appear to be altered when drugs or xenobiotics are coadministered.  Aldehyde oxidase, a molybdenum-contg. enzyme, catalyzes the oxidn. of N-heterocyclic drugs such as famciclovir and zaleplon, in addn. to reducing some agents such as zonisamide.  Both reactions can occur simultaneously.  Although in vitro inhibitors of aldehyde oxidase have been identified, there are no reported clin. interactions with aldehyde oxidase inhibitors or inducers.  There is no evidence of genetic polymorphism in aldehyde oxidase, and thus it is not surprising that ziprasidone exposure demonstrates unimodality in humans.  Aldehyde oxidase is unrelated to the similarly named enzyme aldehyde dehydrogenase, which is predominantly responsible for the oxidn. of acetaldehyde during ethanol metab.  Consequently, it is unlikely that there would be any pharmacokinetic interaction between ethanol and ziprasidone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaMcHVJ3jRXrVg90H21EOLACvtfcHk0lgSxg6Q8SwQ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFKjt7c%253D&md5=1a97e9ae5d19efabe87a67a384847d8f</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1097%2F01.jcp.0000084028.22282.f2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jcp.0000084028.22282.f2%26sid%3Dliteratum%253Aachs%26aulast%3DBeedham%26aufirst%3DC.%26aulast%3DMiceli%26aufirst%3DJ.%2BJ.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DZiprasidone%2520Metabolism%252C%2520Aldehyde%2520Oxidase%252C%2520and%2520Clinical%2520Implications%26jtitle%3DJ.%2520Clin%2520Psychopharmacol.%26date%3D2003%26volume%3D23%26spage%3D229%26epage%3D232%26doi%3D10.1097%2F01.jcp.0000084028.22282.f2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korzekwa, K. R.</span></span> <span> </span><span class="NLM_article-title">Predicting Intrinsic Clearance for Drugs and Drug Candidates Metabolized by Aldehyde Oxidase</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1268</span>, <span class="refDoi"> DOI: 10.1021/mp300568r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300568r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ajtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1262-1268&issue=4&author=J.+P.+Jonesauthor=K.+R.+Korzekwa&title=Predicting+Intrinsic+Clearance+for+Drugs+and+Drug+Candidates+Metabolized+by+Aldehyde+Oxidase&doi=10.1021%2Fmp300568r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting Intrinsic Clearance for Drugs and Drug Candidates Metabolized by Aldehyde Oxidase</span></div><div class="casAuthors">Jones, Jeffrey P.; Korzekwa, Kenneth R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1262-1268</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metab. by aldehyde oxidase (AO) has been responsible for a no. of drug failures in clin. trials.  The main reason is the clearance values for drugs metabolized by AO are underestimated by allometric scaling from preclin. species.  Furthermore, in vitro human data also underestimates clearance.  We have developed the first in silico models to predict both in vitro and in vivo human intrinsic clearance for 8 drugs with just two chem. descriptors.  These models explain a large amt. of the variance in the data using two computational ests. of the electronic and steric features of the reaction.  The in vivo computational models for human metab. are better than in vitro preclin. animal testing at predicting human intrinsic clearance.  Thus, it appears that AO is amenable to computational prediction of rates, which may be used to guide drug discovery, and predict pharmacokinetics for clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMe4imNUVqorVg90H21EOLACvtfcHk0lgPk22ToMA5LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ajtbc%253D&md5=b91f8487291a445d04cccd20fd9227a3</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fmp300568r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300568r%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26atitle%3DPredicting%2520Intrinsic%2520Clearance%2520for%2520Drugs%2520and%2520Drug%2520Candidates%2520Metabolized%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26issue%3D4%26spage%3D1262%26epage%3D1268%26doi%3D10.1021%2Fmp300568r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span> <span> </span><span class="NLM_article-title">Drug Metabolism in Drug Discovery and Development</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.apsb.2018.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30245961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3czhvVOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=721-732&issue=5&author=Z.+Zhangauthor=W.+Tang&title=Drug+Metabolism+in+Drug+Discovery+and+Development&doi=10.1016%2Fj.apsb.2018.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Drug metabolism in drug discovery and development</span></div><div class="casAuthors">Zhang Zhoupeng; Tang Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">721-732</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Drug metabolism as a discipline plays an important role in drug discovery and development and the effects of drug metabolism on pharmacokinetics (PK), pharmacodynamics (PD), and safety should be carefully considered.  This communication provides an overview of common strategies in the area of drug metabolism for improving PK/PD and safety profiles of drug candidates; these include, but are not limited to, collaboration with medicinal chemists on structure-activity relationships (SAR) to overcome high clearance, using deuterium replacement to further optimize a lead, prodrug approaches to circumvent formulation and delivery difficulties, and addressing issues such as species differences in metabolism, drug-drug interactions (DDI) and formation of reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzNUaecqdUJp6t8nS6Nc3fW6udTcc2ebEeSW9U6JR37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhvVOisg%253D%253D&md5=6e4ab48f370b85d3605309ce21eded67</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DDrug%2520Metabolism%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26issue%3D5%26spage%3D721%26epage%3D732%26doi%3D10.1016%2Fj.apsb.2018.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schildknegt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripp, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span> <span> </span><span class="NLM_article-title">Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.042770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.042770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22190693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=625-634&issue=3&author=R.+Sharmaauthor=T.+J.+Strelevitzauthor=H.+Gaoauthor=A.+J.+Clarkauthor=K.+Schildknegtauthor=R.+S.+Obachauthor=S.+L.+Rippauthor=D.+K.+Spracklinauthor=L.+M.+Tremaineauthor=A.+D.+Vaz&title=Deuterium+Isotope+Effects+on+Drug+Pharmacokinetics.+I.+System-Dependent+Effects+of+Specific+Deuteration+with+Aldehyde+Oxidase+Cleared+Drugs&doi=10.1124%2Fdmd.111.042770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs</span></div><div class="casAuthors">Sharma, Raman; Strelevitz, Timothy J.; Gao, Hongying; Clark, Alan J.; Schildknegt, Klaas; Obach, R. Scott; Ripp, Sharon L.; Spracklin, Douglas K.; Tremaine, Larry M.; Vaz, Alfin D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The pharmacokinetic properties of drugs may be altered by kinetic deuterium isotope effects.  With specifically deuterated model substrates and drugs metabolized by aldehyde oxidase, we demonstrate how knowledge of the enzyme's reaction mechanism, species differences in the role played by other enzymes in a drug's metabolic clearance, and differences in systemic clearance mechanisms are critically important for the pharmacokinetic application of deuterium isotope effects.  Ex vivo methods to project the in vivo outcome using deuterated carbazeran and zoniporide with hepatic systems demonstrate the importance of establishing the extent to which other metabolic enzymes contribute to the metabolic clearance mechanism.  Differences in pharmacokinetic outcomes in guinea pig and rat, with the same metabolic clearance mechanism, show how species differences in the systemic clearance mechanism can affect the in vivo outcome.  Overall, to gain from the application of deuteration as a strategy to alter drug pharmacokinetics, these studies demonstrate the importance of understanding the systemic clearance mechanism and knowing the identity of the metabolic enzymes involved, the extent to which they contribute to metabolic clearance, and the extent to which metab. contributes to the systemic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCSMFZQoq7tbVg90H21EOLACvtfcHk0lihhcqR_rDFcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsrc%253D&md5=8d94242f5ef844ab3f45cfe92275ecda</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042770%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DSchildknegt%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26aulast%3DVaz%26aufirst%3DA.%2BD.%26atitle%3DDeuterium%2520Isotope%2520Effects%2520on%2520Drug%2520Pharmacokinetics.%2520I.%2520System-Dependent%2520Effects%2520of%2520Specific%2520Deuteration%2520with%2520Aldehyde%2520Oxidase%2520Cleared%2520Drugs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D3%26spage%3D625%26epage%3D634%26doi%3D10.1124%2Fdmd.111.042770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futatsugi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D. N.</span></span> <span> </span><span class="NLM_article-title">Deuterium Isotope Effects in Drug Pharmacokinetics Ii: Substrate-Dependence of the Reaction Mechanism Influences Outcome for Cytochrome P450 Cleared Drugs</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">11</span>), <span class="NLM_elocation-id">e0206279</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0206279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1371%2Fjournal.pone.0206279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30427871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmsl2lsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&issue=11&author=H.+Sunauthor=D.+W.+Piotrowskiauthor=S.+T.+M.+Orrauthor=J.+S.+Warmusauthor=A.+C.+Wolfordauthor=S.+B.+Coffeyauthor=K.+Futatsugiauthor=Y.+Zhangauthor=A.+D.+N.+Vaz&title=Deuterium+Isotope+Effects+in+Drug+Pharmacokinetics+Ii%3A+Substrate-Dependence+of+the+Reaction+Mechanism+Influences+Outcome+for+Cytochrome+P450+Cleared+Drugs&doi=10.1371%2Fjournal.pone.0206279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects in drug pharmacokinetics II: substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs</span></div><div class="casAuthors">Sun, Hao; Piotrowski, David W.; Orr, Suvi T. M.; Warmus, Joseph S.; Wolford, Angela C.; Coffey, Steven B.; Futatsugi, Kentaro; Zhang, Yinsheng; Vaz, Alfin D. N.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e0206279/1-e0206279/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Two chemotypes were examd. in vitro with CYPs 3A4 and 2C19 by mol. docking, metabolic profiles, and intrinsic clearance deuterium isotope effects with specifically deuterated form to assess the potential for enhancement of pharmacokinetic parameters.  The results show the complexity of deuteration as an approach for pharmacokinetic enhancement when CYP enzymes are involved in metabolic clearance.  With CYP3A4 the rate limiting step was chemotype-dependent.  With one chemotype no intrinsic clearance deuterium isotope effect was obsd. with any deuterated form, whereas with the other chemotype the rate limiting step was isotopically sensitive, and the magnitude of the intrinsic clearance isotope effect was dependent on the position(s) and extent of deuteration.  Mol. docking and metabolic profiles aided in identifying sites for deuteration and predicted the possibility for metabolic switching.  However, the potential for an isotope effect on the intrinsic clearance cannot be predicted and must be established by examg. select deuterated versions of the chemotypes.  The results show how in a deuteration strategy mol. docking, in-vitro metabolic profiles, and intrinsic clearance assessments with select deuterated versions of new chem. entities can be applied to det. the potential for pharmacokinetic enhancement in a discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMi2y94MpYpbVg90H21EOLACvtfcHk0lihhcqR_rDFcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmsl2lsr0%253D&md5=6c8e9623365c6f20b6732e946478d11b</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0206279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0206279%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DOrr%26aufirst%3DS.%2BT.%2BM.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DVaz%26aufirst%3DA.%2BD.%2BN.%26atitle%3DDeuterium%2520Isotope%2520Effects%2520in%2520Drug%2520Pharmacokinetics%2520Ii%253A%2520Substrate-Dependence%2520of%2520the%2520Reaction%2520Mechanism%2520Influences%2520Outcome%2520for%2520Cytochrome%2520P450%2520Cleared%2520Drugs%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26issue%3D11%26doi%3D10.1371%2Fjournal.pone.0206279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Hara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">A Simple Litmus Test for Aldehyde Oxidase Metabolism of Heteroarenes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1616</span>– <span class="NLM_lpage">1620</span>, <span class="refDoi"> DOI: 10.1021/jm4017976</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4017976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1616-1620&issue=4&author=F.+O%E2%80%99Haraauthor=A.+C.+Burnsauthor=M.+R.+Collinsauthor=D.+Dalvieauthor=M.+A.+Ornelasauthor=A.+D.+Vazauthor=Y.+Fujiwaraauthor=P.+S.+Baran&title=A+Simple+Litmus+Test+for+Aldehyde+Oxidase+Metabolism+of+Heteroarenes&doi=10.1021%2Fjm4017976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">A simple litmus test for aldehyde oxidase metabolism of heteroarenes</span></div><div class="casAuthors">O'Hara, Fionn; Burns, Aaron C.; Collins, Michael R.; Dalvie, Deepak; Ornelas, Martha A.; Vaz, Alfin D. N.; Fujiwara, Yuta; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1616-1620</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bioavailability of arom. azaheterocyclic drugs can be affected by the activity of aldehyde oxidase (AO).  Susceptibility to AO metab. is difficult to predict computationally and can be complicated in vivo by differences between species.  The authors report the use of bis(((difluoromethyl)sulfinyl)oxy)zinc (DFMS) as a source of CF2H radical for a rapid and inexpensive chem. "litmus test" for the early identification of heteroarom. drug candidates that have a high probability of metab. by AO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVg4s4JDwh8rVg90H21EOLACvtfcHk0lihhcqR_rDFcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCmsro%253D&md5=f9f4aac781f7fd0966b8faa0469b37da</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fjm4017976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4017976%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hara%26aufirst%3DF.%26aulast%3DBurns%26aufirst%3DA.%2BC.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DOrnelas%26aufirst%3DM.%2BA.%26aulast%3DVaz%26aufirst%3DA.%2BD.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DA%2520Simple%2520Litmus%2520Test%2520for%2520Aldehyde%2520Oxidase%2520Metabolism%2520of%2520Heteroarenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D4%26spage%3D1616%26epage%3D1620%26doi%3D10.1021%2Fjm4017976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skipper, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wogan, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannenbaum, S. R.</span></span> <span> </span><span class="NLM_article-title">Monocyclic Aromatic Amines as Potential Human Carcinogens: Old Is New Again</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1093%2Fcarcin%2Fbgp267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=19887514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=50-58&issue=1&author=P.+L.+Skipperauthor=M.+Y.+Kimauthor=H.+L.+Sunauthor=G.+N.+Woganauthor=S.+R.+Tannenbaum&title=Monocyclic+Aromatic+Amines+as+Potential+Human+Carcinogens%3A+Old+Is+New+Again&doi=10.1093%2Fcarcin%2Fbgp267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Monocyclic aromatic amines as potential human carcinogens: old is new again</span></div><div class="casAuthors">Skipper, Paul L.; Kim, Min Young; Sun, H.-L. Patty; Wogan, Gerald N.; Tannenbaum, Steven R.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-58</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Alkylanilines are a group of chems. whose ubiquitous presence in the environment is a result of the multitude of sources from which they originate.  Exposure assessments indicate that most individuals experience lifelong exposure to these compds.  Many alkylanilines have biol. activity similar to that of the carcinogenic multi-ring arom. amines.  This review provides an overview of human exposure and biol. effects.  It also describes recent investigations into the biochem. mechanisms of action that lead to the assessment that they are most probably more complex than those of the more extensively investigated multi-ring arom. amines.  Not only is nitrenium ion chem. implicated in DNA damage by alkylanilines but also reactions involving quinone imines and perhaps reactive oxygen species.  Recent results described here indicate that alkylanilines can be potent genotoxins for cultured mammalian cells when activated by exogenous or endogenous phase I and phase II xenobiotic-metabolizing enzymes.  The nature of specific DNA damage products responsible for mutagenicity remains to be identified but evidence to date supports mechanisms of activation through obligatory N-hydroxylation as well as subsequent conjugation by sulfation and/or acetylation.  A fuller understanding of the mechanisms of alkylaniline genotoxicity is expected to provide important insights into the environmental and genetic origins of one or more human cancers and may reveal a substantial role for this group of compds. as potential human chem. carcinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu8jtJ_-C4s7Vg90H21EOLACvtfcHk0liVThDkYyQBFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCnsw%253D%253D&md5=37e5a874a1ee9edf96acb3ad73ec2925</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp267%26sid%3Dliteratum%253Aachs%26aulast%3DSkipper%26aufirst%3DP.%2BL.%26aulast%3DKim%26aufirst%3DM.%2BY.%26aulast%3DSun%26aufirst%3DH.%2BL.%26aulast%3DWogan%26aufirst%3DG.%2BN.%26aulast%3DTannenbaum%26aufirst%3DS.%2BR.%26atitle%3DMonocyclic%2520Aromatic%2520Amines%2520as%2520Potential%2520Human%2520Carcinogens%253A%2520Old%2520Is%2520New%2520Again%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26issue%3D1%26spage%3D50%26epage%3D58%26doi%3D10.1093%2Fcarcin%2Fbgp267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascitti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preville, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohrt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, P.</span></span> <span> </span><span class="NLM_article-title">Intrinsic Electrophilicity of a 4-Substituted-5-Cyano-6-(2-Methylpyridin-3-Yloxy)Pyrimidine Derivative: Structural Characterization of Glutathione Conjugates in Vitro</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1021/tx100429x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx100429x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=269-278&issue=2&author=A.+S.+Kalgutkarauthor=V.+Mascittiauthor=R.+Sharmaauthor=G.+W.+Walkerauthor=T.+Ryderauthor=T.+S.+McDonaldauthor=Y.+Chenauthor=C.+Previlleauthor=A.+Basakauthor=K.+F.+McClureauthor=J.+T.+Kohrtauthor=R.+P.+Robinsonauthor=M.+J.+Munchhofauthor=P.+Cornelius&title=Intrinsic+Electrophilicity+of+a+4-Substituted-5-Cyano-6-%282-Methylpyridin-3-Yloxy%29Pyrimidine+Derivative%3A+Structural+Characterization+of+Glutathione+Conjugates+in+Vitro&doi=10.1021%2Ftx100429x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic Electrophilicity of a 4-Substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine Derivative: Structural Characterization of Glutathione Conjugates in Vitro</span></div><div class="casAuthors">Kalgutkar, Amit S.; Mascitti, Vincent; Sharma, Raman; Walker, Gregory W.; Ryder, Tim; McDonald, Thomas S.; Chen, Yue; Preville, Cathy; Basak, Arindrajit; McClure, Kim F.; Kohrt, Jeffrey T.; Robinson, Ralph P.; Munchhof, Michael J.; Cornelius, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-278</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iso-Pr 9-anti-[5-cyano-6-(2-methyl-pyridin-3-yloxy)-pyrimidin-4-yloxy]-3-oxa-7-aza-bicyclo[3.3.1]nonane-7-carboxylate (I) represents a prototypic compd. from a lead chem. series of G protein-coupled receptor 119 agonists, intended for treatment of type 2 diabetes.  A series of these compds. was synthesis and their metab. studies with GSH, β-NADPH, and GST from equine liver were undertaken.  This observation suggests that the electron-withdrawing potential of the C5 cyano group serves to increase the electrophilicity of the C6 carbon (via stabilization of the transition state) and favors reaction with the nucleophilic thiol.  The mechanistic insights gained from these studies should assist medicinal chem. efforts toward the design of analogs that retain primary pharmacol. but are latent toward reaction with biol. nucleophiles, thus mitigating the potential for toxicol. outcome due to adduction with glutathione or proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAN7rYvalUIbVg90H21EOLACvtfcHk0liVThDkYyQBFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSitLo%253D&md5=b1b7d33bccecf36acd24ef5d0b707c3c</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Ftx100429x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx100429x%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DG.%2BW.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPreville%26aufirst%3DC.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DKohrt%26aufirst%3DJ.%2BT.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DCornelius%26aufirst%3DP.%26atitle%3DIntrinsic%2520Electrophilicity%2520of%2520a%25204-Substituted-5-Cyano-6-%25282-Methylpyridin-3-Yloxy%2529Pyrimidine%2520Derivative%253A%2520Structural%2520Characterization%2520of%2520Glutathione%2520Conjugates%2520in%2520Vitro%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26issue%3D2%26spage%3D269%26epage%3D278%26doi%3D10.1021%2Ftx100429x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1023/A:1012188625088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1023%2FA%3A1012188625088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9165525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=568-571&author=K.+Palmauthor=P.+Stenbergauthor=K.+Luthmanauthor=P.+Artursson&title=Polar+Molecular+Surface+Properties+Predict+the+Intestinal+Absorption+of+Drugs+in+Humans&doi=10.1023%2FA%3A1012188625088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface properties predict the intestinal absorption of drugs in humans</span></div><div class="casAuthors">Palm, Katrin; Stenberg, Patric; Luthman, Kristina; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">568-571</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">A theor. method was devised for prediction of drug absorption after oral administration to humans.  Twenty structurally diverse model drugs, ranging from 0.3 to 100% absorbed, were investigated.  The compds. also displayed diversity in physicochem. properties such as lipophilicity, hydrogen bonding potential and mol. size.  The dynamic mol. surface properties of the compds. were calcd., taking into account their 3-dimensional shape and flexibility.  An excellent sigmoidal relationship was established between the absorbed fraction after oral administration to humans (FA) and the dynamic polar mol. surface area (PSAd) (r2 = 0.94).  The relationship was stronger than those obtained for more established predictors of drug absorption.  Drugs that are completely absorbed (FA > 90%) had a PSAd ≤ 60 Å2 while drugs that are < 10% absorbed had a PSAd ≥ 140 Å2.  PSAd can be used to differentiate poorly absorbed drugs at an early stage of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPW66hupHIyLVg90H21EOLACvtfcHk0lg5S3tNR302lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlSksrk%253D&md5=1394f0d1059e7d99ee02be977b92da8b</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1023%2FA%3A1012188625088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1012188625088%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DK.%26aulast%3DStenberg%26aufirst%3DP.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DPolar%2520Molecular%2520Surface%2520Properties%2520Predict%2520the%2520Intestinal%2520Absorption%2520of%2520Drugs%2520in%2520Humans%26jtitle%3DPharm.%2520Res.%26date%3D1997%26volume%3D14%26spage%3D568%26epage%3D571%26doi%3D10.1023%2FA%3A1012188625088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didziapetris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Japertas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrauskas, A.</span></span> <span> </span><span class="NLM_article-title">Classification Analysis of P-Glycoprotein Substrate Specificity</span>. <i>J. Drug Target</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1080/10611860310001648248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F10611860310001648248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15203928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=391-406&issue=7&author=R.+Didziapetrisauthor=P.+Japertasauthor=A.+Avdeefauthor=A.+Petrauskas&title=Classification+Analysis+of+P-Glycoprotein+Substrate+Specificity&doi=10.1080%2F10611860310001648248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Classification Analysis of P-Glycoprotein Substrate Specificity</span></div><div class="casAuthors">Didziapetris, Remigijus; Japertas, Pranas; Avdeef, Alex; Petrauskas, Alanas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">391-406</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Prediction of P-glycoprotein substrate specificity (SPGP) can be viewed as a constituent part of a compd.'s "pharmaceutical profiling" in drug design.  This task is difficult to achieve due to several factors that raised many contradictory opinions: (i) the disparity between the SPGP values obtained in different assays, (ii) the confusion between Pgp substrates and inhibitors, (iii) the confusion between lipophilicity and amphiphilicity of Pgp substrates, and (iv) the dilemma of describing class-specific relationships when Pgp has no binding sites of high ligand specificity.  In this work, the authors compiled SPGP data for 1000 compds.  All data were represented in a binary format, assigning SPGP = 1 for substrates and SPGP = 0 for nonsubstrates.  Each value was ranked according to the reliability of exptl. assay.  Two data sets were considered.  Set 1 included 220 compds. with SPGP from polarized transport across MDR1 transfected cell monolayers.  Set 2 included the entire list of 1000 compds., with SPGP values of generally lower reliability.  Both sets were analyzed using a stepwise classification structure-activity relationship (C-SAR) method, leading to derivation of simple rules for crude estn. of SPGP values.  The obtained rules are based on the following factors: (i) compd.'s size expressed through molar wt. or vol., (ii) H-accepting given by the Abraham's β (that can be crudely approximated by the sum of O and N atoms), and (iii) ionization given by the acid and base pKa values.  Very roughly, SPGP can be estd. by the "rule of fours".  Compds. with (N + O) ≥ 8, MW > 400 and acid pKa > 4 are likely to be Pgp substrates, whereas compds. with (N+O) ≤ 4, MW < 400 and base pKa < 8 are likely to be nonsubstrates.  The obtained results support the view that Pgp functioning can be compared to a complex "mini-pharmacokinetic" system with fuzzy specificity.  This system can be described by a probabilistic version of Abraham's solvation equation, suggesting a certain similarity between Pgp transport and chromatog. retention.  The chromatog. model does not work in the case of "marginal" compds. with properties close to the "global" physicochem. cut-offs.  In the latter case various class-specific rules must be considered.  These can be assocd. with the "amphiphilicity" and "biol. similarity" of compds.  The definition of class-specific effects entails construction of the knowledge base that can be very useful in ADME profiling of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsvKJmruZ7RLVg90H21EOLACvtfcHk0lg5S3tNR302lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D&md5=5b7ea95eb2d9faded5645481c1330f03</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1080%2F10611860310001648248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860310001648248%26sid%3Dliteratum%253Aachs%26aulast%3DDidziapetris%26aufirst%3DR.%26aulast%3DJapertas%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DPetrauskas%26aufirst%3DA.%26atitle%3DClassification%2520Analysis%2520of%2520P-Glycoprotein%2520Substrate%2520Specificity%26jtitle%3DJ.%2520Drug%2520Target%26date%3D2003%26volume%3D11%26issue%3D7%26spage%3D391%26epage%3D406%26doi%3D10.1080%2F10611860310001648248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span> <span> </span><span class="NLM_article-title">Structural Modifications That Alter the P-Glycoprotein Efflux Properties of Compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4877</span>– <span class="NLM_lpage">4895</span>, <span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&issue=11&author=S.+A.+Hitchcock&title=Structural+Modifications+That+Alter+the+P-Glycoprotein+Efflux+Properties+of+Compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0lg5S3tNR302lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520Modifications%2520That%2520Alter%2520the%2520P-Glycoprotein%2520Efflux%2520Properties%2520of%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D11%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nambu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran-Dube, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalaie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grodsky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (C-Met) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-Ylmethyl)-1h-[1,2,3]Triazolo[4,5-B]Pyrazin-6-Yl)-1h-Pyrazol-1 -Yl)Ethanol (Pf-04217903) for the Treatment of Cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8091</span>– <span class="NLM_lpage">8109</span>, <span class="refDoi"> DOI: 10.1021/jm300967g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300967g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8091-8109&issue=18&author=J.+J.+Cuiauthor=M.+McTigueauthor=M.+Nambuauthor=M.+Tran-Dubeauthor=M.+Pairishauthor=H.+Shenauthor=L.+Jiaauthor=H.+Chengauthor=J.+Hoffmanauthor=P.+Leauthor=M.+Jalaieauthor=G.+H.+Goetzauthor=K.+Ryanauthor=N.+Grodskyauthor=Y.+L.+Dengauthor=M.+Parkerauthor=S.+Timofeevskiauthor=B.+W.+Murrayauthor=S.+Yamazakiauthor=S.+Aguirreauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensen&title=Discovery+of+a+Novel+Class+of+Exquisitely+Selective+Mesenchymal-Epithelial+Transition+Factor+%28C-Met%29+Protein+Kinase+Inhibitors+and+Identification+of+the+Clinical+Candidate+2-%284-%281-%28Quinolin-6-Ylmethyl%29-1h-%5B1%2C2%2C3%5DTriazolo%5B4%2C5-B%5DPyrazin-6-Yl%29-1h-Pyrazol-1+-Yl%29Ethanol+%28Pf-04217903%29+for+the+Treatment+of+Cancer&doi=10.1021%2Fjm300967g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer</span></div><div class="casAuthors">Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dube, Michelle; Pairish, Mason; Shen, Hong; Jia, Lei; Cheng, Hengmiao; Hoffman, Jacqui; Le, Phuong; Jalaie, Mehran; Goetz, Gilles H.; Koenig, Marcel; Vojkovsky, Tomas; Zhang, Fang-Jie; Do, Steven; Botrous, Iriny; Ryan, Kevin; Grodsky, Neil; Deng, Ya-li; Parker, Max; Timofeevski, Sergei; Murray, Brion W.; Yamazaki, Shinji; Aguirre, Shirley; Li, Qiuhua; Zou, Helen; Christensen, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8091-8109</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The c-MET receptor tyrosine kinase is an attractive oncol. target because of its crit. role in human oncogenesis and tumor progression.  An oxindole hydrazide hit 6 (VI) was identified during a c-MET HTS campaign and subsequently demonstrated to have an unusual degree of selectivity against a broad array of other kinases.  The cocrystal structure of the related oxindole hydrazide c-MET inhibitor 10 (X) with a nonphosphorylated c-MET kinase domain revealed a unique binding mode assocd. with the exquisite selectivity profile.  The chem. labile oxindole hydrazide scaffold was replaced with a chem. and metabolically stable triazolopyrazine scaffold using structure based drug design.  Medicinal chem. lead optimization produced 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (2, II, PF-04217903), an extremely potent and exquisitely selective c-MET inhibitor.  2 Demonstrated effective tumor growth inhibition in c-MET dependent tumor models with good oral PK properties and an acceptable safety profile in preclin. studies.  2 Progressed to clin. evaluation in a Phase I oncol. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9sgnBFaSHLbVg90H21EOLACvtfcHk0lgnGiztbPOeAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrrL&md5=3c3ecda1c9698f2f16f9ff7c95596105</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm300967g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300967g%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DParker%26aufirst%3DM.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAguirre%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Exquisitely%2520Selective%2520Mesenchymal-Epithelial%2520Transition%2520Factor%2520%2528C-Met%2529%2520Protein%2520Kinase%2520Inhibitors%2520and%2520Identification%2520of%2520the%2520Clinical%2520Candidate%25202-%25284-%25281-%2528Quinolin-6-Ylmethyl%2529-1h-%255B1%252C2%252C3%255DTriazolo%255B4%252C5-B%255DPyrazin-6-Yl%2529-1h-Pyrazol-1%2520-Yl%2529Ethanol%2520%2528Pf-04217903%2529%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D18%26spage%3D8091%26epage%3D8109%26doi%3D10.1021%2Fjm300967g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akabane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerst, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, K.</span></span> <span> </span><span class="NLM_article-title">A Quantitative Approach to Hepatic Clearance Prediction of Metabolism by Aldehyde Oxidase Using Custom Pooled Hepatocytes</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.3109/00498254.2012.670736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2012.670736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22448773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKisLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=863-871&issue=9&author=T.+Akabaneauthor=N.+Gerstauthor=J.+N.+Mastersauthor=K.+Tamura&title=A+Quantitative+Approach+to+Hepatic+Clearance+Prediction+of+Metabolism+by+Aldehyde+Oxidase+Using+Custom+Pooled+Hepatocytes&doi=10.3109%2F00498254.2012.670736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes</span></div><div class="casAuthors">Akabane, Takafumi; Gerst, Nicolas; Masters, Jeffrey N.; Tamura, Kouichi</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">863-871</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">We describe the usability of human pooled hepatocytes for non-CYP metab. evaluation and an in vivo-in vitro correlation anal. for aldehyde oxidase (AO) substrate compds. using pooled hepatocytes.  By comparing intrinsic clearance values of 18 compds. primarily metabolized by AO, UDP-glucuronosyltransferase, carbonyl/aldo-keto reductase, flavin-contg. monooxygenase, and monoamineoxidase in individual hepatocytes and pooled hepatocytes from the same individual donors, intrinsic clearance in the pooled hepatocytes was ±30% of the av. clearance value in individuals for 15 of 18 compds., suggesting that pooled hepatocytes maintained the av. activity of the individual hepatocytes.  Although the results of an in vivo-in vitro correlation anal. for AO substrate compds. showed a trend toward under-prediction, the underestimation ratios for all AO substrates were nevertheless comparable (7.2- to 14.9-fold), suggesting that hepatic clearance prediction for these compds. can be quantified using empirical scaling.  These observations enabled us to obtain specific pooled hepatocytes that showed the expected non-CYP enzyme activities by pre-characterization and to quantify hepatic clearance prediction for AO compds. using an empirical scaling factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_oKqnd67uxLVg90H21EOLACvtfcHk0lgnGiztbPOeAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKisLzO&md5=c37efa2bb66e044b701ece9b606d8426</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.3109%2F00498254.2012.670736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2012.670736%26sid%3Dliteratum%253Aachs%26aulast%3DAkabane%26aufirst%3DT.%26aulast%3DGerst%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DJ.%2BN.%26aulast%3DTamura%26aufirst%3DK.%26atitle%3DA%2520Quantitative%2520Approach%2520to%2520Hepatic%2520Clearance%2520Prediction%2520of%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%2520Using%2520Custom%2520Pooled%2520Hepatocytes%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26issue%3D9%26spage%3D863%26epage%3D871%26doi%3D10.3109%2F00498254.2012.670736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Kinetic Deuterium Isotope Effects in Cytochrome P450 Oxidation Reactions</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">9−10</span>),  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fjlcr.3031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24285515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVemsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=428-431&issue=9%E2%88%9210&author=F.+P.+Guengerich&title=Kinetic+Deuterium+Isotope+Effects+in+Cytochrome+P450+Oxidation+Reactions&doi=10.1002%2Fjlcr.3031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic deuterium isotope effects in cytochrome P 450 oxidation reactions</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (P 450) isoforms account for ∼75% of the metab. of drugs.  Most of the reactions catalyzed by P 450 isoforms are mixed-function oxidns., and a C-H bond is (usually) broken.  The rate-limiting nature of this step can be analyzed using the kinetic isotope effect (KIE) approach.  The most relevant type of KIE is one termed intermol. noncompetitive, indicative of rate-limiting C-H bond breaking.  A plot of KIE vs. kcat for several P 450s showed a correlation coeff. (r2) of 0.62.  Deuterium substitution has been considered as a potential means of slowing drug metab. or redirecting sites of metab. in some cases, and several general points can be made regarding the potential for application of deuterium in drug design/development based on what is known about P 450 KIEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKzliIFqb7trVg90H21EOLACvtfcHk0lgnGiztbPOeAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVemsbw%253D&md5=b06a7c3232f556435d16bf97b567199f</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3031%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DKinetic%2520Deuterium%2520Isotope%2520Effects%2520in%2520Cytochrome%2520P450%2520Oxidation%2520Reactions%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26issue%3D9%25E2%2588%259210%26spage%3D428%26epage%3D431%26doi%3D10.1002%2Fjlcr.3031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pue, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of Famciclovir in Man</span>. <i>Antivir. Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1177/09563202930040S602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1177%2F09563202930040S602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2cXitlGiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=47-55&author=M.+A.+Pueauthor=L.+Z.+Benet&title=Pharmacokinetics+of+Famciclovir+in+Man&doi=10.1177%2F09563202930040S602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of famciclovir in man</span></div><div class="casAuthors">Pue, M. A.; Benet, L. Z.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Chemistry & Chemotherapy</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">ACCHEH</span>;
        ISSN:<span class="NLM_cas:issn">0956-3202</span>.
    </div><div class="casAbstract">A review with 26 refs.  This review presents briefly the results of a no. of studies conducted in healthy volunteers, designed to investigate the pharmacokinetics of famciclovir, the oral form of the antiviral compd., penciclovir.  These studies have shown that famciclovir is absorbed rapidly and extensively following oral administration.  Extensive presystemic metab. of famciclovir occurs since compd.-related material in plasma consists almost entirely of deacetylated and oxidized metabolites.  Little or no parent compd. is detected in plasma or urine.  The major metabolite of famciclovir is penciclovir.  Max. plasma concns. of penciclovir are achieved rapidly following oral administration of famciclovir, and total systemic availability of penciclovir is high (77%).  Pharmacokinetic parameters for penciclovir are linear over the famciclovir oral dose range 125-75 mg and the penciclovir i.v. dose range 10-20 mg kg-1.  The distribution of penciclovir after i.v. administration is consistent with localization out of plasma and into tissues.  Penciclovir is eliminated rapidly and almost unchanged by net active tubular secretion and glomerular filtration in the kidneys.  The terminal phase elimination half-life of the compd. in healthy subjects is approx. 2 h.  A study in healthy elderly male subjects indicated no clin. significant effects of age on the pharmacokinetics of penciclovir following oral famciclovir administration.  Food appears to slow the rate of availability of penciclovir from oral famciclovir, but has no effects on the extent of availability of penciclovir.  These data indicate that famciclovir possesses excellent pharmacokinetic properties for the provision of clin. useful concns. of the antiviral agent penciclovir in the oral treatment of herpesviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCKJ8oqX1D47Vg90H21EOLACvtfcHk0ljNGOR6zcb9Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlGiu7w%253D&md5=b5f8a99ff882c36168a0048489faf478</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1177%2F09563202930040S602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F09563202930040S602%26sid%3Dliteratum%253Aachs%26aulast%3DPue%26aufirst%3DM.%2BA.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26atitle%3DPharmacokinetics%2520of%2520Famciclovir%2520in%2520Man%26jtitle%3DAntivir.%2520Chem.%2520Chemother.%26date%3D1993%26volume%3D4%26spage%3D47%26epage%3D55%26doi%3D10.1177%2F09563202930040S602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krenitsky, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miranda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteman, P. D.</span></span> <span> </span><span class="NLM_article-title">6-Deoxyacyclovir: A Xanthine Oxidase-Activated Prodrug of Acyclovir</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3209</span>– <span class="NLM_lpage">3213</span>, <span class="refDoi"> DOI: 10.1073/pnas.81.10.3209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1073%2Fpnas.81.10.3209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=6587347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL2cXkvVenurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=3209-3213&issue=10&author=T.+A.+Krenitskyauthor=W.+W.+Hallauthor=P.+de+Mirandaauthor=L.+M.+Beauchampauthor=H.+J.+Schaefferauthor=P.+D.+Whiteman&title=6-Deoxyacyclovir%3A+A+Xanthine+Oxidase-Activated+Prodrug+of+Acyclovir&doi=10.1073%2Fpnas.81.10.3209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">6-Deoxyacyclovir:  a xanthine oxidase-activated prodrug of acyclovir</span></div><div class="casAuthors">Krenitsky, Thomas A.; Hall, Willard W.; De Miranda, Paulo; Beauchamp, Lilia M.; Schaeffer, Howard J.; Whiteman, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3209-13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">6-Deoxyacyclovir (I)  [84408-37-7] was synthesized and found to be 18 times more water sol. than acyclovir  [59277-89-3]; I was readily oxidized to acyclovir by xanthine oxidase (EC 1.2.3.2)  [9002-17-9].  It is also oxidized by aldehyde oxidase (EC 1.2.3.1)  [9029-07-6] largely to 8-hydroxy-6-deoxyacyclovir  [91503-60-5].  I and the major products of its oxidn. by aldehyde oxidase are devoid of appreciable activity against herpes simplex type I in vitro.  The success of I as a prodrug in vivo would depend upon how well its desired activation by xanthine oxidase competed with the nonactivating oxidns. by aldehyde oxidase.  In rats dosed orally with I, absorption was extensive and the major urinary metabolite was acyclovir.  In 2 human volunteers, urinary excretions of acyclovir were 5-6 times greater than those typically obsd. after administration of equiv. doses of acyclovir itself.  The areas under the plasma concn.-time curves for acyclovir were also 5-6 times greater.  Plasma levels of acyclovir peaked soon after ingestion of the prodrug, indicating rapid absorption and metabolic conversion.  Thus, 6-deoxyacyclovir may have clin. usefulness as a prodrug of acyclovir suitable for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwm6CfFXKAirVg90H21EOLACvtfcHk0ljNGOR6zcb9Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXkvVenurc%253D&md5=67a3e2a53095adeddbd1b22860300db0</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1073%2Fpnas.81.10.3209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.81.10.3209%26sid%3Dliteratum%253Aachs%26aulast%3DKrenitsky%26aufirst%3DT.%2BA.%26aulast%3DHall%26aufirst%3DW.%2BW.%26aulast%3Dde%2BMiranda%26aufirst%3DP.%26aulast%3DBeauchamp%26aufirst%3DL.%2BM.%26aulast%3DSchaeffer%26aufirst%3DH.%2BJ.%26aulast%3DWhiteman%26aufirst%3DP.%2BD.%26atitle%3D6-Deoxyacyclovir%253A%2520A%2520Xanthine%2520Oxidase-Activated%2520Prodrug%2520of%2520Acyclovir%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1984%26volume%3D81%26issue%3D10%26spage%3D3209%26epage%3D3213%26doi%3D10.1073%2Fpnas.81.10.3209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilsky, R. L.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Clinical Pharmacology of 5-Fluorouracil</span>. <i>Oncology (Williston Park)</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9830619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADyaK1M%252FkvVeisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=13-18&author=R.+L.+Schilsky&title=Biochemical+and+Clinical+Pharmacology+of+5-Fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and clinical pharmacology of 5-fluorouracil</span></div><div class="casAuthors">Schilsky R L</div><div class="citationInfo"><span class="NLM_cas:title">Oncology (Williston Park, N.Y.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10 Suppl 7</span>),
    <span class="NLM_cas:pages">13-8</span>
        ISSN:<span class="NLM_cas:issn">0890-9091</span>.
    </div><div class="casAbstract">The cellular and clinical pharmacology of fluoropyrimidines is characterized by marked interpatient variability in tumor response and patient tolerance.  Understanding the metabolic pathways followed by 5-fluorouracil (5-FU) has led to new strategies to optimize therapy with these important agents.  The "fluoropyrimidine phenotype" of tumor cells can be used to determine whether therapy with these agents is appropriate and, if so, whether one fluoropyrimidine may offer a particular advantage over another.  Combining a dihydropyrimidine dehydrogenase inhibitor with 5-FU offers the potential to minimize pharmacokinetic variability and, in that way, to improve oral bioavailability, facilitate dosage adjustment to achieve desired concentrations, and increase the likelihood of tumor response while minimizing the risk of severe toxicity to individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_qCHOqWTNfYMcDoIzZtNkfW6udTcc2eZK_blncOONWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FkvVeisw%253D%253D&md5=8184a650c6ecd1be52ccade850415ce7</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchilsky%26aufirst%3DR.%2BL.%26atitle%3DBiochemical%2520and%2520Clinical%2520Pharmacology%2520of%25205-Fluorouracil%26jtitle%3DOncology%2520%2528Williston%2520Park%2529%26date%3D1998%26volume%3D12%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinderling, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karara, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span> <span> </span><span class="NLM_article-title">Systemic Availability of the Active Metabolite Hydroxy-Fasudil after Administration of Fasudil to Different Sites of the Human Gastrointestinal Tract</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1177/0091270006293767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1177%2F0091270006293767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=17192498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1altb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=19-25&issue=1&author=P.+H.+Hinderlingauthor=A.+H.+Kararaauthor=B.+Taoauthor=M.+Pawulaauthor=I.+Wildingauthor=M.+Lu&title=Systemic+Availability+of+the+Active+Metabolite+Hydroxy-Fasudil+after+Administration+of+Fasudil+to+Different+Sites+of+the+Human+Gastrointestinal+Tract&doi=10.1177%2F0091270006293767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic availability of the active metabolite hydroxy-fasudil after administration of fasudil to different sites of the human gastrointestinal tract</span></div><div class="casAuthors">Hinderling, Peter H.; Karara, Adel H.; Tao, Ben; Pawula, Maria; Wilding, Ian; Lu, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-25</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">This study evaluated the gastrointestinal absorption of fasudil, a novel Rho kinase inhibitor for the treatment of stable angina, at different sites using remote-controlled capsules and assessed the feasibility of developing an extended-release formulation.  Ten healthy male volunteers were enrolled, and 8 subjects completed this single-dose, open-label, randomized, 5-way crossover study.  Forty milligrams of fasudil HCl was administered as soln. to the distal ileum and ascending colon, as powder to the ascending colon, and orally as an immediate-release tablet and soln.  All treatments were well-tolerated and no serious adverse events were obsd.  The mean systemic availabilities of M3 relative to the oral soln. were 1.04 (distal ileum, soln.), 1.14 (ascending colon, soln.), 1.27 (ascending colon, powder) and 1.04 (oral tablet), indicating similar systemic availability of M3 after administration of fasudil HCl to different gastrointestinal sites.  The results suggest that development of a once-a-day extended-release formulation for fasudil HCl should be readily achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYRn_UaQvwZrVg90H21EOLACvtfcHk0lgy1U3DQA5_ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1altb0%253D&md5=a4654f0b409042d9faa61a0fdc57959c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1177%2F0091270006293767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270006293767%26sid%3Dliteratum%253Aachs%26aulast%3DHinderling%26aufirst%3DP.%2BH.%26aulast%3DKarara%26aufirst%3DA.%2BH.%26aulast%3DTao%26aufirst%3DB.%26aulast%3DPawula%26aufirst%3DM.%26aulast%3DWilding%26aufirst%3DI.%26aulast%3DLu%26aufirst%3DM.%26atitle%3DSystemic%2520Availability%2520of%2520the%2520Active%2520Metabolite%2520Hydroxy-Fasudil%2520after%2520Administration%2520of%2520Fasudil%2520to%2520Different%2520Sites%2520of%2520the%2520Human%2520Gastrointestinal%2520Tract%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2007%26volume%3D47%26issue%3D1%26spage%3D19%26epage%3D25%26doi%3D10.1177%2F0091270006293767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">Metabolomics Reveals the Formation of Aldehydes and Iminium in Gefitinib Metabolism</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2015.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2015.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26212543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Chsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=111-121&issue=1&author=X.+Liuauthor=Y.+Luauthor=X.+Guanauthor=B.+Dongauthor=H.+Chavanauthor=J.+Wangauthor=Y.+Zhangauthor=P.+Krishnamurthyauthor=F.+Li&title=Metabolomics+Reveals+the+Formation+of+Aldehydes+and+Iminium+in+Gefitinib+Metabolism&doi=10.1016%2Fj.bcp.2015.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism</span></div><div class="casAuthors">Liu, Xing; Lu, Yuanfu; Guan, Xinfu; Dong, Bingning; Chavan, Hemantkumar; Wang, Jin; Zhang, Yiqing; Krishnamurthy, Partha; Li, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-121</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gefitinib (GEF), an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, is widely used for the treatment of cancers, particularly non-small cell lung cancer.  However, its clin. use is limited by multiple adverse effects assocd. with GEF, such as liver and lung injuries, severe nausea, and diarrhea.  Although, the exact mechanism of GEF adverse effects are still unknown, xenobiotic-induced bioactivation is thought to play a significant role in GEF induced toxicity.  Using a metabolomic approach, we investigated the metabolic pathways of GEF in human and mouse liver microsomes.  Thirty four GEF metabolites and adducts were identified and half of them are novel.  The potential reactive metabolites, two aldehydes and one iminium, were identified for the first time.  The previously reported GSH adducts and primary amines were obsd. as well.  The aldehyde and iminium pathways were further confirmed by using methoxylamine and potassium cyanide as trapping reagents.  Using recombinant CYP450 isoforms, CYP3A4 inhibitor, and S9 from Cyp3a-null mice, we confirmed CYP3A is the major enzyme contributing to the formation of aldehydes, GSH adducts, and primary amines in liver.  Multiple enzymes contribute to the formation of iminium.  This study provided us more knowledge of GEF bioactivation and enzymes involved in metabolic pathways, which can be utilized for understanding the mechanism of adverse effects assocd. with GEF and predicting possible drug-drug interactions.  Further studies are suggested to det. the roles of these bioactivation pathways in GEF toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrViZ82Ih6lArVg90H21EOLACvtfcHk0lgy1U3DQA5_ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Chsb7M&md5=f95cbe2470bb41319e9e0fd1b5c3e25c</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DB.%26aulast%3DChavan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKrishnamurthy%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DMetabolomics%2520Reveals%2520the%2520Formation%2520of%2520Aldehydes%2520and%2520Iminium%2520in%2520Gefitinib%2520Metabolism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D97%26issue%3D1%26spage%3D111%26epage%3D121%26doi%3D10.1016%2Fj.bcp.2015.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of Tpn729 Metabolites in Humans Using Ultra-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.jpba.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26366939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2jtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=217-226&author=Y.+Zhuauthor=L.+Liauthor=P.+Dengauthor=X.+Chenauthor=D.+Zhong&title=Characterization+of+Tpn729+Metabolites+in+Humans+Using+Ultra-Performance+Liquid+Chromatography%2FQuadrupole+Time-of-Flight+Mass+Spectrometry&doi=10.1016%2Fj.jpba.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of TPN729 metabolites in humans using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry</span></div><div class="casAuthors">Zhu, Yunting; Li, Liang; Deng, Pan; Chen, Xiaoyan; Zhong, Dafang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">217-226</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">TPN729 has been reported as a novel phosphodiesterase type 5 (PDE5) inhibitor to treat erectile dysfunction, and is currently being tested in clin. trials.  In addn. to the potent inhibition against PDE5, TPN729 is regarded as a better alternative to provide fewer side effects and better patient compliance.  Given the potential therapeutic benefits of TPN729, it is of great importance to elucidate its metabolic characteristics in drug development.  This study is the first to investigate the metabolic fate of TPN729 in humans.  A rapid and reliable anal. method based on ultra-performance liq. chromatog./quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF MS) was established to investigate the metabolic profiles of TPN729 in human plasma, urine, and feces after its oral administration.  As a result, a total of 22 metabolites were identified, of which seven were confirmed in comparison with the ref. substances.  The incubations of the metabolite refs. in human hepatocytes and aldehyde trapping expt. were further conducted to investigate its metabolic pathways.  The results of the present study indicated the extensive metab. of TPN729 in humans, including oxidative deamination, oxidative ring opening, N-dealkylation, N-oxidn., hydroxylation, dehydrogenation, lactam formation, and glucuronidation.  M3 resulting from N-dealkylation was the major circulating substance detected in human plasma.  The principal metabolites detected in human feces were products of oxidative deamination and oxidative ring opening.  The parent drug was identified as the major component in urine.  Taken together, this study provided valuable information on the metabolic fate of TPN729 in humans, and applicable anal. strategies for rapid metabolic elucidation in complex matrix samples through the useful and reliable UPLC/Q-TOF MS technique.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVZMcV_WJUjrVg90H21EOLACvtfcHk0lhXPaWj8WDVmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2jtbfL&md5=c62f83995e393bbfb3f5ed259538ad9b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520Tpn729%2520Metabolites%2520in%2520Humans%2520Using%2520Ultra-Performance%2520Liquid%2520Chromatography%252FQuadrupole%2520Time-of-Flight%2520Mass%2520Spectrometry%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2016%26volume%3D117%26spage%3D217%26epage%3D226%26doi%3D10.1016%2Fj.jpba.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span> <span> </span><span class="NLM_article-title">Metabolism and Excretion of Imrecoxib in Rat</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.3109/00498250600595524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498250600595524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16854781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVCgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=441-455&issue=5&author=H.+Xuauthor=Y.+Zhangauthor=Y.+Sunauthor=P.+Zhangauthor=F.+Chuauthor=Z.+Guoauthor=H.+Zhangauthor=D.+Zhong&title=Metabolism+and+Excretion+of+Imrecoxib+in+Rat&doi=10.3109%2F00498250600595524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and excretion of imrecoxib in rat</span></div><div class="casAuthors">Xu, H.; Zhang, Y.; Sun, Y.; Zhang, P.; Chu, F.; Guo, Z.; Zhang, H.; Zhong, D.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">441-455</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The metab. and excretion of imrecoxib, a novel and moderately selective cyclooxygenase-II inhibitor, were investigated in rat.  The structures of metabolites were identified by mass spectrometry (MSn) and NMR.  Metabolic profiles of imrecoxib in urine, bile and feces were obtained by HPLC and LC/MSn, and cumulative excretion was detd. by LC/MSn.  Imrecoxib was extensively metabolized in rat after i.v. administration, with less than 2% of the dose excreted as parent drug in either urine or feces.  The major metabolic pathway was that the 4'-Me group of imrecoxib was first oxidized to the 4'-hydroxymethyl metabolite (M4), followed by addnl. oxidn. to 4'-carboxylic acid metabolite (M2).  The dihydroxylated metabolite, 4'-hydroxymethyl-5-hydroxyl imrecoxib (M3), was further oxidized to 4'-hydroxymethyl-5-carbonyl metabolite (M5), and glucuronide conjugates of M2-4 were formed.  After i.v. (5 mg kg-1) administration, the majority of the dose was recovered in the feces.  The dose was primarily excreted as the carboxylic acid metabolite in addn. to the 4'-hydroxymethyl metabolite.  The carboxylic acid metabolite was mainly excreted in feces, while the 4'-hydroxymethyl metabolite was mainly excreted in urine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL_PHJivoRSbVg90H21EOLACvtfcHk0lhXPaWj8WDVmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVCgtbY%253D&md5=a86e3c236b21fc11050f505eeb9a0fef</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.3109%2F00498250600595524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498250600595524%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DChu%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DD.%26atitle%3DMetabolism%2520and%2520Excretion%2520of%2520Imrecoxib%2520in%2520Rat%26jtitle%3DXenobiotica%26date%3D2006%26volume%3D36%26issue%3D5%26spage%3D441%26epage%3D455%26doi%3D10.3109%2F00498250600595524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D. F.</span></span> <span> </span><span class="NLM_article-title">Formation of 4’-Carboxyl Acid Metabolite of Imrecoxib by Rat Liver Microsomes</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1111/j.1745-7254.2006.00312.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1111%2Fj.1745-7254.2006.00312.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16539853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs12jt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=506-512&issue=4&author=H.+Y.+Xuauthor=P.+Zhangauthor=A.+S.+Gongauthor=Y.+M.+Sunauthor=F.+M.+Chuauthor=Z.+R.+Guoauthor=D.+F.+Zhong&title=Formation+of+4%E2%80%99-Carboxyl+Acid+Metabolite+of+Imrecoxib+by+Rat+Liver+Microsomes&doi=10.1111%2Fj.1745-7254.2006.00312.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes</span></div><div class="casAuthors">Xu, Hai-yan; Zhang, Peng; Gong, Ai-shen; Sun, Yu-ming; Chu, Feng-ming; Guo, Zong-ru; Zhong, Da-fang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">506-512</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Imrecoxib is a novel and moderately selective COX-2 inhibitor.  The aim of the present in vitro investigation was to study the formation of the major metabolite 4'-carboxylic acid imrecoxib (M2) and identify the enzyme(s) involved in the reaction.  The formation of M2 was studied in rat liver cytosol in the absence or presence of liver microsomes.  The formed metabolite was identified and quantified by LC/MSn.  In addn., to characterize the cytochrome P 450 (CYP) isoenzymes involved in M2 formation, the effects of typical CYP inhibitors (such as ketoconazle, quinine, α-naphthoflavone, methylpyrazole, and cimetidine) on the formation rate of M2 were investigated.  The formation of M2 from 4'-hydroxymethyl imrecoxib (M4) was completely dependent on rat liver microsomes and NADPH.  Enzyme kinetic studies demonstrated that the formation rate of M2 conformed to monophasic Michaelis-Menten kinetics.  Addnl. expts. showed that the formation of M2 was induced significantly by dexamethasone and lowered by ketoconazole strongly and concn.-dependently.  By comparison, other CYP inhibitors, such as α-naphthoflavone, cimetidine, quinine, and methylpyrazole had no inhibitory effects on this metabolic pathway.  These biotransformation studies of M4 and imrecoxib in rat liver at the subcellular level showed that the formation of M2 occurs in rat liver microsomes and is NADPH-dependent.  The reaction was mainly catalyzed by CYP 3A in untreated rats and in dexamethasone-induced rats.  Other CYP, such as CYP 1A, 2C, 2D, and 2E, seem unlikely to participate in this metabolic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2-0rMi82MtLVg90H21EOLACvtfcHk0lhXPaWj8WDVmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs12jt78%253D&md5=27d8cd1e66a51c4276632f46d4ed4628</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7254.2006.00312.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7254.2006.00312.x%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%2BY.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DGong%26aufirst%3DA.%2BS.%26aulast%3DSun%26aufirst%3DY.%2BM.%26aulast%3DChu%26aufirst%3DF.%2BM.%26aulast%3DGuo%26aufirst%3DZ.%2BR.%26aulast%3DZhong%26aufirst%3DD.%2BF.%26atitle%3DFormation%2520of%25204%25E2%2580%2599-Carboxyl%2520Acid%2520Metabolite%2520of%2520Imrecoxib%2520by%2520Rat%2520Liver%2520Microsomes%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2006%26volume%3D27%26issue%3D4%26spage%3D506%26epage%3D512%26doi%3D10.1111%2Fj.1745-7254.2006.00312.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomgren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dambach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallion, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropf, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macaluso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheerens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, K. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Potent and Selective Bruton’s Tyrosine Kinase Inhibitors: Pyridazinone Analogs with Improved Metabolic Stability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bmcl.2015.11.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26675441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvF2ms77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=575-579&issue=2&author=W.+B.+Youngauthor=J.+Barbosaauthor=P.+Blomgrenauthor=M.+C.+Bremerauthor=J.+J.+Crawfordauthor=D.+Dambachauthor=C.+Eigenbrotauthor=S.+Gallionauthor=A.+R.+Johnsonauthor=J.+E.+Kropfauthor=S.+H.+Leeauthor=L.+Liuauthor=J.+W.+Lubachauthor=J.+Macalusoauthor=P.+Maciejewskiauthor=S.+A.+Mitchellauthor=D.+F.+Ortwineauthor=J.+Di+Paoloauthor=K.+Reifauthor=H.+Scheerensauthor=A.+Schmittauthor=X.+Wangauthor=H.+Wongauthor=J.+M.+Xiongauthor=J.+Xuauthor=C.+Yuauthor=Z.+Zhaoauthor=K.+S.+Currie&title=Discovery+of+Highly+Potent+and+Selective+Bruton%E2%80%99s+Tyrosine+Kinase+Inhibitors%3A+Pyridazinone+Analogs+with+Improved+Metabolic+Stability&doi=10.1016%2Fj.bmcl.2015.11.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability</span></div><div class="casAuthors">Young, Wendy B.; Barbosa, James; Blomgren, Peter; Bremer, Meire C.; Crawford, James J.; Dambach, Donna; Eigenbrot, Charles; Gallion, Steve; Johnson, Adam R.; Kropf, Jeffrey E.; Lee, Seung H.; Liu, Lichuan; Lubach, Joseph W.; Macaluso, Jen; Maciejewski, Pat; Mitchell, Scott A.; Ortwine, Daniel F.; Di Paolo, Julie; Reif, Karin; Scheerens, Heleen; Schmitt, Aaron; Wang, Xiaojing; Wong, Harvey; Xiong, Jin-Ming; Xu, Jianjun; Yu, Christine; Zhao, Zhongdong; Currie, Kevin S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">575-579</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">BTK inhibitor GDC-0834 was found to be rapidly metabolized in human studies, resulting in a suspension of clin. trials.  The primary route of metab. was through cleavage of the acyclic amide bond connecting the terminal tetrahydrobenzothiophene with the central linker aryl ring.  SAR studies were focused on reducing metabolic cleavage of this amide, and resulted in the identification of several central aryl linker substituents that conferred improved stability.  The most promising substituted aryl linkers were then incorporated into an optimized pyridazinone scaffold, resulting in the identification of lead analog I, possessing improved potency, metabolic stability and preclin. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWhbh3H4N2ErVg90H21EOLACvtfcHk0lhAuspcngtWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2ms77M&md5=ff074fc16518d072ccb9b7b5d8520a03</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.076%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DW.%2BB.%26aulast%3DBarbosa%26aufirst%3DJ.%26aulast%3DBlomgren%26aufirst%3DP.%26aulast%3DBremer%26aufirst%3DM.%2BC.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DDambach%26aufirst%3DD.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGallion%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DKropf%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLubach%26aufirst%3DJ.%2BW.%26aulast%3DMacaluso%26aufirst%3DJ.%26aulast%3DMaciejewski%26aufirst%3DP.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DDi%2BPaolo%26aufirst%3DJ.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DScheerens%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DXiong%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%2520and%2520Selective%2520Bruton%25E2%2580%2599s%2520Tyrosine%2520Kinase%2520Inhibitors%253A%2520Pyridazinone%2520Analogs%2520with%2520Improved%2520Metabolic%2520Stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D575%26epage%3D579%26doi%3D10.1016%2Fj.bmcl.2015.11.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&issue=8&author=N.+A.+Meanwell&title=Synopsis+of+Some+Recent+Tactical+Application+of+Bioisosteres+in+Drug+Design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhAuspcngtWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520Some%2520Recent%2520Tactical%2520Application%2520of%2520Bioisosteres%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helmer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roffel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanteux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garratt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosje, T.</span></span> <span> </span><span class="NLM_article-title">A Dual-Administration Microtracer Technique to Characterize the Absorption, Distribution, Metabolism, and Excretion of [(14) C]Seletalisib (Ucb5857) in Healthy Subjects</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1582</span>– <span class="NLM_lpage">1590</span>, <span class="refDoi"> DOI: 10.1002/jcph.954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fjcph.954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28650526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslymsrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=1582-1590&issue=12&author=E.+Helmerauthor=J.+M.+Nicolasauthor=J.+Longauthor=A.+F.+Roffelauthor=E.+Jonesauthor=H.+Chanteuxauthor=N.+Diazauthor=H.+Garrattauthor=T.+Bosje&title=A+Dual-Administration+Microtracer+Technique+to+Characterize+the+Absorption%2C+Distribution%2C+Metabolism%2C+and+Excretion+of+%5B%2814%29+C%5DSeletalisib+%28Ucb5857%29+in+Healthy+Subjects&doi=10.1002%2Fjcph.954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A Dual-Administration Microtracer Technique to Characterize the Absorption, Distribution, Metabolism, and Excretion of [14C]Seletalisib (UCB5857) in Healthy Subjects</span></div><div class="casAuthors">Helmer, Eric; Nicolas, Jean-Marie; Long, Jeff; Roffel, Ad F.; Jones, Emma; Chanteux, Hugues; Diaz, Nieves; Garratt, Holly; Bosje, Tjerk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1582-1590</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphoinositide 3 kinases are targets for development of small-mol. inhibitors to disrupt progression of immune-inflammatory diseases.  This phase 1 open-label study (Eudract 2014-005353-39) evaluated the safety and relative bioavailability of 2 new seletalisib (UCB5857) formulations (A and B) compared with a ref. formulation.  Abs. bioavailability (period 1a, n = 6) and disposition and metab. (period 1b, n = 6) of the ref. formulation were evaluated: healthy subjects received 30 mg orally plus ∼20 μg of a 14C-labeled microtracer (i.v. in 1a, orally in 1b).  New formulations were evaluated: subjects from periods 1a and 1b were pooled and randomly distributed to receive a single oral dose (30 mg) of formulation A (n = 6) or B (n = 6) in periods 2 and 3, using a crossover design.  Abs. oral bioavailability of seletalisib was 97% (90% confidence interval 87, 107).  Unchanged [14C]seletalisib was the predominant radioactive component in plasma (94.8%).  After oral dosing, the radioactive dose was primarily recovered in feces (74.6%, geometric coeff. of variation [GeoCV] 18.1%), mostly as metabolites.  Seletalisib demonstrated a 24-h terminal half-life, vol. of distribution of 60.9 L (GeoCV 23.8%), and a total plasma clearance of 1.7 L/h (GeoCV 35.4%).  Formulations A and B displayed similar or even higher exposure compared with ref. seletalisib (areas under the concn.-time curves 19 337 [GeoCV 30.8%], 20 380 [GeoCV 37.7%], and 15 932 [GeoCV 36.4%] h·ng/mL, resp.).  New formulations A and B were bioequivalent with each other, and all 3 formulations showed acceptable safety profiles.  This radiolabeled microtracer approach successfully informed on the absorption, distribution, metab., and excretion of seletalisib and further guided the mechanistic pharmacokinetic modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG6cc05A-Y67Vg90H21EOLACvtfcHk0lhAuspcngtWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslymsrnP&md5=b952ae852af8bb6c54001e76694cf55d</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1002%2Fjcph.954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.954%26sid%3Dliteratum%253Aachs%26aulast%3DHelmer%26aufirst%3DE.%26aulast%3DNicolas%26aufirst%3DJ.%2BM.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DRoffel%26aufirst%3DA.%2BF.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DChanteux%26aufirst%3DH.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DGarratt%26aufirst%3DH.%26aulast%3DBosje%26aufirst%3DT.%26atitle%3DA%2520Dual-Administration%2520Microtracer%2520Technique%2520to%2520Characterize%2520the%2520Absorption%252C%2520Distribution%252C%2520Metabolism%252C%2520and%2520Excretion%2520of%2520%255B%252814%2529%2520C%255DSeletalisib%2520%2528Ucb5857%2529%2520in%2520Healthy%2520Subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2017%26volume%3D57%26issue%3D12%26spage%3D1582%26epage%3D1590%26doi%3D10.1002%2Fjcph.954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renard, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arslan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbacki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leval, X.</span></span> <span> </span><span class="NLM_article-title">Pyridine Analogues of Nimesulide: Design, Synthesis, and in Vitro and in Vivo Pharmacological Evaluation as Promising Cyclooxygenase 1 and 2 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5864</span>– <span class="NLM_lpage">5871</span>, <span class="refDoi"> DOI: 10.1021/jm900702b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900702b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2jsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5864-5871&issue=19&author=J.+F.+Renardauthor=D.+Arslanauthor=N.+Garbackiauthor=B.+Pirotteauthor=X.+de+Leval&title=Pyridine+Analogues+of+Nimesulide%3A+Design%2C+Synthesis%2C+and+in+Vitro+and+in+Vivo+Pharmacological+Evaluation+as+Promising+Cyclooxygenase+1+and+2+Inhibitors&doi=10.1021%2Fjm900702b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridine Analogues of Nimesulide: Design, Synthesis, and in Vitro and in Vivo Pharmacological Evaluation as Promising Cyclooxygenase 1 and 2 Inhibitors</span></div><div class="casAuthors">Renard, Jean-Francois; Arslan, Deniz; Garbacki, Nancy; Pirotte, Bernard; de Leval, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5864-5871</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(arylamino)- and (cycloalkylamino)-substituted N-pyridinylsulfonamides I (R = F3C, Me, F3CCH2CH2; R1 = cyclopentyl, cyclohexyl, cycloheptyl, Ph, 2-ClC6H4, 3-ClC6H4, 4-ClC6H4, 3-BrC6H4, 4-BrC6H4, 2-MeC6H4, 3-MeC6H4, 4-MeC6H4, 2-EtC6H4, 3-EtC6H4, 4-EtC6H4, 2-MeOC6H4, 3-MeOC6H4, 4-MeOC6H4; in some cases isolated as hydrochloride salts) are prepd. as nimesulide analogs for use as potential COX-2-selective antiinflammatory agents.  Substitution of 3-bromo-4-nitropyridine 1-oxide, prepd. in two steps from 3-bromopyridine, with amines R1NH2, followed by iron-mediated redn. of the nitro group and the N-oxide and sulfonylation yields I.  I (R = F3C; R1 = 4-ClC6H4) shows selective binding to COX-2 over COX-1 in a human whole blood model, with IC50 values for COX-1 and COX-2 of 0.91 μM and 0.12 μM, resp.; in a rat carrageenan-induced pleurisy model, I (R = F3C; R1 = 4-ClC6H4) decreased the amt. of secretions from the lungs of the rats by 42-65% at doses of 5-20 mg/kg, with similar or better efficacy than nimesulide while avoiding the functionality in nimesulide that may be responsible for its toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsovt9qxEtILVg90H21EOLACvtfcHk0lgOooF7j9XbYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2jsbnN&md5=6f2d163c857fba4fb382f13bcae993a1</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm900702b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900702b%26sid%3Dliteratum%253Aachs%26aulast%3DRenard%26aufirst%3DJ.%2BF.%26aulast%3DArslan%26aufirst%3DD.%26aulast%3DGarbacki%26aufirst%3DN.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3Dde%2BLeval%26aufirst%3DX.%26atitle%3DPyridine%2520Analogues%2520of%2520Nimesulide%253A%2520Design%252C%2520Synthesis%252C%2520and%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Pharmacological%2520Evaluation%2520as%2520Promising%2520Cyclooxygenase%25201%2520and%25202%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D19%26spage%3D5864%26epage%3D5871%26doi%3D10.1021%2Fjm900702b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Firestine, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davisson, V. J.</span></span> <span> </span><span class="NLM_article-title">A Tight Binding Inhibitor of 5-Aminoimidazole Ribonucleotide Carboxylase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">3484</span>– <span class="NLM_lpage">3486</span>, <span class="refDoi"> DOI: 10.1021/jm00074a033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00074a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK3sXms1Gitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3484-3486&issue=22&author=S.+M.+Firestineauthor=V.+J.+Davisson&title=A+Tight+Binding+Inhibitor+of+5-Aminoimidazole+Ribonucleotide+Carboxylase&doi=10.1021%2Fjm00074a033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">A tight binding inhibitor of 5-aminoimidazole ribonucleotide carboxylase</span></div><div class="casAuthors">Firestine, Steven M.; Davisson, V. Jo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3484-6</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">One carbon-carbon bond is made in the course of de novo biosynthesis of purine nucleotides and its formation is catalyzed by 5-aminoimidazole ribonucleotide carboxylase.  The limited no. of inhibitor design efforts for this enzyme has largely been due to a lack of information regarding its mechanism of action.  In this report, a tight binding inhibitor for the avian form of the enzyme is described.  The inhibitor 5-amino-1-(5'-phospho-β-D-ribofuranosyl)-4-nitroimidazole (I) which has an isoelectronic substitution of a nitro group for the carboxylic acid moiety in the normal enzymic product, binds to the enzyme in a reversible fashion with no covalent interactions.  Slow binding and release phases were detected under steady-state conditions, and progress curve analyses were used to establish a Ki of 0.34 nM.  This is the first example of a potent inhibitor targeted for this crit. enzyme.  The inhibitory binding of this simple isostere is consistent with the proposal that I is a mimic of a transition-state and provides the first evidence for a tetrahedral intermediate in the normal turnover process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqusQuuxziOZrVg90H21EOLACvtfcHk0lgOooF7j9XbYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXms1Gitbg%253D&md5=c8c63204f9028a34add95ea2f910485e</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm00074a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00074a033%26sid%3Dliteratum%253Aachs%26aulast%3DFirestine%26aufirst%3DS.%2BM.%26aulast%3DDavisson%26aufirst%3DV.%2BJ.%26atitle%3DA%2520Tight%2520Binding%2520Inhibitor%2520of%25205-Aminoimidazole%2520Ribonucleotide%2520Carboxylase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D22%26spage%3D3484%26epage%3D3486%26doi%3D10.1021%2Fjm00074a033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagarathnam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murali Dhar, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzabadi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broten, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransom, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schorn, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendesky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrell, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluchowski, C.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Novel Alpha(1)(a) Adrenoceptor-Selective Antagonists. 1. Structure-Activity Relationship in Dihydropyrimidinones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">4764</span>– <span class="NLM_lpage">4777</span>, <span class="refDoi"> DOI: 10.1021/jm990200p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990200p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVSqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4764-4777&issue=23&author=D.+Nagarathnamauthor=S.+W.+Miaoauthor=B.+Laguauthor=G.+Chiuauthor=J.+Fangauthor=T.+G.+Murali+Dharauthor=J.+Zhangauthor=S.+Tyagarajanauthor=M.+R.+Marzabadiauthor=F.+Zhangauthor=W.+C.+Wongauthor=W.+Sunauthor=D.+Tianauthor=J.+M.+Wetzelauthor=C.+Forrayauthor=R.+S.+Changauthor=T.+P.+Brotenauthor=R.+W.+Ransomauthor=T.+W.+Schornauthor=T.+B.+Chenauthor=S.+O%E2%80%99Malleyauthor=P.+Klingauthor=K.+Schneckauthor=R.+Bendeskyauthor=C.+M.+Harrellauthor=K.+P.+Vyasauthor=C.+Gluchowski&title=Design+and+Synthesis+of+Novel+Alpha%281%29%28a%29+Adrenoceptor-Selective+Antagonists.+1.+Structure-Activity+Relationship+in+Dihydropyrimidinones&doi=10.1021%2Fjm990200p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel α1a Adrenoceptor-Selective Antagonists. 1. Structure-Activity Relationship in Dihydropyrimidinones</span></div><div class="casAuthors">Nagarathnam, Dhanapalan; Miao, Shou Wu; Lagu, Bharat; Chiu, George; Fang, James; Dhar, T. G. Murali; Zhang, Jack; Tyagarajan, Sriram; Marzabadi, Mohammad R.; Zhang, Fengqi; Wong, Wai C.; Sun, Wanying; Tian, Dake; Wetzel, John M.; Forray, Carlos; Chang, Raymond S. L.; Broten, Theodore P.; Ransom, Richard W.; Schorn, Terry W.; Chen, Tsing B.; O'Malley, Stacey; Kling, Paul; Schneck, Kathryn; Bendesky, Robert; Harrell, Charles M.; Vyas, Kamlesh P.; Gluchowski, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4764-4777</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dihydropyrimidinones such as compd. I exhibited high binding affinity and subtype selectivity for the cloned human α1a receptor.  Systematic modifications of I led to identification of highly potent and subtype-selective compds. with high binding affinity (Ki = 0.2 nM) for α1a receptor and greater than 1500-fold selectivity over α1b and α1d adrenoceptors.  The compds. were found to be functional antagonists in human, rat, and dog prostate tissues.  One of the compds. [(+)SNAP 6201] exhibited excellent selectively to inhibit intraurethral pressure (IUP) as compared to lowering diastolic blood pressure (DBP) in mongrel dogs (Kb(DBP)/Kb(IUP) = 40) suggesting uroselectivity for α1a-selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfso0m6xXmxbVg90H21EOLACvtfcHk0lgOooF7j9XbYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVSqtLk%253D&md5=af256a5faa2aa3c16b0c137b06ae49cb</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Fjm990200p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990200p%26sid%3Dliteratum%253Aachs%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DMiao%26aufirst%3DS.%2BW.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DChiu%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DMurali%2BDhar%26aufirst%3DT.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DMarzabadi%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DWong%26aufirst%3DW.%2BC.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DWetzel%26aufirst%3DJ.%2BM.%26aulast%3DForray%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DR.%2BS.%26aulast%3DBroten%26aufirst%3DT.%2BP.%26aulast%3DRansom%26aufirst%3DR.%2BW.%26aulast%3DSchorn%26aufirst%3DT.%2BW.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DKling%26aufirst%3DP.%26aulast%3DSchneck%26aufirst%3DK.%26aulast%3DBendesky%26aufirst%3DR.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DVyas%26aufirst%3DK.%2BP.%26aulast%3DGluchowski%26aufirst%3DC.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Novel%2520Alpha%25281%2529%2528a%2529%2520Adrenoceptor-Selective%2520Antagonists.%25201.%2520Structure-Activity%2520Relationship%2520in%2520Dihydropyrimidinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D23%26spage%3D4764%26epage%3D4777%26doi%3D10.1021%2Fjm990200p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gneuwuch, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, H. L.</span></span> <span> </span><span class="NLM_article-title">Pyridine Isosteres of The.Beta.-Adrenergic Antagonists, 2-(P-Nitrophenyl)-1-Isopropylamino-2-Ethanol and 3-(P-Nitrophenoxy)-1-Isopropylamino-2-Propanol</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1324</span>, <span class="refDoi"> DOI: 10.1021/jm00282a028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00282a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaE3sXjslyrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1321-1324&issue=12&author=C.+T.+Gneuwuchauthor=H.+L.+Friedman&title=Pyridine+Isosteres+of+The.Beta.-Adrenergic+Antagonists%2C+2-%28P-Nitrophenyl%29-1-Isopropylamino-2-Ethanol+and+3-%28P-Nitrophenoxy%29-1-Isopropylamino-2-Propanol&doi=10.1021%2Fjm00282a028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridine isosteres of the β-adrenergic antagonists, 2-(p-nitrophenyl)-1-isopropylamino-2-ethanol and 3-(p-nitrophenoxy)-1-isopropylamino-2-propanol</span></div><div class="casAuthors">Gneuwuch, C. Thomas; Friedman, Harris L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1321-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Although 2-(p-nitrophenyl)-1-isopropylamino-2-ethanol (INPEA) (I) [7413-36-7] had no β-adrenergic agonist activity (chronotropic activity on isolated spontaneously beating guinea pig atria), its o- and m-nitrophenyl isomers and all 3 1-pyridyl-2-isopropylaminoethanol isomers (α,β, and γ) showed agonist activity.  1-(4-Pyridyl)-2-isopropylaminoethanol-2HCl (II-2HCl) [36696-41-0], an isostere of I, behaved as both a partial agonist and a partial antagonist of the action of isoproterenol.  In the presence of 10-7M propranolol the dose-response curves for the pyridyl compds. were shifted to the right, indicating that these compds. acted on the β-receptors.  Isopropylamino-3-(4-pyridyloxy)-2-propanol-2HCl (III)-2HCl) [37764-36-6] was a pure antagonist 10 times as potent as I.  Evidently the basic N of the pyridine ring did not interfere with antagonist action and was not a site of attachment to the receptor.  To synthesize III, the known 4-allyloxypyridine was reacted with N-bromoacetamide in dilute H2SO4 to add HOBr across the double bond, forming a mixt. of isomers; the mixt. was converted to the epoxide and then to III as the single product using isopropylamine in KOH-EtOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNVWliZaZD_7Vg90H21EOLACvtfcHk0lhzMLdlz1xWgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXjslyrsg%253D%253D&md5=5a2242341f78f591f1f5076e149c122d</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fjm00282a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00282a028%26sid%3Dliteratum%253Aachs%26aulast%3DGneuwuch%26aufirst%3DC.%2BT.%26aulast%3DFriedman%26aufirst%3DH.%2BL.%26atitle%3DPyridine%2520Isosteres%2520of%2520The.Beta.-Adrenergic%2520Antagonists%252C%25202-%2528P-Nitrophenyl%2529-1-Isopropylamino-2-Ethanol%2520and%25203-%2528P-Nitrophenoxy%2529-1-Isopropylamino-2-Propanol%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26issue%3D12%26spage%3D1321%26epage%3D1324%26doi%3D10.1021%2Fjm00282a028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mfuh, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larionov, O. V.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic N-Oxides - an Emerging Class of Therapeutic Agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">2819</span>– <span class="NLM_lpage">2857</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150619104007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.2174%2F0929867322666150619104007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26087764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWmsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=2819-2857&issue=24&author=A.+M.+Mfuhauthor=O.+V.+Larionov&title=Heterocyclic+N-Oxides+-+an+Emerging+Class+of+Therapeutic+Agents&doi=10.2174%2F0929867322666150619104007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents</span></div><div class="casAuthors">Mfuh, A. M.; Larionov, O. V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2819-2857</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Heterocyclic N-oxides have emerged as potent compds. with anticancer, antibacterial, antihypertensive, antiparasitic, anti-HIV, anti-inflammatory, herbicidal, neuroprotective, and procognitive activities.  The N-oxide motif has been successfully employed in a no. of recent drug development projects.  This review surveys the emergence of this scaffold in the mainstream medicinal chem. with a focus on the discovery of the heterocyclic N-oxide drugs, N-oxide-specific mechanisms of action, drug-receptor interactions and synthetic avenues to these compds.  As the first review on this subject that covers the developments since 1950s to date, it is expected that it will inspire wider implementation of the heterocyclic N-oxide motif in the rational design of new medicinal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOWS3-OhnTarVg90H21EOLACvtfcHk0lhzMLdlz1xWgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWmsb%252FE&md5=dfbf6959196155dc9ad4dfe7a016d5d6</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150619104007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150619104007%26sid%3Dliteratum%253Aachs%26aulast%3DMfuh%26aufirst%3DA.%2BM.%26aulast%3DLarionov%26aufirst%3DO.%2BV.%26atitle%3DHeterocyclic%2520N-Oxides%2520-%2520an%2520Emerging%2520Class%2520of%2520Therapeutic%2520Agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26issue%3D24%26spage%3D2819%26epage%3D2857%26doi%3D10.2174%2F0929867322666150619104007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Veldhuizen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedillo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Till, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villasenor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zherebina, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span> <span> </span><span class="NLM_article-title">Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (Pi3k) Beta Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6858</span>– <span class="NLM_lpage">6868</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00797</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00797" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlantLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6858-6868&issue=15&author=J.+Chandrasekharauthor=R.+Dickauthor=J.+Van+Veldhuizenauthor=D.+Koditekauthor=E.+I.+Lepistauthor=M.+E.+McGrathauthor=L.+Patelauthor=G.+Phillipsauthor=K.+Sedilloauthor=J.+R.+Somozaauthor=J.+Therrienauthor=N.+A.+Tillauthor=J.+Treibergauthor=A.+G.+Villasenorauthor=Y.+Zherebinaauthor=S.+Perreault&title=Atropisomerism+by+Design%3A+Discovery+of+a+Selective+and+Stable+Phosphoinositide+3-Kinase+%28Pi3k%29+Beta+Inhibitor&doi=10.1021%2Facs.jmedchem.8b00797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor</span></div><div class="casAuthors">Chandrasekhar, Jayaraman; Dick, Ryan; Van Veldhuizen, Joshua; Koditek, David; Lepist, Eve-Irene; McGrath, Mary E.; Patel, Leena; Phillips, Gary; Sedillo, Kassandra; Somoza, John R.; Therrien, Joseph; Till, Nicholas A.; Treiberg, Jennifer; Villasenor, Armando G.; Zherebina, Yelena; Perreault, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6858-6868</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis.  In this manuscript, we report a case in which torsional scan studies guided the thoughtful creation of a restricted axis of rotation between two heteroarom. systems of a phosphoinositide 3-kinase (PI3K) β inhibitor, generating a pair of atropisomeric compds. with significantly different pharmacol. and pharmacokinetic profiles.  Emblematic of these differences, the metab. of inactive (M)-28 is primarily due to the cytosolic enzyme aldehyde oxidase, while active (P)-28 has lower affinity for aldehyde oxidase, resulting in substantially better metabolic stability.  Addnl., we report torsional scan and exptl. studies used to det. the barriers of rotation of this novel PI3Kβ inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM4lElYFK-4bVg90H21EOLACvtfcHk0lhzMLdlz1xWgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlantLrK&md5=7bf851fb54cf73570f99635622ec9214</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00797%26sid%3Dliteratum%253Aachs%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DDick%26aufirst%3DR.%26aulast%3DVan%2BVeldhuizen%26aufirst%3DJ.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DLepist%26aufirst%3DE.%2BI.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DG.%26aulast%3DSedillo%26aufirst%3DK.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTill%26aufirst%3DN.%2BA.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DVillasenor%26aufirst%3DA.%2BG.%26aulast%3DZherebina%26aufirst%3DY.%26aulast%3DPerreault%26aufirst%3DS.%26atitle%3DAtropisomerism%2520by%2520Design%253A%2520Discovery%2520of%2520a%2520Selective%2520and%2520Stable%2520Phosphoinositide%25203-Kinase%2520%2528Pi3k%2529%2520Beta%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6858%26epage%3D6868%26doi%3D10.1021%2Facs.jmedchem.8b00797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanotta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Isolation and Characterization of the Human Aldehyde Oxidase Gene: Conservation of Intron/Exon Boundaries with the Xanthine Oxidoreductase Gene Indicates a Common Origin</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1042/bj3320383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1042%2Fbj3320383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9601067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1SqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=1998&pages=383-393&author=M.+Teraoauthor=M.+Kurosakiauthor=S.+Demontisauthor=S.+Zanottaauthor=E.+Garattini&title=Isolation+and+Characterization+of+the+Human+Aldehyde+Oxidase+Gene%3A+Conservation+of+Intron%2FExon+Boundaries+with+the+Xanthine+Oxidoreductase+Gene+Indicates+a+Common+Origin&doi=10.1042%2Fbj3320383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Demontis, Silvia; Zanotta, Stefania; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-393</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a molybdo-flavo enzyme involved in the metab. of various endogenous and exogenous N-heterocyclic compds. of pharmacol. and toxicol. importance.  The enzyme is the product of a gene which is implicated in the aetio-pathogenesis of familial recessive amyotrophic lateral sclerosis.  Here, the authors report the cloning and structural characterization of the human AO gene.  AO is a single copy gene approx. 85 kb long with 35 transcribed exons.  The transcription-initiation site and the sequence of the 5'-flanking region, contg. several putative regulatory elements, were detd.  The 5'-flanking region contains a functional promoter, as assessed by appropriate reporter constructs in transient transfection expts.  Comparison of the AO gene structure shows conservation of the position and type of exon/intron junctions relative to those obsd. in the gene coding for another molybdo-flavoprotein, i.e. xanthine oxidoreductase (XOR).  As the two genes code for proteins with a high level of amino acid identity, these results strongly suggest that the AO and XOR genetic loci arose as the consequence of a duplication event.  Southern blot anal. conducted on genomic DNA from various animal species with specific cDNA probes indicates that the AO gene is less conserved than the XOR gene during evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ECIWWYjPubVg90H21EOLACvtfcHk0lgiyHAYicZnsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1SqsLo%253D&md5=c16b9139af69ef8dd39d07ee76866f3f</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1042%2Fbj3320383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3320383%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DDemontis%26aufirst%3DS.%26aulast%3DZanotta%26aufirst%3DS.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520the%2520Human%2520Aldehyde%2520Oxidase%2520Gene%253A%2520Conservation%2520of%2520Intron%252FExon%2520Boundaries%2520with%2520the%2520Xanthine%2520Oxidoreductase%2520Gene%2520Indicates%2520a%2520Common%2520Origin%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D332%26spage%3D383%26epage%3D393%26doi%3D10.1042%2Fbj3320383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Trelles, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, F. J.</span></span> <span> </span><span class="NLM_article-title">Convergent Neofunctionalization by Positive Darwinian Selection after Ancient Recurrent Duplications of the Xanthine Dehydrogenase Gene</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">13413</span>– <span class="NLM_lpage">13417</span>, <span class="refDoi"> DOI: 10.1073/pnas.1835646100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1073%2Fpnas.1835646100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=14576276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFOisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13413-13417&issue=23&author=F.+Rodriguez-Trellesauthor=R.+Tarrioauthor=F.+J.+Ayala&title=Convergent+Neofunctionalization+by+Positive+Darwinian+Selection+after+Ancient+Recurrent+Duplications+of+the+Xanthine+Dehydrogenase+Gene&doi=10.1073%2Fpnas.1835646100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Convergent neofunctionalization by positive Darwinian selection after ancient recurrent duplications of the xanthine dehydrogenase gene</span></div><div class="casAuthors">Rodriguez-trelles, Francisco; Tarrio, Rosa; Ayala, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13413-13417</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Gene duplication is a primary source of mol. substrate for the emergence of evolutionary novelties.  The chances for redundant gene sequences to evolve new functions are small compared with the probability that the copies become disabled by deleterious mutations.  Functional divergence after gene duplication can result in two alternative evolutionary fates: one copy acquires a novel function (neofunctionalization), or each copy adopts part of the tasks of their parental gene (subfunctionalization).  The relative prevalence of each outcome is unknown.  Similarly unknown is the relative importance of pos. selection vs. random fixation of neutral mutations.  Aldehyde oxidase (Ao) and xanthine dehydrogenase (Xdh) genes encode two complex members of the xanthine oxidase family of molybdo-flavoenzymes that carry different functions.  Ao is known to have originated from a duplicate of an Xdh gene in eukaryotes, before the origin of multicellularity.  We show that (i) Ao evolved independently twice from two different Xdh paralogs, the second time in the chordates, before the diversification of vertebrates; (ii) after each duplication, the Ao duplicate underwent a period of rapid evolution during which identical sites across the two mols., involving the FAD and substrate-binding pockets, were subjected to intense pos. Darwinian selection; and (iii) the second Ao gene likely endured two periods of redundancy, initially as a duplicate of Xdh and later as a functional equiv. of the old Ao, which is currently absent from the vertebrate genome.  Caution is appropriate in structural genomics when using sequence similarity for assigning protein function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzgWuQxuLPQLVg90H21EOLACvtfcHk0lgiyHAYicZnsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFOisbo%253D&md5=b9ee535b2dee8d0bae93862a06c1f8d6</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1835646100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1835646100%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Trelles%26aufirst%3DF.%26aulast%3DTarrio%26aufirst%3DR.%26aulast%3DAyala%26aufirst%3DF.%2BJ.%26atitle%3DConvergent%2520Neofunctionalization%2520by%2520Positive%2520Darwinian%2520Selection%2520after%2520Ancient%2520Recurrent%2520Duplications%2520of%2520the%2520Xanthine%2520Dehydrogenase%2520Gene%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26issue%3D23%26spage%3D13413%26epage%3D13417%26doi%3D10.1073%2Fpnas.1835646100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perretta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Structure and Evolution of Vertebrate Aldehyde Oxidases: From Gene Duplication to Gene Suppression</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1807</span>– <span class="NLM_lpage">1830</span>, <span class="refDoi"> DOI: 10.1007/s00018-012-1229-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00018-012-1229-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23263164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsValt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=1807-1830&issue=10&author=M.+Kurosakiauthor=M.+Bolisauthor=M.+Fratelliauthor=M.+M.+Barzagoauthor=L.+Pattiniauthor=G.+Perrettaauthor=M.+Teraoauthor=E.+Garattini&title=Structure+and+Evolution+of+Vertebrate+Aldehyde+Oxidases%3A+From+Gene+Duplication+to+Gene+Suppression&doi=10.1007%2Fs00018-012-1229-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and evolution of vertebrate aldehyde oxidases: from gene duplication to gene suppression</span></div><div class="casAuthors">Kurosaki, Mami; Bolis, Marco; Fratelli, Maddalena; Barzago, Maria Monica; Pattini, Linda; Perretta, Gemma; Terao, Mineko; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1807-1830</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs) and xanthine dehydrogenases (XDHs) belong to the family of molybdo-flavoenzymes.  Although AOXs are not identifiable in fungi, these enzymes are represented in certain protists and the majority of plants and vertebrates.  The physiol. functions and substrates of AOXs are unknown.  Nevertheless, AOXs are major drug metabolizing enzymes, oxidizing a wide range of arom. aldehydes and heterocyclic compds. of medical/toxicol. importance.  Using genome sequencing data, we predict the structures of AOX genes and pseudogenes, reconstructing their evolution.  Fishes are the most primitive organisms with an AOX gene (AOXα), originating from the duplication of an ancestral XDH.  Further evolution of fishes resulted in the duplication of AOXα into AOXβ and successive pseudogenization of AOXα.  AOXβ is maintained in amphibians and it is the likely precursors of reptilian, avian, and mammalian AOX1.  Amphibian AOXγ is a duplication of AOXβ and the likely ancestor of reptilian and avian AOX2, which, in turn, gave rise to mammalian AOX3L1.  Subsequent gene duplications generated the two mammalian genes, AOX3 and AOX4.  The evolution of mammalian AOX genes is dominated by pseudogenization and deletion events.  Our anal. is relevant from a structural point of view, as it provides information on the residues characterizing the three domains of each mammalian AOX isoenzyme.  We cloned the cDNAs encoding the AOX proteins of guinea pig and cynomolgus monkeys, two unique species as to the evolution of this enzyme family.  We identify chimeric RNAs from the human AOX3 and AOX3L1 pseudogenes with potential to encode a novel microRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Ob09YlhEFLVg90H21EOLACvtfcHk0lgiyHAYicZnsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsValt7k%253D&md5=243e225973dec87b8df40beb63c7f583</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1007%2Fs00018-012-1229-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-012-1229-5%26sid%3Dliteratum%253Aachs%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DBolis%26aufirst%3DM.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DPattini%26aufirst%3DL.%26aulast%3DPerretta%26aufirst%3DG.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DStructure%2520and%2520Evolution%2520of%2520Vertebrate%2520Aldehyde%2520Oxidases%253A%2520From%2520Gene%2520Duplication%2520to%2520Gene%2520Suppression%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2013%26volume%3D70%26issue%3D10%26spage%3D1807%26epage%3D1830%26doi%3D10.1007%2Fs00018-012-1229-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Mammalian Aldehyde Oxidases: Genetics, Evolution and Biochemistry</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">7−8</span>),  <span class="NLM_fpage">1019</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1007/s00018-007-7398-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2Fs00018-007-7398-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=18066686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFynt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=1019-1048&issue=7%E2%88%928&author=E.+Garattiniauthor=M.+Fratelliauthor=M.+Terao&title=Mammalian+Aldehyde+Oxidases%3A+Genetics%2C+Evolution+and+Biochemistry&doi=10.1007%2Fs00018-007-7398-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian aldehyde oxidases: genetics, evolution and biochemistry</span></div><div class="casAuthors">Garattini, E.; Fratelli, M.; Terao, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1019-1048</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Mammalian aldehyde oxidases are a small group of proteins belonging to the larger family of molybdo-flavoenzymes along with xanthine oxidoreductase and other bacterial enzymes.  The 2 general types of reactions catalyzed by aldehyde oxidases are the hydroxylation of heterocycles and the oxidn. of aldehydes into the corresponding carboxylic acids.  Different animal species are characterized by a different complement of aldehyde oxidase genes.  Humans contain a single active gene, whereas marsupials and rodents are characterized by 4 such genes clustering at a short distance on the same chromosome.  At present, little is known about the physiol. relevance of aldehyde oxidases in humans and other mammals, although these enzymes are known to play a role in the metab. of drugs and compds. of toxicol. importance in the liver.  The present article provides an overview of the current knowledge of genetics, evolution, structure, enzymol., tissue distribution, and regulation of mammalian aldehyde oxidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsNZuLxV9pxLVg90H21EOLACvtfcHk0liK8TdwOXxW1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFynt70%253D&md5=1aa37435a1d77ca388180937902464dd</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7398-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7398-y%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DMammalian%2520Aldehyde%2520Oxidases%253A%2520Genetics%252C%2520Evolution%2520and%2520Biochemistry%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26issue%3D7%25E2%2588%25928%26spage%3D1019%26epage%3D1048%26doi%3D10.1007%2Fs00018-007-7398-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fagerberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallstrom, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oksvold, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kampf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djureinovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odeberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habuka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahmasebpoor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danielsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asplund, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjostedt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szigyarto, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skogs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takanen, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwenk, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindskog, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danielsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mardinoglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivertsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Feilitzen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwahlen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlen, M.</span></span> <span> </span><span class="NLM_article-title">Analysis of the Human Tissue-Specific Expression by Genome-Wide Integration of Transcriptomics and Antibody-Based Proteomics</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1074/mcp.M113.035600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fmcp.M113.035600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24309898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2nsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=397-406&issue=2&author=L.+Fagerbergauthor=B.+M.+Hallstromauthor=P.+Oksvoldauthor=C.+Kampfauthor=D.+Djureinovicauthor=J.+Odebergauthor=M.+Habukaauthor=S.+Tahmasebpoorauthor=A.+Danielssonauthor=K.+Edlundauthor=A.+Asplundauthor=E.+Sjostedtauthor=E.+Lundbergauthor=C.+A.+Szigyartoauthor=M.+Skogsauthor=J.+O.+Takanenauthor=H.+Berlingauthor=H.+Tegelauthor=J.+Mulderauthor=P.+Nilssonauthor=J.+M.+Schwenkauthor=C.+Lindskogauthor=F.+Danielssonauthor=A.+Mardinogluauthor=A.+Sivertssonauthor=K.+von+Feilitzenauthor=M.+Forsbergauthor=M.+Zwahlenauthor=I.+Olssonauthor=S.+Navaniauthor=M.+Hussauthor=J.+Nielsenauthor=F.+Pontenauthor=M.+Uhlen&title=Analysis+of+the+Human+Tissue-Specific+Expression+by+Genome-Wide+Integration+of+Transcriptomics+and+Antibody-Based+Proteomics&doi=10.1074%2Fmcp.M113.035600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics</span></div><div class="casAuthors">Fagerberg, Linn; Hallstroem, Bjoern M.; Oksvold, Per; Kampf, Caroline; Djureinovic, Dijana; Odeberg, Jacob; Habuka, Masato; Tahmasebpoor, Simin; Danielsson, Angelika; Edlund, Karolina; Asplund, Anna; Sjoestedt, Evelina; Lundberg, Emma; Al-Khalili Szigyarto, Cristina; Skogs, Marie; Takanen, Jenny Ottosson; Berling, Holger; Tegel, Hanna; Mulder, Jan; Nilsson, Peter; Schwenk, Jochen M.; Lindskog, Cecilia; Danielsson, Frida; Mardinoglu, Adil; Sivertsson, Aasa; von Feilitzen, Kalle; Forsberg, Mattias; Zwahlen, Martin; Olsson, IngMarie; Navani, Sanjay; Huss, Mikael; Nielsen, Jens; Ponten, Fredrik; Uhlen, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Global classification of the human proteins with regards to spatial expression patterns across organs and tissues is important for studies of human biol. and disease.  Here, we used a quant. transcriptomics anal. (RNA-Seq) to classify the tissue-specific expression of genes across a representative set of all major human organs and tissues and combined this anal. with antibody-based profiling of the same tissues.  To present the data, we launch a new version of the Human Protein Atlas that integrates RNA and protein expression data corresponding to ∼80% of the human protein-coding genes with access to the primary data for both the RNA and the protein anal. on an individual gene level.  We present a classification of all human protein-coding genes with regards to tissue-specificity and spatial expression pattern.  The integrative human expression map can be used as a starting point to explore the mol. constituents of the human body.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobQBz53bZwcrVg90H21EOLACvtfcHk0liK8TdwOXxW1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2nsrg%253D&md5=7f7946fac7e3108cde53e50f6eeda308</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M113.035600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M113.035600%26sid%3Dliteratum%253Aachs%26aulast%3DFagerberg%26aufirst%3DL.%26aulast%3DHallstrom%26aufirst%3DB.%2BM.%26aulast%3DOksvold%26aufirst%3DP.%26aulast%3DKampf%26aufirst%3DC.%26aulast%3DDjureinovic%26aufirst%3DD.%26aulast%3DOdeberg%26aufirst%3DJ.%26aulast%3DHabuka%26aufirst%3DM.%26aulast%3DTahmasebpoor%26aufirst%3DS.%26aulast%3DDanielsson%26aufirst%3DA.%26aulast%3DEdlund%26aufirst%3DK.%26aulast%3DAsplund%26aufirst%3DA.%26aulast%3DSjostedt%26aufirst%3DE.%26aulast%3DLundberg%26aufirst%3DE.%26aulast%3DSzigyarto%26aufirst%3DC.%2BA.%26aulast%3DSkogs%26aufirst%3DM.%26aulast%3DTakanen%26aufirst%3DJ.%2BO.%26aulast%3DBerling%26aufirst%3DH.%26aulast%3DTegel%26aufirst%3DH.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DNilsson%26aufirst%3DP.%26aulast%3DSchwenk%26aufirst%3DJ.%2BM.%26aulast%3DLindskog%26aufirst%3DC.%26aulast%3DDanielsson%26aufirst%3DF.%26aulast%3DMardinoglu%26aufirst%3DA.%26aulast%3DSivertsson%26aufirst%3DA.%26aulast%3Dvon%2BFeilitzen%26aufirst%3DK.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DZwahlen%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DI.%26aulast%3DNavani%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DJ.%26aulast%3DPonten%26aufirst%3DF.%26aulast%3DUhlen%26aufirst%3DM.%26atitle%3DAnalysis%2520of%2520the%2520Human%2520Tissue-Specific%2520Expression%2520by%2520Genome-Wide%2520Integration%2520of%2520Transcriptomics%2520and%2520Antibody-Based%2520Proteomics%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2014%26volume%3D13%26issue%3D2%26spage%3D397%26epage%3D406%26doi%3D10.1074%2Fmcp.M113.035600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Increasing Recognition of the Importance of Aldehyde Oxidase in Drug Development and Discovery</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.3109/03602532.2011.560606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F03602532.2011.560606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21428696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1ajtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=374-386&issue=3&author=E.+Garattiniauthor=M.+Terao&title=Increasing+Recognition+of+the+Importance+of+Aldehyde+Oxidase+in+Drug+Development+and+Discovery&doi=10.3109%2F03602532.2011.560606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing recognition of the importance of aldehyde oxidase in drug development and discovery</span></div><div class="casAuthors">Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">374-386</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidases are molybdoflavoenzymes with broad substrate specificity, oxidizing different types of aldehydes, and heterocyclic rings.  The physiol. function of aldehyde oxidases is largely unknown, although the enzymes play an important role in the metab. of numerous compds. of medicinal and toxicol. interest, as they oxidize a wide range of aldehydes and heterocyclic compds.  In this article, we review the significance of aldehyde oxidases for the design and development of new drugs and discuss assocd. problems.  These include species-specific differences in the complement of isoenzymes synthesized and general difficulties in studying the enzymic characteristics of purified or recombinant aldehyde oxidases.  We highlight the potential offered by human aldehyde oxidase targeting for the development of new pharmacol. agents, limiting our attention to the realms of antiobesity and anti-cancer drugs.  The last point is discussed in the context of the design of novel anticancer drugs, selectively activated or inactivated by this enzyme, with the final aim of achieving organ and/or tumor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr951BnlwtKZLVg90H21EOLACvtfcHk0liK8TdwOXxW1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1ajtLo%253D&md5=4752bb8ee0ead1ff9e6413b1150a2c5e</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.3109%2F03602532.2011.560606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602532.2011.560606%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DIncreasing%2520Recognition%2520of%2520the%2520Importance%2520of%2520Aldehyde%2520Oxidase%2520in%2520Drug%2520Development%2520and%2520Discovery%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2011%26volume%3D43%26issue%3D3%26spage%3D374%26epage%3D386%26doi%3D10.3109%2F03602532.2011.560606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clancy, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repine, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brownstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, D.</span></span> <span> </span><span class="NLM_article-title">Analysis of Aldehyde Oxidase and Xanthine Dehydrogenase/Oxidase as Possible Candidate Genes for Autosomal Recessive Familial Amyotrophic Lateral Sclerosis</span>. <i>Somatic Cell Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1007/BF02255787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2FBF02255787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=7570184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2MXot1aiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1995&pages=121-131&issue=2&author=R.+Bergerauthor=E.+Mezeyauthor=K.+P.+Clancyauthor=G.+Hartaauthor=R.+M.+Wrightauthor=J.+E.+Repineauthor=R.+H.+Brownauthor=M.+Brownsteinauthor=D.+Patterson&title=Analysis+of+Aldehyde+Oxidase+and+Xanthine+Dehydrogenase%2FOxidase+as+Possible+Candidate+Genes+for+Autosomal+Recessive+Familial+Amyotrophic+Lateral+Sclerosis&doi=10.1007%2FBF02255787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of aldehyde oxidase and xanthine dehydrogenase/oxidase as possible candidate genes for autosomal recessive familial amyotrophic lateral sclerosis</span></div><div class="casAuthors">Berger, Ralph; Mezey, Eva; Clancy, Kevin P.; Harta, Gyongyi; Wright, Richard M.; Repine, John E.; Brown, Robert H.; Brownstein, Michael; Patterson, David</div><div class="citationInfo"><span class="NLM_cas:title">Somatic Cell and Molecular Genetics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-31</span>CODEN:
                <span class="NLM_cas:coden">SCMGDN</span>;
        ISSN:<span class="NLM_cas:issn">0740-7750</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">Recently, point mutations in superoxide dismutase 1 (SOD1) have been shown to lead to a subset of autosomal dominantly inherited familial amyotrophic lateral sclerosis (ALS).  These findings have led to the hypothesis that defects in oxygen radical metab. may be involved in the pathogenesis of ALS.  Therefore, the authors decided to analyze other enzymes involved in oxygen radical metab. for possible involvement in other forms of ALS.  The authors report here anal. of two genes encoding the molybdenum hydroxylases aldehyde oxidase (AO) and xanthine dehydrogenase/oxidase (XDH) for involvement in ALS.  Of particular interest, one gene identified as encoding aldehyde oxidase is shown to map to 2q33, a region recently shown to contain a gene responsible for a familial form of ALS with autosomal recessive inheritance (FALS-AR).  The AO gene appears to be located within 280,000 bp of the simple sequence repeat marker D2S116, which shows no recombination with the FALs-AR locus.  The AO gene is highly expressed in glial cells of human spinal cord.  In addn., the authors mapped a gene for XDH to 2p22, a region previously shown to contain a highly homologous but different form of XDH.  Neither of these XDH genes appears to be highly expressed in human spinal cord.  This evidence suggests that AO may be a candidate gene for FALS-AR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVH8YkabRr_rVg90H21EOLACvtfcHk0lisgDE0dQE8gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXot1aiurc%253D&md5=2d9a5f589da63767def5a43d20b3e80a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1007%2FBF02255787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02255787%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DMezey%26aufirst%3DE.%26aulast%3DClancy%26aufirst%3DK.%2BP.%26aulast%3DHarta%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DR.%2BM.%26aulast%3DRepine%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26aulast%3DBrownstein%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DD.%26atitle%3DAnalysis%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Dehydrogenase%252FOxidase%2520as%2520Possible%2520Candidate%2520Genes%2520for%2520Autosomal%2520Recessive%2520Familial%2520Amyotrophic%2520Lateral%2520Sclerosis%26jtitle%3DSomatic%2520Cell%2520Mol.%2520Genet.%26date%3D1995%26volume%3D21%26issue%3D2%26spage%3D121%26epage%3D131%26doi%3D10.1007%2FBF02255787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manevski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camenisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pognan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litherland, K.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase Activity in Fresh Human Skin</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2049</span>– <span class="NLM_lpage">2057</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.060368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.060368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25249692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFagsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=2049-2057&issue=12&author=N.+Manevskiauthor=K.+K.+Balavenkatramanauthor=B.+Bertschiauthor=P.+Swartauthor=M.+Wallesauthor=G.+Camenischauthor=H.+Schillerauthor=O.+Kretzauthor=B.+Lingauthor=R.+Wettsteinauthor=D.+J.+Schaeferauthor=F.+Pognanauthor=A.+Wolfauthor=K.+Litherland&title=Aldehyde+Oxidase+Activity+in+Fresh+Human+Skin&doi=10.1124%2Fdmd.114.060368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase activity in fresh human skin</span></div><div class="casAuthors">Manevski, Nenad; Balavenkatraman, Kamal Kumar; Bertschi, Barbara; Swart, Piet; Walles, Markus; Camenisch, Gian; Schiller, Hilmar; Kretz, Olivier; Ling, Barbara; Wettstein, Reto; Schaefer, Dirk J.; Pognan, Francois; Wolf, Armin; Litherland, Karine</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2049-2057, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Human aldehyde oxidase (AO) is a molybdoflavoenzyme that commonly oxidizes azaheterocycles in therapeutic drugs.  Although high metabolic clearance by AO resulted in several drug failures, existing in vitro-in vivo correlations are often poor and the extrahepatic role of AO practically unknown.  This study investigated enzymic activity of AO in fresh human skin, the largest organ of the body, frequently exposed to therapeutic drugs and xenobiotics.  Fresh, full-thickness human skin was obtained from 13 individual donors and assayed with two specific AO substrates: carbazeran and zoniporide.  Human skin explants from all donors metabolized carbazeran to 4-hydroxycarbazeran and zoniporide to 2-oxo-zoniporide.  Av. rates of carbazeran and zoniporide hydroxylations were 1.301 and 0.164 pmol × mg skin-1 × h-1, resulting in 13 and 2 % substrate turnover, resp., after 24 h of incubation with 10 μM substrate.  Hydroxylation activities for the two substrates were significantly correlated (r2 = 0.769), with interindividual variability ranging from 3-fold (zoniporide) to 6-fold (carbazeran).  Inclusion of hydralazine, an irreversible inhibitor of AO, resulted in concn.-dependent decrease of hydroxylation activities, exceeding 90% inhibition of carbazeran 4-hydroxylation at 100 μM inhibitor.  Reaction rates were linear up to 4 h and well described by Michaelis-Menten enzyme kinetics.  Comparison of carbazeran and zoniporide hydroxylation with rates of triclosan glucuronidation and sulfation and p-toluidine N-acetylation showed that cutaneous AO activity is comparable to tested phase II metabolic reactions, indicating a significant role of AO in cutaneous drug metab.  To our best knowledge, this is the first report of AO enzymic activity in human skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaynQ-Veyf0bVg90H21EOLACvtfcHk0lisgDE0dQE8gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFagsr7M&md5=ec72b646e63d9e7c429203baf1836337</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.060368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.060368%26sid%3Dliteratum%253Aachs%26aulast%3DManevski%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DSwart%26aufirst%3DP.%26aulast%3DWalles%26aufirst%3DM.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DKretz%26aufirst%3DO.%26aulast%3DLing%26aufirst%3DB.%26aulast%3DWettstein%26aufirst%3DR.%26aulast%3DSchaefer%26aufirst%3DD.%2BJ.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DLitherland%26aufirst%3DK.%26atitle%3DAldehyde%2520Oxidase%2520Activity%2520in%2520Fresh%2520Human%2520Skin%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D12%26spage%3D2049%26epage%3D2057%26doi%3D10.1124%2Fdmd.114.060368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hada, T.</span></span> <span> </span><span class="NLM_article-title">Widespread Cellular Distribution of Aldehyde Oxidase in Human Tissues Found by Immunohistochemistry Staining</span>. <i>Histol. Histopathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.14670/HH-16.745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.14670%2FHH-16.745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=11510964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmslyhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=745-753&author=Y.+Moriwakiauthor=T.+Yamamotoauthor=S.+Takahashiauthor=Z.+Tsutsumiauthor=T.+Hada&title=Widespread+Cellular+Distribution+of+Aldehyde+Oxidase+in+Human+Tissues+Found+by+Immunohistochemistry+Staining&doi=10.14670%2FHH-16.745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Widespread cellular distribution of aldehyde oxidase in human tissues found by immunohistochemistry staining</span></div><div class="casAuthors">Moriwaki, Y.; Yamamoto, T.; Takahashi, S.; Tsutsumi, Z.; Hada, T.</div><div class="citationInfo"><span class="NLM_cas:title">Histology and Histopathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-753</span>CODEN:
                <span class="NLM_cas:coden">HIHIES</span>;
        ISSN:<span class="NLM_cas:issn">0213-3911</span>.
    
            (<span class="NLM_cas:orgname">Histology and Histopathology</span>)
        </div><div class="casAbstract">Aldehyde oxidase (EC 1.2.3.1) (I) is a xenobiotic-metabolizing enzyme that catalyzes a variety of org. aldehydes and N-heterocyclic compds.  However, its precise pathophysiol. function in humans, other than its xenobiotic metab., remains unknown.  In order to gain a better understanding of the role of I, it was important to know its exact localization in human tissues.  Here, the authors investigated the distribution of I at the cellular level in a variety of human tissues by immunohistochem.  I was found to be widespread in respiratory, digestive, urogenital, and endocrine tissues, although a cell-specific localization in the various tissues studied was also obsd.  In the respiratory system, it was particularly abundant in epithelial cells from the trachea and bronchium, as well as alveolar cells.  In the digestive system, I was obsd. in surface epithelia of the small and large intestines, in addn. to hepatic cells.  Furthermore, the proximal, distal, and collecting tubules of the kidney were immunostained with various intensities, whereas glomerulus tissues were not.  In epididymis and prostate tissues, staining was obsd. in the ductuli epididymidis and glandular epithelia.  Moreover, the adrenal gland, cortex, and notably the zona reticularis, showed strong immunostaining.  This prevalent tissue distribution of I in humans suggests some addnl. pathophysiol. functions besides xenobiotic metab.  Accordingly, some possible roles were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw_iviNY40NrVg90H21EOLACvtfcHk0lisgDE0dQE8gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmslyhsr8%253D&md5=db271afdd0790738b94efec55ba58a7e</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.14670%2FHH-16.745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14670%252FHH-16.745%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DZ.%26aulast%3DHada%26aufirst%3DT.%26atitle%3DWidespread%2520Cellular%2520Distribution%2520of%2520Aldehyde%2520Oxidase%2520in%2520Human%2520Tissues%2520Found%2520by%2520Immunohistochemistry%2520Staining%26jtitle%3DHistol.%2520Histopathol.%26date%3D2001%26volume%3D16%26spage%3D745%26epage%3D753%26doi%3D10.14670%2FHH-16.745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yue, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breschi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vierstra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandstrom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervouchine, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djebali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurman, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaul, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rynes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirilusha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinov, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trout, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amrhein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher-Aylor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoshechkin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSalvo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fastuca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenkow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaleski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagarde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bussotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groudine, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCleary, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edsall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrissey, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cayting, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euskirchen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundaje, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malladi, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cline, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkup, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Learned, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbloom, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacerda de Sousa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pignatelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flicek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahveci, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James Kent, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalho Santos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notredame, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diegel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canfield, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabo, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilken, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reh, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giste, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutyavin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neph, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott Hansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bruijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selleri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudensky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josefowicz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichler, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orkin, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levasseur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papayannopoulou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoultchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disteche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treuting, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowdon, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feingold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortazavi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamatoyannopoulos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guigo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingeras, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardison, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, B.</span></span> <span> </span><span class="NLM_article-title">A Comparative Encyclopedia of DNA Elements in the Mouse Genome</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>515</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1038/nature13992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Fnature13992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25409824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGlt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=515&publication_year=2014&pages=355-364&author=F.+Yueauthor=Y.+Chengauthor=A.+Breschiauthor=J.+Vierstraauthor=W.+Wuauthor=T.+Rybaauthor=R.+Sandstromauthor=Z.+Maauthor=C.+Davisauthor=B.+D.+Popeauthor=Y.+Shenauthor=D.+D.+Pervouchineauthor=S.+Djebaliauthor=R.+E.+Thurmanauthor=R.+Kaulauthor=E.+Rynesauthor=A.+Kirilushaauthor=G.+K.+Marinovauthor=B.+A.+Williamsauthor=D.+Troutauthor=H.+Amrheinauthor=K.+Fisher-Aylorauthor=I.+Antoshechkinauthor=G.+DeSalvoauthor=L.-H.+Seeauthor=M.+Fastucaauthor=J.+Drenkowauthor=C.+Zaleskiauthor=A.+Dobinauthor=P.+Prietoauthor=J.+Lagardeauthor=G.+Bussottiauthor=A.+Tanzerauthor=O.+Denasauthor=K.+Liauthor=M.+A.+Benderauthor=M.+Zhangauthor=R.+Byronauthor=M.+T.+Groudineauthor=D.+McClearyauthor=L.+Phamauthor=Z.+Yeauthor=S.+Kuanauthor=L.+Edsallauthor=Y.-C.+Wuauthor=M.+D.+Rasmussenauthor=M.+S.+Bansalauthor=M.+Kellisauthor=C.+A.+Kellerauthor=C.+S.+Morrisseyauthor=T.+Mishraauthor=D.+Jainauthor=N.+Doganauthor=R.+S.+Harrisauthor=P.+Caytingauthor=T.+Kawliauthor=A.+P.+Boyleauthor=G.+Euskirchenauthor=A.+Kundajeauthor=S.+Linauthor=Y.+Linauthor=C.+Jansenauthor=V.+S.+Malladiauthor=M.+S.+Clineauthor=D.+T.+Ericksonauthor=V.+M.+Kirkupauthor=K.+Learnedauthor=C.+A.+Sloanauthor=K.+R.+Rosenbloomauthor=B.+Lacerda+de+Sousaauthor=K.+Bealauthor=M.+Pignatelliauthor=P.+Flicekauthor=J.+Lianauthor=T.+Kahveciauthor=D.+Leeauthor=W.+James+Kentauthor=M.+Ramalho+Santosauthor=J.+Herreroauthor=C.+Notredameauthor=A.+Johnsonauthor=S.+Vongauthor=K.+Leeauthor=D.+Batesauthor=F.+Neriauthor=M.+Diegelauthor=T.+Canfieldauthor=P.+J.+Saboauthor=M.+S.+Wilkenauthor=T.+A.+Rehauthor=E.+Gisteauthor=A.+Shaferauthor=T.+Kutyavinauthor=E.+Haugenauthor=D.+Dunnauthor=A.+P.+Reynoldsauthor=S.+Nephauthor=R.+Humbertauthor=R.+Scott+Hansenauthor=M.+De+Bruijnauthor=L.+Selleriauthor=A.+Rudenskyauthor=S.+Josefowiczauthor=R.+Samsteinauthor=E.+E.+Eichlerauthor=S.+H.+Orkinauthor=D.+Levasseurauthor=T.+Papayannopoulouauthor=K.-H.+Changauthor=A.+Skoultchiauthor=S.+Goshauthor=C.+Distecheauthor=P.+Treutingauthor=Y.+Wangauthor=M.+J.+Weissauthor=G.+A.+Blobelauthor=X.+Caoauthor=S.+Zhongauthor=T.+Wangauthor=P.+J.+Goodauthor=R.+F.+Lowdonauthor=L.+B.+Adamsauthor=X.-Q.+Zhouauthor=M.+J.+Pazinauthor=E.+A.+Feingoldauthor=B.+Woldauthor=J.+Taylorauthor=A.+Mortazaviauthor=S.+M.+Weissmanauthor=J.+A.+Stamatoyannopoulosauthor=M.+P.+Snyderauthor=R.+Guigoauthor=T.+R.+Gingerasauthor=D.+M.+Gilbertauthor=R.+C.+Hardisonauthor=M.+A.+Beerauthor=B.+Ren&title=A+Comparative+Encyclopedia+of+DNA+Elements+in+the+Mouse+Genome&doi=10.1038%2Fnature13992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative encyclopedia of DNA elements in the mouse genome</span></div><div class="casAuthors">Yue, Feng; Cheng, Yong; Breschi, Alessandra; Vierstra, Jeff; Wu, Weisheng; Ryba, Tyrone; Sandstrom, Richard; Ma, Zhihai; Davis, Carrie; Pope, Benjamin D.; Shen, Yin; Pervouchine, Dmitri D.; Djebali, Sarah; Thurman, Robert E.; Kaul, Rajinder; Rynes, Eric; Kirilusha, Anthony; Marinov, Georgi K.; Williams, Brian A.; Trout, Diane; Amrhein, Henry; Fisher-Aylor, Katherine; Antoshechkin, Igor; De Salvo, Gilberto; See, Lei-Hoon; Fastuca, Meagan; Drenkow, Jorg; Zaleski, Chris; Dobin, Alex; Prieto, Pablo; Lagarde, Julien; Bussotti, Giovanni; Tanzer, Andrea; Denas, Olgert; Li, Kanwei; Bender, M. A.; Zhang, Miaohua; Byron, Rachel; Groudine, Mark T.; McCleary, David; Pham, Long; Ye, Zhen; Kuan, Samantha; Edsall, Lee; Wu, Yi-Chieh; Rasmussen, Matthew D.; Bansal, Mukul S.; Kellis, Manolis; Keller, Cheryl A.; Morrissey, Christapher S.; Mishra, Tejaswini; Jain, Deepti; Dogan, Nergiz; Harris, Robert S.; Cayting, Philip; Kawli, Trupti; Boyle, Alan P.; Euskirchen, Ghia; Kundaje, Anshul; Lin, Shin; Lin, Yiing; Jansen, Camden; Malladi, Venkat S.; Cline, Melissa S.; Erickson, Drew T.; Kirkup, Vanessa M.; Learned, Katrina; Sloan, Cricket A.; Rosenbloom, Kate R.; Lacerda de Sousa, Beatriz; Beal, Kathryn; Pignatelli, Miguel; Flicek, Paul; Lian, Jin; Kahveci, Tamer; Lee, Dongwon; James Kent, W.; Ramalho Santos, Miguel; Herrero, Javier; Notredame, Cedric; Johnson, Audra; Vong, Shinny; Lee, Kristen; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Canfield, Theresa; Sabo, Peter J.; Wilken, Matthew S.; Reh, Thomas A.; Giste, Erika; Shafer, Anthony; Kutyavin, Tanya; Haugen, Eric; Dunn, Douglas; Reynolds, Alex P.; Neph, Shane; Humbert, Richard; Scott Hansen, R.; De Bruijn, Marella; Selleri, Licia; Rudensky, Alexander; Josefowicz, Steven; Samstein, Robert; Eichler, Evan E.; Orkin, Stuart H.; Levasseur, Dana; Papayannopoulou, Thalia; Chang, Kai-Hsin; Skoultchi, Arthur; Gosh, Srikanta; Disteche, Christine; Treuting, Piper; Wang, Yanli; Weiss, Mitchell J.; Blobel, Gerd A.; Cao, Xiaoyi; Zhong, Sheng; Wang, Ting; Good, Peter J.; Lowdon, Rebecca F.; Adams, Leslie B.; Zhou, Xiao-Qiao; Pazin, Michael J.; Feingold, Elise A.; Wold, Barbara; Taylor, James; Mortazavi, Ali; Weissman, Sherman M.; Stamatoyannopoulos, John A.; Snyder, Michael P.; Guigo, Roderic; Gingeras, Thomas R.; Gilbert, David M.; Hardison, Ross C.; Beer, Michael A.; Ren, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">515</span>
        (<span class="NLM_cas:issue">7527</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The lab. mouse shares the majority of its protein-coding genes with humans, making it the premier model organism in biomedical research, yet the two mammals differ in significant ways.  To gain greater insights into both shared and species-specific transcriptional and cellular regulatory programs in the mouse, the Mouse ENCODE Consortium has mapped transcription, DNase I hypersensitivity, transcription factor binding, chromatin modifications and replication domains throughout the mouse genome in diverse cell and tissue types.  By comparing with the human genome, we not only confirm substantial conservation in the newly annotated potential functional sequences, but also find a large degree of divergence of sequences involved in transcriptional regulation, chromatin state and higher order chromatin organization.  Our results illuminate the wide range of evolutionary forces acting on genes and their regulatory regions, and provide a general resource for research into mammalian biol. and mechanisms of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqifWSL34UuZrVg90H21EOLACvtfcHk0lg2d7RcylIqxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGlt7rI&md5=45adfc6779f3b152275db8bb471fe960</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1038%2Fnature13992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13992%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBreschi%26aufirst%3DA.%26aulast%3DVierstra%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DRyba%26aufirst%3DT.%26aulast%3DSandstrom%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DPope%26aufirst%3DB.%2BD.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DPervouchine%26aufirst%3DD.%2BD.%26aulast%3DDjebali%26aufirst%3DS.%26aulast%3DThurman%26aufirst%3DR.%2BE.%26aulast%3DKaul%26aufirst%3DR.%26aulast%3DRynes%26aufirst%3DE.%26aulast%3DKirilusha%26aufirst%3DA.%26aulast%3DMarinov%26aufirst%3DG.%2BK.%26aulast%3DWilliams%26aufirst%3DB.%2BA.%26aulast%3DTrout%26aufirst%3DD.%26aulast%3DAmrhein%26aufirst%3DH.%26aulast%3DFisher-Aylor%26aufirst%3DK.%26aulast%3DAntoshechkin%26aufirst%3DI.%26aulast%3DDeSalvo%26aufirst%3DG.%26aulast%3DSee%26aufirst%3DL.-H.%26aulast%3DFastuca%26aufirst%3DM.%26aulast%3DDrenkow%26aufirst%3DJ.%26aulast%3DZaleski%26aufirst%3DC.%26aulast%3DDobin%26aufirst%3DA.%26aulast%3DPrieto%26aufirst%3DP.%26aulast%3DLagarde%26aufirst%3DJ.%26aulast%3DBussotti%26aufirst%3DG.%26aulast%3DTanzer%26aufirst%3DA.%26aulast%3DDenas%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DBender%26aufirst%3DM.%2BA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DByron%26aufirst%3DR.%26aulast%3DGroudine%26aufirst%3DM.%2BT.%26aulast%3DMcCleary%26aufirst%3DD.%26aulast%3DPham%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DKuan%26aufirst%3DS.%26aulast%3DEdsall%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.-C.%26aulast%3DRasmussen%26aufirst%3DM.%2BD.%26aulast%3DBansal%26aufirst%3DM.%2BS.%26aulast%3DKellis%26aufirst%3DM.%26aulast%3DKeller%26aufirst%3DC.%2BA.%26aulast%3DMorrissey%26aufirst%3DC.%2BS.%26aulast%3DMishra%26aufirst%3DT.%26aulast%3DJain%26aufirst%3DD.%26aulast%3DDogan%26aufirst%3DN.%26aulast%3DHarris%26aufirst%3DR.%2BS.%26aulast%3DCayting%26aufirst%3DP.%26aulast%3DKawli%26aufirst%3DT.%26aulast%3DBoyle%26aufirst%3DA.%2BP.%26aulast%3DEuskirchen%26aufirst%3DG.%26aulast%3DKundaje%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DJansen%26aufirst%3DC.%26aulast%3DMalladi%26aufirst%3DV.%2BS.%26aulast%3DCline%26aufirst%3DM.%2BS.%26aulast%3DErickson%26aufirst%3DD.%2BT.%26aulast%3DKirkup%26aufirst%3DV.%2BM.%26aulast%3DLearned%26aufirst%3DK.%26aulast%3DSloan%26aufirst%3DC.%2BA.%26aulast%3DRosenbloom%26aufirst%3DK.%2BR.%26aulast%3DLacerda%2Bde%2BSousa%26aufirst%3DB.%26aulast%3DBeal%26aufirst%3DK.%26aulast%3DPignatelli%26aufirst%3DM.%26aulast%3DFlicek%26aufirst%3DP.%26aulast%3DLian%26aufirst%3DJ.%26aulast%3DKahveci%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DJames%2BKent%26aufirst%3DW.%26aulast%3DRamalho%2BSantos%26aufirst%3DM.%26aulast%3DHerrero%26aufirst%3DJ.%26aulast%3DNotredame%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DVong%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DBates%26aufirst%3DD.%26aulast%3DNeri%26aufirst%3DF.%26aulast%3DDiegel%26aufirst%3DM.%26aulast%3DCanfield%26aufirst%3DT.%26aulast%3DSabo%26aufirst%3DP.%2BJ.%26aulast%3DWilken%26aufirst%3DM.%2BS.%26aulast%3DReh%26aufirst%3DT.%2BA.%26aulast%3DGiste%26aufirst%3DE.%26aulast%3DShafer%26aufirst%3DA.%26aulast%3DKutyavin%26aufirst%3DT.%26aulast%3DHaugen%26aufirst%3DE.%26aulast%3DDunn%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DA.%2BP.%26aulast%3DNeph%26aufirst%3DS.%26aulast%3DHumbert%26aufirst%3DR.%26aulast%3DScott%2BHansen%26aufirst%3DR.%26aulast%3DDe%2BBruijn%26aufirst%3DM.%26aulast%3DSelleri%26aufirst%3DL.%26aulast%3DRudensky%26aufirst%3DA.%26aulast%3DJosefowicz%26aufirst%3DS.%26aulast%3DSamstein%26aufirst%3DR.%26aulast%3DEichler%26aufirst%3DE.%2BE.%26aulast%3DOrkin%26aufirst%3DS.%2BH.%26aulast%3DLevasseur%26aufirst%3DD.%26aulast%3DPapayannopoulou%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DK.-H.%26aulast%3DSkoultchi%26aufirst%3DA.%26aulast%3DGosh%26aufirst%3DS.%26aulast%3DDisteche%26aufirst%3DC.%26aulast%3DTreuting%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWeiss%26aufirst%3DM.%2BJ.%26aulast%3DBlobel%26aufirst%3DG.%2BA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGood%26aufirst%3DP.%2BJ.%26aulast%3DLowdon%26aufirst%3DR.%2BF.%26aulast%3DAdams%26aufirst%3DL.%2BB.%26aulast%3DZhou%26aufirst%3DX.-Q.%26aulast%3DPazin%26aufirst%3DM.%2BJ.%26aulast%3DFeingold%26aufirst%3DE.%2BA.%26aulast%3DWold%26aufirst%3DB.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DMortazavi%26aufirst%3DA.%26aulast%3DWeissman%26aufirst%3DS.%2BM.%26aulast%3DStamatoyannopoulos%26aufirst%3DJ.%2BA.%26aulast%3DSnyder%26aufirst%3DM.%2BP.%26aulast%3DGuigo%26aufirst%3DR.%26aulast%3DGingeras%26aufirst%3DT.%2BR.%26aulast%3DGilbert%26aufirst%3DD.%2BM.%26aulast%3DHardison%26aufirst%3DR.%2BC.%26aulast%3DBeer%26aufirst%3DM.%2BA.%26aulast%3DRen%26aufirst%3DB.%26atitle%3DA%2520Comparative%2520Encyclopedia%2520of%2520DNA%2520Elements%2520in%2520the%2520Mouse%2520Genome%26jtitle%3DNature%26date%3D2014%26volume%3D515%26spage%3D355%26epage%3D364%26doi%3D10.1038%2Fnature13992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning of the Cdna Coding for Mouse Aldehyde Oxidase: Tissue Distribution and Regulation in Vivo by Testosterone</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1042/bj3410071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1042%2Fbj3410071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10377246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=71-80&author=M.+Kurosakiauthor=S.+Demontisauthor=M.+M.+Barzagoauthor=E.+Garattiniauthor=M.+Terao&title=Molecular+Cloning+of+the+Cdna+Coding+for+Mouse+Aldehyde+Oxidase%3A+Tissue+Distribution+and+Regulation+in+Vivo+by+Testosterone&doi=10.1042%2Fbj3410071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of the cDNA coding for mouse aldehyde oxidase: tissue distribution and regulation in vivo by testosterone</span></div><div class="casAuthors">Kurosaki, Mami; Demontis, Silvia; Barzago, Maria Monica; Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-80</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The cDNA coding for mouse aldehyde oxidase (AO), a molybdoflavoprotein, has been isolated and characterized.  The cDNA is 4347 nt long and consists of an open reading frame predicting a polypeptide of 1333 amino acid residues, with 5' and 3' untranslated regions of 13 and 335 nt resp.  The apparent mol. mass of the translation product in vitro derived from the corresponding cRNA is consistent with that of the monomeric subunit of the AO holoenzyme.  The cDNA codes for a catalytically active form of AO, as demonstrated by transient transfection expts. conducted in the HC11 mouse mammary epithelial cell line.  The deduced primary structure of the AO protein contains consensus sequences for two distinct 2Fe2S redox centers and a molybdopterin-binding site.  The amino acid sequence of the mouse AO has a high degree of similarity with the human and bovine counterparts, and a significant degree of relatedness to AO proteins of plant origin.  Northern blot and in situ hybridization analyses demonstrate that hepatocytes, cardiocytes, lung endothelial or epithelial cells and esophagus epithelial cells express high levels of AO mRNA.  In the various tissues and organs considered, the level of AO mRNA expression is not strictly correlated with the amt. of the corresponding protein, suggesting that the synthesis of the AO enzyme is under translational or post-translational control.  In addn., we obsd. sex-related regulation of AO protein synthesis.  In the liver of male animals, despite similar amts. of AO mRNA, the levels of the AO enzyme and corresponding polypeptide are significantly higher than those in female animals.  Treatment of female mice with testosterone increases the amts. of AO mRNA and of the relative translation product to levels similar to those in male animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7FXG7lmMAKbVg90H21EOLACvtfcHk0lhq00ABdY8d4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKisLY%253D&md5=041161a72629d21baf8397a774aa9011</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1042%2Fbj3410071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3410071%26sid%3Dliteratum%253Aachs%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DDemontis%26aufirst%3DS.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DMolecular%2520Cloning%2520of%2520the%2520Cdna%2520Coding%2520for%2520Mouse%2520Aldehyde%2520Oxidase%253A%2520Tissue%2520Distribution%2520and%2520Regulation%2520in%2520Vivo%2520by%2520Testosterone%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D341%26spage%3D71%26epage%3D80%26doi%3D10.1042%2Fbj3410071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bendotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosperini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Selective Localization of Mouse Aldehyde Oxidase Mrna in the Choroid Plexus and Motor Neurons</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9−10</span>),  <span class="NLM_fpage">2343</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1097/00001756-199707070-00048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1097%2F00001756-199707070-00048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9243637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1Wgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=2343-2349&issue=9%E2%88%9210&author=C.+Bendottiauthor=E.+Prosperiniauthor=M.+Kurosakiauthor=E.+Garattiniauthor=M.+Terao&title=Selective+Localization+of+Mouse+Aldehyde+Oxidase+Mrna+in+the+Choroid+Plexus+and+Motor+Neurons&doi=10.1097%2F00001756-199707070-00048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Selective localization of mouse aldehyde oxidase mRNA in the choroid plexus and motor neurons</span></div><div class="casAuthors">Bendotti, Caterina; Prosperini, Elena; Kurosaki, Mami; Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">2343-2349</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO), a protein involved in the catabolism of catecholamines, is the product of a gene potentially responsible for 1 of the familial forms of the motor neuron disease, amyotrophic lateral sclerosis (ALS).  Here, we report on the cloning of a partial cDNA coding for the mouse enzyme.  Using this cDNA as a probe, we demonstrate that the AO transcript is expressed in the epithelial component of the choroid plexus.  More importantly, in the gray matter, the mRNA is selectively localized in the large motor neurons of the nuclei of facial, motor trigemini and hypoglossus nerves and in the motor neurons of the anterior horns of the spinal cord.  This localization is consistent with a possible role of AO in the pathogenesis of ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4GKDiDr3VRrVg90H21EOLACvtfcHk0lhq00ABdY8d4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1Wgt7s%253D&md5=2c5b0cb47a6666e63bb256270b068b28</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1097%2F00001756-199707070-00048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199707070-00048%26sid%3Dliteratum%253Aachs%26aulast%3DBendotti%26aufirst%3DC.%26aulast%3DProsperini%26aufirst%3DE.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DSelective%2520Localization%2520of%2520Mouse%2520Aldehyde%2520Oxidase%2520Mrna%2520in%2520the%2520Choroid%2520Plexus%2520and%2520Motor%2520Neurons%26jtitle%3DNeuroReport%26date%3D1997%26volume%3D8%26issue%3D9%25E2%2588%259210%26spage%3D2343%26epage%3D2349%26doi%3D10.1097%2F00001756-199707070-00048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Cloning of the Cdnas Coding for Two Novel Molybdo-Flavoproteins Showing High Similarity with Aldehyde Oxidase and Xanthine Oxidoreductase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">30690</span>– <span class="NLM_lpage">30700</span>, <span class="refDoi"> DOI: 10.1074/jbc.M005355200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M005355200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10893244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1agtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30690-30700&issue=39&author=M.+Teraoauthor=M.+Kurosakiauthor=G.+Saltiniauthor=S.+Demontisauthor=M.+Mariniauthor=M.+Salmonaauthor=E.+Garattini&title=Cloning+of+the+Cdnas+Coding+for+Two+Novel+Molybdo-Flavoproteins+Showing+High+Similarity+with+Aldehyde+Oxidase+and+Xanthine+Oxidoreductase&doi=10.1074%2Fjbc.M005355200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Saltini, Giuliana; Demontis, Silvia; Marini, Massimiliano; Salmona, Mario; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">30690-30700</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cDNAs coding for two novel mouse molybdo-flavoproteins, AOH1 and AOH2 (aldehyde oxidase homolog 1 and 2), were isolated.  The AOH1 and AOH2 cDNAs code for polypeptides of 1336 amino acids.  The two proteins have similar primary structure and show striking amino acid identity with aldehyde oxidase and xanthine oxidoreductase, two other molybdo-flavoenzymes.  AOH1 and AOH2 contain consensus sequences for a molybdopterin-binding site and two distinct 2Fe-2S redox centers.  In its native conformation, AOH1 has a mol. wt. consistent with a homotetrameric structure.  Transfection of the AOH1 and AOH2 cDNAs results in the prodn. of proteins with phenanthridine but not hypoxanthine oxidizing activity.  Furthermore, the AOH1 protein has benzaldehyde oxidizing activity with electrophoretic characteristics identical to those of a previously identified aldehyde oxidase isoenzyme.  The AOH1 transcript is expressed in the hepatocytes of the adult and fetal liver and in spermatogonia.  In liver, the AOH1 protein is synthesized in a gender-specific fashion.  The expression of AOH2 is limited to keratinized epithelia and the basal layer of the epidermis and hair folliculi.  The selective cell and tissue distribution of AOH1 and AOH2 mRNAs is consistent with the localization of the resp. protein products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPqzdTq52-i7Vg90H21EOLACvtfcHk0lhsmay2lvtAaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1agtbw%253D&md5=4e030e708b88fa580c7a2a7a0fe49617</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M005355200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M005355200%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DSaltini%26aufirst%3DG.%26aulast%3DDemontis%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DM.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DCloning%2520of%2520the%2520Cdnas%2520Coding%2520for%2520Two%2520Novel%2520Molybdo-Flavoproteins%2520Showing%2520High%2520Similarity%2520with%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidoreductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D39%26spage%3D30690%26epage%3D30700%26doi%3D10.1074%2Fjbc.M005355200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardinello, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">The Aldehyde Oxidase Gene Cluster in Mice and Rats. Aldehyde Oxidase Homologue 3, a Novel Member of the Molybdo-Flavoenzyme Family with Selective Expression in the Olfactory Mucosa</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">50482</span>– <span class="NLM_lpage">50498</span>, <span class="refDoi"> DOI: 10.1074/jbc.M408734200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M408734200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15383531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWjsL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=50482-50498&issue=48&author=M.+Kurosakiauthor=M.+Teraoauthor=M.+M.+Barzagoauthor=A.+Bastoneauthor=D.+Bernardinelloauthor=M.+Salmonaauthor=E.+Garattini&title=The+Aldehyde+Oxidase+Gene+Cluster+in+Mice+and+Rats.+Aldehyde+Oxidase+Homologue+3%2C+a+Novel+Member+of+the+Molybdo-Flavoenzyme+Family+with+Selective+Expression+in+the+Olfactory+Mucosa&doi=10.1074%2Fjbc.M408734200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The Aldehyde Oxidase Gene Cluster in Mice and Rats: Aldehyde Oxidase Homologue 3, A Novel Member of the Molybdo-Flavoenzyme Family with Selective Expression in the Olfactory Mucosa</span></div><div class="casAuthors">Kurosaki, Mami; Terao, Mineko; Barzago, Maria Monica; Bastone, Antonio; Bernardinello, Davide; Salmona, Mario; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">50482-50498</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mammalian molybdo-flavoenzymes are oxidases requiring FAD and molybdopterin (molybdenum cofactor) for their catalytic activity.  This family of proteins was thought to consist of four members, xanthine oxidoreductase, aldehyde oxidase 1 (AOX1), and the aldehyde oxidase homologs 1 and 2 (AOH1 and AOH2, resp.).  Whereas the first two enzymes are present in humans and various other mammalian species, the last two proteins have been described only in mice.  Here, the authors report on the identification, in both mice and rats, of a novel molybdo-flavoenzyme, AOH3.  In addn., the authors have cloned the cDNAs coding for rat AOH1 and AOH2, demonstrating that this animal species has the same complement of molybdo-flavoproteins as the mouse.  The AOH3 cDNA is characterized by remarkable similarity to AOX1, AOH1, AOH2, and xanthine oxidoreductase cDNAs.  Mouse AOH3 is selectively expressed in Bowman's glands of the olfactory mucosa, although small amts. of the corresponding mRNA are present also in the skin.  In the former location, two alternatively spliced forms of the AOH3 transcript with different 3'-untranslated regions were identified.  The general properties of AOH3 were detd. by purifn. of mouse AOH3 from the olfactory mucosa.  The enzyme possesses aldehyde oxidase activity and oxidizes, albeit with low efficiency, exogenous substrates that are recognized by AOH1 and AOX1.  The Aoh3 gene maps to mouse chromosome 1 band c1 and rat chromosome 7 [sic] in close proximity to the Aox1, Aoh1, and Aoh2 loci and has an exon/intron structure almost identical to that of the other molybdo-flavoenzyme genes in the two species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr48cuzOskc97Vg90H21EOLACvtfcHk0lhsmay2lvtAaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWjsL7N&md5=3a61fa5d905fcc7ffab3b1ac420dfdaf</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M408734200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M408734200%26sid%3Dliteratum%253Aachs%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DBernardinello%26aufirst%3DD.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DThe%2520Aldehyde%2520Oxidase%2520Gene%2520Cluster%2520in%2520Mice%2520and%2520Rats.%2520Aldehyde%2520Oxidase%2520Homologue%25203%252C%2520a%2520Novel%2520Member%2520of%2520the%2520Molybdo-Flavoenzyme%2520Family%2520with%2520Selective%2520Expression%2520in%2520the%2520Olfactory%2520Mucosa%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D48%26spage%3D50482%26epage%3D50498%26doi%3D10.1074%2Fjbc.M408734200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagnati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giudice, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanziani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiveron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Role of the Molybdoflavoenzyme Aldehyde Oxidase Homolog 2 in the Biosynthesis of Retinoic Acid: Generation and Characterization of a Knockout Mouse</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1128/MCB.01385-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1128%2FMCB.01385-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=18981221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=357-377&issue=2&author=M.+Teraoauthor=M.+Kurosakiauthor=M.+M.+Barzagoauthor=M.+Fratelliauthor=R.+Bagnatiauthor=A.+Bastoneauthor=C.+Giudiceauthor=E.+Scanzianiauthor=A.+Mancusoauthor=C.+Tiveronauthor=E.+Garattini&title=Role+of+the+Molybdoflavoenzyme+Aldehyde+Oxidase+Homolog+2+in+the+Biosynthesis+of+Retinoic+Acid%3A+Generation+and+Characterization+of+a+Knockout+Mouse&doi=10.1128%2FMCB.01385-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the molybdoflavoenzyme aldehyde oxidase homolog 2 in the biosynthesis of retinoic acid: generation and characterization of a knockout mouse</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Barzago, Maria Monica; Fratelli, Maddalena; Bagnati, Renzo; Bastone, Antonio; Giudice, Chiara; Scanziani, Eugenio; Mancuso, Alessandra; Tiveron, Cecilia; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-377</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mouse aldehyde oxidase AOH2 (aldehyde oxidase homolog 2) is a molybdoflavoenzyme.  Harderian glands are the richest source of AOH2, although the protein is detectable also in sebaceous glands, epidermis, and other keratinized epithelia.  The levels of AOH2 in the Harderian gland and skin are controlled by genetic background, being maximal in CD1 and C57BL/6 and minimal in DBA/2, CBA, and 129/Sv strains.  Testosterone is a neg. regulator of AOH2 in Harderian glands.  Purified AOH2 oxidizes retinaldehyde into retinoic acid, while it is devoid of pyridoxal-oxidizing activity.  Aoh2-/- mice, the first aldehyde oxidase knockout animals ever generated, are viable and fertile.  The data obtained for this knockout model indicate a significant role of AOH2 in the local synthesis and biodisposition of endogenous retinoids in the Harderian gland and skin.  The Harderian gland's transcriptome of knockout mice demonstrates overall downregulation of direct retinoid-dependent genes as well as perturbations in pathways controlling lipid homeostasis and cellular secretion, particularly in sexually immature animals.  The skin of knockout mice is characterized by thickening of the epidermis in basal conditions and after UV light exposure.  This has correlates in the corresponding transcriptome, which shows enrichment and overall upregulation of genes involved in hypertrophic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj5bWJ7gFLjLVg90H21EOLACvtfcHk0lhsmay2lvtAaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChurw%253D&md5=c8903d17989a0a44f11511cb5c9f5f1e</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1128%2FMCB.01385-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01385-08%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DBagnati%26aufirst%3DR.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DGiudice%26aufirst%3DC.%26aulast%3DScanziani%26aufirst%3DE.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DTiveron%26aufirst%3DC.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DRole%2520of%2520the%2520Molybdoflavoenzyme%2520Aldehyde%2520Oxidase%2520Homolog%25202%2520in%2520the%2520Biosynthesis%2520of%2520Retinoic%2520Acid%253A%2520Generation%2520and%2520Characterization%2520of%2520a%2520Knockout%2520Mouse%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26issue%3D2%26spage%3D357%26epage%3D377%26doi%3D10.1128%2FMCB.01385-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanoni, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonetto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saccone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Purification of the Aldehyde Oxidase Homolog 1 (Aoh1) Protein and Cloning of the Aoh1 and Aldehyde Oxidase Homolog 2 (Aoh2) Genes. Identification of a Novel Molybdo-Flavoprotein Gene Cluster on Mouse Chromosome 1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">49</span>),  <span class="NLM_fpage">46347</span>– <span class="NLM_lpage">46363</span>, <span class="refDoi"> DOI: 10.1074/jbc.M105744200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M105744200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=11562361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVymtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=46347-46363&issue=49&author=M.+Teraoauthor=M.+Kurosakiauthor=M.+Mariniauthor=M.+A.+Vanoniauthor=G.+Saltiniauthor=V.+Bonettoauthor=A.+Bastoneauthor=C.+Federicoauthor=S.+Sacconeauthor=R.+Fanelliauthor=M.+Salmonaauthor=E.+Garattini&title=Purification+of+the+Aldehyde+Oxidase+Homolog+1+%28Aoh1%29+Protein+and+Cloning+of+the+Aoh1+and+Aldehyde+Oxidase+Homolog+2+%28Aoh2%29+Genes.+Identification+of+a+Novel+Molybdo-Flavoprotein+Gene+Cluster+on+Mouse+Chromosome+1&doi=10.1074%2Fjbc.M105744200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes: identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Marini, Massimiliano; Vanoni, Maria Antonietta; Saltini, Giuliana; Bonetto, Valentina; Bastone, Antonio; Federico, Concetta; Saccone, Salvatore; Fanelli, Roberto; Salmona, Mario; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">46347-46363</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We report the cloning of the AOH1 and AOH2 genes, which encode two novel mammalian molybdo-flavoproteins.  We have purified the AOH1 protein to homogeneity in its catalytically active form from mouse liver.  Twenty tryptic peptides, identified or directly sequenced by mass spectrometry, confirm the primary structure of the polypeptide deduced from the AOH1 gene.  The enzyme contains one mol. of FAD, one atom of molybdenum, and four atoms of iron per subunit and shows spectroscopic features similar to those of the prototypic molybdo-flavoprotein xanthine oxidoreductase.  The AOH1 and AOH2 genes are 98 and 60 kilobases long, resp., and consist of 35 coding exons.  The AOH1 gene has the potential to transcribe an extra leader non-coding exon, which is located downstream of exon 26, and is transcribed in the opposite orientation relative to all the other exons.  AOH1 and AOH2 map to chromosome 1 in close proximity to each other and to the aldehyde oxidase gene, forming a molybdo-flavoenzyme gene cluster.  Conservation in the position of exon/intron junctions among the mouse AOH1, AOH2, aldehyde oxidase, and xanthine oxidoreductase loci indicates that these genes are derived from the duplication of an ancestral precursor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwPMePV2jiBLVg90H21EOLACvtfcHk0liLLCbFzJzllw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVymtbg%253D&md5=93ee5bf46eb7bb5ac383c5380a81179b</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M105744200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M105744200%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DMarini%26aufirst%3DM.%26aulast%3DVanoni%26aufirst%3DM.%2BA.%26aulast%3DSaltini%26aufirst%3DG.%26aulast%3DBonetto%26aufirst%3DV.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DFederico%26aufirst%3DC.%26aulast%3DSaccone%26aufirst%3DS.%26aulast%3DFanelli%26aufirst%3DR.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DPurification%2520of%2520the%2520Aldehyde%2520Oxidase%2520Homolog%25201%2520%2528Aoh1%2529%2520Protein%2520and%2520Cloning%2520of%2520the%2520Aoh1%2520and%2520Aldehyde%2520Oxidase%2520Homolog%25202%2520%2528Aoh2%2529%2520Genes.%2520Identification%2520of%2520a%2520Novel%2520Molybdo-Flavoprotein%2520Gene%2520Cluster%2520on%2520Mouse%2520Chromosome%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D49%26spage%3D46347%26epage%3D46363%26doi%3D10.1074%2Fjbc.M105744200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuscoe, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannon, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancashire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moland, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branham, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfinger, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolsky, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerksen-Hughes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thierry-Mieg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thierry-Mieg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">A Rat Rna-Seq Transcriptomic Bodymap across 11 Organs and 4 Developmental Stages</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3230</span>, <span class="refDoi"> DOI: 10.1038/ncomms4230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1038%2Fncomms4230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24510058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BC2cvjsFChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3230&author=Y.+Yuauthor=J.+C.+Fuscoeauthor=C.+Zhaoauthor=C.+Guoauthor=M.+Jiaauthor=T.+Qingauthor=D.+I.+Bannonauthor=L.+Lancashireauthor=W.+Baoauthor=T.+Duauthor=H.+Luoauthor=Z.+Suauthor=W.+D.+Jonesauthor=C.+L.+Molandauthor=W.+S.+Branhamauthor=F.+Qianauthor=B.+Ningauthor=Y.+Liauthor=H.+Hongauthor=L.+Guoauthor=N.+Meiauthor=T.+Shiauthor=K.+Y.+Wangauthor=R.+D.+Wolfingerauthor=Y.+Nikolskyauthor=S.+J.+Walkerauthor=P.+Duerksen-Hughesauthor=C.+E.+Masonauthor=W.+Tongauthor=J.+Thierry-Miegauthor=D.+Thierry-Miegauthor=L.+Shiauthor=C.+Wang&title=A+Rat+Rna-Seq+Transcriptomic+Bodymap+across+11+Organs+and+4+Developmental+Stages&doi=10.1038%2Fncomms4230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages</span></div><div class="casAuthors">Yu Ying; Fuscoe James C; Zhao Chen; Jia Meiwen; Qing Tao; Du Tingting; Luo Heng; Guo Chao; Bannon Desmond I; Lancashire Lee; Nikolsky Yuri; Bao Wenjun; Wolfinger Russell D; Su Zhenqiang; Moland Carrie L; Branham William S; Qian Feng; Ning Baitang; Li Yan; Hong Huixiao; Guo Lei; Mei Nan; Tong Weida; Jones Wendell D; Shi Tieliu; Wang Kevin Y; Walker Stephen J; Duerksen-Hughes Penelope; Mason Christopher E; Thierry-Mieg Jean; Thierry-Mieg Danielle; Shi Leming; Wang Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3230</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The rat has been used extensively as a model for evaluating chemical toxicities and for understanding drug mechanisms.  However, its transcriptome across multiple organs, or developmental stages, has not yet been reported.  Here we show, as part of the SEQC consortium efforts, a comprehensive rat transcriptomic BodyMap created by performing RNA-Seq on 320 samples from 11 organs of both sexes of juvenile, adolescent, adult and aged Fischer 344 rats.  We catalogue the expression profiles of 40,064 genes, 65,167 transcripts, 31,909 alternatively spliced transcript variants and 2,367 non-coding genes/non-coding RNAs (ncRNAs) annotated in AceView.  We find that organ-enriched, differentially expressed genes reflect the known organ-specific biological activities.  A large number of transcripts show organ-specific, age-dependent or sex-specific differential expression patterns.  We create a web-based, open-access rat BodyMap database of expression profiles with crosslinks to other widely used databases, anticipating that it will serve as a primary resource for biomedical research using the rat model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqocd3VPk6-yA3UY9EwTNrfW6udTcc2eYcnIHGD-ZNTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvjsFChtA%253D%253D&md5=c07d485c0ef192adcc30404b3d539cab</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1038%2Fncomms4230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4230%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DFuscoe%26aufirst%3DJ.%2BC.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DQing%26aufirst%3DT.%26aulast%3DBannon%26aufirst%3DD.%2BI.%26aulast%3DLancashire%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DJones%26aufirst%3DW.%2BD.%26aulast%3DMoland%26aufirst%3DC.%2BL.%26aulast%3DBranham%26aufirst%3DW.%2BS.%26aulast%3DQian%26aufirst%3DF.%26aulast%3DNing%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DMei%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DK.%2BY.%26aulast%3DWolfinger%26aufirst%3DR.%2BD.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DWalker%26aufirst%3DS.%2BJ.%26aulast%3DDuerksen-Hughes%26aufirst%3DP.%26aulast%3DMason%26aufirst%3DC.%2BE.%26aulast%3DTong%26aufirst%3DW.%26aulast%3DThierry-Mieg%26aufirst%3DJ.%26aulast%3DThierry-Mieg%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DA%2520Rat%2520Rna-Seq%2520Transcriptomic%2520Bodymap%2520across%252011%2520Organs%2520and%25204%2520Developmental%2520Stages%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3230%26doi%3D10.1038%2Fncomms4230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span> <span> </span><span class="NLM_article-title">Comparative Localization of Aldehyde Oxidase and Xanthine Oxidoreductase Activity in Rat Tissues</span>. <i>Histochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1023/A:1003222831002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1023%2FA%3A1003222831002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10192546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1cXisVCns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=69-74&issue=2&author=Y.+Moriwakiauthor=T.+Yamamotoauthor=J.+Yamakitaauthor=S.+Takahashiauthor=K.+Higashino&title=Comparative+Localization+of+Aldehyde+Oxidase+and+Xanthine+Oxidoreductase+Activity+in+Rat+Tissues&doi=10.1023%2FA%3A1003222831002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative localization of aldehyde oxidase and xanthine oxidoreductase activity in rat tissues</span></div><div class="casAuthors">Moriwaki, Yuji; Yamamoto, Tetsuya; Yamakita, Jun-Ichi; Takahashi, Sumio; Higashino, Kazuya</div><div class="citationInfo"><span class="NLM_cas:title">Histochemical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-74</span>CODEN:
                <span class="NLM_cas:coden">HISJAE</span>;
        ISSN:<span class="NLM_cas:issn">0018-2214</span>.
    
            (<span class="NLM_cas:orgname">Chapman & Hall</span>)
        </div><div class="casAbstract">The distribution of aldehyde oxidase (I) activity was evaluated in unfixed cryostat sections from tissues of male Wistar rats using a tissue protectant, polyvinyl alc., with Tetra Nitro BT as a final electron acceptor.  The distribution of I activity was compared with that of xanthine oxidoreductase (II).  The enzyme histochem. method demonstrated I activity in the epithelium of the tongue, renal tubules, and bronchioles, as well as in the cytoplasm of liver cells.  Such activity was not detected in esophagus, stomach, spleen, adrenal glands, small or large intestine, or skeletal and heart muscle fibers.  In contrast, II activity was demonstrated in the tongue, renal tubules, bronchioles, esophageal, gastric, small and large intestinal epithelial cells, adrenal glands, spleen and liver cytoplasm, but not in skeletal and heart muscle fibers.  The significance of the ubiquitous distribution of I activity, esp. in surface epithelial cells from various tissues, except for the gastrointestinal tract, is unclear.  However, I may possess some physiol. activity other than in the metab. of N-heterocyclics or of certain drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6gPO2AWUBb7Vg90H21EOLACvtfcHk0li50hQug6RHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVCns7w%253D&md5=3f2492fe3630405e5094a4f28aeccb42</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1023%2FA%3A1003222831002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1003222831002%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamakita%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26atitle%3DComparative%2520Localization%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidoreductase%2520Activity%2520in%2520Rat%2520Tissues%26jtitle%3DHistochem.%2520J.%26date%3D1998%26volume%3D30%26issue%3D2%26spage%3D69%26epage%3D74%26doi%3D10.1023%2FA%3A1003222831002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span> <span> </span><span class="NLM_article-title">Zonal Distribution of Allopurinol-Oxidizing Enzymes in Rat Liver</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>431</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1007/978-1-4615-5381-6_9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2F978-1-4615-5381-6_9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=9598029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK1cXls12hur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=1998&pages=47-50&author=Y.+Moriwakiauthor=T.+Yamamotoauthor=J.+Yamakitaauthor=S.+Takahashiauthor=Z.+Tsutsumiauthor=K.+Higashino&title=Zonal+Distribution+of+Allopurinol-Oxidizing+Enzymes+in+Rat+Liver&doi=10.1007%2F978-1-4615-5381-6_9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Zonal distribution of allopurinol-oxidizing enzymes in rat liver</span></div><div class="casAuthors">Moriwaki, Yuji; Yamamoto, Tetsuya; Yamakita, Jun-ichi; Takahashi, Sumio; Tsutsumi, Zenta; Higashino, Kazuya</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">431</span>
        (<span class="NLM_cas:issue">Purine and Pyrimidine Metabolism in Man IX, 1998</span>),
    <span class="NLM_cas:pages">47-50</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">We describe an enzymic histochem. localization of two allopurinol-oxidizing enzymes, xanthine oxidase and aldehyde oxidase in rat hepatic tissues.  This method is based on the tetrazolium salt procedures by use of a tissue protectant, polyvinyl alc., with tetra-nitro BT as the final electron acceptor.  The present study demonstrated that both oxidases are present in the cytoplasm of hepatic cells.  However, the distribution of the enzymes were uneven, being seen mainly in the pericentral rather than the periportal area.  When allopurinol was used as a substrate, the specific staining by xanthine oxidase was more prominent than that of aldehyde oxidase.  The results suggested that xanthine oxidase is more effective in oxidizing allopurinol than aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKDD7dHysSq7Vg90H21EOLACvtfcHk0li50hQug6RHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls12hur0%253D&md5=98e64280f3c4320e09c7673b9279a50c</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1007%2F978-1-4615-5381-6_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4615-5381-6_9%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamakita%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DZ.%26aulast%3DHigashino%26aufirst%3DK.%26atitle%3DZonal%2520Distribution%2520of%2520Allopurinol-Oxidizing%2520Enzymes%2520in%2520Rat%2520Liver%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1998%26volume%3D431%26spage%3D47%26epage%3D50%26doi%3D10.1007%2F978-1-4615-5381-6_9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical Localization of Aldehyde and Xanthine Oxidase in Rat Tissues Using Polyclonal Antibodies</span>. <i>Histochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1007/BF01450880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2FBF01450880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=8824908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaK28XkvVaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1996&pages=71-79&issue=1&author=Y.+Moriwakiauthor=T.+Yamamotoauthor=K.+Yamaguchiauthor=S.+Takahashiauthor=K.+Higashino&title=Immunohistochemical+Localization+of+Aldehyde+and+Xanthine+Oxidase+in+Rat+Tissues+Using+Polyclonal+Antibodies&doi=10.1007%2FBF01450880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies</span></div><div class="casAuthors">Moriwaki, Yuji; Yamamoto, Tetsuya; Yamaguchi, Kei; Takahashi, Sumio; Higashino, Kazuya</div><div class="citationInfo"><span class="NLM_cas:title">Histochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-9</span>CODEN:
                <span class="NLM_cas:coden">HCBIFP</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Tissues from male Wistar rats, fixed with 4% paraformaldehyde and embedded in paraffin, were studied with immunoperoxidase techniques using polyclonal antibodies raised against aldehyde oxidase (AO) or xanthine oxidase (XO) purified from rat liver.  Immunohistochem. studies demonstrated that AO-bearing cells were strongly stained in renal tubules, esophageal, gastric, intestinal and bronchial epithelium as well as liver cytoplasm.  Weak but pos. immunoreactivity was obsd. on the pulmonary alveolar epithelial cells, gastric glands and intestinal goblet cells.  In contrast, it was demonstrated that cells with XO were strongly stained in renal tubules, esophageal, gastric, and small and large intestinal and bronchial epithelia etc.  Pos. immunostaining was also found in adrenal gland, skeletal muscle, spleen and cerebral hippocampus.  Immunoreactivity against AO was not found in adrenal gland, spleen, mesentery, or aorta, whereas immunoreactivity against XO was not found in mesentery or aorta.  Although the significance of this ubiquitous and similar localization of AO and XO seems unclear at present, these results may provide a clue as to the full understanding of the pathophysiol. role of these oxidases in tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkrmijY6jYdbVg90H21EOLACvtfcHk0li50hQug6RHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvVaguw%253D%253D&md5=273c7eedc37ae05c11211f225114f567</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1007%2FBF01450880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01450880%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26atitle%3DImmunohistochemical%2520Localization%2520of%2520Aldehyde%2520and%2520Xanthine%2520Oxidase%2520in%2520Rat%2520Tissues%2520Using%2520Polyclonal%2520Antibodies%26jtitle%3DHistochem.%2520Cell%2520Biol.%26date%3D1996%26volume%3D105%26issue%3D1%26spage%3D71%26epage%3D79%26doi%3D10.1007%2FBF01450880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzago, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boldetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fratelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span> <span> </span><span class="NLM_article-title">Avian and Canine Aldehyde Oxidases. Novel Insights into the Biology and Evolution of Molybdo-Flavoenzymes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">19748</span>– <span class="NLM_lpage">19761</span>, <span class="refDoi"> DOI: 10.1074/jbc.M600850200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1074%2Fjbc.M600850200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=16672219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Gqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=19748-19761&issue=28&author=M.+Teraoauthor=M.+Kurosakiauthor=M.+M.+Barzagoauthor=E.+Varasanoauthor=A.+Boldettiauthor=A.+Bastoneauthor=M.+Fratelliauthor=E.+Garattini&title=Avian+and+Canine+Aldehyde+Oxidases.+Novel+Insights+into+the+Biology+and+Evolution+of+Molybdo-Flavoenzymes&doi=10.1074%2Fjbc.M600850200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Avian and Canine Aldehyde Oxidases: Novel insights into the biology and evolution of molybdo-flavoenzymes</span></div><div class="casAuthors">Terao, Mineko; Kurosaki, Mami; Barzago, Maria Monica; Varasano, Emanuela; Boldetti, Andrea; Bastone, Antonio; Fratelli, Maddalena; Garattini, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">19748-19761</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aldehyde oxidases are molybdo-flavoenzymes structurally related to xanthine oxidoreductase.  They catalyze the oxidn. of aldehydes or N-heterocycles of physiol., pharmacol., and toxicol. relevance.  Rodents are characterized by four aldehyde oxidases as follows: AOX1 and aldehyde oxidase homologs 1-3 (AOH1, AOH2, and AOH3).  Humans synthesize a single functional aldehyde oxidase, AOX1.  Here we define the structure and the characteristics of the aldehyde oxidase genes and proteins in chicken and dog.  The avian genome contains two aldehyde oxidase genes, AOX1 and AOH, mapping to chromosome 7.  AOX1 and AOH are structurally very similar and code for proteins whose sequence was deduced from the corresponding cDNAs.  AOX1 is the ortholog of the same gene in mammals, whereas AOH represents the likely ancestor of rodent AOH1, AOH2, and AOH3.  The dog genome is endowed with two structurally conserved and active aldehyde oxidases clustering on chromosome 37.  Cloning of the corresponding cDNAs and tissue distribution studies demonstrate that they are the orthologs of rodent AOH2 and AOH3.  The vestiges of dog AOX1 and AOH1 are recognizable upstream of AOH2 and AOH3 on the same chromosome.  Comparison of the complement and the structure of the aldehyde oxidase and xanthine oxidoreductase genes in vertebrates and other animal species indicates that they evolved through a series of duplication and inactivation events.  Purifn. of the chicken AOX1 protein to homogeneity from kidney demonstrates that the enzyme possesses retinaldehyde oxidase activity.  Unlike humans and most other mammals, dog and chicken are devoid of liver aldehyde oxidase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgrgmQLkVMCLVg90H21EOLACvtfcHk0li50hQug6RHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Gqtrs%253D&md5=6614f74868cbc3ae79bb1a611cd55875</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M600850200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M600850200%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DBarzago%26aufirst%3DM.%2BM.%26aulast%3DVarasano%26aufirst%3DE.%26aulast%3DBoldetti%26aufirst%3DA.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DFratelli%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26atitle%3DAvian%2520and%2520Canine%2520Aldehyde%2520Oxidases.%2520Novel%2520Insights%2520into%2520the%2520Biology%2520and%2520Evolution%2520of%2520Molybdo-Flavoenzymes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D28%26spage%3D19748%26epage%3D19761%26doi%3D10.1074%2Fjbc.M600850200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palpant, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parast, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzman, J.</span></span> <span> </span><span class="NLM_article-title">Statistically Based Splicing Detection Reveals Neural Enrichment and Tissue-Specific Induction of Circular Rna During Human Fetal Development</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">126</span>, <span class="refDoi"> DOI: 10.1186/s13059-015-0690-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1186%2Fs13059-015-0690-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26076956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BC2Mbjs12qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=126&author=L.+Szaboauthor=R.+Moreyauthor=N.+J.+Palpantauthor=P.+L.+Wangauthor=N.+Afariauthor=C.+Jiangauthor=M.+M.+Parastauthor=C.+E.+Murryauthor=L.+C.+Laurentauthor=J.+Salzman&title=Statistically+Based+Splicing+Detection+Reveals+Neural+Enrichment+and+Tissue-Specific+Induction+of+Circular+Rna+During+Human+Fetal+Development&doi=10.1186%2Fs13059-015-0690-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development</span></div><div class="casAuthors">Szabo Linda; Wang Peter L; Salzman Julia; Morey Robert; Afari Nastaran; Jiang Chuan; Laurent Louise C; Palpant Nathan J; Murry Charles E; Parast Mana M</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">126</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The pervasive expression of circular RNA is a recently discovered feature of gene expression in highly diverged eukaryotes, but the functions of most circular RNAs are still unknown.  Computational methods to discover and quantify circular RNA are essential.  Moreover, discovering biological contexts where circular RNAs are regulated will shed light on potential functional roles they may play.  RESULTS:  We present a new algorithm that increases the sensitivity and specificity of circular RNA detection by discovering and quantifying circular and linear RNA splicing events at both annotated and un-annotated exon boundaries, including intergenic regions of the genome, with high statistical confidence.  Unlike approaches that rely on read count and exon homology to determine confidence in prediction of circular RNA expression, our algorithm uses a statistical approach.  Using our algorithm, we unveiled striking induction of general and tissue-specific circular RNAs, including in the heart and lung, during human fetal development.  We discover regions of the human fetal brain, such as the frontal cortex, with marked enrichment for genes where circular RNA isoforms are dominant.  CONCLUSIONS:  The vast majority of circular RNA production occurs at major spliceosome splice sites; however, we find the first examples of developmentally induced circular RNAs processed by the minor spliceosome, and an enriched propensity of minor spliceosome donors to splice into circular RNA at un-annotated, rather than annotated, exons.  Together, these results suggest a potentially significant role for circular RNA in human development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQypielIS9HBQWRJ3OJdH_qfW6udTcc2ebca8cjPAOjP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mbjs12qsQ%253D%253D&md5=ea95d2021bbd83fc5cca0b29f890a69a</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1186%2Fs13059-015-0690-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13059-015-0690-5%26sid%3Dliteratum%253Aachs%26aulast%3DSzabo%26aufirst%3DL.%26aulast%3DMorey%26aufirst%3DR.%26aulast%3DPalpant%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DP.%2BL.%26aulast%3DAfari%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DParast%26aufirst%3DM.%2BM.%26aulast%3DMurry%26aufirst%3DC.%2BE.%26aulast%3DLaurent%26aufirst%3DL.%2BC.%26aulast%3DSalzman%26aufirst%3DJ.%26atitle%3DStatistically%2520Based%2520Splicing%2520Detection%2520Reveals%2520Neural%2520Enrichment%2520and%2520Tissue-Specific%2520Induction%2520of%2520Circular%2520Rna%2520During%2520Human%2520Fetal%2520Development%26jtitle%3DGenome%2520Biol.%26date%3D2015%26volume%3D16%26spage%3D126%26doi%3D10.1186%2Fs13059-015-0690-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, D. A.</span></span> <span> </span><span class="NLM_article-title">Absolute Quantification of Aldehyde Oxidase Protein in Human Liver Using Liquid Chromatography-Tandem Mass Spectrometry</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3842</span>– <span class="NLM_lpage">3849</span>, <span class="refDoi"> DOI: 10.1021/mp4003046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp4003046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=3842-3849&issue=10&author=J.+T.+Barrauthor=J.+P.+Jonesauthor=C.+A.+Joswig-Jonesauthor=D.+A.+Rock&title=Absolute+Quantification+of+Aldehyde+Oxidase+Protein+in+Human+Liver+Using+Liquid+Chromatography-Tandem+Mass+Spectrometry&doi=10.1021%2Fmp4003046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute Quantification of Aldehyde Oxidase Protein in Human Liver Using Liquid Chromatography-Tandem Mass Spectrometry</span></div><div class="casAuthors">Barr, John T.; Jones, Jeffrey P.; Joswig-Jones, Carolyn A.; Rock, Dan A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3842-3849</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The function of the enzyme human aldehyde oxidase (AOX1) is uncertain; however, recent studies have implicated significant biochem. involvement in humans.  AOX1 has also rapidly become an important drug-metabolizing enzyme.  Until now, quantitation of AOX1 in complex matrixes such as tissue has not been achieved.  Herein, we developed and employed a trypsin digest and subsequent liq. chromatog.-tandem mass spectrometry anal. to det. abs. amts. of AOX1 in human liver.  E. coli expressed human purified AOX1 was used to validate the linearity, sensitivity, and selectivity of the method.  Overall, the method is highly efficient and sensitive for detn. of AOX1 in cytosolic liver fractions.  Using this method, we obsd. substantial batch-to-batch variation in AOX1 content (21-40 pmol AOX1/mg total protein) between various pooled human liver cytosol prepns.  We also obsd. interbatch variation in Vmax (3.3-4.9 nmol min-1 mg-1) and a modest correlation between enzyme concn. and activity.  In addn., we measured a large difference in kcat/Km, between purified (kcat/Km of 1.4) and human liver cytosol (kcat/Km of 15-20) indicating cytosol to be 11-14 times more efficient in the turnover of DACA than the E. coli expressed purified enzyme.  Finally, we discussed the future impact of this method for the development of drug metab. models and understanding the biochem. role of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdDihdSekMBLVg90H21EOLACvtfcHk0li3P-LYf2kc-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtbvJ&md5=22a216a3f9acbea90ae6d8d6cf4948d9</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fmp4003046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp4003046%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DRock%26aufirst%3DD.%2BA.%26atitle%3DAbsolute%2520Quantification%2520of%2520Aldehyde%2520Oxidase%2520Protein%2520in%2520Human%2520Liver%2520Using%2520Liquid%2520Chromatography-Tandem%2520Mass%2520Spectrometry%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26issue%3D10%26spage%3D3842%26epage%3D3849%26doi%3D10.1021%2Fmp4003046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderstrom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase 1 (Aox1) in Human Liver Cytosols: Quantitative Characterization of Aox1 Expression Level and Activity Relationship</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1797</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.113.053082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23857892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVygtrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1797-1804&issue=10&author=C.+Fuauthor=L.+Diauthor=X.+Hanauthor=C.+Soderstromauthor=M.+Snyderauthor=M.+D.+Troutmanauthor=R.+S.+Obachauthor=H.+Zhang&title=Aldehyde+Oxidase+1+%28Aox1%29+in+Human+Liver+Cytosols%3A+Quantitative+Characterization+of+Aox1+Expression+Level+and+Activity+Relationship&doi=10.1124%2Fdmd.113.053082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase 1 (AOX1) in human liver cytosols: quantitative characterization of AOX1 expression level and activity relationship</span></div><div class="casAuthors">Fu, Cexiong; Di, Li; Han, Xiaogang; Soderstrom, Cathy; Snyder, Mark; Troutman, Matthew D.; Obach, R. Scott; Zhang, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1797-1804</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase 1 (AOX1) is a cytosolic enzyme highly expressed in liver and plays a key role in metabolizing drugs contg. arom. azaheterocyclic substituents.  Rapid metab. catalyzed by AOX1 can cause a drug to exhibit high clearance, low exposure, and hence decreased efficacy or even increased toxicity (if AOX1 generated metabolites are toxic).  There is a need to develop the correlation between AOX1 expression levels and AOX1-substrate clearance.  A fast, sensitive, and robust liq. chromatog.-tandem mass spectrometry (LC-MS/MS) method was developed to quantify AOX1 in human liver cytosol for the first time.  This LC-MS/MS method includes a straightforward ultrafiltration fractionation step and gives great selectivity and wide dynamic range (5.2 pM to 20.7 nM).  The AOX1 levels in human liver cytosols of 20 donors were quantified using this method to investigate individual differences in AOX1 expression.  No significant individual or gender differences in AOX1 levels were obsd., although male donors exhibited a broader distribution than female donors (0.74-2.30 pmol/mg vs. 0.74-1.69 pmol/mg, resp.).  The AOX1 protein levels measured by LC-MS/MS were consistent with those measured by an ELISA.  Several donors have a normal AOX1 protein level but low enzyme activity, which might be due to cofactor deficiency, single nucleotide polymorphism, or homodimer dissocn.  Cytosols from donors with chronic alc. consumption had low AOX1-catalyzed carbazeran oxidn. activities (<51 μl/min per mg compared with a median of 455 μl/min per mg), but preserved similar AOX1 protein expression levels (approx. 15% less than the median value).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB97GlLsl1vLVg90H21EOLACvtfcHk0li3P-LYf2kc-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVygtrfF&md5=5f0ca934bbaaf65670abab7b2d44cf37</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053082%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DC.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DSoderstrom%26aufirst%3DC.%26aulast%3DSnyder%26aufirst%3DM.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DAldehyde%2520Oxidase%25201%2520%2528Aox1%2529%2520in%2520Human%2520Liver%2520Cytosols%253A%2520Quantitative%2520Characterization%2520of%2520Aox1%2520Expression%2520Level%2520and%2520Activity%2520Relationship%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26issue%3D10%26spage%3D1797%26epage%3D1804%26doi%3D10.1124%2Fdmd.113.053082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyward, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, T.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase Activity in Donor-Matched Fresh and Cryopreserved Human Hepatocytes and Assessment of Variability in 75 Donors</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1090</span>– <span class="NLM_lpage">1097</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.057984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.057984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24713130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKnt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1090-1097&issue=6&author=J.+M.+Hutzlerauthor=Y.+S.+Yangauthor=C.+Brownauthor=S.+Heywardauthor=T.+Moeller&title=Aldehyde+Oxidase+Activity+in+Donor-Matched+Fresh+and+Cryopreserved+Human+Hepatocytes+and+Assessment+of+Variability+in+75+Donors&doi=10.1124%2Fdmd.114.057984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase activity in donor-matched fresh and cryopreserved human hepatocytes and assessment of variability in 75 donors</span></div><div class="casAuthors">Hutzler, J. Matthew; Yang, Young-Sun; Brown, Caitlin; Heyward, Scott; Moeller, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1090-1097, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Studies were conducted to evaluate the impact of time and cryopreservation on aldehyde oxidase (AO) activity in human hepatocytes isolated from 10 donor livers, using O6-benzylguanine as a probe substrate.  In addn., variability in activity was assessed using cryopreserved hepatocytes from 75 donors.  Substantial donor-dependent loss in AO activity within 24 h after isolation of hepatocytes was obsd. (av. loss of 42%, range 15%-81%).  Meanwhile, AO activity in cryopreserved hepatocytes more closely represented the activity obsd. in fresh hepatocytes that were incubated immediately after isolation for the same donors (within 81% of fresh, range 48%-100%).  Activity of AO in cryopreserved hepatocytes from 75 donors varied by at least 17-fold (≤5.4 to 90 mL/min per kg of body wt.), with 63% of the donors having higher activity than a pooled 19-donor lot (34.2 mL/min per kg).  Comparison of demographics such as gender, body mass index, age, and ethnicity showed no statistically significant correlations with activity.  Evaluation of medical histories revealed that three of the five donors with no measurable activity had immediate histories of extensive alc. abuse.  Meanwhile, two single nucleotide polymorphisms (SNPs) for AOX1 (rs3731772 and rs55754655) were detected in our donor pool and showed allelic frequencies similar to those reported from other cohort studies.  However, these SNPs did not correlate with a statistically significant difference in intrinsic clearance compared with wild-type donors.  With a general lack of clarity about what causes highly variable AO activity, prescreening donors for AO activity and creating a custom high-activity pooled lot of cryopreserved hepatocytes are advised to minimize underpredictions of clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI1CETO4hEdrVg90H21EOLACvtfcHk0lie2TFYW5a3bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKnt7%252FF&md5=21a11c73049d04fcace46fccf757c302</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.057984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.057984%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DHeyward%26aufirst%3DS.%26aulast%3DMoeller%26aufirst%3DT.%26atitle%3DAldehyde%2520Oxidase%2520Activity%2520in%2520Donor-Matched%2520Fresh%2520and%2520Cryopreserved%2520Human%2520Hepatocytes%2520and%2520Assessment%2520of%2520Variability%2520in%252075%2520Donors%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D6%26spage%3D1090%26epage%3D1097%26doi%3D10.1124%2Fdmd.114.057984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teutloff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfaro, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">The Impact of Single Nucleotide Polymorphisms on Human Aldehyde Oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">856</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.043828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.043828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22279051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=856-864&issue=5&author=T.+Hartmannauthor=M.+Teraoauthor=E.+Garattiniauthor=C.+Teutloffauthor=J.+F.+Alfaroauthor=J.+P.+Jonesauthor=S.+Leimkuhler&title=The+Impact+of+Single+Nucleotide+Polymorphisms+on+Human+Aldehyde+Oxidase&doi=10.1124%2Fdmd.111.043828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of single nucleotide polymorphisms on human aldehyde oxidase</span></div><div class="casAuthors">Hartmann, Tobias; Terao, Mineko; Garattini, Enrico; Teutloff, Christian; Alfaro, Joshua F.; Jones, Jeffrey P.; Leimkuehler, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">856-864</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a complex molybdo-flavoprotein that belongs to the xanthine oxidase family.  AO is active as a homodimer, and each 150-kDa monomer binds 2 distinct [2Fe-2S] clusters, FAD, and the Mo cofactor.  AO plays an important role in the metab. of drugs based on its broad substrate specificity oxidizing arom. aza-heterocycles, e.g., N1-methylnicotinamide and N-methylphthalazinium, or aldehydes, such as benzaldehyde, retinal, and vanillin.  Sequencing the 35 coding exons of the human AOX1 gene in a sample of 180 Italian individuals led to the identification of relatively frequent, synonymous, missense, and nonsense single-nucleotide polymorphisms (SNPs).  Here, human aldehyde oxidase (hAOX1) was purified after heterologous expression in Escherichia coli.  The recombinant protein was obtained with a purity of 95% and a yield of 50 μg/L E. coli culture.  Site-directed mutagenesis of the hAOX1 cDNA allowed the purifn. of protein variants bearing amino acid changes R802C, R921H, N1135S, and H1297R, which corresponded to some of the identified SNPs.  The hAOX1 variants were purified and compared with the wild-type protein relative to activity, oligomerization state, and metal content.  The data showed that the mutation of each amino acid residue had a variable impact on the ability of hAOX1 to metabolize selected substrates.  Thus, the human population is characterized by the presence of functionally inactive hAOX1 allelic variants as well as variants encoding enzymes with different catalytic activities.  These results indicate that the presence of these allelic variants should be considered for the design of future drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPZuTJ_uSE37Vg90H21EOLACvtfcHk0lie2TFYW5a3bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kgu7w%253D&md5=2f4880516d41161df95ef9a7b037bdd5</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.043828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.043828%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTeutloff%26aufirst%3DC.%26aulast%3DAlfaro%26aufirst%3DJ.%2BF.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DThe%2520Impact%2520of%2520Single%2520Nucleotide%2520Polymorphisms%2520on%2520Human%2520Aldehyde%2520Oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D5%26spage%3D856%26epage%3D864%26doi%3D10.1124%2Fdmd.111.043828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorendorf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">A Single Nucleotide Polymorphism Causes Enhanced Radical Oxygen Species Production by Human Aldehyde Oxidase</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0182061</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0182061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1371%2Fjournal.pone.0182061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28750088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlaqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&issue=7&author=A.+Fotiauthor=F.+Dorendorfauthor=S.+Leimkuhler&title=A+Single+Nucleotide+Polymorphism+Causes+Enhanced+Radical+Oxygen+Species+Production+by+Human+Aldehyde+Oxidase&doi=10.1371%2Fjournal.pone.0182061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">A single nucleotide polymorphism causes enhanced radical oxygen species production by human aldehyde oxidase</span></div><div class="casAuthors">Foti, Alessandro; Dorendorf, Frank; Leimkuehler, Silke</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0182061/1-e0182061/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs) are molybdo-flavoenzymes characterized by broad substrate specificity, oxidizing arom./aliph. aldehydes into the corresponding carboxylic acids and hydroxylating various heteroarom. rings.  The enzymes use oxygen as the terminal electron acceptor and produce reduced oxygen species during turnover.  The physiol. function of mammalian AOX isoenzymes is still unclear, however, human AOX (hAOX1) is an emerging enzyme in phase-I drug metab.  Indeed, the no. of xenobiotics acting as hAOX1 substrates is increasing.  Further, numerous single-nucleotide polymorphisms (SNPs) have been identified within the hAOX1 gene.  SNPs are a major source of inter-individual variability in the human population, and SNP-based amino acid exchanges in hAOX1 reportedly modulate the catalytic function of the enzyme in either a pos. or neg. fashion.  In this report we selected ten novel SNPs resulting in amino acid exchanges in proximity to the FAD site of hAOX1 and characterized the purified enzymes after heterologous expression in Escherichia coli.  The hAOX1 variants were characterized carefully by quant. differences in their ability to produce superoxide radical.  ROS represent prominent key mols. in physiol. and pathol. conditions in the cell.  Our data reveal significant alterations in superoxide anion prodn. among the variants.  In particular the SNP-based amino acid exchange L438V in proximity to the isoalloxanzine ring of the FAD cofactor resulted in increased rate of superoxide radical prodn. of 75%.  Considering the high toxicity of the superoxide in the cell, the hAOX1-L438V SNP variant is an eventual candidate for crit. or pathol. roles of this natural variant within the human population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtSFZjw7z8bVg90H21EOLACvtfcHk0lie2TFYW5a3bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlaqurw%253D&md5=28472e1f132c811860fb71661edcac1b</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0182061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0182061%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DDorendorf%26aufirst%3DF.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DA%2520Single%2520Nucleotide%2520Polymorphism%2520Causes%2520Enhanced%2520Radical%2520Oxygen%2520Species%2520Production%2520by%2520Human%2520Aldehyde%2520Oxidase%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0182061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Simultaneous Determination of Idelalisib and Its Metabolite Gs-563117 in Dog Plasma by Lc-Ms/Ms: Application to a Pharmacokinetic Study</span>. <i>Biomed. Chromatogr.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e4511</span> <span class="refDoi"> DOI: 10.1002/bmc.4511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fbmc.4511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30773664" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&issue=5&author=C.+Wangauthor=F.+Jiaauthor=Y.+Zhang&title=Simultaneous+Determination+of+Idelalisib+and+Its+Metabolite+Gs-563117+in+Dog+Plasma+by+Lc-Ms%2FMs%3A+Application+to+a+Pharmacokinetic+Study&doi=10.1002%2Fbmc.4511"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1002%2Fbmc.4511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbmc.4511%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DSimultaneous%2520Determination%2520of%2520Idelalisib%2520and%2520Its%2520Metabolite%2520Gs-563117%2520in%2520Dog%2520Plasma%2520by%2520Lc-Ms%252FMs%253A%2520Application%2520to%2520a%2520Pharmacokinetic%2520Study%26jtitle%3DBiomed.%2520Chromatogr.%26date%3D2019%26volume%3D33%26issue%3D5%26doi%3D10.1002%2Fbmc.4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">Mammalian Molybdo-Flavoenzymes, an Expanding Family of Proteins: Structure, Genetics, Regulation, Function and Pathophysiology</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1042/bj20030121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1042%2Fbj20030121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=12578558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2003&pages=15-32&author=E.+Garattiniauthor=R.+Mendelauthor=M.+J.+Romaoauthor=R.+Wrightauthor=M.+Terao&title=Mammalian+Molybdo-Flavoenzymes%2C+an+Expanding+Family+of+Proteins%3A+Structure%2C+Genetics%2C+Regulation%2C+Function+and+Pathophysiology&doi=10.1042%2Fbj20030121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology</span></div><div class="casAuthors">Garattini, Enrico; Mendel, Ralf; Romao, Maria Joao; Wright, Richard; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-32</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The molybdo-flavoenzymes are structurally related proteins that require a molybdopterin cofactor and FAD for their catalytic activity.  In mammals, four enzymes are known: xanthine oxidoreductase, aldehyde oxidase and two recently described mouse proteins known as aldehyde oxidase homolog 1 and aldehyde oxidase homolog 2.  The present review article summarizes current knowledge on the structure, enzymol., genetics, regulation and pathophysiol. of mammalian molybdo-flavoenzymes.  Molybdo-flavoenzymes are structurally complex oxidoreductases with an equally complex mechanism of catalysis.  Our knowledge has greatly increased due to the recent crystn. of two xanthine oxidoreductases and the detn. of the amino acid sequences of many members of the family.  The evolution of molybdo-flavoenzymes can now be traced, given the availability of the structures of the corresponding genes in many organisms.  The genes coding for molybdo-flavoenzymes are expressed in a cell-specific fashion and are controlled by endogenous and exogenous stimuli.  The recent cloning of the genes involved in the biosynthesis of the molybdenum cofactor has increased our knowledge on the assembly of the apo-forms of molybdo-flavoproteins into the corresponding holo-forms.  Xanthine oxidoreductase is the key enzyme in the catabolism of purines, although recent data suggest that the physiol. function of this enzyme is more complex than previously assumed.  The enzyme has been implicated in such diverse pathol. situations as organ ischemia, inflammation and infection.  At present, very little is known about the pathophysiol. relevance of aldehyde oxidase, aldehyde oxidase homolog 1 and aldehyde oxidase homolog 2, which do not as yet have an accepted endogenous substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF9AyORLkqFbVg90H21EOLACvtfcHk0li18wbt62XZcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFeitbg%253D&md5=3004079e3d63655d84db5df06656d339</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1042%2Fbj20030121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20030121%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DMendel%26aufirst%3DR.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DR.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DMammalian%2520Molybdo-Flavoenzymes%252C%2520an%2520Expanding%2520Family%2520of%2520Proteins%253A%2520Structure%252C%2520Genetics%252C%2520Regulation%252C%2520Function%2520and%2520Pathophysiology%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D372%26spage%3D15%26epage%3D32%26doi%3D10.1042%2Fbj20030121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kucukgoze, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">Direct Comparison of the Four Aldehyde Oxidase Enzymes Present in Mouse Gives Insight into Their Substrate Specificities</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e0191819</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0191819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1371%2Fjournal.pone.0191819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29370288" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&issue=1&author=G.+Kucukgozeauthor=S.+Leimkuhler&title=Direct+Comparison+of+the+Four+Aldehyde+Oxidase+Enzymes+Present+in+Mouse+Gives+Insight+into+Their+Substrate+Specificities&doi=10.1371%2Fjournal.pone.0191819"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0191819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0191819%26sid%3Dliteratum%253Aachs%26aulast%3DKucukgoze%26aufirst%3DG.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DDirect%2520Comparison%2520of%2520the%2520Four%2520Aldehyde%2520Oxidase%2520Enzymes%2520Present%2520in%2520Mouse%2520Gives%2520Insight%2520into%2520Their%2520Substrate%2520Specificities%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26issue%3D1%26doi%3D10.1371%2Fjournal.pone.0191819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotake, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effects of Drugs on the Metabolic Activity of Mouse and Human Aldehyde Oxidases and Influence on Drug-Drug Interactions</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bcp.2018.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=29678521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFWjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=28-38&author=N.+Takaokaauthor=S.+Sanohauthor=K.+Okudaauthor=Y.+Kotakeauthor=G.+Sugaharaauthor=A.+Yanagiauthor=Y.+Ishidaauthor=C.+Tatenoauthor=Y.+Tayamaauthor=K.+Sugiharaauthor=S.+Kitamuraauthor=M.+Kurosakiauthor=M.+Teraoauthor=E.+Garattiniauthor=S.+Ohta&title=Inhibitory+Effects+of+Drugs+on+the+Metabolic+Activity+of+Mouse+and+Human+Aldehyde+Oxidases+and+Influence+on+Drug-Drug+Interactions&doi=10.1016%2Fj.bcp.2018.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions</span></div><div class="casAuthors">Takaoka, Naoki; Sanoh, Seigo; Okuda, Katsuhiro; Kotake, Yaichiro; Sugahara, Go; Yanagi, Ami; Ishida, Yuji; Tateno, Chise; Tayama, Yoshitaka; Sugihara, Kazumi; Kitamura, Shigeyuki; Kurosaki, Mami; Terao, Mineko; Garattini, Enrico; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28-38</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As aldehyde oxidase (AOX) plays an emerging role in drug metab., understanding its significance for drug-drug interactions (DDI) is important.  Therefore, we tested 10 compds. for species-specific and substrate-dependent differences in the inhibitory effect of AOX activity using genetically engineered HEK293 cells over-expressing human AOX1, mouse AOX1 or mouse AOX3.  The IC50 values of 10 potential inhibitors of the three AOX enzymes were detd. using phthalazine and O6-benzylguanine as substrates. 17β-Estradiol, menadione, norharmane and raloxifene exhibited marked differences in inhibitory effects between the human and mouse AOX isoforms when the phthalazine substrate was used.  Some of the compds. tested exhibited substrate-dependent differences in their inhibitory effects.  Docking simulations with human AOX1 and mouse AOX3 were conducted for six representative inhibitors.  The rank order of the min. binding energy reflected the order of the corresponding IC50 values.  We also evaluated the potential DDI between an AOX substrate (O6-benzylguanine) and an inhibitor (hydralazine) using chimeric mice with humanized livers.  Pretreatment of hydralazine increased the max. plasma concn. (Cmax) and the area under the plasma concn.-time curve (AUC0-24) of O6-benzylguanine compared to single administration.  Our in vitro data indicate species-specific and substrate-dependent differences in the inhibitory effects on AOX activity.  Our in vivo data demonstrate the existence of a DDI which may be of relevance in the clin. context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsgVzzBcETA7Vg90H21EOLACvtfcHk0li18wbt62XZcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFWjsr0%253D&md5=5af239255a886296d31fded9ee1c10c3</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DTakaoka%26aufirst%3DN.%26aulast%3DSanoh%26aufirst%3DS.%26aulast%3DOkuda%26aufirst%3DK.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DSugahara%26aufirst%3DG.%26aulast%3DYanagi%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DY.%26aulast%3DTateno%26aufirst%3DC.%26aulast%3DTayama%26aufirst%3DY.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DKurosaki%26aufirst%3DM.%26aulast%3DTerao%26aufirst%3DM.%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DInhibitory%2520Effects%2520of%2520Drugs%2520on%2520the%2520Metabolic%2520Activity%2520of%2520Mouse%2520and%2520Human%2520Aldehyde%2520Oxidases%2520and%2520Influence%2520on%2520Drug-Drug%2520Interactions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D154%26spage%3D28%26epage%3D38%26doi%3D10.1016%2Fj.bcp.2018.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">al-Tayib, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span> <span> </span><span class="NLM_article-title">Species Variation in Hepatic Aldehyde Oxidase Activity</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1007/BF03189919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1007%2FBF03189919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3130251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVaksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1987&pages=307-310&issue=4&author=C.+Beedhamauthor=S.+E.+Bruceauthor=D.+J.+Critchleyauthor=Y.+al-Tayibauthor=D.+J.+Rance&title=Species+Variation+in+Hepatic+Aldehyde+Oxidase+Activity&doi=10.1007%2FBF03189919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Species variation in hepatic aldehyde oxidase activity</span></div><div class="casAuthors">Beedham, C.; Bruce, S. E.; Critchley, D. J.; Al-Tayib, Y.; Rance, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-10</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0398-7639</span>.
    </div><div class="casAbstract">The activity of hepatic aldehyde oxidase from rabbit, guinea pig, rat, marmoset, dog, baboon, and man was investigated in vitro with charged and uncharged N-heterocyclic substrates: Km and Vmax values were detd. for phthalazine, carbazeran, quinine, and quinidine.  The oxidn. of N-phenylquinolinium chloride to N-phenyl-2-quinolone and N-phenyl-4-quinolone was followed spectrophotometrically.  Rat or dog liver showed low and negligible enzyme activity, resp., whereas baboon liver contained a highly active aldehyde oxidase.  Enzyme from marmoset and guinea pig liver had the closest spectrum of activity to human liver aldehyde oxidase.  Unlike that from man, rabbit hepatic aldehyde oxidase was refractory toward carbazeran and converted N-phenylquinolinium chloride predominantly to the 2-quinolone.  N-Phenyl-4-quinolone was the major oxidn. product with enzyme from guinea pig, marmoset, baboon, and man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeSk-deE5ie7Vg90H21EOLACvtfcHk0lib6Qdhcx5cgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVaksro%253D&md5=8f146a62d4462dfeb5daa121c4d5baab</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1007%2FBF03189919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03189919%26sid%3Dliteratum%253Aachs%26aulast%3DBeedham%26aufirst%3DC.%26aulast%3DBruce%26aufirst%3DS.%2BE.%26aulast%3DCritchley%26aufirst%3DD.%2BJ.%26aulast%3Dal-Tayib%26aufirst%3DY.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26atitle%3DSpecies%2520Variation%2520in%2520Hepatic%2520Aldehyde%2520Oxidase%2520Activity%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1987%26volume%3D12%26issue%3D4%26spage%3D307%26epage%3D310%26doi%3D10.1007%2FBF03189919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beedham, C.</span></span> <span> </span><span class="NLM_article-title">Molybdenum Hydroxylases: Biological Distribution and Substrate-Inhibitor Specificity</span>. <i>Prog. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1016/S0079-6468(08)70420-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2FS0079-6468%2808%2970420-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=3332920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADyaL1cXhtVyms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1987&pages=85-127&author=C.+Beedham&title=Molybdenum+Hydroxylases%3A+Biological+Distribution+and+Substrate-Inhibitor+Specificity&doi=10.1016%2FS0079-6468%2808%2970420-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Molybdenum hydroxylases:  biological distribution and substrate-inhibitor specificity</span></div><div class="casAuthors">Beedham, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-127</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    </div><div class="casAbstract">A review with 240 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_OHtxc9-yZLVg90H21EOLACvtfcHk0lib6Qdhcx5cgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtVyms7w%253D&md5=6097afb5ac4830cffe9380e142816921</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970420-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970420-X%26sid%3Dliteratum%253Aachs%26aulast%3DBeedham%26aufirst%3DC.%26atitle%3DMolybdenum%2520Hydroxylases%253A%2520Biological%2520Distribution%2520and%2520Substrate-Inhibitor%2520Specificity%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D1987%26volume%3D24%26spage%3D85%26epage%3D127%26doi%3D10.1016%2FS0079-6468%2808%2970420-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyson, C. A.</span></span> <span> </span><span class="NLM_article-title">Variation of Hepatic Methotrexate 7-Hydroxylase Activity in Animals and Humans</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">611</span>, <span class="refDoi"> DOI: 10.1080/713803569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F713803569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10683765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1Wntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=607-611&author=S.+Kitamuraauthor=K.+Sugiharaauthor=K.+Nakataniauthor=S.+Ohtaauthor=T.+Ohharaauthor=S.+Ninomiyaauthor=C.+E.+Greenauthor=C.+A.+Tyson&title=Variation+of+Hepatic+Methotrexate+7-Hydroxylase+Activity+in+Animals+and+Humans&doi=10.1080%2F713803569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans</span></div><div class="casAuthors">Kitamura, Shigeyuki; Sugihara, Kazumi; Nakatani, Keiko; Ohta, Shigeru; Oh-hara, Toshinari; Ninomiya, Shin-ichi; Green, Carol E.; Tyson, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">607-611</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis</span>)
        </div><div class="casAbstract">This study deals with individual and species variations in the converting activity of methotrexate (MTX) to 7-hydroxymethotrexate in animals and humans.  When MTX 7-hydroxylase was assayed in six human liver cytosols, a 48-fold range of inter-subject variation of the activity was obsd.  The variations were correlated to the concns. of aldehyde oxidase activity in human subjects assayed with benzaldehyde as a substrate.  Species differences of liver MTX 7-hydroxylase activity were also obsd.  The activity was highest in rabbits, followed by rats, hamsters, and monkeys but was undetectable in dogs.  Strain differences of MTX 7-hydroxylase activity based on aldehyde oxidase activity were also obsd. in rats and mice.  The results suggest that aldehyde oxidase functions as MTX 7-hydroxylase in livers of animals and humans, and the obsd. differences of MTX 7-hydroxylase activity are due to variations in the amt. of aldehyde oxidase present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5SW80Ec5an7Vg90H21EOLACvtfcHk0lib6Qdhcx5cgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1Wntw%253D%253D&md5=ed6aa79830882ac56611902083edeb09</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1080%2F713803569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F713803569%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DNakatani%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DOhhara%26aufirst%3DT.%26aulast%3DNinomiya%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DC.%2BE.%26aulast%3DTyson%26aufirst%3DC.%2BA.%26atitle%3DVariation%2520of%2520Hepatic%2520Methotrexate%25207-Hydroxylase%2520Activity%2520in%2520Animals%2520and%2520Humans%26jtitle%3DIUBMB%2520Life%26date%3D1999%26volume%3D48%26spage%3D607%26epage%3D611%26doi%3D10.1080%2F713803569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span> <span> </span><span class="NLM_article-title">Interspecies Variation in the Metabolism of Zoniporide by Aldehyde Oxidase</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.3109/00498254.2012.727499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2012.727499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23046389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVOqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=399-408&issue=5&author=D.+Dalvieauthor=C.+Xiangauthor=P.+Kangauthor=S.+Zhou&title=Interspecies+Variation+in+the+Metabolism+of+Zoniporide+by+Aldehyde+Oxidase&doi=10.3109%2F00498254.2012.727499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Interspecies variation in the metabolism of zoniporide by aldehyde oxidase</span></div><div class="casAuthors">Dalvie, Deepak; Xiang, Cathie; Kang, Ping; Zhou, Sue</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-408</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">1. Aldehyde oxidase (AO) is a cytosolic enzyme that contributes to the Phase I metab. of xenobiotics in human and preclin. species.  2.Current studies explored in vitro metab. of zoniporide in various animal species and humans using S9 fractions.  The animal species included commonly used pharmacol. and toxicol. models and domestic animals such as the cat, cow or bull, pig and horse.  3. In addn., gender and strain differences in some species were also explored.  4. All animals except the dog and cat converted zoniporide to 2-oxozoniporide (M1).  5. Michael-Menten kinetic studies were conducted in species that turned over zoniporide to M1.6.  Marked differences in KM, Vmax and Clint were obsd. in the oxidn. of zoniporide.7.  Although the KM and Vmax of zoniporide oxidn. in male and female human S9 was similar, some gender difference was obsd. in animals esp., in Vmax.8.  The domestic animals also showed marked species differences in the AO activity and affinity toward zoniporide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnm9ba7EGMubVg90H21EOLACvtfcHk0lib6Qdhcx5cgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVOqs70%253D&md5=aa979b370a1489c3570ea7a9510bd7c8</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.3109%2F00498254.2012.727499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2012.727499%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DXiang%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DS.%26atitle%3DInterspecies%2520Variation%2520in%2520the%2520Metabolism%2520of%2520Zoniporide%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DXenobiotica%26date%3D2013%26volume%3D43%26issue%3D5%26spage%3D399%26epage%3D408%26doi%3D10.3109%2F00498254.2012.727499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">A Novel in Vitro Allometric Scaling Methodology for Aldehyde Oxidase Substrates to Enable Selection of Appropriate Species for Traditional Allometry</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1080/00498254.2017.1296208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1080%2F00498254.2017.1296208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=28281401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFyksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=219-231&issue=3&author=R.+D.+Crouchauthor=J.+M.+Hutzlerauthor=J.+S.+Daniels&title=A+Novel+in+Vitro+Allometric+Scaling+Methodology+for+Aldehyde+Oxidase+Substrates+to+Enable+Selection+of+Appropriate+Species+for+Traditional+Allometry&doi=10.1080%2F00498254.2017.1296208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry</span></div><div class="casAuthors">Crouch, Rachel D.; Hutzler, J. Matthew; Daniels, J. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-231</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. Failure to predict human pharmacokinetics of aldehyde oxidase (AO) substrates using traditional allometry has been attributed to species differences in AO metab.2.  To identify appropriate species for predicting human in vivo clearance by single-species scaling (SSS) or multispecies allometry (MA), we scaled in vitro intrinsic clearance (CLint) of five AO substrates obtained from hepatic S9 of mouse, rat, guinea pig, monkey and minipig to human in vitro CLint.3.  When predicting human in vitro CLint, av. abs. fold-error was ≤2.0 by SSS with monkey, minipig and guinea pig (rat/mouse >3.0) and was <3.0 by most MA species combinations (including rat/mouse combinations).4.  Interspecies variables, including fraction metabolized by AO (Fm,AO) and hepatic extn. ratios (E) were estd. in vitro.  SSS prediction fold-errors correlated with the animal:human ratio of E (r2 = 0.6488), but not Fm,AO (r2 = 0.0051).5.  Using plasma clearance (CLp) from the literature, SSS with monkey was superior to rat or mouse at predicting human CLp of BIBX1382 and zoniporide, consistent with in vitro SSS assessments.6.  Evaluation of in vitro allometry, Fm,AO and E may prove useful to guide selection of suitable species for traditional allometry and prediction of human pharmacokinetics of AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqACaT1Bvbi47Vg90H21EOLACvtfcHk0ljznNbuA4Wy5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFyksrs%253D&md5=824ee5fbec02c33e03f72007f16f4b1c</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1080%2F00498254.2017.1296208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2017.1296208%26sid%3Dliteratum%253Aachs%26aulast%3DCrouch%26aufirst%3DR.%2BD.%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DA%2520Novel%2520in%2520Vitro%2520Allometric%2520Scaling%2520Methodology%2520for%2520Aldehyde%2520Oxidase%2520Substrates%2520to%2520Enable%2520Selection%2520of%2520Appropriate%2520Species%2520for%2520Traditional%2520Allometry%26jtitle%3DXenobiotica%26date%3D2018%26volume%3D48%26issue%3D3%26spage%3D219%26epage%3D231%26doi%3D10.1080%2F00498254.2017.1296208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumeier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mages, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzbauer, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groschl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanidis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholmerich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, C.</span></span> <span> </span><span class="NLM_article-title">Small-Interference Rna-Mediated Knock-Down of Aldehyde Oxidase 1 in 3t3-L1 Cells Impairs Adipogenesis and Adiponectin Release</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>582</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2965</span>– <span class="NLM_lpage">2972</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2008.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.febslet.2008.07.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=18671973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpslSmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2008&pages=2965-2972&issue=19&author=J.+Weigertauthor=M.+Neumeierauthor=S.+Bauerauthor=W.+Magesauthor=A.+A.+Schnitzbauerauthor=A.+Obedauthor=B.+Groschlauthor=A.+Hartmannauthor=A.+Schafflerauthor=C.+Aslanidisauthor=J.+Scholmerichauthor=C.+Buechler&title=Small-Interference+Rna-Mediated+Knock-Down+of+Aldehyde+Oxidase+1+in+3t3-L1+Cells+Impairs+Adipogenesis+and+Adiponectin+Release&doi=10.1016%2Fj.febslet.2008.07.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release</span></div><div class="casAuthors">Weigert, Johanna; Neumeier, Markus; Bauer, Sabrina; Mages, Wolfgang; Schnitzbauer, Andreas A.; Obed, Aiman; Groeschl, Benedikt; Hartmann, Arndt; Schaeffler, Andreas; Aslanidis, Charalampos; Schoelmerich, Juergen; Buechler, Christa</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2965-2972</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidase 1 (AOX1) is highly abundant in the liver and oxidizes aldehydes thereby generating reactive oxygen species.  Enzymes involved in detoxification of aldehydes are expressed in adipocytes and alter adipogenesis, therefore the functional role of AOX1 in adipocytes was analyzed.  AOX1 mRNA was higher in visceral compared to s.c. human adipose tissue but AOX1 protein was detected in both fat depots.  AOX1 expression in adipocytes was confirmed by immunohistochem. and immunoblot.  AOX1 was induced during adipocytic differentiation and was downregulated by fenofibrate in differentiated cells.  Knock-down of AOX1 in preadipocytes led to impaired lipid storage and adiponectin release in the differentiated cells.  These data indicate that AOX1 is essential for adipogenesis and may link energy and drug metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEiK9kLbcXf7Vg90H21EOLACvtfcHk0ljznNbuA4Wy5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpslSmtrg%253D&md5=cb8f9009d488d3869c8dec146f0de4f9</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2008.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2008.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DWeigert%26aufirst%3DJ.%26aulast%3DNeumeier%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DMages%26aufirst%3DW.%26aulast%3DSchnitzbauer%26aufirst%3DA.%2BA.%26aulast%3DObed%26aufirst%3DA.%26aulast%3DGroschl%26aufirst%3DB.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DSchaffler%26aufirst%3DA.%26aulast%3DAslanidis%26aufirst%3DC.%26aulast%3DScholmerich%26aufirst%3DJ.%26aulast%3DBuechler%26aufirst%3DC.%26atitle%3DSmall-Interference%2520Rna-Mediated%2520Knock-Down%2520of%2520Aldehyde%2520Oxidase%25201%2520in%25203t3-L1%2520Cells%2520Impairs%2520Adipogenesis%2520and%2520Adiponectin%2520Release%26jtitle%3DFEBS%2520Lett.%26date%3D2008%26volume%3D582%26issue%3D19%26spage%3D2965%26epage%3D2972%26doi%3D10.1016%2Fj.febslet.2008.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sigruener, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracciano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncalli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornstein, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, G.</span></span> <span> </span><span class="NLM_article-title">Human Aldehyde Oxidase 1 Interacts with Atp-Binding Cassette Transporter-1 and Modulates Its Activity in Hepatocytes</span>. <i>Horm. Metab. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1055/s-2007-992129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1055%2Fs-2007-992129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=17992631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=781-789&issue=11&author=A.+Sigruenerauthor=C.+Buechlerauthor=E.+Orsoauthor=A.+Hartmannauthor=P.+J.+Wildauthor=L.+Terraccianoauthor=M.+Roncalliauthor=S.+R.+Bornsteinauthor=G.+Schmitz&title=Human+Aldehyde+Oxidase+1+Interacts+with+Atp-Binding+Cassette+Transporter-1+and+Modulates+Its+Activity+in+Hepatocytes&doi=10.1055%2Fs-2007-992129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes</span></div><div class="casAuthors">Sigruener, A.; Buechler, C.; Orso, E.; Hartmann, A.; Wild, P. J.; Terracciano, L.; Roncalli, M.; Bornstein, S. R.; Schmitz, G.</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and Metabolic Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">781-789</span>CODEN:
                <span class="NLM_cas:coden">HMMRA2</span>;
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">AOX1, a member of the cytosolic molybdenum hydroxylase family, has been identified by us earlier as an ABCA1-interacting protein.  AOX1 is well-described as xenobiotic metabolizing enzyme, which upon oxidn. of acetaldehyde and retinaldehyde to acetic acid and retinoic acid generates reactive oxygen species.  Here we show that knock-down of AOX1 in HepG2 by small interfering RNA significantly reduced ABCA1-dependent lipid efflux and enhanced phagocytic uptake of microspheres similar to ABCA1 deficiency, without affecting ABCA1 mRNA and protein levels.  ABCA1 and AOX1 are coexpressed in human hepatocytes, kidney proximal tubular epithelial cells, Leydig, and adrenocortical cells.  Expression of ABCA1 and AOX1 was investigated by immunohistochem. in liver tissue arrays.  A strong AOX1 expression was found in normal liver, and in cirrhosis.  In contrast, hepatocellular carcinomas showed either a complete loss or reduced expression of AOX1.  Significant correlations were found between reduced AOX1 expression and tumor stage, or metastatic or regional lymph node states.  Deregulation was also obsd. for ABCA1 expression but to a lesser extent.  Our findings show that the interaction of ABCA1 with AOX1 modulates ABCA1-linked cellular functions such as lipid efflux and phagocytosis in hepatocytes, and the reduced expression of AOX1 in malignant transformed hepatocytes supports the differentiation dependent upregulation of AOX1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHgXRNXB80xbVg90H21EOLACvtfcHk0ljznNbuA4Wy5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjsQ%253D%253D&md5=d2c7a135c094fd7209517cf5890810a4</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-992129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-992129%26sid%3Dliteratum%253Aachs%26aulast%3DSigruener%26aufirst%3DA.%26aulast%3DBuechler%26aufirst%3DC.%26aulast%3DOrso%26aufirst%3DE.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DWild%26aufirst%3DP.%2BJ.%26aulast%3DTerracciano%26aufirst%3DL.%26aulast%3DRoncalli%26aufirst%3DM.%26aulast%3DBornstein%26aufirst%3DS.%2BR.%26aulast%3DSchmitz%26aufirst%3DG.%26atitle%3DHuman%2520Aldehyde%2520Oxidase%25201%2520Interacts%2520with%2520Atp-Binding%2520Cassette%2520Transporter-1%2520and%2520Modulates%2520Its%2520Activity%2520in%2520Hepatocytes%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D2007%26volume%3D39%26issue%3D11%26spage%3D781%26epage%3D789%26doi%3D10.1055%2Fs-2007-992129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamli, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokharel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, I.</span></span> <span> </span><span class="NLM_article-title">Expressional Studies of the Aldehyde Oxidase (Aox1) Gene During Myogenic Differentiation in C2c12 Cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>450</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1296</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.06.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bbrc.2014.06.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24996175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyjtrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2014&pages=1291-1296&issue=4&author=M.+R.+Kamliauthor=J.+Kimauthor=S.+Pokharelauthor=A.+T.+Janauthor=E.+J.+Leeauthor=I.+Choi&title=Expressional+Studies+of+the+Aldehyde+Oxidase+%28Aox1%29+Gene+During+Myogenic+Differentiation+in+C2c12+Cells&doi=10.1016%2Fj.bbrc.2014.06.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Expressional studies of the aldehyde oxidase (AOX1) gene during myogenic differentiation in C2C12 cells</span></div><div class="casAuthors">Kamli, Majid Rasool; Kim, Jihoe; Pokharel, Smritee; Jan, Arif Tasleem; Lee, Eun Ju; Choi, Inho</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1291-1296</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidases (AOXs), which catalyze the hydroxylation of heterocycles and oxidn. of a wide variety of aldehydic compds., have been present throughout evolution from bacteria to humans.  While humans have only a single functional aldehyde oxidase (AOX1) gene, rodents are endowed with four AOXs; AOX1 and three aldehyde oxidase homologs (AOH1, AOH2 and AOH3).  In continuation of our previous study conducted to identify genes differentially expressed during myogenesis using a microarray approach, we investigated AOX1 with respect to its role in myogenesis to conceptualize how it is regulated in C2C12 cells.  The results obtained were validated by silencing of the AOX1 gene.  Anal. of their fusion index revealed that formation of myotubes showed a marked redn. of up to 40% in AOX1kd cells.  Expression of myogenin (MYOG), one of the marker genes used to study myogenesis, was also found to be reduced in AOX1kd cells.  AOX1 is an enzyme of pharmacol. and toxicol. importance that metabolizes numerous xenobiotics to their resp. carboxylic acids.  Hydrogen peroxide (H2O2) produced as a byproduct in this reaction is considered to be involved as a part of the signaling mechanism during differentiation.  An obsd. redn. in the level of H2O2 among AOX1kd cells confirmed prodn. of H2O2 in the reaction catalyzed by AOX1.  Taken together, these findings suggest that AOX1 acts as a contributor to the process of myogenesis by influencing the level of H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Odmy__Vx7LVg90H21EOLACvtfcHk0liRkE9yJ1vKwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyjtrfF&md5=d63a17f4939240d412043250587a45e4</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.06.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.06.126%26sid%3Dliteratum%253Aachs%26aulast%3DKamli%26aufirst%3DM.%2BR.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DPokharel%26aufirst%3DS.%26aulast%3DJan%26aufirst%3DA.%2BT.%26aulast%3DLee%26aufirst%3DE.%2BJ.%26aulast%3DChoi%26aufirst%3DI.%26atitle%3DExpressional%2520Studies%2520of%2520the%2520Aldehyde%2520Oxidase%2520%2528Aox1%2529%2520Gene%2520During%2520Myogenic%2520Differentiation%2520in%2520C2c12%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D450%26issue%3D4%26spage%3D1291%26epage%3D1296%26doi%3D10.1016%2Fj.bbrc.2014.06.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshita, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, S.</span></span> <span> </span><span class="NLM_article-title">Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Airway Epithelial Barrier Integrity</span>. <i>Allergol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">Suppl</span>),  <span class="NLM_fpage">S54</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.alit.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.alit.2015.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26344081" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=S54-63&issue=Suppl&author=Y.+Shintaniauthor=S.+Maruokaauthor=Y.+Gonauthor=D.+Koyamaauthor=A.+Yoshidaauthor=Y.+Kozuauthor=K.+Kurodaauthor=I.+Takeshitaauthor=E.+Tsuboiauthor=K.+Sodaauthor=S.+Hashimoto&title=Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Nrf2%29+Regulates+Airway+Epithelial+Barrier+Integrity&doi=10.1016%2Fj.alit.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1016%2Fj.alit.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.alit.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DShintani%26aufirst%3DY.%26aulast%3DMaruoka%26aufirst%3DS.%26aulast%3DGon%26aufirst%3DY.%26aulast%3DKoyama%26aufirst%3DD.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DKozu%26aufirst%3DY.%26aulast%3DKuroda%26aufirst%3DK.%26aulast%3DTakeshita%26aufirst%3DI.%26aulast%3DTsuboi%26aufirst%3DE.%26aulast%3DSoda%26aufirst%3DK.%26aulast%3DHashimoto%26aufirst%3DS.%26atitle%3DNuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Nrf2%2529%2520Regulates%2520Airway%2520Epithelial%2520Barrier%2520Integrity%26jtitle%3DAllergol.%2520Int.%26date%3D2015%26volume%3D64%26issue%3DSuppl%26spage%3DS54%26epage%3D63%26doi%3D10.1016%2Fj.alit.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaglia, F.</span></span> <span> </span><span class="NLM_article-title">Molybdenum Cofactor Deficiency</span>. <i>Mol. Genet. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1016/j.ymgme.2015.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.ymgme.2015.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26653176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFeqs7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=1-4&issue=1&author=P.+S.+Atwalauthor=F.+Scaglia&title=Molybdenum+Cofactor+Deficiency&doi=10.1016%2Fj.ymgme.2015.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Molybdenum cofactor deficiency</span></div><div class="casAuthors">Atwal, Paldeep S.; Scaglia, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Molybdenum cofactor deficiency (MoCD) is a severe autosomal recessive inborn error of metab. first described in 1978.  It is characterized by a neonatal presentation of intractable seizures, feeding difficulties, severe developmental delay, microcephaly with brain atrophy and coarse facial features.  MoCD results in deficiency of the molybdenum cofactor dependent enzymes sulfite oxidase, xanthine dehydrogenase, aldehyde oxidase and mitochondrial amidoxime reducing component.  The resultant accumulation of sulfite, taurine, S-sulfocysteine and thiosulfate contributes to the severe neurol. impairment.  Recently, initial evidence has demonstrated early treatment with cyclic PMP can turn MoCD type A from a previously neonatal lethal condition with only palliative options, to near normal neurol. outcomes in affected patients.  We review MoCD and focus on describing the currently published evidence of this exciting new therapeutic option for MoCD type A caused by pathogenic variants in MOCD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdWcfzQ6LNNbVg90H21EOLACvtfcHk0liRkE9yJ1vKwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFeqs7bJ&md5=57fbdc22e31d5676979094968caea933</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2015.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2015.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DP.%2BS.%26aulast%3DScaglia%26aufirst%3DF.%26atitle%3DMolybdenum%2520Cofactor%2520Deficiency%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2016%26volume%3D117%26issue%3D1%26spage%3D1%26epage%3D4%26doi%3D10.1016%2Fj.ymgme.2015.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokouchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, Y.</span></span> <span> </span><span class="NLM_article-title">Alleviation of Fatty Liver in a Rat Model by Enhancing N(1)-Methylnicotinamide Bioavailability through Aldehyde Oxidase Inhibition</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>507</i></span> (<span class="NLM_issue">1−4</span>),  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.bbrc.2018.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30446221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyhtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2018&pages=203-210&issue=1%E2%88%924&author=K.+Takeuchiauthor=C.+Yokouchiauthor=H.+Gotoauthor=K.+Umeharaauthor=H.+Yamadaauthor=Y.+Ishii&title=Alleviation+of+Fatty+Liver+in+a+Rat+Model+by+Enhancing+N%281%29-Methylnicotinamide+Bioavailability+through+Aldehyde+Oxidase+Inhibition&doi=10.1016%2Fj.bbrc.2018.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Alleviation of fatty liver in a rat model by enhancing N1-methylnicotinamide bioavailability through aldehyde oxidase inhibition</span></div><div class="casAuthors">Takeuchi, Kenji; Yokouchi, Chie; Goto, Hirohiko; Umehara, Ken; Yamada, Hideyuki; Ishii, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">203-210</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nonalcoholic fatty liver disease (NAFLD) has increased worldwide in recent years.  NAFLD is classified into two types, nonalcoholic fatty liver (NAFL), with few complications, and nonalcoholic steatohepatitis (NASH), which leads to liver cirrhosis or cancer.  This study was based on previous reports that N1-methylnicotinamide (MNA) can stabilize sirtuin 1 protein, leading to decreased lipid levels in the liver.  We hypothesised that fatty liver improvement by MNA would be further enhanced by suppressing its rapid metab. by aldehyde oxidase in the liver.  To test this, hydralazine (HYD), a potent aldehyde oxidase inhibitor, was administered orally to NAFL model rats.  Liver triglyceride (TG) levels in the model were nearly unchanged by administration of MNA alone.  In contrast, TG levels were marked decreased in NAFL rats treated with a combination of MNA and HYD.  In addn., TG levels were decreased even in NAFL rats treated with only HYD.  These findings supported our hypothesis that maintaining MNA concns. in the liver, by suppressing MNA metab., would at least partially ameliorate fatty liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozCz2rGNA8YbVg90H21EOLACvtfcHk0liRkE9yJ1vKwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyhtb3I&md5=318b9ce0e7a7f8c2d6f665c7084e97c5</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DYokouchi%26aufirst%3DC.%26aulast%3DGoto%26aufirst%3DH.%26aulast%3DUmehara%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DY.%26atitle%3DAlleviation%2520of%2520Fatty%2520Liver%2520in%2520a%2520Rat%2520Model%2520by%2520Enhancing%2520N%25281%2529-Methylnicotinamide%2520Bioavailability%2520through%2520Aldehyde%2520Oxidase%2520Inhibition%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D507%26issue%3D1%25E2%2588%25924%26spage%3D203%26epage%3D210%26doi%3D10.1016%2Fj.bbrc.2018.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marathe, P. H.</span></span> <span> </span><span class="NLM_article-title">Challenges and Opportunities with Non-Cyp Enzymes Aldehyde Oxidase, Carboxylesterase, and Udp-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1391</span>– <span class="NLM_lpage">1405</span>, <span class="refDoi"> DOI: 10.1208/s12248-016-9962-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1208%2Fs12248-016-9962-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=27495117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCrt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=1391-1405&issue=6&author=U.+A.+Argikarauthor=P.+M.+Potterauthor=J.+M.+Hutzlerauthor=P.+H.+Marathe&title=Challenges+and+Opportunities+with+Non-Cyp+Enzymes+Aldehyde+Oxidase%2C+Carboxylesterase%2C+and+Udp-Glucuronosyltransferase%3A+Focus+on+Reaction+Phenotyping+and+Prediction+of+Human+Clearance&doi=10.1208%2Fs12248-016-9962-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance</span></div><div class="casAuthors">Argikar, Upendra A.; Potter, Philip M.; Hutzler, J. Matthew; Marathe, Punit H.</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1391-1405</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Over the years, significant progress has been made in reducing metabolic instability due to cytochrome P 450-mediated oxidn.  High-throughput metabolic stability screening has enabled the advancement of compds. with little to no oxidative metab.  Furthermore, high lipophilicity and low aq. soly. of presently pursued chemotypes reduces the probability of renal excretion.  As such, these low microsomal turnover compds. are often substrates for non-CYP-mediated metab.  UGTs, esterases, and aldehyde oxidase are major enzymes involved in catalyzing such metab.  Hepatocytes provide an excellent tool to identify such pathways including elucidation of major metabolites.  To predict human PK parameters for P 450-mediated metab., in vitro-in vivo extrapolation using hepatic microsomes, hepatocytes, and intestinal microsomes has been actively investigated.  However, such methods have not been sufficiently evaluated for non-P 450 enzymes.  In addn. to the involvement of the liver, extrahepatic enzymes (intestine, kidney, lung) are also likely to contribute to these pathways.  While there has been considerable progress in predicting metabolic pathways and clearance primarily mediated by the liver, progress in characterizing extrahepatic metab. and prediction of clearance has been slow.  Well-characterized in vitro systems or in vivo animal models to assess drug-drug interaction potential and intersubject variability due to polymorphism are not available.  Here we focus on the utility of appropriate in vitro studies to characterize non-CYP-mediated metab. and to understand the enzymes involved followed by pharmacokinetic studies in the appropriately characterized surrogate species.  The review will highlight progress made in establishing in vitro-in vivo correlation, predicting human clearance and avoiding costly clin. failures when non-CYP-mediated metabolic pathways are predominant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwZGibSne69rVg90H21EOLACvtfcHk0lgDB7gTkeWeVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCrt77P&md5=968b8545e96e4a7aaed240d8efa71eae</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1208%2Fs12248-016-9962-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-016-9962-6%26sid%3Dliteratum%253Aachs%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DPotter%26aufirst%3DP.%2BM.%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26atitle%3DChallenges%2520and%2520Opportunities%2520with%2520Non-Cyp%2520Enzymes%2520Aldehyde%2520Oxidase%252C%2520Carboxylesterase%252C%2520and%2520Udp-Glucuronosyltransferase%253A%2520Focus%2520on%2520Reaction%2520Phenotyping%2520and%2520Prediction%2520of%2520Human%2520Clearance%26jtitle%3DAAPS%2520J.%26date%3D2016%26volume%3D18%26issue%3D6%26spage%3D1391%26epage%3D1405%26doi%3D10.1208%2Fs12248-016-9962-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santomango, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Ponce, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corlew, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">The Role of Aldehyde Oxidase and Xanthine Oxidase in the Biotransformation of a Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1834</span>– <span class="NLM_lpage">1845</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.046136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.046136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22711749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1834-1845&issue=9&author=R.+D.+Morrisonauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=T.+S.+Santomangoauthor=T.+M.+Bridgesauthor=D.+Stecauthor=K.+A.+Brewerauthor=R.+Sanchez-Ponceauthor=M.+M.+Corlewauthor=R.+Rushauthor=A.+S.+Feltsauthor=J.+Mankaauthor=B.+S.+Batesauthor=D.+F.+Venableauthor=A.+L.+Rodriguezauthor=C.+K.+Jonesauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=J.+S.+Daniels&title=The+Role+of+Aldehyde+Oxidase+and+Xanthine+Oxidase+in+the+Biotransformation+of+a+Novel+Negative+Allosteric+Modulator+of+Metabotropic+Glutamate+Receptor+Subtype+5&doi=10.1124%2Fdmd.112.046136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5</span></div><div class="casAuthors">Morrison, Ryan D.; Blobaum, Anna L.; Byers, Frank W.; Santomango, Tammy S.; Bridges, Thomas M.; Stec, Donald; Brewer, Katrina A.; Sanchez-Ponce, Raymundo; Corlew, Melany M.; Rush, Roger; Felts, Andrew S.; Manka, Jason; Bates, Brittney S.; Venable, Daryl F.; Rodriguez, Alice L.; Jones, Carrie K.; Niswender, Colleen M.; Conn, P. Jeffrey; Lindsley, Craig W.; Emmitte, Kyle A.; Daniels, J. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1834-1845</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neg. allosteric modulation (NAM) of metabotropic glutamate receptor subtype 5 (mGlu5) represents a therapeutic strategy for the treatment of childhood developmental disorders, such as fragile X syndrome and autism.  VU0409106 emerged as a lead compd. within a biaryl ether series, displaying potent and selective inhibition of mGlu5.  Despite its high clearance and short half-life, VU0409106 demonstrated efficacy in rodent models of anxiety after extravascular administration.  However, lack of a consistent correlation in rat between in vitro hepatic clearance and in vivo plasma clearance for the biaryl ether series prompted an investigation into the biotransformation of VU0409106 using hepatic subcellular fractions.  An in vitro appraisal in rat, monkey, and human liver S9 fractions indicated that the principal pathway was NADPH-independent oxidn. to metabolite M1 (+16 Da).  Both raloxifene (aldehyde oxidase inhibitor) and allopurinol (xanthine oxidase inhibitor) attenuated the formation of M1, thus implicating the contribution of both molybdenum hydroxylases in the biotransformation of VU0409106.  The use of 18O-labeled water in the S9 expts. confirmed the hydroxylase mechanism proposed, because 18O was incorporated into M1 (+18 Da) as well as in a secondary metabolite (M2; +36 Da), the formation of which was exclusively xanthine oxidase-mediated.  This unusual dual and sequential hydroxylase metab. was confirmed in liver S9 and hepatocytes of multiple species and correlated with in vivo data because M1 and M2 were the principal metabolites detected in rats administered VU0409106.  An in vitro-in vivo correlation of predicted hepatic and plasma clearance was subsequently established for VU0409106 in rats and nonhuman primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCTcWSe8Xod7Vg90H21EOLACvtfcHk0lgDB7gTkeWeVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShtbfK&md5=6a1840588e53a456fc2f188f349bb730</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046136%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DSantomango%26aufirst%3DT.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DStec%26aufirst%3DD.%26aulast%3DBrewer%26aufirst%3DK.%2BA.%26aulast%3DSanchez-Ponce%26aufirst%3DR.%26aulast%3DCorlew%26aufirst%3DM.%2BM.%26aulast%3DRush%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DManka%26aufirst%3DJ.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520Role%2520of%2520Aldehyde%2520Oxidase%2520and%2520Xanthine%2520Oxidase%2520in%2520the%2520Biotransformation%2520of%2520a%2520Novel%2520Negative%2520Allosteric%2520Modulator%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D9%26spage%3D1834%26epage%3D1845%26doi%3D10.1124%2Fdmd.112.046136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weidert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenborn, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantu-Medellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choughule, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, E. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Xanthine Oxidase by the Aldehyde Oxidase Inhibitor Raloxifene: Implications for Identifying Molybdopterin Nitrite Reductases</span>. <i>Nitric Oxide</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.niox.2013.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.niox.2013.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24406683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVOiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=41-45&author=E.+R.+Weidertauthor=S.+O.+Schoenbornauthor=N.+Cantu-Medellinauthor=K.+V.+Choughuleauthor=J.+P.+Jonesauthor=E.+E.+Kelley&title=Inhibition+of+Xanthine+Oxidase+by+the+Aldehyde+Oxidase+Inhibitor+Raloxifene%3A+Implications+for+Identifying+Molybdopterin+Nitrite+Reductases&doi=10.1016%2Fj.niox.2013.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: Implications for identifying molybdopterin nitrite reductases</span></div><div class="casAuthors">Weidert, E. R.; Schoenborn, S. O.; Cantu-Medellin, N.; Choughule, K. V.; Jones, J. P.; Kelley, E. E.</div><div class="citationInfo"><span class="NLM_cas:title">Nitric Oxide</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41-45</span>CODEN:
                <span class="NLM_cas:coden">NIOXF5</span>;
        ISSN:<span class="NLM_cas:issn">1089-8603</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sources of nitric oxide alternative to nitric oxide synthases are gaining significant traction as crucial mediators of vessel function under hypoxic inflammatory conditions.  For example, capacity to catalyze the one electron redn. of nitrite (NO-2) to ·NO has been reported for Hb, myoglobin and molybdopterin-contg. enzymes including xanthine oxidoreductase (XOR) and aldehyde oxidase (AO).  For XOR and AO, use of selective inhibition strategies is therefore crucial when attempting to assign relative contributions to nitrite-mediated ·NO formation in cells and tissue.  To this end, XOR inhibition has been accomplished with application of classic pyrazolopyrimidine-based inhibitors allo/oxypurinol or the newly FDA-approved XOR-specific inhibitor, Uloric (febuxostat).  Likewise, raloxifene, an estrogen receptor antagonist, has been identified as a potent (Ki = 1.0 nM) inhibitor of AO.  Herein, we characterize the inhibition kinetics of raloxifene for XOR and describe the resultant effects on inhibiting XO-catalyzed ·NO formation.  Exposure of purified XO to raloxifene (PBS, pH 7.4) resulted in a dose-dependent (12.5-100 μM) inhibition of xanthine oxidn. to uric acid.  Dixon plot anal. revealed a competitive inhibition process with a Ki = 13 μM.  This inhibitory process was more effective under acidic pH; similar to values encountered under hypoxic/inflammatory conditions.  In addn., raloxifene also inhibited anoxic XO-catalyzed redn. of NO-2 to NO (EC50 = 64 μM).  In contrast to having no effect on XO-catalyzed uric acid prodn., the AO inhibitor menadione demonstrated potent inhibition of XO-catalyzed NO-2 redn. (EC50 = 60 nM); somewhat similar to the XO-specific inhibitor, febuxostat (EC50 = 4 nM).  Importantly, febuxostat was found to be a very poor inhibitor of human AO (EC50 = 613 μM) suggesting its usefulness for validating XO-dependent contributions to NO-2 redn. in biol. systems.  Combined, these data indicate care should be taken when choosing inhibition strategies as well as inhibitor concns. when assigning relative NO-2 reductase activity of AO and XOR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqicWXInWyd6rVg90H21EOLACvtfcHk0lgkaf09fgvWVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVOiurw%253D&md5=a118eb46dba38456b25aaca3da192d01</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2013.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2013.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DWeidert%26aufirst%3DE.%2BR.%26aulast%3DSchoenborn%26aufirst%3DS.%2BO.%26aulast%3DCantu-Medellin%26aufirst%3DN.%26aulast%3DChoughule%26aufirst%3DK.%2BV.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DKelley%26aufirst%3DE.%2BE.%26atitle%3DInhibition%2520of%2520Xanthine%2520Oxidase%2520by%2520the%2520Aldehyde%2520Oxidase%2520Inhibitor%2520Raloxifene%253A%2520Implications%2520for%2520Identifying%2520Molybdopterin%2520Nitrite%2520Reductases%26jtitle%3DNitric%2520Oxide%26date%3D2014%26volume%3D37%26spage%3D41%26epage%3D45%26doi%3D10.1016%2Fj.niox.2013.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paragas, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joswig-Jones, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Ecoao: A Simple System for the Study of Human Aldehyde Oxidases Role in Drug Metabolism</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4820</span>– <span class="NLM_lpage">4827</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b01054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b01054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKisb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=4820-4827&issue=8&author=E.+M.+Paragasauthor=S.+C.+Humphreysauthor=J.+Minauthor=C.+A.+Joswig-Jonesauthor=S.+Leimkuhlerauthor=J.+P.+Jones&title=Ecoao%3A+A+Simple+System+for+the+Study+of+Human+Aldehyde+Oxidases+Role+in+Drug+Metabolism&doi=10.1021%2Facsomega.7b01054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">ecoAO: A Simple System for the Study of Human Aldehyde Oxidases Role in Drug Metabolism</span></div><div class="casAuthors">Paragas, Erickson M.; Humphreys, Sara C.; Min, Joshua; Joswig-Jones, Carolyn A.; Leimkuhler, Silke; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4820-4827</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">AO metabolite stds. are often difficult to synthesize due to the chemo- and regio-selectivity of the enzyme, precluding metabolic studies.  Furthermore, human aldehyde oxidase (AO) is recalcitrant to study because established in vitro AO systems such as liver cytosol, S9 fractions, and primary hepatocytes, lack specificity and/or display variability in their AO expression and activity profiles.  Here, the authors describe a practical E. coli-based system---ecoAO---that addresses these issues simultaneously. ecoAO is a cell paste of Moco-producing E. coli strain TP1017 expressing human AO. ecoAO exhibits specific AO activity with the known substrates zoniporide, DACA, O6-benzylguanine, and zaleplon as well as 3-aminoquinoline, simplifying detn. of metabolic parameters such as Km and kcat/Km.  Furthermore, it has utility as a biocatalyst, yielding mg quantities of AO metabolites of each of these substrates.  Accordingly, ecoAO promises to provide easy access to metabolites with the potential to improve pharmacokinetic clearance predictions and guide drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQNFZ-z437XrVg90H21EOLACvtfcHk0lgkaf09fgvWVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKisb%252FJ&md5=37ba9d707d4ff3842362858a5b1016d5</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b01054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b01054%26sid%3Dliteratum%253Aachs%26aulast%3DParagas%26aufirst%3DE.%2BM.%26aulast%3DHumphreys%26aufirst%3DS.%2BC.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DEcoao%253A%2520A%2520Simple%2520System%2520for%2520the%2520Study%2520of%2520Human%2520Aldehyde%2520Oxidases%2520Role%2520in%2520Drug%2520Metabolism%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26issue%3D8%26spage%3D4820%26epage%3D4827%26doi%3D10.1021%2Facsomega.7b01054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romao, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, S.</span></span> <span> </span><span class="NLM_article-title">Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide Polymorphisms</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.068395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.115.068395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=26842593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1277-1285&issue=8&author=A.+Fotiauthor=T.+Hartmannauthor=C.+Coelhoauthor=T.+Santos-Silvaauthor=M.+J.+Romaoauthor=S.+Leimkuhler&title=Optimization+of+the+Expression+of+Human+Aldehyde+Oxidase+for+Investigations+of+Single-Nucleotide+Polymorphisms&doi=10.1124%2Fdmd.115.068395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the expression of human aldehyde oxidase for investigations of single-nucleotide polymorphisms</span></div><div class="casAuthors">Foti, Alessandro; Hartmann, Tobias; Coelho, Catarina; Santos-Silva, Teresa; Romao, Maria Joao; Leimkuehler, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1277-1285</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AOX1) is an enzyme with broad substrate specificity, catalyzing the oxidn. of a wide range of endogenous and exogenous aldehydes as well as N-heterocyclic arom. compds.  In humans, the enzyme's role in phase I drug metab. has been established and its importance is now emerging.  However, the true physiol. function of AOX1 in mammals is still unknown.  Further, numerous single-nucleotide polymorphisms (SNPs) have been identified in human AOX1.  SNPs are a major source of interindividual variability in the human population, and SNP-based amino acid exchanges in AOX1 reportedly modulate the catalytic function of the enzyme in either a pos. or neg. fashion.  For the reliable anal. of the effect of amino acid exchanges in human proteins, the existence of reproducible expression systems for the prodn. of active protein in ample amts. for kinetic, spectroscopic, and crystallog. studies is required.  In our study we report an optimized expression system for hAOX1 in Escherichia coli using a codon-optimized construct.  The codon-optimization resulted in an up to 15-fold increase of protein prodn. and a simplified purifn. procedure.  The optimized expression system was used to study three SNPs that result in amino acid changes C44W, G1269R, and S1271L.  In addn., the crystal structure of the S1271L SNP was solved.  We demonstrate that the recombinant enzyme can be used for future studies to exploit the role of AOX in drug metab., and for the identification and synthesis of new drugs targeting AOX when combined with crystallog. and modeling studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO20NfuioFBLVg90H21EOLACvtfcHk0lgkaf09fgvWVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2gurrO&md5=3e33e7bf0cf356549e3b47cbf91e9b00</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.068395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.068395%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DCoelho%26aufirst%3DC.%26aulast%3DSantos-Silva%26aufirst%3DT.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DLeimkuhler%26aufirst%3DS.%26atitle%3DOptimization%2520of%2520the%2520Expression%2520of%2520Human%2520Aldehyde%2520Oxidase%2520for%2520Investigations%2520of%2520Single-Nucleotide%2520Polymorphisms%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1277%26epage%3D1285%26doi%3D10.1124%2Fdmd.115.068395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saburulla, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Carbazeran 4-Oxidation and O (6)-Benzylguanine 8-Oxidation as Catalytic Markers of Human Aldehyde Oxidase: Impact of Cytosolic Contamination of Liver Microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.082099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.118.082099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30337443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVGisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=26-37&issue=1&author=J.+Xieauthor=N.+F.+Saburullaauthor=S.+Chenauthor=S.+Y.+Wongauthor=Z.+P.+Yapauthor=L.+H.+Zhangauthor=A.+J.+Lau&title=Evaluation+of+Carbazeran+4-Oxidation+and+O+%286%29-Benzylguanine+8-Oxidation+as+Catalytic+Markers+of+Human+Aldehyde+Oxidase%3A+Impact+of+Cytosolic+Contamination+of+Liver+Microsomes&doi=10.1124%2Fdmd.118.082099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of carbazeran 4-oxidation and O6-benzylguanine 8-oxidation as catalytic markers of human aldehyde oxidase: impact of cytosolic contamination of liver microsomes</span></div><div class="casAuthors">Xie, Jiarong; Saburulla, Nur Fazilah; Chen, Shiyan; Wong, Siew Ying; Yap, Ze Ping; Zhang, Linghua Harris; Lau, Aik Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-37</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study investigated the contribution of microsomal cytochrome P 450 and cytosolic aldehyde oxidase-1 (AOX-1) to carbazeran 4-oxidn. and O6-benzylguanine 8-oxidn. in human liver microsomal, cytosolic, and S9 fractions.  Incubations contg. carbazeran and human liver microsomes with or without exogenously added NADPH yielded comparable levels of 4-oxo-carbazeran.  O6-Benzylguanine 8-oxidn. occurred in microsomal incubations, and the extent was increased by NADPH.  Human recombinant CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 did not catalyze carbazeran 4-oxidn., whereas CYP1A2 was highly active in O6-benzylguanine 8-oxidn. 1-Aminobenzotriazole, a pan-cytochrome P 450 inhibitor, decreased O6-benzylguanine 8-oxidn., but not carbazeran 4-oxidn., in microsomal incubations, whereas 1-aminobenzotriazole and furafylline (a CYP1A2-selective inhibitor) did not inhibit carbazeran 4-oxidn. or O6-benzylguanine 8-oxidn. in human liver S9 fraction.  Carbazeran 4-oxidn. in incubations contg. human liver microsomes (from multiple donors and com. suppliers) was attributed to microsomal prepns. contaminated with AOX-1, as suggested by liver microsomal expts. indicating a decrease in carbazeran 4-oxidn. by an AOX-1 inhibitor (hydralazine), and to detection of AOX-1 protein (at one-third the level of that in liver cytosol).  Cytosolic contamination of liver microsomes was further demonstrated by the formation of dehydroepiandrosterone sulfate (catalyzed by cytosolic sulfotransferases) in liver microsomal incubations contg. dehydroepiandrosterone.  In conclusion, carbazeran 4-oxidn. and O6-benzylguanine 8-oxidn. are enzyme-selective catalytic markers of human AOX-1, as shown in human liver S9 fraction expressing cytochrome P 450 and AOX-1.  This study highlights the neg. impact of cytosolic contamination of liver microsomes on the interpretation of reaction phenotyping data collected in an in vitro study performed in microsomal fractions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruul-70K9zeLVg90H21EOLACvtfcHk0lizlwa6iaI8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVGisrc%253D&md5=a6936ce3e69422b1181c7e098bb36260</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.082099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.082099%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DSaburulla%26aufirst%3DN.%2BF.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DS.%2BY.%26aulast%3DYap%26aufirst%3DZ.%2BP.%26aulast%3DZhang%26aufirst%3DL.%2BH.%26aulast%3DLau%26aufirst%3DA.%2BJ.%26atitle%3DEvaluation%2520of%2520Carbazeran%25204-Oxidation%2520and%2520O%2520%25286%2529-Benzylguanine%25208-Oxidation%2520as%2520Catalytic%2520Markers%2520of%2520Human%2520Aldehyde%2520Oxidase%253A%2520Impact%2520of%2520Cytosolic%2520Contamination%2520of%2520Liver%2520Microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2019%26volume%3D47%26issue%3D1%26spage%3D26%26epage%3D37%26doi%3D10.1124%2Fdmd.118.082099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Human Carboxylesterases: A Comprehensive Review</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.apsb.2018.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30245959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=699-712&issue=5&author=D.+Wangauthor=L.+Zouauthor=Q.+Jinauthor=J.+Houauthor=G.+Geauthor=L.+Yang&title=Human+Carboxylesterases%3A+A+Comprehensive+Review&doi=10.1016%2Fj.apsb.2018.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Human carboxylesterases: a comprehensive review</span></div><div class="casAuthors">Wang Dandan; Zou Liwei; Jin Qiang; Ge Guangbo; Yang Ling; Hou Jie</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">699-712</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Mammalian carboxylesterases (CEs) are key enzymes from the serine hydrolase superfamily.  In the human body, two predominant carboxylesterases (CES1 and CES2) have been identified and extensively studied over the past decade.  These two enzymes play crucial roles in the metabolism of a wide variety of endogenous esters, ester-containing drugs and environmental toxicants.  The key roles of CES in both human health and xenobiotic metabolism arouse great interest in the discovery of potent CES modulators to regulate endobiotic metabolism or to improve the efficacy of ester drugs.  This review covers the structural and catalytic features of CES, tissue distributions, biological functions, genetic polymorphisms, substrate specificities and inhibitor properties of CES1 and CES2, as well as the significance and recent progress on the discovery of CES modulators.  The information presented here will help pharmacologists explore the relevance of CES to human diseases or to assign the contribution of certain CES in xenobiotic metabolism.  It will also facilitate medicinal chemistry efforts to design prodrugs activated by a given CES isoform, or to develop potent and selective modulators of CES for potential biomedical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzNUaecqdULHHuJhbyicZfW6udTcc2eb685wjK5GoZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D&md5=4c0b70b0208577496c8e0270af5eda8e</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DHuman%2520Carboxylesterases%253A%2520A%2520Comprehensive%2520Review%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26issue%3D5%26spage%3D699%26epage%3D712%26doi%3D10.1016%2Fj.apsb.2018.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Human Liver Aldehyde Oxidase: Implications for Potential Drug-Drug Interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2381</span>– <span class="NLM_lpage">2386</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.041806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.041806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21940905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCru77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=2381-2386&issue=12&author=J.+T.+Barrauthor=J.+P.+Jones&title=Inhibition+of+Human+Liver+Aldehyde+Oxidase%3A+Implications+for+Potential+Drug-Drug+Interactions&doi=10.1124%2Fdmd.111.041806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions</span></div><div class="casAuthors">Barr, John T.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2381-2386</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">During the course of our research efforts to understand the kinetics of human aldehyde oxidase as a xenobiotic-clearing enzyme, we investigated the effect of eight different inhibitors on the oxidn. of the probe substrate phthalazine.  Satn. kinetic parameters for phthalazine oxidn. in human liver cytosol were found to be the following: Km = 8.0 ± 0.4 μM and Vmax = 4.3 ± 0.1 nmol · min-1 · mg protein-1.  Inhibitory potency of the inhibitors tested ranged from 0.1 to 5 μM.  Of the eight different inhibitor compds. tested, seven were obsd. to inhibit through a mixed mode and one through a strictly competitive mode.  A ratio of the Kii and Kis values was used to assess the relative competitiveness of each inhibitor.  For the mixed inhibitors, the mode of inhibition varied from mostly uncompetitive to predominantly competitive (Kii/Kis values ranging from 0.1 to 15).  The implications for potential drug-drug interactions and inhibition mechanism are discussed.  We found two inhibitors, clozapine and chlorpromazine, that have a moderate predicted risk of drug-drug interactions based on the Ki value relative to the inhibitor concn. in human plasma, having a calcd. [I]/Ki value of 0.4 and 0.8, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS6gGC3rD4U7Vg90H21EOLACvtfcHk0lizlwa6iaI8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCru77F&md5=1113e63fdb48c3f8ed07c5ca4ae8cf24</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.041806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.041806%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520Human%2520Liver%2520Aldehyde%2520Oxidase%253A%2520Implications%2520for%2520Potential%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26issue%3D12%26spage%3D2381%26epage%3D2386%26doi%3D10.1124%2Fdmd.111.041806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuneo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barosi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danesi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagiuoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poletti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viale, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinzani, P. L.</span></span> <span> </span><span class="NLM_article-title">Management of Adverse Events Associated with Idelalisib Treatment in Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Multidisciplinary Position Paper</span>. <i>Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1002/hon.2540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fhon.2540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30187496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3c3mtVGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=3-14&issue=1&author=A.+Cuneoauthor=G.+Barosiauthor=R.+Danesiauthor=S.+Fagiuoliauthor=P.+Ghiaauthor=A.+Marzanoauthor=M.+Montilloauthor=V.+Polettiauthor=P.+Vialeauthor=P.+L.+Zinzani&title=Management+of+Adverse+Events+Associated+with+Idelalisib+Treatment+in+Chronic+Lymphocytic+Leukemia+and+Follicular+Lymphoma%3A+A+Multidisciplinary+Position+Paper&doi=10.1002%2Fhon.2540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper</span></div><div class="casAuthors">Cuneo Antonio; Barosi Giovanni; Danesi Romano; Fagiuoli Stefano; Ghia Paolo; Marzano Alfredo; Montillo Marco; Poletti Venerino; Poletti Venerino; Viale Pierluigi; Zinzani Pier Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Hematological oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The introduction of new therapeutic agents in chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL), including the new kinase inhibitor idelalisib, has changed the therapeutic landscape of these diseases.  However, the use of idelalisib is associated with a peculiar profile of side effects, which require an optimization of the current approach to prophylaxis and supportive treatment.  Moving from the recognition that the abovementioned issue represents an unmet need in CLL and FL, a multidisciplinary panel of experts was convened to produce a consensus document aiming to provide practical recommendations for the management of the side effects during idelalisib therapy for CLL and FL.  The present publication represents a consensus document from a series of meetings held during 2017.  The Panel generated clinical key questions using the criterion of clinical relevance through a Delphi process and explored 4 domains, ie, diarrhea/colitis, transaminitis, pneumonitis, and infectious complications.  Using the consensus method, the Panel was able to shape recommendations which may assist hematologist to minimize adverse events and guarantee adherence to treatment in patients with CLL and FL candidate to receive idelalisib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReSzyGASKhvxFwe7cAcrfPfW6udTcc2eb685wjK5GoZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3mtVGjsw%253D%253D&md5=0766c852e9cb404ce6c8d7769ce8ac58</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1002%2Fhon.2540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhon.2540%26sid%3Dliteratum%253Aachs%26aulast%3DCuneo%26aufirst%3DA.%26aulast%3DBarosi%26aufirst%3DG.%26aulast%3DDanesi%26aufirst%3DR.%26aulast%3DFagiuoli%26aufirst%3DS.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DMarzano%26aufirst%3DA.%26aulast%3DMontillo%26aufirst%3DM.%26aulast%3DPoletti%26aufirst%3DV.%26aulast%3DViale%26aufirst%3DP.%26aulast%3DZinzani%26aufirst%3DP.%2BL.%26atitle%3DManagement%2520of%2520Adverse%2520Events%2520Associated%2520with%2520Idelalisib%2520Treatment%2520in%2520Chronic%2520Lymphocytic%2520Leukemia%2520and%2520Follicular%2520Lymphoma%253A%2520A%2520Multidisciplinary%2520Position%2520Paper%26jtitle%3DHematol.%2520Oncol.%26date%3D2019%26volume%3D37%26issue%3D1%26spage%3D3%26epage%3D14%26doi%3D10.1002%2Fhon.2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, K.</span></span> <span> </span><span class="NLM_article-title">Reaction Phenotyping: Advances in the Experimental Strategies Used to Characterize the Contribution of Drug-Metabolizing Enzymes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.058750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.114.058750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25297949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOlu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=163-181&issue=1&author=M.+A.+Zientekauthor=K.+Youdim&title=Reaction+Phenotyping%3A+Advances+in+the+Experimental+Strategies+Used+to+Characterize+the+Contribution+of+Drug-Metabolizing+Enzymes&doi=10.1124%2Fdmd.114.058750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes</span></div><div class="casAuthors">Zientek, Michael A.; Youdim, Kuresh</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163-181, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  During the process of drug discovery, the pharmaceutical industry is faced with numerous challenges.  One challenge is the successful prediction of the major routes of human clearance of new medications.  For compds. cleared by metab., accurate predictions help provide an early risk assessment of their potential to exhibit significant interpatient differences in pharmacokinetics via routes of metab. catalyzed by functionally polymorphic enzymes and/or clin. significant metabolic drug-drug interactions.  This review details the most recent and emerging in vitro strategies used by drug metab. and pharmacokinetic scientists to better det. rates and routes of metabolic clearance and how to translate these parameters to est. the amt. these routes contribute to overall clearance, commonly referred to as fraction metabolized.  The enzymes covered in this review include cytochrome P450s together with other enzymic pathways whose involvement in metabolic clearance has become increasingly important as efforts to mitigate cytochrome P 450 clearance are successful.  Advances in the prediction of the fraction metabolized include newly developed methods to differentiate CYP3A4 from the polymorphic enzyme CYP3A5, scaling tools for UDP-glucuronosyltranferase, and estn. of fraction metabolized for substrates of aldehyde oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphbnT5ibiuKrVg90H21EOLACvtfcHk0lj4TXuMSoUG6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOlu7jJ&md5=cf94d4e64207e9b56120570bfa74a2ac</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.058750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.058750%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%2BA.%26aulast%3DYoudim%26aufirst%3DK.%26atitle%3DReaction%2520Phenotyping%253A%2520Advances%2520in%2520the%2520Experimental%2520Strategies%2520Used%2520to%2520Characterize%2520the%2520Contribution%2520of%2520Drug-Metabolizing%2520Enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26issue%3D1%26spage%3D163%26epage%3D181%26doi%3D10.1124%2Fdmd.114.058750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M. A.</span></span> <span> </span><span class="NLM_article-title">Strategies for a Comprehensive Understanding of Metabolism by Aldehyde Oxidase</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1517/17425255.2013.738668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1517%2F17425255.2013.738668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=23231678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFGmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=153-168&issue=2&author=J.+M.+Hutzlerauthor=R.+S.+Obachauthor=D.+Dalvieauthor=M.+A.+Zientek&title=Strategies+for+a+Comprehensive+Understanding+of+Metabolism+by+Aldehyde+Oxidase&doi=10.1517%2F17425255.2013.738668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for a comprehensive understanding of metabolism by aldehyde oxidase</span></div><div class="casAuthors">Hutzler, James Matthew; Obach, Ronald Scott; Dalvie, Deepak; Zientek, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-168</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Aldehyde oxidase (AO) is a drug-metabolizing molybdo-flavoenzyme with profound species differences in expression and activity toward various substrates.  The contribution of this enzyme to the metab. and clearance of heterocyclic-contg. xenobiotics appears to have increased in recent years, but has not always been identified prior to clin. studies.  As a result, drug candidates have been neg. impacted in development.Areas covered: This review provides the most recent in vitro and in vivo strategies for the drug metab.-pharmacokinetic (DMPK) scientist.  The review details approaches for confirmation of AO as an operable metabolic pathway, estg. clearance and fraction of total metab., and identification of an appropriate surrogate species for human AO activity for evaluating safety of clin. relevant metabolites.Expert opinion: As the role of AO in metab. of new drug mols. continues to emerge, it is crit. that DMPK scientists have the most updated methodologies to enable formulation of a thorough exptl. plan to understand the potential implications of this metabolic pathway.  Whether it is higher-than-expected clearance, contributing to an unfavorable half-life, or the formation of an AO-derived disproportionate human metabolite (DHM), such a plan would serve to minimize complications or attrition of drug candidates due to unforeseen issues in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIyqFAKQ_oc7Vg90H21EOLACvtfcHk0lj4TXuMSoUG6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFGmt70%253D&md5=b8c7e4fe65773a2c5e40d4556b3b5eb5</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1517%2F17425255.2013.738668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2013.738668%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DZientek%26aufirst%3DM.%2BA.%26atitle%3DStrategies%2520for%2520a%2520Comprehensive%2520Understanding%2520of%2520Metabolism%2520by%2520Aldehyde%2520Oxidase%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2013%26volume%3D9%26issue%3D2%26spage%3D153%26epage%3D168%26doi%3D10.1517%2F17425255.2013.738668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullenwider, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmenk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of Aldehyde Oxidase Enzyme Activity in Cryopreserved Human Hepatocytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.042861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.042861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22031625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=267-275&issue=2&author=J.+M.+Hutzlerauthor=Y.+S.+Yangauthor=D.+Albaughauthor=C.+L.+Fullenwiderauthor=J.+Schmenkauthor=M.+B.+Fisher&title=Characterization+of+Aldehyde+Oxidase+Enzyme+Activity+in+Cryopreserved+Human+Hepatocytes&doi=10.1124%2Fdmd.111.042861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes</span></div><div class="casAuthors">Hutzler, J. Matthew; Yang, Young-Sun; Albaugh, Daniel; Fullenwider, Cody L.; Schmenk, Jennifer; Fisher, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Substrates of aldehyde oxidase (AO), for which human clin. pharmacokinetics are reported, were selected and evaluated in pooled mixed-gender cryopreserved human hepatocytes in an effort to quant. characterize AO activity.  Estd. hepatic clearance (Clh) for BIBX1382, carbazeran, O6-benzylguanine, zaleplon, and XK-469 using cryopreserved hepatocytes was 18, 17, 12, <4.3, and <4.3 mL · min-1 · kg-1, resp.  The obsd. metabolic clearance in cryopreserved hepatocytes was confirmed to be a result of AO-mediated metab. via two approaches.  Metabolite identification after incubations in the presence of H218O confirmed that the predominant oxidative metabolite was generated by AO, as expected isotope patterns in mass spectra were obsd. after anal. by high-resoln. mass spectrometry.  Second, clearance values were efficiently attenuated upon coincubation with hydralazine, an inhibitor of AO.  The low exposure after oral doses of BIBX1382 and carbazeran (∼5% F) would have been fairly well predicted using simple hepatic extn. (fh) values derived from cryopreserved hepatocytes.  In addn., the estd. hepatic clearance value for O6-benzylguanine was within ∼80% of the obsd. total clearance in humans after i.v. administration (15 mL · min-1 · kg-1), indicating a reasonable level of quant. activity from this in vitro system.  However, a 3.5-fold underprediction of total clearance was obsd. for zaleplon, despite the 5-oxo metabolite being clearly obsd.  These data taken together suggest that the use of cryopreserved hepatocytes may be a practical approach for assessing AO-mediated metab. in discovery and potentially useful for predicting hepatic clearance of AO substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9RVqtqeCaRrVg90H21EOLACvtfcHk0lj4TXuMSoUG6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsL8%253D&md5=efa4198748bd5990222f53121a4c196c</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042861%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DAlbaugh%26aufirst%3DD.%26aulast%3DFullenwider%26aufirst%3DC.%2BL.%26aulast%3DSchmenk%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26atitle%3DCharacterization%2520of%2520Aldehyde%2520Oxidase%2520Enzyme%2520Activity%2520in%2520Cryopreserved%2520Human%2520Hepatocytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D2%26spage%3D267%26epage%3D275%26doi%3D10.1124%2Fdmd.111.042861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Hydralazine as a Selective Probe Inactivator of Aldehyde Oxidase in Human Hepatocytes: Estimation of the Contribution of Aldehyde Oxidase to Metabolic Clearance</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1441</span>– <span class="NLM_lpage">1448</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.045195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.112.045195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22522748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrs7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1441-1448&issue=7&author=T.+J.+Strelevitzauthor=C.+C.+Orozcoauthor=R.+S.+Obach&title=Hydralazine+as+a+Selective+Probe+Inactivator+of+Aldehyde+Oxidase+in+Human+Hepatocytes%3A+Estimation+of+the+Contribution+of+Aldehyde+Oxidase+to+Metabolic+Clearance&doi=10.1124%2Fdmd.112.045195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance</span></div><div class="casAuthors">Strelevitz, Timothy J.; Orozco, Christine C.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1441-1448</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) metab. could lead to significant underestimation of clearance in prediction of human pharmacokinetics as well as unanticipated exposure to AO-generated metabolites, if not accounted for early in drug research.  We report a method using cryopreserved human hepatocytes and the time-dependent AO inhibitor hydralazine (KI = 83 ± 27 μM, kintact = 0.063 ± 0.007 min-1), which ests. the contribution of AO metab. relative to total hepatic clearance.  Using zaleplon as a probe substrate and simultaneously monitoring the AO-catalyzed formation of oxozaleplon and the CYP3A-catalyzed formation of desethyzaleplon in the presence of a range of hydralazine concns., it was detd. that >90% inhibition of the AO activity with minimal effect on the CYP3A activity could be achieved with 25 to 50 μM hydralazine.  This method was used to est. the fraction metabolized due to AO [fm(AO)] for six compds. with clearance attributed to AO along with four other drugs not metabolized by AO.  The fm(AO) values for the AO substrates ranged between 0.49 and 0.83.  Differences in estd. fm(AO) between two batches of pooled human hepatocytes suggest that sensitivity to hydralazine varies slightly with hepatocyte prepns.  Substrates with a CYP2D6 contribution to clearance were affected by hydralazine to a minor extent, because of weak inhibition of this enzyme.  Overall, these findings demonstrate that hydralazine, at a concn. of 25 to 50 μM, can be used in human hepatocyte incubations to est. the contribution of AO to the hepatic clearance of drugs and other compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBKznnCiG-LVg90H21EOLACvtfcHk0ljUGcauKxTpNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrs7vJ&md5=6237313df0fe4ded2d2f37e55c3d4b03</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.045195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.045195%26sid%3Dliteratum%253Aachs%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DOrozco%26aufirst%3DC.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DHydralazine%2520as%2520a%2520Selective%2520Probe%2520Inactivator%2520of%2520Aldehyde%2520Oxidase%2520in%2520Human%2520Hepatocytes%253A%2520Estimation%2520of%2520the%2520Contribution%2520of%2520Aldehyde%2520Oxidase%2520to%2520Metabolic%2520Clearance%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D7%26spage%3D1441%26epage%3D1448%26doi%3D10.1124%2Fdmd.112.045195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toselli, F.</span>; <span class="NLM_string-name">Golding, M.</span>; <span class="NLM_string-name">Manevski, N.</span>; <span class="NLM_string-name">King, L.</span>; <span class="NLM_string-name">Nicolaï, J.</span>; <span class="NLM_string-name">Gillent, E.</span>; <span class="NLM_string-name">Delatour, C.</span>; <span class="NLM_string-name">Isin, E. M.</span>; <span class="NLM_string-name">Henshall, J.</span>; <span class="NLM_string-name">Chanteux, H.</span>; <span class="NLM_string-name">Ungell, A. L.</span></span> In  <i>Aldehyde Oxidase: A New Foe in Drug Discovery?</i>; <span class="NLM_publisher-name">DMDG-SPS Joint Meeting, October 16−18, 2018, Gothenburg, Sweden</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=F.+Toselli&author=M.+Golding&author=N.+Manevski&author=L.+King&author=J.+Nicola%C3%AF&author=E.+Gillent&author=C.+Delatour&author=E.+M.+Isin&author=J.+Henshall&author=H.+Chanteux&author=A.+L.+Ungell&title=Aldehyde+Oxidase%3A+A+New+Foe+in+Drug+Discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DToselli%26aufirst%3DF.%26jtitle%3DAldehyde%2520Oxidase%253A%2520A%2520New%2520Foe%2520in%2520Drug%2520Discovery%253F%26pub%3DDMDG-SPS%2520Joint%2520Meeting%252C%2520October%252016%25E2%2588%259218%252C%25202018%252C%2520Gothenburg%252C%2520Sweden%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1630</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2018.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1016%2Fj.xphs.2018.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30448524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVejtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2019&pages=1627-1630&issue=4&author=X.+Yangauthor=N.+Johnsonauthor=L.+Di&title=Evaluation+of+Cytochrome+P450+Selectivity+for+Hydralazine+as+an+Aldehyde+Oxidase+Inhibitor+for+Reaction+Phenotyping&doi=10.1016%2Fj.xphs.2018.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping</span></div><div class="casAuthors">Yang, Xin; Johnson, Nathaniel; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences (Philadelphia, PA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1627-1630</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hydralazine has been reported as a selective mechanism-based inactivator of aldehyde oxidase (AO) and it is widely used in the pharmaceutical industry for reaction phenotyping to est. fraction metabolized by AO and to identify AO substrates.  In this study, however, hydralazine was found to inhibit CYP1A2, 2B6, 2D6, and 3A in human suspension hepatocytes under reaction phenotyping assay conditions, at concns. that chem. knocked out most of the AO activities (≥50 μM).  Furthermore, hydralazine is a time-dependent inhibitor of CYP1A2.  Based on these findings, precautions need to be taken when using hydralazine as an AO inhibitor for in vitro studies because fraction metabolized by AO is likely to be overestimated and the likelihood of false positives in identifying AO substrates increases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgqUrRsY_No7Vg90H21EOLACvtfcHk0ljUGcauKxTpNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVejtb4%253D&md5=4445e552c958712215442f3b648c9ec1</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2018.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2018.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DJohnson%26aufirst%3DN.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DEvaluation%2520of%2520Cytochrome%2520P450%2520Selectivity%2520for%2520Hydralazine%2520as%2520an%2520Aldehyde%2520Oxidase%2520Inhibitor%2520for%2520Reaction%2520Phenotyping%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2019%26volume%3D108%26issue%3D4%26spage%3D1627%26epage%3D1630%26doi%3D10.1016%2Fj.xphs.2018.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Potent Inhibition of Human Liver Aldehyde Oxidase by Raloxifene</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1124/dmd.32.1.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.32.1.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=14709625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFWqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=89-97&issue=1&author=R.+S.+Obach&title=Potent+Inhibition+of+Human+Liver+Aldehyde+Oxidase+by+Raloxifene&doi=10.1124%2Fdmd.32.1.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Potent inhibition of human liver aldehyde oxidase by raloxifene</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The selective estrogen receptor modulator, raloxifene, has been demonstrated as a potent uncompetitive inhibitor of human liver aldehyde oxidase-catalyzed oxidn. of phthalazine, vanillin, and nicotine-Δ1'(5')-iminium ion, with Ki values of 0.87 to 1.4 nM.  Inhibition was not time-dependent.  Raloxifene has also been shown to be a noncompetitive inhibitor of an aldehyde oxidase-catalyzed redn. reaction of a hydroxamic acid-contg. compd., with a Ki of 51 nM.  However, raloxifene had only small effects on xanthine oxidase, an enzyme related to aldehyde oxidase.  In addn., several other compds. of the same therapeutic class as raloxifene were examd. for their potential to inhibit aldehyde oxidase.  However, none were as potent as raloxifene, since IC50 values were orders of magnitude higher and ranged from 0.29 to 57 μM.  In an examn. of analogs of raloxifene, it was shown that the bisphenol structure with a hydrophobic group on the 3-position of the benzothiophene ring system was the most important element that imparts inhibitory potency.  The relevance of these data to the mechanistic understanding of aldehyde oxidase catalysis, as well as to the potential for raloxifene to cause drug interactions with agents for which aldehyde oxidase-mediated metab. is important, such as zaleplon or famciclovir, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6iDLIEl8GgrVg90H21EOLACvtfcHk0ljUGcauKxTpNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFWqs7w%253D&md5=a693f57077e2d685eea25a998f4603d7</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.1.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.1.89%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPotent%2520Inhibition%2520of%2520Human%2520Liver%2520Aldehyde%2520Oxidase%2520by%2520Raloxifene%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26issue%3D1%26spage%3D89%26epage%3D97%26doi%3D10.1124%2Fdmd.32.1.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandikere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanamarlapudi, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnamaneni, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, A. K.</span></span> <span> </span><span class="NLM_article-title">Identification of a Suitable and Selective Inhibitor Towards Aldehyde Oxidase Catalyzed Reactions</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.3109/00498254.2013.819594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.3109%2F00498254.2013.819594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=24156774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=197-204&issue=3&author=R.+Nirogiauthor=V.+Kandikereauthor=R.+C.+Palacharlaauthor=G.+Bhyrapuneniauthor=V.+B.+Kanamarlapudiauthor=R.+K.+Ponnamaneniauthor=A.+K.+Manoharan&title=Identification+of+a+Suitable+and+Selective+Inhibitor+Towards+Aldehyde+Oxidase+Catalyzed+Reactions&doi=10.3109%2F00498254.2013.819594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions</span></div><div class="casAuthors">Nirogi, Ramakrishna; Kandikere, Vishwottam; Palacharla, Raghava Choudary; Bhyrapuneni, Gopinadh; Kanamarlapudi, Vijaya Bhargava; Ponnamaneni, Ranjith Kumar; Manoharan, Arun Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-204</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">1. Aldehyde oxidase (AO) is a liver cytosolic molybdoflavoprotein enzyme whose importance in drug metab. is gaining in the recent.  The objective of this work is to find a potent and selective inhibitor for AO activity using phthalazine oxidn. as a marker reaction.  2. Among org. solvents tested, it was identified that methanol was not a suitable choice for AO activity even at concns. less than 0.2% vol./vol.  Acetonitrile and DMSO did not show any effect till 0.5% vol./vol. but thereafter activities tend to decrease.  3. For selectivity, 23 compds. were selected and evaluated for their effects on AO and nine CYP450 enzymes.  Among the tested compds. chlorpromazine, estradiol, hydralazine, quetiapine and raloxifene were selected based on their potency of inhibition towards AO activity.  4. Raloxifene was found to be a non-specific inhibitor of all major tested CYP450 enzymes and was excluded as a selective inhibitor for AO.  Quetiapine also showed a degree of inhibition towards the major CYP450 tested.  Hydralazine used as a specific inhibitor during the past for AO activity demonstrated a stimulation of AO activity at high and low concns. resp. and the inhibition noted to be time dependent while inhibiting other enzymes like monoamine oxidase.  5. Estradiol showed no inhibition towards the tested CYP450 enzymes and thus proved to be a selective and specific inhibitor for AO activity with an uncompetitive mode of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1yYD_spWMv7Vg90H21EOLACvtfcHk0lgDJbBLOqkVew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyntr0%253D&md5=46c6e4947b4296da9e6e30d319bdc7a2</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.3109%2F00498254.2013.819594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2013.819594%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DKanamarlapudi%26aufirst%3DV.%2BB.%26aulast%3DPonnamaneni%26aufirst%3DR.%2BK.%26aulast%3DManoharan%26aufirst%3DA.%2BK.%26atitle%3DIdentification%2520of%2520a%2520Suitable%2520and%2520Selective%2520Inhibitor%2520Towards%2520Aldehyde%2520Oxidase%2520Catalyzed%2520Reactions%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26issue%3D3%26spage%3D197%26epage%3D204%26doi%3D10.3109%2F00498254.2013.819594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span> <span> </span><span class="NLM_article-title">The Effects of Drug Metabolizing Enzyme Inhibitors on Hepatic Efflux and Uptake Transporters</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.2174/1872312811666171010101248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.2174%2F1872312811666171010101248" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=111-118&issue=2&author=J.+Cheongauthor=J.+S.+Halladayauthor=E.+Pliseauthor=J.+K.+Sodhiauthor=L.+Salphati&title=The+Effects+of+Drug+Metabolizing+Enzyme+Inhibitors+on+Hepatic+Efflux+and+Uptake+Transporters&doi=10.2174%2F1872312811666171010101248"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.2174%2F1872312811666171010101248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1872312811666171010101248%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DSodhi%26aufirst%3DJ.%2BK.%26aulast%3DSalphati%26aufirst%3DL.%26atitle%3DThe%2520Effects%2520of%2520Drug%2520Metabolizing%2520Enzyme%2520Inhibitors%2520on%2520Hepatic%2520Efflux%2520and%2520Uptake%2520Transporters%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2018%26volume%3D11%26issue%3D2%26spage%3D111%26epage%3D118%26doi%3D10.2174%2F1872312811666171010101248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin-Muttitt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, J. G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A. J.</span></span> <span> </span><span class="NLM_article-title">In Vitro and in Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1124/jpet.119.259267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fjpet.119.259267" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=S.+Chenauthor=K.+Austin-Muttittauthor=L.+H.+Zhangauthor=J.+G.+L.+Mullinsauthor=A.+J.+Lau&title=In+Vitro+and+in+Silico+Analyses+of+the+Inhibition+of+Human+Aldehyde+Oxidase+by+Bazedoxifene%2C+Lasofoxifene%2C+and+Structural+Analogues&doi=10.1124%2Fjpet.119.259267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1124%2Fjpet.119.259267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.119.259267%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DAustin-Muttitt%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%2BH.%26aulast%3DMullins%26aufirst%3DJ.%2BG.%2BL.%26aulast%3DLau%26aufirst%3DA.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Silico%2520Analyses%2520of%2520the%2520Inhibition%2520of%2520Human%2520Aldehyde%2520Oxidase%2520by%2520Bazedoxifene%252C%2520Lasofoxifene%252C%2520and%2520Structural%2520Analogues%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2019%26doi%3D10.1124%2Fjpet.119.259267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishimuta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bando, K.</span></span> <span> </span><span class="NLM_article-title">Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from in Vivo Monkey Pharmacokinetics Study and in Vitro Metabolic Stability Tests Using Hepatocytes</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">20</span>, <span class="refDoi"> DOI: 10.1208/s12248-019-0294-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1208%2Fs12248-019-0294-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=30673906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A280%3ADC%252BB3cjksVyjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=20&author=H.+Nishimutaauthor=T.+Watanabeauthor=K.+Bando&title=Quantitative+Prediction+of+Human+Hepatic+Clearance+for+P450+and+Non-P450+Substrates+from+in+Vivo+Monkey+Pharmacokinetics+Study+and+in+Vitro+Metabolic+Stability+Tests+Using+Hepatocytes&doi=10.1208%2Fs12248-019-0294-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes</span></div><div class="casAuthors">Nishimuta Haruka; Watanabe Takao; Bando Kiyoko</div><div class="citationInfo"><span class="NLM_cas:title">The AAPS journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Accurate prediction of human pharmacokinetics for drugs remains challenging, especially for non-cytochrome P450 (P450) substrates.  Hepatocytes might be suitable for predicting hepatic intrinsic clearance (CLint) of new chemical entities, because they can be applied to various compounds regardless of the metabolic enzymes.  However, it was reported that hepatic CLint is underestimated in hepatocytes.  The purpose of the present study was to confirm the predictability of human hepatic clearance for P450 and non-P450 substrates in hepatocytes and the utility of animal scaling factors for the prediction using hepatocytes.  CLint values for 30 substrates of P450, UDP-glucuronosyltransferase, flavin-containing monooxygenase, esterases, reductases, and aldehyde oxidase in human microsomes, human S9 and human, rat, and monkey hepatocytes were estimated.  Hepatocytes were incubated in serum of each species.  Furthermore, CLint values in human hepatocytes were corrected with empirical, monkey, and rat scaling factors.  CLint values in hepatocytes for most compounds were underestimated compared to observed values regardless of the metabolic enzyme, and the predictability was improved by using the scaling factors.  The prediction using human hepatocytes corrected with monkey scaling factor showed the highest predictability for both P450 and non-P450 substrates among the predictions using liver microsomes, liver S9, and hepatocytes with or without scaling factors.  CLint values by this method for 80% and 90% of all compounds were within 2- and 3-fold of observed values, respectively.  This method is accurate and useful for estimating new chemical entities, with no need to care about cofactors, localization of metabolic enzymes, or protein binding in plasma and incubation mixture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQ1ByXKj3fVN-cVm4E2RlLfW6udTcc2eaY6LEcIeV0ULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjksVyjsg%253D%253D&md5=7b095a8ea124c39d49a722c3b08f82ff</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1208%2Fs12248-019-0294-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-019-0294-1%26sid%3Dliteratum%253Aachs%26aulast%3DNishimuta%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DBando%26aufirst%3DK.%26atitle%3DQuantitative%2520Prediction%2520of%2520Human%2520Hepatic%2520Clearance%2520for%2520P450%2520and%2520Non-P450%2520Substrates%2520from%2520in%2520Vivo%2520Monkey%2520Pharmacokinetics%2520Study%2520and%2520in%2520Vitro%2520Metabolic%2520Stability%2520Tests%2520Using%2520Hepatocytes%26jtitle%3DAAPS%2520J.%26date%3D2019%26volume%3D21%26spage%3D20%26doi%3D10.1208%2Fs12248-019-0294-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Aldehyde Oxidase-Catalyzed Metabolism of N1-Methylnicotinamide in Vivo and in Vitro in Chimeric Mice with Humanized Liver</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1202</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.019075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.107.019075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=18332084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotVegur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=1202-1205&issue=7&author=S.+Kitamuraauthor=K.+Nittaauthor=Y.+Tayamaauthor=C.+Tanoueauthor=K.+Sugiharaauthor=T.+Inoueauthor=T.+Horieauthor=S.+Ohta&title=Aldehyde+Oxidase-Catalyzed+Metabolism+of+N1-Methylnicotinamide+in+Vivo+and+in+Vitro+in+Chimeric+Mice+with+Humanized+Liver&doi=10.1124%2Fdmd.107.019075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver</span></div><div class="casAuthors">Kitamura, Shigeyuki; Nitta, Kayoko; Tayama, Yoshitaka; Tanoue, Chiaki; Sugihara, Kazumi; Inoue, Tae; Horie, Toru; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1202-1205</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase-mediated oxidn. of N1-methylnicotinamide to N1-methyl-2-pyridine-5-carboxamide (2-PY) and N1-methyl-4-pyridone-5-carboxamide (4-PY) in chimeric mice constructed by transplanting human hepatocytes into urokinase-type plasminogen activator-transgenic severe combined immunodeficient mice was examd. in vivo and in vitro.  The activity in liver cytosol of chimeric mice with a high replacement index was approx. 4-fold higher than that in control mice.  Furthermore, the oxidn. products in control mice were 2-PY and 4-PY, whereas, in chimeric mice, the major product was 2-PY, as in humans.  The aldehyde oxidase in chimeric mouse liver was confirmed to be of human type by immunoblotting anal.  The ratio of pyridones (2-PY/4-PY) excreted in the urine of chimeric mice was closer to that of humans than to that of control mice.  Thus, the aldehyde oxidase in chimeric mice has human-type functional characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOv9qznxXoY7Vg90H21EOLACvtfcHk0liJ6pi2nMDdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotVegur4%253D&md5=14985abbc5c43cbc4bd31c2cd98c4e8b</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.019075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.019075%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNitta%26aufirst%3DK.%26aulast%3DTayama%26aufirst%3DY.%26aulast%3DTanoue%26aufirst%3DC.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DHorie%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DAldehyde%2520Oxidase-Catalyzed%2520Metabolism%2520of%2520N1-Methylnicotinamide%2520in%2520Vivo%2520and%2520in%2520Vitro%2520in%2520Chimeric%2520Mice%2520with%2520Humanized%2520Liver%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26issue%3D7%26spage%3D1202%26epage%3D1205%26doi%3D10.1124%2Fdmd.107.019075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotake, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohshita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Prediction of in Vivo Hepatic Clearance and Half-Life of Drug Candidates in Human Using Chimeric Mice with Humanized Liver</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.040923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.040923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=22048522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=322-328&issue=2&author=S.+Sanohauthor=A.+Horiguchiauthor=K.+Sugiharaauthor=Y.+Kotakeauthor=Y.+Tayamaauthor=H.+Ohshitaauthor=C.+Tatenoauthor=T.+Horieauthor=S.+Kitamuraauthor=S.+Ohta&title=Prediction+of+in+Vivo+Hepatic+Clearance+and+Half-Life+of+Drug+Candidates+in+Human+Using+Chimeric+Mice+with+Humanized+Liver&doi=10.1124%2Fdmd.111.040923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver</span></div><div class="casAuthors">Sanoh, Seigo; Horiguchi, Aya; Sugihara, Kazumi; Kotake, Yaichiro; Tayama, Yoshitaka; Ohshita, Hiroki; Tateno, Chise; Horie, Toru; Kitamura, Shigeyuki; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">322-328</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Accurate prediction of pharmacokinetics (PK) parameters in humans from animal data is difficult for various reasons, including species differences.  However, chimeric mice with humanized liver (PXB mice; urokinase-type plasminogen activator/severe combined immunodeficiency mice repopulated with approx. 80% human hepatocytes) have been developed.  The expression levels and metabolic activities of cytochrome P 450 (P 450) and non-P 450 enzymes in the livers of PXB mice are similar to those in humans.  In this study, we examd. the predictability for human PK parameters from data obtained in PXB mice.  Elimination of selected drugs involves multiple metabolic pathways mediated not only by P 450 but also by non-P 450 enzymes, such as UDP-glucuronosyltransferase, sulfotransferase, and aldehyde oxidase in liver.  Direct comparison between in vitro intrinsic clearance (CLint,in vitro) in PXB mice hepatocytes and in vivo intrinsic clearance (CLint,in vivo) in humans, calcd. based on a well stirred model, showed a moderate correlation (r2 = 0.475, p = 0.009).  However, when CLint,in vivo values in humans and PXB mice were compared similarly, there was a good correlation (r2 = 0.754, p = 1.174 × 10-4).  Elimination half-life (t1/2) after i.v. administration also showed a good correlation (r2 = 0.886, p = 1.506 × 10-4) between humans and PXB mice.  The rank order of CL and t1/2 in human could be predicted at least, although it may not be possible to predict abs. values due to rather large prediction errors.  Our results indicate that in vitro and in vivo expts. with PXB mice should be useful at least for semiquant. prediction of the PK characteristics of candidate drugs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJRoBSzD2uXLVg90H21EOLACvtfcHk0liJ6pi2nMDdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsb0%253D&md5=b139c1e654c4d21752aea5112aa167c6</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.040923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.040923%26sid%3Dliteratum%253Aachs%26aulast%3DSanoh%26aufirst%3DS.%26aulast%3DHoriguchi%26aufirst%3DA.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DTayama%26aufirst%3DY.%26aulast%3DOhshita%26aufirst%3DH.%26aulast%3DTateno%26aufirst%3DC.%26aulast%3DHorie%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DPrediction%2520of%2520in%2520Vivo%2520Hepatic%2520Clearance%2520and%2520Half-Life%2520of%2520Drug%2520Candidates%2520in%2520Human%2520Using%2520Chimeric%2520Mice%2520with%2520Humanized%2520Liver%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D2%26spage%3D322%26epage%3D328%26doi%3D10.1124%2Fdmd.111.040923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teramura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Prediction of Human Metabolism of Fk3453 by Aldehyde Oxidase Using Chimeric Mice Transplanted with Human or Rat Hepatocytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.041954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1124%2Fdmd.111.041954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21984595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=76-82&issue=1&author=S.+Sanohauthor=K.+Nozakiauthor=H.+Muraiauthor=S.+Terashitaauthor=T.+Teramuraauthor=S.+Ohta&title=Prediction+of+Human+Metabolism+of+Fk3453+by+Aldehyde+Oxidase+Using+Chimeric+Mice+Transplanted+with+Human+or+Rat+Hepatocytes&doi=10.1124%2Fdmd.111.041954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes</span></div><div class="casAuthors">Sanoh, Seigo; Nozaki, Kazuyoshi; Murai, Hidetsugu; Terashita, Shigeyuki; Teramura, Toshio; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-82</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">During drug development, it is important to predict the activities of multiple metabolic enzymes, not only cytochrome P 450 (P 450) but also non-P 450 enzymes, such as conjugative enzymes and aldehyde oxidase (AO).  In this study, we focused on prediction of AO-mediated human metab. and pharmacokinetics (PK) of 6-(2-amino-4-phenylpyrimidine-5-yl)-2-isopropylpyridazin-3(2H)-one (FK3453) (Astollas Pharma Inc.), the development of which was suspended due to extremely low exposure in human, despite good oral bioavailability in rat and dog.  We examd. species difference in oxidative metab. of the aminopyrimidine moiety of FK3453, catalyzed by AO, using human-chimeric mice with humanized liver (h-PXB mice) and rat-chimeric mice (r-PXB mice) transplanted with rat hepatocytes.  AO activity of h-PXB mouse hepatocytes was higher than that of r-PXB mouse hepatocytes.  Moreover, higher concns. of human-specific AO-generated FK3453 metabolite A-M were detected in urine and feces after administration of FK3453 to h-PXB mice vs. r-PXB mice.  The total clearance of h-PXB mice was 2-fold higher than that of r-PXB mice.  These results agreed reasonably well with the metab. and PK profiles of FK3453 in human and rat.  Our results indicated that h-PXB mice should be helpful for predicting the metabolic profile of drugs in humans, and the use of both h-PXB and r-PXB mice should be helpful for evaluation of species differences of AO metabolic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOPbv2yx-v07Vg90H21EOLACvtfcHk0liJ6pi2nMDdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajtb8%253D&md5=3b0b8dbf8a5065f76d86b7820f8990e1</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.041954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.041954%26sid%3Dliteratum%253Aachs%26aulast%3DSanoh%26aufirst%3DS.%26aulast%3DNozaki%26aufirst%3DK.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DTeramura%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DPrediction%2520of%2520Human%2520Metabolism%2520of%2520Fk3453%2520by%2520Aldehyde%2520Oxidase%2520Using%2520Chimeric%2520Mice%2520Transplanted%2520with%2520Human%2520or%2520Rat%2520Hepatocytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D1%26spage%3D76%26epage%3D82%26doi%3D10.1124%2Fdmd.111.041954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittelmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camattari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glieder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lütz, S.</span></span> <span> </span><span class="NLM_article-title">Production of Recombinant Human Aldehyde Oxidase in Escherichia Coli and Optimization of Its Application for the Preparative Synthesis of Oxidized Drug Metabolites</span>. <i>ChemCatChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1028</span>– <span class="NLM_lpage">1042</span>, <span class="refDoi"> DOI: 10.1002/cctc.201301094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fcctc.201301094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFKrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1028-1042&issue=4&author=D.+Rodriguesauthor=M.+Kittelmannauthor=F.+Eggimannauthor=T.+Bachlerauthor=S.+Abadauthor=A.+Camattariauthor=A.+Gliederauthor=M.+Winklerauthor=S.+L%C3%BCtz&title=Production+of+Recombinant+Human+Aldehyde+Oxidase+in+Escherichia+Coli+and+Optimization+of+Its+Application+for+the+Preparative+Synthesis+of+Oxidized+Drug+Metabolites&doi=10.1002%2Fcctc.201301094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Production of Recombinant Human Aldehyde Oxidase in Escherichia coli and Optimization of Its Application for the Preparative Synthesis of Oxidized Drug Metabolites</span></div><div class="casAuthors">Rodrigues, Diogo; Kittelmann, Matthias; Eggimann, Fabian; Bachler, Thorsten; Abad, Sandra; Camattari, Andrea; Glieder, Anton; Winkler, Margit; Luetz, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">ChemCatChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1028-1042</span>CODEN:
                <span class="NLM_cas:coden">CHEMK3</span>;
        ISSN:<span class="NLM_cas:issn">1867-3880</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Recombinant human aldehyde oxidase (AO) was expressed in Escherichia coli.  Different cell disruption methods and conditions of cell culture in shake flasks and bioreactors and of biotransformation on an anal. scale were tested to optimize the synthesis of oxidized AO drug metabolites.  The volumetric productivity was increased 24-fold by optimizing the cell culture conditions.  The highest yield was achieved in a 25 L stirred tank bioreactor under non-oxygen-limited conditions and high lactose feed rate.  Suspensions of highly concd. and well-aerated whole cells at neutral pH and relatively low temps. led to the best conversion.  The solvent for the substrate and the buffering agent for the biotransformation had an important effect.  In a biotransformation with AO, 210 mg of famciclovir was converted to in a yield of 82 %.  The optimized protocol represents a viable method for the preparative synthesis of oxidized AO metabolites of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy384rQSslSrVg90H21EOLACvtfcHk0liCNMWdP2lqIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFKrs7w%253D&md5=2791e07f54c683f4b567f22485c97afa</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1002%2Fcctc.201301094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcctc.201301094%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DD.%26aulast%3DKittelmann%26aufirst%3DM.%26aulast%3DEggimann%26aufirst%3DF.%26aulast%3DBachler%26aufirst%3DT.%26aulast%3DAbad%26aufirst%3DS.%26aulast%3DCamattari%26aufirst%3DA.%26aulast%3DGlieder%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DL%25C3%25BCtz%26aufirst%3DS.%26atitle%3DProduction%2520of%2520Recombinant%2520Human%2520Aldehyde%2520Oxidase%2520in%2520Escherichia%2520Coli%2520and%2520Optimization%2520of%2520Its%2520Application%2520for%2520the%2520Preparative%2520Synthesis%2520of%2520Oxidized%2520Drug%2520Metabolites%26jtitle%3DChemCatChem%26date%3D2014%26volume%3D6%26issue%3D4%26spage%3D1028%26epage%3D1042%26doi%3D10.1002%2Fcctc.201301094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jairaj, M.</span></span> <span> </span><span class="NLM_article-title">Introduction of a Routine Quan/Qual Approach into Research Dmpk: Experiences and Evolving Strategies</span>. <i>Bioanalysis</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3337</span>– <span class="NLM_lpage">3348</span>, <span class="refDoi"> DOI: 10.4155/bio.14.233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.4155%2Fbio.14.233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=25534790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFaqtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=3337-3348&issue=24&author=L.+Kingauthor=A.+Kotianauthor=M.+Jairaj&title=Introduction+of+a+Routine+Quan%2FQual+Approach+into+Research+Dmpk%3A+Experiences+and+Evolving+Strategies&doi=10.4155%2Fbio.14.233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of a routine quan/qual approach into research DMPK: experiences and evolving strategies</span></div><div class="casAuthors">King, Lloyd; Kotian, Apoorva; Jairaj, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Bioanalysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3337-3348</span>CODEN:
                <span class="NLM_cas:coden">BIOAB4</span>;
        ISSN:<span class="NLM_cas:issn">1757-6180</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The application of liq. chromatog. high-resoln. mass spectrometry for simultaneous quant. and qual. (quan/qual) anal. has gained momentum across a range of different scientific arenas in recent years.  The ability to acquire high quality quant. data, while also capturing qual. data for either parallel or retrospective anal., is a powerful resource, esp. in view of ever-reducing cycle times, lab. space and budgets.  The quan/qual approach employing a Q-Exactive® Orbitrap high-resoln. mass spectrometer has been successfully introduced into UCB's research DMPK department.  This article describes our experiences in introducing quan/qual, issues that we discovered in establishing this new working paradigm, the evolution of the strategy and its future potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTqLFIfyyXvLVg90H21EOLACvtfcHk0liCNMWdP2lqIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFaqtbbO&md5=70e3ff7cfe9e9b773d25d42e7bb1b980</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.4155%2Fbio.14.233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fbio.14.233%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DL.%26aulast%3DKotian%26aufirst%3DA.%26aulast%3DJairaj%26aufirst%3DM.%26atitle%3DIntroduction%2520of%2520a%2520Routine%2520Quan%252FQual%2520Approach%2520into%2520Research%2520Dmpk%253A%2520Experiences%2520and%2520Evolving%2520Strategies%26jtitle%3DBioanalysis%26date%3D2014%26volume%3D6%26issue%3D24%26spage%3D3337%26epage%3D3348%26doi%3D10.4155%2Fbio.14.233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muenster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L.</span></span> <span> </span><span class="NLM_article-title">Quantitative-Qualitative Data Acquisition Using a Benchtop Orbitrap Mass Spectrometer</span>. <i>J. Am. Soc. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1441</span>– <span class="NLM_lpage">1450</span>, <span class="refDoi"> DOI: 10.1016/j.jasms.2009.03.002</span> </span><div class="citationLinks">[<a href="/doi/10.1016/j.jasms.2009.03.002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptV2msLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1441-1450&issue=8&author=K.+P.+Batemanauthor=M.+Kellmannauthor=H.+Muensterauthor=R.+Pappauthor=L.+Taylor&title=Quantitative-Qualitative+Data+Acquisition+Using+a+Benchtop+Orbitrap+Mass+Spectrometer&doi=10.1016%2Fj.jasms.2009.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative-Qualitative Data Acquisition Using a Benchtop Orbitrap Mass Spectrometer</span></div><div class="casAuthors">Bateman, Kevin P.; Kellmann, Markus; Muenster, Helmut; Papp, Robert; Taylor, Lester</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society for Mass Spectrometry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1441-1450</span>CODEN:
                <span class="NLM_cas:coden">JAMSEF</span>;
        ISSN:<span class="NLM_cas:issn">1044-0305</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Current approaches to discovery-stage drug metab. studies (pharmacokinetics, microsomal stability, etc.) typically use triple-quadrupole-based approaches for quant. anal.  This necessitates the optimization of parameters such as Q1 and Q3 m/z values, collision energy, and interface voltages.  These studies detect only the specified compd. and information about other components, such as metabolites, is lost.  The ability to perform full-scan acquisition for quant. anal. would eliminate the need for compd. optimization while enabling the detection of metabolites and other non-drug-related endogenous components.  Such an instrument would have to provide sensitivity, selectivity, dynamic range, and scan speed suitable for discovery-stage quant. studies.  In this study, a prototype benchtop Orbitrap-based mass analyzer was used to collect both quant. and qual. data from human microsomal incubation samples as well as rat plasma from pharmacokinetic studies.  Instrumental parameters such as scan speed, resoln., and mass accuracy are discussed in relation to the requirements for a quant.-qual. workflow.  The ability to perform highly selective quant. anal. while simultaneously characterizing metabolites from both in vitro and in vivo studies is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEoT2w34dt0rVg90H21EOLACvtfcHk0liCNMWdP2lqIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptV2msLo%253D&md5=1801c665bea72d2904d6709545de9ab6</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1016%2Fj.jasms.2009.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jasms.2009.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DK.%2BP.%26aulast%3DKellmann%26aufirst%3DM.%26aulast%3DMuenster%26aufirst%3DH.%26aulast%3DPapp%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DL.%26atitle%3DQuantitative-Qualitative%2520Data%2520Acquisition%2520Using%2520a%2520Benchtop%2520Orbitrap%2520Mass%2520Spectrometer%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D2009%26volume%3D20%26issue%3D8%26spage%3D1441%26epage%3D1450%26doi%3D10.1016%2Fj.jasms.2009.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramagiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humpreys, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfmacher, W. A.</span></span> <span> </span><span class="NLM_article-title">It Is Time for a Paradigm Shift in Drug Discovery Bioanalysis: From Srm to Hrms</span>. <i>J. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1002/jms.1921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1002%2Fjms.1921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=21630388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFChtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=595-601&issue=6&author=R.+Ramanathanauthor=M.+Jemalauthor=S.+Ramagiriauthor=Y.+Q.+Xiaauthor=W.+G.+Humpreysauthor=T.+Olahauthor=W.+A.+Korfmacher&title=It+Is+Time+for+a+Paradigm+Shift+in+Drug+Discovery+Bioanalysis%3A+From+Srm+to+Hrms&doi=10.1002%2Fjms.1921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS</span></div><div class="casAuthors">Ramanathan, Ragu; Jemal, Mohammed; Ramagiri, Suma; Xia, Yuan-Qing; Humpreys, W. Griffith; Olah, Timothy; Korfmacher, Walter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Mass Spectrometry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-601</span>CODEN:
                <span class="NLM_cas:coden">JMSPFJ</span>;
        ISSN:<span class="NLM_cas:issn">1076-5174</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  It can be argued that the last true paradigm shift in the bioanal. (BA) arena was the shift from high-performance liq. chromatog. (HPLC) with UV detection to HPLC with tandem mass spectrometry (MS/MS) detection after the commercialization of the triple quadrupole mass spectrometer in the 1990s.  HPLC-MS/MS anal. based on selected reaction monitoring (SRM) has become the gold std. for BA assays and is used by all the major pharmaceutical companies for the quant. anal. of new drug entities (NCEs) as part of the new drug discovery and development process.  While LC-MS/MS continues to be the best tool for drug discovery bioanal., a new paradigm involving high-resoln. mass spectrometry (HRMS) and ultrahigh-pressure liq. chromatog. (uHPLC) is starting to make inroads into the pharmaceutical industry.  The ability to collect full scan spectra, with excellent mass accuracy, mass resoln., 10-250 ms scan speeds and no NCE-related MS parameter optimization, makes the uHPLC-HRMS techniques suitable for quant. anal. of NCEs while preserving max. qual. information about other drug-related and endogenous components such as metabolites, degradants, biomarkers and formulation materials.  In this perspective article, we provide some insight into the evolution of the hybrid quadrupole-time-of-flight (Qq-TOF) mass spectrometer and propose some of the desirable specifications that such HRMS systems should have to be integrated into the drug discovery bioanal. workflow for performing integrated qual. and quant. bioanal. of drugs and related components.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUJ1FXoDKA7bVg90H21EOLACvtfcHk0lhJ42r1UkyV-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFChtL4%253D&md5=34bb55be25538d3b18ed198b5f04ebb5</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1002%2Fjms.1921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjms.1921%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DR.%26aulast%3DJemal%26aufirst%3DM.%26aulast%3DRamagiri%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DY.%2BQ.%26aulast%3DHumpreys%26aufirst%3DW.%2BG.%26aulast%3DOlah%26aufirst%3DT.%26aulast%3DKorfmacher%26aufirst%3DW.%2BA.%26atitle%3DIt%2520Is%2520Time%2520for%2520a%2520Paradigm%2520Shift%2520in%2520Drug%2520Discovery%2520Bioanalysis%253A%2520From%2520Srm%2520to%2520Hrms%26jtitle%3DJ.%2520Mass%2520Spectrom.%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D595%26epage%3D601%26doi%3D10.1002%2Fjms.1921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, A. E.</span></span> <span> </span><span class="NLM_article-title">Online Hydrogen-Deuterium Exchange and a Tandem-Quadrupole Time-of-Flight Mass Spectrometer Coupled with Liquid Chromatography for Metabolite Identification in Drug Metabolism</span>. <i>J. Chromatogr. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1093/chromsci/41.8.398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1093%2Fchromsci%2F41.8.398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=14558931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Sgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2003&pages=398-404&issue=8&author=A.+E.+Nassar&title=Online+Hydrogen-Deuterium+Exchange+and+a+Tandem-Quadrupole+Time-of-Flight+Mass+Spectrometer+Coupled+with+Liquid+Chromatography+for+Metabolite+Identification+in+Drug+Metabolism&doi=10.1093%2Fchromsci%2F41.8.398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Online Hydrogen-Deuterium Exchange and a Tandem-Quadrupole Time-of-Flight Mass Spectrometer Coupled with Liquid Chromatography for Metabolite Identification in Drug Metabolism</span></div><div class="casAuthors">Nassar, A.-E. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatographic Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">398-404</span>CODEN:
                <span class="NLM_cas:coden">JCHSBZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-9665</span>.
    
            (<span class="NLM_cas:orgname">Preston Publications</span>)
        </div><div class="casAbstract">A method for metabolite identification in drug discovery and development utilizing online hydrogen-deuterium (H-D) exchange and a tandem-quadrupole time-of-flight mass spectrometer coupled with liq. chromatog. has been developed for the first time.  For purposes of evaluating this method, nimodipine is incubated with rat, dog, monkey, and human hepatic microsomes over a 60-min period.  This procedure involves the replacement of H2O with D2O in the mobile phase.  The equilibration time required to change (switch) from H2O in the mobile phase into D2O is approx. 10 min.  There is no significant difference between the retention times in H2O or D2O mobile phase.  The results show that the sepns. of nimodipine and its metabolites and the subsequent H-D exchanges were achieved online.  This leads to the identification of nimodipine metabolites formed in vitro.  Five metabolites of nimodipine are identified and characterized.  These metabolites are formed by dehydrogenation, demethylation of methoxy group, cleavage of the ester groups by hydrolysis or oxidn., and hydroxylation of Me groups.  The combination of the H-D exchange process and the assay system is a powerful tool for the study of metabolite identification.  The method appears to be highly desirable for identification of metabolites produced by dehydrogenation, oxidn., and dealkylation, which are discussed herein.  This method also greatly enhances throughput, which in turn facilitates the ability to rapidly provide metabolite elucidation.  (c) 2003 Preston Publications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkvoX1gRdVGLVg90H21EOLACvtfcHk0lhJ42r1UkyV-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Sgu7c%253D&md5=3c15037601d67033539128241b882a74</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1093%2Fchromsci%2F41.8.398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fchromsci%252F41.8.398%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.%2BE.%26atitle%3DOnline%2520Hydrogen-Deuterium%2520Exchange%2520and%2520a%2520Tandem-Quadrupole%2520Time-of-Flight%2520Mass%2520Spectrometer%2520Coupled%2520with%2520Liquid%2520Chromatography%2520for%2520Metabolite%2520Identification%2520in%2520Drug%2520Metabolism%26jtitle%3DJ.%2520Chromatogr.%2520Sci.%26date%3D2003%26volume%3D41%26issue%3D8%26spage%3D398%26epage%3D404%26doi%3D10.1093%2Fchromsci%2F41.8.398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munson, B.</span></span> <span> </span><span class="NLM_article-title">Collisionally-Induced Dissociation of Purine Antiviral Agents: Mechanisms of Ion Formation Using Gas Phase Hydrogen/Deuterium Exchange and Electrospray Ionization Tandem Mass Spectrometry</span>. <i>Eur. J. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1255/ejms.538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=10.1255%2Fejms.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=15103102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVamtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=239-257&issue=2&author=A.+M.+Kamelauthor=B.+Munson&title=Collisionally-Induced+Dissociation+of+Purine+Antiviral+Agents%3A+Mechanisms+of+Ion+Formation+Using+Gas+Phase+Hydrogen%2FDeuterium+Exchange+and+Electrospray+Ionization+Tandem+Mass+Spectrometry&doi=10.1255%2Fejms.538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Collision-induced dissociation of purine antiviral agents: mechanisms of ion formation using gas-phase hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry</span></div><div class="casAuthors">Kamel, Amin M.; Munson, Burnaby</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-257</span>CODEN:
                <span class="NLM_cas:coden">EJMSCL</span>;
        ISSN:<span class="NLM_cas:issn">1469-0667</span>.
    
            (<span class="NLM_cas:orgname">IM Publications</span>)
        </div><div class="casAbstract">Electrospray ionization (ESI) and collision-induced dissocn. (CID) mass spectra were obtained for two purine nucleoside antiviral agents (acycloguanosine and vidarabine) and one purine nucleotide (vidarabine monophosphate) and for the corresponding compds. in which the labile hydrogens were replaced by deuterium gas-phase exchange.  The no. of labile hydrogens, x, was detd. from a comparison of ESI spectra obtained with N2 and with ND3 as the nebulizer gas.  CID mass spectra were obtained for [M+H]+ and [M-H]- ions and the exchanged analogs, [M(Dx)+D]+ and [M(Dx)-D]-, produced by ESI using a Sciex API-IIIplus mass spectrometer.  Compns. of product ions were detd. and mechanisms of decompn. elucidated by comparison of the CID mass spectra of the un-deuterated and deuterated species.  Protonated purine antiviral agents dissoc. through rearrangement decompns. of base-protonated [M+H]+ ions by cleavage of the glycosidic bonds to give the protonated bases with a sugar moiety as the neutral fragment.  Cleavage of the same bonds with charge retention on the sugar moiety gives low abundance ions, due to the low proton affinity of the sugar moiety compared with that of the purine base.  CID of protonated purine bases [B+H]+ occurs through two major pathways: (1) elimination of NH3 (ND3) and (2) loss of NH2CN (ND2CN).  Minor pathways include elimination of HNCO (DNCO), loss of CO and loss of HCN (DCN).  Deprotonated acycloguanosine and vidarabine exhibit the deprotonated base [B-H]- as a major fragment from glycosidic bond cleavage and charge delocalization on the base.  Deprotonated vidarabine monophosphate, however, shows predominantly phosphate-related product ions.  CID of deprotonated guanine shows two principal pathways: (1) elimination of NH3 (ND3) and (2) loss of NH2CN (ND2CN).  Minor pathways include elimination of HNCO (DNCO), loss of CO and loss of HCN (DCN).  The dissocn. reactions of deprotonated adenine, however, proceed by elimination of HCN and elimination of NCHNH (NCHND).  The mass spectra of the antiviral agents studied in this paper may be useful in predicting reaction pathways in other heteroarom. ring decompns. of nucleosides and nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVD35ob8XOWbVg90H21EOLACvtfcHk0lhJ42r1UkyV-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVamtL8%253D&md5=96299e7946c81e1a944612a3df7e9e10</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1255%2Fejms.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1255%252Fejms.538%26sid%3Dliteratum%253Aachs%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DMunson%26aufirst%3DB.%26atitle%3DCollisionally-Induced%2520Dissociation%2520of%2520Purine%2520Antiviral%2520Agents%253A%2520Mechanisms%2520of%2520Ion%2520Formation%2520Using%2520Gas%2520Phase%2520Hydrogen%252FDeuterium%2520Exchange%2520and%2520Electrospray%2520Ionization%2520Tandem%2520Mass%2520Spectrometry%26jtitle%3DEur.%2520J.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D10%26issue%3D2%26spage%3D239%26epage%3D257%26doi%3D10.1255%2Fejms.538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span> <span> </span><span class="NLM_article-title">Oxidative Metabolism of a Quinoxaline Derivative by Xanthine Oxidase in Rodent Plasma</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2207</span>– <span class="NLM_lpage">2216</span>, <span class="refDoi"> DOI: 10.1021/tx200329k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200329k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GgtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=2207-2216&issue=12&author=R.+Sharmaauthor=H.+Engauthor=G.+S.+Walkerauthor=G.+Barreiroauthor=A.+F.+Stepanauthor=K.+F.+McClureauthor=A.+Wolfordauthor=P.+D.+Boninauthor=P.+Corneliusauthor=A.+S.+Kalgutkar&title=Oxidative+Metabolism+of+a+Quinoxaline+Derivative+by+Xanthine+Oxidase+in+Rodent+Plasma&doi=10.1021%2Ftx200329k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Metabolism of a Quinoxaline Derivative by Xanthine Oxidase in Rodent Plasma</span></div><div class="casAuthors">Sharma, Raman; Eng, Heather; Walker, Gregory S.; Barreiro, Gabriela; Stepan, Antonia F.; McClure, Kim F.; Wolford, Angela; Bonin, Paul D.; Cornelius, Peter; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2207-2216</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of efforts directed at the G protein-coupled receptor 119 agonist program for type 2 diabetes, a series of cyanopyridine derivs. exemplified by isopropyl-4-(3-cyano-5-(quinoxalin-6-yl)pyridine-2-yl)piperazine-1-carboxylate (1) were identified as novel chemotypes worthy of further hit-to-lead optimization.  Compd. 1, however, was found to be unstable in plasma (37 °C, pH 7.4) from rat (T1/2 = 16 min), mouse (T1/2 = 61 min), and guinea pig (T1/2 = 4 min).  Lowering the temp. of plasma incubations (4-25 °C) attenuated the degrdn. of 1, implicating the involvement of an enzyme-mediated process.  Failure to detect any appreciable amt. of 1 in plasma samples from protein binding and pharmacokinetic studies in rats was consistent with its labile nature in plasma.  Instability noted in rodent plasma was not obsd. in plasma from dogs, monkeys, and humans (T1/2 > 370 min at 37 °C, pH 7.4).  Metabolite identification studies in rodent plasma revealed the formation of a single metabolite (M1), which was 16 Da higher than the mol. wt. of 1 (compd. 1, MH+ = 403; M1, MH+ = 419).  Pretreatment of rat plasma with allopurinol, but not raloxifene, abolished the conversion of 1 to M1, suggesting that xanthine oxidase (XO) was responsible for the oxidative instability.  Consistent with the known catalytic mechanism of XO, the source of oxygen incorporated in M1 was derived from water rather than mol. oxygen.  The formation of M1 was also demonstrated in incubations of 1 with purified bovine XO.  The structure of M1 was detd. by NMR anal. to be isopropyl-4-(3-cyano-5-(3-oxo-3,4-dihydroquinoxalin-6-yl)pyridine-2-yl)piperazine-1-carboxylate.  The regiochem. of quinoxaline ring oxidn. in 1 was consistent with ab initio calcns. and mol. docking studies using a published crystal structure of bovine XO.  A close-in analog of 1, which lacked the quinoxaline motif (e.g., 5-(4-cyano-3-methylphenyl)-2-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)nicotinitrile (2)) was stable in rat plasma and possessed substantially improved GPR119 agonist properties.  To the best of our knowledge, our studies constitute the first report on the involvement of rodent XO in oxidative drug metab. in plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqifhwdppp75LVg90H21EOLACvtfcHk0lhGTO4QZ1OpYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GgtbvN&md5=859662ffb3a9f9989b9be9a1b33b6a33</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1021%2Ftx200329k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200329k%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DWolford%26aufirst%3DA.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DCornelius%26aufirst%3DP.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DOxidative%2520Metabolism%2520of%2520a%2520Quinoxaline%2520Derivative%2520by%2520Xanthine%2520Oxidase%2520in%2520Rodent%2520Plasma%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26issue%3D12%26spage%3D2207%26epage%3D2216%26doi%3D10.1021%2Ftx200329k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Hara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackmond, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Radical-Based Regioselective C-H Functionalization of Electron-Deficient Heteroarenes: Scope, Tunability, and Predictability</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">32</span>),  <span class="NLM_fpage">12122</span>– <span class="NLM_lpage">12134</span>, <span class="refDoi"> DOI: 10.1021/ja406223k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja406223k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=12122-12134&issue=32&author=F.+O%E2%80%99Haraauthor=D.+G.+Blackmondauthor=P.+S.+Baran&title=Radical-Based+Regioselective+C-H+Functionalization+of+Electron-Deficient+Heteroarenes%3A+Scope%2C+Tunability%2C+and+Predictability&doi=10.1021%2Fja406223k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Radical-Based Regioselective C-H Functionalization of Electron-Deficient Heteroarenes: Scope, Tunability, and Predictability</span></div><div class="casAuthors">O'Hara, Fionn; Blackmond, Donna G.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">12122-12134</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Radical addn. processes can be ideally suited for the direct functionalization of heteroarom. bases, yet these processes are only sparsely used due to the perception of poor or unreliable control of regiochem.  A systematic investigation of factors affecting the regiochem. of radical functionalization of heterocycles using alkylsulfinate salts revealed that certain types of substituents exert consistent and additive effects on the regioselectivity of substitution.  This allowed us to establish guidelines for predicting regioselectivity on complex π-deficient heteroarenes, including pyridines, pyrimidines, pyridazines, and pyrazines.  Since the relative contribution from opposing directing factors was dependent on solvent and pH, it was sometimes possible to tune the regiochem. to a desired result by modifying reaction conditions.  This methodol. was applied to the direct, regioselective introduction of iso-Pr groups into complex, biol. active mols., such as diflufenican (I; R = H → R = iso-Pr) and nevirapine (II; R = H → R = iso-Pr).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEOGesZTIMOrVg90H21EOLACvtfcHk0lhGTO4QZ1OpYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3M&md5=e12331edd20ef03aafe3c7a7145a8f6e</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1021%2Fja406223k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja406223k%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hara%26aufirst%3DF.%26aulast%3DBlackmond%26aufirst%3DD.%2BG.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DRadical-Based%2520Regioselective%2520C-H%2520Functionalization%2520of%2520Electron-Deficient%2520Heteroarenes%253A%2520Scope%252C%2520Tunability%252C%2520and%2520Predictability%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D32%26spage%3D12122%26epage%3D12134%26doi%3D10.1021%2Fja406223k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UHX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UHX','PDB','4UHX'); return false;">PDB: 4UHX</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00875&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00875%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00875" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995a2feb6524bf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
